<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33197396</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>396</Volume><Issue>10265</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial.</ArticleTitle><Pagination><StartPage>1807</StartPage><EndPage>1816</EndPage><MedlinePgn>1807-1816</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(20)32338-2</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(20)32338-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Among patients with out-of-hospital cardiac arrest (OHCA) and ventricular fibrillation, more than half present with refractory ventricular fibrillation unresponsive to initial standard advanced cardiac life support (ACLS) treatment. We did the first randomised clinical trial in the USA of extracorporeal membrane oxygenation (ECMO)-facilitated resuscitation versus standard ACLS treatment in patients with OHCA and refractory ventricular fibrillation.</AbstractText><AbstractText Label="METHODS">For this phase 2, single centre, open-label, adaptive, safety and efficacy randomised clinical trial, we included adults aged 18-75 years presenting to the University of Minnesota Medical Center (MN, USA) with OHCA and refractory ventricular fibrillation, no return of spontaneous circulation after three shocks, automated cardiopulmonary resuscitation with a Lund University Cardiac Arrest System, and estimated transfer time shorter than 30 min. Patients were randomly assigned to early ECMO-facilitated resuscitation or standard ACLS treatment on hospital arrival by use of a secure schedule generated with permuted blocks of randomly varying block sizes. Allocation concealment was achieved by use of a randomisation schedule that required scratching off an opaque layer to reveal assignment. The primary outcome was survival to hospital discharge. Secondary outcomes were safety, survival, and functional assessment at hospital discharge and at 3 months and 6 months after discharge. All analyses were done on an intention-to-treat basis. The study qualified for exception from informed consent (21 Code of Federal Regulations 50.24). The ARREST trial is registered with ClinicalTrials.gov, NCT03880565.</AbstractText><AbstractText Label="FINDINGS">Between Aug 8, 2019, and June 14, 2020, 36 patients were assessed for inclusion. After exclusion of six patients, 30 were randomly assigned to standard ACLS treatment (n=15) or to early ECMO-facilitated resuscitation (n=15). One patient in the ECMO-facilitated resuscitation group withdrew from the study before discharge. The mean age was 59 years (range 36-73), and 25 (83%) of 30 patients were men. Survival to hospital discharge was observed in one (7%) of 15 patients (95% credible interval 1&#xb7;6-30&#xb7;2) in the standard ACLS treatment group versus six (43%) of 14 patients (21&#xb7;3-67&#xb7;7) in the early ECMO-facilitated resuscitation group (risk difference 36&#xb7;2%, 3&#xb7;7-59&#xb7;2; posterior probability of ECMO superiority 0&#xb7;9861). The study was terminated at the first preplanned interim analysis by the National Heart, Lung, and Blood Institute after unanimous recommendation from the Data Safety Monitoring Board after enrolling 30 patients because the posterior probability of ECMO superiority exceeded the prespecified monitoring boundary. Cumulative 6-month survival was significantly better in the early ECMO group than in the standard ACLS group. No unanticipated serious adverse events were observed.</AbstractText><AbstractText Label="INTERPRETATION">Early ECMO-facilitated resuscitation for patients with OHCA and refractory ventricular fibrillation significantly improved survival to hospital discharge compared with standard ACLS treatment.</AbstractText><AbstractText Label="FUNDING">National Heart, Lung, and Blood Institute.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yannopoulos</LastName><ForeName>Demetris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA; Division of Cardiology, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA. Electronic address: yanno001@umn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartos</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA; Division of Cardiology, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raveendran</LastName><ForeName>Ganesh</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA; Division of Cardiology, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walser</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA; Division of Cardiology, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connett</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Rajat</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA; Division of Cardiology, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosmopoulos</LastName><ForeName>Marinos</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA; Division of Cardiology, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Ranjit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaffer</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frascone</LastName><ForeName>R J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>St Paul Fire and Emergency Medical Services, St Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wesley</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>M Health Fairview Emergency Medical Services, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conterato</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>North Memorial Emergency Medical Services, Robbinsdale, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biros</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolar</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aufderheide</LastName><ForeName>Tom P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03880565</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R33 HL142696</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R61 HL142696</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2021 Jul 3;398(10294):22-23. doi: 10.1016/S0140-6736(21)00263-4.</RefSource><PMID Version="1">34217390</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022561" MajorTopicYN="N">Advanced Cardiac Life Support</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="N">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058687" MajorTopicYN="N">Out-of-Hospital Cardiac Arrest</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015424" MajorTopicYN="N">Reperfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012449" MajorTopicYN="N">Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013534" MajorTopicYN="N">Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>16</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33197396</ArticleId><ArticleId IdType="mid">NIHMS1648530</ArticleId><ArticleId IdType="pmc">PMC7856571</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)32338-2</ArticleId><ArticleId IdType="pii">S0140-6736(20)32338-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: adult advanced cardiovascular life support: 2015 American Heart Association Guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015; 132 (suppl 2): S444&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">26472995</ArticleId></ArticleIdList></Reference><Reference><Citation>Yannopoulos D, Bartos JA, Aufderheide TP, et al. The evolving role of the cardiac catheterization laboratory in the management of patients with out-of-hospital cardiac arrest: a scientific statement from the American Heart Association. Circulation 2019; 139: e530&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">30760026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartos JA, Grunau B, Carlson C, et al. Improved survival with extracorporeal cardiopulmonary resuscitation despite progressive metabolic derangement associated with prolonged resuscitation. Circulation 2020; 141: 877&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7069385</ArticleId><ArticleId IdType="pubmed">31896278</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunau B, Reynolds J, Scheuermeyer F, et al. Relationship between time-to-ROSC and survival in out-of-hospital cardiac arrest ECPR candidates: when is the best time to consider transport to hospital? Prehosp Emerg Care 2016; 20: 615&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">27018764</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunau B, Reynolds JC, Scheuermeyer FX, et al. Comparing the prognosis of those with initial shockable and non-shockable rhythms with increasing durations of CPR: informing minimum durations of resuscitation. Resuscitation 2016; 101: 50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">26851705</ArticleId></ArticleIdList></Reference><Reference><Citation>Yannopoulos D, Bartos JA, Raveendran G, et al. Coronary artery disease in patients with out-of-hospital refractory ventricular fibrillation cardiac arrest. J Am Coll Cardiol 2017; 70: 1109&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">28838358</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamhaut L, Tea V, Raphalen JH, et al. Coronary lesions in refractory out of hospital cardiac arrest (OHCA) treated by extra corporeal pulmonary resuscitation (ECPR). Resuscitation 2017; 126: 154&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">29253646</ArticleId></ArticleIdList></Reference><Reference><Citation>Yannopoulos D, Bartos JA, Martin C, et al. Minnesota Resuscitation Consortium&#x2019;s advanced perfusion and reperfusion cardiac life support strategy for out-of-hospital refractory ventricular fibrillation. J Am Heart Assoc 2016; 5: 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937292</ArticleId><ArticleId IdType="pubmed">27412906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartos JA, Carlson K, Carlson C, et al. Surviving refractory out-of-hospital ventricular fibrillation cardiac arrest: critical care and extracorporeal membrane oxygenation management. Resuscitation 2018; 132: 47&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">30171974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yannopoulos D, Kalra R, Kosmopoulos M, et al. Rationale and methods of the Advanced R2Eperfusion STrategies for refractory cardiac arrest (ARREST) trial. Am Heart J 2020; 229: 29&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">32911433</ArticleId></ArticleIdList></Reference><Reference><Citation>Geocadin RG, Callaway CW, Fink EL, et al. Standards for studies of neurological prognostication in comatose survivors of cardiac arrest: a scientific statement from the American Heart Association. Circulation 2019; 140: e517&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">31291775</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao K, Nonogi H, Yonemoto N, et al. Duration of prehospital resuscitation efforts after out-of-hospital cardiac arrest. Circulation 2016; 133: 1386&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">26920493</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunau B, Reynolds JC, Scheuermeyer FX, et al. Comparing the prognosis of those with initial shockable and non-shockable rhythms with increasing durations of CPR: informing minimum durations of resuscitation. Resuscitation 2016; 101: 50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">26851705</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchal AR, Berg KM, Caba&#xf1;as JG, et al. 2019 American Heart Association focused update on systems of care: dispatcher-assisted cardiopulmonary resuscitation and cardiac arrest centers: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2019; 140: e895&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">31722563</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchal AR, Berg KM, Hirsch KG, et al. 2019 American Heart Association focused update on advanced cardiovascular life support: use of advanced airways, vasopressors, and extracorporeal cardiopulmonary resuscitation during cardiac arrest: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2019; 140: e881&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">31722552</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougouin W, Dumas F, Lamhaut L, et al. Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study. Eur Heart J 2020; 41: 1961&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">31670793</ArticleId></ArticleIdList></Reference><Reference><Citation>Danial P, Hajage D, Nguyen LS, et al. Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched study. Intensive Care Med 2018; 44: 2153&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">30430207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sideris G, Voicu S, Yannopoulos D, et al. Favourable 5-year postdischarge survival of comatose patients resuscitated from out-of-hospital cardiac arrest, managed with immediate coronary angiogram on admission. Eur Heart J Acute Cardiovasc Care 2014; 3: 183&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24569450</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartos JA, Frascone RJ, Conterato M, et al. The Minnesota Mobile Extracorporeal Cardiopulmonary Resuscitation Consortium for Treatment of Out-of-Hospital Refractory Ventricular Fibrillation: Program Description, Performance, and Outcomes. EClinicalMedicine 2020; published online November 13. 10.1016/j.eclinm.2020.100632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100632</ArticleId><ArticleId IdType="pmc">PMC7788435</ArticleId><ArticleId IdType="pubmed">33437949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34623788</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>385</Volume><Issue>22</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults.</ArticleTitle><Pagination><StartPage>2025</StartPage><EndPage>2035</EndPage><MedlinePgn>2025-2035</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa2113514</ELocationID><Abstract><AbstractText Label="BACKGROUND">The effects of spinal anesthesia as compared with general anesthesia on the ability to walk in older adults undergoing surgery for hip fracture have not been well studied.</AbstractText><AbstractText Label="METHODS">We conducted a pragmatic, randomized superiority trial to evaluate spinal anesthesia as compared with general anesthesia in previously ambulatory patients 50 years of age or older who were undergoing surgery for hip fracture at 46 U.S. and Canadian hospitals. Patients were randomly assigned in a 1:1 ratio to receive spinal or general anesthesia. The primary outcome was a composite of death or an inability to walk approximately 10 ft (3 m) independently or with a walker or cane at 60 days after randomization. Secondary outcomes included death within 60 days, delirium, time to discharge, and ambulation at 60 days.</AbstractText><AbstractText Label="RESULTS">A total of 1600 patients were enrolled; 795 were assigned to receive spinal anesthesia and 805 to receive general anesthesia. The mean age was 78 years, and 67.0% of the patients were women. A total of 666 patients (83.8%) assigned to spinal anesthesia and 769 patients (95.5%) assigned to general anesthesia received their assigned anesthesia. Among patients in the modified intention-to-treat population for whom data were available, the composite primary outcome occurred in 132 of 712 patients (18.5%) in the spinal anesthesia group and 132 of 733 (18.0%) in the general anesthesia group (relative risk, 1.03; 95% confidence interval [CI], 0.84 to 1.27; P&#x2009;=&#x2009;0.83). An inability to walk independently at 60 days was reported in 104 of 684 patients (15.2%) and 101 of 702 patients (14.4%), respectively (relative risk, 1.06; 95% CI, 0.82 to 1.36), and death within 60 days occurred in 30 of 768 (3.9%) and 32 of 784 (4.1%), respectively (relative risk, 0.97; 95% CI, 0.59 to 1.57). Delirium occurred in 130 of 633 patients (20.5%) in the spinal anesthesia group and in 124 of 629 (19.7%) in the general anesthesia group (relative risk, 1.04; 95% CI, 0.84 to 1.30).</AbstractText><AbstractText Label="CONCLUSIONS">Spinal anesthesia for hip-fracture surgery in older adults was not superior to general anesthesia with respect to survival and recovery of ambulation at 60 days. The incidence of postoperative delirium was similar with the two types of anesthesia. (Funded by the Patient-Centered Outcomes Research Institute; REGAIN ClinicalTrials.gov number, NCT02507505.).</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Massachusetts Medical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carson</LastName><ForeName>Jeffrey L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaskins</LastName><ForeName>Lakisha J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dillane</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sieber</LastName><ForeName>Frederick</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magaziner</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcantonio</LastName><ForeName>Edward R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Samir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menio</LastName><ForeName>Diane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Trevor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papp</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwenk</LastName><ForeName>Eric S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkassabany</LastName><ForeName>Nabil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaffe</LastName><ForeName>J Douglas</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luke</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Balram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azim</LastName><ForeName>Syed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hymes</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Ki-Jinn</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheppard</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perlman</LastName><ForeName>Barry</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sappenfield</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauck</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoeft</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giska</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranganath</LastName><ForeName>Yatish</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6106-4687</Identifier><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedore</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinlei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwofie</LastName><ForeName>M Kwesi</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nader</LastName><ForeName>Antoun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Brian F S</ForeName><Initials>BFS</Initials><Identifier Source="ORCID">0000-0002-6279-9757</Identifier><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlassakov</LastName><ForeName>Kamen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kates</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dattilo</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tierney</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephens-Shields</LastName><ForeName>Alisa J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellenberg</LastName><ForeName>Susan S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>REGAIN Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02507505</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>1406-18876</GrantID><Acronym>PCORI</Acronym><Agency>Patient-Centered Outcomes Research Institute</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2021 Nov 25;385(22):2088-2089. doi: 10.1056/NEJMe2116017.</RefSource><PMID Version="1">34818484</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anaesth Crit Care Pain Med. 2022 Apr;41(2):101045. doi: 10.1016/j.accpm.2022.101045.</RefSource><PMID Version="1">35192948</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Feb 24;386(8):801. doi: 10.1056/NEJMc2119756.</RefSource><PMID Version="1">35196436</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Feb 24;386(8):801. doi: 10.1056/NEJMc2119756.</RefSource><PMID Version="1">35196437</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Feb 24;386(8):801-802. doi: 10.1056/NEJMc2119756.</RefSource><PMID Version="1">35196438</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Feb 24;386(8):802. doi: 10.1056/NEJMc2119756.</RefSource><PMID Version="1">35196439</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anaesthesist. 2022 May;71(5):400-402. doi: 10.1007/s00101-022-01104-z.</RefSource><PMID Version="1">35199183</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feng</LastName><ForeName>Rui</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carson</LastName><ForeName>Jeffrey L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaskins</LastName><ForeName>Lakisha J</ForeName><Initials>LJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dillane</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sieber</LastName><ForeName>Frederick</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magaziner</LastName><ForeName>Jay</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcantonio</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stone</LastName><ForeName>Trevor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papp</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwenk</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaffe</LastName><ForeName>J Douglas</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luke</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Balram</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azim</LastName><ForeName>Syed</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hymes</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chin</LastName><ForeName>Ki-Jinn</ForeName><Initials>KJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheppard</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perelman</LastName><ForeName>Barry</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sappenfield</LastName><ForeName>Joshua</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hauck</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoeft</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giska</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ranganath</LastName><ForeName>Yatish</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tedore</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choi</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Jinlei</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwofie</LastName><ForeName>M Kwesi</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nader</LastName><ForeName>Antoun</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanders</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allen</LastName><ForeName>Brian F S</ForeName><Initials>BFS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vlassakov</LastName><ForeName>Kamen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kates</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elkassabany</LastName><ForeName>Nabil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>Samir</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dattilo</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tierney</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menio</LastName><ForeName>Diane</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stephens-Shields</LastName><ForeName>Alisa J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellenberg</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Looke</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bent</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franco-Mora</LastName><ForeName>Ariana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hedrick</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newbern</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Health</LastName><ForeName>Advent</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tadros</LastName><ForeName>Rafik</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pealer</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buckley</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gavin</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorbatov</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gosnell</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steen</LastName><ForeName>Talora</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vafai</LastName><ForeName>Avery</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zeballos</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hruslinski</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cardenas</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berry</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Getchell</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quercetti</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hospital</LastName><ForeName>Christiana</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassan</LastName><ForeName>Manal</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bajracharya</LastName><ForeName>Gauasan</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Billow</LastName><ForeName>Damien</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bloomfield</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuko</LastName><ForeName>Evis</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elyaderani</LastName><ForeName>Mehrun K</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hampton</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Honar</LastName><ForeName>Hooman</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khoshknabi</LastName><ForeName>Dilara</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krahe</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lew</LastName><ForeName>Michael M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maheshwer</LastName><ForeName>Conjeevram B</ForeName><Initials>CB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niazi</LastName><ForeName>Azfar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saha</LastName><ForeName>Partha</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salih</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Swart</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volio</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bolkus</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeAngelis</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dodson</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerritsen</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McEniry</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitrev</LastName><ForeName>Ludmil</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belliveau</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonazza</LastName><ForeName>Flynn</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Vera</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panek</LastName><ForeName>Izabela</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dabiri</LastName><ForeName>Jared</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chavez</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craig</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davidson</LastName><ForeName>Todd</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dietrichs</LastName><ForeName>Chad</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleetwood</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foley</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Getto</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hailes</LastName><ForeName>Susie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hermes</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hooper</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koener</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kohls</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Law</LastName><ForeName>Leslie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lipp</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Losey</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelson</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nieto</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rogers</LastName><ForeName>Pam</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rutman</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scales</LastName><ForeName>Garrett</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sebastian</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stanciu</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lobel</LastName><ForeName>Gregg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giampiccolo</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herman</LastName><ForeName>Dara</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaufman</LastName><ForeName>Margit</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Bryan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pau</LastName><ForeName>Clara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Puzio</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veselsky</LastName><ForeName>Marlene</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Apostle</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boyer</LastName><ForeName>Dory</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fan</LastName><ForeName>Brenda Chen</ForeName><Initials>BC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lemke</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merchant</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moola</LastName><ForeName>Farhad</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Payne</LastName><ForeName>Kyrsten</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perey</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viskontas</LastName><ForeName>Darius</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poler</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Antonio</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Amer</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fish-Fuhrmann</LastName><ForeName>Jamie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hospital</LastName><ForeName>Hartford</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fidkowski</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guthrie</LastName><ForeName>Stuart Trent</ForeName><Initials>ST</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hakeos</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayes</LastName><ForeName>Lillian</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoegler</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nowak</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beck</LastName><ForeName>Jeffery</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuff</LastName><ForeName>Jaslynn</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaski</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haaser</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holzman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malekzadeh</LastName><ForeName>A Stephen</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramsey</LastName><ForeName>Lolita</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schulman</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartzbach</LastName><ForeName>Cary</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azefor</LastName><ForeName>Tangwan</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davani</LastName><ForeName>Arman</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaberi</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masear</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haider</LastName><ForeName>Syed Basit</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chungu</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ebrahimi</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fikry</LastName><ForeName>Karim</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcantonio</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shelvan</LastName><ForeName>Anitha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanders</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clarke</LastName><ForeName>Collin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawendy</LastName><ForeName>Abdel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Gary</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Mohit</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caruci</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Commeh</LastName><ForeName>Ekow</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuevas</LastName><ForeName>Randy</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuff</LastName><ForeName>Germaine</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franco</LastName><ForeName>Lola</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Furgiuele</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giuca</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barzideh</LastName><ForeName>Omid</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cossaro</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Arduini</LastName><ForeName>Armando</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farhi</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gould</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kafel</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Anuj</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peller</LastName><ForeName>Abraham</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reshef</LastName><ForeName>Hadas</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Safur</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toscano</LastName><ForeName>Fiore</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akerman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brumberger</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>Sunday</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Friedlander</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jegarl</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lane</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyden</LastName><ForeName>John P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>Nili</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murrell</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Painter</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ricci</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sbrollini</LastName><ForeName>Kaitlyn</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rahul</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steel</LastName><ForeName>Peter A D</ForeName><Initials>PAD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steinkamp</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Roniel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wellman</LastName><ForeName>David Stephenson</ForeName><Initials>DS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fitzgerald</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritz</LastName><ForeName>Michaela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bryson</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craig</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farhat</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gammon</LastName><ForeName>Braden</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gofton</LastName><ForeName>Wade</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lalonde</LastName><ForeName>Karl</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liew</LastName><ForeName>Allan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meulenkamp</LastName><ForeName>Bradley</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sonnenburg</LastName><ForeName>Kendra</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wai</LastName><ForeName>Eugene</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilkin</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hospital</LastName><ForeName>Ottawa</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Troxell</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alderfer</LastName><ForeName>Mary Ellen</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brannen</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cupitt</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerhart</LastName><ForeName>Stacy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McLin</LastName><ForeName>Renee</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheidy</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yurick</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hospital</LastName><ForeName>Reading</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Fei</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dragert</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiss</LastName><ForeName>Geza</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malveaux</LastName><ForeName>Halina</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCloskey</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mellender</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mungekar</LastName><ForeName>Sagar S</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noveck</LastName><ForeName>Helaine</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sagebien</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biby</LastName><ForeName>Luat</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKelvy</LastName><ForeName>Gail</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abola</LastName><ForeName>Ramon</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayala</LastName><ForeName>Brittney</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Halper</LastName><ForeName>Darcy</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mavarez</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rizwan</LastName><ForeName>Sabeen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Awad</LastName><ForeName>Imad</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flynn</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henry</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jenkinson</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaustov</LastName><ForeName>Lilia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lappin</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McHardy</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Amara</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donnelly</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Meera</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haydel</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Livelsberger</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pazionis</LastName><ForeName>Theresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slattery</LastName><ForeName>Bridget</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vazquez-Trejo</LastName><ForeName>Maritza</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baratta</LastName><ForeName>Jaime</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cirullo</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deiling</LastName><ForeName>Brittany</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deschamps</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glick</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Katz</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krieg</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lessin</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mojica</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torjman</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jin</LastName><ForeName>Rongyu</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salpeter</LastName><ForeName>Mary Jane</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Powell</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simmons</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawson</LastName><ForeName>Prentiss</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kukreja</LastName><ForeName>Promil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graves</LastName><ForeName>Shanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sturdivant</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bryant</LastName><ForeName>Ayesha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crump</LastName><ForeName>Sandra Joyce</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verrier</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menon</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Applegate</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arias</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pineiro</LastName><ForeName>Natasha</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uppington</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wolinsky</LastName><ForeName>Phillip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gunnett</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hagen</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hollen</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holloway</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horodyski</LastName><ForeName>Mary Beth</ForeName><Initials>MB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pogue</LastName><ForeName>Trevor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramani</LastName><ForeName>Ramachandran</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Cameron</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woods</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warrick</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flynn</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mongan</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernholz</LastName><ForeName>Sean</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ingersoll-Weng</LastName><ForeName>Esperanza</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marian</LastName><ForeName>Anil</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seering</LastName><ForeName>Melinda</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sibenaller</LastName><ForeName>Zita</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stout</LastName><ForeName>Lori</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wagner</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walter</LastName><ForeName>Alicia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orwig</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Trina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dinh</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donegan</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horan</LastName><ForeName>Annamarie</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goud</LastName><ForeName>Maithri</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helker</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mezenghie</LastName><ForeName>Lydia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Brittany</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Preston</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartz</LastName><ForeName>J Sanford</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weber</LastName><ForeName>Ramona</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chelly</LastName><ForeName>Jacques E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goel</LastName><ForeName>Shiv</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goncz</LastName><ForeName>Wende</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kawabe</LastName><ForeName>Touichi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khetarpal</LastName><ForeName>Sharad</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monroe</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shick</LastName><ForeName>Vladislav</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Breidenstein</LastName><ForeName>Max</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dominick</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Friend</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathews</LastName><ForeName>Donald</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lennertz</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akere</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balweg</LastName><ForeName>Tyler</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bo</LastName><ForeName>Amber</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doro</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodspeed</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lang</LastName><ForeName>Gerald</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName><ForeName>Maggie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rettammel</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roth</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Marissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whiting</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>Tracie</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craven</LastName><ForeName>Debra</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McEvoy</LastName><ForeName>Matt</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turnbo</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morgan</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Willoughby</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weigel</LastName><ForeName>Wade</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Auyong</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fox</LastName><ForeName>Ellie</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welsh</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cusson</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dobson</LastName><ForeName>Sean</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edwards</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Lynette</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henshaw</LastName><ForeName>Daryl</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKinney</LastName><ForeName>Glen</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Segal</LastName><ForeName>B Scott</ForeName><Initials>BS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>VanEenenaam</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weller</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Treggiari</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akhtar</LastName><ForeName>Shamsuddin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blessing</LastName><ForeName>Marcelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Chanel</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kampp</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kunze</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carson</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papp</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perlman</LastName><ForeName>Barry</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chin</LastName><ForeName>Ki Jinn</ForeName><Initials>KJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allen</LastName><ForeName>Brian F S</ForeName><Initials>BFS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Rene&#xe9; H</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Alexander K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tosi</LastName><ForeName>Laura L</ForeName><Initials>LL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hymes</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Langlois</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oduwole</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rose</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34623788</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2113514</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39288368</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>210</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Lung-Protective Mechanical Ventilation in Patients with Severe Acute Brain Injury: A Multicenter Randomized Clinical Trial (PROLABI).</ArticleTitle><Pagination><StartPage>1123</StartPage><EndPage>1131</EndPage><MedlinePgn>1123-1131</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.202402-0375OC</ELocationID><Abstract><AbstractText><b>Rationale:</b> Lung-protective strategies using low Vt and moderate positive end-expiratory pressure (PEEP) are considered best practice in critical care, but interventional trials have never been conducted in patients with acute brain injuries because of concerns about carbon dioxide control and the effect of PEEP on cerebral hemodynamics. <b>Objectives:</b> To test the hypothesis that ventilation with lower VT and higher PEEP compared to conventional ventilation would improve clinical outcomes in patients with acute brain injury. <b>Methods:</b> In this multicenter, open-label, controlled clinical trial, 190 adult patients with acute brain injury were assigned to receive either a lung-protective or a conventional ventilatory strategy. The primary outcome was a composite endpoint of death, ventilator dependency, and acute respiratory distress syndrome (ARDS) at Day 28. Neurological outcome was assessed at ICU discharge by the Oxford Handicap Scale and at 6 months by the Glasgow Outcome Scale. <b>Measurements and Main Results:</b> The two study arms had similar characteristics at baseline. In the lung-protective and conventional strategy groups, using an intention-to-treat approach, the composite outcome at 28 days was 61.5% and 45.3% (relative risk [RR], 1.35; 95% confidence interval [CI], 1.03-1.79; <i>P</i>&#x2009;=&#x2009;0.025). Mortality was 28.9% and 15.1% (RR, 1.91; 95% CI, 1.06-3.42; <i>P</i>&#x2009;=&#x2009;0.02), ventilator dependency was 42.3% and 27.9% (RR, 1.52; 95% CI, 1.01-2.28; <i>P</i>&#x2009;=&#x2009;0.039), and incidence of ARDS was 30.8% and 22.1% (RR, 1.39; 95% CI, 0.85-2.27; <i>P</i>&#x2009;=&#x2009;0.179), respectively. The trial was stopped after enrolling 190 subjects because of termination of funding. <b>Conclusions:</b> In patients with acute brain injury without ARDS, a lung-protective ventilatory strategy, as compared with a conventional strategy, did not reduce mortality, percentage of patients weaned from mechanical ventilation, or incidence of ARDS and was not beneficial in terms of neurological outcomes. Because of the early termination, these preliminary results require confirmation in larger trials. Clinical trial registered with www.clinicaltrials.gov (NCT01690819).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mascia</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine (DIMES), Campus Ecotekne, University of Salento, Lecce, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fanelli</LastName><ForeName>Vito</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care, and Emergency, Citt&#xe0; della Salute e della Scienza di Torino University Hospital - Molinette Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mistretta</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Unit, Citt&#xe0; della Salute e della Scienza di Torino University Hospital - Orthopedic and Trauma Center, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care, and Emergency, Spedali Civili University Hospital, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanin</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berardino</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Unit, Citt&#xe0; della Salute e della Scienza di Torino University Hospital - Orthopedic and Trauma Center, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzeo</LastName><ForeName>Anna Teresa</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Adult and Pediatric Pathology, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caricato</LastName><ForeName>Anselmo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurosurgical Intensive Care Unit and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesiology and Critical Care, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Corte</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine, Universit&#xe0; del Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care Medicine, Maggiore della Carit&#xe0; University Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grossi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care Medicine, Maggiore della Carit&#xe0; University Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munari</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, University Hospital of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caravello</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, University Hospital of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessandri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General Surgery and Organ Transplantation Unit, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavalli</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences (DIMEC) and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezzapesa</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Surgery and Organ Transplantation Unit, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvestri</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Surgery and Organ Transplantation Unit, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casartelli Liviero</LastName><ForeName>Marilena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Integrated University Hospital of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanatta</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Integrated University Hospital of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Citerio</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Neuroscience, Neurointensive Care, ASST-Monza, Monza, Italy; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rucci</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), Alma Mater Studiorum University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasulo</LastName><ForeName>Frank A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care, and Emergency, Spedali Civili University Hospital, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonetti</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9676-3595</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences (DIMEC) and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and General Intensive Care Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01690819</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>ex 60% 2012-2015</GrantID><Agency>Universit&#xe0; degli Studi di Torino</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2024 Nov 1;210(9):1073-1075. doi: 10.1164/rccm.202409-1766ED.</RefSource><PMID Version="1">39404599</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="N">Brain Injuries</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute brain injury</Keyword><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">lung-protective ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>17</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>17</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39288368</ArticleId><ArticleId IdType="doi">10.1164/rccm.202402-0375OC</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35422240</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-3597</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>15</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.</ArticleTitle><Pagination><StartPage>1441</StartPage><EndPage>1453</EndPage><MedlinePgn>1441-1453</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2022.01.050</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-1097(22)00386-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">In patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (ICD), catheter ablation and antiarrhythmic drugs (AADs) reduce ICD shocks, but the most effective approach remains uncertain.</AbstractText><AbstractText Label="OBJECTIVES">This trial compares the efficacy and safety of catheter ablation vs AAD as first-line therapy in ICD patients with symptomatic ventricular tachycardias (VTs).</AbstractText><AbstractText Label="METHODS">The SURVIVE-VT (Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia) is a prospective, multicenter, randomized trial including patients with ischemic cardiomyopathy and appropriated ICD shock. Patients were 1:1 randomized to complete endocardial substrate-based catheter ablation or antiarrhythmic therapy (amiodarone&#xa0;+ beta-blockers, amiodarone alone, or sotalol &#xb1; beta-blockers). The primary outcome was a composite of cardiovascular death, appropriate ICD shock, unplanned hospitalization for worsening heart failure, or severe treatment-related complications.</AbstractText><AbstractText Label="RESULTS">In this trial, 144 patients (median age, 70 years; 96% male) were randomized to catheter ablation (71 patients) or AAD (73 patients). After 24&#xa0;months, the primary outcome occurred in 28.2% of patients in the ablation group and 46.6% of those in the AAD group (hazard ratio [HR]: 0.52; 95%&#xa0;CI: 0.30-0.90; P&#xa0;=&#xa0;0.021). This difference was driven by a significant reduction in severe treatment-related complications (9.9% vs 28.8%, HR: 0.30; 95%&#xa0;CI: 0.13-0.71; P&#xa0;=&#xa0;0.006). Eight patients were hospitalized for heart failure in the ablation group and 13 in the AAD group (HR: 0.56; 95%&#xa0;CI: 0.23-1.35; P&#xa0;=&#xa0;0.198). There was no difference in cardiac mortality (HR: 0.93; 95%&#xa0;CI: 0.19-4.61; P&#xa0;=&#xa0;0.929).</AbstractText><AbstractText Label="CONCLUSIONS">In ICD patients with ischemic cardiomyopathy and symptomatic VT, catheter ablation reduced the composite endpoint of cardiovascular death, appropriate ICD shock, hospitalization due to heart failure, or severe treatment-related complications compared to AAD. (Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia [SURVIVE-VT]: NCT03734562).</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arenal</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Center for Biomedical Research in Cardiovascular Disease Network (CIBERCV). Electronic address: arenal@secardiologia.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;vila</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Center for Biomedical Research in Cardiovascular Disease Network (CIBERCV).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Candil</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Biomedical Research in Cardiovascular Disease Network (CIBERCV); Arrhythmia Unit, Cardiology Department, IBSAL-Hospital Universitario, Universidad de Salamanca, Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tercedor</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, Hospital General Virgen de las Nieves, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, Hospital Universitario Central de Asturias, Instituto de Investigaci&#xf3;n Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arribas</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Doce de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Portales</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Complejo Hospitalario Universitario de C&#xe1;ceres, C&#xe1;ceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merino</LastName><ForeName>Jos&#xe9; Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, IdiPAZ, Universidad Aut&#xf3;noma, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Madrid</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Hospital Ram&#xf3;n y Cajal, Universidad de Alcal&#xe1; de Henares, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Avil&#xe9;s</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Instituto de Investigaci&#xf3;n Sanitaria Gregorio Mara&#xf1;&#xf3;n, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Center for Biomedical Research in Cardiovascular Disease Network (CIBERCV).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berruezo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, Hospital Clinic and Teknon Medical Center, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03734562</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber><NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2022 Apr 19;79(15):1454-1457. doi: 10.1016/j.jacc.2022.01.051.</RefSource><PMID Version="1">35422241</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2022 Sep 6;80(10):e75. doi: 10.1016/j.jacc.2022.05.056.</RefSource><PMID Version="1">36049809</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2022 Sep 6;80(10):e77. doi: 10.1016/j.jacc.2022.05.057.</RefSource><PMID Version="1">36049810</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2022 Sep 6;80(10):e79-e80. doi: 10.1016/j.jacc.2022.06.024.</RefSource><PMID Version="1">36049811</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000638" MajorTopicYN="Y">Amiodarone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiarrhythmic drugs</Keyword><Keyword MajorTopicYN="N">substrate ablation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures Dr Arenal has received honoraria for lectures from Medtronic and Biosense Webster; has received honoraria for advisory board activities from Medtronic; and has received grants from Biosense Webster, Boston Scientific, and Medtronic. Dr &#xc1;vila has received teaching honoraria from Medtronic; and has served as Advisory Board member for Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>5</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35422240</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2022.01.050</ArticleId><ArticleId IdType="pii">S0735-1097(22)00386-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31144997</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>200</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort.</ArticleTitle><Pagination><StartPage>1002</StartPage><EndPage>1012</EndPage><MedlinePgn>1002-1012</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201806-1094OC</ELocationID><Abstract><AbstractText><b>Rationale:</b> Current practices regarding mechanical ventilation in patients treated with extracorporeal membrane oxygenation (ECMO) for acute respiratory distress syndrome are unknown.<b>Objectives:</b> To report current practices regarding mechanical ventilation in patients treated with ECMO for severe acute respiratory distress syndrome (ARDS) and their association with 6-month outcomes.<b>Methods:</b> This was an international, multicenter, prospective cohort study of patients undergoing ECMO for ARDS during a 1-year period in 23 international ICUs.<b>Measurements and Main Results:</b> We collected demographics, daily pre- and per-ECMO mechanical ventilation settings and use of adjunctive therapies, ICU, and 6-month outcome data for 350 patients (mean&#x2009;&#xb1;&#x2009;SD pre-ECMO Pa<sub>O<sub>2</sub></sub>/Fi<sub>O<sub>2</sub></sub> 71&#x2009;&#xb1;&#x2009;34 mm Hg). Pre-ECMO use of prone positioning and neuromuscular blockers were 26% and 62%, respectively. Vt (6.4&#x2009;&#xb1;&#x2009;2.0 vs. 3.7&#x2009;&#xb1;&#x2009;2.0 ml/kg), plateau pressure (32&#x2009;&#xb1;&#x2009;7 vs. 24&#x2009;&#xb1;&#x2009;7 cm H<sub>2</sub>O), driving pressure (20&#x2009;&#xb1;&#x2009;7 vs. 14&#x2009;&#xb1;&#x2009;4 cm H<sub>2</sub>O), respiratory rate (26&#x2009;&#xb1;&#x2009;8 vs. 14&#x2009;&#xb1;&#x2009;6 breaths/min), and mechanical power (26.1&#x2009;&#xb1;&#x2009;12.7 vs. 6.6&#x2009;&#xb1;&#x2009;4.8 J/min) were markedly reduced after ECMO initiation. Six-month survival was 61%. No association was found between ventilator settings during the first 2 days of ECMO and survival in multivariable analysis. A time-varying Cox model retained older age, higher fluid balance, higher lactate, and more need for renal-replacement therapy along the ECMO course as being independently associated with 6-month mortality. A higher Vt and lower driving pressure (likely markers of static compliance improvement) across the ECMO course were also associated with better outcomes.<b>Conclusions:</b> Ultraprotective lung ventilation on ECMO was largely adopted across medium- to high-case volume ECMO centers. In contrast with previous observations, mechanical ventilation settings during ECMO did not impact patients' prognosis in this context.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, UPMC Univ Paris 06, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Medical Intensive Care Unit, Piti&#xe9;-Salp&#xea;tri&#xe8;re Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>T&#xe0;i</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcadipane</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS-ISMETT Istituto Mediterraneo per i Trapianti e terapie ad alta specializzazione, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agerstrand</LastName><ForeName>Cara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohshimo</LastName><ForeName>Shinichiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Graduate School of Biomedical &amp; Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrino</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuylsteke</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Royal Papworth Hospital, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guervilly</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Studies and Research on Health Services and Quality of Life EA3279, Service de Medecine Intensive et Reanimation, CHU Hopital Nord, Assistance Publique H&#xf4;pitaux de Marseille, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGuinness</LastName><ForeName>Shay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiothoracic &amp; Vascular ICU, Auckland City Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierard</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>P&#xf4;le de Recherche Cardiovasculaire, Institute de Recherche Exp&#xe9;rimentale et Clinique, Cardiothoracic Intensive Care, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breeding</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St. Vincent's Hospital, New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney University Medical School, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ching</LastName><ForeName>Simon Sin Wai</ForeName><Initials>SSW</Initials><AffiliationInfo><Affiliation>Department of Adult Intensive Care, Queen Mary Hospital, the University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camuso</LastName><ForeName>Janice M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephens</LastName><ForeName>R Scott</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Bobby</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herr</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Maryland, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuville</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bichat Hospital, Medical and Infectious Diseases Intensive Care Unit, Paris Diderot University, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR1148, LVTS, Sorbonne Paris Cit&#xe9;, Inserm/Paris Diderot University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zogheib</LastName><ForeName>Elie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiothoracic and Vascular Intensive Care Unit, Amiens University Hospital, Amiens, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1088, Jules Verne University of Picardy, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Assistance Publique des H&#xf4;pitaux de Paris, Groupe Hospitalier Universitaire de Paris Centre, M&#xe9;decine Intensive R&#xe9;animationH&#xf4;pital Cochin, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Descartes Sorbonne Paris Cit&#xe9; University, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection, Immunity and Inflammation, Cochin Institute, Inserm U1016, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roz&#xe9;</LastName><ForeName>Hadrien</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>South Department of Anesthesiology and Critical Care, Bordeaux University Hospital, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierrot</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de R&#xe9;animation M&#xe9;dicale, Centre Hospitalier Universitaire d'Angers, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobin</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, St. Vincent's Hospital Melbourne, Fitzroy, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodgson</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevret</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biostatistics Team, Saint-Louis Hospital, AP-HP, Paris, France; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ECSTRA Team, Biostatistics and Clinical Epidemiology, UMR 1153 (CRESS), INSERM, Paris Diderot Sorbonne University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodie</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Combes</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, UPMC Univ Paris 06, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Medical Intensive Care Unit, Piti&#xe9;-Salp&#xea;tri&#xe8;re Hospital, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2019 Oct 15;200(8):954-956. doi: 10.1164/rccm.201906-1164ED.</RefSource><PMID Version="1">31216180</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECMO</Keyword><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">mechanical ventilation</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">prone position</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31144997</ArticleId><ArticleId IdType="doi">10.1164/rccm.201806-1094OC</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37380314</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy.</ArticleTitle><Pagination><StartPage>808</StartPage><EndPage>821</EndPage><MedlinePgn>808-821</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2023.01.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(23)00088-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Catheter ablation improves ventricular tachycardia (VT) event-free (time to event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous myocardial infarction (MI). The effects of ablation on recurrent VT and implantable cardioverter-defibrillator (ICD) therapy (burden) have yet to be investigated.</AbstractText><AbstractText Label="OBJECTIVES">This study sought to compare the VT and ICD therapy burden following treatment with either ablation or escalated AAD therapy among patients with VT and previous MI in the VANISH (Ventricular tachycardia AblatioN versus escalated antiarrhythmic drug therapy in ISchemic Heart disease) trial.</AbstractText><AbstractText Label="METHODS">The VANISH trial randomized patients with previous MI and VT despite initial AAD therapy to either escalated AAD treatment or catheter ablation. VT burden was defined as the total number of VT events treated with&#xa0;&#x2265;1 appropriate ICD therapy. Appropriate ICD therapy burden was defined as the total number of appropriate shocks or antitachycardia pacing therapies (ATPs) delivered. The Anderson-Gill recurrent event model was used to compare burden between the treatment arms.</AbstractText><AbstractText Label="RESULTS">Of the 259 enrolled patients (median age, 69.8 years; 7.0% women), 132 patients were randomized to ablation and 129 patients were randomized to escalated AAD therapy. Over 23.4&#xa0;months of follow-up, ablation-treated patients had a 40% lower shock-treated VT event burden and a 39% lower appropriate shock burden compared with patients who received escalated AAD therapy (P&#xa0;&lt;0.05 for all). A reduction in VT burden, ATP-treated VT event burden, and appropriate ATP burden among ablation patients was only demonstrated in the stratum of patients with amiodarone-refractory VT (P&#xa0;&lt;0.05 for all).</AbstractText><AbstractText Label="CONCLUSIONS">Among patients with AAD-refractory VT and a previous MI, catheter ablation reduced shock-treated VT event burden and appropriate shock burden compared with escalated AAD therapy. There was also lower VT burden, ATP-treated VT event burden, and appropriate ATP burden among ablation-treated patients; however, the effect was limited to patients with amiodarone-refractory VT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Healey</LastName><ForeName>Jeff S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nault</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Quebec Heart and Lung Institute, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterns</LastName><ForeName>Laurence D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Royal Jubilee Hospital, Victoria, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Essebag</LastName><ForeName>Vidal</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>McGill University Health Centre, Montreal, Quebec, Canada; H&#xf4;pital Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hruczkowski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardner</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parkash</LastName><ForeName>Ratika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapp</LastName><ForeName>John L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: John.Sapp@nshealth.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber><NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2023 Jun;9(6):822-823. doi: 10.1016/j.jacep.2023.05.017.</RefSource><PMID Version="1">37380315</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000638" MajorTopicYN="Y">Amiodarone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICD shocks</Keyword><Keyword MajorTopicYN="N">antiarrhythmic drugs</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">shock burden</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia burden</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures The VANISH trial was funded by the Canadian Institutes of Health Research, with additional financial support from St. Jude Medical and Biosense Webster. Dr Healey has served as a consultant for and has received speaker fees and research grants from Medtronic, Boston Scientific, and Abbott. Dr Nault has received honoraria from Biosense Webster, Servier, BMS-Pfizer, and Bayer. Dr Essebag has received a Fonds de recherche du Qu&#xe9;bec clinical research scholar award; and has received honoraria from Medtronic, Abbott, and Biosense Webster. Dr Parkash has received research funding from Abbott, Medtronic, and Novartis. Dr Sapp has received research funding from Biosense Webster and Abbott; and has received speaker fees or consulting honoraria from Medtronic, Abbott, Varian, and Biosense Webster. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>20</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37380314</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2023.01.030</ArticleId><ArticleId IdType="pii">S2405-500X(23)00088-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40287932</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>COOPERATIVE-PFA: A Three-Arm Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>150</StartPage><EndPage>159</EndPage><MedlinePgn>150-159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.125.074427</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Deep analgosedation (DAS) or general anesthesia is mandatory for pulsed-field ablation of atrial fibrillation. In contrast to DAS, general anesthesia (conventional or total intravenous anesthesia [TIVA]) requires airway management. To find the optimal sedation regimen, this study compared ketamine-remimazolam DAS and propofol-opioid TIVA with propofol-opioid DAS, focusing on sedation-related adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients indicated for atrial fibrillation catheter ablation were randomly assigned at a 1:1:1 ratio to: (1) DAS using intermittent propofol-opioid boluses (arm P), (2) continuous remimazolam-ketamine DAS (arm R), or (3) continuous propofol-opioid TIVA with secured airway (arm TIVA). Catheter ablation was performed using the FARAPULSE system (Boston Scientific, MA). The major exclusion criterion was obstructive sleep apnea syndrome. The primary end point was defined as a composite of hypoxemia, hypotensive, or hypertensive events requiring intervention or leading to procedure discontinuation. Secondary end points included hemodynamic instability events, procedure time, serious adverse events, and patient satisfaction.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">One-hundred twenty-seven patients (mean age 62.9&#xb1;10.3 years, 35.1% women, 47.2% with paroxysmal atrial fibrillation) were enrolled and randomized to the P (n=42), R (n=43), or TIVA (n=42) arms. The primary end point occurred in 85.7% of P patients, 27.9% of R patients, and 66.7% of TIVA patients (<i>P</i>&lt;0.001), driven by hypoxemia in the P arm (100% of patients with the primary end point) and by hypotension in the TIVA arm (100%). The R arm showed a similar distribution of hypoxemia (50%) and hypotensive (66.7%) events. No differences were observed in mean procedural time, rate of serious adverse events, and assessment of patient satisfaction.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In pulsed-field ablation procedures for atrial fibrillation, remimazolam-ketamine DAS was superior to propofol-opioid regimens (either boluses or continuous) and had the lowest risk of hypoxemia and hypotensive events. More than 80% of patients undergoing conventional propofol-opioid analgosedation experienced hypoxemia.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="UNASSIGNED">URL: https://www.clinicaltrials.gov; Unique identifier: NCT06013345.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sochorov&#xe1;</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (V.S., V.K., F.D., P.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kun&#x161;t&#xe1;tov&#xe1;</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (V.S., V.K., F.D., P.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman&#x10d;&#xed;k</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0482-4448</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du&#x161;ka</LastName><ForeName>Franti&#x161;ek</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1559-4078</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (V.S., V.K., F.D., P.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He&#x159;man</LastName><ForeName>Dalibor</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7436-1154</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldauf</LastName><ForeName>Petr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4668-5837</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (V.S., V.K., F.D., P.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povi&#x161;er</LastName><ForeName>Luk&#xe1;&#x161;</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Znojilov&#xe1;</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipcov&#xe1;</LastName><ForeName>V&#x11b;ra</ForeName><Initials>V</Initials><Identifier Source="ORCID">0009-0002-9536-2911</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hozmanov&#xe1;</LastName><ForeName>Jana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vesel&#xe1;</LastName><ForeName>Jana</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1048-2598</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hozman</LastName><ForeName>Marek</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4111-4218</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06013345</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Circulation. 2025 Jul 22;152(3):160-162. doi: 10.1161/CIRCULATIONAHA.125.075339.</RefSource><PMID Version="1">40690554</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="Y">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054810" MajorTopicYN="Y">Deep Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">deep sedation</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>18</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>27</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>27</Day><Hour>11</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40287932</ArticleId><ArticleId IdType="pmc">PMC12272916</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.125.074427</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, et al. ; ESC Scientific Document Group. 2024 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024;45:3314&#x2013;3414. doi: 10.1093/eurheartj/ehae176</Citation><ArticleIdList><ArticleId IdType="pubmed">39210723</ArticleId></ArticleIdList></Reference><Reference><Citation>Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, et al. ; Peer Review Committee Members. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1&#x2013;e156. doi: 10.1161/CIR.0000000000001193</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11095842</ArticleId><ArticleId IdType="pubmed">38033089</ArticleId></ArticleIdList></Reference><Reference><Citation>Dello Russo A, Compagnucci P, Anselmino M, Schillaci V, Campanelli F, Ascione MR, Volpato G, Cipolletta L, Parisi Q, Valeri Y, et al. Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation: results of a multicenter, real-world experience. Heart Rhythm. 2024;21:1526&#x2013;1536. doi: 10.1016/j.hrthm.2024.05.042</Citation><ArticleIdList><ArticleId IdType="pubmed">38810922</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, Sediva L, Chovanec M, Dukkipati SR, Jais P. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74:315&#x2013;326. doi: 10.1016/j.jacc.2019.04.021</Citation><ArticleIdList><ArticleId IdType="pubmed">31085321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekanem E, Reddy VY, Schmidt B, Reichlin T, Neven K, Metzner A, Hansen J, Blaauw Y, Maury P, Arentz T, et al. ; MANIFEST-PF Cooperative. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace. 2022;24:1256&#x2013;1266. doi: 10.1093/europace/euac050</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9435639</ArticleId><ArticleId IdType="pubmed">35647644</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, Cochet H, Minami K, Breskovic T, Sikiric I, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7:614&#x2013;627. doi: 10.1016/j.jacep.2021.02.014</Citation><ArticleIdList><ArticleId IdType="pubmed">33933412</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt B, Bordignon S, Neven K, Reichlin T, Blaauw Y, Hansen J, Adelino R, Ouss A, F&#xfc;ting A, Roten L, et al. European real-world outcomes with pulsed field ablation in patients with symptomatic atrial fibrillation: lessons from the multi-centre EU-PORIA registry. Europace. 2023;25. doi: 10.1093/europace/euad185</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10320231</ArticleId><ArticleId IdType="pubmed">37379528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JG, Yoo KS, Byun YJ. Continuous infusion versus intermittent bolus injection of propofol during endoscopic retrograde cholangiopancreatography. Korean J Intern Med. 2020;35:1338&#x2013;1345. doi: 10.3904/kjim.2018.233</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652665</ArticleId><ArticleId IdType="pubmed">32126750</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacopino S, Colella J, Dini D, Mantovani L, Sorrenti PF, Malacrida M, Filannino P. Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration. Europace. 2023;25. doi: 10.1093/europace/euad230</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10434732</ArticleId><ArticleId IdType="pubmed">37494101</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler DA, Bukoye B, Sawhney M, Berzin T, Sands K, Chowdary S, Shah A, Barnett S. Development and validation of the PROcedural Sedation Assessment Survey (PROSAS) for assessment of procedural sedation quality. Gastrointest Endosc. 2015;81:194&#x2013;203.e1. doi: 10.1016/j.gie.2014.07.062</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272880</ArticleId><ArticleId IdType="pubmed">25293829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode K, Whittaker P, Lucas J, M&#xfc;ssigbrodt A, Hindricks G, Richter S, Doering M. Deep sedation for transvenous lead extraction: a large single-centre experience. Europace. 2019;21:1246&#x2013;1253. doi: 10.1093/europace/euz131</Citation><ArticleIdList><ArticleId IdType="pubmed">31102530</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y, Gu W, Zhao M, Zhang Y, Wu J. The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: a randomized trial. Front Med (Lausanne). 2022;9. doi: 10.3389/fmed.2022.938940</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9394743</ArticleId><ArticleId IdType="pubmed">36004376</ArticleId></ArticleIdList></Reference><Reference><Citation>Dossa F, Medeiros B, Keng C, Acuna SA, Baxter NN. Propofol versus midazolam with or without short-acting opioids for sedation in colonoscopy: a systematic review and meta-analysis of safety, satisfaction, and efficiency outcomes. Gastrointest Endosc. 2020;91:1015&#x2013;1026.e7. doi: 10.1016/j.gie.2019.12.047</Citation><ArticleIdList><ArticleId IdType="pubmed">31926966</ArticleId></ArticleIdList></Reference><Reference><Citation>Karanth H, Murali S, Koteshwar R, Shetty V, Adappa K. Comparative study between propofol and dexmedetomidine for conscious sedation in patients undergoing outpatient colonoscopy. Anesth Essays Res. 2018;12:98&#x2013;102. doi: 10.4103/aer.AER_206_17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5872902</ArticleId><ArticleId IdType="pubmed">29628562</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang RB, Dong JZ, Zhao WD, Liu XP, Kang JP, Long DY, Yu RH, Hu FL, Liu XH, Ma CS. Unconscious sedation/analgesia with propofol versus conscious sedation with fentanyl/midazolam for catheter ablation of atrial fibrillation: a prospective, randomized study. Chin Med J (Engl). 2007;120:2036&#x2013;2038.</Citation><ArticleIdList><ArticleId IdType="pubmed">18067792</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens A, Kreuzmayr A, Manner H, Koop H, Lorenz A, Schaefer C, Plauth M, Jetschmann JU, von Tirpitz C, Ewald M, et al. Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications. Gut. 2019;68:445&#x2013;452. doi: 10.1136/gutjnl-2015-311037</Citation><ArticleIdList><ArticleId IdType="pubmed">29298872</ArticleId></ArticleIdList></Reference><Reference><Citation>van Loon K, van Rheineck Leyssius AT, van Zaane B, Denteneer M, Kalkman CJ. Capnography during deep sedation with propofol by nonanesthesiologists: a randomized controlled trial. Anesth Analg. 2014;119:49&#x2013;55. doi: 10.1213/ANE.0b013e3182a1f0a2</Citation><ArticleIdList><ArticleId IdType="pubmed">24836471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Zhang X, Li L, Wei M, Zhao B, Wang X, Pan Z, Tian J, Yu W, Su D. High-flow nasal cannula oxygen therapy and hypoxia during gastroscopy with propofol sedation: a randomized multicenter clinical trial. Gastrointest Endosc. 2019;90:591&#x2013;601. doi: 10.1016/j.gie.2019.06.033</Citation><ArticleIdList><ArticleId IdType="pubmed">31278907</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho PH, Otoch JP, Khan MA, Sakai P, Guedes HG, Artifon EL. Sedation in colonoscopy by using three different propofol infusion methods and analysis of plasma concentration levels: a prospective comparative study. Arq Bras Cir Dig. 2016;29:264&#x2013;268. doi: 10.1590/0102-6720201600040012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5225868</ArticleId><ArticleId IdType="pubmed">28076483</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia R, Waldmann V, Vanduynhoven P, Nesti M, Jansen de Oliveira Figueiredo M, Narayanan K, Conte G, Guerra JM, Boveda S, Duncker D. Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade. Europace. 2021;23:2039&#x2013;2045. doi: 10.1093/europace/euab154</Citation><ArticleIdList><ArticleId IdType="pubmed">34308973</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarracino F, Bertini P. Perioperative hypotension: causes and remedies. J Anesth Analg Crit Care. 2022;2:17. doi: 10.1186/s44158-022-00045-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10245539</ArticleId><ArticleId IdType="pubmed">37386537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu K, Wei S, Ling W, Wei Y, Ran X, Huang H, Wang M, Wei N, Liao Y, Qin Z, et al. Remimazolam versus propofol for deep sedation/anaesthesia in upper gastrointestinal endoscopy in elderly patients: a multicenter, randomized controlled trial. J Clin Pharm Ther. 2022;47:2230&#x2013;2236. doi: 10.1111/jcpt.13797</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10100088</ArticleId><ArticleId IdType="pubmed">36334013</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical Advisory Secretariat. Bispectral index monitor: an evidence-based analysis. Ont Health Technol Assess Ser. 2004;4:1&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387745</ArticleId><ArticleId IdType="pubmed">23074459</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, Lee G, Jung J, Lee T, Park S. Monitored anesthesia care using remimazolam and ketamine combination for brief gynecological surgeries: a report for four cases. J Clin Med. 2023;12:3558. doi: 10.3390/jcm12103558</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219363</ArticleId><ArticleId IdType="pubmed">37240664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Q, Liu X, Wen C, Li D, Lei X. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022;16:3957&#x2013;3974. doi: 10.2147/DDDT.S384155</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9675580</ArticleId><ArticleId IdType="pubmed">36411859</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115:274&#x2013;283. doi: 10.1213/ANE.0b013e31823f0c28</Citation><ArticleIdList><ArticleId IdType="pubmed">22190555</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Liu C, Zhu Y, Peng L, Zhang X, Wei W, Zhu T. Hemodynamic influences of remimazolam versus propofol during the induction period of general anesthesia: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2023;26:E761&#x2013;E773.</Citation><ArticleIdList><ArticleId IdType="pubmed">37976477</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55:1059&#x2013;1077. doi: 10.1007/s40262-016-0383-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27028535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippmann M, Appel PL, Mok MS, Shoemaker WC. Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients. Crit Care Med. 1983;11:730&#x2013;734. doi: 10.1097/00003246-198309000-00012</Citation><ArticleIdList><ArticleId IdType="pubmed">6884053</ArticleId></ArticleIdList></Reference><Reference><Citation>Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med. 2011;57:109&#x2013;114.e2. doi: 10.1016/j.annemergmed.2010.09.010</Citation><ArticleIdList><ArticleId IdType="pubmed">20970888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif S, Kang J, Sadeghirad B, Rizvi F, Forestell B, Greer A, Hewitt M, Fernando SM, Mehta S, Eltorki M, et al. Pharmacological agents for procedural sedation and analgesia in the emergency department and intensive care unit: a systematic review and network meta-analysis of randomised trials. Br J Anaesth. 2024;132:491&#x2013;506. doi: 10.1016/j.bja.2023.11.050</Citation><ArticleIdList><ArticleId IdType="pubmed">38185564</ArticleId></ArticleIdList></Reference><Reference><Citation>Belrose JC, Noppens RR. Anesthesiology and cognitive impairment: a narrative review of current clinical literature. BMC Anesthesiol. 2019;19:241. doi: 10.1186/s12871-019-0903-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933922</ArticleId><ArticleId IdType="pubmed">31881996</ArticleId></ArticleIdList></Reference><Reference><Citation>Furniss SS, Sneyd JR. Safe sedation in modern cardiological practice. Heart. 2015;101:1526&#x2013;1530. doi: 10.1136/heartjnl-2015-307656</Citation><ArticleIdList><ArticleId IdType="pubmed">26085525</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele H, Kurz T, Feistritzer H-J, Stachel G, Hartung P, Lurz P, Eitel I, Marquetand C, Nef H, Doerr O, et al. ; SOLVE-TAVI Investigators. General versus local anesthesia with conscious sedation in transcatheter aortic valve implantation. Circulation. 2020;142:1437&#x2013;1447. doi: 10.1161/CIRCULATIONAHA.120.046451</Citation><ArticleIdList><ArticleId IdType="pubmed">32819145</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40492704</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1523-4681</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</Title><ISOAbbreviation>J Bone Miner Res</ISOAbbreviation></Journal><ArticleTitle>Effects of vitamin D3, omega-3s, and a simple home exercise program on incident vertebral fractures: the DO-HEALTH randomized controlled trial.</ArticleTitle><Pagination><StartPage>1035</StartPage><EndPage>1044</EndPage><MedlinePgn>1035-1044</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jbmr/zjaf058</ELocationID><Abstract><AbstractText>Vertebral fractures (VFs) are among the most common osteoporotic fractures. The effect of vitamin D3, omega-3s or a simple home exercise program (SHEP) on VFs is unclear. We examined whether vitamin D3, omega-3s, or SHEP, alone or in combination, over 3 years, reduce the incidence rate of VFs among European older adults. DO-HEALTH is a multi-center, 2&#x2009;&#xd7;&#x2009;2&#x2009;&#xd7;&#x2009;2 factorial design, randomized controlled trial, which included older adults (&#x2265;70&#xa0;years) free from major health events in the 5 years prior to enrollment. The study interventions were vitamin D3 (2000IU/d), omega-3s (1&#xa0;g/d), and SHEP (3&#x2009;&#xd7;&#x2009;30&#xa0;min/wk), applied alone or in combination. Quantitative and qualitative VF assessment was determined from lateral thoracolumbar DXA scans. The primary outcome for this analysis was the incidence rate (IR) of total VFs, defined as the number of any new and progressed VFs over the 3-year follow-up. Sensitivity analyses were conducted for only new VFs and only VF progressions. Negative binomial regression models were fit, adjusted for age, sex, prior fall, BMI, study site and participants' follow-up time. 1488 participants (mean age 74.9&#xa0;years; 77% had low bone mass or osteoporosis; 43.8% had 25(OH)D levels &lt;20&#xa0;ng/mL) were included. There were 93 incident VFs, of which 58 were new VFs and 35 were progressions. None of the three treatments reduced the IR of total VFs overall, however, the IR was reduced with SHEP compared to the control exercise program in women (IR ratio 0.52, 95% CI 0.28, 0.98). In the sensitivity analysis for VF progressions, SHEP reduced the IR (IR ratio 0.34, 95% CI 0.16, 0.75). Among generally healthy older adults, vitamin D3 and omega-3s supplementation did not reduce the incidence rate of VFs. SHEP reduced the incidence rate of total VFs in women and of VF progressions overall. Exercise may play a role in the prevention of VFs.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kistler-Fischbacher</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre on Aging and Mobility, University of Zurich and Stadtspital Zurich Waid, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armbrecht</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Berlin 12203, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Silva</LastName><ForeName>Jos&#xe9; A P</ForeName><Initials>JAP</Initials><AffiliationInfo><Affiliation>Centro Hospitalar e Universit&#xe1;rio de Coimbra, Coimbra 3004-561, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra 3004-504, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Godoi Rezende Costa Molino</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre on Aging and Mobility, University of Zurich and Stadtspital Zurich Waid, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theiler</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre on Aging and Mobility, University of Zurich and Stadtspital Zurich Waid, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzoli</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vellas</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>G&#xe9;rontop&#xf4;le de Toulouse, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, Toulouse 31059, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Toulouse III, UMR INSERM 1027, Toulouse 31062, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawson-Hughes</LastName><ForeName>Bess</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3136-0386</Identifier><AffiliationInfo><Affiliation>Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanis</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for Metabolic Diseases, University of Sheffield Medical School, Sheffield S10 2TN, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofbauer</LastName><ForeName>Lorenz C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Medicine III, Centre for Healthy Aging, TU Dresden Medical Centre, Dresden 01307, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orav</LastName><ForeName>Endel John</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02120, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kressig</LastName><ForeName>Reto W</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0002-3215-7681</Identifier><AffiliationInfo><Affiliation>University Department of Geriatric Medicine FELIX PLATTER, 4055 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egli</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre on Aging and Mobility, University of Zurich and Stadtspital Zurich Waid, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanner</LastName><ForeName>Guido A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Spine Clinic and Traumatology, Private Hospital Bethanien, 8044 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bischoff-Ferrari</LastName><ForeName>Heike A</ForeName><Initials>HA</Initials><Identifier Source="ORCID">0000-0002-4554-658X</Identifier><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre on Aging and Mobility, University of Zurich and Stadtspital Zurich Waid, 8037 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>DO-HEALTH Research Group
</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>EC-GA No. 278588</GrantID><Agency>European Union</Agency><Country/></Grant><Grant><GrantID>278588</GrantID><Agency>7th framework program of the European Union</Agency><Country/></Grant><Grant><Agency>Chair for Geriatric Medicine and Aging Research</Agency><Country/></Grant><Grant><Agency>Vontobel Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Bone Miner Res</MedlineTA><NlmUniqueID>8610640</NlmUniqueID><ISSNLinking>0884-0431</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1C6V77QF41</RegistryNumber><NameOfSubstance UI="D002762">Cholecalciferol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1093/jbmr/zjaf081</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002762" MajorTopicYN="Y">Cholecalciferol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015525" MajorTopicYN="Y">Fatty Acids, Omega-3</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="Y">Exercise Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Vertebral fractures are one of the most common consequences of osteoporosis. Vitamin D, omega-3 fatty acids (omega-3s), and exercise are simple but promising strategies to improve bone health and reduce fracture risk, however, their effect on vertebral fractures in healthy older adults across a 3-year duration was unclear. In this study, we examined whether daily vitamin D supplementation (2000&#xa0;IU/d), daily omega-3&#xa0;s supplementation (1&#xa0;g/d) or a simple home exercise program performed three times per week, either applied alone (eg, only vitamin D supplements) or in combination (eg, vitamin D and omega-3s supplements) would reduce the number of new vertebral fractures over 3 years. We included 1488 healthy older adults from Switzerland, Germany, France, and Portugal who were at least 70&#xa0;years of age and who had not experienced any major health events in the 5 years before study start. Taking omega-3s or vitamin D supplements showed no benefit. The simple home exercise program reduced the number of new fractures in women, and reduced the number of vertebral fractures that progressed in their severity (ie, collapsed further). Exercise may therefore play a role in the prevention of vertebral fractures.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Vertebral morphology</Keyword><Keyword MajorTopicYN="N">community-dwelling older adults</Keyword><Keyword MajorTopicYN="N">low bone mass</Keyword><Keyword MajorTopicYN="N">nutritional supplements</Keyword><Keyword MajorTopicYN="N">osteoporosis</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">vertebral deformity</Keyword><Keyword MajorTopicYN="N">vertebral fracture progression</Keyword></KeywordList><CoiStatement>J.A.K. is a director of Osteoporosis Research Ltd that maintains FRAX. L.C.H. has received honoraria for advisory boards or educational lectures from Amgen, Ascendis, BluePrint, and UCB to himself, and support for clinical trials from Ascendis and Amolyt to his institution. H.A.B.-F. reports as the PI of the DO-HEALTH trial, grants from the European Commission (Grant Agreement No. 278588), from the University of Zurich, from NESTEC, from PFIZER Consumer Healthcare, from Streuli Pharma, plus non-financial support from DSM Nutritional Products and from Roche Diagnostics. Furthermore, H.A.B.-F. reports speaker fees from Wild, Pfizer, Vifor, Mylan, Roche Diagnostics, and independent and investigator initiated grants from Pfizer and from Vifor, outside the submitted work. M.K.-F., G.A., J.A.P.D., C.G., R.T., R.R., B.V., B.D.-H., E.J.O., R.W.K., A.E., and G.A.W. declare no conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Bischoff-Ferrari</LastName><ForeName>Heike A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Egli</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rival</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wanner</LastName><ForeName>Guido A</ForeName><Initials>GA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vellas</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guyonnet</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rizzoli</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biver</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merminod</LastName><ForeName>Fanny</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kressig Reto</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bridenbaugh</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suhm</LastName><ForeName>Norbert</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Da Silva Jos&#xe9;</LastName><ForeName>A P</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duarte C&#xe1;tia</LastName><ForeName>C M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto Filipa</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Felsenberg</LastName><ForeName>Dieter</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>B&#xf6;rst</LastName><ForeName>Hendrikje</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Armbrecht</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blauth</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spicher</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Felson</LastName><ForeName>David T</ForeName><Initials>DT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kanis</LastName><ForeName>John A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mccloskey</LastName><ForeName>Eugene V</ForeName><Initials>EV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johansson</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Watzl</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gomez</LastName><ForeName>Rodriguez Manuel</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hofbauer</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsourdi</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rauner</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siebert</LastName><ForeName>Uwe</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kanis</LastName><ForeName>John A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Halbout</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gut</LastName><ForeName>Benno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ba</LastName><ForeName>Mari&#xe8;me</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wittwer Schegg</LastName><ForeName>Jonas</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Etheve</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eggersdorfer</LastName><ForeName>Manfred</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delannoy Carla</LastName><ForeName>Sofa</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reuschling</LastName><ForeName>Monika</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orav</LastName><ForeName>Endel J</ForeName><Initials>EJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Willett Walter</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manson</LastName><ForeName>JoAnn E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dawson-Hughes</LastName><ForeName>Bess</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Staehelin</LastName><ForeName>Hannes B</ForeName><Initials>HB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walter Paul</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dick</LastName><ForeName>Walter</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fried</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>von Eckardstein</LastName><ForeName>Arnold</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Theiler</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simmen</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Langhans</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zinkernagel</LastName><ForeName>Annelies</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mueller</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Distler</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graetz</LastName><ForeName>Klaus</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nitschke</LastName><ForeName>Ina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dietrich</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baer</LastName><ForeName>Walter</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landau</LastName><ForeName>Klara</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruschitzka</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manz</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burckhardt</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>18</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>10</Day><Hour>13</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>10</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40492704</ArticleId><ArticleId IdType="pmc">PMC12406121</ArticleId><ArticleId IdType="doi">10.1093/jbmr/zjaf058</ArticleId><ArticleId IdType="pii">8159681</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kanis &#xa0;JA, Norton &#xa0;N, Harvey &#xa0;NC, et al. &#xa0;SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021;16(1):82. 10.1007/s11657-020-00871-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-020-00871-9</ArticleId><ArticleId IdType="pmc">PMC8172408</ArticleId><ArticleId IdType="pubmed">34080059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemmler &#xa0;W, H&#xe4;berle &#xa0;L, von Stengel &#xa0;S. Effects of exercise on fracture reduction in older adults: a systematic review and meta-analysis. Osteoporos Int. 2013;24(7):1937-1950. 10.1007/s00198-012-2248-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-012-2248-7</ArticleId><ArticleId IdType="pubmed">23306820</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong &#xa0;Y, Peng &#xa0;R, Kang &#xa0;H, et al. &#xa0;Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019. Spine J. 2022;22(5):857-868. 10.1016/j.spinee.2021.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2021.12.007</ArticleId><ArticleId IdType="pubmed">34906740</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizkallah &#xa0;M, Bachour &#xa0;F, Khoury &#xa0;ME, et al. &#xa0;Comparison of morbidity and mortality of hip and vertebral fragility fractures: which one has the highest burden? &#xa0;Osteoporos Sarcopenia. 2020;6(3):146-150. 10.1016/j.afos.2020.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.afos.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7573502</ArticleId><ArticleId IdType="pubmed">33102809</ArticleId></ArticleIdList></Reference><Reference><Citation>Koel&#xe9; &#xa0;MC, Lems &#xa0;WF, Willems &#xa0;HC. The clinical relevance of hyperkyphosis: a narrative review. Front Endocrinol (Lausanne). 2020;11:5. 10.3389/fendo.2020.00005</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00005</ArticleId><ArticleId IdType="pmc">PMC6993454</ArticleId><ArticleId IdType="pubmed">32038498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevitt &#xa0;MC, Ettinger &#xa0;B, Black &#xa0;DM, et al. &#xa0;The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998;128(10):793-800. 10.7326/0003-4819-128-10-199805150-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-128-10-199805150-00001</ArticleId><ArticleId IdType="pubmed">9599190</ArticleId></ArticleIdList></Reference><Reference><Citation>Black &#xa0;DM, Arden &#xa0;NK, Palermo &#xa0;L, Pearson &#xa0;J, Cummings &#xa0;SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of osteoporotic fractures research group. J Bone Miner Res. 1999;14(5):821-828. 10.1359/jbmr.1999.14.5.821</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.1999.14.5.821</ArticleId><ArticleId IdType="pubmed">10320531</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLuca &#xa0;HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 Suppl):1689s-1696s. 10.1093/ajcn/80.6.1689S</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/80.6.1689S</ArticleId><ArticleId IdType="pubmed">15585789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolland &#xa0;MJ, Grey &#xa0;A, Avenell &#xa0;A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6(11):847-858. 10.1016/s2213-8587(18)30265-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-8587(18)30265-1</ArticleId><ArticleId IdType="pubmed">30293909</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver &#xa0;CM, Alexander &#xa0;DD, Boushey &#xa0;CJ, et al. &#xa0;Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27(1):367-376. 10.1007/s00198-015-3386-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-015-3386-5</ArticleId><ArticleId IdType="pmc">PMC4715837</ArticleId><ArticleId IdType="pubmed">26510847</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBoff &#xa0;MS, Chou &#xa0;SH, Ratliff &#xa0;KA, et al. &#xa0;Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med. 2022;387(4):299-309. 10.1056/NEJMoa2202106</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2202106</ArticleId><ArticleId IdType="pmc">PMC9716639</ArticleId><ArticleId IdType="pubmed">35939577</ArticleId></ArticleIdList></Reference><Reference><Citation>Myung &#xa0;S-K, Cho &#xa0;H. Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis. Osteoporos Int. 2023;34(8):1355-1367. 10.1007/s00198-023-06761-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-023-06761-3</ArticleId><ArticleId IdType="pubmed">37120684</ArticleId></ArticleIdList></Reference><Reference><Citation>Avenell &#xa0;A, Mak &#xa0;JC, O'Connell &#xa0;D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014;2014(4):Cd000227. 10.1002/14651858.CD000227.pub4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000227.pub4</ArticleId><ArticleId IdType="pmc">PMC7032685</ArticleId><ArticleId IdType="pubmed">24729336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao &#xa0;JG, Zeng &#xa0;XT, Wang &#xa0;J, Liu &#xa0;L. Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: a systematic review and Meta-analysis. JAMA. 2017;318(24):2466-2482. 10.1001/jama.2017.19344</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.19344</ArticleId><ArticleId IdType="pmc">PMC5820727</ArticleId><ArticleId IdType="pubmed">29279934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu &#xa0;ZC, Tang &#xa0;Q, Sang &#xa0;CM, et al. &#xa0;Comparison of fracture risk using different supplemental doses of vitamin D, calcium or their combination: a network meta-analysis of randomised controlled trials. BMJ Open. 2019;9(10):e024595. 10.1136/bmjopen-2018-024595</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-024595</ArticleId><ArticleId IdType="pmc">PMC6797303</ArticleId><ArticleId IdType="pubmed">31619412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazess &#xa0;RB, Bischoff-Ferrari &#xa0;HA, Dawson-Hughes &#xa0;B. Vitamin D: bolus is bogus-a narrative review. JBMR Plus. 2021;5(12):e10567. 10.1002/jbm4.10567</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10567</ArticleId><ArticleId IdType="pmc">PMC8674779</ArticleId><ArticleId IdType="pubmed">34950828</ArticleId></ArticleIdList></Reference><Reference><Citation>Orchard &#xa0;TS, Pan &#xa0;X, Cheek &#xa0;F, Ing &#xa0;SW, Jackson &#xa0;RD. A systematic review of omega-3 fatty acids and osteoporosis. Br J Nutr. 2012;107(02):S253-S260. 10.1017/s0007114512001638</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0007114512001638</ArticleId><ArticleId IdType="pmc">PMC3899785</ArticleId><ArticleId IdType="pubmed">22591899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistler-Fischbacher &#xa0;M, Armbrecht &#xa0;G, G&#xe4;ngler &#xa0;S, et al. &#xa0;Effects of vitamin D3, omega-3 s and a simple strength training exercise program on bone health: the DO-HEALTH randomized controlled trial. J Bone Miner Res. 2024;39(6):661-671. 10.1093/jbmr/zjae054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jbmr/zjae054</ArticleId><ArticleId IdType="pubmed">38613445</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhamid &#xa0;A, Hooper &#xa0;L, Sivakaran &#xa0;R, Hayhoe &#xa0;RPG, Welch &#xa0;A. The relationship between Omega-3, Omega-6 and Total polyunsaturated fat and musculoskeletal health and functional status in adults: a systematic review and Meta-analysis of RCTs. Calcif Tissue Int. 2019;105(4):353-372. 10.1007/s00223-019-00584-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-019-00584-3</ArticleId><ArticleId IdType="pubmed">31346665</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou &#xa0;Y, Wang &#xa0;Y, Chen &#xa0;Z, Yu &#xa0;X, Ma &#xa0;D. Effect of n-3 polyunsaturated fatty acid on bone health: a systematic review and meta-analysis of randomized controlled trials. Food Sci Nutr. 2022;10(1):145-154. 10.1002/fsn3.2655</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.2655</ArticleId><ArticleId IdType="pmc">PMC8751426</ArticleId><ArticleId IdType="pubmed">35035917</ArticleId></ArticleIdList></Reference><Reference><Citation>

Le Boff &#xa0;MS, Sharon &#xa0;HC, Kristin &#xa0;AR, et al.  &#xa0;Effects of Omega-3 fatty acid supplementation on incident fractures in midlife and older adults enrolled in VITamin D and OmegA-3 TriaL (VITAL). J Bone Miner Res. 2022;38(Suppl 1):Accessed July 5, 2023. Available at https://www.asbmr.org/meetings/2022-abstracts.</Citation></Reference><Reference><Citation>Kistler-Fischbacher &#xa0;M, Weeks &#xa0;BK, Beck &#xa0;BR. The effect of exercise intensity on bone in postmenopausal women (part 1): a systematic review. Bone. 2021;143:115696. 10.1016/j.bone.2020.115696</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2020.115696</ArticleId><ArticleId IdType="pubmed">33357833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistler-Fischbacher &#xa0;M, Weeks &#xa0;BK, Beck &#xa0;BR. The effect of exercise intensity on bone in postmenopausal women (part 2): a meta-analysis. Bone. 2021;143:115697. 10.1016/j.bone.2020.115697</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2020.115697</ArticleId><ArticleId IdType="pubmed">33357834</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang &#xa0;X, Xu &#xa0;S, Zhang &#xa0;H. Regulation of bone health through physical exercise: mechanisms and types. Front Endocrinol (Lausanne). &#xa0;2022;13:1029475. 10.3389/fendo.2022.1029475</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1029475</ArticleId><ArticleId IdType="pmc">PMC9768366</ArticleId><ArticleId IdType="pubmed">36568096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherrington &#xa0;C, Fairhall &#xa0;NJ, Wallbank &#xa0;GK, et al. &#xa0;Exercise for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2019;1(1):Cd012424. 10.1002/14651858.CD012424.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD012424.pub2</ArticleId><ArticleId IdType="pmc">PMC6360922</ArticleId><ArticleId IdType="pubmed">30703272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari &#xa0;HA, Vellas &#xa0;B, Rizzoli &#xa0;R, et al. &#xa0;Effect of vitamin D supplementation, Omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial. JAMA. 2020;324(18):1855-1868. 10.1001/jama.2020.16909</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16909</ArticleId><ArticleId IdType="pmc">PMC7656284</ArticleId><ArticleId IdType="pubmed">33170239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari &#xa0;HA, de Godoi Rezende Costa Molino &#xa0;C, Rival &#xa0;S, et al. &#xa0;DO-HEALTH: vitamin D3 - Omega-3 - home exercise - healthy aging and longevity trial - design of a multinational clinical trial on healthy aging among European seniors. Contemp Clin Trials. 2021;100:106124. 10.1016/j.cct.2020.106124</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2020.106124</ArticleId><ArticleId IdType="pubmed">32858228</ArticleId></ArticleIdList></Reference><Reference><Citation>Armbrecht &#xa0;G, Blenk &#xa0;T, Chesnut &#xa0;CH &#xa0;3rd, et al. &#xa0;Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology. J Clin Densitom. 2008;11(2):221-231. 10.1016/j.jocd.2007.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2007.10.002</ArticleId><ArticleId IdType="pubmed">18158264</ArticleId></ArticleIdList></Reference><Reference><Citation>Genant &#xa0;HK, Wu &#xa0;CY, van Kuijk &#xa0;C, Nevitt &#xa0;MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137-1148. 10.1002/jbmr.5650080915</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.5650080915</ArticleId><ArticleId IdType="pubmed">8237484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann &#xa0;I, Shojaa &#xa0;M, Kohl &#xa0;M, et al. &#xa0;Exercise reduces the number of overall and major osteoporotic fractures in adults. Does supervision make a difference? Systematic review and Meta-analysis. J Bone Miner Res. 2022;37(11):2132-2148. 10.1002/jbmr.4683</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.4683</ArticleId><ArticleId IdType="pubmed">36082625</ArticleId></ArticleIdList></Reference><Reference><Citation>Akeda &#xa0;K, Nakase &#xa0;K, Yamada &#xa0;J, Takegami &#xa0;N, Fujiwara &#xa0;T, Sudo &#xa0;A. Progression of vertebral deformity of prevalent vertebral fractures in the elderly: a population-based study. BMC Musculoskelet Disord. 2024;25(1):110. 10.1186/s12891-024-07254-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-024-07254-y</ArticleId><ArticleId IdType="pmc">PMC10840146</ArticleId><ArticleId IdType="pubmed">38317112</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs &#xa0;JC, MacIntyre &#xa0;NJ, Ponzano &#xa0;M, et al. &#xa0;Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev. 2019;7(7):Cd008618. 10.1002/14651858.CD008618.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008618.pub3</ArticleId><ArticleId IdType="pmc">PMC6609547</ArticleId><ArticleId IdType="pubmed">31273764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis &#xa0;JA, Cooper &#xa0;C, Rizzoli &#xa0;R, Reginster &#xa0;JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3-44. 10.1007/s00198-018-4704-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-018-4704-5</ArticleId><ArticleId IdType="pmc">PMC7026233</ArticleId><ArticleId IdType="pubmed">30324412</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari &#xa0;HA, Freyst&#xe4;tter &#xa0;G, Vellas &#xa0;B, et al. &#xa0;Effects of vitamin D, omega-3 fatty acids, and a simple home strength exercise program on fall prevention: the DO-HEALTH randomized clinical trial. Am J Clin Nutr. 2022;115(5):1311-1321. 10.1093/ajcn/nqac022</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqac022</ArticleId><ArticleId IdType="pubmed">35136915</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBoff &#xa0;MS, Chou &#xa0;SH, Murata &#xa0;EM, et al. &#xa0;Effects of supplemental vitamin D on bone health outcomes in women and men in the VITamin D and OmegA-3 TriaL (VITAL). J Bone Miner Res. 2020;35(5):883-893. 10.1002/jbmr.3958</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3958</ArticleId><ArticleId IdType="pmc">PMC7217747</ArticleId><ArticleId IdType="pubmed">31923341</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari &#xa0;HA. Hype about vitamin D substitution: what remains? &#xa0;Internist (Berl). 2020;61(11):1196-1203. 10.1007/s00108-020-00869-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00108-020-00869-y</ArticleId><ArticleId IdType="pmc">PMC7581590</ArticleId><ArticleId IdType="pubmed">32970191</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman &#xa0;DC, Curry &#xa0;SJ, Owens &#xa0;DK, et al. &#xa0;Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US preventive services task force recommendation statement. JAMA. 2018;319(15):1592-1599. 10.1001/jama.2018.3185</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.3185</ArticleId><ArticleId IdType="pubmed">29677309</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauley &#xa0;JA, Lacroix &#xa0;AZ, Wu &#xa0;L, et al. &#xa0;Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149(4):242-250. 10.7326/0003-4819-149-4-200808190-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-149-4-200808190-00005</ArticleId><ArticleId IdType="pmc">PMC2743412</ArticleId><ArticleId IdType="pubmed">18711154</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher &#xa0;JC, Sai &#xa0;A, Templin &#xa0;T &#xa0;2nd, Smith &#xa0;L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012;156(6):425-437. 10.7326/0003-4819-156-6-201203200-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-156-6-201203200-00005</ArticleId><ArticleId IdType="pubmed">22431675</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari &#xa0;HA, Orav &#xa0;EJ, Abderhalden &#xa0;L, Dawson-Hughes &#xa0;B, Willett &#xa0;WC. Vitamin D supplementation and musculoskeletal health. Lancet Diabetes Endocrinol. 2019;7(2):85. 10.1016/s2213-8587(18)30347-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-8587(18)30347-4</ArticleId><ArticleId IdType="pubmed">30683217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakhtoura &#xa0;M, Bacha &#xa0;DS, Gharios &#xa0;C, et al. &#xa0;Vitamin D supplementation and fractures in adults: a systematic umbrella review of Meta-analyses of controlled trials. J Clin Endocrinol Metab. 2022;107(3):882-898. 10.1210/clinem/dgab742</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab742</ArticleId><ArticleId IdType="pmc">PMC8852203</ArticleId><ArticleId IdType="pubmed">34687206</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBoff &#xa0;MS, Bischoff-Ferrari &#xa0;HA. The effects of vitamin D supplementation on musculoskeletal health: the VITAL and DO-health trials. J Gerontol A Biol Sci Med Sci. 2023;78(Supplement_1):73-78. 10.1093/gerona/glad073</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glad073</ArticleId><ArticleId IdType="pmc">PMC10272981</ArticleId><ArticleId IdType="pubmed">37325962</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina &#xa0;EK, Kiel &#xa0;DP, Roubenoff &#xa0;R, Schaefer &#xa0;EJ, Cupples &#xa0;LA, Tucker &#xa0;KL. Dietary intakes of arachidonic acid and &#x3b1;-linolenic acid are associated with reduced risk of hip fracture in older Adults12. J Nutr. 2011;141(6):1146-1153. 10.3945/jn.110.133728</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.110.133728</ArticleId><ArticleId IdType="pmc">PMC3095142</ArticleId><ArticleId IdType="pubmed">21508210</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsourdi &#xa0;E, G&#xe4;ngler &#xa0;S, Kistler-Fischbacher &#xa0;M, et al. &#xa0;Effect of vitamin D3, omega-3 fatty acids, and exercise on serum sclerostin levels and bone turnover markers. J Clin Endocrinol Metab. 2024:dgae859. Online ahead of print. 10.1210/clinem/dgae859</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgae859</ArticleId><ArticleId IdType="pubmed">39657964</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40280495</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Antiosteoporosis medication in patients with posterior spine fusion: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1877</StartPage><EndPage>1898</EndPage><MedlinePgn>1877-1898</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2025.04.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(25)00204-9</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">Osteoporosis and osteopenia are common among patients undergoing posterior spine fusion surgery, presenting challenges such as pseudarthrosis, screw loosening, and poor patient outcomes. While pharmacological interventions are available, no consensus exists regarding the optimal perioperative treatment for these patients. Furthermore, the effectiveness of various treatment options in improving fusion rates and minimizing complications remains uncertain.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the effects of teriparatide, bisphosphonates, denosumab, and romosozumab in patients with posterior spine fusion with low bone mineral density (BMD).</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">Adult patients with low BMD receiving osteoporosis medications and undergoing posterior spine fusion surgery.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Fusion rate, subsequent vertebral fracture (VF), screw loosening, cage subsidence, proximal junctional kyphosis (PJK), and patient-reported outcomes (PROs), particularly the Visual Analogue Scale (VAS) and Oswestry Disability Index (ODI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search was conducted using PubMed, EMBASE, and Cochrane Library. Two reviewers independently selected and assessed relevant studies. Four groups were analyzed to evaluate the comparative effectiveness of antiosteoporosis medication on the outcome measures: Bisphosphonate versus Control; Teriparatide versus Control; Teriparatide versus Bisphosphonate; and Denosumab versus Control.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Bisphosphonate showed reduced subsequent VFs (odds ratio [OR]=0.27, 95% confidence interval [CI]=0.09-0.81) and cage subsidence (OR=0.29, 95% CI=0.11-0.75) and improved ODI scores at 12 months (standardized mean difference [SMD] [95% CI]=-0.75 [-1.42, -0.08]) compared to the control. Teriparatide showed a higher fusion rate (OR=3.52, 95% CI=1.84-6.75), lower screw loosening (OR=0.23, 95% CI=0.09-0.60), and improved ODI scores at 24 months (SMD [95% CI]=-0.57 [-0.99, -0.15]) compared to the control. Moreover, teriparatide showed a higher fusion rate (OR=2.28, 95% CI=1.67-3.11), lower subsequent VF (OR=0.22, 95% CI=0.09-0.51), and improved VAS score for back pain (VASB) (mean difference [MD] [95% CI]=-0.30 [-0.54, -0.07]) and ODI (SMD [95% CI]=-0.38[-0.64, -0.12]) scores at 12 months compared to bisphosphonate. Denosumab showed no significant difference in fusion rate or other complications compared to control.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results indicated that teriparatide should be used as the first-line perioperative treatment for patients with poor bone quality scheduled for posterior spine fusion. Teriparatide exhibited better fusion rates and reduced complications than controls and bisphosphonates, resulting in improved PROs. Moreover, bisphosphonates can be utilized in patients with contraindications to teriparatide since the former prevents osteoporosis-related complications compared to controls, resulting in improved PROs. Further studies are warranted to evaluate the potential effects of denosumab and romosozumab.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>HyungSub</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>HyungJu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yonsei University College of Medicine, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suk</LastName><ForeName>Kyung-Soo</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Byung Ho</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Si Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hak-Sun</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Seong-Hwan</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sub-Ri</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Namhoo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Jae Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Ji-Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. Electronic address: kwonjjanng@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050071">Bone Density Conservation Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>10T9CSU89I</RegistryNumber><NameOfSubstance UI="D019379">Teriparatide</NameOfSubstance></Chemical><Chemical><RegistryNumber>4EQZ6YO2HI</RegistryNumber><NameOfSubstance UI="D000069448">Denosumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004164">Diphosphonates</NameOfSubstance></Chemical><Chemical><RegistryNumber>3VHF2ZD92J</RegistryNumber><NameOfSubstance UI="C557282">romosozumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="Y">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050071" MajorTopicYN="Y">Bone Density Conservation Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="Y">Osteoporosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019379" MajorTopicYN="N">Teriparatide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069448" MajorTopicYN="N">Denosumab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004164" MajorTopicYN="N">Diphosphonates</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bisphosphonate</Keyword><Keyword MajorTopicYN="N">Cage subsidence</Keyword><Keyword MajorTopicYN="N">Denosumab</Keyword><Keyword MajorTopicYN="N">Fusion</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Proximal junctional kyphosis</Keyword><Keyword MajorTopicYN="N">Romosozumab</Keyword><Keyword MajorTopicYN="N">Screw loosening</Keyword><Keyword MajorTopicYN="N">Teriparatide</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>7</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>26</Day><Hour>16</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>19</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40280495</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2025.04.018</ArticleId><ArticleId IdType="pii">S1529-9430(25)00204-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34104317</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1947-6108</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Methodist DeBakey cardiovascular journal</Title><ISOAbbreviation>Methodist Debakey Cardiovasc J</ISOAbbreviation></Journal><ArticleTitle>Surgical Cardiac Sympathetic Denervation for Ventricular Arrhythmias: A Systematic Review.</ArticleTitle><Pagination><StartPage>24</StartPage><EndPage>35</EndPage><MedlinePgn>24-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14797/QIQG9041</ELocationID><Abstract><AbstractText>Ventricular arrhythmias are potentially life-threatening disorders that are commonly treated with medications, catheter ablation and implantable cardioverter defibrillator (ICD). Adult patients who continue to be symptomatic, with frequent ventricular arrhythmia cardiac events or defibrillation from ICD despite medical treatment, are a challenging subgroup to manage. Surgical cardiac sympathetic denervation has emerged as a possible treatment option for people refractory to less invasive medical options. Recent treatment guidelines have recommendedcardiac sympathectomy for ventricular tachycardia (VT) or VT/fibrillation storm refractory to antiarrhythmic medications, long QT syndrome, and catecholaminergic polymorphic VT, with much of the data pertaining to pediatric literature. However, for the adult population, the disease indications, complications, and risks of cardiac sympathectomy are less understood, as are the most effective surgical cardiac denervation techniques for this patient demographic. This systematic review navigates available literature evaluating surgical denervation disease state indications, techniques, and sympathectomy risks for medically refractory ventricular arrhythmia in the adult patient population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chihara</LastName><ForeName>Ray K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Houston Methodist Hospital, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Weill Cornell Medical College, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Edward Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Houston Methodist Hospital, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Weill Cornell Medical College, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meisenbach</LastName><ForeName>Leonora M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Houston Methodist Hospital, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Houston Methodist Hospital, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Weill Cornell Medical College, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methodist Debakey Cardiovasc J</MedlineTA><NlmUniqueID>101508600</NlmUniqueID><ISSNLinking>1947-6108</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="Y">innervation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013562" MajorTopicYN="Y">Sympathectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013564" MajorTopicYN="N">Sympathetic Nervous System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VATS</Keyword><Keyword MajorTopicYN="N">denervation</Keyword><Keyword MajorTopicYN="N">electrical storm</Keyword><Keyword MajorTopicYN="N">ganglion</Keyword><Keyword MajorTopicYN="N">ganglionectomy</Keyword><Keyword MajorTopicYN="N">stellate</Keyword><Keyword MajorTopicYN="N">stellectomy</Keyword><Keyword MajorTopicYN="N">sympathectomy</Keyword><Keyword MajorTopicYN="N">thoracoscopy</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmias</Keyword><Keyword MajorTopicYN="N">ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors have completed and submitted the Methodist DeBakey Cardiovascular Journal Conflict of Interest Statement and none were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34104317</ArticleId><ArticleId IdType="pmc">PMC8158456</ArticleId><ArticleId IdType="doi">10.14797/QIQG9041</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adabag A. Selcuk, Luepker Russell V., Roger V&#xe9;ronique L., Gersh Bernard J. Nature Reviews Cardiology. 4. Vol. 7. Springer Science and Business Media LLC; 2010. Sudden cardiac death: epidemiology and risk factors; pp. 216&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2010.3</ArticleId><ArticleId IdType="pmc">PMC5014372</ArticleId><ArticleId IdType="pubmed">20142817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella Della, Baratto P, Tsiachris F D. Management of ventricular tachy- cardia in the setting of a dedicated unit for the treatment of complex ventric- ular arrhythmias: long-term outcome after ablation. Circulation. 2013;127(13):1359&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">23439513</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson W G, Wilber D J, Natale A. Irrigated radiofrequency cath- eter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118(25):2773&#x2013;2782. doi: 10.1161/CIRCULATIONAHA.108.788604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.788604</ArticleId><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R, Vaseghi M, Frankel D S. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015;12(9):1997&#x2013;2007. doi: 10.1016/j.hrthm.2015.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.05.036</ArticleId><ArticleId IdType="pmc">PMC4549209</ArticleId><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Mark J., Zipes Douglas P. Circulation Research. 6. Vol. 114. Ovid Technologies (Wolters Kluwer Health); 2014. Role of the Autonomic Nervous System in Modulating Cardiac Arrhythmias; pp. 1004&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.113.302549</ArticleId><ArticleId IdType="pubmed">24625726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilde Arthur A.M., Bhuiyan Zahurul A., Crotti Lia, Facchini Mario, De Ferrari Gaetano M., Paul Thomas, Ferrandi Chiara, Koolbergen Dave R., Odero Attilio, Schwartz Peter J. New England Journal of Medicine. 19. Vol. 358. Massachusetts Medical Society; 2008. Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia; pp. 2024&#x2013;2029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa0708006</ArticleId><ArticleId IdType="pubmed">18463378</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib S M, Stevenson W G, Ackerman M J. AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;138(13):272&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">29084731</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi Marmar, Barwad Parag, Malavassi Corrales Federico J., Tandri Harikrishna, Mathuria Nilesh, Shah Rushil, Sorg Julie M., Gima Jean, Mandal Kaushik, S&#xe0;enz Morales Luis C., Lokhandwala Yash, Shivkumar Kalyanam. Journal of the American College of Cardiology. 25. Vol. 69. Elsevier BV; 2017. Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias; pp. 3070&#x2013;3080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.04.035</ArticleId><ArticleId IdType="pmc">PMC6330109</ArticleId><ArticleId IdType="pubmed">28641796</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtaza G, Sharma S P, Akella K. Role of cardiac sympathetic denerva- tion in ventricular tachycardia: A meta-analysis. Pacing Clin Electrophysiol. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32460366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola Olujimi A., Lellouche Nicholas, Bourke Tara, Tung Roderick, Ahn Samuel, Mahajan Aman, Shivkumar Kalyanam. Journal of the American College of Cardiology. 1. Vol. 59. Elsevier BV; 2012. Bilateral Cardiac Sympathetic Denervation for the Management of Electrical Storm; pp. 91&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.09.043</ArticleId><ArticleId IdType="pmc">PMC3470807</ArticleId><ArticleId IdType="pubmed">22192676</ArticleId></ArticleIdList></Reference><Reference><Citation>Assis F R, Krishnan A, Zhou X, et al. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2019;16(7):1003&#x2013;1010. doi: 10.1016/j.hrthm.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.01.019</ArticleId><ArticleId IdType="pubmed">30677492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke T, Vaseghi M, Michowitz Y. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation. 2010;121(21):2255&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2896716</ArticleId><ArticleId IdType="pubmed">20479150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai C, Dai M Y, Tian Y. Electrophysiologic effects and outcomes of sympatholysis in patients with recurrent ventricular arrhythmia and struc- tural heart disease. J Cardiovasc Electrophysiol. 2019;30(9):1499&#x2013;1507.</Citation><ArticleIdList><ArticleId IdType="pubmed">31199536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona-Guarache Ricardo, Padala Santosh K., Velazco-Davila Luis, Cassano Anthony, Abbate Antonio, Ellenbogen Kenneth A., Koneru Jayanthi N. Journal of Cardiovascular Electrophysiology. 8. Vol. 28. Wiley; 2017. Stellate ganglion blockade and bilateral cardiac sympathetic denervation in patients with life-threatening ventricular arrhythmias; pp. 903&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.13249</ArticleId><ArticleId IdType="pubmed">28471068</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinathannair R., Olshansky B., Iannettoni M., Mazur A. Europace. 7. Vol. 12. Oxford University Press (OUP); 2010. Delayed maximal response to left cardiac sympathectomy for catecholaminergic polymorphic ventricular tachycardia; pp. 1035&#x2013;1039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euq058</ArticleId><ArticleId IdType="pubmed">20219758</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez Oswaldo, Garita Elliot, Salazar Carlos. International Journal of Cardiology. 2. Vol. 119. Elsevier BV; 2007. Thoracoscopic sympathectomy for incessant polymorphic ventricular tachycardia in chronic chagasic myocarditis A case report; pp. 255&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2006.07.138</ArticleId><ArticleId IdType="pubmed">17079033</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S Y, Cho Y, Kim N K. Video-Assisted Thoracoscopic Left Cardiac Sympathetic Denervation in Patients with Hereditary Ventricular Arrhyth- mias. Pacing Clin Electrophysiol. 2017;40(3):232&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">28012188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopecky Kathleen, Afzal Aasim, Felius Joost, Hall Shelley A., Mendez Jose C., Assar Manish, Mason David P., Bindra Amarinder S. Pacing and Clinical Electrophysiology. Vol. 41. Wiley; 2018. Bilateral sympathectomy for treatment of refractory ventricular tachycardia; pp. 93&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.13164</ArticleId><ArticleId IdType="pubmed">28851062</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan Aravind, Suarez-Pierre Alejandro, Crawford Todd C., Zhou Xun, Russell Stuart D., Berger Ronald D., Calkins Hugh, Baumgartner William A., Tandri Harikrishna, Mandal Kaushik. The Annals of Thoracic Surgery. 2. Vol. 105. Elsevier BV; 2018. Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia; pp. e51&#x2013;e53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.09.023</ArticleId><ArticleId IdType="pubmed">29362191</ArticleId></ArticleIdList></Reference><Reference><Citation>Methangkool Emily, Chua Jason H., Gopinath Anupama, Shivkumar Kalyanam, Mahajan Aman. Journal of Cardiothoracic and Vascular Anesthesia. 1. Vol. 28. Elsevier BV; 2014. Anesthetic Considerations for Thoracoscopic Sympathetic Ganglionectomy to Treat Ventricular Tachycardia Storm: A Single-Center Experience; pp. 69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.08.019</ArticleId><ArticleId IdType="pmc">PMC4253028</ArticleId><ArticleId IdType="pubmed">24290748</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada David R., Assis Fabrizio R., Gilotra Nisha A., Ha Jinny S., Berger Ronald D., Calkins Hugh, Chrispin Jonathan, Mandal Kaushik, Tandri Harikrishna. Heart Rhythm. 9. Vol. 16. Elsevier BV; 2019. Cardiac sympathectomy for refractory ventricular arrhythmias in cardiac sarcoidosis; pp. 1408&#x2013;1413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.02.025</ArticleId><ArticleId IdType="pubmed">30818090</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu Mukund A., Prasad Srinivas B. V., Abhilash S. P., Thajudeen Anees, R. Balasubramoniam K., Namboodiri Narayanan. Journal of Interventional Cardiac Electrophysiology. 3. Vol. 47. Springer Science and Business Media LLC; 2016. Left sympathetic cardiac denervation in managing electrical storm: acute outcome and long term follow up; pp. 285&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-016-0153-2</ArticleId><ArticleId IdType="pubmed">27318998</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson T, Lugo R, Saavedra P. Cardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablation. Heart Rhythm. 2018;15(1):56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">28917558</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenz L C, Corrales F M, Bautista W. Cardiac sympathetic denervation for intractable ventricular arrhythmias in Chagas disease. Heart Rhythm. 2016;13(7):1388&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">26969783</ArticleId></ArticleIdList></Reference><Reference><Citation>Stec Sebastian, Zamorski Piotr, Wo&#x142;ek Wojciech, Suwalski Piotr, Zienciuk-Krajka Agnieszka. Kardiologia Polska. 6. Vol. 77. Polskie Towarzystwo Kardiologiczne; 2019. Bilateral cardiac sympathetic denervation in catecholaminergic polymorphic ventricular tachycardia; pp. 653&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/kp.14834</ArticleId><ArticleId IdType="pubmed">31099757</ArticleId></ArticleIdList></Reference><Reference><Citation>Tellez L J, Garzon J C, Vinck E E, Castellanos J D. Video-assisted thoracoscopic cardiac denervation of refractory ventricular arrhythmias and electrical storms: a single-center series. J Cardiothorac Surg. 2019;14(1):17&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6341718</ArticleId><ArticleId IdType="pubmed">30665431</ArticleId></ArticleIdList></Reference><Reference><Citation>Vel&#xe1;squez Mauricio, Fern&#xe1;ndez Liliana, Leib Carl S., Orozco Viviana, Pava Fernando, Perafan Pablo. Archivos de cardiolog&#xfffd;a de M&#xfffd;xico (English ed. Internet) 3. Vol. 89. Publicidad Permanyer, SLU; 2020. Cardiac sympathetic denervation for conventional treatment refractory arrhythmias; pp. 191&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/acme.m19000059</ArticleId><ArticleId IdType="pubmed">31967585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehman Brody, Mazzeffi Michael, Chow Robert, Watkins A. Claire, Aicher Brittany, Pham Si, Burrows Whitney, Taylor Bradley. The Annals of Thoracic Surgery. 3. Vol. 105. Elsevier BV; 2018. Thoracoscopic Sympathectomy for Refractory Electrical Storm After Coronary Artery Bypass Grafting; pp. e99&#x2013;e101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.10.005</ArticleId><ArticleId IdType="pubmed">29455831</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalin Kivanc, Liosis Spyridon, Palade Emanuel, Fink Thomas, Schierholz Stefanie, Sawan Noureddin, Eitel Charlotte, Heeger Christian H., Sciacca Vanessa, Sano Makoto, Vogler Julia, Tilz Roland Richard. Clinical Research in Cardiology. 1. Vol. 110. Springer Science and Business Media LLC; 2021. Cardiac sympathetic denervation in patients with nonischemic cardiomyopathy and refractory ventricular arrhythmias: a single-center experience; pp. 21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01643-8</ArticleId><ArticleId IdType="pubmed">32328735</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtaza Ghulam, Sharma Sharan P., Akella Krishna, Turagam Mohit K., Rocca Domenico G. Della, Lakkireddy Dhanunjaya, Gopinathannair Rakesh. Pacing and Clinical Electrophysiology. 8. Vol. 43. Wiley; 2020. Role of cardiac sympathetic denervation in ventricular tachycardia: A meta&#x2010;analysis; pp. 828&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.13968</ArticleId><ArticleId IdType="pubmed">32460366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer William H., Zado Erica, Gerstenfeld Edward P., Marchlinski Francis E., Callans David J. Heart Rhythm. Vol. 7. Elsevier BV; 2010. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator; pp. 9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2009.09.014</ArticleId><ArticleId IdType="pubmed">19939743</ArticleId></ArticleIdList></Reference><Reference><Citation>Marhold F, Izay B, Zacherl J, Tschabitscher M, Neumayer C. Thoraco- scopic and anatomic landmarks of Kuntz&#x2019;s nerve: implications for sympa- thetic surgery. Ann Thorac Surg. 2008;86(5):1653&#x2013;1661.</Citation><ArticleIdList><ArticleId IdType="pubmed">19049766</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Hidehiro, Okada Masayoshi. The Journal of Thoracic and Cardiovascular Surgery. 5. Vol. 158. Elsevier BV; 2019. The management of compensatory sweating after thoracic sympathectomy; pp. 1481&#x2013;1488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.05.062</ArticleId><ArticleId IdType="pubmed">31358338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39624903</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-3084</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Circulation. Arrhythmia and electrophysiology</Title><ISOAbbreviation>Circ Arrhythm Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>In Vivo Mapping of Human Ventricular Fibrillation in Brugada Syndrome: The Role of Repolarization Heterogeneity.</ArticleTitle><Pagination><StartPage>e013290</StartPage><MedlinePgn>e013290</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCEP.124.013290</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Brugada syndrome (BrS) is associated with ventricular fibrillation (VF). Different VF mechanisms have been described, and repolarization gradients were associated with VF in a BrS model. The aim of this study is to map VF in BrS with ECG imaging. Furthermore, spatial correlation between sinus rhythm maps and VF maps was evaluated.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Inclusion criteria were (1) BrS diagnosis and (2) VF mapped with ECG imaging during right ventricle outflow tract ablation. VF mechanism was classified into (1) rotational, (2) focal, and (3) irregular. For comparison, 6 controls were enrolled. The following sinus rhythm maps were performed: activation, recovery time, and activation-recovery interval time. Spatial overlap between steep repolarization gradients (cliffs) at recovery time and activation-recovery interval time maps and initiating VF rotational activity was evaluated with photogrammetry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 28 VF maps in 21 patients with BrS were analyzed. In the first &#x2248;7 seconds of VF, rotational, focal, and irregular mechanisms were found. In 19 patients with BrS (90.5%) and none of the controls, a right ventricle outflow tract repolarization cliff only was found. In all these patients, the singularity point of the first initiating rotational VF activity spatially overlapped with the right ventricle outflow tract cliff. Abolition of right ventricle outflow tract repolarization cliffs was confirmed in all but 2 patients (94.3%). In one patient with recurrence, VF was mapped on the anterior right ventricle over a cliff that was not targeted at the first ablation procedure.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In patients with BrS, repolarization heterogeneity has a critical role in VF. Repolarization cliffs might be a therapeutic target in VF ablation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pannone</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9769-1511</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Rocca</LastName><ForeName>Domenico Giovanni</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0003-3837-3462</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergara</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7751-6871</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorgente</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0078-9393</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Monte</LastName><ForeName>Alvise</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6672-4931</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vetta</LastName><ForeName>Giampaolo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1120-0492</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cespon Fernandez</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6549-4994</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talevi</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eltsov</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-2832-9556</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calburean</LastName><ForeName>Paul-Adrian</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-4948-2587</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overeinder</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bala</LastName><ForeName>Gezim</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7613-0712</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almorad</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9743-1661</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Str&#xf6;ker</LastName><ForeName>Erwin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappaert</LastName><ForeName>Gudrun</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9912-7121</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sieira</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Ravel</LastName><ForeName>Thomy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3361-3781</Identifier><AffiliationInfo><Affiliation>Centre for Medical Genetics (T.d.R., S.V.D.), Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Clinical Sciences, Research Group Reproduction and Genetics, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Dooren</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8583-1994</Identifier><AffiliationInfo><Affiliation>Centre for Medical Genetics (T.d.R., S.V.D.), Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Clinical Sciences, Research Group Reproduction and Genetics, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brussels Interuniversity Genomics High Throughput Core (S.V.D.), Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Clinical Sciences, Research Group Reproduction and Genetics, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gharaviri</LastName><ForeName>Ali</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1803-8237</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Meir</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6261-5110</Identifier><AffiliationInfo><Affiliation>Cardiac Surgery Department (M.L.M.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugada</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3172-6106</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chierchia</LastName><ForeName>Gian Battista</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarkozy</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6327-0487</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Asmundis</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9351-0760</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Arrhythm Electrophysiol</MedlineTA><NlmUniqueID>101474365</NlmUniqueID><ISSNLinking>1941-3084</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053840" MajorTopicYN="Y">Brugada Syndrome</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="Y">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brugada syndrome</Keyword><Keyword MajorTopicYN="N">coronary angiography</Keyword><Keyword MajorTopicYN="N">death, sudden, cardiac</Keyword><Keyword MajorTopicYN="N">heart ventricles</Keyword><Keyword MajorTopicYN="N">ventricular fibrillation</Keyword></KeywordList><CoiStatement>Dr Sorgente received research grants from Daiichi Sankyo and Bayer; he received speaker fees from Menarini and Bayer. Dr La Meir is a consultant for AtriCure. Dr Chierchia received compensation for teaching purposes and proctoring from Medtronic, Abbott, Biotronik, and Boston Scientific. Dr Sarkozy is a consultant for Biosense Webster and Medtronic and received speaker fees from Biosense Webster, Biotronik, Pfizer, and Microport. Dr de Asmundis receives research grants on behalf of the center from Biotronik, Medtronic, Abbott, Microport, Boston Scientific, and AtriCure. Dr de Asmundis received compensation for teaching purposes and proctoring from Medtronic, Abbott, Biotronik, MicroPort, Boston Scientific, AtriCure, and Daiichi Sankyo. The other authors report no conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>17</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39624903</ArticleId><ArticleId IdType="doi">10.1161/CIRCEP.124.013290</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35504741</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1913</ISSN><JournalIssue CitedMedium="Internet"><Volume>174</Volume><PubDate><Year>2022</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>The American journal of cardiology</Title><ISOAbbreviation>Am J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Meta-Analysis of Catheter Ablation Outcomes in Patients With Cardiac Sarcoidosis Refractory Ventricular Tachycardia.</ArticleTitle><Pagination><StartPage>136</StartPage><EndPage>142</EndPage><MedlinePgn>136-142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2022.03.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9149(22)00339-3</ELocationID><Abstract><AbstractText>Cardiac sarcoidosis (CS) frequently leads to ventricular tachycardia (VT), which is often refractory to antiarrhythmic and/or immunosuppressive medications and requires catheter ablation. We conducted a systematic review and meta-analysis to evaluate the role of catheter ablation in patients with refractory VT undergoing catheter ablation. We searched PubMed, Embase, and Scopus databases from their inception to December 31, 2021 with search terms "cardiac sarcoidosis" AND "electrophysiological studies OR ablation." Fifteen studies were ultimately included for evaluation. Patient demographics, VT mapping, and acute and long-term procedural outcomes were extracted. A total of 15 studies were included in our meta-analysis, with a total of 401 patients, of whom 66% were male, with ages ranging from 39 to 64&#xa0;years. A total of 95% of patients were on antiarrhythmics and 79% of patients were on immunosuppressants. Left ventricular ejection fraction ranged from 35% to 49% and procedure duration ranged from 269 to 462&#xa0;minutes. Ablation was reported using both irrigated and nonirrigated catheter tips. A total of 25% of patients (84/339) underwent repeat ablation. Acute procedural success was achieved in 57% (161/285). Procedure complications occurred in 5.7% (17/297) procedures. VT recurrence after first ablation was 55% (confidence interval 48% to 63%, 213/401); VT recurrence after multiple ablations was 37% (81/220). The composite end point of death, heart transplant, and left ventricular assist device implantation was 21% (confidence interval 14% to 30%, 55/297). In conclusion, catheter ablation is a useful modality in patients with CS with refractory VT. However, patients with CS presenting with refractory VT after undergoing VT ablation carry a poor prognosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adhaduk</LastName><ForeName>Mehul</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine. Electronic address: mehul-adhaduk@uiowa.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paudel</LastName><ForeName>Bishow</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashwath</LastName><ForeName>Mahi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giudici</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Cardiol</MedlineTA><NlmUniqueID>0207277</NlmUniqueID><ISSNLinking>0002-9149</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012507" MajorTopicYN="Y">Sarcoidosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosures The authors have NO conflict of interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>22</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35504741</ArticleId><ArticleId IdType="doi">10.1016/j.amjcard.2022.03.038</ArticleId><ArticleId IdType="pii">S0002-9149(22)00339-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31977352</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-943X</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Season>Sep/Oct</Season></PubDate></JournalIssue><Title>ASAIO journal (American Society for Artificial Internal Organs : 1992)</Title><ISOAbbreviation>ASAIO J</ISOAbbreviation></Journal><ArticleTitle>Venoarterial Extracorporeal Membrane Oxygenation Support for Ventricular Tachycardia Ablation: A Systematic Review.</ArticleTitle><Pagination><StartPage>980</StartPage><EndPage>985</EndPage><MedlinePgn>980-985</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MAT.0000000000001125</ELocationID><Abstract><AbstractText>Refractory ventricular tachycardia (VT) and electrical storm are frequently associated with hemodynamic compromise requiring mechanical support. This study sought to review the current literature on the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for hemodynamic support during VT ablation. This was a systematic review of all published literature from 2000 to 2019 evaluating patients with VT undergoing ablation with VA-ECMO support. Studies that reported mortality, safety, and efficacy outcomes in adult (&gt;18 years) patients were included. The primary outcome was short-term mortality (intensive care unit stay, hospital stay, or &#x2264;30 days). The literature search identified 4,802 citations during the study period, of which seven studies comprising 867 patients met the inclusion criteria. Periprocedural VA-ECMO was used in 129 (15%) patients and all were placed peripherally. Average inducible VTs were 2-3 per procedure and ablation time varied between 34 mins and 4.7 hours. Median ages were between 61 and 68 years with 93% males. Median duration of VA-ECMO varied between 140 minutes and 6 days. Short-term mortality was 15% (19 patients), with the most frequent causes being refractory VT, cardiac arrest, and acute heart failure. All-cause mortality at the longest follow-up was 25%. Major bleeding, vascular/access complications, limb ischemia, stroke, and acute kidney injury were reported with varying frequency of 1-6%. In conclusion, VA-ECMO is used infrequently for hemodynamic support for VT ablation. Further data on patient selection, procedural optimization, and clinical outcomes are needed to evaluate the efficacy of this strategy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vallabhajosyula</LastName><ForeName>Saraschandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallabhajosyula</LastName><ForeName>Saarwaani</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Vaidya</LastName><ForeName>Vaibhav R</ForeName><Initials>VR</Initials></Author><Author ValidYN="Y"><LastName>Patlolla</LastName><ForeName>Sri Harsha</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Viral</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Mulpuru</LastName><ForeName>Siva K</ForeName><Initials>SK</Initials></Author><Author ValidYN="Y"><LastName>Noseworthy</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Kapa</LastName><ForeName>Suraj</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Egbe</LastName><ForeName>Alexander C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Gersh</LastName><ForeName>Bernard J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Deshmukh</LastName><ForeName>Abhishek J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000135</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ASAIO J</MedlineTA><NlmUniqueID>9204109</NlmUniqueID><ISSNLinking>1058-2916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31977352</ArticleId><ArticleId IdType="doi">10.1097/MAT.0000000000001125</ArticleId><ArticleId IdType="pii">00002480-202009000-00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eifling M, Razavi M, Massumi A. The evaluation and management of electrical storm. Tex Heart Inst J 2011.38: 111&#x2013;121.</Citation></Reference><Reference><Citation>Hendel RC, Berman DS, Di Carli MF, et al.; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Nuclear Cardiology; American College of Radiology; American Heart Association; American Society of Echocardiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; Society of Nuclear Medicine: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: A report of the American College of Cardiology Foundation appropriate use criteria task force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the society of cardiovascular computed tomography, the society for cardiovascular magnetic resonance, and the society of nuclear medicine. J Am Coll Cardiol 2009.53: 2201&#x2013;2229.</Citation></Reference><Reference><Citation>Haegeli LM, Della Bella P, Brunckhorst CB. Management of a patient with electrical storm: Role of epicardial catheter ablation. Circulation 2016.133: 672&#x2013;676.</Citation></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 2018.138: e272&#x2013;e391.</Citation></Reference><Reference><Citation>Virk SA, Keren A, John RM, Santageli P, Eslick A, Kumar S. Mechanical circulatory support during catheter ablation of ventricular tachycardia: Indications and options. Heart Lung Circ 2019.28: 134&#x2013;145.</Citation></Reference><Reference><Citation>Nakahara S, Tung R, Ramirez RJ, et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol 2010.55: 2355&#x2013;2365.</Citation></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, et al.; SOAP II Investigators: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010.362: 779&#x2013;789.</Citation></Reference><Reference><Citation>Santangeli P, Zado ES, Supple GE, et al. Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2015.8: 1413&#x2013;1421.</Citation></Reference><Reference><Citation>Bunch TJ, Mahapatra S, Madhu Reddy Y, Lakkireddy D. The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation. Europace 2012.14(suppl 2): ii26&#x2013;ii32.</Citation></Reference><Reference><Citation>Reddy YM, Chinitz L, Mansour M, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation: Multicenter experience. Circ Arrhythm Electrophysiol 2014.7: 244&#x2013;250.</Citation></Reference><Reference><Citation>Turagam MK, Vuddanda V, Koerber S, et al. Percutaneous ventricular assist device in ventricular tachycardia ablation: A systematic review and meta-analysis. J Interv Card Electrophysiol 2019.55: 197&#x2013;205.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Arora S, Lahewala S, et al. Temporary mechanical circulatory support for refractory cardiogenic shock before left ventricular assist device surgery. J Am Heart Assoc 2018.7: e010193.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Arora S, Sakhuja A, et al. Trends, predictors, and outcomes of temporary mechanical circulatory support for postcardiac surgery cardiogenic shock. Am J Cardiol 2019.123: 489&#x2013;497.</Citation></Reference><Reference><Citation>Vallabhajosyula S, O&#x2019;Horo JC, Antharam P, et al. Concomitant intra-aortic balloon pump use in cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation. Circ Cardiovasc Interv 2018.11: e006930.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Patlolla SH, Sandhyavenu H, et al. Periprocedural cardiopulmonary bypass or venoarterial extracorporeal membrane oxygenation during transcatheter aortic valve replacement: A systematic review. J Am Heart Assoc. 2018.7; e009608.</Citation></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, et al.; STROBE Initiative: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Med 2007.4: e297.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Kanmanthareddy A, Erwin PJ, Esterbrooks DJ, Morrow LE. Role of statins in delirium prevention in critical ill and cardiac surgery patients: A systematic review and meta-analysis. J Crit Care 2017.37: 189&#x2013;196.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Rayes HA, Sakhuja A, Murad MH, Geske JB, Jentzer JC. Global longitudinal strain using speckle-tracking echocardiography as a mortality predictor in sepsis: A systematic review. J Intensive Care Med 2019.34: 87&#x2013;93.</Citation></Reference><Reference><Citation>Vallabhajosyula S, O&#x2019;Horo JC, Antharam P, et al. Venoarterial extracorporeal membrane oxygenation with concomitant impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock. ASAIO J. 2020.66:497&#x2013;503.</Citation></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2012. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Baratto F, Pappalardo F, Oloriz T, et al. Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 2016.9: e004492.</Citation></Reference><Reference><Citation>Di Monaco A, Quadrini F, Troisi F, et al. Cardiopulmonary support in patients undergoing catheter ablation of poorly tolerated ventricular arrhythmias and electrical storm. J Cardiovasc Electrophysiol 2019.30: 1281&#x2013;1286.</Citation></Reference><Reference><Citation>Enriquez A, Liang J, Gentile J, et al. Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm. Heart Rhythm 2018.15: 75&#x2013;80.</Citation></Reference><Reference><Citation>Garc&#xed;a Carre&#xf1;o J, Sousa-Casasnovas I, Vicent Alaminos ML, Atienza Fern&#xe1;ndez F, Mart&#xed;nez Sell&#xe9;s M, Fern&#xe1;ndez Avil&#xe9;s F. Extracorporeal membrane oxygenation in patients with electrical storm: A single-center experience. Rev Esp Cardiol (Engl Ed) 2019.72: 182&#x2013;183.</Citation></Reference><Reference><Citation>L&#xfc; F, Eckman PM, Liao KK, et al. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. Int J Cardiol 2013.168: 3859&#x2013;3865.</Citation></Reference><Reference><Citation>Uribarri A, Bravo L, Jimenez-Candil J, Martin-Moreiras J, Villacorta E, Sanchez PL. Percutaneous extracorporeal membrane oxygenation in electrical storm: Five case reports addressing efficacy, transferring allowance or radiofrequency ablation support. Eur Heart J Acute Cardiovasc Care 2018.7: 484&#x2013;489.</Citation></Reference><Reference><Citation>Zanobini M, Rossi F, Bertera A, et al. Cardiopulmonary support during electrophysiological procedures for ventricular tachycardias not haemodynamically tolerated. Perfusion 2003.18: 79&#x2013;82.</Citation></Reference><Reference><Citation>Bhandary SP, Joseph N, Hofmann JP, Saranteas T, Papadimos TJ. Extracorporeal life support for refractory ventricular tachycardia. Ann Transl Med 2017.5: 73.</Citation></Reference><Reference><Citation>Mazzucotelli JP, Leprince P, Litzler PY, et al.; reflection group on mechanical circulatory support (GRAM): Results of mechanical circulatory support in France. Eur J Cardiothorac Surg 2011.40: e112&#x2013;e117.</Citation></Reference><Reference><Citation>Ostadal P, Mlcek M, Holy F, et al. Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model. Circ Arrhythm Electrophysiol 2012.5: 1202&#x2013;1206.</Citation></Reference><Reference><Citation>Della Bella P, Baratto F, Tsiachris D, et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation 2013.127: 1359&#x2013;1368.</Citation></Reference><Reference><Citation>Mathuria N, Wu G, Rojas-Delgado F, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol 2017.48: 27&#x2013;34.</Citation></Reference><Reference><Citation>Chen CY, Tsai J, Hsu TY, et al. ECMO used in a refractory ventricular tachycardia and ventricular fibrillation patient: A National Case-Control Study. Medicine (Baltimore) 2016.95: e3204.</Citation></Reference><Reference><Citation>Exner DV, Pinski SL, Wyse DG, et al.; AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators: Electrical storm presages nonsudden death: The antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001.103: 2066&#x2013;2071.</Citation></Reference><Reference><Citation>Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia: A single-center experience. Circ Arrhythm Electrophysiol 2014.7: 684&#x2013;690.</Citation></Reference><Reference><Citation>Smith A, Hardison D, Bridges B, Pietsch J. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion 2013.28: 54&#x2013;60.</Citation></Reference><Reference><Citation>Tanaka D, Hirose H, Cavarocchi N, Entwistle JW. The impact of vascular complications on survival of patients on venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg 2016.101: 1729&#x2013;1734.</Citation></Reference><Reference><Citation>Aziz F, Brehm CE, El-Banyosy A, Han DC, Atnip RG, Reed AB. Arterial complications in patients undergoing extracorporeal membrane oxygenation via femoral cannulation. Ann Vasc Surg 2014.28: 178&#x2013;183.</Citation></Reference><Reference><Citation>Foley PJ, Morris RJ, Woo EY, et al. Limb ischemia during femoral cannulation for cardiopulmonary support. J Vasc Surg 2010.52: 850&#x2013;853.</Citation></Reference><Reference><Citation>Tung R, Boyle NG, Shivkumar K. Catheter ablation of ventricular tachycardia. Circulation 2010.122: e389&#x2013;e391.</Citation></Reference><Reference><Citation>Rao G, Lopez-Jimenez F, Boyd J, et al.; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; and Stroke Council: Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: A scientific statement from the American Heart Association. Circulation 2017.136: e172&#x2013;e194.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33512605</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>67</EndPage><MedlinePgn>59-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-021-00948-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Catheter ablation of ventricular tachycardia (VT) is associated with potential major complications, including mortality. The risk of acute complications in patients with ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy (NICM) has not been systematically evaluated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed was searched for studies of catheter ablation of VT published between September 2009 and September 2019. Pre-specified primary outcomes were (1) rate of major acute complications, including death, and (2) mortality rate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 7395 references were evaluated for relevance. From this, 50 studies with a total of 3833 patients undergoing 4319 VT ablation procedures fulfilled the inclusion criteria (mean age 59&#xa0;years; male 82%; 2363 [62%] ICM; 1470 [38%] NICM). The overall major complication rate in ICM cohorts was 9.4% (95% CI, 8.1-10.7) and NICM cohorts was 7.1% (95% CI, 6.0-8.3). Reported complication rates were highly variable between studies (ICM I<sup>2</sup>&#xa0;=&#x2009;90%; NICM I<sup>2</sup>&#xa0;=&#x2009;89%). Vascular complications (ICM 2.5% [95% CI, 1.9-3.1]; NICM 1.2% [95% CI, 0.7-1.7]) and cerebrovascular events (ICM 0.5% [95% CI, 0.2-0.7]; NICM, 0.1% [95% CI, 0-0.2]) were significantly higher in ICM cohorts. Acute mortality rates in the ICM and NICM cohorts were low (ICM 0.9% [95% CI, 0.5-1.3]; NICM 0.6% [95% CI, 0.3-1.0]) with the majority of overall deaths (ICM 75%; NICM 80%) due to either recurrent VT or cardiogenic shock.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Overall acute complication rates of VT ablation are comparable between ICM and NICM patients. However, the pattern and predictors of complications vary depending on the underlying cardiomyopathy.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Wern Yew</ForeName><Initials>WY</Initials><Identifier Source="ORCID">0000-0003-3596-6545</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK. dwyew@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science, Liverpool, UK. dwyew@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearman</LastName><ForeName>Charles M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Cardiac Physiology, Institute of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnett</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adlan</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Shui Hao</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denham</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unit of Cardiac Physiology, Institute of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modi</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Derick</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Mark C S</ForeName><Initials>MCS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahida</LastName><ForeName>Saagar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science, Liverpool, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Death</Keyword><Keyword MajorTopicYN="N">Ischaemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Non-ischaemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Structural heart disease</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList><CoiStatement>The author declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33512605</ArticleId><ArticleId IdType="pmc">PMC8755671</ArticleId><ArticleId IdType="doi">10.1007/s10840-021-00948-6</ArticleId><ArticleId IdType="pii">10.1007/s10840-021-00948-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877&#x2013;883. doi: 10.1056/NEJMoa013474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa013474</ArticleId><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225&#x2013;237. doi: 10.1056/NEJMoa043399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa043399</ArticleId><ArticleId IdType="pubmed">15659722</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, di Biase L, Roux JF, Verma A, Natale A, Essebag V. A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol. 2015;31(3):270&#x2013;277. doi: 10.1016/j.cjca.2014.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2014.11.023</ArticleId><ArticleId IdType="pubmed">25746019</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Armenta J, Andreu D, Penela D, Trucco E, Cipolletta L, Arbelo E, et al. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014;11(5):747&#x2013;754. doi: 10.1016/j.hrthm.2014.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2014.02.016</ArticleId><ArticleId IdType="pubmed">24561159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck K-H, Schaumann A, Eckardt L, Willems S, Ventura R, Delacretaz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375(9708):31&#x2013;40. doi: 10.1016/S0140-6736(09)61755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61755-4</ArticleId><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin J-F, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111&#x2013;121. doi: 10.1056/NEJMoa1513614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1513614</ArticleId><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Barra S, Begley D, Heck P, Turner I, Agarwal S. Ablation of ventricular tachycardia in the very elderly patient with cardiomyopathy: how old is too old? Can J Cardiol. 2015;31(6):717&#x2013;722. doi: 10.1016/j.cjca.2014.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2014.12.016</ArticleId><ArticleId IdType="pubmed">25869352</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahapatra S, Tucker-Schwartz J, Wiggins D, Gillies GT, Mason PK, McDaniel G, LaPar DJ, Stemland C, Sosa E, Ferguson JD, Bunch TJ, Ailawadi G, Scanavacca M. Pressure frequency characteristics of the pericardial space and thorax during subxiphoid access for epicardial ventricular tachycardia ablation. Heart Rhythm. 2010;7(5):604&#x2013;609. doi: 10.1016/j.hrthm.2010.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2010.01.011</ArticleId><ArticleId IdType="pmc">PMC3047445</ArticleId><ArticleId IdType="pubmed">20156612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunch TJ, Darby A, May HT, Ragosta M, Lim DS, Taylor AM, DiMarco JP, Ailawadi G, Revenaugh JR, Weiss JP, Mahapatra S. Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace. 2012;14(5):709&#x2013;714. doi: 10.1093/europace/eur347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eur347</ArticleId><ArticleId IdType="pmc">PMC3598428</ArticleId><ArticleId IdType="pubmed">22080473</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;2012. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Perera T, Ganesan A, Sullivan T, Lau DH, Roberts-Thomson KC, Brooks AG, Sanders P. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol. 2013;6(6):1082&#x2013;1088. doi: 10.1161/CIRCEP.113.000768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.113.000768</ArticleId><ArticleId IdType="pubmed">24243785</ArticleId></ArticleIdList></Reference><Reference><Citation>Core Team R. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2019.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046&#x2013;1055. doi: 10.1016/s0895-4356(01)00377-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0895-4356(01)00377-8</ArticleId><ArticleId IdType="pubmed">11576817</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Armenta J, Soto-Iglesias D, Silva E, Penela D, J&#xe1;uregui B, Linhart M, Bisbal F, Acosta J, Fernandez M, Borras R, Villuendas R, Cano L, Guasch E, Mont L, Berruezo A. Safety and outcomes of ventricular tachycardia substrate ablation during sinus rhythm: a prospective multicenter registry. JACC Clin Electrophysiol. 2020;6(11):1435&#x2013;1448. doi: 10.1016/j.jacep.2020.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2020.07.028</ArticleId><ArticleId IdType="pubmed">33121673</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein K, Dalziel K, Garside R, Castelnuovo E, Round A. Association between methodological characteristics and outcome in health technology assessments which included case series. Int J Technol Assess Health Care. 2005;21(3):277&#x2013;287. doi: 10.1017/S0266462305050373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462305050373</ArticleId><ArticleId IdType="pubmed">16110706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23264584</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>8</Issue><PubDate><Year>2013</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>560</StartPage><EndPage>571</EndPage><MedlinePgn>560-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehs453</ELocationID><Abstract><AbstractText>Ablation has substantial evidence base in the management of ventricular arrhythmia (VA). It can be a 'lifesaving' procedure in the acute setting of VA storm. Current reports on ablation in VA storm are in the form of small series and have relative small representation in a large observational series. The purpose of this study was to systematically synthesize the available literature to appreciate the efficacy and safety of ablation in the setting of VA storm. The medical electronic databases through 31 January 2012 were searched. Ventricular arrhythmia storm was defined as recurrent (&#x2265; 3 episodes or defibrillator therapies in 24 h) or incessant (continuous &gt;12 h) VA. Studies reporting data on VA storm patients at the individual or study level were included. A total of 471 VA storm patients from 39 publications were collated for the analysis. All VAs were successfully ablated in 72% [95% confidence interval (CI) 71-89%] and 9% (95% CI: 3-10%) had a failed procedure. Procedure-related mortality occurred in three patients (0.6%). Only 6% patients had a recurrence of VA storm. The recurrence of VA was significantly higher after ablation for arrhythmic storm of monomorphic ventricular tachycardia (VT) relative to ventricular fibrillation or polymorphic VT with underlying cardiomyopathy (odds ratio 3.76; 95% CI: 1.65-8.57; P = 0.002). During the follow-up (61 &#xb1; 37 weeks), 17% of patients died (heart failure 62%, arrhythmias 23%, and non-cardiac 15%) with 55% deaths occurring within 12 weeks of intervention. The odds of death were four times higher after a failed procedure compared with those with a successful procedure (95% CI: 2.04-8.01, P &lt; 0.001). Ventricular arrhythmia storm ablation has high-acute success rates, with a low rate of recurrent storms. Heart failure is the dominant cause of death in the long term. Failure of the acute procedure carries a high mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nayyar</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, SA 5000, Australia. sachin.nayyar@adelaide.edu.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesan</LastName><ForeName>Anand N</ForeName><Initials>AN</Initials></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Roberts-Thomson</LastName><ForeName>Kurt C</ForeName><Initials>KC</Initials></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>Prashanthan</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23264584</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehs453</ArticleId><ArticleId IdType="pii">ehs453</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32124074</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1862-3514</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>02</Day></PubDate></JournalIssue><Title>Archives of osteoporosis</Title><ISOAbbreviation>Arch Osteoporos</ISOAbbreviation></Journal><ArticleTitle>A systematic review of the Irish osteoporotic vertebral fracture literature.</ArticleTitle><Pagination><StartPage>34</StartPage><MedlinePgn>34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11657-020-0704-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Vertebral fractures (VF) are the most common osteoporotic fracture. They are associated with significant morbidity and mortality and are an important predictor of future fractures. The epidemiology of VF in Ireland is limited and a greater understanding of their scale and impact is needed. Therefore, we conducted a systematic review of publications on osteoporotic VF in Ireland.</AbstractText><AbstractText Label="METHODS">Systematic searches were conducted using PubMed, Medline, Embase, Scopus and Cochrane electronic databases to identify eligible publications from Ireland addressing osteoporotic VF.</AbstractText><AbstractText Label="RESULTS">Twenty studies met the inclusion criteria out of 1558 citations. All studies were published since 2000. Data was obtained on 182,771 patients with fractures. Nine studies included more than 100 subjects and three included more than 1000. Females accounted for 70% with an overall mean age of 65.2&#xa0;years (30-94). There was significant heterogeneity in study design, methods and outcome measures including the following: use of administrative claims data on public hospital admissions, surgical and medical interventions, the impact of a fracture liaison service and the osteoporosis economic burden. The prevalence of VF was difficult to ascertain due to definitions used and differences in the study populations. Only two studies systematically reviewed spine imaging using blinded assessors and validated diagnostic criteria to assess the prevalence of fractures in patient cohorts.</AbstractText><AbstractText Label="CONCLUSIONS">Several studies show that VF are common when addressed systematically and the prevalence may be rising. However, there is a deficit of large studies systematically addressing the epidemiology and their importance in Ireland.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCabe</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland. eva.mccabe@nuigalway.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland. eva.mccabe@nuigalway.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Rajneet</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedic Surgery, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heaney</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergin</LastName><ForeName>Diane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCabe</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedic Surgery, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carey</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Osteoporos</MedlineTA><NlmUniqueID>101318988</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007494" MajorTopicYN="N" Type="Geographic">Ireland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Spine</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32124074</ArticleId><ArticleId IdType="doi">10.1007/s11657-020-0704-0</ArticleId><ArticleId IdType="pii">10.1007/s11657-020-0704-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34935704</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4023</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of cardiovascular pharmacology</Title><ISOAbbreviation>J Cardiovasc Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Effect of Dexmedetomidine on Tachyarrhythmias After Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>315</StartPage><EndPage>324</EndPage><MedlinePgn>315-324</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/FJC.0000000000001196</ELocationID><Abstract><AbstractText>Tachyarrhythmias after cardiac surgery is a common occurrence in clinical practice, which can be life threatening. We searched 6 databases, including Embase, PubMed, Cochrane, CNKI, Wanfang, and Sinomed, to evaluate the effect of dexmedetomidine on tachyarrhythmias after adult cardiac surgery. The primary end point was the number of patients with atrial fibrillation (AF) after cardiac surgery. The secondary end points included the number of patients with supraventricular tachycardia or with ventricular tachycardia or with ventricular fibrillation or with myocardial infarction or deceased patients, the duration of mechanical ventilation, the intensive care unit stay, hospital stay, and the number of patients with bradycardia and those with hypotension. Among the 1388 retrieved studies, 18 studies (n = 3171 participants) met our inclusion criteria. Dexmedetomidine reduced the incidence of AF by 17% [relative risk (RR) = 0.83; 95% confidence interval (CI), 0.73-0.93; P = 0.002]. Through subgroup analysis, we found that when the maintenance dose of dexmedetomidine was &gt;0.7 &#xb5;g&#xb7;kg-1&#xb7;h-1, the effect of preventing AF was obvious (RR = 0.58; 95%CI 0.43-0.78; P = 0.0003). Dexmedetomidine also reduced the incidence of supraventricular tachycardia by approximately 70% (RR = 0.29; 95% CI, 0.11-0.77; P = 0.01) and the incidence of ventricular tachycardia by approximately 80% (RR = 0.23; 95% CI, 0.08-0.63; P = 0.004) but had no effect on ventricular fibrillation (RR = 1.02; 95% CI, 0.14-7.31; P = 0.99). The major side effect of dexmedetomidine was bradycardia. Dexmedetomidine can reduce the incidence of AF (especially high dosages), supraventricular tachycardia, and ventricular tachycardia after cardiac surgery in adults, but it does not affect the occurrence of ventricular fibrillation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenzhu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Jining No. 1 People's Hospital, Jining, Shandong, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency, Jining No. 1 People's Hospital, Jining, Shandong, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sishui County Hospital, Jining, Shandong, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mingshan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Qingdao Municipal Hospital Group, Qingdao, Shandong, P.R. China ; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Pharmacol</MedlineTA><NlmUniqueID>7902492</NlmUniqueID><ISSNLinking>0160-2446</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013617" MajorTopicYN="Y">Tachycardia, Supraventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>12</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34935704</ArticleId><ArticleId IdType="doi">10.1097/FJC.0000000000001196</ArticleId><ArticleId IdType="pii">00005344-202203000-00010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitchell LB. Incidence, timing and outcome of atrial tachyarrhythmias after cardiac surgery. In: Steinberg JS, ed. Atrial Fibrillation After Cardiac Surgery. Kluwer Academic Publishers, 2000:37&#x2013;50.</Citation></Reference><Reference><Citation>Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56:539&#x2013;549.</Citation></Reference><Reference><Citation>Yiin GS, Howard DP, Paul NL, et al. Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation 2014;130:1236&#x2013;1244.</Citation></Reference><Reference><Citation>Fax&#xe9;n J, Jernberg T, Hollenberg J, et al. Incidence and predictors of out-of-hospital cardiac arrest within 90 Days after myocardial infarction. J Am Coll Cardiol. 2020;76:2926&#x2013;2936.</Citation></Reference><Reference><Citation>Stanley TO, Mackensen GB, Grocott HP, et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002;94:290&#x2013;295.</Citation></Reference><Reference><Citation>Conen D, Alonso-Coello P, Douketis J, et al. Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. Eur Heart J. 2020;41:645&#x2013;651.</Citation></Reference><Reference><Citation>Kim D, Yang PS, Yu HT, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. Eur Heart J. 2019;40:2313&#x2013;2323.</Citation></Reference><Reference><Citation>Ueki M, Kawasaki T, Habe K, et al. The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass. Anaesthesia 2014;69:693&#x2013;700.</Citation></Reference><Reference><Citation>Narisawa A, Nakane M, Kano T, et al. Dexmedetomidine sedation during the nighttime reduced the incidence of postoperative atrial fibrillation in cardiovascular surgery patients after tracheal extubation. J Intensive Care 2015;3:26.</Citation></Reference><Reference><Citation>Turan A, Bashour CA, You J, et al. Dexmedetomidine sedation after cardiac surgery decreases atrial arrhythmias. J Clin Anesth. 2014;26:634&#x2013;642.</Citation></Reference><Reference><Citation>Liu X, Zhang K, Wang W, et al. Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Crit Care 2016;20:298.</Citation></Reference><Reference><Citation>Zhaoqing C, Guohua C, Liwei D, et al. Application of dexmedetomidine hydrochloride in the prevention and treatment of postoperative complications in patients undergoing valve replacement surgery. Lingnan J Cardiovasc Dis. 2018;3:293&#x2013;300.</Citation></Reference><Reference><Citation>Ren J, Zhang H, Huang L, et al. Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Exp Ther Med. 2013;6:497&#x2013;502.</Citation></Reference><Reference><Citation>Yu X, Zhang Y, Wan H. The preventive effect of dexmedetomidine on postoperative atrial fibrillation in patients undergoing cardiac surgery. Mod Chin Doctors 2019:25&#x2013;28.</Citation></Reference><Reference><Citation>G&#xf6;ksedef D, Balkanay OO, &#xd6;mero&#x11f;lu SN, et al. The effects of dexmedetomidine infusion on renal functions after coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled study. Turkish J Thorac Cardiovasc Surg. 2013;21:594&#x2013;602.</Citation></Reference><Reference><Citation>Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;17:576&#x2010;84.</Citation></Reference><Reference><Citation>Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 1997;86:331&#x2013;345.</Citation></Reference><Reference><Citation>Shi C, Jin J, Qiao L, et al. Effect of perioperative administration of dexmedetomidine on delirium after cardiac surgery in elderly patients: a double-blinded, multi-center, randomized study. Clin interventions Aging 2019;14:571&#x2013;575.</Citation></Reference><Reference><Citation>Zi J, Fan Y, Dong C, et al. Anxiety administrated by dexmedetomidine to prevent new-onset of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass graft. Int Heart J. 2020;61:263&#x2013;272.</Citation></Reference><Reference><Citation>Zhu Z, Zhou H, Ni Y, et al. Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis. Drug Des Development Ther. 2018;12:521&#x2013;531.</Citation></Reference><Reference><Citation>Balkanay OO, Goksedef D, Omeroglu SN, et al. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interactive Cardiovasc Thorac Surg. 2015;20:209&#x2013;214.</Citation></Reference><Reference><Citation>Corbett SM, Rebuck JA, Greene CM, et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med. 2005;33:940&#x2013;945.</Citation></Reference><Reference><Citation>Djaiani G, Silverton N, Fedorko L, et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology. 2016;124:362&#x2013;368.</Citation></Reference><Reference><Citation>Karaman Y, Abud B, Tekgul ZT, et al. Effects of dexmedetomidine and propofol on sedation in patients after coronary artery bypass graft surgery in a fast-track recovery room setting. J Anesth. 2015;29:522&#x2010;8.</Citation></Reference><Reference><Citation>Li X, Yang J, Nie XL, et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PLoS One 2017;12:e0170757.</Citation></Reference><Reference><Citation>Liu X, Zhang K, Wang W, et al. Dexmedetomidine versus propofol sedation improves sublingual microcirculation after cardiac surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2016;30:1509&#x2013;1515.</Citation></Reference><Reference><Citation>Park JB, Bang SH, Chee HK, et al. Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean J Thorac Cardiovasc Surg. 2014;47:249&#x2013;254.</Citation></Reference><Reference><Citation>Shehabi Y, Grant P, Wolfenden H, et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study). Anesthesiology. 2009;111:1075&#x2013;1084.</Citation></Reference><Reference><Citation>Turan A, Duncan A, Leung S, et al. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020;396:177&#x2013;185.</Citation></Reference><Reference><Citation>Hayashi Y, Sumikawa K, Maze M, et al. Dexmedetomidine prevents epinephrine-induced arrhythmias through stimulation of central alpha 2 adrenoceptors in halothane-anesthetized dogs. Anesthesiology. 1991;75:113&#x2013;117.</Citation></Reference><Reference><Citation>Tsutsui K, Hayami N, Kunishima T, et al. Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome. Circ J. 2012;76:2343&#x2013;2347.</Citation></Reference><Reference><Citation>Yu T, Liu D, Gao M, et al. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of &#x3b1;7nAChR and PI3K/Akt- mediated autophagy. Biomed Pharmacother. 2019;120:109231.</Citation></Reference><Reference><Citation>Liu XR, Li T, Cao L, et al. Dexmedetomidine attenuates H2O2-induced neonatal rat cardiomyocytes apoptosis through mitochondria- and ER-medicated oxidative stress pathways. Mol Med Rep. 2018;17:7258&#x2013;7264.</Citation></Reference><Reference><Citation>Liu Y, Zhang L, Wang S, et al. Dexmedetomidine reduces atrial fibrillation after adult cardiac surgery: a meta-analysis of randomized controlled trials. Am J Cardiovasc Drugs. 2020;20:271&#x2013;281.</Citation></Reference><Reference><Citation>Mir&#xf3; O, de la Red G, Fontanals J. Cessation of paroxysmal atrial fibrillation during acute intravenous propofol administration. Anesthesiology. 2000;92:910.</Citation></Reference><Reference><Citation>Lai LP, Lin JL, Wu MH, et al. Usefulness of intravenous propofol anesthesia for radiofrequency catheter ablation in patients with tachyarrhythmias: infeasibility for pediatric patients with ectopic atrial tachycardia. Pacing Clin Electrophysiol. 1999;22:1358&#x2013;1364.</Citation></Reference><Reference><Citation>Peng K, Ji FH, Liu HY, et al. Effects of perioperative dexmedetomidine on postoperative mortality and Morbidity: a systematic review and meta-analysis. Clin Ther. 2019;41:138&#x2013;154.e4.</Citation></Reference><Reference><Citation>Lin YY, He B, Chen J, et al. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis. Crit Care. 2012;16:R169.</Citation></Reference><Reference><Citation>Celis-Rodr&#xed;guez E, D&#xed;az Cort&#xe9;s JC, C&#xe1;rdenas Bol&#xed;var YR, et al. Evidence-based clinical practice guidelines for the management of sedoanalgesia and delirium in critically ill adult patients. Med Intensiva. 2020;44:171&#x2013;184.</Citation></Reference><Reference><Citation>Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012;307:1151&#x2013;1160.</Citation></Reference><Reference><Citation>Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;17:576&#x2013;584.</Citation></Reference><Reference><Citation>Martin E, Ramsay G, Mantz J, et al. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med. 2003;18:29&#x2013;41.</Citation></Reference><Reference><Citation>Kirchhof P, Benussi S, Kotecha D, et al. ESC guidelines for the management of atrial fibrillation Developed in Collaboration with EACTS. Rev Esp Cardiol. 2017;70:50.</Citation></Reference><Reference><Citation>Arsenault KA, Yusuf AM, Crystal E, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2013;2013:Cd003611.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35270411</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Efficacy of Treatments in Nonarteritic Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2718</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph19052718</ELocationID><Abstract><AbstractText Label="BACKGROUND">Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) is the second most common cause of optic nerve-related permanent visual loss in adults.</AbstractText><AbstractText Label="AIM">We aimed to analyze the efficacy of the noninvasive and minimally invasive therapeutic options of NAION.</AbstractText><AbstractText Label="METHODS">We performed a systematic literature search in MEDLINE, EMBASE, and CENTRAL from inception to 10 June 2019 to identify the studies that report on the effect of different therapies on visual acuity (VA) and visual field (VF). Weighted mean difference (WMD) with 95% confidence interval (CI) was calculated for these outcomes. The efficacy of steroids was investigated in quantitative, oxygen, steroid plus erythropoietin (EPO), levodopa/carbidopa, memantine, and heparin-induced extracorporeal LDL/fibrinogen precipitation (HELP) therapies and other therapeutic modalities in qualitative synthesis.</AbstractText><AbstractText Label="RESULTS">Thirty-two studies were found to be eligible. We found that steroid therapy compared to control did not improve VA (<i>p</i> = 0.182, WMD = 0.14, 95% CI: -0.07, 0.35) or VF (<i>p</i> = 0.853, WMD = 0.16, 95% CI: -1.54, 1.86). Qualitative analysis could be performed for oxygen, steroid plus EPO, and HELP as well, however, none of them showed VA and VF benefit. Two individual studies found memantine and levodopa beneficial regarding VA.</AbstractText><AbstractText Label="CONCLUSION">Our systematic review did not reveal any effective treatment. Further investigations are needed to find therapy for NAION.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lantos</LastName><ForeName>Krisztina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Medical School, University of P&#xe9;cs, 7632 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xf6;m&#xf6;t&#xf6;r</LastName><ForeName>Zsuzsa R&#xe9;ka</ForeName><Initials>ZR</Initials><Identifier Source="ORCID">0000-0002-3561-2539</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Medical School, University of Debrecen, 4032 Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farkas</LastName><ForeName>Nelli</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Bioanalysis, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiss</LastName><ForeName>Szabolcs</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5032-866X</Identifier><AffiliationInfo><Affiliation>Doctoral School of Clinical Medicine, University of Szeged, 6720 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szak&#xe1;cs</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7035-941X</Identifier><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garami</LastName><ForeName>Andr&#xe1;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2493-0571</Identifier><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varga</LastName><ForeName>G&#xe1;bor</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5506-8198</Identifier><AffiliationInfo><Affiliation>Department of Oral Biology, Faculty of Dentistry, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lujber</LastName><ForeName>L&#xe1;szl&#xf3;</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Medical School, University of P&#xe9;cs, 7621 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaan</LastName><ForeName>Reem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Public Health Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegyi</LastName><ForeName>P&#xe9;ter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feh&#xe9;r</LastName><ForeName>Gergely</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Primary Health Care, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ga&#xe1;l</LastName><ForeName>Val&#xe9;ria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-3905-1414</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Medical School, University of P&#xe9;cs, 7632 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013256">Steroids</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical><Chemical><RegistryNumber>W8O17SJF3T</RegistryNumber><NameOfSubstance UI="D008559">Memantine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008559" MajorTopicYN="N">Memantine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018917" MajorTopicYN="Y">Optic Neuropathy, Ischemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013256" MajorTopicYN="N">Steroids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NAION</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">nonarteritic ischemic optic neuropathy</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>15</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35270411</ArticleId><ArticleId IdType="pmc">PMC8910678</ArticleId><ArticleId IdType="doi">10.3390/ijerph19052718</ArticleId><ArticleId IdType="pii">ijerph19052718</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pakravan M., Sanjari N., Esfandiari H., Pakravan P., Yaseri M. The effect of high-dose steroids, and normobaric oxygen therapy, on recent onset non-arteritic anterior ischemic optic neuropathy: A randomized clinical trial. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2016;254:2043&#x2013;2048. doi: 10.1007/s00417-016-3451-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-016-3451-6</ArticleId><ArticleId IdType="pubmed">27510295</ArticleId></ArticleIdList></Reference><Reference><Citation>Judit Somlai T.K.E. Neuro-Ophthalmology, Vascular Diseases of the Optic Nerve: The Neuro-Ophthalmologist&#x2019;s Approach. Springer International Publishing; Cham, Switzerland: 2016. p. 395.</Citation></Reference><Reference><Citation>Atkins E.J., Bruce B., Newman N.J., Biousse V. Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy. Surv. Ophthalmol. 2010;55:47&#x2013;63. doi: 10.1016/j.survophthal.2009.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.survophthal.2009.06.008</ArticleId><ArticleId IdType="pmc">PMC3721361</ArticleId><ArticleId IdType="pubmed">20006051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebolleda G., P&#xe9;rez-L&#xf3;pez M., Casas-Llera P., Contreras I., Mu&#xf1;oz-Negrete F.J. Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2013;251:255&#x2013;260. doi: 10.1007/s00417-012-1995-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-012-1995-7</ArticleId><ArticleId IdType="pubmed">22441810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakravan M., Esfandiari H., Hassanpour K., Razavi S., Pakravan P. The Effect of Combined Systemic Erythropoietin and Steroid on Non-arteritic Anterior Ischemic Optic Neuropathy: A Prospective Study. Curr. Eye Res. 2017;42:1079&#x2013;1084. doi: 10.1080/02713683.2016.1270328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02713683.2016.1270328</ArticleId><ArticleId IdType="pubmed">28632028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinori M., Ben-Bassat I., Wasserzug Y., Chetrit A., Huna-Baron R. Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy&#x2013;retrospective analysis. BMC Ophthalmol. 2014;14:62. doi: 10.1186/1471-2415-14-62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2415-14-62</ArticleId><ArticleId IdType="pmc">PMC4017224</ArticleId><ArticleId IdType="pubmed">24886579</ArticleId></ArticleIdList></Reference><Reference><Citation>Steigerwalt R.D., Cesarone M.R., Belcaro G., Pascarella A., De Angelis M., Bacci S. Nonarteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids. Int. J. Angiol. 2008;17:193&#x2013;196. doi: 10.1055/s-0031-1278308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1278308</ArticleId><ArticleId IdType="pmc">PMC2728919</ArticleId><ArticleId IdType="pubmed">22477448</ArticleId></ArticleIdList></Reference><Reference><Citation>Radoi C., Garcia T., Brugniart C., Ducasse A., Arndt C. Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2013;252:339&#x2013;345. doi: 10.1007/s00417-013-2499-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-013-2499-9</ArticleId><ArticleId IdType="pubmed">24178807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaderli B., Avci R., Yucel A., Guler K., Gelisken O. Intravitreal Triamcinolone Improves Recovery of Visual Acuity in Nonarteritic Anterior Ischemic Optic Neuropathy. J. Neuro-Ophthalmol. 2007;27:164&#x2013;168. doi: 10.1097/WNO.0b013e31814a5a9a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0b013e31814a5a9a</ArticleId><ArticleId IdType="pubmed">17895814</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayreh S.S., Zimmerman M.B. Non-arteritic anterior ischemic optic neuropathy: Role of systemic corticosteroid therapy. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2008;246:1029&#x2013;1046. doi: 10.1007/s00417-008-0805-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-008-0805-8</ArticleId><ArticleId IdType="pmc">PMC2712323</ArticleId><ArticleId IdType="pubmed">18404273</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena R., Singh D., Sharma M., James M., Sharma P., Menon V. Steroids versus No Steroids in Nonarteritic Anterior Ischemic Optic Neuropathy: A Randomized Controlled Trial. Ophthalmology. 2018;125:1623&#x2013;1627. doi: 10.1016/j.ophtha.2018.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2018.03.032</ArticleId><ArticleId IdType="pubmed">29705054</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidovi&#x107; T., Cerovski B., Peri&#x107; S., Kordi&#x107; R., Mrazovac D. Corticosteroid therapy in patients with non-arteritic anterior ischemic optic neuropathy. Coll. Antropol. 2015;39:63&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">26040070</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaman A., Selver O.B., Saatci A.O., Soylev M.F. Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy. Clin. Exp. Optom. 2008;91:561&#x2013;564. doi: 10.1111/j.1444-0938.2008.00287.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1444-0938.2008.00287.x</ArticleId><ArticleId IdType="pubmed">18976422</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokosch V., Thanos S. Visual outcome of patients following NAION after treatment with adjunctive fluocortolone. Restor. Neurol. Neurosci. 2014;32:381&#x2013;389. doi: 10.3233/RNN-120292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/RNN-120292</ArticleId><ArticleId IdType="pubmed">24225379</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson L.N., Gould T.J., Krohel G.B. Effect of Levodopa and Carbidopa on Recovery of Visual Function in Patients With Nonarteritic Anterior Ischemic Optic Neuropathy of Longer Than Six Months&#x2019; Duration. Am. J. Ophthalmol. 1996;121:77&#x2013;83. doi: 10.1016/S0002-9394(14)70536-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9394(14)70536-7</ArticleId><ArticleId IdType="pubmed">8554083</ArticleId></ArticleIdList></Reference><Reference><Citation>Simsek T., Eryilmaz T., Acaroglu G. Efficacy of levodopa and carbidopa on visual function in patients with non-arteritic anterior ischaemic optic neuropathy. Int. J. Clin. Pr. 2005;59:287&#x2013;290. doi: 10.1111/j.1742-1241.2005.00462.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2005.00462.x</ArticleId><ArticleId IdType="pubmed">15857324</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson L.N., E Guy M., Krohel G.B., Madsen R.W. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107:521&#x2013;526. doi: 10.1016/S0161-6420(99)00133-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-6420(99)00133-5</ArticleId><ArticleId IdType="pubmed">10711891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyttle D.P., Johnson L.N., Margolin E.A., Madsen R.W. Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2016;254:757&#x2013;764. doi: 10.1007/s00417-015-3191-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-015-3191-z</ArticleId><ArticleId IdType="pubmed">26483145</ArticleId></ArticleIdList></Reference><Reference><Citation>Modarres M., Falavarjani K.G., Nazari H., Sanjari M.S., Aghamohammadi F., Homaii M., Samiy N. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br. J. Ophthalmol. 2011;95:992&#x2013;995. doi: 10.1136/bjo.2010.191627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.2010.191627</ArticleId><ArticleId IdType="pubmed">21131378</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazzone H.E., Kupersmith M.J., Leibmann J. Does topical brimonidine tartrate help NAION? Br. J. Ophthalmol. 2003;87:1193&#x2013;1194. doi: 10.1136/bjo.87.9.1193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.87.9.1193</ArticleId><ArticleId IdType="pmc">PMC1771838</ArticleId><ArticleId IdType="pubmed">12928304</ArticleId></ArticleIdList></Reference><Reference><Citation>The BRAION study group. Wilhelm B., L&#xfc;dtke H., Wilhelm H. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): A 3-month, double-masked, randomised, placebo-controlled trial. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2005;244:551&#x2013;558. doi: 10.1007/s00417-005-0102-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-005-0102-8</ArticleId><ArticleId IdType="pubmed">16151785</ArticleId></ArticleIdList></Reference><Reference><Citation>Riazi E.M., Aalami H.Z., Kiumehr S., Gholmi A., Tabasi A., Piri N., Mirshahi A., Nili A.M., Movassat M., Fakhraee G. Memantine treatment in acute nonarteric anterior ischemic optic neuropathy: A Randomized Clinical Trial. J. Curr. Ophthalmol. 2011;23:11&#x2013;20.</Citation></Reference><Reference><Citation>Aftab A.M., Iqbal M., Rauf A., Ali A. Non arteritic anterior ischemic optic neuropathy; does Anticoagulation help? J. Ayub Med Coll. Abbottabad. 2017;28:776&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">28586576</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas A., Walzl M., Jesenik F., Walzl B., Berghold A., Bergl&#xf6;ff J., Feigl B., Faulborn J. Application of HELP in nonarteritic anterior ischemic optic neuropathy: A prospective, randomized, controlled study. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 1997;235:14&#x2013;19. doi: 10.1007/BF01007832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01007832</ArticleId><ArticleId IdType="pubmed">9034837</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramunni A., Giancipoli G., Guerriero S., Lapenna L., Saracino A., Saliani M.T., Capurso A., Sborgia C., Coratelli P. LDL-Apheresis Accelerates the Recovery of Nonarteritic Acute Anterior Ischemic Optic Neuropathy. Ther. Apher. Dial. 2005;9:53&#x2013;58. doi: 10.1111/j.1774-9987.2005.00205.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1774-9987.2005.00205.x</ArticleId><ArticleId IdType="pubmed">15828907</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerriero S., Giancipoli G., Cantatore A., Sacco G., Brescia P., Saliani M.T., Ramunni A., Guerriero G.G.S. LDL apheresis in the treatment of non-arteritic ischaemic optic neuropathy: A 6-month follow-up study. Eye. 2008;23:1343&#x2013;1344. doi: 10.1038/eye.2008.287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/eye.2008.287</ArticleId><ArticleId IdType="pubmed">18806764</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajin M.S., Selver O.B., Taskin O., Yaman A., Saatci A.O. Single intravitreal ranibizumab injection in eyes with acute non-arteritic anterior ischaemic optic neuropathy. Clin. Exp. Optom. 2011;94:367&#x2013;370. doi: 10.1111/j.1444-0938.2010.00570.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1444-0938.2010.00570.x</ArticleId><ArticleId IdType="pubmed">21255078</ArticleId></ArticleIdList></Reference><Reference><Citation>Saatci A.O., Taskin O., Selver O.B., Yaman A., Bajin M.S. Efficacy of Intravitreal Ranibizumab Injection in Acute Nonarteritic Ischemic Optic Neuropathy: A Long-Term Follow Up&#xa7;. Open Ophthalmol. J. 2013;7:58&#x2013;62. doi: 10.2174/1874364101307010058.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874364101307010058</ArticleId><ArticleId IdType="pmc">PMC3795401</ArticleId><ArticleId IdType="pubmed">24133556</ArticleId></ArticleIdList></Reference><Reference><Citation>Rootman D.B., Gill H.S., A Margolin E. Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: A prospective trial. Eye. 2013;27:538&#x2013;544. doi: 10.1038/eye.2012.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/eye.2012.296</ArticleId><ArticleId IdType="pmc">PMC3626001</ArticleId><ArticleId IdType="pubmed">23370417</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L.A., PRISMA-P Group Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A., editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; Oxford, UK: 2020. Version 6.1. updated September 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Holladay J.T. Proper method for calculating average visual acuity. J. Refract. Surg. 1997;13:388&#x2013;391. doi: 10.3928/1081-597X-19970701-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/1081-597X-19970701-16</ArticleId><ArticleId IdType="pubmed">9268940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeting M.J., Sutton A., Lambert P.C. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat. Med. 2004;23:1351&#x2013;1375. doi: 10.1002/sim.1761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1761</ArticleId><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Altman D.G., G&#xf8;tzsche P.C., J&#xfc;ni P., Moher D., Oxman A.D., Savovi&#x107; J., Schulz K.F., Weeks L., Sterne J.A. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A., Hern&#xe1;n M.A., McAleenan A., Reeves B.C., Higgins J.P. Chapter 25: Assessing risk of bias in a non-randomized study. In: Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020) Cochrane; Oxford, UK: 2020.</Citation></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., Sch&#xfc;nemann H.J. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayreh S.S., Zimmerman M.B. Nonarteritic Anterior Ischemic Optic Neuropathy: Natural History of Visual Outcome. Ophthalmology. 2008;115:298&#x2013;305.e2. doi: 10.1016/j.ophtha.2007.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2007.05.027</ArticleId><ArticleId IdType="pmc">PMC2782939</ArticleId><ArticleId IdType="pubmed">17698200</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott C.R., Sklar C.A., Lesser R.L., Adelman R.A. Is Intravitreal Bevacizumab an Effective Treatment Option for Nonarteritic Anterior Ischemic Optic Neuropathy? J. Neuro-Ophthalmol. 2012;32:51&#x2013;53. doi: 10.1097/WNO.0b013e318240596e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0b013e318240596e</ArticleId><ArticleId IdType="pubmed">22269947</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas A., Uyguner I., Sochor G., Schmut O., Vidic B., Faulborn J. Nichtarteriitische vordere isch&#xe4;mische Optikusneuropathie: Langzeitergebnisse nach H&#xe4;modilutionstherapie. Klin. Mon. F&#xfc;r Augenheilkd. 1994;205:143&#x2013;146. doi: 10.1055/s-2008-1045507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1045507</ArticleId><ArticleId IdType="pubmed">7527879</ArticleId></ArticleIdList></Reference><Reference><Citation>Boji&#x107; L., Kovacevi&#x107; H., Andri&#x107; D., Karaman-Kraljevi&#x107; K., Cagalj S. The effects of hyperbaric oxygen on visual functions in ischaemic optic neuropathy. Arch. Ind. Hyg. Toxicol. 1994;45:19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">8067909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjari N., Pakravan M., Nourinia R., Esfandiari H., Hafezi-Moghadam A., Zandi S., Nakao S., Shah-Heidari M.-H., Jamali A., Yaseri M., et al. Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy. J. Clin. Pharmacol. 2015;56:749&#x2013;753. doi: 10.1002/jcph.655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.655</ArticleId><ArticleId IdType="pubmed">26444290</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Zhu J., Chen L., Hu C., Du Y. Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2019;98:e17861. doi: 10.1097/MD.0000000000017861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000017861</ArticleId><ArticleId IdType="pmc">PMC6867765</ArticleId><ArticleId IdType="pubmed">31725628</ArticleId></ArticleIdList></Reference><Reference><Citation>Mac Grory B., Lavin P., Kirshner H., Schrag M. Thrombolytic Therapy for Acute Central Retinal Artery Occlusion. Stroke. 2020;51:687&#x2013;695. doi: 10.1161/STROKEAHA.119.027478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.119.027478</ArticleId><ArticleId IdType="pubmed">31865896</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33478701</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Renal Denervation for the Management of Refractory Ventricular Arrhythmias: A&#xa0;Systematic&#xa0;Review.</ArticleTitle><Pagination><StartPage>100</StartPage><EndPage>108</EndPage><MedlinePgn>100-108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2020.07.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(20)30701-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The authors performed a systematic review and meta-analysis to determine the efficacy of renal denervation (RDN) in patients with refractory ventricular arrhythmias (VA) or electrical storm (ES).</AbstractText><AbstractText Label="BACKGROUND">Although catheter ablation is efficacious for the treatment of structural heart disease ventricular tachycardia (VT), there are proportion of patients who have refractory VT despite multiple procedures. In this setting, novel adjunctive therapies such as renal denervation have been performed.</AbstractText><AbstractText Label="METHODS">A systematic review of published data was performed. Studies that evaluated patients undergoing RDN for VA or ES were included. Outcome measures of VA, sudden cardiac death, ES, or device therapy were required. Case reports, editorials, and conference presentations were excluded. Random effects meta-analysis was conducted to explore change or final mean values in the study outcomes.</AbstractText><AbstractText Label="RESULTS">A total of 328 articles were identified by the literature search. Seven studies met the eligibility criteria and were included in the systematic review, with a total of 121 pooled patients. The weighted mean age was 63.8 &#xb1; 13.1 years, ejection fraction 30.5 &#xb1; 10.3%, 76% were men, 99% were on a beta blocker, 79% were on amiodarone, 46% had previously undergone catheter ablation, and 8.3% had previously undergone cardiac sympathetic denervation. Meta-analysis demonstrated a significant effect of RDN in reducing implantable cardiac defibrillator therapies, with a standardized mean difference (SMD) of&#xa0;-3.11 (p&#xa0;&lt;&#xa0;0.001). RDN also reduced the number of VA episodes (SMD&#xa0;-2.13; p&#xa0;&lt;&#xa0;0.001), antitachycardia pacing episodes (SMD&#xa0;-2.82; p&#xa0;=&#xa0;0.002), and shocks (SMD&#xa0;-2.82; p&#xa0;=&#xa0;0.002).</AbstractText><AbstractText Label="CONCLUSIONS">RDN is an effective treatment for refractory VAs and ES, although randomized data are lacking.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hawson</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmer</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia; Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowan</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohaib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital and Westmead Applied Research Centre, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Western Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Western Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia; Western Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalman</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital and Westmead Applied Research Centre, Westmead, New South Wales, Australia. Electronic address: saurabh.kumar@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013562" MajorTopicYN="N">Sympathectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">electrical storm</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">renal denervation</Keyword><Keyword MajorTopicYN="N">sudden cardiac death</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmias</Keyword><Keyword MajorTopicYN="N">ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>22</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33478701</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2020.07.019</ArticleId><ArticleId IdType="pii">S2405-500X(20)30701-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28444174</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review.</ArticleTitle><Pagination><StartPage>682</StartPage><EndPage>691</EndPage><MedlinePgn>682-691</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/eux077</ELocationID><Abstract><AbstractText Label="AIMS">Cardiac sarcoidosis (CS) is associated with a poor prognosis. Important features of CS include heart failure, conduction abnormalities, and ventricular arrhythmias. Ventricular tachycardia (VT) is often refractory to antiarrhythmic drugs (AAD) and immunosuppression. Catheter ablation has emerged as a treatment option for recurrent VT. However, data on the efficacy and outcomes of VT ablation in this context are sparse.</AbstractText><AbstractText Label="METHODS AND RESULTS">A systematic search was performed on PubMed, EMBASE, and Cochrane database (from inception to September 2016) with included studies providing a minimum of information on CS patients undergoing VT ablation: age, gender, VT cycle length, CS diagnosis criteria, and baseline medications. Five studies reporting on 83 patients were identified. The mean age of patients was 50&#x2009;&#xb1;&#x2009;8 years, 53/30 (males/females) with a maximum of 56 patients receiving immunosuppressive therapy, mean ejection fraction was 39.1&#x2009;&#xb1;&#x2009;3.1% and 94% had an implantable cardioverter defibrillator in situ. The median number of VTs was 3 (2.6-4.9)/patient, mean cycle length of 360&#x2009;ms (326-400&#x2009;ms). Hundred percent of VTs received endocardial ablation, and 18% required epicardial ablation. The complication rates were 4.7-6.3%. Relapse occurred in 45 (54.2%) patients with an incidence of relapse 0.33 (95% confidence interval 0.108-0.551, P&#x2009;&lt;&#x2009;0.004). Employing a less stringent endpoint (i.e. freedom from arrhythmia or reduction of ventricular arrhythmia burden), 61 (88.4%) patients improved following ablation.</AbstractText><AbstractText Label="CONCLUSIONS">These data support the utilization of catheter ablation in selected CS cases resistant to medical treatment. However, data are derived from observational non-controlled case series, with low-methodological quality. Therefore, future well-designed, randomized controlled trials, or large-scale registries are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Papageorgiou</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Science, University College London, Gower St, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provid&#xea;ncia</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bronis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiology Department, Royal Brompton Hospital, Sydney St, SW3 6NP, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dechering</LastName><ForeName>Dirk G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital of M&#xfc;nster, Albert-Schweitzer-Campus 1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasan</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckardt</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital of M&#xfc;nster, Albert-Schweitzer-Campus 1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambiase</LastName><ForeName>Pier D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Science, University College London, Gower St, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012507" MajorTopicYN="N">Sarcoidosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28444174</ArticleId><ArticleId IdType="doi">10.1093/europace/eux077</ArticleId><ArticleId IdType="pii">3748228</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33616221</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1594</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Artificial organs</Title><ISOAbbreviation>Artif Organs</ISOAbbreviation></Journal><ArticleTitle>Prophylactic mechanical circulatory support for protected ventricular tachycardia ablation: A meta-analysis of the literature.</ArticleTitle><Pagination><StartPage>987</StartPage><EndPage>997</EndPage><MedlinePgn>987-997</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aor.13945</ELocationID><Abstract><AbstractText>Acute hemodynamic decompensation (AHD) during ventricular tachycardia (VT) ablation occurs in about 11% of cases. Prophylactic use of temporary mechanical circulatory support (pro-tMCS) has been applied to prevent AHD during VT ablation, but evidence supporting this practice is still lacking. This systematic review and meta-analysis assessed the procedural characteristics and outcomes of pro-tMCS for VT ablation. PubMed/Medline was screened until February 2020. Articles including adults receiving pro-tMCS for VT ablation were included, and a meta-analysis to compare proMCS and no-tMCS was performed. Primary outcome was in-hospital/30-day mortality. Five observational studies presenting 400 procedures (pro-tMCS: n&#xa0;=&#xa0;187; no-tMCS: n&#xa0;=&#xa0;213) were included. Baseline characteristics were comparable between groups. Impella and TandemHeart were used in 86.6% and 13.4% of cases, respectively. In the pro-tMCS group, more VTs were induced (mean difference: 0.52, confidence interval [CI]: 0.26-0.77, P&#xa0;&lt;&#xa0;.0001), and patients remained in VT on average for 24.04&#xa0;minutes longer (CI: 18.28-29.80, P&#xa0;&lt;&#xa0;.00001). Procedural success was comparable between groups, as was VT recurrence. Pro-tMCS patients had an odds ratio of 0.55 (CI: 0.28-1.05, P&#xa0;=&#xa0;.07) for in-hospital/30-day mortality and 0.55 (CI: 0.32-0.94, P&#xa0;=&#xa0;.03) for mortality at follow-up. Sixty-four percent of no-tMCS patients received rescue tMCS. The most common tMCS-related complications were bleeding events. Pro-tMCS allowed for a prolonged time on VTs and the induction of more VTs. Although these advantages were not associated with differences in procedural success, VT recurrence, or in-hospital/30-day mortality in the overall population, pro-tMCS might improve long-term survival. Further prospective studies are urgently needed to confirm these results.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2238-1399</Identifier><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Heart and Vascular Center, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Napp</LastName><ForeName>L Christian</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0001-9945-0842</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraaier</LastName><ForeName>Karin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8589-5138</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Hart-en Vaatcentrum Leeuwarden, Medical Center Leeuwarden, Leeuwarden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bounader</LastName><ForeName>Karl</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5410-7917</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanke</LastName><ForeName>Jasmin S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-1434-6905</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dogan</LastName><ForeName>G&#xfc;nes</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5984-9426</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitto</LastName><ForeName>Jan D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0002-0344-1405</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorusso</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1777-2045</Identifier><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Heart and Vascular Center, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Artif Organs</MedlineTA><NlmUniqueID>7802778</NlmUniqueID><ISSNLinking>0160-564X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">shock</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>22</Day><Hour>9</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33616221</ArticleId><ArticleId IdType="doi">10.1111/aor.13945</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Mariani S, Napp LC, Lo Coco V, Delnoij TSR, Luermans J, Ter Bekke RMA, et al. Mechanical circulatory support for life-threatening arrhythmia: a systematic review. Int J Cardiol. 2020;308:42-9.</Citation></Reference><Reference><Citation>Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793-867.</Citation></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e272-391.</Citation></Reference><Reference><Citation>Sharma P, Tripathi B, Naraparaju V, Patel M, Bhagat A, Yerasi C, et al. Short term outcomes associated with inpatient ventricular tachycardia catheter ablation. Pacing Clin Electrophysiol. 2020;43:444-55.</Citation></Reference><Reference><Citation>Konig S, Ueberham L, Muller-Rothing R, Wiedemann M, Ulbrich M, Sause A, et al. Catheter ablation of ventricular arrhythmias and in-hospital mortality: insights from the German-wide Helios hospital network of 5052 cases. Europace. 2020;22:100-8.</Citation></Reference><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020;17:e2-154.</Citation></Reference><Reference><Citation>Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, Hutchinson MD, et al. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8:68-75.</Citation></Reference><Reference><Citation>Turagam MK, Vuddanda V, Koerber S, Garg J, Yarlagadda B, Dar T, et al. Percutaneous ventricular assist device in ventricular tachycardia ablation: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2018;55:197-205.</Citation></Reference><Reference><Citation>Virk SA, Keren A, John RM, Santageli P, Eslick A, Kumar S. Mechanical circulatory support during catheter ablation of ventricular tachycardia: indications and options. Heart Lung Circ. 2019;28:134-45.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Vallabhajosyula S, Vaidya VR, Patlolla SH, Desai V, Mulpuru SK, et al. Venoarterial extracorporeal membrane oxygenation support for ventricular tachycardia ablation: a systematic review. ASAIO J. 2020;66:980-5.</Citation></Reference><Reference><Citation>Subramaniam AV, Barsness GW, Vallabhajosyula S, Vallabhajosyula S. Complications of temporary percutaneous mechanical circulatory support for cardiogenic shock: an appraisal of contemporary literature. Cardiol Ther. 2019;8:211-28.</Citation></Reference><Reference><Citation>Masyuk M, Abel P, Hug M, Wernly B, Haneya A, Sack S, et al. Extracorporeal life support system during cardiovascular procedures: insights from the German Lifebridge registry. Artif Organs. 2020;44:1259-66.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.</Citation></Reference><Reference><Citation>Wallace B, Small K, Brodley C, Lau J, Trikalinos T. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. Proceedings of the ACM International Health Informatics Symposium (IHI); 2012. p. 819-24.</Citation></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester, UK: John Wiley &amp; Sons; 2019.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785-805.</Citation></Reference><Reference><Citation>Muser D, Liang JJ, Castro SA, Hayashi T, Enriquez A, Troutman GS, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Heart Rhythm. 2018;15:1500-6.</Citation></Reference><Reference><Citation>Mathuria N, Wu G, Rojas-Delgado F, Shuraih M, Razavi M, Civitello A, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017;48:27-34.</Citation></Reference><Reference><Citation>Aryana A, Gearoid O'Neill P, Gregory D, Scotti D, Bailey S, Brunton S, et al. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device. Heart Rhythm. 2014;11:1122-30.</Citation></Reference><Reference><Citation>Reddy YM, Chinitz L, Mansour M, Bunch TJ, Mahapatra S, Swarup V, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol. 2014;7:244-50.</Citation></Reference><Reference><Citation>Miller MA, Dukkipati SR, Mittnacht AJ, Chinitz JS, Belliveau L, Koruth JS, et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. J Am Coll Cardiol. 2011;58:1363-71.</Citation></Reference><Reference><Citation>Bunch TJ, Darby A, May HT, Ragosta M, Lim DS, Taylor AM, et al. Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace. 2012;14:709-14.</Citation></Reference><Reference><Citation>Aryana A, d'Avila A, Cool CL, Miller MA, Garcia FC, Supple GE, et al. Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: an analysis of the Medicare database. J Cardiovasc Electrophysiol. 2017;28:1295-302.</Citation></Reference><Reference><Citation>Miller MA, Dukkipati SR, Koruth JS, d'Avila A, Reddy VY. How to perform ventricular tachycardia ablation with a percutaneous left ventricular assist device. Heart Rhythm. 2012;9:1168-76.</Citation></Reference><Reference><Citation>Kumar S, Romero J, Mehta NK, Fujii A, Kapur S, Baldinger SH, et al. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Heart Rhythm. 2016;13:1957-63.</Citation></Reference><Reference><Citation>Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, Frankel DS, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13:1552-9.</Citation></Reference><Reference><Citation>Kitamura T, Nakajima M, Kawamura I, Ohbe H, Sasabuchi Y, Matsui H, et al. Patient characteristics, procedure details including catheter devices, and complications of catheter ablation for ventricular tachycardia: a nationwide observational study. J Arrhythm. 2020;36:464-70.</Citation></Reference><Reference><Citation>Turagam MK, Vuddanda V, Atkins D, Santangeli P, Frankel DS, Tung R, et al. Hemodynamic support in ventricular tachycardia ablation: an international VT Ablation Center Collaborative Group study. JACC Clin Electrophysiol. 2017;3:1534-43.</Citation></Reference><Reference><Citation>Palaniswamy C, Miller MA, Reddy VY, Dukkipati SR. Hemodynamic support for ventricular tachycardia ablation. Card Electrophysiol Clin. 2017;9:141-52.</Citation></Reference><Reference><Citation>Miller MA, Dukkipati SR, Chinitz JS, Koruth JS, Mittnacht AJ, Napolitano C, et al. Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythm Electrophysiol. 2013;6:151-9.</Citation></Reference><Reference><Citation>Ghanbari H, Baser K, Yokokawa M, Stevenson W, Della Bella P, Vergara P, et al. Noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes: a meta-analysis. Circ Arrhythm Electrophysiol. 2014;7:677-83.</Citation></Reference><Reference><Citation>Yokokawa M, Kim HM, Baser K, Stevenson W, Nagashima K, Della Bella P, et al. Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2015;65:1954-9.</Citation></Reference><Reference><Citation>Ostadal P, Mlcek M, Holy F, Horakova S, Kralovec S, Skoda J, et al. Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model. Circ Arrhythm Electrophysiol. 2012;5:1202-6.</Citation></Reference><Reference><Citation>Pappalardo F, Scandroglio AM, Latib A. Full percutaneous biventricular support with two Impella pumps: the Bi-Pella approach. ESC Heart Fail. 2018;5:368-71.</Citation></Reference><Reference><Citation>Lo Coco V, Swol J, De Piero ME, Massimi G, Chiarini G, Broman LM, et al. Dynamic extracorporeal life support: a novel management modality in temporary cardio-circulatory assistance. Artif Organs. 2020. [Epub ahead of print].</Citation></Reference><Reference><Citation>Lorusso R, Raffa GM, Heuts S, Lo Coco V, Meani P, Natour E, et al. Pulmonary artery cannulation to enhance extracorporeal membrane oxygenation management in acute cardiac failure. Interact Cardiovasc Thorac Surg. 2020;30:215-22.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39023485</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation.</ArticleTitle><Pagination><StartPage>2049</StartPage><EndPage>2058</EndPage><MedlinePgn>2049-2058</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2024.04.037</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(24)00457-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Left ventricular assist device (LVAD) recipients have a higher incidence of ventricular tachycardia (VT). However, the role of VT ablation in this population is not well-established.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This single-center retrospective cohort study sought to examine the impact of post-LVAD implant VT ablation on survival.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study examined a cohort of patients that underwent LVAD implantation at Baylor St. Luke's Medical Center and Texas Heart Institute between January 2011 and January 2021. All-cause estimated mortality was compared across LVAD recipients based on the incidence of VT, timing of VT onset, and the occurrence and timing of VT ablation utilizing Kaplan-Meier survival analysis and Cox proportional hazards models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Post-implant VT occurred in 53% of 575 LVAD recipients. Higher mortality was seen among patients with post-implant VT within a year of implantation (HR: 1.62 [95%&#xa0;CI: 1.15-2.27]). Among this cohort, patients who were treated with a catheter ablation had superior survival compared with patients treated with medical therapy alone for the 45&#xa0;months following VT onset (HR: 0.48 [95%&#xa0;CI: 0.26-0.89]). Moreover, performance of an ablation in this population aligned mortality rates with those who did not experience post-implant VT (HR: 1.18 [95%&#xa0;CI: 0.71-1.98]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VT occurrence within 1 year of LVAD implantation was associated with worse survival. However, performance of VT ablation in this population was correlated with improved survival compared with medical management alone. Among patients with refractory VT, catheter ablation aligned survival with other LVAD participants without post-implant VT. Catheter ablation of VT is associated with improved survival in LVAD recipients, but further prospective randomized studies are needed to compare VT ablation to medical management in LVAD recipients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Patrick T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA. Electronic address: Patrick.Lynch@bcm.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maloof</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badjatiya</LastName><ForeName>Anish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safavi-Naeini</LastName><ForeName>Payam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segar</LastName><ForeName>Matthew W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jitae A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marashly</LastName><ForeName>Qussay</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Montefiore Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina-Razavi</LastName><ForeName>Joanna E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Leo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oberton</LastName><ForeName>Selby B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Lola X</ForeName><Initials>LX</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Civitello</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathuria</LastName><ForeName>Nilesh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasekh</LastName><ForeName>Abdi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saeed</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razavi</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Ajith</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chelu</LastName><ForeName>Mihail G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA. Electronic address: Mihail.Chelu@bcm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">advanced heart failure</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">left ventricular assist device</Keyword><Keyword MajorTopicYN="N">mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">survival</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures Dr Chelu has received funding from Patient-Centered Outcomes Research Institute (PLACER grant 2021C3-24160). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>10</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39023485</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2024.04.037</ArticleId><ArticleId IdType="pii">S2405-500X(24)00457-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38717772</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Ventricular Arrhythmias After Primary Percutaneous Coronary Intervention for STEMI.</ArticleTitle><Pagination><StartPage>e2410288</StartPage><MedlinePgn>e2410288</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2410288</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2024.10288</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Currently, mortality risk for patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) with an uncomplicated postprocedure course is low. Less is known regarding the risk of in-hospital ventricular tachycardia (VT) and ventricular fibrillation (VF).</AbstractText><AbstractText Label="OBJECTIVE">To evaluate the risk of late VT and VF after primary PCI for STEMI.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cohort study included adults aged 18 years or older with STEMI treated with primary PCI between January 1, 2015, and December 31, 2018, identified in the US National Cardiovascular Data Registry Chest Pain-MI Registry. Data were analyzed from April to December 2020.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Multivariable logistic regression was used to evaluate the risk of late VT (&#x2265;7 beat run of VT during STEMI hospitalization &#x2265;1 day after PCI) or VF (any episode of VF&#x2265;1 day after PCI) associated with cardiac arrest and associations between late VT or VF and in-hospital mortality in the overall cohort and a cohort with uncomplicated STEMI without prior myocardial infarction or heart failure, systolic blood pressure less than 90 mm Hg, cardiogenic shock, cardiac arrest, reinfarction, or left ventricular ejection fraction (LVEF) less than 40%.</AbstractText><AbstractText Label="RESULTS">A total of 174&#x202f;126 eligible patients with STEMI were treated with primary PCI at 814 sites in the study; 15&#x202f;460 (8.9%) had VT or VF after primary PCI, and 4156 (2.4%) had late VT or VF. Among the eligible patients, 99&#x202f;905 (57.4%) at 807 sites had uncomplicated STEMI. The median age for patients with late VT or VF overall was 63 years (IQR, 55-73 years), and 75.5% were men; the median age for patients with late VT or VF with uncomplicated STEMI was 60 years (IQR, 53-69 years), and 77.7% were men. The median length of stay was 3 days (IQR, 2-7 days) for the overall cohort with late VT or VF and 3 days (IQR, 2-4 days) for the cohort with uncomplicated STEMI with late VT or VF. The risk of late VT or VF was 2.4% (overall) and 1.7% (uncomplicated STEMI). Late VT or VF with cardiac arrest occurred in 674 patients overall (0.4%) and in 117 with uncomplicated STEMI (0.1%). LVEF was the most significant factor associated with late VT or VF with cardiac arrest (adjusted odds ratio [AOR] for every 5-unit decrease &#x2264;40%: 1.67; 95% CI, 1.54-1.85). Late VT or VF events were associated with increased odds of in-hospital mortality in the overall cohort (AOR, 6.40; 95% CI, 5.63-7.29) and the cohort with uncomplicated STEMI (AOR, 8.74; 95% CI, 6.53-11.70).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this study, a small proportion of patients with STEMI treated with primary PCI had late VT or VF. However, late VT or VF with cardiac arrest was rare, particularly in the cohort with uncomplicated STEMI. This information may be useful when determining the optimal timing for hospital discharge after STEMI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rymer</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Duke University Hospital, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegermann</LastName><ForeName>Zachary K</ForeName><Initials>ZK</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Duke University Hospital, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tracy Y</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Patient-Centered Outcomes Research Institute, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smilowitz</LastName><ForeName>Nathaniel R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Medicine, NYU Langone Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>B Hadley</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Atrium Health Sanger Heart &amp; Vascular Institute, Charlotte, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jneid</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Texas Medical Branch, Galveston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamis-Holland</LastName><ForeName>Jacqueline E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Heart, Vascular &amp; Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Rymer reported receiving grants from Chiesi, the American College of Cardiology&#x2019;s National Cardiovascular Data Registry (NCDR), and Abiomed outside the submitted work. Dr Smilowitz reported receiving personal fees from Abbott Vascular outside the submitted work. Dr Tamis-Holland reported having stock ownership in Pfizer outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38717772</ArticleId><ArticleId IdType="pmc">PMC11079687</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.10288</ArticleId><ArticleId IdType="pii">2818409</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Orvin K, Eisen A, Goldenberg I, et al. . Outcome of contemporary acute coronary syndrome complicated by ventricular tachyarrhythmias. Europace. 2016;18(2):219-226. doi:10.1093/europace/euv027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euv027</ArticleId><ArticleId IdType="pubmed">25840284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Starr AZ, Lopes RD, et al. ; APEX AMI Investigators . Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301(17):1779-1789. doi:10.1001/jama.2009.600</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.600</ArticleId><ArticleId IdType="pubmed">19417195</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Yu J, Piccini JP, et al. . Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). Am J Cardiol. 2012;109(6):805-812. doi:10.1016/j.amjcard.2011.10.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2011.10.043</ArticleId><ArticleId IdType="pubmed">22196782</ArticleId></ArticleIdList></Reference><Reference><Citation>Askari AT, Shishehbor MH, Kaminski MA, Riley MJ, Hsu A, Lincoff AM; GUSTO-V Investigators . The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: insights from Global Use of Strategies to Open Coronary Arteries (GUSTO) V. Am Heart J. 2009;158(2):238-243. doi:10.1016/j.ahj.2009.05.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2009.05.023</ArticleId><ArticleId IdType="pubmed">19619700</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccini JP, Berger JS, Brown DL. Early sustained ventricular arrhythmias complicating acute myocardial infarction. Am J Med. 2008;121(9):797-804. doi:10.1016/j.amjmed.2008.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.04.024</ArticleId><ArticleId IdType="pubmed">18724970</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Stebbins AL, Califf RM, et al. ; GUSTO-III trial . Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Am Heart J. 2003;145(3):515-521. doi:10.1067/mhj.2003.170</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mhj.2003.170</ArticleId><ArticleId IdType="pubmed">12660676</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbari R, Risgaard B, Fosb&#xf8;l EL, et al. . Factors associated with and outcomes after ventricular fibrillation before and during primary angioplasty in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2015;116(5):678-685. doi:10.1016/j.amjcard.2015.05.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.05.037</ArticleId><ArticleId IdType="pubmed">26150175</ArticleId></ArticleIdList></Reference><Reference><Citation>Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A; the GUSTO Investigators . Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. Circulation. 1998;98(23):2567-2573. doi:10.1161/01.CIR.98.23.2567</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.98.23.2567</ArticleId><ArticleId IdType="pubmed">9843464</ArticleId></ArticleIdList></Reference><Reference><Citation>Fordyce CB, Al-Khalidi HR, Jollis JG, et al. ; STEMI Systems Accelerator Project . Association of rapid care process implementation on reperfusion times across multiple st-segment-elevation myocardial infarction networks. Circ Cardiovasc Interv. 2017;10(1):e004061. doi:10.1161/CIRCINTERVENTIONS.116.004061</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.116.004061</ArticleId><ArticleId IdType="pmc">PMC6561112</ArticleId><ArticleId IdType="pubmed">28082714</ArticleId></ArticleIdList></Reference><Reference><Citation>Jollis JG, Al-Khalidi HR, Roettig ML, et al. . Impact of regionalization of ST-segment-elevation myocardial infarction care on treatment times and outcomes for emergency medical services-transported patients presenting to hospitals with percutaneous coronary intervention: Mission: Lifeline Accelerator-2. Circulation. 2018;137(4):376-387. doi:10.1161/CIRCULATIONAHA.117.032446</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.032446</ArticleId><ArticleId IdType="pubmed">29138292</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. . 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91-e220. doi:10.1016/j.jacc.2017.10.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.10.054</ArticleId><ArticleId IdType="pubmed">29097296</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Gara PT, Kushner FG, Ascheim DD, et al. . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78-e140. doi:10.1016/j.jacc.2012.11.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.11.019</ArticleId><ArticleId IdType="pubmed">23256914</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson ED, Roe MT, Rumsfeld JS, et al. . A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009;2(5):491-499. doi:10.1161/CIRCOUTCOMES.108.847145</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.108.847145</ArticleId><ArticleId IdType="pubmed">20031882</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan JZ, Jentzer JC, Ward RC, et al. . Safe triage of STEMI patients to general telemetry units after successful primary percutaneous coronary intervention. Mayo Clin Proc Innov Qual Outcomes. 2021;5(6):1118-1127. doi:10.1016/j.mayocpiqo.2021.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8633820</ArticleId><ArticleId IdType="pubmed">34877476</ArticleId></ArticleIdList></Reference><Reference><Citation>Valley TS, Iwashyna TJ, Cooke CR, et al. . Intensive care use and mortality among patients with ST elevation myocardial infarction: retrospective cohort study. BMJ. 2019;365:l1927. doi:10.1136/bmj.l1927</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l1927</ArticleId><ArticleId IdType="pmc">PMC6547840</ArticleId><ArticleId IdType="pubmed">31164326</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30703355</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1891</ISSN><JournalIssue CitedMedium="Internet"><Volume>201</Volume><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>American journal of ophthalmology</Title><ISOAbbreviation>Am J Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma.</ArticleTitle><Pagination><StartPage>19</StartPage><EndPage>30</EndPage><MedlinePgn>19-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajo.2019.01.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9394(19)30040-6</ELocationID><Abstract><AbstractText Label="PURPOSE">To test the hypothesis that cataract surgery slows the apparent rate of visual field (VF) decay in primary open-angle glaucoma patients compared with rates measured during cataract progression.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="METHODS">Consecutive open-angle glaucoma patients who underwent cataract surgery and who had &#x2265;4 VFs and &#x2265;3 years of follow-up before and after surgery were retrospectively reviewed. Mean deviation (MD) rate, visual field index (VFI) rate, pointwise linear regression (PLR), pointwise rate of change (PRC), and the Glaucoma Rate Index (GRI) were compared before and after cataract surgery.</AbstractText><AbstractText Label="RESULTS">A total of 134 eyes of 99 patients were included. Median (interquartile range) follow-up was 6.5 (4.7-8.1) and 5.3 (4.0-7.3) years before and after cataract surgery, respectively. All intraocular pressure (IOP) parameters (mean IOP, standard deviation of IOP, and peak IOP) significantly improved (P &lt; .001) after cataract surgery. All VF indices indicated an accelerated VF decay rate after cataract surgery: MD rate (-0.18 &#xb1; 0.40 dB/year vs -0.40 &#xb1; 0.62 dB/year, P &lt; .001), VFI rate (-0.44% &#xb1; 1.09%/year vs -1.19% &#xb1; 1.85%/year, P &lt; .001), GRI (-5.5 &#xb1; 10.8 vs -13.5 &#xb1; 21.5; P &lt; .001), and PRC (-0.62% &#xb1; 2.47%/year before and -1.35% &#xb1; 3.71%/year after surgery; P &lt; .001) and PLR (-0.20 &#xb1; 0.82 dB/year before and -0.42 &#xb1; 1.16 dB/year after surgery; P &lt; .001) for all VF locations. Worse baseline MD and postoperative peak IOP were significantly associated with the postoperative VF decay rate and the change in the decay rate after cataract surgery.</AbstractText><AbstractText Label="CONCLUSION">Although all IOP parameters improved after cataract surgery, VFs continued to progress. Cataract surgery does not slow the apparent rate of glaucomatous VF decay as compared to rates measured during the progression of the cataract.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA; Siloam Eye Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabiolo</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA; Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fatehi</LastName><ForeName>Nima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Wen-Shin</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA; Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afifi</LastName><ForeName>Abdelmonem A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouri-Mahdavi</LastName><ForeName>Kouros</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caprioli</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA. Electronic address: caprioli@jsei.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Ophthalmol</MedlineTA><NlmUniqueID>0370500</NlmUniqueID><ISSNLinking>0002-9394</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Ophthalmol. 2019 Aug;204:140-141. doi: 10.1016/j.ajo.2019.04.028.</RefSource><PMID Version="1">31256801</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Ophthalmol. 2019 Sep;205:197-198. doi: 10.1016/j.ajo.2019.03.035.</RefSource><PMID Version="1">31284934</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Ophthalmol. 2020 Jan;209:216-217. doi: 10.1016/j.ajo.2019.06.034.</RefSource><PMID Version="1">31706641</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019654" MajorTopicYN="Y">Lens Implantation, Intraocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018918" MajorTopicYN="Y">Phacoemulsification</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019591" MajorTopicYN="N">Pseudophakia</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014065" MajorTopicYN="N">Tonometry, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30703355</ArticleId><ArticleId IdType="doi">10.1016/j.ajo.2019.01.019</ArticleId><ArticleId IdType="pii">S0002-9394(19)30040-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27111408</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1755-3768</ISSN><JournalIssue CitedMedium="Internet"><Volume>94 Suppl 2</Volume><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta ophthalmologica</Title><ISOAbbreviation>Acta Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Recovery after cataract surgery.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>34</EndPage><MedlinePgn>1-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aos.13055</ELocationID><Abstract><AbstractText>Cataract surgery is the most common ophthalmological surgical procedure, and it is predicted that the number of surgeries will increase significantly in the future. However, little is known about the recovery after surgery. The first aim of this study was to evaluate the prevalence, severity and duration of pain and other ocular discomfort symptoms experienced after cataract surgery. The other objectives were to identify the factors associated with lower postoperative patient satisfaction and to measure the effect of cataract surgery on patients' health-related quality of life (HRQoL) and visual function in everyday life. The study design was a prospective follow-up study. The course of the recovery and the presence of ocular symptoms were evaluated by interviewing the patients via a questionnaire at 1&#xa0;day, 1&#xa0;week, 6&#xa0;weeks and one year after surgery The visual functioning in everyday life was measured with Visual Functioning Index VF-7 and Catquest-9SF-questionnaires and furthermore the HRQoL was measured with the 15D-instrument before surgery and at 12&#xa0;months after surgery. The patients returned the questionnaires by mail and were interviewed in the hospital on the day of the surgery. The same patients filled-in all the questionnaires. The patient reports were used to collect the data on medical history. A total of 303 patients were approached at Kuopio University Hospital in 2010-2011 and of these 196 patients were eligible and willing to participate, with postoperative data being available from 186 (95%) patients. A systematic review article was included in the study procedure and it revealed the wide range in the reported incidence of postoperative ocular pain. Some of the identified randomized controlled studies reported no or only minor pain whereas in some studies significant pain or pain lasting for several weeks has been described in more than 50% of the study patients. In the present study setting, pain was reported by 34% during the first postoperative hours and by approximately 10% of patients during the first six weeks after surgery. During the early recovery in the hospital, only a minority of the patients reporting pain were provided with pain medication. The ocular discomfort symptoms such as itchiness, burning, foreign-body sensation and tearing were common both before (54%) and after surgery (38-52%). These symptoms can also be described as painful symptoms and are often difficult to distinguish from ocular pain. The symptoms are also typical of ocular surface disease, and some patients may benefit from the postoperative administration of tear substitutes. The patients reporting postoperative ocular symptoms were less satisfied with the treatment outcome at 12&#xa0;months after surgery (p&#xa0;=&#xa0;0.001) compared to the patients who experienced no symptoms. Those patients reporting less disability in visual functioning before surgery were more satisfied than patients with more reported disability. The HRQoL improved significantly after cataract surgery (p&#xa0;=&#xa0;0.002). However, when compared to an age-and gender-standardized control population, in cataract subjects the HRQoL remained slightly worse both before and at 12&#xa0;months after surgery.</AbstractText><CopyrightInformation>&#xa9; 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Porela-Tiihonen</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Department of Intensive Care Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokki</LastName><ForeName>Hannu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Department of Intensive Care Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaarniranta</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokki</LastName><ForeName>Merja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Department of Intensive Care Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Ophthalmol</MedlineTA><NlmUniqueID>101468102</NlmUniqueID><ISSNLinking>1755-375X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002387" MajorTopicYN="N">Cataract Extraction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019654" MajorTopicYN="N">Lens Implantation, Intraocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="Y">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014785" MajorTopicYN="N">Vision, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="Y">Visual Acuity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27111408</ArticleId><ArticleId IdType="doi">10.1111/aos.13055</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34028002</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-5415</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of the American Geriatrics Society</Title><ISOAbbreviation>J Am Geriatr Soc</ISOAbbreviation></Journal><ArticleTitle>Osteoporosis, bisphosphonate use, and risk of moderate or worse hearing loss in women.</ArticleTitle><Pagination><StartPage>3103</StartPage><EndPage>3113</EndPage><MedlinePgn>3103-3113</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jgs.17275</ELocationID><Abstract><AbstractText Label="BACKGROUND">Osteoporosis and low bone density (LBD) may be associated with higher risk of hearing loss, but findings are inconsistent and longitudinal data are scarce. Bisphosphonates may influence risk, but the relation has not been studied in humans. We longitudinally investigated associations of osteoporosis and LBD, bisphosphonate use, vertebral fracture (VF), hip fracture (HF), and risk of self-reported moderate or worse hearing loss.</AbstractText><AbstractText Label="DESIGN">Longitudinal cohort study.</AbstractText><AbstractText Label="SETTING">The Nurses' Health Study (NHS) (1982-2016) and Nurses' Health Study II (NHS II) (1995-2017).</AbstractText><AbstractText Label="PARTICIPANTS">Participants included 60,821 NHS women, aged 36-61&#x2009;years at baseline, and 83,078 NHS II women, aged 31-48&#x2009;years at baseline (total n&#xa0;=&#xa0;143,899).</AbstractText><AbstractText Label="MEASUREMENTS">Information on osteoporosis, LBD, bisphosphonate use, VF, HF, and hearing status was obtained from validated biennial questionnaires. In a subcohort (n&#xa0;=&#xa0;3749), objective hearing thresholds were obtained by audiometry. Multivariable-adjusted Cox proportional hazards models were used to examine independent associations between osteoporosis (NHS), osteoporosis/LBD (NHS II), and risk of hearing loss.</AbstractText><AbstractText Label="RESULTS">The multivariable-adjusted relative risk (MVRR, 95% confidence interval) of moderate or worse hearing loss was higher among women with osteoporosis or LBD in both cohorts. In NHS, compared with women without osteoporosis, the MVRR was 1.14 (1.09, 1.19) among women with osteoporosis; in NHS II, the MVRR was 1.30 (1.21, 1.40) among women with osteoporosis/LBD. The magnitude of the elevated risk was similar among women who did and did not use bisphosphonates. VF was associated with higher risk (NHS: 1.31 [1.16, 1.49]; NHS II: 1.39 [1.13, 1.71]), but HF was not (NHS: 1.00 [0.86, 1.16];NHS II: 1.15 [0.75,1.74]). Among participants with audiometric measurements, compared with women without osteoporosis/LBD, the mean multivariable-adjusted hearing thresholds were higher (i.e., worse) among those with osteoporosis/LBD who used bisphosphonates.</AbstractText><AbstractText Label="CONCLUSION">Osteoporosis and LBD may be important contributors to aging-related hearing loss. Among women with osteoporosis, the risk of hearing loss was not influenced by bisphosphonate use.</AbstractText><CopyrightInformation>&#xa9; 2021 The American Geriatrics Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Curhan</LastName><ForeName>Sharon G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stankovic</LastName><ForeName>Konstantina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halpin</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Molin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eavey</LastName><ForeName>Roland D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paik</LastName><ForeName>Julie M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curhan</LastName><ForeName>Gary C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UM1 CA186107</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR075117</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DC010811</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UO1 CA176726</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 CA186107</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA176726</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DC017717</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DC010811</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AR075117</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Geriatr Soc</MedlineTA><NlmUniqueID>7503062</NlmUniqueID><ISSNLinking>0002-8614</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004164">Diphosphonates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Geriatr Soc. 2021 Nov;69(11):3074-3076. doi: 10.1111/jgs.17444.</RefSource><PMID Version="1">34498269</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001299" MajorTopicYN="N">Audiometry</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004164" MajorTopicYN="Y">Diphosphonates</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006309" MajorTopicYN="N">Hearing</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034381" MajorTopicYN="N">Hearing Loss</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">bisphosphonates</Keyword><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">hearing loss</Keyword><Keyword MajorTopicYN="N">osteoporosis</Keyword></KeywordList><CoiStatement>Conflicts of Interest. Dr. S. Curhan serves as a consultant to Decibel Therapeutics. Dr. G. Curhan serves as a consultant to Decibel Therapeutics, AstraZeneca, Shire, Allena Pharmaceuticals, RenalGuard, OrfanBiotech, OM1, and Merck. He receives royalties from UpToDate for being an author and Section Editor. The other authors declare no conflicts of interest. All authors had access to the data and participated in the preparation of the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>24</Day><Hour>10</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34028002</ArticleId><ArticleId IdType="mid">NIHMS1710029</ArticleId><ArticleId IdType="pmc">PMC8595486</ArticleId><ArticleId IdType="doi">10.1111/jgs.17275</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Summary health statistics for US adults: National Health Interview Survey. 2012. at http://www.cdc.gov/nchs/data/series/sr_10/sr10_260.pdf.)</Citation><ArticleIdList><ArticleId IdType="pubmed">24819891</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton DS, Cruickshanks KJ, Klein BE, Klein R, Wiley TL, Nondahl DM. The impact of hearing loss on quality of life in older adults. Gerontologist 2003;43:661&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14570962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiely KM, Anstey KJ, Luszcz MA. Dual sensory loss and depressive symptoms: the importance of hearing, daily functioning, and activity engagement. Front Hum Neurosci 2013;7:837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3864127</ArticleId><ArticleId IdType="pubmed">24379769</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin FR, Yaffe K, Xia J, et al. Hearing loss and cognitive decline in older adults. JAMA Intern Med 2013;173:293&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3869227</ArticleId><ArticleId IdType="pubmed">23337978</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561509</ArticleId><ArticleId IdType="pubmed">26063472</ArticleId></ArticleIdList></Reference><Reference><Citation>Nih Consensus Development Panel on Osteoporosis Prevention D, Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">11176917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensrud KE. Epidemiology of fracture risk with advancing age. J Gerontol A Biol Sci Med Sci 2013;68:1236&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">23833201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelsey JL, Samelson EJ. Variation in risk factors for fractures at different sites. Curr Osteoporos Rep 2009;7:127&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3570963</ArticleId><ArticleId IdType="pubmed">19968916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao SY, Kempfle JS, Jensen JB, et al. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. Neurobiol Dis 2013;56:25&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3752395</ArticleId><ArticleId IdType="pubmed">23607938</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Hong HS, Yang SC, Kim KS, Kim HJ. Is There a Relationship Between Bone Quality and Hearing Level? Otol Neurotol 2018;39:e752&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30199495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kshithi K, Vijendra Shenoy S, Panduranga Kamath M, et al. Audiological profiling in postmenopausal women with osteoporosis. Am J Otolaryngol 2018;39:271&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29530429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewiecki EM. Bisphosphonates for the treatment of osteoporosis: insights for clinicians. Ther Adv Chronic Dis 2010;1:115&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3513863</ArticleId><ArticleId IdType="pubmed">23251734</ArticleId></ArticleIdList></Reference><Reference><Citation>Seist R, Tong M, Landegger LD, et al. Regeneration of Cochlear Synapses by Systemic Administration of a Bisphosphonate. Front Mol Neurosci 2020;13:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381223</ArticleId><ArticleId IdType="pubmed">32765216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy DW, Hoffer ME, Holliday M. The effects of etidronate disodium on progressive hearing loss from otosclerosis. Otolaryngol Head Neck Surg 1993;109:461&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8414563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Y, Bertoia ML, Lenart EB, et al. Origin, Methods, and Evolution of the Three Nurses&#x2019; Health Studies. Am J Public Health 2016;106:1573&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4981810</ArticleId><ArticleId IdType="pubmed">27459450</ArticleId></ArticleIdList></Reference><Reference><Citation>Prochaska M, Taylor E, Vaidya A, Curhan G. Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones. Clin J Am Soc Nephrol 2017;12:1284&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544505</ArticleId><ArticleId IdType="pubmed">28576907</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik JM, Rosen HN, Gordon CM, Curhan GC. Diuretic Use and Risk of Vertebral Fracture in Women. Am J Med 2016;129:1299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5118092</ArticleId><ArticleId IdType="pubmed">27542612</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang T, Tworoger SS, Redline S, Curhan GC, Paik JM. Obstructive Sleep Apnea and Risk for Incident Vertebral and Hip Fracture in Women. J Bone Miner Res 2020;35:2143&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7719618</ArticleId><ArticleId IdType="pubmed">32909307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrite S, Santana VS, Marshall SW. Validity of self-reported hearing loss in adults: performance of three single questions. Revista de saude publica 2011;45:824&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">21808834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindhusake D, Mitchell P, Smith W, et al. Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol 2001;30:1371&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11821349</ArticleId></ArticleIdList></Reference><Reference><Citation>Curhan SG, Shargorodsky J, Eavey R, Curhan GC. Analgesic use and the risk of hearing loss in women. Am J Epidemiol 2012;176:544&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530351</ArticleId><ArticleId IdType="pubmed">22933387</ArticleId></ArticleIdList></Reference><Reference><Citation>Curhan SG, Wang M, Eavey RD, Stampfer MJ, Curhan GC. Adherence to Healthful Dietary Patterns Is Associated with Lower Risk of Hearing Loss in Women. J Nutr 2018;148:944&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6481387</ArticleId><ArticleId IdType="pubmed">29757402</ArticleId></ArticleIdList></Reference><Reference><Citation>Curhan SG HC, Wang M, Eavey RD, Curhan GC. Tinnitus and 3-Year Change in Audiometric Hearing Thresholds 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222055</ArticleId><ArticleId IdType="pubmed">33577220</ArticleId></ArticleIdList></Reference><Reference><Citation>Curhan SG, Halpin C, Wang M, Eavey RD, Curhan GC. Prospective Study of Dietary Patterns and Hearing Threshold Decline. Am J Epidemiol 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217280</ArticleId><ArticleId IdType="pubmed">31608356</ArticleId></ArticleIdList></Reference><Reference><Citation>Therneau TM. Extending the Cox model. 2nd ed. New York: Springer Verlag; 1997.</Citation></Reference><Reference><Citation>Osteoporosis. 2019. (Accessed 11-24-2020, at https://www.cdc.gov/nchs/fastats/osteoporosis.htm.)</Citation></Reference><Reference><Citation>Black DM, Rosen CJ. Clinical Practice. Postmenopausal Osteoporosis. N Engl J Med 2016;374:254&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">26789873</ArticleId></ArticleIdList></Reference><Reference><Citation>Black DM, Rosen CJ. Postmenopausal Osteoporosis. N Engl J Med 2016;374:2096&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27223157</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller PD, Zapalowski C, Kulak CA, Bilezikian JP. Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab 1999;84:1867&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">10372677</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Lee SB, Lee CH, Kim HM. Hearing loss in postmenopausal women with low bone mineral density. Auris Nasus Larynx 2016;43:155&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">26277375</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh MC, Weng SF, Shen YC, et al. Increased Risk of Sudden Sensorineural Hearing Loss in Patients With Osteoporosis: A Population-based, Propensity Score-matched, Longitudinal Follow-Up Study. J Clin Endocrinol Metab 2015;100:2413&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25879512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahveci OK, Demirdal US, Yucedag F, Cerci U. Patients with osteoporosis have higher incidence of sensorineural hearing loss. Clin Otolaryngol 2014;39:145&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24716511</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao SY, Katsumi S, Han D, et al. Postnatal expression and possible function of RANK and RANKL in the murine inner ear. Bone 2020;145:115837.</Citation><ArticleIdList><ArticleId IdType="pubmed">33385614</ArticleId></ArticleIdList></Reference><Reference><Citation>Huizing EH, de Groot JA. Densitometry of the cochlear capsule and correlation between bone density loss and bone conduction hearing loss in otosclerosis. Acta Otolaryngol 1987;103:464&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">3618174</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsell EM, Cody DD, Bone HG, Divine GW. Hearing loss as a complication of Paget&#x2019;s disease of bone. J Bone Miner Res 1999;14 Suppl 2:92&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10510222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin YJ, Fraysse B, Deguine O, Cognard C, Charlet JP, Sevely A. Sensorineural hearing loss and otosclerosis: a clinical and radiologic survey of 437 cases. Acta Otolaryngol 2001;121:200&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11349779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wangemann P Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential. J Physiol 2006;576:11&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1995626</ArticleId><ArticleId IdType="pubmed">16857713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Shen N, Feng M, Liu H, Duan M, Huang X. Study of age-related changes in Middle ear transfer function. Comput Methods Biomech Biomed Engin 2019;22:1093&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">31268350</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung DJ, Cho HH, Lee KY. Association of Bone Mineral Density With Hearing Impairment in Postmenopausal Women in Korea. Clin Exp Otorhinolaryngol 2016;9:319&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5115157</ArticleId><ArticleId IdType="pubmed">27136368</ArticleId></ArticleIdList></Reference><Reference><Citation>Helzner EP, Cauley JA, Pratt SR, et al. Hearing sensitivity and bone mineral density in older adults: the Health, Aging and Body Composition Study. Osteoporos Int 2005;16:1675&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">15883660</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo JI, Park KS, Seo SH, Park HW. Osteoporosis and hearing loss: findings from the Korea National Health and Nutrition Examination Survey 2009-2011. Braz J Otorhinolaryngol 2020;86:332&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9422524</ArticleId><ArticleId IdType="pubmed">30827872</ArticleId></ArticleIdList></Reference><Reference><Citation>Seref-Ferlengez Z, Kennedy OD, Schaffler MB. Bone microdamage, remodeling and bone fragility: how much damage is too much damage? Bonekey Rep 2015;4:644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371415</ArticleId><ArticleId IdType="pubmed">25848533</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan M, Reddy S, Berkman N, et al. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2018;319:2532&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">29946734</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan TA, Remenschneider AK, Halpin C, Seton M, McKenna MJ, Quesnel AM. Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up. Laryngoscope Investig Otolaryngol 2017;2:262&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655565</ArticleId><ArticleId IdType="pubmed">29094069</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberman MC, Kujawa SG. Cochlear synaptopathy in acquired sensorineural hearing loss: Manifestations and mechanisms. Hear Res 2017;349:138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5438769</ArticleId><ArticleId IdType="pubmed">28087419</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson GP. Hearing Difficulties in the Absence of Hearing Loss. J Am Acad Audiol 2018;29:456.</Citation><ArticleIdList><ArticleId IdType="pubmed">29863460</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27808415</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Laryngoscope</Title><ISOAbbreviation>Laryngoscope</ISOAbbreviation></Journal><ArticleTitle>An open-label study of sodium oxybate in Spasmodic dysphonia.</ArticleTitle><Pagination><StartPage>1402</StartPage><EndPage>1407</EndPage><MedlinePgn>1402-1407</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.26381</ELocationID><Abstract><AbstractText Label="OBJECTIVES/HYPOTHESIS">Spasmodic dysphonia (SD) is a task-specific laryngeal dystonia that affects speech production. Co-occurring voice tremor (VT) often complicates the diagnosis and clinical management of SD. Treatment of SD and VT is largely limited to botulinum toxin injections into laryngeal musculature; other pharmacological options are not sufficiently developed.</AbstractText><AbstractText Label="STUDY DESIGN">Open-label study.</AbstractText><AbstractText Label="METHODS">We conducted an open-label study in 23 SD and 22 SD/VT patients to examine the effects of sodium oxybate (Xyrem), an oral agent with therapeutic effects similar to those of alcohol in these patients. Blinded randomized analysis of voice and speech samples assessed symptom improvement before and after drug administration.</AbstractText><AbstractText Label="RESULTS">Sodium oxybate significantly improved voice symptoms (P = .001) primarily by reducing the number of SD-characteristic voice breaks and severity of VT. Sodium oxybate further showed a trend for improving VT symptoms (P = .03) in a subset of patients who received successful botulinum toxin injections for the management of their SD symptoms. The drug's effects were observed approximately 30 to 40 minutes after its intake and lasted about 3.5 to 4 hours.</AbstractText><AbstractText Label="CONCLUSIONS">Our study demonstrated that sodium oxybate reduced voice symptoms in 82.2% of alcohol-responsive SD patients both with and without co-occurring VT. Our findings suggest that the therapeutic mechanism of sodium oxybate in SD and SD/VT may be linked to that of alcohol, and as such, sodium oxybate might be beneficial for alcohol-responsive SD and SD/VT patients.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">4 Laryngoscope, 127:1402-1407, 2017.</AbstractText><CopyrightInformation>&#xa9; 2016 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rumbach</LastName><ForeName>Anna F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>School of Health and Rehabilitation Sciences, Speech Pathology, University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blitzer</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Head and Neck Surgical Group, New York, New York, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frucht</LastName><ForeName>Steven J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonyan</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, U.S.A.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DC012545</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Laryngoscope</MedlineTA><NlmUniqueID>8607378</NlmUniqueID><ISSNLinking>0023-852X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018377">Neurotransmitter Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>3K9958V90M</RegistryNumber><NameOfSubstance UI="D000431">Ethanol</NameOfSubstance></Chemical><Chemical><RegistryNumber>7G33012534</RegistryNumber><NameOfSubstance UI="D012978">Sodium Oxybate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055154" MajorTopicYN="N">Dysphonia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000431" MajorTopicYN="N">Ethanol</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018377" MajorTopicYN="N">Neurotransmitter Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012978" MajorTopicYN="N">Sodium Oxybate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013060" MajorTopicYN="N">Speech</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014831" MajorTopicYN="N">Voice</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014832" MajorTopicYN="N">Voice Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Laryngeal dystonia</Keyword><Keyword MajorTopicYN="N">Xyrem</Keyword><Keyword MajorTopicYN="N">alcohol</Keyword></KeywordList><CoiStatement>Conflict of interest: None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27808415</ArticleId><ArticleId IdType="mid">NIHMS820846</ArticleId><ArticleId IdType="pmc">PMC5415435</ArticleId><ArticleId IdType="doi">10.1002/lary.26381</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schweinfurth JM, Billante M, Courey MS. Risk factors and demographics in patients with spasmodic dysphonia. Laryngoscope. 2002;112:220&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">11889373</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitzer A, Brin MF, Stewart C. Botulinum Toxin Management of Spasmodic Dysphonia (Laryngeal Dystonia): A 12 Year Experience in More Than 900 Patients. Laryngoscope. 1998;108:1435&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pubmed">9778279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirke DN, Frucht SJ, Simonyan K. Alcohol responsiveness in laryngeal dystonia: a survey study. J Neurol. 2015;262:1548&#x2013;1556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4674786</ArticleId><ArticleId IdType="pubmed">25929664</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitzer A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol. 2010;17(Suppl 1):28&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">20590805</ArticleId></ArticleIdList></Reference><Reference><Citation>Novakovic D, Waters HH, D&#x2019;Elia JB, Blitzer A. Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes. Laryngoscope. 2011;121:606&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">21298641</ArticleId></ArticleIdList></Reference><Reference><Citation>Waszkielewicz A, Bojarski J. Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system. Pol J Pharmacol. 2004;56:43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">15047976</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunelli V, Emri Z, Leresche N. Unravelling the brain targets of gamma-hydroxybutyric acid. Curr Opin Pharmacol. 2006;6:44&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2174623</ArticleId><ArticleId IdType="pubmed">16368267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YG, Swick TJ, Carter LP, Thorpy MJ, Benowitz NL. Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion. J Clin Sleep Med. 2009;5:365&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2725257</ArticleId><ArticleId IdType="pubmed">19968016</ArticleId></ArticleIdList></Reference><Reference><Citation>Arpesella R, Dallocchio C, Arbasino C, Imberti R, Martinotti R, Frucht SJ. A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate. Anaesthesia and intensive care. 2009;37:314&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">19400500</ArticleId></ArticleIdList></Reference><Reference><Citation>Frucht SJ, Bordelon Y, Houghton WH, Reardan D. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord. 2005;20:1330&#x2013;1337.</Citation><ArticleIdList><ArticleId IdType="pubmed">15986420</ArticleId></ArticleIdList></Reference><Reference><Citation>Frucht SJ, Houghton WC, Bordelon Y, Greene PE, Louis ED. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology. 2005;65:1967&#x2013;1969.</Citation><ArticleIdList><ArticleId IdType="pubmed">16382538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludlow CL, Adler CH, Berke GS, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 2008;139:495&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2643054</ArticleId><ArticleId IdType="pubmed">18922334</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonyan K, Frucht SJ. Long-term Effect of Sodium Oxybate (Xyrem(R)) in Spasmodic Dysphonia with Vocal Tremor. Tremor and other hyperkinetic movements. 2013 Dec 9;3 eCollection 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863985</ArticleId><ArticleId IdType="pubmed">24386608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirke DN, Battistella G, Kumar V, et al. Neural correlates of dystonic tremor: a multimodal study of voice tremor in spasmodic dysphonia. Brain Imaging Behav. 2016 Feb 3; Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972702</ArticleId><ArticleId IdType="pubmed">26843004</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonyan K, Berman BD, Herscovitch P, Hallett M. Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. J Neurosci. 2013;33:14705&#x2013;14714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3771037</ArticleId><ArticleId IdType="pubmed">24027271</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonyan K, Ludlow CL. Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex. 2010;20:2749&#x2013;2759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951850</ArticleId><ArticleId IdType="pubmed">20194686</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonyan K, Ludlow CL. Abnormal structure-function relationship in spasmodic dysphonia. Cereb Cortex. 2012;22:417&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256408</ArticleId><ArticleId IdType="pubmed">21666131</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonyan K, Tovar-Moll F, Ostuni J, et al. Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain. 2008;131:447&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2376833</ArticleId><ArticleId IdType="pubmed">18083751</ArticleId></ArticleIdList></Reference><Reference><Citation>Brin MF, Blitzer A, Stewart C. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Adv Neurol. 1998;78:237&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">9750921</ArticleId></ArticleIdList></Reference><Reference><Citation>Papavasiliou PS, Cotzias GC, Mena I, Bell M. Oxybate sodium for parkinsonism. JAMA. 1973;224:130.</Citation><ArticleIdList><ArticleId IdType="pubmed">4570141</ArticleId></ArticleIdList></Reference><Reference><Citation>Costardi JV, Nampo RA, Silva GL, et al. A review on alcohol: from the central action mechanism to chemical dependency. Rev Assoc Med Bras. 2015;61:381&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">26466222</ArticleId></ArticleIdList></Reference><Reference><Citation>Haubenberger D, Nahab FB, Voller B, Hallett M. Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time? Tremor and other hyperkinetic movements. 2014:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3918508</ArticleId><ArticleId IdType="pubmed">24587968</ArticleId></ArticleIdList></Reference><Reference><Citation>Snead OC, 3rd, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med. 2005;352:2721&#x2013;2732.</Citation><ArticleIdList><ArticleId IdType="pubmed">15987921</ArticleId></ArticleIdList></Reference><Reference><Citation>Keating GM. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clin Drug Investig. 2014;34:63&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">24307430</ArticleId></ArticleIdList></Reference><Reference><Citation>Gessa GL, Agabio R, Carai MA, et al. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. Alcohol. 2000;20:271&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">10869869</ArticleId></ArticleIdList></Reference><Reference><Citation>Garibotto V, Romito LM, Elia AE, et al. In vivo evidence for GABA(A) receptor changes in the sensorimotor system in primary dystonia. Mov Disord. 2011;26:852&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">21370265</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlmutter JS, Stambuk MK, Markham J, et al. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci. 1997;17:843&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573223</ArticleId><ArticleId IdType="pubmed">8987805</ArticleId></ArticleIdList></Reference><Reference><Citation>Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord. 2013;28:958&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159671</ArticleId><ArticleId IdType="pubmed">23893452</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31157716</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2154-4212</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Female pelvic medicine &amp; reconstructive surgery</Title><ISOAbbreviation>Female Pelvic Med Reconstr Surg</ISOAbbreviation></Journal><ArticleTitle>Is a Postvoid Residual Necessary? A Randomized Trial of Two Postoperative Voiding Protocols.</ArticleTitle><Pagination><StartPage>e256</StartPage><EndPage>e260</EndPage><MedlinePgn>e256-e260</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SPV.0000000000000743</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study aimed to compare a backfill-assisted voiding trial (VT) with and without a postvoid residual (PVR) after pelvic reconstructive surgery.</AbstractText><AbstractText Label="METHODS">This was a nonblinded randomized controlled trial of women undergoing pelvic organ prolapse and/or stress incontinence surgery. Participants were randomized immediately after surgery to either a PVR VT or a PVR-free VT. Our primary outcome was the rate of VT failure at discharge. Secondary outcomes included days of catheterization, urinary tract infection (UTI), and prolonged voiding dysfunction. With a power of 80% and an &#x3b1; of 0.05, we needed 126 participants to detect a 25% difference in VT failure (60% in PVR VT vs 35% in PVR-free VT).</AbstractText><AbstractText Label="RESULTS">Participants were enrolled from March 2017 to October 2017. Of the 150 participants, mean age was 59 years, and 33% underwent vaginal hysterectomy, 48% underwent anterior repair, and 75% underwent midurethral sling. Seventy-five (50%) were randomized to PVR VT and 75 (50%) to PVR-free VT, with no differences in baseline demographic or intraoperative characteristics between the 2 groups. Our primary outcome, VT failure, was not significantly different (53% PVR VT vs 53% PVR-free VT, P = 1.0). There were no significant differences in days of postoperative catheterization (1 [0, 4] in PVR VT vs 1 [0, 4] in PVR-free VT, P = 0.90), UTI (20% PVR VT vs 20% PVR-free VT, P = 1.0), or postoperative voiding dysfunction (4% PVR VT vs 5% PVR-free VT, P = 1.0).</AbstractText><AbstractText Label="CONCLUSIONS">When performing a backfill-assisted VT, checking a PVR does not affect VT failure, postoperative duration of catheterization, UTI, or voiding dysfunction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 American Urogynecologic Society. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Willis-Gray</LastName><ForeName>Marcella G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of OB/GYN, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pulliam</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Renovia Inc, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husk</LastName><ForeName>Katherine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brueseke</LastName><ForeName>Taylor J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of California, Irvine, Irvine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geller</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>AnnaMarie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieter</LastName><ForeName>Alexis A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03009968</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Female Pelvic Med Reconstr Surg</MedlineTA><NlmUniqueID>101528690</NlmUniqueID><ISSNLinking>2151-8378</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056887" MajorTopicYN="N">Pelvic Organ Prolapse</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053825" MajorTopicYN="N">Suburethral Slings</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014546" MajorTopicYN="N">Urinary Catheterization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014550" MajorTopicYN="N">Urinary Incontinence, Stress</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016055" MajorTopicYN="N">Urinary Retention</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013520" MajorTopicYN="Y">Urologic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31157716</ArticleId><ArticleId IdType="doi">10.1097/SPV.0000000000000743</ArticleId><ArticleId IdType="pii">01436319-202102000-00014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geller EJ, Hankins KJ, Parnell BA, et al. Diagnostic accuracy of retrograde and spontaneous voiding trials for postoperative voiding dysfunction: a randomized controlled trial. Obstet Gynecol 2011;118(3):637&#x2013;642.</Citation></Reference><Reference><Citation>Schiotz HA, Tanbo TG. Postoperative voiding, bacteriuria and urinary tract infection with Foley catheterization after gynecological surgery. Acta Obstet Gynecol Scand 2006;85(4):476&#x2013;481.</Citation></Reference><Reference><Citation>Foster RT Sr., Borawski KM, South MM, et al. A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 2007;197(6):627 e621&#x2013;627 e624.</Citation></Reference><Reference><Citation>Hakvoort RA, Thijs SD, Bouwmeester FW, et al. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG 2011;118(9):1055&#x2013;1060.</Citation></Reference><Reference><Citation>Hakvoort RA, Burger MP, Emanuel MH, et al. A nationwide survey to measure practice variation of catheterisation management in patients undergoing vaginal prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct 2009;20(7):813&#x2013;818.</Citation></Reference><Reference><Citation>Sutkin G, Alperin M, Meyn L, et al. Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J 2010;21(8):955&#x2013;961.</Citation></Reference><Reference><Citation>Dieter AA, Amundsen CL, Edenfield AL, et al. Oral antibiotics to prevent postoperative urinary tract infection: a randomized controlled trial. Obstet Gynecol 2014;123(1):96&#x2013;103.</Citation></Reference><Reference><Citation>Dieter AA, Amundsen CL, Visco AG, et al. Treatment for urinary tract infection after midurethral sling: a retrospective study comparing patients who receive short-term postoperative catheterization and patients who pass a void trial on the day of surgery. Female Pelvic Med Reconstr Surg 2012;18(3):175&#x2013;178.</Citation></Reference><Reference><Citation>Elkadry EA, Kenton KS, FitzGerald MP, et al. Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 2003;189(6):1551&#x2013;1557; discussion 1557&#x2013;1558.</Citation></Reference><Reference><Citation>Pulvino JQ, Duecy EE, Buchsbaum GM, et al. Comparison of 2 techniques to predict voiding efficiency after inpatient urogynecologic surgery. J Urol 2010;184(4):1408&#x2013;1412.</Citation></Reference><Reference><Citation>Ingber MS, Vasavada SP, Moore CK, et al. Force of stream after sling therapy: safety and efficacy of rapid discharge care pathway based on subjective patient report. J Urol 2011;185(3):993&#x2013;997.</Citation></Reference><Reference><Citation>Tunitsky-Bitton E, Murphy A, Barber MD, et al. Assessment of voiding after sling: a randomized trial of 2 methods of postoperative catheter management after midurethral sling surgery for stress urinary incontinence in women. Am J Obstet Gynecol 2015;212(5):597 e591&#x2013;597 e599.</Citation></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol 2010;115(5):1063&#x2013;1070.</Citation></Reference><Reference><Citation>Barber MD, Kleeman S, Karram MM, et al. Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol 2008;111(3):611&#x2013;621.</Citation></Reference><Reference><Citation>Meekins AR, Siddiqui NY, Amundsen CL, et al. Improving postoperative efficiency: an algorithm for expedited void trials after urogynecologic surgery. South Med J 2017;110(12):785&#x2013;790.</Citation></Reference><Reference><Citation>Myers EM, Matthews CA, Crane AK, et al. Two techniques for assessing postoperative voiding function, a randomized trial. Int Urogynecol J 2017;28(10):1567&#x2013;1572.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31318497</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1930-739X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Obesity (Silver Spring, Md.)</Title><ISOAbbreviation>Obesity (Silver Spring)</ISOAbbreviation></Journal><ArticleTitle>BMI, Waist Circumference, and Risk of Incident Vertebral Fracture in Women.</ArticleTitle><Pagination><StartPage>1513</StartPage><EndPage>1519</EndPage><MedlinePgn>1513-1519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/oby.22555</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The study aimed to investigate the association between BMI, waist circumference, and vertebral fracture (VF) risk in women.</AbstractText><AbstractText Label="METHODS">This prospective study was conducted in 54,934 Nurses' Health Study participants. BMI was assessed biennially, and waist circumference was assessed in the year 2000. Self-reports of VF were confirmed by record review. BMI reflects lean body mass, and waist circumference reflects abdominal adiposity when included in the same regression model.</AbstractText><AbstractText Label="RESULTS">This study included 536 VF cases (2002 to 2014). Compared with women with BMI of 21.0 to 24.9 kg/m<sup>2</sup> , the multivariable-adjusted relative risk (RR) of VF for women with BMI&#x2009;&#x2265;&#x2009;32.0 was 0.84 (95% CI: 0.61-1.14; P<sub>trend</sub> &#x2009;=&#x2009;0.08). After further adjustment for waist circumference, the multivariable-adjusted RR of VF for women with BMI&#x2009;&#x2265;&#x2009;32.0 was 0.70 (95% CI: 0.49-0.98; P<sub>trend</sub> &#x2009;=&#x2009;0.003). Compared with women with waist circumference &lt;&#x2009;71.0 cm, the multivariable-adjusted RR of VF for women with waist circumference&#x2009;&#x2265;&#x2009;108.0 cm was 1.76 (95% CI: 1.06-2.92; P<sub>trend</sub> &#x2009;=&#x2009;0.01), and after further adjustment for BMI, the multivariable-adjusted RR of VF was 2.49 (95% CI: 1.44-4.33; P<sub>trend</sub> &#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Greater lean body mass was independently associated with lower VF risk. Larger waist circumference was independently associated with higher VF risk. These findings suggest that fat distribution is an important predictor of VF and that avoiding central adiposity, as well as maintaining muscle mass, may potentially confer reduced risk of VF in older women.</AbstractText><CopyrightInformation>&#xa9; 2019 The Obesity Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paik</LastName><ForeName>Julie M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-1315-5445</Identifier><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>Harold N</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Endocrinology Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Jeffrey N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosner</LastName><ForeName>Bernard A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rimm</LastName><ForeName>Eric B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curhan</LastName><ForeName>Gary C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 DK100447</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 DK091417</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR075117</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 CA186107</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obesity (Silver Spring)</MedlineTA><NlmUniqueID>101264860</NlmUniqueID><ISSNLinking>1930-7381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Obesity (Silver Spring). 2019 Sep;27(9):1389. doi: 10.1002/oby.22596.</RefSource><PMID Version="1">31347790</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="Y">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055105" MajorTopicYN="Y">Waist Circumference</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflicts of Interest:</b> All authors state that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31318497</ArticleId><ArticleId IdType="mid">NIHMS1030973</ArticleId><ArticleId IdType="pmc">PMC6707901</ArticleId><ArticleId IdType="doi">10.1002/oby.22555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999;159: 1215&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pubmed">10371229</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd. Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res 2014;29: 581&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929546</ArticleId><ArticleId IdType="pubmed">23959594</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LJ 3rd, Kan SH, Frye MA, Wahner HW, O&#x2019;Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989;129: 1000&#x2013;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">2784934</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein EM, Liu XS, Nickolas TL, Cohen A, McMahon DJ, Zhou B, et al. Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab 2012;97: E1918&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674300</ArticleId><ArticleId IdType="pubmed">22821893</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers ER, Wilson SE. Biomechanics of osteoporosis and vertebral fracture. Spine (Phila Pa 1976) 1997;22: 25S&#x2013;31S.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431641</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen BA, Bouxsein ML. Biomechanics of vertebral fractures and the vertebral fracture cascade. Curr Osteoporos Rep 2010;8: 198&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">20838942</ArticleId></ArticleIdList></Reference><Reference><Citation>De Laet C, Kanis J, Od&#xe9;n A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005;16: 1330&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">15928804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewiecki EM, Bilezikian JP, Bonewald L, Compston JE, Heaney RP, Kiel DP, et al. Osteoporosis update: proceedings of the 2013 Santa Fe Bone Symposium. J Clin Densitom 2014;17: 330&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">24613387</ArticleId></ArticleIdList></Reference><Reference><Citation>Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 2011;124: 1043&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4897773</ArticleId><ArticleId IdType="pubmed">22017783</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen A, Dempster DW, Recker RR, Lappe JM, Zhou H, Zwahlen A, et al. Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab 2013;98: 2562&#x2013;2572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3667251</ArticleId><ArticleId IdType="pubmed">23515452</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer HE, Willett WC, Flint AJ, Feskanich D. Abdominal obesity and hip fracture: results from the Nurses&#x2019; Health Study and the Health Professionals Follow-up Study. Osteoporos Int 2016;27: 2127&#x2013;2136.</Citation><ArticleIdList><ArticleId IdType="pubmed">26849456</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson H, Kanis JA, Oden A, McCloskey E, Chapurlat RD, Christiansen C, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 2014;29: 223&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">23775829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaze AD, Rosen HN, Paik JM. A meta-analysis of the association between body mass index and risk of vertebral fracture. Osteoporos Int 2018;29: 31&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">29098347</ArticleId></ArticleIdList></Reference><Reference><Citation>Compston JE, Flahive J, Hosmer DW, Watts NB, Siris ES, Silverman S, et al. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res 2014;29: 487&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878680</ArticleId><ArticleId IdType="pubmed">23873741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Kuroda T, Saito M, Shiraki M. Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women. Osteoporos Int 2013;24: 69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">23229467</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Akesson K. Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 2006;17: 1065&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">16758143</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevitt MC, Cummings SR, Stone KL, Palermo L, Black DM, Bauer DC, et al. Risk factors for a first-incident radiographic vertebral fracture in women &gt; or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res 2005;20: 131&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">15619679</ArticleId></ArticleIdList></Reference><Reference><Citation>Papaioannou A, Joseph L, Ioannidis G, Berger C, Anastassiades T, Brown JP, et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2005;16: 568&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pubmed">15517191</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy DK, O&#x2019;Neill TW, Finn JD, Lunt M, Silman AJ, Felsenberg D, et al. Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 2003;14: 19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">12577181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimm E, Stampfer M, Colditz GA, Chute C, Litin L, Willett W. Validity of self-reported waist and hip circumference in men and women. Epidemiology 1990;1: 466&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">2090285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf A, Hunter D, Colditz G, Manson J, Stampfer M, Corsano K, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 1994;23: 991&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pubmed">7860180</ArticleId></ArticleIdList></Reference><Reference><Citation>Prochaska M, Taylor E, Vaidya A, Curhan G. Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones. Clin J Am Soc Nephrol 2017;12: 1284&#x2013;1290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544505</ArticleId><ArticleId IdType="pubmed">28576907</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Spiegelman D, Rimm EB, Rosner BA, Stampfer MJ, Barnett JB, et al. Validity of a Dietary Questionnaire Assessed by Comparison With Multiple Weighed Dietary Records or 24-Hour Recalls. Am J Epidemiol 2017;185: 570&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859994</ArticleId><ArticleId IdType="pubmed">28338828</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik JM, Rosen HN, Gordon CM, Curhan GC. Diuretic Use and Risk of Vertebral Fracture in Women. Am J Med 2016;129: 1299&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5118092</ArticleId><ArticleId IdType="pubmed">27542612</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik JM, Rosen HN, Gordon CM, Curhan GC. Proton Pump Inhibitor Use, H2-Receptor Antagonist Use, and Risk of Incident Clinical Vertebral Fracture in Women. Calcif Tissue Int 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6231994</ArticleId><ArticleId IdType="pubmed">29754277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu FB. Obesity epidemiology. Oxford University Press: Oxford; New York, 2008; 74&#x2013;76.</Citation></Reference><Reference><Citation>Willett W Nutritional epidemiology, Third edition Oxford University Press: Oxford; New York, 2013; 259&#x2013;60.</Citation></Reference><Reference><Citation>Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996;143: 228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">8561156</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 2007;92: 1640&#x2013;1646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868430</ArticleId><ArticleId IdType="pubmed">17299077</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbour KE, Zmuda JM, Boudreau R, Strotmeyer ES, Horwitz MJ, Evans RW, et al. Adipokines and the risk of fracture in older adults. J Bone Miner Res 2011;26: 1568&#x2013;1576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733555</ArticleId><ArticleId IdType="pubmed">21312272</ArticleId></ArticleIdList></Reference><Reference><Citation>Araneta MR, von Muhlen D, Barrett-Connor E. Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study. J Bone Miner Res 2009;24: 2016&#x2013;2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791515</ArticleId><ArticleId IdType="pubmed">19453256</ArticleId></ArticleIdList></Reference><Reference><Citation>Komorita Y, Iwase M, Fujii H, Ohkuma T, Ide H, Jodai-Kitamura T, et al. Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetologia 2017;60: 1922&#x2013;1930.</Citation><ArticleIdList><ArticleId IdType="pubmed">28721438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, et al. Determinants of bone mineral density in obese premenopausal women. Bone 2011;48: 748&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3073669</ArticleId><ArticleId IdType="pubmed">21195217</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredella MA, Lin E, Gerweck AV, Landa MG, Thomas BJ, Torriani M, et al. Determinants of bone microarchitecture and mechanical properties in obese men. J Clin Endocrinol Metab 2012;97: 4115&#x2013;4122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3485587</ArticleId><ArticleId IdType="pubmed">22933540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmann KN, Bruno AG, Bredella MA, Schorr M, Lawson EA, Gill CM, et al. Vertebral Strength and Estimated Fracture Risk Across the BMI Spectrum in Women. J Bone Miner Res 2016;31: 281&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4833882</ArticleId><ArticleId IdType="pubmed">26332401</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009;94: 3387&#x2013;3393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2741723</ArticleId><ArticleId IdType="pubmed">19531595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hind K, Pearce M, Birrell F. Total and Visceral Adiposity Are Associated With Prevalent Vertebral Fracture in Women but Not Men at Age 62 Years: The Newcastle Thousand Families Study. J Bone Miner Res 2017;32: 1109&#x2013;1115.</Citation><ArticleIdList><ArticleId IdType="pubmed">28261864</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell M, Mendes N, Miller KK, Rosen CJ, Lee H, Klibanski A, et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab 2010;95: 1247&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2841531</ArticleId><ArticleId IdType="pubmed">20080853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundh D, Rudang R, Zoulakis M, Nilsson AG, Darelid A, Lorentzon M. A High Amount of Local Adipose Tissue Is Associated With High Cortical Porosity and Low Bone Material Strength in Older Women. J Bone Miner Res 2016;31: 749&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pubmed">26588353</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JF, Davis M, Alexander R, Zemel BS, Mostoufi-Moab S, Shults J, et al. Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone 2013;53: 34&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3552077</ArticleId><ArticleId IdType="pubmed">23238122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrasseur NK, Achenbach SJ, Melton LJ, 3rd, Amin S, Khosla S. Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. J Bone Miner Res 2012;27: 2159&#x2013;2169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3645866</ArticleId><ArticleId IdType="pubmed">22623219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 2012;3: 260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429036</ArticleId><ArticleId IdType="pubmed">22934016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtarzadeh H, Anderson DE. The Role of Trunk Musculature in Osteoporotic Vertebral Fractures: Implications for Prediction, Prevention, and Management. Curr Osteoporos Rep 2016;14: 67&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hida T, Shimokata H, Sakai Y, Ito S, Matsui Y, Takemura M, et al. Sarcopenia and sarcopenic leg as potential risk factors for acute osteoporotic vertebral fracture among older women. Eur Spine J 2016;25: 3424&#x2013;3431.</Citation><ArticleIdList><ArticleId IdType="pubmed">25690348</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott D, Seibel M, Cumming R, Naganathan V, Blyth F, Le Couteur DG, et al. Sarcopenic Obesity and Its Temporal Associations With Changes in Bone Mineral Density, Incident Falls, and Fractures in Older Men: The Concord Health and Ageing in Men Project. J Bone Miner Res 2017;32: 575&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">27736026</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30847997</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Percutaneous left ventricular assist device support during ablation of ventricular tachycardia: A meta-analysis of current evidence.</ArticleTitle><Pagination><StartPage>886</StartPage><EndPage>895</EndPage><MedlinePgn>886-895</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.13907</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Catheter ablation of ventricular tachycardia (VT) can be an effective therapy to reduce VT burden, but often it is limited by the potential for hemodynamic instability. Percutaneous left ventricular assist devices (pLVADs) have been used to maintain hemodynamic support during VT ablation but the evidence regarding its clinical impact has been inconclusive.</AbstractText><AbstractText Label="METHODS AND RESULTS">We sought to assess the clinical impact of pLVAD when used in VT ablation by conducting a meta-analysis of the current evidence. We searched Pubmed and found nine observational studies that compared clinical outcomes of VT ablation in patients with pLVAD support to controls with no pLVAD support. The pooled data did not show a significant difference in mortality between both groups, nor a difference in acute procedural success or in recurrence of VT. There was also no difference in the number of patients receiving a cardiac transplant or being enrolled in the transplant list. Although there was no difference in the ablation time between the groups, patients in the pLVAD group had a longer total procedural time and more procedure-related adverse effects.</AbstractText><AbstractText Label="CONCLUSION">This meta-analysis did not show clinical benefits from using pLVAD support during VT ablation, whereas it was associated with longer procedure times and more complications. This study was, however, limited by the observational nature of the data. In view of these data, the risk and benefit of pLVAD support during VT ablation should be considered on an individual basis.</AbstractText><CopyrightInformation>&#xa9; 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luni</LastName><ForeName>Faraz Khan</ForeName><Initials>FK</Initials><Identifier Source="ORCID">0000-0003-3785-431X</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zungsontiporn</LastName><ForeName>Nath</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farid</LastName><ForeName>Talha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Louisville, Louisville, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Sonia Ali</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Sobia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Louisville, Louisville, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Link</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-5277-9296</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joglar</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiovasc Electrophysiol. 2019 Oct;30(10):2187-2188. doi: 10.1111/jce.14047.</RefSource><PMID Version="1">31310362</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="Y">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ablation</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">percutaneous left ventricular assist device (pLVAD)</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30847997</ArticleId><ArticleId IdType="doi">10.1111/jce.13907</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24349972</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2225-319X</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of cardiothoracic surgery</Title><ISOAbbreviation>Ann Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Custodiol for myocardial protection and preservation: a systematic review.</ArticleTitle><Pagination><StartPage>717</StartPage><EndPage>728</EndPage><MedlinePgn>717-28</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3978/j.issn.2225-319X.2013.11.10</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Custodiol cardioplegia is attractive for minimally invasive cardiac surgery, as a single dose provides a long period of myocardial protection. Despite widespread use in Europe, there is little data confirming its efficacy compared with conventional (blood or crystalloid) cardioplegia. There is similar enthusiasm for its use in organ preservation for transplant, but also a lack of data. This systematic review aimed to assess the evidence for the efficacy of Custodiol in myocardial protection and as a preservation solution in heart transplant.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic searches were performed of six databases from inception to October 2013. Reviewers independently identified studies that compared Custodiol with conventional cardioplegia (blood or extracellular crystalloid) in adult patients for meta-analysis; large case series that reported results using Custodiol were analyzed. Next, we identified studies that compared Custodiol with other organ preservation solutions for organ preservation in heart transplant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen studies compared Custodiol with conventional cardioplegia for myocardial protection in adult cardiac surgery. No difference was identified in mortality; there was a trend for increased incidence of ventricular fibrillation in the Custodiol group that did not reach statistical significance. No difference was identified in studies that compared Custodiol with other solutions for heart transplant.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite widespread clinical use, the evidence supporting the superiority of Custodiol over other solutions for myocardial protection or organ preservation is limited. Large randomised trials are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Edelman</LastName><ForeName>J James B</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Australia; ; The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seco</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunne</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Royal Perth Hospital, Perth, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matzelle</LastName><ForeName>Shannon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Sir Charles Gairdner Hospital, Nedlands, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Sir Charles Gairdner Hospital, Nedlands, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joshi</LastName><ForeName>Pragnesh</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Tristan D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia; ; Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Michael K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia; ; Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia; ; Australian School of Advanced Medicine, Macquarie University, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bannon</LastName><ForeName>Paul G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia; ; Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallely</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia; ; Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia; ; Australian School of Advanced Medicine, Macquarie University, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passage</LastName><ForeName>Jurgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Australia; ; Notre Dame Medical School, Fremantle, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Cardiothorac Surg</MedlineTA><NlmUniqueID>101605877</NlmUniqueID><ISSNLinking>2225-319X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Custodiol solution</Keyword><Keyword MajorTopicYN="N">cardiac transplantation</Keyword><Keyword MajorTopicYN="N">heart arrest</Keyword><Keyword MajorTopicYN="N">histidine-tryptophan-ketoglutarate solution</Keyword><Keyword MajorTopicYN="N">induced</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24349972</ArticleId><ArticleId IdType="pmc">PMC3857005</ArticleId><ArticleId IdType="doi">10.3978/j.issn.2225-319X.2013.11.10</ArticleId><ArticleId IdType="pii">acs-02-06-717</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gebhard MM, Preusse CJ, Schnabel PA, et al. Different effects of cardioplegic solution HTK during single or intermittent administration. Thorac Cardiovasc Surg 1984;32:271-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6083614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980;28:295-302</Citation><ArticleIdList><ArticleId IdType="pubmed">6161427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretschneider HJ, H&#xfc;bner G, Knoll D, et al. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg (Torino) 1975;16:241-60</Citation><ArticleIdList><ArticleId IdType="pubmed">239002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 2003;75:S661-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12607709</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana FF, Shi WY, Hayward PA, et al. Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience. Eur J Cardiothorac Surg 2013;43:526-31</Citation><ArticleIdList><ArticleId IdType="pubmed">22665382</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji B, Liu J, Long C, et al. Potential risk of hyponatremia using histidine-tryptophan-ketoglutarate solution during pediatric cardiopulmonary bypass. Ann Thorac Surg 2012;93:2120-1; author reply 2121</Citation><ArticleIdList><ArticleId IdType="pubmed">22632526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JT, Park YH, Chang YE, et al. The effect of cardioplegic solution-induced sodium concentration fluctuation on postoperative seizure in pediatric cardiac patients. Ann Thorac Surg 2011;91:1943-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21511247</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenspurner H, Russ C, Uberfuhr P, et al. Myocardial preservation using HTK solution for heart transplantation. A multicenter study. Eur J Cardiothorac Surg 1993;7:414-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8398188</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;lscher M, Groenewoud AF. Current status of the HTK solution of Bretschneider in organ preservation. Transplant Proc 1991;23:2334-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1926380</ArticleId></ArticleIdList></Reference><Reference><Citation>Demmy TL, Biddle JS, Bennett LE, et al. Organ preservation solutions in heart transplantation--patterns of usage and related survival. Transplantation 1997;63:262-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9020328</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman JJ, Seco M, Dunne B, et al. Systematic review protocol: single-dose histidine-tryptophan-ketoglutarate vs. intermittent crystalloid or blood cardioplegia. Ann Cardiothorac Surg 2013;2:677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791192</ArticleId><ArticleId IdType="pubmed">24109584</ArticleId></ArticleIdList></Reference><Reference><Citation>Braathen B, Jeppsson A, Scherst&#xe9;n H, et al. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg 2011;141:995-1001</Citation><ArticleIdList><ArticleId IdType="pubmed">20800244</ArticleId></ArticleIdList></Reference><Reference><Citation>Careaga G, Salazar D, T&#xe9;llez S, et al. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients. Arch Med Res 2001;32:296-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11440787</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707010</ArticleId><ArticleId IdType="pubmed">19621070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderdiek U, Feindt P, Gams E.Aortocoronary bypass grafting: a comparison of HTK cardioplegia vs. intermittent aortic cross-clamping. Eur J Cardiothorac Surg 2000;18:393-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11024374</ArticleId></ArticleIdList></Reference><Reference><Citation>Imanaka K, Kyo S, Ogiwara M, et al. Mitral valve surgery under perfused ventricular fibrillation with moderate hypothermia. Circ J 2002;66:450-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12030338</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M, Pragliola C, Anselmi A, et al. Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery. Scand Cardiovasc J. 2013 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">24053647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kammerer I, Nagib R, Hipp G, et al. Myocardial Protection in Minimally Invasive Mitral Valve Surgery: Comparison of the Cold-Blood Cardioplegia of the Bretschneider Solution and the Warm-Blood Cardioplegia of the Calafiore Protocol. Arch Clin Exp Surg 2012;1:14-21</Citation></Reference><Reference><Citation>Sansone F, Punta G, Parisi F, et al. Right minithoracotomy versus full sternotomy for the aortic valve replacement: preliminary results. Heart Lung Circ 2012;21:169-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22071201</ArticleId></ArticleIdList></Reference><Reference><Citation>Scrascia G, Guida P, Rotunno C, et al. Myocardial protection during aortic surgery: comparison between Bretschneider-HTK and cold blood cardioplegia. Perfusion 2011;26:427-33</Citation><ArticleIdList><ArticleId IdType="pubmed">21665911</ArticleId></ArticleIdList></Reference><Reference><Citation>Demmy TL, Molina JE, Ward HB, et al. Custodiol versus Plegisol: A phase 3 multicentre myocardial protection study. Int J Angiol 2008;17:149-53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2727762</ArticleId><ArticleId IdType="pubmed">22477420</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan A, Sezgin A, Gultekin B, et al. Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection. Transplant Proc 2005;37:3219-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16213352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesenack C, Liebold A, Philipp A, et al. Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 2004;28:1082-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15554936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata J, Morishita K, Ito T, et al. Comparison of clinical outcome between histidine-triptophan-ketoglutalate solution and cold blood cardioplegic solution in mitral valve replacement. J Card Surg 1998;13:43-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9892485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachida M, Nonoyama M, Bonkohara Y, et al. Clinical assessment of prolonged myocardial preservation for patients with a severely dilated heart. Ann Thorac Surg 1997;64:59-63</Citation><ArticleIdList><ArticleId IdType="pubmed">9236335</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyersdorf F, Krause E, Sarai K, et al. Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery. Thorac Cardiovasc Surg 1990;38:20-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2106735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallandat Huet RC, Karliczek GF, van der Heide JN, et al. Clinical effect of Bretschneider-HTK and St. Thomas cardioplegia on hemodynamic performance after bypass measured using an automatic datalogging database system. Thorac Cardiovasc Surg 1988;36:151-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3145585</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Eusanio M, Pantaleo A, Murana G, et al. Frozen elephant trunk surgery-the Bologna&#x2019;s experience. Ann Cardiothorac Surg 2013;2:597-605</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791204</ArticleId><ArticleId IdType="pubmed">24109567</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami K, Zittermann A, Schulte-Eistrup S, et al. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg 2005;80:1699-705</Citation><ArticleIdList><ArticleId IdType="pubmed">16242441</ArticleId></ArticleIdList></Reference><Reference><Citation>Misfeld M, Davierwala P.Crystalloid-based cardioplegia for minimally invasive cardiac surgery. Semin Thorac Cardiovasc Surg 2012;24:305-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23465680</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha M, Baraki H, Maeding I, et al. Long-term results after aortic valve-sparing operation (David I). Eur J Cardiothorac Surg 2012;41:56-61; discussion 61-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241084</ArticleId><ArticleId IdType="pubmed">21632258</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha M, Martens A, Kr&#xfc;ger H, et al. Total aortic arch replacement with the elephant trunk technique: single-centre 30-year results. Eur J Cardiothorac Surg. 2013 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">23872461</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K, Wiesner G, Breuer T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008;107:1783-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19020118</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvador L, Mirone S, Bianchini R, et al. A 20-year experience with mitral valve repair with artificial chordae in 608 patients. J Thorac Cardiovasc Surg 2008;135:1280-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18544371</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis F, Kilger E, Beiras-Fernandez A, et al. Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 2006;61:938-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16978306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannata A, Botta L, Colombo T, et al. Does the cardioplegic solution have an effect on early outcomes following heart transplantation? Eur J Cardiothorac Surg 2012;41:e48-52; discussion e52-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">22423082</ArticleId></ArticleIdList></Reference><Reference><Citation>Garlicki M.May preservation solution affect the incidence of graft vasculopathy in transplanted heart? Ann Transplant 2003;8:19-24</Citation><ArticleIdList><ArticleId IdType="pubmed">12848379</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenspurner H, Russ C, Wagner F, et al. Comparison of UW versus HTK solution for myocardial protection in heart transplantation. Transpl Int 1994;7Suppl 1:S481-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11271286</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofler S, Bigdeli AK, Kaczmarek I, et al. Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center. Transpl Int 2009;22:1140-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19891043</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami K, Omoto T, B&#xf6;thig D, et al. Creatine kinase and troponin after myocardial preservation using HTK solution (Custoidol) for clinical heart transplantation. J Heart Lung Transplant 2003;22:192-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12581768</ArticleId></ArticleIdList></Reference><Reference><Citation>Guru V, Omura J, Alghamdi AA, et al. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation 2006;114:I331-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16820596</ArticleId></ArticleIdList></Reference><Reference><Citation>Fannelop T, Dahle GO, Salminen PR, et al. Multidose cold oxygenated blood is superior to a single dose of Bretschneider HTK-cardioplegia in the pig. Ann Thorac Surg 2009;87:1205-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19324152</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarsaether E, Stenberg TA, Jakobsen &#xd8;, et al. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas&#x2019; and histidine-tryptophan-ketoglutarate cardioplegia-- an experimental comparative study in pigs. Interact Cardiovasc Thorac Surg 2009;9:635-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19628529</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Liu J, Li S, et al. Which is the better option during neonatal cardiopulmonary bypass: HTK solution or cold blood cardioplegia? ASAIO J 2013;59:69-74</Citation><ArticleIdList><ArticleId IdType="pubmed">23263337</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojan M, Peperstraete H, Lilot M, et al. Cold histidine-tryptophan-ketoglutarate solution and repeated oxygenated warm blood cardioplegia in neonates with arterial switch operation. Ann Thorac Surg 2013;95:1390-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23462260</ArticleId></ArticleIdList></Reference><Reference><Citation>Korun O, &#xd6;zkan M, Terzi A, et al. The comparison of the effects of Bretschneider's histidine-tryptophan-ketoglutarate and conventional crystalloid cardioplegia on pediatric myocardium at tissue level. Artif Organs 2013;37:76-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23305576</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Feng Z, Zhao J, et al. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. ASAIO J 2008;54:470-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18812735</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad F, Couture P, Tousignant C, et al. The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management. Anesth Analg 2009;108:422-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19151265</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner G, Zapletal B, Schwarz C, et al. Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate--a retrospective study. J Cardiothorac Surg 2012;7:52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430602</ArticleId><ArticleId IdType="pubmed">22681759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lueck S, Preusse CJ, Welz A. Clinical relevance of HTK-induced hyponatremia. Ann Thorac Surg 2013;95:1844-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23608285</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh Y, Hashimoto M, Ku K, et al. Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function. Ann Thorac Surg 2000;69:107-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10654496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Huang CS, Kawamura T, et al. Histidine-tryptophan-ketoglutarate or celsior: which is more suitable for cold preservation for cardiac grafts from older donors? Ann Thorac Surg 2011;91:755-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21352993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Huang CS, Kawamura T, et al. Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia. Surgery 2010;148:463-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20627336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima ML, Fiorelli AI, Vassallo DV, et al. Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation. Rev Bras Cir Cardiovasc 2012;27:110-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22729308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackemann J, Gross W, Mory M, et al. Celsior versus custodiol: early postischemic recovery after cardioplegia and ischemia at 5 degrees C. Ann Thorac Surg 2002;74:522-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12173839</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26438309</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>Non-hip and non-vertebral fractures: the neglected fracture sites.</ArticleTitle><Pagination><StartPage>905</StartPage><EndPage>913</EndPage><MedlinePgn>905-913</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-015-3322-8</ELocationID><Abstract><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Non-hip, non-vertebral fractures (NHNVF) were compared with hip, vertebral and controls. NHNVF were younger and heavier than controls and hip/vertebral fractures in both men and women, respectively. Falls and prior fractures were less common in NHNVF than hip fractures. Glucocorticoid use was lower in NHNVF compared to vertebral fracture (VF) in men.</AbstractText><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Although hip fracture (HF) and vertebral fractures (VF) receive the most attention in the literature and are the targeted sites for fracture prevention, non-hip, non-vertebral fracture (NHNVF) sites account for a greater proportion of fractures than the hip or vertebrae. This study aimed to assess risk factors for NHNVF and compare them with those for HF, VF and controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Incident fractures during 2005-2007 for men and 1994-1996 for women were identified using computerised keyword searches of radiological reports, and controls were selected at random from electoral rolls for participation in the Geelong Osteoporosis Study. Participants aged 60+ years were included in this study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared to controls, men and women with NHNVF were younger (ORs, 0.90, 95% CI 0.86-0.94; and 0.96, 0.93-0.98, respectively) and had a lower femoral neck bone mineral density (BMD) T-score (age-adjusted; difference [men] 0.383, P&#x2009;=&#x2009;0.002; [women] 0.287, P&#x2009;=&#x2009;0.001). Compared to HF, men and women with NHNVF were heavier (difference [men] 9.0 kg, P&#x2009;=&#x2009;0.01; [women] 7.6 kg, P&#x2009;&lt;&#x2009;0.001). Heavier weight was also a risk factor for women with NHNVF compared to VF (1.03, 1.01-1.06). In men with NHNVF, falls (0.37, 0.14-0.97) and prior fractures (0.38, 0.15-0.98) were less common compared to HF; and glucocorticoid use was less common for NHNVF (0.30, 0.11-0.85) compared to VF.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Given the high numbers of NHNVF sustained by men and women in this study, fracture prevention strategies should focus on individuals with high risk of sustaining these types of fractures, as well as on individuals who are more likely to sustain a HF or VF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holloway</LastName><ForeName>K L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Epi-Centre for Healthy Ageing (ECHA), IMPACT Strategic Research Centre, Kitchener House (Barwon Health), PO Box 281, Geelong, VIC, 3220, Australia. khollo@barwonhealth.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Barwon Health, Ryrie Street, Geelong, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan-Olsen</LastName><ForeName>S L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Epi-Centre for Healthy Ageing (ECHA), IMPACT Strategic Research Centre, Kitchener House (Barwon Health), PO Box 281, Geelong, VIC, 3220, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute for Health and Ageing, Australian Catholic University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The University of Melbourne, St Albans, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Institute for Musculoskeletal Science, The University of Melbourne, 176 Furlong Rd, St Albans, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucki-Smith</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Epi-Centre for Healthy Ageing (ECHA), IMPACT Strategic Research Centre, Kitchener House (Barwon Health), PO Box 281, Geelong, VIC, 3220, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>G C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>The Institute for Health and Ageing, Australian Catholic University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rural Clinical School, The University of Queensland, Toowoomba, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korn</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Barwon Health, Ryrie Street, Geelong, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>K M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>The Institute for Health and Ageing, Australian Catholic University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The University of Melbourne, St Albans, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Institute for Musculoskeletal Science, The University of Melbourne, 176 Furlong Rd, St Albans, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasco</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Epi-Centre for Healthy Ageing (ECHA), IMPACT Strategic Research Centre, Kitchener House (Barwon Health), PO Box 281, Geelong, VIC, 3220, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Barwon Health, Ryrie Street, Geelong, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The University of Melbourne, St Albans, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotowicz</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Epi-Centre for Healthy Ageing (ECHA), IMPACT Strategic Research Centre, Kitchener House (Barwon Health), PO Box 281, Geelong, VIC, 3220, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Barwon Health, Ryrie Street, Geelong, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The University of Melbourne, St Albans, VIC, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000058" MajorTopicYN="N">Accidental Falls</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005272" MajorTopicYN="N">Femur Neck</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014739" MajorTopicYN="N">Victoria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Fractures</Keyword><Keyword MajorTopicYN="N">Non-hip</Keyword><Keyword MajorTopicYN="N">Non-vertebral fractures</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26438309</ArticleId><ArticleId IdType="doi">10.1007/s00198-015-3322-8</ArticleId><ArticleId IdType="pii">10.1007/s00198-015-3322-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Epidemiol. 2004 Aug 15;160(4):360-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15286021</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 1999;10(3):240-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10525717</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Geriatr. 2014 Dec 04;14:131</Citation><ArticleIdList><ArticleId IdType="pubmed">25475854</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 1998 Aug;13(8):1337-42</Citation><ArticleIdList><ArticleId IdType="pubmed">9718203</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2011 Nov;124(11):1043-50</Citation><ArticleIdList><ArticleId IdType="pubmed">22017783</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust Fam Physician. 2002 Dec;31(12):1111-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12516514</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Med. 1999 Apr;29(2):203-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10342018</ArticleId></ArticleIdList></Reference><Reference><Citation>Obes Rev. 2006 Aug;7(3):239-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16866972</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2014 Jan;29(1):223-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23775829</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pract. 2010 May;64(6):817-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20518955</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcif Tissue Int. 2008 Sep;83(3):155-66</Citation><ArticleIdList><ArticleId IdType="pubmed">18787887</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2001;12(2):124-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11303712</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2000 Aug 21;173(4):179-82</Citation><ArticleIdList><ArticleId IdType="pubmed">11008589</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2006 Oct;241(1):190-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16928979</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Metab. 2009;27(4):479-84</Citation><ArticleIdList><ArticleId IdType="pubmed">19277453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2011 Mar;26(3):496-502</Citation><ArticleIdList><ArticleId IdType="pubmed">20814955</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2012 Dec;41(6):1565-75</Citation><ArticleIdList><ArticleId IdType="pubmed">23283714</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2012 Sep;27(9):1907-15</Citation><ArticleIdList><ArticleId IdType="pubmed">22550021</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone. 2013 Feb;52(2):541-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23159464</ArticleId></ArticleIdList></Reference><Reference><Citation>Obes Res. 2004 Jun;12(6):913-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15229329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone. 2001 Dec;29(6):517-22</Citation><ArticleIdList><ArticleId IdType="pubmed">11728921</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Nutr. 2004 Feb;7(1A):227-43</Citation><ArticleIdList><ArticleId IdType="pubmed">14972062</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcif Tissue Int. 2015 Jan;96(1):38-44</Citation><ArticleIdList><ArticleId IdType="pubmed">25467009</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2014 Oct 28;349:g6015</Citation><ArticleIdList><ArticleId IdType="pubmed">25352269</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2011 Feb;22(2):635-45</Citation><ArticleIdList><ArticleId IdType="pubmed">20533027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38373241</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2771-1897</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Urogynecology (Philadelphia, Pa.)</Title><ISOAbbreviation>Urogynecology (Phila)</ISOAbbreviation></Journal><ArticleTitle>A Retrospective Cohort Study of At-Home Catheter Removal After Urogynecologic Surgery.</ArticleTitle><Pagination><StartPage>550</StartPage><EndPage>556</EndPage><MedlinePgn>550-556</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SPV.0000000000001430</ELocationID><Abstract><AbstractText Label="IMPORTANCE">In-office postoperative voiding trials (VTs) increase health care burden for patients and physicians. Adoption of an at-home VT option may decrease burden without increasing adverse events postoperatively.</AbstractText><AbstractText Label="OBJECTIVE">The purpose of this study was to compare 30-day postoperative outcomes between participants who performed an at-home autofill VT after catheter self-discontinuation during the Assessing Healthcare Utilization and Feasibility of Transurethral Catheter Self-discontinuation (FLOTUS) study and a "historic" control cohort of patients who presented to the office for backfill-assisted VT on postoperative day (POD) 1.</AbstractText><AbstractText Label="STUDY DESIGN">This was a retrospective cohort study of women with postoperative urinary retention after urogynecologic surgery between June 2020 and March 2022. Outcomes from the FLOTUS study were compared with a "historic" control cohort of patients that were identified on chart review from the year before FLOTUS initiation. Demographic, medical history, and procedure-related data were collected. Thirty-day outcome data included office calls/messages, office visits, emergency department visits, complications, and catheterization outcomes.</AbstractText><AbstractText Label="RESULTS">Forty-six participants were included in the FLOTUS cohort and 65 participants in the historic cohort. There was no difference in the POD1 VT pass rate, number of office calls/messages, emergency department visits, or postoperative complications between the 2 cohorts. The FLOTUS patients attended 1 less office visit (1 vs 2 office visits, P &lt;0.001), and this difference persisted on regression analysis (-0.87 office visits; 95% CI, -1.18 to -0.56, P &lt;0.001).</AbstractText><AbstractText Label="CONCLUSION">Patients who had backfill-assisted VTs on POD1 attended 1 additional office visit compared with those who removed their catheters at home.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American Urogynecologic Society. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>Abigail P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yi W</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Georgetown University School of Medicine, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefbom</LastName><ForeName>Lucie T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>From the MedStar Washington Hospital Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iglesia</LastName><ForeName>Cheryl B</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Dieter</LastName><ForeName>Alexis A</ForeName><Initials>AA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Urogynecology (Phila)</MedlineTA><NlmUniqueID>9918452588006676</NlmUniqueID><ISSNLinking>2771-1897</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020878" MajorTopicYN="Y">Device Removal</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016055" MajorTopicYN="Y">Urinary Retention</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014546" MajorTopicYN="Y">Urinary Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="N">Gynecologic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062885" MajorTopicYN="N">Urinary Catheters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012648" MajorTopicYN="N">Self Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosures: Cheryl B. Iglesia reported the following: Executive Board SGS; Editorial Board Urogynecology and OBG Management; Special Government Employee, US FDA; Chair, NICHD PFDN Advisory Board; Medical Advisory Board for the Patty Brisben Foundation, Healthy Women Foundation, Foundation for Female Health Awareness. The other authors did not report any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>15</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38373241</ArticleId><ArticleId IdType="doi">10.1097/SPV.0000000000001430</ArticleId><ArticleId IdType="pii">02273501-202406000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geller EJ. Prevention and management of postoperative urinary retention after urogynecologic surgery. Int J Womens Health . 2014;6:829&#x2013;838. doi:10.2147/ijwh.s55383.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ijwh.s55383</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieter AA, Conklin JL, Willis-Gray MG, et al. A systematic review of randomized trials investigating methods of postoperative void trials following benign gynecologic and urogynecologic surgeries. J Minim Invasive Gynecol . 2021;28(6):1160&#x2013;1170.e2. doi:10.1016/j.jmig.2021.01.016 Epub 2021 Jan 23. PMID: 33497726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmig.2021.01.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatkin-Margolis A, Yook E, Hill AM, et al. Self-removal of a urinary catheter after urogynecologic surgery: a randomized controlled trial. Obstet Gynecol . 2019;134(5):1027&#x2013;1036. doi:10.1097/AOG.0000000000003531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000003531</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport A, Li Y, Melvin E, et al. Assessing health care utilization and feasibility of transurethral catheter self-discontinuation. Obstet Gynecol . 2023;141(4):773&#x2013;781. doi:10.1097/AOG.0000000000005105 Epub 2023 Mar 9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000005105</ArticleId></ArticleIdList></Reference><Reference><Citation>Schachar JS, Ossin D, Plair AR, et al. Optimal timing of a second postoperative voiding trial in women with incomplete bladder emptying after vaginal reconstructive surgery: a randomized trial. Am J Obstet Gynecol . 2020;223(2):260.e1&#x2013;260.e9. doi:10.1016/j.ajog.2020.06.001 Epub 2020 Jun 3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Popiel P, Getaneh F, Yeh J, et al. Voided volume for assessment of bladder emptying after female pelvic floor surgery: a randomized controlled trial. Urogynecology (Phila.) . 2022;28(12):811&#x2013;818. doi:10.1097/SPV.0000000000001230 Epub 2022 Jun 22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SPV.0000000000001230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35880155</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5141</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of hand surgery global online</Title><ISOAbbreviation>J Hand Surg Glob Online</ISOAbbreviation></Journal><ArticleTitle>Peripheral Nerve Injury After Upper-Extremity Surgery Performed Under Regional Anesthesia: A Systematic Review.</ArticleTitle><Pagination><StartPage>201</StartPage><EndPage>207</EndPage><MedlinePgn>201-207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhsg.2022.04.011</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Peripheral nerve injury (PNI) is a known adverse event following upper-limb surgery performed under brachial plexus regional anesthesia (RA). When PNI is noted after surgery, patients and providers often have questions about which factors might have contributed to this complication. This systematic review evaluates the literature on hand and shoulder surgeries performed under ultrasound-guided, plexus RA to identify factors potentially associated with PNI, including the surgery location and block type. We hypothesized that shoulder surgery might be associated with an increased risk of PNI compared to hand surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systematic review of the relevant literature was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Only prospective studies on the use of ultrasound-guided, preoperative, brachial plexus RA for hand or shoulder surgery on adult patients were included. Study groups were categorized according to surgery location and block type and compared across a number of factors via univariate and multivariate analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 3,037 abstracts were screened; 192 full-text articles were independently reviewed by 2 of the authors; and 53 studies were included in the systematic review analysis. Following hand surgery, PNI was reported at an average rate of 1.35% &#xb1; 3.21% across 836 subjects in 40 study groups; after shoulder surgery, the average rate was 0.50% &#xb1; 1.57% across 3,383 subjects in 15 study groups. There was no statistically significant correlation between the incidence of PNI and surgery location (<i>P</i>&#xa0;=.70) or any of the most common approaches for brachial plexus anesthesia in the multivariate analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This systematic review of over 50 articles on upper-limb surgery performed under RA shows no association between the incidence of PNI and the location of surgery or type of brachial plexus block.</AbstractText><AbstractText Label="TYPE OF STUDY/LEVEL OF EVIDENCE" NlmCategory="UNASSIGNED">Diagnostic II.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silverstein</LastName><ForeName>Max Lester</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Division of Plastic and Reconstructive Surgery, Stanford Hospital and Clinics, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tevlin</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Plastic and Reconstructive Surgery, Stanford Hospital and Clinics, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higgins</LastName><ForeName>Kenneth Elliott</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Vermont Larner College of Medicine, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedreira</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Plastic and Reconstructive Surgery, Stanford Hospital and Clinics, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curtin</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Plastic and Reconstructive Surgery, Stanford Hospital and Clinics, Palo Alto, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Palo Alto Veterans Hospital, Palo Alto, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Hand Surg Glob Online</MedlineTA><NlmUniqueID>101759126</NlmUniqueID><ISSNLinking>2589-5141</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brachial plexus</Keyword><Keyword MajorTopicYN="N">Nerve injury</Keyword><Keyword MajorTopicYN="N">PNI</Keyword><Keyword MajorTopicYN="N">Regional anesthesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>2</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35880155</ArticleId><ArticleId IdType="pmc">PMC9308165</ArticleId><ArticleId IdType="doi">10.1016/j.jhsg.2022.04.011</ArticleId><ArticleId IdType="pii">S2589-5141(22)00057-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hadzic A., Williams B.A., Karaca P.E., et al. For outpatient rotator cuff surgery, nerve block anesthesia provides superior same-day recovery over general anesthesia. Anesthesiology. 2005;102(5):1001&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">15851888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie E.D., Tong D., Chung F., Norris A.M., Miniaci A., Vairavanathan S.D. Suprascapular nerve block for postoperative pain relief in arthroscopic shoulder surgery: a new modality? Anesth Analg. 1997;84(6):1306&#x2013;1312.</Citation><ArticleIdList><ArticleId IdType="pubmed">9174311</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V.W., Peng P.W., Kaszas Z., et al. A&#xa0;comparative study of general anesthesia, intravenous regional anesthesia, and axillary block for outpatient hand surgery: clinical outcome and cost analysis. Anesth Analg. 2001;93(5):1181&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11682392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadzic A., Arliss J., Kerimoglu B., et al. A&#xa0;comparison of infraclavicular nerve block versus general anesthesia for hand and wrist day-case surgeries. Anesthesiology. 2004;101(1):127&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15220781</ArticleId></ArticleIdList></Reference><Reference><Citation>Sites B.D., Taenzer A.H., Herrick M.D., et al. Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks: an analysis from a prospective clinical registry. Reg Anesth Pain Med. 2012;37(5):478&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">22705953</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal J.M., Barrington M.J., Brull R., et al. The second ASRA practice advisory on neurologic complications associated with regional anesthesia and pain medicine: executive summary 2015. Reg Anesth Pain Med. 2015;40(5):401&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">26288034</ArticleId></ArticleIdList></Reference><Reference><Citation>Droog W., Lin D.Y., van Wijk J.J., et al. Is it the surgery or the block? Incidence, risk factors, and outcome of nerve injury following upper extremity surgery. Plast Reconstr Surg Glob Open. 2019;7(9):e2458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6799396</ArticleId><ArticleId IdType="pubmed">31741818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwyer T., Henry P.D., Cholvisudhi P., Chan V.W., Theodoropoulos J.S., Brull R. Neurological complications related to elective orthopedic surgery: part 1: common shoulder and elbow procedures. Reg Anesth Pain Med. 2015;40(5):431&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pubmed">26192546</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgeat A., Ekatodramis G., Kalberer F., Benz C. Acute and nonacute complications associated with interscalene block and shoulder surgery: a prospective study. Anesthesiology. 2001;95(4):875&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">11605927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sviggum H.P., Jacob A.K., Mantilla C.B., Schroeder D.R., Sperling J.W., Hebl J.R. Perioperative nerve injury after total shoulder arthroplasty: assessment of risk after regional anesthesia. Reg Anesth Pain Med. 2012;37(5):490&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">22705952</ArticleId></ArticleIdList></Reference><Reference><Citation>Boardman N.D., III, Cofield R.H. Neurologic complications of shoulder surgery. Clin Orthop Relat Res. 1999;368(368):44&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">10613152</ArticleId></ArticleIdList></Reference><Reference><Citation>Candido K.D., Sukhani R., Doty R., II, et al. Neurologic sequelae after interscalene brachial plexus block for shoulder/upper arm surgery: the association of patient, anesthetic, and surgical factors to the incidence and clinical course. Anesth Analg. 2005;100(5):1489&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">15845712</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdecchia N., Johnson J., Baratz M., Orebaugh S. Neurologic complications in common wrist and hand surgical procedures. Orthop Rev (Pavia) 2018;10(1):7355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5937362</ArticleId><ArticleId IdType="pubmed">29770175</ArticleId></ArticleIdList></Reference><Reference><Citation>Seddon H.J. Three types of nerve injury. Brain. 1943;66(4):237&#x2013;288.</Citation></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapral S., Krafft P., Eibenberger K., Fitzgerald R., Gosch M., Weinstabl C. Ultrasound-guided supraclavicular approach for regional anesthesia of the brachial plexus. Anesth Analg. 1994;78(3):507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pubmed">8109769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ootaki C., Hayashi H., Amano M. Ultrasound-guided infraclavicular brachial plexus block: an alternative technique to anatomical landmark-guided approaches. Reg Anesth Pain Med. 2000;25(6):600&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">11097667</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams S.R., Chouinard P., Arcand G., et al. Ultrasound guidance speeds execution and improves the quality of supraclavicular block. Anesth Analg. 2003;97(5):1518&#x2013;1523.</Citation><ArticleIdList><ArticleId IdType="pubmed">14570678</ArticleId></ArticleIdList></Reference><Reference><Citation>Brull R., Lupu M., Perlas A., Chan V.W., McCartney C.J. Compared with dual nerve stimulation, ultrasound guidance shortens the time for infraclavicular block performance. Can J Anaesth. 2009;56(11):812&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">19728002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran D.Q., Clemente A., Tran D.Q., Finlayson R.J. A&#xa0;comparison between ultrasound-guided infraclavicular block using the "Double Bubble" sign and neurostimulation-guided axillary block. Anesth Analg. 2008;107(3):1075&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">18713932</ArticleId></ArticleIdList></Reference><Reference><Citation>Zencirci B. Comparision of nerve stimulator and ultrasonography as the techniques applied for brachial plexus anesthesia. Int Arch Med. 2011;4(1):4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035035</ArticleId><ArticleId IdType="pubmed">21255404</ArticleId></ArticleIdList></Reference><Reference><Citation>Holbrook H.S., Parker B.R. Peripheral nerve injury following interscalene blocks: a systematic review to guide orthopedic surgeons. Orthopedics. 2018;41(5):e598&#x2013;e606.</Citation><ArticleIdList><ArticleId IdType="pubmed">30125041</ArticleId></ArticleIdList></Reference><Reference><Citation>Azmin F., Choy Y. Regional infraclavicular blocks via the coracoid approach for below-elbow surgery: a comparison between ultrasound guidance with, or without, nerve stimulation. South Afr J Anaesth Analg. 2013;19(5):263&#x2013;269.</Citation></Reference><Reference><Citation>Imasogie N., Ganapathy S., Singh S., Armstrong K., Armstrong P. A&#xa0;prospective, randomized, double-blind comparison of ultrasound-guided axillary brachial plexus blocks using 2 versus 4 injections. Anesth Analg. 2010;110(4):1222&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pubmed">20142336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V.W., Perlas A., McCartney C.J., Brull R., Xu D., Abbas S. Ultrasound guidance improves success rate of axillary brachial plexus block. Can J Anaesth. 2007;54(3):176&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">17331928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderland S. A&#xa0;classification of peripheral nerve injuries producing loss of function. Brain. 1951;74(4):491&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">14895767</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E.J., Choi Y.M., Jang E.J., Kim J.Y., Kim T.K., Kim K.H. Neural ablation and regeneration in pain practice. Korean J Pain. 2016;29(1):3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731549</ArticleId><ArticleId IdType="pubmed">26839664</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvites R., Rita Caseiro A., Santos Pedrosa S., et al. Peripheral nerve injury and axonotmesis: state of the art and recent advances. Cogent Med. 2018;5(1):1466404.</Citation></Reference><Reference><Citation>Burnett M.G., Zager E.L. Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus. 2004;16(5):E1.</Citation><ArticleIdList><ArticleId IdType="pubmed">15174821</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell W.W. Evaluation and management of peripheral nerve injury. Clin Neurophysiol. 2008;119(9):1951&#x2013;1965.</Citation><ArticleIdList><ArticleId IdType="pubmed">18482862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambi U., Bhanupriya P., Hulkund S.Y., Prakashappa D.S. Comparison between perivascular and perineural ultrasound-guided axillary brachial plexus block using levobupivacaine: a prospective, randomised clinical study. Indian J Anaesth. 2015;59(10):658&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4645355</ArticleId><ArticleId IdType="pubmed">26644614</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcand G., Williams S.R., Chouinard P., et al. Ultrasound-guided infraclavicular versus supraclavicular block. Anesth Analg. 2005;101(3):886&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pubmed">16116009</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloc S., Mercadal L., Garnier T., et al. Comfort of the patient during axillary blocks placement: a randomized comparison of the neurostimulation and the ultrasound guidance techniques. Eur J Anaesthesiol. 2010;27(7):628&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">20299995</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin A., Nadeau M.J., Dion N., L&#xe9;vesque S., Nicole P.C., Turgeon A.F. Ultrasound-guided single-injection infraclavicular block versus ultrasound-guided double-injection axillary block: a noninferiority randomized controlled trial. Anesth Analg. 2016;122(1):273&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">26516803</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Iohom G., Mahon P., Shorten G. Efficacy of axillary versus infraclavicular brachial plexus block in preventing tourniquet pain: a randomised trial. Eur J Anaesthesiol. 2019;36(1):48&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">30461447</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A., Danelli G., Baciarello M., et al. A&#xa0;prospective, randomized comparison between ultrasound and nerve stimulation guidance for multiple injection axillary brachial plexus block. Anesthesiology. 2007;106(5):992&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pubmed">17457131</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary N., Kumar A., Kohli A., et al. Single-point versus double-point injection technique of ultrasound-guided supraclavicular block: a randomized controlled study. J&#xa0;Anaesthesiol Clin Pharmacol. 2019;35(3):373&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6748018</ArticleId><ArticleId IdType="pubmed">31543588</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgagn&#xe9;s M.C., L&#xe9;vesque S., Dion N., et al. A&#xa0;comparison of a single or triple injection technique for ultrasound-guided infraclavicular block: a prospective randomized controlled study. Anesth Analg. 2009;109(2):668&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pubmed">19608845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertikin A., Argun G., M&#x131;s&#x131;rl&#x131;o&#x11f;lu M., Ayd&#x131;n M., Ar&#x131;kan M., Kad&#x131;o&#x11f;ullar&#x131; N. Comparison between the two-injection technique and the four-injection technique in axillary brachial plexus block with articaine. Turk J Anaesthesiol Reanim. 2017;45(5):289&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5656164</ArticleId><ArticleId IdType="pubmed">29114414</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen B.S., Koscielniak-Nielsen Z.J., Jacobsen R.B., Rasmussen H., Hesselbjerg L. Procedural pain of an ultrasound-guided brachial plexus block: a comparison of axillary and infraclavicular approaches. Acta Anaesthesiol Scand. 2010;54(4):408&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">20055762</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredrickson M.J., Kilfoyle D.H. Neurological complication analysis of 1000 ultrasound guided peripheral nerve blocks for elective orthopaedic surgery: a prospective study. Anaesthesia. 2009;64(8):836&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">19604186</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredrickson M.J., Patel A., Young S., Chinchanwala S. Speed of onset of &#x201c;corner pocket supraclavicular&#x201d; and infraclavicular ultrasound guided brachial plexus block: a randomised observer-blinded comparison. Anaesthesia. 2009;64(7):738&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">19624628</ArticleId></ArticleIdList></Reference><Reference><Citation>Grape S., Pawa A., Weber E., Albrecht E. Retroclavicular vs supraclavicular brachial plexus block for distal upper limb surgery: a randomised, controlled, single-blinded trial. Br J Anaesth. 2019;122(4):518&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6435841</ArticleId><ArticleId IdType="pubmed">30857608</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussien R.M., Ibrahim D.A. Ultrasound guided axillary brachial plexus block versus supraclavicular block in emergency crushed hand patients: a comparative study. Open Anesthesiol J. 2018;12(1):34&#x2013;41.</Citation></Reference><Reference><Citation>Kavrut Ozturk N., Kavakli A.S. Comparison of the coracoid and retroclavicular approaches for ultrasound-guided infraclavicular brachial plexus block. J&#xa0;Anesth. 2017;31(4):572&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pubmed">28421316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kii N., Yamauchi M., Takahashi K., Yamakage M., Wada T. Differential axillary nerve block for hand or forearm soft-tissue surgery. J&#xa0;Anesth. 2014;28(4):549&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">24375222</ArticleId></ArticleIdList></Reference><Reference><Citation>Koscielniak-Nielsen Z.J., Frederiksen B.S., Rasmussen H., Hesselbjerg L. A&#xa0;comparison of ultrasound-guided supraclavicular and infraclavicular blocks for upper extremity surgery. Acta Anaesthesiol Scand. 2009;53(5):620&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">19419356</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F.C., Liou J.T., Tsai Y.F., et al. Efficacy of ultrasound-guided axillary brachial plexus block: a comparative study with nerve stimulator-guided method. Chang Gung Med J. 2005;28(6):396&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">16124155</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q., Yao W., Chai Y., et al. Comparison of ultrasound-guided supraclavicular and costoclavicular brachial plexus block using a modified double-injection technique: a randomized non-inferiority trial. Biosci Rep. 2020;40(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7284325</ArticleId><ArticleId IdType="pubmed">32441302</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q., Yao W., Shu H., Zhong M. Double-injection technique assisted by a nerve stimulator for ultrasound-guided supraclavicular brachial plexus block results in better distal sensory-motor block: a randomised controlled trial. Eur J Anaesthesiol. 2017;34(3):127&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">27798452</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauter A.R., Dodgson M.S., Stubhaug A., Halstensen A.M., Klaastad &#xd8;. Electrical nerve stimulation or ultrasound guidance for lateral sagittal infraclavicular blocks: a randomized, controlled, observer-blinded, comparative study. Anesth Analg. 2008;106(6):1910&#x2013;1915.</Citation><ArticleIdList><ArticleId IdType="pubmed">18499631</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha C., Kumar N., Kumar A., Kumar A., Kumar A. Comparative evaluation of two approaches of infraclavicular brachial plexus block for upper-limb surgeries. Saudi J Anaesth. 2019;13(1):35&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329239</ArticleId><ArticleId IdType="pubmed">30692886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivashanmugam T., Ray S., Ravishankar M., Jaya V., Selvam E., Karmakar M.K. Randomized comparison of extrafascial versus subfascial injection of local anesthetic during ultrasound-guided supraclavicular brachial plexus block. Reg Anesth Pain Med. 2015;40(4):337&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">26066385</ArticleId></ArticleIdList></Reference><Reference><Citation>Stav A., Reytman L., Stav M.Y., et al. Comparison of the supraclavicular, infraclavicular and axillary approaches for ultrasound-guided brachial plexus block for surgical anesthesia. Rambam Maimonides Med J. 2016;7(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839540</ArticleId><ArticleId IdType="pubmed">27101216</ArticleId></ArticleIdList></Reference><Reference><Citation>Strub B., Sonderegger J., Von Campe A., Gr&#xfc;nert J., Osterwalder J.J. What benefits does ultrasound-guided axillary block for brachial plexus anaesthesia offer over the conventional blind approach in hand surgery? J&#xa0;Hand Surg Eur Vol. 2011;36(9):778&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pubmed">21750097</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanyam R., Vaishnav V., Chan V.W., Brown-Shreves D., Brull R. Lateral versus medial needle approach for ultrasound-guided supraclavicular block: a randomized controlled trial. Reg Anesth Pain Med. 2011;36(4):387&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">21555965</ArticleId></ArticleIdList></Reference><Reference><Citation>Techasuk W., Gonz&#xe1;lez A.P., Bernucci F., Cupido T., Finlayson R.J., Tran D.Q. A&#xa0;randomized comparison between double-injection and targeted intracluster-injection ultrasound-guided supraclavicular brachial plexus block. Anesth Analg. 2014;118(6):1363&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pubmed">24842181</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedore T.R., YaDeau J.T., Maalouf D.B., et al. Comparison of the transarterial axillary block and the ultrasound-guided infraclavicular block for upper extremity surgery: a prospective randomized trial. Reg Anesth Pain Med. 2009;34(4):361&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">19574870</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazin M., Jensen K., Kristensen D.L., et al. Low-volume brachial plexus block providing surgical anesthesia for distal arm surgery comparing supraclavicular, infraclavicular, and axillary approach: a randomized observer blind trial. BioMed Res Int. 2016;2016:7094121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136641</ArticleId><ArticleId IdType="pubmed">27990435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.S., Chan W.S., Fang C., et al. Infraclavicular nerve block reduces postoperative pain after distal radial fracture fixation: a randomized controlled trial. BMC Anesthesiol. 2020;20(1):130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254671</ArticleId><ArticleId IdType="pubmed">32466746</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazer M.S., Finlayson R.J., Tran D.Q. A&#xa0;randomized comparison between infraclavicular block and targeted intracluster injection supraclavicular block. Reg Anesth Pain Med. 2015;40(1):11&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">25478758</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdallah F.W., Wijeysundera D.N., Laupacis A., et al. Subomohyoid anterior suprascapular block versus interscalene block for arthroscopic shoulder surgery: a multicenter randomized trial. Anesthesiology. 2020;132(4):839&#x2013;853.</Citation><ArticleIdList><ArticleId IdType="pubmed">32044802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayyanagouda B., Hosalli V., Kaur P., Ambi U., Hulkund S.Y. Hemi-diaphragmatic paresis following extrafascial versus conventional intrafascial approach for interscalene brachial plexus block: a double-blind randomised, controlled trial. Indian J Anaesth. 2019;63(5):375&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6530291</ArticleId><ArticleId IdType="pubmed">31142881</ArticleId></ArticleIdList></Reference><Reference><Citation>Desroches A., Klouche S., Schlur C., Bauer T., Waitzenegger T., Hardy P. Suprascapular nerve block versus interscalene block as analgesia after arthroscopic rotator cuff repair: a randomized controlled noninferiority trial. Arthroscopy. 2016;32(11):2203&#x2013;2209.</Citation><ArticleIdList><ArticleId IdType="pubmed">27177436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhir S., Sondekoppam R.V., Sharma R., Ganapathy S., Athwal G.S. A&#xa0;comparison of combined suprascapular and axillary nerve blocks to interscalene nerve block for analgesia in arthroscopic shoulder surgery: an equivalence study. Reg Anesth Pain Med. 2016;41(5):564&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">27380105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapral S., Greher M., Huber G., et al. Ultrasonographic guidance improves the success rate of interscalene brachial plexus blockade. Reg Anesth Pain Med. 2008;33(3):253&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">18433677</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Lin Y., Beathe J.C., et al. Superior trunk block: a phrenic-sparing alternative to the interscalene block: a randomized controlled trial. Anesthesiology. 2019;131(3):521&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">31283740</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Y.C., Koo Z.K., Ho V.W., Chang S.S., Manohara S., Tong Q.J. Randomized, controlled trial comparing respiratory and analgesic effects of interscalene, anterior suprascapular, and posterior suprascapular nerve blocks for arthroscopic shoulder surgery. Korean J Anesthesiol. 2020;73(5):408&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533176</ArticleId><ArticleId IdType="pubmed">32668833</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.S., Gordon M.A., Shaw P.M., Wilfred S., Shetty T., Yadeau J.T. A&#xa0;prospective clinical registry of ultrasound-guided regional anesthesia for ambulatory shoulder surgery. Anesth Analg. 2010;111(3):617&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">20686013</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.S., Zayas V.M., Gordon M.A., et al. A&#xa0;prospective, randomized, controlled trial comparing ultrasound versus nerve stimulator guidance for interscalene block for ambulatory shoulder surgery for postoperative neurological symptoms. Anesth Analg. 2009;109(1):265&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">19535720</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik T., Mass D., Cohn S. Postoperative analgesia in a prolonged continuous interscalene block versus single-shot block in outpatient arthroscopic rotator cuff repair: a prospective randomized study. Arthroscopy. 2016;32(8):1544&#x2013;1550.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">27107906</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoroha K.R., Lynch J.R., Keller R.A., et al. Liposomal bupivacaine versus interscalene nerve block for pain control after shoulder arthroplasty: a prospective randomized trial. J&#xa0;Shoulder Elbow Surg. 2016;25(11):1742&#x2013;1748.</Citation><ArticleIdList><ArticleId IdType="pubmed">27422692</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M.A., Gadsden J.C., Nedeljkovic S.S., et al. Brachial plexus block with liposomal bupivacaine for shoulder surgery improves analgesia and reduces opioid consumption: results from a multicenter, randomized, double-blind, controlled trial. Pain Med. 2020;21(2):387&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">31150095</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal G., Winger D.G., Cortazzo M., Kentor M.L., Orebaugh S.L. Neurologic outcomes after low-volume, ultrasound-guided interscalene block and ambulatory shoulder surgery. Reg Anesth Pain Med. 2016;41(4):477&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">27281729</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Kelly C., O'Brien T., Wilson J., Warner J.J. Ultrasound-guided interscalene block anesthesia for shoulder arthroscopy: a prospective study of 1319 patients. J&#xa0;Bone Joint Surg Am. 2012;94(22):2040&#x2013;2046.</Citation><ArticleIdList><ArticleId IdType="pubmed">23172321</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.J., Ge Y.L., Gao J., et al. Comparison of single- and triple-injection methods for ultrasound-guided interscalene brachial plexus blockade. Exp Ther Med. 2018;15(3):3006&#x2013;3011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5795379</ArticleId><ArticleId IdType="pubmed">29456706</ArticleId></ArticleIdList></Reference><Reference><Citation>Payton O.D., Jackson O., Di Fabio R.P. Churchill Livingstone; 1989. Manual of Physical Therapy.</Citation></Reference><Reference><Citation>Tubbs R.S., Rizk E., Shoja M.M., Loukas M., Barbaro N., Spinner R.J. Elsevier Science; 2015. Nerves and Nerve Injuries: Vol 2: Pain, Treatment, Injury, Disease and Future Directions.</Citation></Reference><Reference><Citation>Chemnitz A., Dahlin L.B., Carlsson I.K. Consequences and adaptation in daily life&#x2013;patients' experiences three decades after a nerve injury sustained in adolescence. BMC Musculoskelet Disord. 2013;14:252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765266</ArticleId><ArticleId IdType="pubmed">23968274</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray P.M., Hammert W.C. American Society for Surgery of the Hand; 2016. American Society for Surgery of the Hand. Hand Surgery Update VI.</Citation></Reference><Reference><Citation>Woolley E.J., Vandam L.D. Neurological sequelae of brachial plexus nerve block. Ann Surg. 1959;149(1):53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1450959</ArticleId><ArticleId IdType="pubmed">13617908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Park S.H., Shin H.Y., Choi Y.S. Brachial plexus injury as a complication after nerve block or vessel puncture. Korean J Pain. 2014;27(3):210&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4099233</ArticleId><ArticleId IdType="pubmed">25031806</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita A., Matsumoto M., Matsumoto S., Itoh M., Kawai K., Sakabe T. A&#xa0;comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg. 2003;97(2):512&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">12873946</ArticleId></ArticleIdList></Reference><Reference><Citation>Radwan I.A., Saito S., Goto F. The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth Analg. 2002;94(2):319&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">11812691</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock E.L., Brenner M.J., Fox I.K., Moradzadeh A., Hunter D.A., Mackinnon S.E. Ropivacaine-induced peripheral nerve injection injury in the rodent model. Anesth Analg. 2010;111(1):214&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">20442258</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal J.M. Effects of epinephrine in local anesthetics on the central and peripheral nervous systems: neurotoxicity and neural blood flow. Reg Anesth Pain Med. 2003;28(2):124&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">12677623</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Keefe D.M. Brachial plexus injury following axillary arteriography. Case report and review of the literature. J&#xa0;Neurosurg. 1980;53(6):853&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">7441349</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao B.E., Wilbourn A.J. Infraclavicular brachial plexus injury following axillary regional block. Muscle Nerve. 2004;30(1):44&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">15221877</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebou&#xe7;as F., Filho R.B., Filardis C., Pereira R.R., Cardoso A.A. Anatomical study of the musculocutaneous nerve in relation to the coracoid process. Rev Bras Ortop. 2010;45(4):400&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4799129</ArticleId><ArticleId IdType="pubmed">27022570</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas J., Familiari F., Bitzer A., Srikumaran U., Papalia R., McFarland E.G. Patient positioning in shoulder arthroscopy: which is best? Joints. 2019;7(2):46&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6930847</ArticleId><ArticleId IdType="pubmed">31879731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitman M.I., Nainzadeh N., Ergas E., Springer S. The use of somatosensory evoked potentials for detection of neuropraxia during shoulder arthroscopy. Arthroscopy. 1988;4(4):250&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">3233113</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjano P., Gonz&#xe1;lez B.G., Olmedo J.F., Perez-Espa&#xf1;a L.A., Munilla M.G. Complications in arthroscopic shoulder surgery. Arthroscopy. 1998;14(8):785&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">9848586</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane B.T., Tsui B.C.H. In: Complications of Regional Anesthesia. Finucane B.T., editor. Springer; 2007. Complications of brachial plexus anesthesia; pp. 121&#x2013;148.</Citation></Reference><Reference><Citation>Robinson L.R. Traumatic injury to peripheral nerves. Muscle Nerve. 2000;23(6):863&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pubmed">10842261</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson L.R. How electrodiagnosis predicts clinical outcome of focal peripheral nerve lesions. Muscle Nerve. 2015;52(3):321&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">25989907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31403976</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications after Cardiac Surgery.</ArticleTitle><Pagination><StartPage>1046</StartPage><EndPage>1062</EndPage><MedlinePgn>1046-1062</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000002909</ELocationID><Abstract><AbstractText Label="BACKGROUND">Compared with historic ventilation strategies, modern lung-protective ventilation includes lower tidal volumes (VT), lower driving pressures, and application of positive end-expiratory pressure (PEEP). The contributions of each component to an overall intraoperative protective ventilation strategy aimed at reducing postoperative pulmonary complications have neither been adequately resolved, nor comprehensively evaluated within an adult cardiac surgical population. The authors hypothesized that a bundled intraoperative protective ventilation strategy was independently associated with decreased odds of pulmonary complications after cardiac surgery.</AbstractText><AbstractText Label="METHODS">In this observational cohort study, the authors reviewed nonemergent cardiac surgical procedures using cardiopulmonary bypass at a tertiary care academic medical center from 2006 to 2017. The authors tested associations between bundled or component intraoperative protective ventilation strategies (VT below 8 ml/kg ideal body weight, modified driving pressure [peak inspiratory pressure - PEEP] below 16 cm H2O, and PEEP greater than or equal to 5 cm H2O) and postoperative outcomes, adjusting for previously identified risk factors. The primary outcome was a composite pulmonary complication; secondary outcomes included individual pulmonary complications, postoperative mortality, as well as durations of mechanical ventilation, intensive care unit stay, and hospital stay.</AbstractText><AbstractText Label="RESULTS">Among 4,694 cases reviewed, 513 (10.9%) experienced pulmonary complications. After adjustment, an intraoperative lung-protective ventilation bundle was associated with decreased pulmonary complications (adjusted odds ratio, 0.56; 95% CI, 0.42-0.75). Via a sensitivity analysis, modified driving pressure below 16 cm H2O was independently associated with decreased pulmonary complications (adjusted odds ratio, 0.51; 95% CI, 0.39-0.66), but VT below 8 ml/kg and PEEP greater than or equal to 5 cm H2O were not.</AbstractText><AbstractText Label="CONCLUSIONS">The authors identified an intraoperative lung-protective ventilation bundle as independently associated with pulmonary complications after cardiac surgery. The findings offer insight into components of protective ventilation associated with adverse outcomes and may serve as targets for future prospective interventional studies investigating the impact of specific protective ventilation strategies on postoperative outcomes after cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mathis</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology (M.R.M., N.M.D., N.J.D., M.T.V., M.D.M., D.A.C., A.M.J., S.K., M.C.E.) Cardiac Surgery (D.S.L., J.W.H., R.J.S.), University of Michigan Medical School Department of Biostatistics, University of Michigan (M.Z.), Ann Arbor, Michigan Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville, Virginia (R.S.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duggal</LastName><ForeName>Neal M</ForeName><Initials>NM</Initials></Author><Author ValidYN="Y"><LastName>Likosky</LastName><ForeName>Donald S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Haft</LastName><ForeName>Jonathan W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Douville</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials></Author><Author ValidYN="Y"><LastName>Vaughn</LastName><ForeName>Michelle T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Maile</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Blank</LastName><ForeName>Randal S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Colquhoun</LastName><ForeName>Douglas A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Strobel</LastName><ForeName>Raymond J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Janda</LastName><ForeName>Allison M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Engoren</LastName><ForeName>Milo C</ForeName><Initials>MC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 HL141701</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS022535</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM103730</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR002242</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Anesthesiology. 2020 Jan;132(1):217. doi: 10.1097/ALN.0000000000003038.</RefSource><PMID Version="1">31651530</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2020 Jun;132(6):1610-1611. doi: 10.1097/ALN.0000000000003292.</RefSource><PMID Version="1">32287044</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2020 Jun;132(6):1611-1613. doi: 10.1097/ALN.0000000000003294.</RefSource><PMID Version="1">32287045</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2020 Jun;132(6):1611. doi: 10.1097/ALN.0000000000003293.</RefSource><PMID Version="1">32287046</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><u><b>Conflict of Interest</b></u>: The authors declare no competing interests beyond those described in the funding statement.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31403976</ArticleId><ArticleId IdType="mid">NIHMS1048111</ArticleId><ArticleId IdType="pmc">PMC6800803</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000002909</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zochios V, Klein AA, Gao F: Protective Invasive Ventilation in Cardiac Surgery: A Systematic Review With a Focus on Acute Lung Injury in Adult Cardiac Surgical Patients. J Cardiothorac Vasc Anesth 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">29199052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez J, Riera M, Amezaga R, Herrero J, Colomar A, Campillo-Artero C, Ibarra JI de, Bonnin O: Long-Term Mortality After Pneumonia in Cardiac Surgery Patients: A Propensity-Matched Analysis. J Intensive Care Med 2016; 31:34&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">24578466</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Culler SD, Dee AD, Simon AW: The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg 2008; 85:1980&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">18498806</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Delgado M, Navarrete-Sanchez I, Colmenero M: Preventing and managing perioperative pulmonary complications following cardiac surgery. Curr Opin Anaesthesiol 2014; 27:146&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pubmed">24514031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Delorme M, Bussieres J, Ouattara A: Perioperative ventilatory strategies in cardiac surgery. Best Pract Res Clin Anaesthesiol 2015; 29:381&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10068651</ArticleId><ArticleId IdType="pubmed">26643102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL: Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 2006; 296:1851&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">17047215</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolakis E, Filos KS, Koletsis E, Dougenis D: Lung dysfunction following cardiopulmonary bypass. J Card Surg 2010; 25:47&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">19549041</ArticleId></ArticleIdList></Reference><Reference><Citation>Slinger P, Kilpatrick B: Perioperative lung protection strategies in cardiothoracic anesthesia: are they useful? Anesthesiol Clin 2012; 30:607&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">23089498</ArticleId></ArticleIdList></Reference><Reference><Citation>Canet J, Gallart L, Gomar C, Paluzie G, Valles J, Castillo J, Sabate S, Mazo V, Briones Z, Sanchis J: Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 2010; 113:1338&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pubmed">21045639</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH: The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75:1856&#x2013;64; discussion 1864&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">12822628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brescia AA, Rankin JS, Cyr DD, Jacobs JP, Prager RL, Zhang M, Matsouaka RA, Harrington SD, Dokholyan RS, Bolling SF, Fishstrom A, Pasquali SK, Shahian DM, Likosky DS: Determinants of Variation in Pneumonia Rates After Coronary Artery Bypass Grafting. Ann Thorac Surg 2018; 105:513&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5783740</ArticleId><ArticleId IdType="pubmed">29174785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu WJ, Wang F, Liu JC: Effect of lung-protective ventilation with lower tidal volumes on clinical outcomes among patients undergoing surgery: a meta-analysis of randomized controlled trials. CMAJ 2015; 187:E101&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4330165</ArticleId><ArticleId IdType="pubmed">25512653</ArticleId></ArticleIdList></Reference><Reference><Citation>Guldner A, Kiss T, Serpa Neto A, Hemmes SN, Canet J, Spieth PM, Rocco PR, Schultz MJ, Pelosi P, Gama de Abreu M: Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology 2015; 123:692&#x2013;713</Citation><ArticleIdList><ArticleId IdType="pubmed">26120769</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Ochroch EA: Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in patients without acute lung injury. Cochrane Database Syst Rev 2015:CD011151.</Citation><ArticleIdList><ArticleId IdType="pubmed">26641378</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Hemmes SN, Barbas CS, Beiderlinden M, Biehl M, Binnekade JM, Canet J, Fernandez-Bustamante A, Futier E, Gajic O, Hedenstierna G, Hollmann MW, Jaber S, Kozian A, Licker M, Lin WQ, Maslow AD, Memtsoudis SG, Reis Miranda D, Moine P, Ng T, Paparella D, Putensen C, Ranieri M, Scavonetto F, Schilling T, Schmid W, Selmo G, Severgnini P, Sprung J, Sundar S, Talmor D, Treschan T, Unzueta C, Weingarten TN, Wolthuis EK, Wrigge H, Gama de Abreu M, Pelosi P, Schultz MJ: Protective versus Conventional Ventilation for Surgery: A Systematic Review and Individual Patient Data Meta-analysis. Anesthesiology 2015; 123:66&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pubmed">25978326</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SN, Barbas CS, Beiderlinden M, Fernandez-Bustamante A, Futier E, Gajic O, El-Tahan MR, Ghamdi AA, Gunay E, Jaber S, Kokulu S, Kozian A, Licker M, Lin WQ, Maslow AD, Memtsoudis SG, Reis Miranda D, Moine P, Ng T, Paparella D, Ranieri VM, Scavonetto F, Schilling T, Selmo G, Severgnini P, Sprung J, Sundar S, Talmor D, Treschan T, Unzueta C, Weingarten TN, Wolthuis EK, Wrigge H, Amato MB, Costa EL, de Abreu MG, Pelosi P, Schultz MJ: Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med 2016; 4:272&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, Stewart TE, Briel M, Talmor D, Mercat A, Richard JC, Carvalho CR, Brower RG: Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015; 372:747&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">25693014</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama H, Pettenuzzo T, Aoyama K, Pinto R, Englesakis M, Fan E: Association of Driving Pressure With Mortality Among Ventilated Patients With Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Crit Care Med 2018; 46:300&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">29135500</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ: High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet 2014; 384:495&#x2013;503</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW: Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth 2014; 113:97&#x2013;108</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9585620</ArticleId><ArticleId IdType="pubmed">24623057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Dionne S, Simard S, Bussieres J, Dagenais F: High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology 2012; 116:1072&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">22450472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Gomersall CD, Ng SK, Underwood MJ, Lee A: A randomized controlled trial of adaptive support ventilation mode to wean patients after fast-track cardiac valvular surgery. Anesthesiology 2015; 122:832&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">25569810</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesia Clinical Research Committee
at &lt;https://anes.med.umich.edu/research/acrc.html&gt;</Citation></Reference><Reference><Citation>Society of Thoracic Surgeons Adult Cardiac Surgery Database Data Specifications
2017. 
at &lt;https://www.sts.org/sites/default/files/documents/ACSD_DataSpecificationsV2_9.pdf&gt;</Citation></Reference><Reference><Citation>Freundlich RE, Kheterpal S: Perioperative effectiveness research using large databases. Best Pract Res Clin Anaesthesiol 2011; 25:489&#x2013;98</Citation><ArticleIdList><ArticleId IdType="pubmed">22099915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S: Clinical research using an information system: the multicenter perioperative outcomes group. Anesthesiol Clin 2011; 29:377&#x2013;88</Citation><ArticleIdList><ArticleId IdType="pubmed">21871400</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroyer AL, Edwards FH, Grover FL: Updates to the Data Quality Review Program: the Society of Thoracic Surgeons Adult Cardiac National Database. Ann Thorac Surg 1998; 65:1494&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">9594906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender SP, Paganelli WC, Gerety LP, Tharp WG, Shanks AM, Housey M, Blank RS, Colquhoun DA, Fernandez-Bustamante A, Jameson LC, Kheterpal S: Intraoperative Lung-Protective Ventilation Trends and Practice Patterns: A Report from the Multicenter Perioperative Outcomes Group. Anesth Analg 2015; 121:1231&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">26332856</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JP, He X, O&#x2019;Brien SM, Welke KF, Filardo G, Han JM, Ferraris VA, Prager RL, Shahian DM: Variation in ventilation time after coronary artery bypass grafting: an analysis from the society of thoracic surgeons adult cardiac surgery database. Ann Thorac Surg 2013; 96:757&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">23731610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Healy D, Aziz MF, Shanks AM, Freundlich RE, Linton F, Martin LD, Linton J, Epps JL, Fernandez-Bustamante A, Jameson LC, Tremper T, Tremper KK: Incidence, predictors, and outcome of difficult mask ventilation combined with difficult laryngoscopy: a report from the multicenter perioperative outcomes group. Anesthesiology 2013; 119:1360&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">24071617</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahian DM, O&#x2019;Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP: The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88:S2&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">19559822</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteve F, Lopez-Delgado JC, Javierre C, Skaltsa K, Carrio ML, Rodriguez-Castro D, Torrado H, Farrero E, Diaz-Prieto A, Ventura JL, Manez R: Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay. BMC Anesthesiol 2014; 14:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4448284</ArticleId><ArticleId IdType="pubmed">25928646</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Turanzas M, Ensor J, Wakefield C, Zhang K, Wallace SK, Price KJ, Nates JL: Cross-validation of a Sequential Organ Failure Assessment score-based model to predict mortality in patients with cancer admitted to the intensive care unit. J Crit Care 2012; 27:673&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">22762932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307:2526&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott TEF, Fowler AJ, Pelosi P, Gama de Abreu M, Moller AM, Canet J, Creagh-Brown B, Mythen M, Gin T, Lalu MM, Futier E, Grocott MP, Schultz MJ, Pearse RM: A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth 2018; 120:1066&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">29661384</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, Leva B, Rhodes A, Hoeft A, Walder B, Chew MS, Pearse RM: Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol 2015; 32:88&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha K, Vidal Melo MF, McLean DJ, Wanderer JP, Grabitz SD, Kurth T, Eikermann M: Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ 2015; 351:h3646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4501577</ArticleId><ArticleId IdType="pubmed">26174419</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin Jm, Fau-Paugam-Burtz C, Paugam-Burtz C, Fau-Pascal J, Pascal J, Fau-Eurin M, Eurin M, Fau-Neuschwander A, Neuschwander A, Fau-Marret E, Marret E, Fau-Beaussier M, Beaussier M, Fau-Gutton C, Gutton C, Fau-Lefrant J-Y, Lefrant Jy, Fau-Allaouchiche B, Allaouchiche B, Fau-Verzilli D, Verzilli D, Fau-Leone M, Leone M, Fau-De Jong A, De Jong A, Fau-Bazin J-E, Bazin Je, Fau-Pereira B, Pereira B, Fau-Jaber S, Jaber S: A trial of intraoperative low-tidal-volume ventilation in abdominal surgery 20130801 DCOM- 20130806</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz MJ, Haitsma JJ, Slutsky AS, Gajic O: What tidal volumes should be used in patients without acute lung injury? Anesthesiology 2007; 106:1226&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pubmed">17525599</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville NJ, Jewell ES, Duggal N, Blank R, Kheterpal S, Engoren MC, Mathis MR: Association of Intraoperative Ventilator Management With Postoperative Oxygenation, Pulmonary Complications, and Mortality 2019:p 1 doi:10.1213/ane.0000000000004191</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000004191</ArticleId><ArticleId IdType="pmc">PMC8592391</ArticleId><ArticleId IdType="pubmed">31107262</ArticleId></ArticleIdList></Reference><Reference><Citation>Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum JM, Stentz MJ, Dechert R, Jewell E, Engoren M, Rosenberg AL, Park PK: Preoperative and intraoperative predictors of postoperative acute respiratory distress syndrome in a general surgical population. Anesthesiology 2013; 118:19&#x2013;29</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3813014</ArticleId><ArticleId IdType="pubmed">23221870</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers J, Pullan M, Fabri B, McShane J, Shaw M, Mediratta N, Poullis M: Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur J Cardiothorac Surg 2013; 43:688&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pubmed">22833541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R: Regression Shrinkage and Selection Via the LASSO. J R Stat Soc Series B Stat Methodol 1996; 58:267&#x2013;88</Citation></Reference><Reference><Citation>Katz MH: Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003; 138:644&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pubmed">12693887</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens RS, Whitman GJ: Postoperative Critical Care of the Adult Cardiac Surgical Patient. Part I: Routine Postoperative Care 2015. 0617 DCOM- 20150826</Citation><ArticleIdList><ArticleId IdType="pubmed">25962078</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens RS, Whitman GJ: Postoperative Critical Care of the Adult Cardiac Surgical Patient: Part II: Procedure-Specific Considerations, Management of Complications, and Quality Improvement. Crit Care Med 2015; 43:1995&#x2013;2014</Citation><ArticleIdList><ArticleId IdType="pubmed">26136101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong WT, Lai VK, Chee YE, Lee A: Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev 2016; 9:Cd003587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457798</ArticleId><ArticleId IdType="pubmed">27616189</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M, Ahn HJ, Kim JA, Yang M, Heo BY, Choi JW, Kim YR, Lee SH, Jeong H, Choi SJ, Song IS: Driving Pressure during Thoracic Surgery: A Randomized Clinical Trial. Anesthesiology 2019; 130:385&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">30664548</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RG, Naidu B: Does a conservative fluid management strategy in the perioperative management of lung resection patients reduce the risk of acute lung injury? Interact Cardiovasc Thorac Surg 2012; 15:498&#x2013;504</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422923</ArticleId><ArticleId IdType="pubmed">22617510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristovska AM, Duch P, Allingstrup M, Afshari A: Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev 2017; 8:Cd012763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6483345</ArticleId><ArticleId IdType="pubmed">28806470</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy GS, Brull SJ: Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111:120&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">20442260</ArticleId></ArticleIdList></Reference><Reference><Citation>Damas P, Frippiat F, Ancion A, Canivet JL, Lambermont B, Layios N, Massion P, Morimont P, Nys M, Piret S, Lancellotti P, Wiesen P, D&#x2019;Orio V, Samalea N, Ledoux D: Prevention of ventilator-associated pneumonia and ventilator-associated conditions: a randomized controlled trial with subglottic secretion suctioning. Crit Care Med 2015; 43:22&#x2013;30</Citation><ArticleIdList><ArticleId IdType="pubmed">25343570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodpoor A, Hamishehkar H, Hamidi M, Shadvar K, Sanaie S, Golzari SE, Khan ZH, Nader ND: A prospective randomized trial of tapered-cuff endotracheal tubes with intermittent subglottic suctioning in preventing ventilator-associated pneumonia in critically ill patients. J Crit Care 2017; 38:152&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">27912161</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson WR, Chen L, Amato MBP, Brochard LJ: Fifty Years of Research in ARDS. Respiratory Mechanics in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2017; 196:822&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">28306327</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40172532</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov Disord</ISOAbbreviation></Journal><ArticleTitle>Antero-Lateral Subthalamic Nucleus Theta Stimulation Improves Verbal Fluency in Parkinson's Disease.</ArticleTitle><Pagination><StartPage>1195</StartPage><EndPage>1199</EndPage><MedlinePgn>1195-1199</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.30185</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Low-frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been associated with positive effects on verbal fluency (VF) in patients with Parkinson's disease. This prospective study investigates stimulation direction-dependent and site-specific effects of theta frequency DBS on VF.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a double-blind, cross-over design (n&#x2009;=&#x2009;20), we tested VF during left subthalamic theta stimulation (stimulation-off, omnidirectional, and threedirectional stimulation conditions). DBS electrode localization and electric field calculations were performed (n&#x2009;=&#x2009;18). Probabilistic sweet spot mapping identified voxels with significant change in VF.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Best directional stimulation improved VF performance significantly compared with the stimulation-off and omnidirectional stimulation condition. This effect followed a medial-to-anterolateral gradient with higher VF improvement observed on the border between the motor and associative subparts of the STN.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We provide first proof-of-principle evidence that directional theta frequency DBS improves VF, possibly related to stimulation of the anterolateral STN. &#xa9; 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schoenwald</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0001-7469-8910</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahners</LastName><ForeName>Bahne H</ForeName><Initials>BH</Initials><Identifier Source="ORCID">0000-0003-1963-9798</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannenberg</LastName><ForeName>Silja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dembek</LastName><ForeName>Till A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0001-7023-146X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbe</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sylaj</LastName><ForeName>Dafina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiewok</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elben</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muettel</LastName><ForeName>Tomke</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Leverkusen, Leverkusen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vesper</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Functional Neurosurgery and Stereotaxy, Department of Neurosurgery, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slotty</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinic for Orthopaedics and Trauma Surgery, Functional Neurosurgery and Neuromodulation, Helios St. Josefhospital Uerdingen, Krefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schnitzler</LastName><ForeName>Alfons</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groiss</LastName><ForeName>Stefan J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurocenter, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020531" MajorTopicYN="Y">Subthalamic Nucleus</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046690" MajorTopicYN="Y">Deep Brain Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013826" MajorTopicYN="Y">Theta Rhythm</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">deep brain stimulation</Keyword><Keyword MajorTopicYN="N">left hemisphere</Keyword><Keyword MajorTopicYN="N">low&#x2010;frequency stimulation</Keyword><Keyword MajorTopicYN="N">neurocognitive side effects</Keyword><Keyword MajorTopicYN="N">verbal fluency sweet spot</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>2</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>2</Day><Hour>10</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40172532</ArticleId><ArticleId IdType="pmc">PMC12160961</ArticleId><ArticleId IdType="doi">10.1002/mds.30185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deuschl G, Krack P, B&#xf6;tzel K, et al. A randomized trial of deep&#x2010;brain stimulation for Parkinson's disease. N Engl J Med 2006;355(9):896&#x2013;908. 10.1056/NEJMoa060281</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa060281</ArticleId><ArticleId IdType="pubmed">16943402</ArticleId></ArticleIdList></Reference><Reference><Citation>Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339(16):1105&#x2013;1111. 10.1056/NEJM199810153391603</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199810153391603</ArticleId><ArticleId IdType="pubmed">9770557</ArticleId></ArticleIdList></Reference><Reference><Citation>Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009;8(1):67&#x2013;81. 10.1016/S1474-4422(08)70291-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70291-6</ArticleId><ArticleId IdType="pubmed">19081516</ArticleId></ArticleIdList></Reference><Reference><Citation>Saint&#x2010;Cyr JA. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123(10):2091&#x2013;2108. 10.1093/brain/123.10.2091</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.10.2091</ArticleId><ArticleId IdType="pubmed">11004126</ArticleId></ArticleIdList></Reference><Reference><Citation>Mossner JM, Chou KL, Maher AH, Persad CC, Patil PG. Localization of motor and verbal fluency effects in subthalamic DBS for Parkinson's disease. Parkinsonism Relat Disord 2020;79:55&#x2013;59. 10.1016/j.parkreldis.2020.08.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.08.023</ArticleId><ArticleId IdType="pubmed">32866879</ArticleId></ArticleIdList></Reference><Reference><Citation>Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008;7(7):605&#x2013;614. 10.1016/S1474-4422(08)70114-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70114-5</ArticleId><ArticleId IdType="pubmed">18538636</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;jlund A, Petersen MV, Sridharan KS, &#xd8;stergaard K. Worsening of verbal fluency after deep brain stimulation in Parkinson's disease: a focused review. Comput Struct Biotechnol J 2017;15:68&#x2013;74. 10.1016/j.csbj.2016.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5155048</ArticleId><ArticleId IdType="pubmed">27994799</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Bene VA, Martin RC, Brinkerhoff SA, et al. Differential cognitive effects of unilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Ann Neurol 2024;95:1205&#x2013;1219. 10.1002/ana.26903</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26903</ArticleId><ArticleId IdType="pmc">PMC11102318</ArticleId><ArticleId IdType="pubmed">38501317</ArticleId></ArticleIdList></Reference><Reference><Citation>John KD, Wylie SA, Dawant BM, et al. Deep brain stimulation effects on verbal fluency dissociated by target and active contact location. Ann Clin Transl Neurol 2021;8(3):613&#x2013;622. 10.1002/acn3.51304</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51304</ArticleId><ArticleId IdType="pmc">PMC7951101</ArticleId><ArticleId IdType="pubmed">33596331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtecki L, Timmermann L, J&#xf6;rgens S, et al. Frequency&#x2010;dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol 2006;63(9):1273&#x2013;1276. 10.1001/archneur.63.9.1273</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.63.9.1273</ArticleId><ArticleId IdType="pubmed">16966504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DJ, Drummond NM, Saha U, et al. Acute low frequency dorsal subthalamic nucleus stimulation improves verbal fluency in Parkinson's disease. Brain Stimul 2021;14(4):754&#x2013;760. 10.1016/j.brs.2021.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2021.04.016</ArticleId><ArticleId IdType="pubmed">33940243</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro E, Esselink RJA, Xie J, Hommel M, Benabid AL, Pollak P. The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology 2002;59(5):706&#x2013;713. 10.1212/WNL.59.5.706</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.5.706</ArticleId><ArticleId IdType="pubmed">12221161</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry JD, Crawford JR. Verbal fluency deficits in Parkinson's disease: a meta&#x2010;analysis. J Int Neuropsychol Soc 2004;10(4):608&#x2013;622. 10.1017/S1355617704104141</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617704104141</ArticleId><ArticleId IdType="pubmed">15327739</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hn AA, Volkmann J. Innovations in deep brain stimulation methodology. Mov Disord 2017;32(1):11&#x2013;19. 10.1002/mds.26703</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26703</ArticleId><ArticleId IdType="pubmed">27400763</ArticleId></ArticleIdList></Reference><Reference><Citation>Steigerwald F, M&#xfc;ller L, Johannes S, Matthies C, Volkmann J. Directional deep brain stimulation of the subthalamic nucleus: a pilot study using a novel neurostimulation device. Mov Disord 2016;31(8):1240&#x2013;1243. 10.1002/mds.26669</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26669</ArticleId><ArticleId IdType="pmc">PMC5089579</ArticleId><ArticleId IdType="pubmed">27241197</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnitzler A, Mir P, Brodsky MA, Verhagen L, Groppa S, Alvarez R, et al. Directional deep brain stimulation for Parkinson's disease: results of an international crossover study with randomized, double&#x2010;blind primary endpoint. Neuromodulation 2022;25(6):817&#x2013;828. 10.1111/ner.13407</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ner.13407</ArticleId><ArticleId IdType="pubmed">34047410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno S, Nikolov P, Hartmann CJ, Trenado C, Slotty PJ, Vesper J, et al. Directional deep brain stimulation of the thalamic ventral intermediate area for essential tremor increases therapeutic window. Neuromodulation 2021;24(2):343&#x2013;352. 10.1111/ner.13234</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ner.13234</ArticleId><ArticleId IdType="pubmed">32666569</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn A, K&#xfc;hn AA. Lead&#x2010;DBS: a toolbox for deep brain stimulation electrode localizations and visualizations. Neuroimage 2015;107:127&#x2013;135. 10.1016/j.neuroimage.2014.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2014.12.002</ArticleId><ArticleId IdType="pubmed">25498389</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn A, Li N, Dembek TA, et al. Lead&#x2010;DBS v2: towards a comprehensive pipeline for deep brain stimulation imaging. Neuroimage 2019;184:293&#x2013;316. 10.1016/j.neuroimage.2018.08.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2018.08.068</ArticleId><ArticleId IdType="pmc">PMC6286150</ArticleId><ArticleId IdType="pubmed">30179717</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitz A, Hoevels M, Hellerbach A, et al. Determining the orientation angle of directional leads for deep brain stimulation using computed tomography and digital x&#x2010;ray imaging: a phantom study. Med Phys 2017;44(9):4463&#x2013;4473. 10.1002/mp.12424</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mp.12424</ArticleId><ArticleId IdType="pubmed">28639387</ArticleId></ArticleIdList></Reference><Reference><Citation>Baniasadi M, Proverbio D, Gon&#xe7;alves J, Hertel F, Husch A. FastField: an open&#x2010;source toolbox for efficient approximation of deep brain stimulation electric fields. Neuroimage 2020;223:117330. 10.1016/j.neuroimage.2020.117330</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117330</ArticleId><ArticleId IdType="pubmed">32890746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewert S, Plettig P, Li N, et al. Toward defining deep brain stimulation targets in MNI space: a subcortical atlas based on multimodal MRI, histology and structural connectivity. Neuroimage 2018;170:271&#x2013;282. 10.1016/j.neuroimage.2017.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.05.015</ArticleId><ArticleId IdType="pubmed">28536045</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldmann LK, Lofredi R, Neumann WJ, Al&#x2010;Fatly B, Roediger J, Bahners BH, et al. Toward therapeutic electrophysiology: beta&#x2010;band suppression as a biomarker in chronic local field potential recordings. NPJ Parkinsons Dis 2022;8(1):44. 10.1038/s41531-022-00301-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-022-00301-2</ArticleId><ArticleId IdType="pmc">PMC9018912</ArticleId><ArticleId IdType="pubmed">35440571</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35759160</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies.</ArticleTitle><Pagination><StartPage>161</StartPage><EndPage>175</EndPage><MedlinePgn>161-175</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-022-01287-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In patients with cardiomyopathy, radiofrequency catheter ablation (CA) for ventricular tachycardia (VT) is an adjunctive and alternative treatment option to long-term anti-arrhythmic drug therapy. We sought to compare CA with medical therapy for the management of VT in patients with ischemic and non-ischemic cardiomyopathies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, Cochrane, and ClinicalTrials.gov databases were evaluated for relevant studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven studies with 2126 adult patients were included (711 in CA, 1415 in medical therapy). In the randomized controlled trial (RCT) analysis, CA reduced risk of recurrent VT (risk ratio (RR) 0.79 [95% CI 0.67 to 0.93], p&#x2009;=&#x2009;0.005), ICD shocks (RR 0.64 [95% CI 0.45 to 0.89] p&#x2009;=&#x2009;0.008), and cardiac hospitalizations (RR 0.76 [95% CI 0.63 to 0.92] p&#x2009;=&#x2009;0.005). There was no difference in all-cause mortality (RR 0.94, p&#x2009;=&#x2009;0.71). In combined RCT and observational study analysis, there was a trend for reduction in all-cause mortality (RR 0.75 [95% CI 0.55 to 1.02] p&#x2009;=&#x2009;0.07). In subgroup analysis of studies with mean left ventricular ejection fraction (LVEF)&#x2009;&lt;&#x2009;35%, CA demonstrated reduction in mortality (RR 0.71, p&#x2009;=&#x2009;0.004), ICD shocks (RR 0.63, p&#x2009;=&#x2009;0.03), VT recurrence (RR 0.76, p&#x2009;=&#x2009;0.004), and cardiac hospitalizations (RR 0.75, p&#x2009;=&#x2009;0.02). The subgroup of early CA prior to ICD shocks demonstrated reduction in ICD shocks (RR 0.57, p&#x2009;&lt;&#x2009;0.001) and VT recurrence (RR 0.74, p&#x2009;=&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CA for VT demonstrated a lower risk of VT recurrence, ICD shocks, and hospitalization in comparison to medical therapy. The subgroups of early CA and LVEF&#x2009;&lt;&#x2009;35% demonstrated better outcomes.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ravi</LastName><ForeName>Venkatesh</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-6826-9231</Identifier><AffiliationInfo><Affiliation>Warren Clinic Cardiology, Saint Francis Health System, 6151 South Yale Ave, Tulsa, OK, 74136, USA. venkateshravi.8711@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poudyal</LastName><ForeName>Abhushan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cook County Health, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanal</LastName><ForeName>Smriti</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cook County Health, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Charl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cook County Health, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vij</LastName><ForeName>Aviral</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cook County Health, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trohman</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aksu</LastName><ForeName>Tolga</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Yeditepe University Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Roderick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, University of Arizona College of Medicine, Phoenix, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santangeli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Hospital of University of Pennsylvania, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winterfield</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Parikshit S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Henry D</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Interv Card Electrophysiol. 2023 Jan;66(1):177-178. doi: 10.1007/s10840-022-01309-7.</RefSource><PMID Version="1">35895221</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Medical therapy</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>27</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35759160</ArticleId><ArticleId IdType="doi">10.1007/s10840-022-01287-w</ArticleId><ArticleId IdType="pii">10.1007/s10840-022-01287-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91&#x2013;220. https://doi.org/10.1016/j.jacc.2017.10.054 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.10.054</ArticleId><ArticleId IdType="pubmed">29097296</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein AE, DiMarco JP, Ellenbogen KA, American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices), American Association for Thoracic Surgery; Society of Thoracic Surgeons, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51(21):e1-62. https://doi.org/10.1016/j.jacc.2008.02.032 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.02.032</ArticleId><ArticleId IdType="pubmed">18498951</ArticleId></ArticleIdList></Reference><Reference><Citation>Members Writing Committee, Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;S0735&#x2013;1097(21):08395&#x2013;9. https://doi.org/10.1016/j.jacc.2021.12.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120(22):2170&#x2013;6. https://doi.org/10.1161/CIRCULATIONAHA.109.853689 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.853689</ArticleId><ArticleId IdType="pubmed">19917887</ArticleId><ArticleId IdType="pmc">2922511</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657&#x2013;65. https://doi.org/10.1056/NEJMoa065457 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065457</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId><ArticleId IdType="pmc">2390777</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems S, Tilz RR, Steven D, BERLIN VT Investigators, et al. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141(13):1057&#x2013;67. https://doi.org/10.1161/CIRCULATIONAHA.119.043400 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043400</ArticleId><ArticleId IdType="pubmed">32000514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Schaumann A, Eckardt L, VTACH study group, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375(9708):31&#x2013;40. https://doi.org/10.1016/S0140-6736(09)61755-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61755-4</ArticleId><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima Silva G, Nunes-Ferreira A, Cortez-Dias N, de Sousa J, Pinto JF, Caldeira D. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2020;59(3):603&#x2013;16. https://doi.org/10.1007/s10840-020-00870-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-020-00870-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Bella P, Baratto F, Vergara P, et al. Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation. 2022. https://doi.org/10.1161/CIRCULATIONAHA.122.059598 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059598</ArticleId><ArticleId IdType="pubmed">35969654</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenal &#xc1;, &#xc1;vila P, Jim&#xe9;nez-Candil J, et al. Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol. 2022;79(15):1441&#x2013;53. https://doi.org/10.1016/j.jacc.2022.01.050 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.01.050</ArticleId><ArticleId IdType="pubmed">35422240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R, Xue Y, Chen M, Jiang C, et al; PAUSE-SCD Investigators. First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial. Circulation. 2022. https://doi.org/10.1161/CIRCULATIONAHA.122.060039 .</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, PRISMA Group. Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook .</Citation></Reference><Reference><Citation>Borenstein M, Hedges L, Higgins J, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.12</ArticleId><ArticleId IdType="pubmed">26061376</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman A, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence&#x2014;inconsistency. J Clin Epidemiol. 2011;64:1294&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.03.017</ArticleId><ArticleId IdType="pubmed">21803546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J, Harbord R. Funnel plots in meta-analysis. The Stata Journal: Promoting communications on statistics and Stata. 2004;4:127&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X0400400204</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Daubert JP, Anstrom KJ, et al. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2015;26(2):151&#x2013;7. https://doi.org/10.1111/jce.12567 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.12567</ArticleId><ArticleId IdType="pubmed">25332150</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111&#x2013;21. https://doi.org/10.1056/NEJMoa1513614 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1513614</ArticleId><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Tilz RR, Deneke T, SMS Investigators, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol. 2017;10(3):e004422. https://doi.org/10.1161/CIRCEP.116.004422 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.116.004422</ArticleId><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunch TJ, Weiss JP, Crandall BG, et al. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart Rhythm. 2014;11(4):533&#x2013;40. https://doi.org/10.1016/j.hrthm.2013.12.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2013.12.014</ArticleId><ArticleId IdType="pubmed">24333283</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez Candil J, Castro JC, Hern&#xe1;ndez J, et al. Timing of ablation and prognosis of patients with electrical storm and scar-related left ventricular dysfunction. Am J Cardiol. 2020;136:87&#x2013;93. https://doi.org/10.1016/j.amjcard.2020.09.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.09.010</ArticleId><ArticleId IdType="pubmed">32946863</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez BK, Baker WL, Konopka A, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020;17(1):e206&#x2013;19. https://doi.org/10.1016/j.hrthm.2019.04.024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.04.024</ArticleId><ArticleId IdType="pubmed">31082362</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Dorian P, Roberts RS, Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006;295(2):165&#x2013;71. https://doi.org/10.1001/jama.295.2.165 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.2.165</ArticleId><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2004;110(2):112&#x2013;6. https://doi.org/10.1161/01.CIR.0000134957.51747.6E .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000134957.51747.6E</ArticleId><ArticleId IdType="pubmed">15238454</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams ES, Viswanathan MN. Current and emerging antiarrhythmic drug therapy for ventricular tachycardia. Cardiol Ther. 2013;2(1):27&#x2013;46. https://doi.org/10.1007/s40119-013-0012-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-013-0012-5</ArticleId><ArticleId IdType="pubmed">25135287</ArticleId><ArticleId IdType="pmc">4107437</ArticleId></ArticleIdList></Reference><Reference><Citation>Brice&#xf1;o DF, Romero J, Villablanca PA, et al. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. Europace. 2018;20(1):104&#x2013;15. https://doi.org/10.1093/europace/eux109 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eux109</ArticleId><ArticleId IdType="pubmed">28575378</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Cochet H, Sacher F, et al. Impact of new technologies and approaches for post-myocardial infarction ventricular tachycardia ablation during long-term follow-up. Circ Arrhythm Electrophysiol. 2016;9(7):e003901. https://doi.org/10.1161/CIRCEP.116.003901 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.116.003901</ArticleId><ArticleId IdType="pubmed">27406604</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31743177</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Global and Regional Respiratory Mechanics During Robotic-Assisted Laparoscopic Surgery: A Randomized Study.</ArticleTitle><Pagination><StartPage>1564</StartPage><EndPage>1573</EndPage><MedlinePgn>1564-1573</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000004289</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pneumoperitoneum and nonphysiological positioning required for robotic surgery increase cardiopulmonary risk because of the use of larger airway pressures (Paws) to maintain tidal volume (VT). However, the quantitative partitioning of respiratory mechanics and transpulmonary pressure (PL) during robotic surgery is not well described. We tested the following hypothesis: (1) the components of driving pressure (transpulmonary and chest wall components) increase in a parallel fashion at robotic surgical stages (Trendelenburg and robot docking); and (2) deep, when compared to routine (moderate), neuromuscular blockade modifies those changes in PLs as well as in regional respiratory mechanics.</AbstractText><AbstractText Label="METHODS">We studied 35 American Society of Anesthesiologists (ASA) I-II patients undergoing elective robotic surgery. Airway and esophageal balloon pressures and respiratory flows were measured to calculate respiratory mechanics. Regional lung aeration and ventilation was assessed with electrical impedance tomography and level of neuromuscular blockade with acceleromyography. During robotic surgical stages, 2 crossover randomized groups (conditions) of neuromuscular relaxation were studied: Moderate (1 twitch in the train-of-four stimulation) and Deep (1-2 twitches in the posttetanic count).</AbstractText><AbstractText Label="RESULTS">Pneumoperitoneum was associated with increases in driving pressure, tidal changes in PL, and esophageal pressure (Pes). Steep Trendelenburg position during robot docking was associated with further worsening of the respiratory mechanics. The fraction of driving pressures that partitioned to the lungs decreased from baseline (63% &#xb1; 15%) to Trendelenburg position (49% &#xb1; 14%, P &lt; .001), due to a larger increase in chest wall elastance (Ecw; 12.7 &#xb1; 7.6 cm H2O&#xb7;L) than in lung elastance (EL; 4.3 &#xb1; 5.0 cm H2O&#xb7;L, P &lt; .001). Consequently, from baseline to Trendelenburg, the component of Paw affecting the chest wall increased by 6.6 &#xb1; 3.1 cm H2O, while PLs increased by only 3.4 &#xb1; 3.1 cm H2O (P &lt; .001). PL and driving pressures were larger at surgery end than at baseline and were accompanied by dorsal aeration loss. Deep neuromuscular blockade did not change respiratory mechanics, regional aeration and ventilation, and hemodynamics.</AbstractText><AbstractText Label="CONCLUSIONS">In robotic surgery with pneumoperitoneum, changes in ventilatory driving pressures during Trendelenburg and robot docking are distributed less to the lungs than to the chest wall as compared to routine mechanical ventilation for supine patients. This effect of robotic surgery derives from substantially larger increases in Ecw than ELs and reduces the risk of excessive PLs. Deep neuromuscular blockade does not meaningfully change global or regional lung mechanics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brand&#xe3;o</LastName><ForeName>Julio C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, UNIFESP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessa</LastName><ForeName>Marcos A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Cardiovascular Investigation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motta-Ribeiro</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Soshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paula</LastName><ForeName>Luis Felipe</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torsani</LastName><ForeName>Vinicius</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardio-Pulmonary Department, Pulmonary Division, Heart Institute (Incor), University of S&#xe3;o Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Linh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eikermann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl</LastName><ForeName>Douglas M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabatabaei</LastName><ForeName>Shahin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amato</LastName><ForeName>Marcelo B P</ForeName><Initials>MBP</Initials><AffiliationInfo><Affiliation>Cardio-Pulmonary Department, Pulmonary Division, Heart Institute (Incor), University of S&#xe3;o Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal Melo</LastName><ForeName>Marcos F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Anesth Analg. 2020 Apr;130(4):e118. doi: 10.1213/ANE.0000000000004640.</RefSource><PMID Version="1">33034983</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001900" MajorTopicYN="N" Type="Geographic">Boston</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018475" MajorTopicYN="N">Head-Down Tilt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061886" MajorTopicYN="Y">Neuromuscular Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011028" MajorTopicYN="Y">Pneumoperitoneum, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="N">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="Y">Respiratory Mechanics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055397" MajorTopicYN="N">Ventilator-Induced Lung Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31743177</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000004289</ArticleId><ArticleId IdType="pii">00000539-201912000-00022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36335616</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Clinical outcomes of radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy.</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>224</EndPage><MedlinePgn>219-224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.15739</ELocationID><Abstract><AbstractText Label="BACKGROUND">Monomorphic ventricular tachycardia (VT) is rare in patients with hypertrophic cardiomyopathy (HCM), management of which is challenging. Limited data exists on the utility of catheter ablation for the treatment of VT in this population.</AbstractText><AbstractText Label="OBJECTIVES">We aimed to assess clinical outcomes of catheter ablation for VT in HCM patients.</AbstractText><AbstractText Label="METHODS">A systematic search, without language restriction, using PubMed, EMBASE, SCOPUS, Google Scholar, and ClinicalTrials.gov was performed. The meta-analysis was performed using a meta-package for R version 4.0/RStudio version 1.2 and Freeman Tukey double arcsine method to establish the variance of raw proportions. Outcomes measured included (1) acute procedure success (defined as noninducible for clinical VT),&#xa0;(2) freedom from VT at follow-up, (3) mortality.</AbstractText><AbstractText Label="RESULTS">This systematic review of six studies (three from the&#xa0;United States and three from Japan) incorporated a total of 68 drug-refractory HCM patients who underwent VT radiofrequency catheter ablation (mean age 57.6&#x2009;&#xb1;&#x2009;13.3&#x2009;years, mean LVEF 45.8&#x2009;&#xb1;&#x2009;15.4%, 85% men, maximum septal wall thickness 17.4&#x2009;&#xb1;&#x2009;4.6&#x2009;mm, and 32.3% with an apical aneurysm). Acute procedural success was achieved in 84.5% patients (95% confidence interval&#xa0;[CI]: 70.6%-95.2%) with 27.9% patients had recurrent VT requiring multiple ablations (median 1, IQR 1-3). During the follow-up period (18.3&#x2009;&#xb1;&#x2009;11.7&#x2009;months), the pooled incidence of freedom from recurrent VT after index procedure was 70.2% (95% CI: 51.9%-86.2%), while after the last ablation was 82.8% (95% CI: 57%-99.2%). There were two deaths during follow-up, one from heart failure and one from SCD 0.8% (95% CI: 0%-5.8%).</AbstractText><AbstractText Label="CONCLUSION">The results of our pooled analysis demonstrated that catheter ablation for VT in HCM patients was associated with high acute procedural success, and reduced VT recurrence-findings comparable to previously published reports in other disease substrates.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Jalaj</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6857-7418</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kewcharoen</LastName><ForeName>Jakrin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Kuldeep</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1345-0719</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Beaumont Hospital, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turagam</LastName><ForeName>Mohit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhardwaj</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7734-8660</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contractor</LastName><ForeName>Tahmeed</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandapati</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1492-2693</Identifier><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute and Research Foundation, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="Y">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">death</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>6</Day><Hour>16</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36335616</ArticleId><ArticleId IdType="pmc">PMC10100142</ArticleId><ArticleId IdType="doi">10.1111/jce.15739</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dukkipati SR, d'Avila A, Soejima K, et al. Long&#x2010;term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy. Circ&#xa0;Arrhyt&#xa0;Electrophysiol. 2011;4:185&#x2010;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">21270104</ArticleId></ArticleIdList></Reference><Reference><Citation>Inada K, Seiler J, Roberts&#x2010;Thomson KC, et al. Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011;22:41&#x2010;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">20807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangeli P, Di Biase L, Lakkireddy D, et al. Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility. Heart Rhythm. 2010;7:1036&#x2010;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">20493276</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi M, Nogami A, Kurosaki K, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy and apical aneurysm. JACC&#xa0;Clin Electrophysiol. 2018;4:339&#x2010;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">30089559</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeemah QJ, Komatsu Y, Nogami A, et al. Catheter ablation of ventricular tachycardia in dilated&#x2010;phase hypertrophic cardiomyopathy: substrate characterization and ablation outcome. Pacing&#xa0;Clin&#xa0;Electrophysiol. 2022;45(6):773&#x2010;785. 10.1111/pace.14508</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14508</ArticleId><ArticleId IdType="pubmed">35430753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda A, Fukamizu S, Soejima K, et al. Clinical and electrophysiological characteristics in patients with sustained monomorphic reentrant ventricular tachycardia associated with dilated&#x2010;phase hypertrophic cardiomyopathy. Europace. 2012;14:734&#x2010;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">22048994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic cardiomyopathy with left ventricular apical aneurysm. J Am Coll Cardiol. 2017;69:761&#x2010;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">28209216</ArticleId></ArticleIdList></Reference><Reference><Citation>Matoh F, Satoh H, Shiraki K, et al. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Card Failure. 2007;13:372&#x2010;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">17602984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hocini M, Ramirez FD, Szumowski &#x141;, et al. Purkinje triggers of ventricular fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2021;32:2987&#x2010;2994.</Citation><ArticleIdList><ArticleId IdType="pubmed">34453363</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39002088</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1912</ISSN><JournalIssue CitedMedium="Internet"><Volume>397</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Naunyn-Schmiedeberg's archives of pharmacology</Title><ISOAbbreviation>Naunyn Schmiedebergs Arch Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a double-blind randomized controlled trial.</ArticleTitle><Pagination><StartPage>10191</StartPage><EndPage>10201</EndPage><MedlinePgn>10191-10201</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00210-024-03224-2</ELocationID><Abstract><AbstractText>Sodium-glucose transporter 2 (SGLT2) inhibitors such as empagliflozin are one of the main treatments for type 2 diabetes mellitus (DM2) and heart failure (HF). They have also demonstrated anti-arrhythmic effects in some preclinical and clinical studies. The purpose of this study was to assess the effects of empagliflozin on ventricular arrhythmias in HF patients with an implantable cardioverter-defibrillator (ICD). In a prospective double-blinded, randomized controlled trial of Iran County, Mashhad (72 patients 1:1), we compared the frequency and proportion of ventricular arrhythmias and ICD therapies during the 24&#xa0;weeks to the prior 24&#xa0;weeks. Results revealed that empagliflozin significantly reduced the frequency and proportion of ventricular tachycardia (VT)/fibrillation (VF) episodes (P&#x2009;=&#x2009;0.019 and 0.039, respectively). Moreover, it tended to reduce the frequency and proportion of ICD therapies, including anti-tachycardia pacing (ATP) and shock. Subgroup analysis of patients with or without any antiarrhythmic drugs (digoxin, mexiletine, amiodarone, or sotalol) revealed that only patients who were previously on the antiarrhythmic drugs benefit from empagliflozin antiarrhythmic effects. In conclusion, empagliflozin exhibits anti-arrhythmic effects in HF patients with an ICD. Larger and long-term clinical studies are still needed to investigate and confirm all positive effects of SGLT2 inhibitors in this regard. Trial registration number: IRCT20120520009801N7 (Approval date: June 11, 2022).</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abedi</LastName><ForeName>Farshad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadpour</LastName><ForeName>Amir Hooshang</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghavami</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heidari-Bakavoli</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jomezadeh</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. JomehzadehV@mums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tayyebi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Tayyebim@mums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Naunyn Schmiedebergs Arch Pharmacol</MedlineTA><NlmUniqueID>0326264</NlmUniqueID><ISSNLinking>0028-1298</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>HDC1R2M35U</RegistryNumber><NameOfSubstance UI="C570240">empagliflozin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005960">Glucosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001559">Benzhydryl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005960" MajorTopicYN="Y">Glucosides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="Y">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001559" MajorTopicYN="Y">Benzhydryl Compounds</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Empagliflozin</Keyword><Keyword MajorTopicYN="N">ICD</Keyword><Keyword MajorTopicYN="N">SGLT2 inhibitor</Keyword><Keyword MajorTopicYN="N">Shock</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmia</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval: The local Ethics Committee of Mashhad University of Medical Sciences (MUMS) approved the study protocol (reference number: IR.MUMS.REC.1401.052) and registered it on the Iranian registry of clinical trials as IRCT20120520009801N7 (approval date: June 11, 2022). All participants were explained and informed of the protocol of the study and signed written consent forms. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>21</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>14</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>13</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39002088</ArticleId><ArticleId IdType="doi">10.1007/s00210-024-03224-2</ArticleId><ArticleId IdType="pii">10.1007/s00210-024-03224-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Azam MA, Chakraborty P, Si D, Du B, Mass&#xe9; S, Lai PF, Ha AC, Nanthakumar K (2021) Anti-arrhythmic and inotropic effects of empagliflozin following myocardial ischemia. Life Sci 276:119440</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119440</ArticleId><ArticleId IdType="pubmed">33781832</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtain JP, Docherty KF, Jhund PS, Petrie MC, Inzucchi SE, K&#xf8;ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS (2021) Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF. Eur Heart J 42:3727&#x2013;3738</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab560</ArticleId><ArticleId IdType="pubmed">34448003</ArticleId><ArticleId IdType="pmc">8455345</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes GC, Fernandes A, Cardoso R, Penalver J, Knijnik L, Mitrani RD, Myerburg RJ, Goldberger JJ (2021) Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: a meta-analysis of 34 randomized controlled trials. Heart Rhythm 18:1098&#x2013;1105</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.03.028</ArticleId><ArticleId IdType="pubmed">33757845</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J (2020) Placebo-controlled, double-blind study of empagliflozin (EMPA) and implantable cardioverter-defibrillator (EMPA-ICD) in patients with type 2 diabetes (T2DM): rationale and design. Diabetes Ther 11:2739&#x2013;2755</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13300-020-00924-9</ArticleId><ArticleId IdType="pubmed">32968947</ArticleId><ArticleId IdType="pmc">7547938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghzally Y, Mahajan K (2023) Implantable Defibrillator. StatPearls Publishing, Treasure Island (FL). https://europepmc.org/article/nbk/nbk459196 . Accessed 31 Oct 2017</Citation></Reference><Reference><Citation>Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79:e263&#x2013;e421</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.012</ArticleId><ArticleId IdType="pubmed">35379503</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y, Yang R, Chen W, Ye Q (2022) Anti-arrhythmic effects of sodium-glucose co-transporter 2 inhibitors. Front Pharmacol 13:898718</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.898718</ArticleId><ArticleId IdType="pubmed">35814223</ArticleId><ArticleId IdType="pmc">9263384</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna VK, Khanna VK (2016) Implantable cardioverter defibrillators. Implantable Medical Electronics: Prosthetics, Drug Delivery, and Health Monitoring 293&#x2013;307</Citation></Reference><Reference><Citation>Kheiri B, Barbarawi M, Zayed Y, Hicks M, Osman M, Rashdan L, Kyi HH, Bachuwa G, Hassan M, Stecker EC (2019) Antiarrhythmic drugs or catheter ablation in the management of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Circ: Arrhythm Electrophysiol 12:e007600</Citation></Reference><Reference><Citation>Kolesnik E, Scherr D, Rohrer U, Benedikt M, Manninger M, Sourij H, von Lewinski D (2022) SGLT2 inhibitors and their antiarrhythmic properties. Int J Mol Sci 23:1678</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031678</ArticleId><ArticleId IdType="pubmed">35163599</ArticleId><ArticleId IdType="pmc">8835896</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AH, Aronow WS (2019) Prevention of recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators&#x2014;a network meta-analysis. Am J Ther 26:e469&#x2013;e480</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000000928</ArticleId><ArticleId IdType="pubmed">30946044</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B&#xf6;hm M, Burri H, Butler J, &#x10c;elutkien&#x117; J, Chioncel O (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 42:3599&#x2013;3726</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab368</ArticleId><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurray JJ, Solomon SD, Inzucchi SE, K&#xf8;ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B&#x11b;lohl&#xe1;vek J (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995&#x2013;2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1911303</ArticleId><ArticleId IdType="pubmed">31535829</ArticleId></ArticleIdList></Reference><Reference><Citation>Noyes K, Corona E, Veazie P, Dick AW, Zhao H, Moss AJ (2009) Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II. Am J Cardiovasc Drugs 9:393&#x2013;400</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11317980-000000000-00000</ArticleId><ArticleId IdType="pubmed">19929037</ArticleId><ArticleId IdType="pmc">4743243</ArticleId></ArticleIdList></Reference><Reference><Citation>Paasche A, Wiedmann F, Kraft M, Seibertz F, Herlt V, Blochberger PL, J&#xe1;vorszky N, Beck M, Weirauch L, Seeger T (2024) Acute antiarrhythmic effects of SGLT2 inhibitors&#x2013;dapagliflozin lowers the excitability of atrial cardiomyocytes. Basic Res Cardiol 119:93&#x2013;112</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-023-01022-0</ArticleId><ArticleId IdType="pubmed">38170280</ArticleId><ArticleId IdType="pmc">10837223</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383:1413&#x2013;1424</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2022190</ArticleId><ArticleId IdType="pubmed">32865377</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz SM, Massa C, Grzbiela A, Dengler W, Wiedemann G, Pauli P (2013) Implantable cardioverter defibrillator shocks are prospective predictors of anxiety. Heart Lung 42:105&#x2013;111</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2012.08.006</ArticleId><ArticleId IdType="pubmed">23110854</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva dos Santos D, Tura&#xe7;a LT, Coutinho KCdS, Barbosa RAQ, Polidoro JZ, Kasai-Brunswick TH, Campos de Carvalho AC, Girardi ACC (2023) Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1. Sci Rep 13:8689</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-35944-5</ArticleId><ArticleId IdType="pubmed">37248416</ArticleId><ArticleId IdType="pmc">10226982</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiles M (2019) Implantable cardioverter-defibrillators: Optimal programming. Up to Date</Citation></Reference><Reference><Citation>Vallon V (2015) The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu Rev Med 66:255&#x2013;270</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-051013-110046</ArticleId><ArticleId IdType="pubmed">25341005</ArticleId></ArticleIdList></Reference><Reference><Citation>von Lewinski D, Tripolt NJ, Sourij H, Pferschy PN, Oulhaj A, Alber H, Gwechenberger M, Martinek M, Seidl S, Moertl D (2022) Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial)&#x2013;a phase III study. Am Heart J 246:152&#x2013;160</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2022.01.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Liu Y, Wei X, Zhang X, Ye Y, Li W, Su X (2022) Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: a mini review. Front Cardiovasc Med 9:915455</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.915455</ArticleId><ArticleId IdType="pubmed">36003915</ArticleId><ArticleId IdType="pmc">9393294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C (2018) Ranolazine in high-risk patients with implanted cardioverter-defibrillators: the RAID trial. J Am Coll Cardiol 72:636&#x2013;645</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.04.086</ArticleId><ArticleId IdType="pubmed">30071993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35475882</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Mechanical Power during General Anesthesia and Postoperative Respiratory Failure: A Multicenter Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>54</EndPage><MedlinePgn>41-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004256</ELocationID><Abstract><AbstractText Label="BACKGROUND">Mechanical power during ventilation estimates the energy delivered to the respiratory system through integrating inspiratory pressures, tidal volume, and respiratory rate into a single value. It has been linked to lung injury and mortality in the acute respiratory distress syndrome, but little evidence exists regarding whether the concept relates to lung injury in patients with healthy lungs. This study hypothesized that higher mechanical power is associated with greater postoperative respiratory failure requiring reintubation in patients undergoing general anesthesia.</AbstractText><AbstractText Label="METHODS">In this multicenter, retrospective study, 230,767 elective, noncardiac adult surgical out- and inpatients undergoing general anesthesia between 2008 and 2018 at two academic hospital networks in Boston, Massachusetts, were included. The risk-adjusted association between the median intraoperative mechanical power, calculated from median values of tidal volume (Vt), respiratory rate (RR), positive end-expiratory pressure (PEEP), plateau pressure (Pplat), and peak inspiratory pressure (Ppeak), using the following formula: mechanical power (J/min) = 0.098 &#xd7; RR &#xd7; Vt &#xd7; (PEEP + &#xbd;[Pplat - PEEP] + [Ppeak - Pplat]), and postoperative respiratory failure requiring reintubation within 7 days, was assessed.</AbstractText><AbstractText Label="RESULTS">The median intraoperative mechanical power was 6.63 (interquartile range, 4.62 to 9.11) J/min. Postoperative respiratory failure occurred in 2,024 (0.9%) patients. The median (interquartile range) intraoperative mechanical power was higher in patients with postoperative respiratory failure than in patients without (7.67 [5.64 to 10.11] vs. 6.62 [4.62 to 9.10] J/min; P &lt; 0.001). In adjusted analyses, a higher mechanical power was associated with greater odds of postoperative respiratory failure (adjusted odds ratio, 1.31 per 5 J/min increase; 95% CI, 1.21 to 1.42; P &lt; 0.001). The association between mechanical power and postoperative respiratory failure was robust to additional adjustment for known drivers of ventilator-induced lung injury, including tidal volume, driving pressure, and respiratory rate, and driven by the dynamic elastic component (adjusted odds ratio, 1.35 per 5 J/min; 95% CI, 1.05 to 1.73; P = 0.02).</AbstractText><AbstractText Label="CONCLUSIONS">Higher mechanical power during ventilation is statistically associated with a greater risk of postoperative respiratory failure requiring reintubation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, the American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santer</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wachtendorf</LastName><ForeName>Luca J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Anesthesiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suleiman</LastName><ForeName>Aiman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houle</LastName><ForeName>Timothy T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fassbender</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Anesthesiology, Intensive Care Medicine, Pain and Palliative Care, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Herne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Eduardo L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Laboratory of Pneumology LIM-09, Department of Pneumology, Heart Institute (Incor), Hospital of the Medical College of the University of S&#xe3;o Paulo, Brazil; Research and Education Institute, Hospital S&#xed;rio-Libanes, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talmor</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eikermann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York; Department of Anaesthesiology and Intensive Care Medicine, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baedorf-Kassis</LastName><ForeName>Elias</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary and Critical Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaefer</LastName><ForeName>Maximilian S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Anesthesiology, Duesseldorf University Hospital, Duesseldorf, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2022 Jul 1;137(1):6-8. doi: 10.1097/ALN.0000000000004240.</RefSource><PMID Version="1">35560172</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055397" MajorTopicYN="Y">Ventilator-Induced Lung Injury</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>12</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35475882</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004256</ArticleId><ArticleId IdType="pii">136245</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29270467</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2405-500X</ISSN><JournalIssue CitedMedium="Print"><Volume>3</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Efficacy of Stellate Ganglion Blockade in Managing Electrical Storm: A Systematic Review.</ArticleTitle><Pagination><StartPage>942</StartPage><EndPage>949</EndPage><MedlinePgn>942-949</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2017.06.006</ELocationID><Abstract><AbstractText Label="BACKGROUND">The efficacy of percutaneous stellate ganglion block (SGB) for managing electrical storm (ES) is not well understood.</AbstractText><AbstractText Label="OBJECTIVE">To characterize the efficacy of SGB as a treatment for ES.</AbstractText><AbstractText Label="METHODS">We conducted literature searches using PubMed/Medline and Google Scholar, for mixed combinations of terms including "stellate ganglion block", *ganglion block (ade)", "sympathetic block (ade)" and "arrhythmia", "ventricular arrhythmia (VA)" or "tachycardia" (VT), "ventricular fibrillation" (VF), "electrical storm". Inclusion criteria were presentation with guideline-defined ES and treatment with SGB. Exclusion criteria: presentation with any supraventricular arrhythmia, VA without ES, or surgical sympathectomy. Studies lacking basic demographic data, arrhythmia description, and outcomes were excluded.</AbstractText><AbstractText Label="RESULTS">Of 3,374 publications reviewed, 38 patients from 23 studies met study criteria (52 &#xb1; 19.1 years, 11 F, 17 with ischemic cardiomyopathy). Anti-arrhythmics were used in all patients. Mean Left ventricular ejection fraction was 31 &#xb1; 10%. ES was triggered by acute myocardial infarction in 15 patients and QT prolongation in 7 patients. The most common local anesthetic used for SGB was bupivacaine (0.25-0.5%). SGB resulted in a significant decrease in VA burden (12.4&#xb1;8.8 vs. 1.04&#xb1;2.12 episodes/day, p&lt; 0.001) and number of external and ICD shocks (10.0&#xb1;9.1 vs. 0.05&#xb1;0.22 shocks/day, p&lt; 0.01). Following SGB, 80.6% of patients survived to discharge.</AbstractText><AbstractText Label="CONCLUSION">SGB is an effective acute treatment for ES. However, larger prospective randomized studies are needed to better understand the role of SGB in ES and other VAs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Lingjin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chi-Hong</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shivkumar</LastName><ForeName>Kalyanam</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajijola</LastName><ForeName>Olujimi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP2 HL142045</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 HL125730</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL084261</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>Y8335394RO</RegistryNumber><NameOfSubstance UI="D002045">Bupivacaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001340" MajorTopicYN="N">Autonomic Nerve Block</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002045" MajorTopicYN="N">Bupivacaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013233" MajorTopicYN="N">Stellate Ganglion</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018084" MajorTopicYN="N">Ultrasonography, Interventional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Stellate ganglion block</Keyword><Keyword MajorTopicYN="N">autonomic nervous system</Keyword><Keyword MajorTopicYN="N">electrical storm</Keyword><Keyword MajorTopicYN="N">neuromodulation</Keyword><Keyword MajorTopicYN="N">sympathetic nerves</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29270467</ArticleId><ArticleId IdType="mid">NIHMS902084</ArticleId><ArticleId IdType="pmc">PMC5734652</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2017.06.006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Heart Rhythm. 2009;6:886&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pubmed">19467519</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao D, Sapp JL. Electrical storm: definitions, clinical importance, and treatment. Curr Opin Cardiol. 2013;28:72&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23160339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death,&#xc4;&#xee;executive summaryA report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. European Heart Journal. 2006;27:2099&#x2013;2140.</Citation><ArticleIdList><ArticleId IdType="pubmed">16923744</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circulation research. 2014;114:1004&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">24625726</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivkumar K, Ajijola OA, Anand I, et al. Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. J Physiol. 2016;594:3911&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945719</ArticleId><ArticleId IdType="pubmed">27114333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Lellouche N, Bourke T, et al. Bilateral Cardiac Sympathetic Denervation for the Management of Electrical Storm. Journal of the American College of Cardiology. 2012;59:91&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3470807</ArticleId><ArticleId IdType="pubmed">22192676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Vaseghi M, Mahajan A, Shivkumar K. Bilateral cardiac sympathetic denervation: why, who and when? Expert review of cardiovascular therapy. 2012;10:947&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551540</ArticleId><ArticleId IdType="pubmed">23030281</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi M, Gima J, Kanaan C, et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart rhythm. 2014;11:360&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4253031</ArticleId><ArticleId IdType="pubmed">24291775</ArticleId></ArticleIdList></Reference><Reference><Citation>Collura CA, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm. 2009;6:752&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19467503</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Liu Y, Yang F, Jiang G, Li C, Hu D, et al. Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome. Ann Thorac Surg. 2008;6:1955&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19022016</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;16:903&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">5112730</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitter-Hauge S, Storstein O. Surgical treatment of recurrent ventricular tachycardia. Br Heart J. 1973;11:1132&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC458767</ArticleId><ArticleId IdType="pubmed">4761114</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;15:1826&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">15051644</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz PJ, Zaza A, Locati E, Moss AJ. Stress and sudden death. The case of the long QT syndrome. Circulation. 1991;83:II71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">2009631</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagini A, Sabino F, Paladini G, et al. Treatment of perinfarction recurrent ventricular fibrillation by percutaneous pharmacological block of left stellate ganglion. Clin Cardiol. 1985;8:111&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3971606</ArticleId></ArticleIdList></Reference><Reference><Citation>Boe BA, Webster G, Asher Y, Tsao S, Suresh S, Steinhorn DM. Percutaneous, ultrasound-guided stellate ganglion nerve block suppresses recurrent ventricular fibrillation in an infant awaiting heart transplant. Circulation Arrhythmia and electrophysiology. 2012;5:e93&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">23074329</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadhinglajkar S, Sreedhar R, Unnikrishnan M, Namboodiri N. Electrical storm: Role of stellate ganglion blockade and anesthetic implications of left cardiac sympathetic denervation. Indian J Anaesth. 2013;57:397&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3800335</ArticleId><ArticleId IdType="pubmed">24163457</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Moran E, Sandin-Fuentes MG, Alvarez Lopez JC, Duro-Aguado I, Uruena-Martinez N, Hernandez-Luis C. Electrical storm secondary to acute myocardial infarction and heart failure treated with left stellate ganglion block. Rev Esp Cardiol. 2013;66:595&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24776216</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Moran E, Sliwinski-Herrera F, Cortes-Villar C, Sandin-Fuentes M, Pastor Baez G, San Roman A. Refractory Electrical Storm: A Role for Transient Sympathetic Blockade. Rev Esp Cardiol. 2016;69:76&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26699097</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman MA. Cardiac arrhythmias in acute central nervous system disease. Successful management with stellate ganglion block. Arch Intern Med. 1976;136:203&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">1247352</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayase J, Patel J, Narayan SM, Krummen DE. Percutaneous stellate ganglion block suppressing VT and VF in a patient refractory to VT ablation. Journal of cardiovascular electrophysiology. 2013;24:926&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733785</ArticleId><ArticleId IdType="pubmed">23574305</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoepp HW, Eggeling T, Hombach V. Pharmacologic blockade of the left stellate ganglion using a drug-reservoir-pump system. Chest. 1990;97:250&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">1967234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulata DF, Le-Wendling L, Boezaart AP, Hurley RW. Stellate ganglion local anesthetic blockade and neurolysis for the treatment of refractory ventricular fibrillation. A A Case Rep. 2015;4:49&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">25730409</ArticleId></ArticleIdList></Reference><Reference><Citation>Loyalka P, Hariharan R, Gholkar G, et al. Left stellate ganglion block for continuous ventricular arrhythmias during percutaneous left ventricular assist device support. Tex Heart Inst J. 2011;38:409&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3147196</ArticleId><ArticleId IdType="pubmed">21841870</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AA, Khan AA, Dingmann K, et al. Percutaneous inferior cervical sympathetic ganglion blockade for the treatment of ventricular tachycardia storm: case report and review of the literature. J Vasc Interv Neurol. 2014;7:48&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4280879</ArticleId><ArticleId IdType="pubmed">25566341</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesa A, Kaplan RF. Dysrhythmias controlled with stellate ganglion block in a child with diabetes and a variant of long QT syndrome. Reg Anesth. 1993;18:60&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">8095401</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair L, Tseng PS, Manninen PH, Teo WS. Anaesthetic management of idiopathic long QT syndrome--a case report. Ann Acad Med Singapore. 1994;23:582&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">7979136</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen H, Badskjaer J. Blockade of the left stellate ganglion. Treatment of ventricular arrhythmias in secondary QT prolongation. Ugeskr Laeger. 1986;148:3221&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3810919</ArticleId></ArticleIdList></Reference><Reference><Citation>Parris WC, Reddy BC, White HW, McGrath DM. Stellate ganglion blocks in pediatric patients. Anesth Analg. 1991;72:552&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">2006747</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel RA, Priore DL, Szeto WY, Slevin KA. Left stellate ganglion blockade for the management of drug-resistant electrical storm. Pain Med. 2011;12:1196&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21692973</ArticleId></ArticleIdList></Reference><Reference><Citation>Platia EV, Griffith LS, Watkins L, Mirowski M, Mower MM, Reid PR. Management of the prolonged QT syndrome and recurrent ventricular fibrillation with an implantable automatic cardioverter-defibrillator. Clin Cardiol. 1985;8:490&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">4042451</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu MA, Prasad SB, Abhilash SP, Thajudeen A, R BK, Namboodiri N. Left sympathetic cardiac denervation in managing electrical storm: acute outcome and long term follow up. J Interv Card Electrophysiol. 2016;47:285&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">27318998</ArticleId></ArticleIdList></Reference><Reference><Citation>Scanlon MM, Gillespie SM, Schaff HV, Cha YM, Wittwer ED. Urgent Ultrasound-Guided Bilateral Stellate Ganglion Blocks in a Patient With Medically Refractory Ventricular Arrhythmias. Crit Care Med. 2015;43:e316&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25978339</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DI, Jones C, Morris GK, Kralovic S, Massey HT, Sifain A. Trial ultrasound-guided continuous left stellate ganglion blockade before surgical gangliolysis in a patient with a left ventricular assist device and intractable ventricular tachycardia: a pain control application to a complex hemodynamic condition. Asaio J. 2015;61:104&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25303796</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan AY, Abdi S, Buxton AE, Anter E. Percutaneous stellate ganglia block for acute control of refractory ventricular tachycardia. Heart rhythm. 2012;9:2063&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22863887</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudim M, Boortz-Marx R, Patel CB, Sun AY, Piccini JP. Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks. J Cardiovasc Electrophysiol. 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">28019045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudim M, Boortz-Marx R, Patel CB, Sun AY, Piccini JP. Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks. Journal of cardiovascular electrophysiology. 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">28019045</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivkumar K, Ajijola OA, Anand I, et al. Clinical neurocardiology-defining the value of neuroscience-based cardiovascular therapeutics. J Physiol. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945719</ArticleId><ArticleId IdType="pubmed">27114333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardell JL, Andresen MC, Armour JA, et al. Translational Neurocardiology: preclinical models and cardioneural integrative aspects. J Physiol. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945715</ArticleId><ArticleId IdType="pubmed">27098459</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y, Wang L, Wang X, Tang Y, Cao F, Fang Y. Assessment of ventricular electrophysiological characteristics at periinfarct zone of postmyocardial infarction in rabbits following stellate ganglion block. J Cardiovasc Electrophysiol. 2012;23:S29&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">22994966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipes DP, Rubart M. Neural modulation of cardiac arrhythmias and sudden cardiac death. Heart Rhythm. 2006;3:108&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566299</ArticleId><ArticleId IdType="pubmed">16399065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Jung BC, Tan AY, Trang VQ, Gholmieh G, Han SW, et al. Spontaneous stellate ganglion nerve activity and ventricular arrhythmia in a canine model of sudden death. Heart Rhythm. 2008;5:131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18055272</ArticleId></ArticleIdList></Reference><Reference><Citation>Doytchinova A, Patel J, Zhou S, Chen LS, Lin H, Shen C, et al. Subcutaneous nerve activity and spontaneous ventricular arrhythmias in ambulatory dogs. Heart Rhythm. 2015;12:612&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4339615</ArticleId><ArticleId IdType="pubmed">25460171</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Yagishita D, Patel KJ, et al. Focal myocardial infarction induces global remodeling of cardiac sympathetic innervation: neural remodeling in a spatial context. American journal of physiology Heart and circulatory physiology. 2013;305:H1031&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3798751</ArticleId><ArticleId IdType="pubmed">23893167</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi M, Yamakawa K, Sinha A, et al. Modulation of regional dispersion of repolarization and T-peak to T-end interval by the right and left stellate ganglia. American journal of physiology Heart and circulatory physiology. 2013;305:H1020&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3798747</ArticleId><ArticleId IdType="pubmed">23893168</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagishita D, Chui RW, Yamakawa K, et al. Sympathetic Nerve Stimulation, Not Circulating Norepinephrine, Modulates T-Peak to T-End Interval by Increasing Global Dispersion of Repolarization. Circulation Arrhythmia and electrophysiology. 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4405126</ArticleId><ArticleId IdType="pubmed">25532528</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori SG, Corr PB. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. The American journal of physiology. 1990;258:H1796&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">2163219</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori SG, Mantica M, Schwartz PJ. Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation. Circulation. 1988;78:178&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">3383403</ArticleId></ArticleIdList></Reference><Reference><Citation>Irie T, Yamakawa K, Hamon D, Nakamura K, Shivkumar K, Vaseghi M. Cardiac Sympathetic Innervation Via the Middle Cervical and Stellate Ganglia and Anti-Arrhythmic Mechanism of Bilateral Stellectomy. Am J Physiol Heart Circ Physiol. 2016 ajpheart 00644 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5402012</ArticleId><ArticleId IdType="pubmed">28011590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Lux RL, Khahera A, et al. Sympathetic Modulation of Electrical Activation In Normal and Infarcted Myocardium: Implications for Arrhythmogenesis. Am J Physiol Heart Circ Physiol. 2017 ajpheart 00575 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5402014</ArticleId><ArticleId IdType="pubmed">28087519</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68:1476&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">27216111</ArticleId></ArticleIdList></Reference><Reference><Citation>Janes RD, Brandys JC, Hopkins DA, Johnstone DE, Murphy DA, Armour JA. Anatomy of human extrinsic cardiac nerves and ganglia. The American journal of cardiology. 1986;57:299&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">3946219</ArticleId></ArticleIdList></Reference><Reference><Citation>Herring N, Cranley J, Lokale MN, et al. The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability. Journal of molecular and cellular cardiology. 2012;52:667&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3314977</ArticleId><ArticleId IdType="pubmed">22172449</ArticleId></ArticleIdList></Reference><Reference><Citation>Herring N, Lokale MN, Danson EJ, Heaton DA, Paterson DJ. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. Journal of molecular and cellular cardiology. 2008;44:477&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">17996892</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucker IH, Patel KP, Schultz HD. Neurohumoral stimulation. Heart failure clinics. 2012;8:87&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3224981</ArticleId><ArticleId IdType="pubmed">22108729</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HJ, Wang W, Cornish KG, Rozanski GJ, Zucker IH. Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure. Hypertension. 2014;64:745&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4162756</ArticleId><ArticleId IdType="pubmed">24980663</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31166234</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Association of Intraoperative Tidal Volumes and Acute Kidney Injury After Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>925</StartPage><EndPage>932</EndPage><MedlinePgn>925-932</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000004254</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with acute lung injury who received lower tidal volume (VT) ventilation had significantly fewer days with acute kidney injury (AKI) when compared to those receiving higher VTs. There is a paucity of studies on the relationship between intraoperative VTs and postoperative AKI in patients undergoing noncardiac surgery. We therefore sought to assess the association of mean delivered intraoperative VT per kilogram based on predicted body weight (PBW) and postoperative AKI.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study was conducted in a large tertiary multispecialty academic medical center. Adult patients who underwent noncardiac surgery between January 2005 and July 2016 under general anesthesia with endotracheal intubation and mechanical ventilation were included. A total of 41,224 patients were included in the study.The relationship between mean intraoperative VT per PBW and AKI was assessed using logistic regression, adjusting for prespecified potential confounding variables. The secondary outcomes were postoperative major pulmonary complications, myocardial injury after noncardiac surgery (MINS), and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">The incidence of AKI was 10.9% in the study population. Postoperative renal replacement therapy was required in 0.1% of patients. Higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of AKI. The estimated odds ratio for each 1 mL increase in VT per kilogram of PBW (1 unit) was 1.05 (95% confidence interval [CI], 1.02-1.08; P = .001), after adjusting for potential confounding variables. A higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of postoperative myocardial injury and was not significantly associated with major postoperative pulmonary complications or in-hospital mortality after noncardiac surgery.</AbstractText><AbstractText Label="CONCLUSIONS">In adult patients undergoing noncardiac surgery, higher delivered mean intraoperative VTs per PBW are associated with an increased odds of developing AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Argalious</LastName><ForeName>Maged Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesiology and the Center for Anesthesiology Education, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Guangmei</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Rajeev Krishnaney</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bhavani</LastName><ForeName>Sekar</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006335" MajorTopicYN="N">Heart Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="Y">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31166234</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000004254</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33332854</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2154-4212</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Female pelvic medicine &amp; reconstructive surgery</Title><ISOAbbreviation>Female Pelvic Med Reconstr Surg</ISOAbbreviation></Journal><ArticleTitle>Timing and Success of Postoperative Voiding Trial After Colpocleisis With and Without Concomitant Midurethral Sling.</ArticleTitle><Pagination><StartPage>e608</StartPage><EndPage>e613</EndPage><MedlinePgn>e608-e613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SPV.0000000000000996</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aim of this study was to compare failure rates of first voiding trial (VT) within 7 days and on postoperative day (POD) 1 after colpocleisis with versus without concomitant midurethral sling (MUS). Predictors of POD 1 VT failure were also examined.</AbstractText><AbstractText Label="METHODS">This was a retrospective cohort study of women undergoing colpocleisis from January 2012 to October 2019 comparing VT outcomes with versus without MUS. Primary outcome was first VT failure within 7 days; outcomes of VTs performed on POD 1 were also assessed. Association between MUS and VT failure and predictors of POD 1 VT failure were assessed via logistic regression.</AbstractText><AbstractText Label="RESULTS">Of 119 women, 45.4% had concomitant MUS. First VT was performed on mean POD 3.1 &#xb1; 2.2 in the MUS group versus POD 1.8 &#xb1; 1.8 in the no MUS group (P &lt; 0.01). The MUS group was less likely to undergo POD 1 VT (50% vs 83%, P &lt; 0.01). Failure of the first VT did not differ (22.2% with MUS vs 32.8% without MUS, P = 0.20); no association between VT failure and MUS was noted (adjusted odds ratio [aOR], 0.6; 95% confidence interval [CI], 0.18-2.1). There were 68.1% (81/119) of participants who underwent POD 1 VT, MUS was performed in 33.3% (27/81). The POD 1 failure did not differ between those with 33.3% versus 40.7% without MUS (P = 0.52). Midurethral sling was not associated with POD 1 VT failure (aOR, 0.93; 95% CI, 0.27-3.23). In women undergoing POD 1 VT, preoperative postvoid residual was associated with VT failure (aOR, 1.39; 95% CI, 1.01-1.92).</AbstractText><AbstractText Label="CONCLUSIONS">In women undergoing colpocleisis, MUS was not associated with VT failure within 7 days or on POD 1. Increased preoperative postvoid residual was associated with POD 1 VT failure.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Urogynecologic Society. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>T Clark</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>From the Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Isuzu</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chee Paul</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Center for Clinical and Translational Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipking</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Holly E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>From the Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12 HD001258</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Female Pelvic Med Reconstr Surg</MedlineTA><NlmUniqueID>101528690</NlmUniqueID><ISSNLinking>2151-8378</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020884" MajorTopicYN="N">Colpotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053825" MajorTopicYN="N">Suburethral Slings</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016055" MajorTopicYN="N">Urinary Retention</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014596" MajorTopicYN="N">Uterine Prolapse</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>17</Day><Hour>17</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33332854</ArticleId><ArticleId IdType="mid">NIHMS1637725</ArticleId><ArticleId IdType="pmc">PMC8203756</ArticleId><ArticleId IdType="doi">10.1097/SPV.0000000000000996</ArticleId><ArticleId IdType="pii">01436319-900000000-99274</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hullfish KL, Bovbjerg VE, Steers WD. Colpocleisis for pelvic organ prolapse: patient goals, quality of life, and satisfaction. Obstetrics and gynecology. August2007;110(2 Pt 1):341&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">17666609</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadsworth K, Lovatsis D. A qualitative study of women&#x2019;s values and decision-making surrounding LeFort colpocleisis. International urogynecology journal. September 9 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31501943</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald MP, Richter HE, Bradley CS, et al.Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. International urogynecology journal and pelvic floor dysfunction. December2008;19(12):1603&#x2013;1609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3691385</ArticleId><ArticleId IdType="pubmed">18690402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AJ, Walters MD, Unger CA. Perioperative adverse events associated with colpocleisis for uterovaginal and posthysterectomy vaginal vault prolapse. American journal of obstetrics and gynecology. April2016;214(4):501.e501&#x2013;501.e506.</Citation><ArticleIdList><ArticleId IdType="pubmed">26529371</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore RD, Miklos JR. Colpocleisis and tension-free vaginal tape sling for severe uterine and vaginal prolapse and stress urinary incontinence under local anesthesia. The Journal of the American Association of Gynecologic Laparoscopists. May2003;10(2):276&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">12732784</ArticleId></ArticleIdList></Reference><Reference><Citation>Suskind AM, Jin C, Walter LC, Finlayson E. Frailty and the Role of Obliterative versus Reconstructive Surgery for Pelvic Organ Prolapse: A National Study. The Journal of urology. June 2017;197(6):1502&#x2013;1506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472344</ArticleId><ArticleId IdType="pubmed">27939512</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonathan Vespa DMA, and Lauren Medina. Demographic Turning Points for the United States:
Population Projections for 2020 to 2060. United
States Census Bureau Report Number P25&#x2013;1144.
2020. https://www.census.gov/library/publications/2020/demo/p25-1144.html#:~:text=The%20year%202030%20marks%20a%20demographic%20turning%20point%20for%20the%20United%20States.&amp;text=Despite%20slowing%20population%20growth%2C%20particularly,400%20million%20threshold%20in%202058.</Citation></Reference><Reference><Citation>Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. April 1997;89(4):501&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">9083302</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall LL, Hewitt JK. Urodynamic characteristics of women with complete posthysterectomy vaginal vault prolapse. Urology. September 1994;44(3):336&#x2013;341; discussion 341&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">8073549</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanzi LJ, Chaikin DC, Blaivas JG. The effect of genital prolapse on voiding. The Journal of urology. February 1999;161(2):581&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">9915453</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates KW, Harris RL, Cundiff GW, Bump RC. Uroflowmetry in women with urinary incontinence and pelvic organ prolapse. British journal of urology. August1997;80(2):217&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">9284191</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasy S, Lowenstein L, Pham T, Mueller ER, Kenton K, Brubaker L. Urinary retention is uncommon after colpocleisis with concomitant mid-urethral sling. International urogynecology journal and pelvic floor dysfunction. February 2009;20(2):213&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">19002367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald MP, Kulkarni N, Fenner D. Postoperative resolution of urinary retention in patients with advanced pelvic organ prolapse. American journal of obstetrics and gynecology. December 2000;183(6):1361&#x2013;1363; discussion 1363&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pubmed">11120497</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanzarite T, Rambachan A, Mueller MG, Pilecki MA, Kim JY, Kenton K. Risk factors for 30-day perioperative complications after Le Fort colpocleisis. The Journal of urology. September2014;192(3):788&#x2013;792.</Citation><ArticleIdList><ArticleId IdType="pubmed">24641911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler TL, 2nd, Richter HE, Greer WJ, Bowling CB, Redden DT, Varner RE. Predictors of success with postoperative voiding trials after a mid urethral sling procedure. The Journal of urology. February2008;179(2):600&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">18082219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutone N, Brizendine E, Hale D. Factors that influence voiding function after the tension-free vaginal tape procedure for stress urinary incontinence. American journal of obstetrics and gynecology. June2003;188(6):1477&#x2013;1481; discussion 1481&#x2013;1473.</Citation><ArticleIdList><ArticleId IdType="pubmed">12824981</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakvoort RA, Dijkgraaf MG, Burger MP, Emanuel MH, Roovers JP. Predicting short-term urinary retention after vaginal prolapse surgery. Neurourology and urodynamics. 2009;28(3):225&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">19130599</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol AI, Jelovsek JE, Walters MD, Paraiso MF, Barber MD. Incidence and predictors of prolonged urinary retention after TVT with and without concurrent prolapse surgery. American journal of obstetrics and gynecology. May 2005;192(5):1537&#x2013;1543.</Citation><ArticleIdList><ArticleId IdType="pubmed">15902154</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatkin-Margolis A, Yook E, Hill AM, et al.Self-Removal of a Urinary Catheter After Urogynecologic Surgery: A Randomized Controlled Trial. Obstetrics and gynecology. November2019;134(5):1027&#x2013;1036.</Citation><ArticleIdList><ArticleId IdType="pubmed">31599827</ArticleId></ArticleIdList></Reference><Reference><Citation>Behbehani S, Pham T, Kunze K, Wasson M, Yi J. Voiding Trial in Office after Unsuccessful Voiding Trial in Postoperative Unit: How Many More Days Is Enough? Journal of minimally invasive gynecology. Nov-Dec 2019;26(7):1376&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pubmed">30826451</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong B, Park S, Kim HS, Choo MS. Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence. The Journal of urology. September 2003;170(3):852&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">12913715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yune JJ, Cheng JW, Wagner H, Kim J, Hardesty JS, Siddighi S. Postoperative urinary retention after pelvic organ prolapse repair: Vaginal versus robotic transabdominal approach. Neurourology and urodynamics. June 2018;37(5):1794&#x2013;1800.</Citation><ArticleIdList><ArticleId IdType="pubmed">29572921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hengel AR, Carlson KV, Baverstock RJ. Prevention, diagnosis, and management of midurethral mesh sling complications. Canadian Urological Association journal = Journal de l&#x2019;Association des urologues du Canada. June2017;11(6Suppl2):S135&#x2013;s140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5461146</ArticleId><ArticleId IdType="pubmed">28616113</ArticleId></ArticleIdList></Reference><Reference><Citation>Minassian VA, Al-Badr A, Drutz HP, Lovatsis D. Tension-free vaginal tape, Burch, and slings: are there predictors for early postoperative voiding dysfunction? International urogynecology journal and pelvic floor dysfunction. May-Jun 2004;15(3):183&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">15167998</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EA, Amundsen CL, Toh KL, Flynn BJ, Webster GD. Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling. The Journal of urology. June 2003;169(6):2234&#x2013;2237.</Citation><ArticleIdList><ArticleId IdType="pubmed">12771757</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller EJ, Hankins KJ, Parnell BA, Robinson BL, Dunivan GC. Diagnostic accuracy of retrograde and spontaneous voiding trials for postoperative voiding dysfunction: a randomized controlled trial. Obstetrics and gynecology. September2011;118(3):637&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">21860294</ArticleId></ArticleIdList></Reference><Reference><Citation>Karp NE, Kobernik EK, Kamdar NS, Fore AM, Morgan DM. Length of Catheter Use After Hysterectomy as a Risk Factor for Urinary Tract Infection. Female pelvic medicine &amp; reconstructive surgery. Nov-Dec 2018;24(6):430&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">28914703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutkin G, Alperin M, Meyn L, Wiesenfeld HC, Ellison R, Zyczynski HM. Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. International urogynecology journal. August2010;21(8):955&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pubmed">20354678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieter AA, Wu JM, Gage JL, Feliciano KM, Willis-Gray MG. Catheter burden following urogynecologic surgery. American journal of obstetrics and gynecology. November2019;221(5):507.e501&#x2013;507.e507.</Citation><ArticleIdList><ArticleId IdType="pubmed">31121138</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29694702</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-410X</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>BJU international</Title><ISOAbbreviation>BJU Int</ISOAbbreviation></Journal><ArticleTitle>WATER II (80-150 mL) procedural outcomes.</ArticleTitle><Pagination><StartPage>106</StartPage><EndPage>112</EndPage><MedlinePgn>106-112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bju.14360</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To present early safety and feasibility data from a multicentre prospective study (WATER II) of aquablation in the treatment of symptomatic men with large-volume benign prostatic hyperplasia (BPH).</AbstractText><AbstractText Label="METHODS">Between September and December 2017, 101 men with moderate-to-severe BPH symptoms and prostate volume of 80-150 mL underwent aquablation in a prospective multicentre international clinical trial. Baseline demographics and standardized postoperative management variables were carefully recorded in a central independently monitored database. Surgeons answered analogue scale questionnaires on intra-operative technical factors and postoperative management. Adverse events up to 1 month were adjudicated by an independent clinical events committee.</AbstractText><AbstractText Label="RESULTS">The mean (range) prostate volume was 107 (80-150) mL. The mean (range) operating time was 37 (15-97) min and aquablation resection time was 8 (3-15) min. Adequate adenoma resection was achieved with a single pass in 34 patients and with additional passes in 67 patients (mean 1.8 treatment passes), all in a single operating session. Haemostasis was achieved using either a Foley balloon catheter placed in the bladder under traction (n = 98, mean duration 18 h) or direct tamponade using a balloon inflated in the prostate fossa (n = 3, mean duration 15 h). No patient required electrocautery for haemostasis at the time of the primary procedure. The mean length of stay after the procedure was 1.6 days (range same day to 6 days). The Clavien-Dindo grade &#x2265;2 event rate observed at 1 month was 29.7%. Bleeding complications were recorded in 10 patients (9.9%) during the index procedure hospitalization prior to discharge, and included six (5.9%) peri-operative transfusions.</AbstractText><AbstractText Label="CONCLUSIONS">Aquablation is feasible and safe in treating men with men with large prostates (80-150 mL). The 6-month efficacy data are being accrued and will be presented in future publications (ClinicalTrials.gov number, NCT03123250).</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors BJU International &#xa9; 2018 BJU International Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Mihir</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3744-8234</Identifier><AffiliationInfo><Affiliation>Institute of Urology, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bidair</LastName><ForeName>Mo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>San Diego Clinical Trials, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhojani</LastName><ForeName>Naeem</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2679-2635</Identifier><AffiliationInfo><Affiliation>University of Montreal Hospital Centre, University of Montr&#xe9;al, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trainer</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Adult Paediatric Urology and Urogynecology, P.C., Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arther</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Adult Paediatric Urology and Urogynecology, P.C., Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramolowsky</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Virginia Urology, Richmond, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doumanian</LastName><ForeName>Leo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Urology, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elterman</LastName><ForeName>Dean</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Health Network University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>Ronald P</ForeName><Initials>RP</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Albany Medical College, Albany, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lingeman</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Indiana University Health Physicians, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krambeck</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Indiana University Health Physicians, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eure</LastName><ForeName>Gregg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Urology of Virginia, Virginia Beach, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badlani</LastName><ForeName>Gopal</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plante</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8874-9483</Identifier><AffiliationInfo><Affiliation>University of Vermont Medical Centre, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uchio</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>VA Long Beach Healthcare System, Long Beach, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gin</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>VA Long Beach Healthcare System, Long Beach, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldenberg</LastName><ForeName>Larry</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>So</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Mitch</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mayo Clinic Arizona, Scottsdale, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roehrborn</LastName><ForeName>Claus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Urology, UT Southwestern Medical Centre, University of Texas Southwestern, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motola</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zorn</LastName><ForeName>Kevin C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>University of Montreal Hospital Centre, University of Montr&#xe9;al, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03123250</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJU Int</MedlineTA><NlmUniqueID>100886721</NlmUniqueID><ISSNLinking>1464-4096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>059QF0KO0R</RegistryNumber><NameOfSubstance UI="D014867">Water</NameOfSubstance></Chemical></ChemicalList><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>BJU Int. 2019 Jan;123(1):2-3. doi: 10.1111/bju.14559.</RefSource><PMID Version="1">30565405</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Urol. 2019 Jul;202(1):12. doi: 10.1097/JU.0000000000000258.</RefSource><PMID Version="1">30925128</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D055011" MajorTopicYN="N">Ablation Techniques</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000236" MajorTopicYN="N">Adenoma</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019160" MajorTopicYN="N">Endosonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006488" MajorTopicYN="N">Hemostasis, Surgical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011467" MajorTopicYN="N">Prostate</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011470" MajorTopicYN="N">Prostatic Hyperplasia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053448" MajorTopicYN="N">Prostatism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014867" MajorTopicYN="Y">Water</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aquablation</Keyword><Keyword MajorTopicYN="N">benign prostatic hyperplasia</Keyword><Keyword MajorTopicYN="N">large prostates</Keyword><Keyword MajorTopicYN="N">robotics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29694702</ArticleId><ArticleId IdType="doi">10.1111/bju.14360</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37819047</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2047-2412</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>European heart journal. Cardiovascular Imaging</Title><ISOAbbreviation>Eur Heart J Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study).</ArticleTitle><Pagination><StartPage>188</StartPage><EndPage>198</EndPage><MedlinePgn>188-198</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjci/jead261</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Conducting channels (CCs) detected by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) are related to ventricular tachycardia (VT). The aim of this work was to study the ability of post-ablation LGE-CMR to evaluate ablation lesions.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This is a prospective study of consecutive patients referred for a scar-related VT ablation. LGE-CMR was performed 6-12 months prior to ablation and 3-6 months after ablation. Scar characteristics of pre- and post-ablation LGE-CMR were compared. During the study period (March 2019-April 2021), 61 consecutive patients underwent scar-related VT ablation after LGE-CMR. Overall, 12 patients were excluded (4 had poor-quality LGE-CMR, 2 died before post-ablation LGE-CMR, and 6 underwent post-ablation LGE-CMR 12 months after ablation). Finally, 49 patients (age: 65.5 &#xb1; 9.8 years, 97.9% male, left ventricular ejection fraction: 34.8 &#xb1; 10.4%, 87.7% ischaemic cardiomyopathy) were included. Post-ablation LGE-CMR showed a decrease in the number (3.34 &#xb1; 1.03 vs. 1.6 &#xb1; 0.2; P &lt; 0.0001) and mass (8.45 &#xb1; 1.3 vs. 3.5 &#xb1; 0.6 g; P &lt; 0.001) of CCs. Arrhythmogenic CCs disappeared in 74.4% of patients. Dark core was detected in 75.5% of patients, and its presence was not related to CC reduction (52.2 &#xb1; 7.4% vs. 40.8 &#xb1; 10.6%, P = 0.57). VT recurrence after one year follow-up was 16.3%. The presence of two or more channels in the post-ablation LGE-CMR was a predictor of VT recurrence (31.82% vs. 0%, P = 0.0038) with a sensibility of 100% and specificity of 61% (area under the curve 0.82). In the same line, a reduction of CCs &lt; 55% had sensibility of 100% and specificity of 61% (area under the curve 0.83) to predict VT recurrence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Post-ablation LGE-CMR is feasible, and a reduction in the number of CCs is related with lower risk of VT recurrence. The dark core was not present in all patients. A decrease in VT substrate was also observed in patients without a dark core area in the post-ablation LGE-CMR.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roca-Luque</LastName><ForeName>Ivo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0731-3731</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Calvo</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garre</LastName><ForeName>Paz</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz-Perez</LastName><ForeName>Jose T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prat-Gonzalez</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Somonte</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferro</LastName><ForeName>Elisenda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinto</LastName><ForeName>Levio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarc&#xf3;n</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Althoff</LastName><ForeName>Till</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perea</LastName><ForeName>Rosario Jes&#xfa;s</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Diagn&#xf2;stic per la Imatge, Hospital Cl&#xed;nic, Universitat de Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figueras I Ventura</LastName><ForeName>Rosa M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Adas3D Medical S.L., Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guasch</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4238-5319</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolosana</LastName><ForeName>Jos&#xe9; Maria</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzatti</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morr-Verenzuela</LastName><ForeName>Carlos Igor</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta-Sanchez</LastName><ForeName>Andreu</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3510-1488</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbelo</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sitges</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1300-4732</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugada</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5662-8302</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mont</LastName><ForeName>Llu&#xed;s</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8115-5906</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Emile Letang Grand of Hospital Clinic de Barcelona</Agency><Country/></Grant><Grant><GrantID>PI20/00693/CB16/11/00354</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>CB16/11/00354</GrantID><Agency>European Union</Agency><Country/></Grant><Grant><Agency>Generalitat de Catalunya</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Cardiovasc Imaging</MedlineTA><NlmUniqueID>101573788</NlmUniqueID><ISSNLinking>2047-2404</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>AU0V1LM3JT</RegistryNumber><NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Heart J Cardiovasc Imaging. 2024 Jan 29;25(2):199-200. doi: 10.1093/ehjci/jead275.</RefSource><PMID Version="1">37861369</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Eur Heart J Cardiovasc Imaging. 2024 Jan 29;25(2):e100. doi: 10.1093/ehjci/jead316.</RefSource><PMID Version="1">37988586</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019028" MajorTopicYN="N">Magnetic Resonance Imaging, Cine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002921" MajorTopicYN="N">Cicatrix</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005682" MajorTopicYN="N">Gadolinium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac magnetic resonance</Keyword><Keyword MajorTopicYN="N">late gadolinium enhancement</Keyword><Keyword MajorTopicYN="N">scar characterization</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia ablation</Keyword></KeywordList><CoiStatement>Conflict of interest: L.M. and J.B. report activities as a consultant, lecturer, and advisory board member for Abbott Medical, Boston Scientific, Biosense Webster, Medtronic, and Biotronik. They are also shareholders of Adas3D Medical S.L. I.R.-L. and A.P.-S. have served as a consultant for Biosense Webster, Medtronic, Boston Scientific, and Abbott Medical. M.S. reports activities as a consultant, lecturer, advisory board member, and grant recipient for Abbott Medical, Edwards Lifesciences, Sanofi, General Electric, and Medtronic. All other authors report that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>11</Day><Hour>14</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>11</Day><Hour>8</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37819047</ArticleId><ArticleId IdType="pmc">PMC10824475</ArticleId><ArticleId IdType="doi">10.1093/ehjci/jead261</ArticleId><ArticleId IdType="pii">7306657</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berruezo A, Fern&#xe1;ndez-Armenta J, Andreu D, Penela D, Herczku C, Evertz Ret al. . Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythm Electrophysiol 2015;8:326&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25583983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mountantonakis SE, Park RE, Frankel DS, Hutchinson MD, Dixit S, Cooper Jet al. . Relationship between voltage map &#x201c;channels&#x201d; and the location of critical isthmus sites in patients with post-infarction cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol 2013;61:2088&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">23524215</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu D, Ortiz-Perez JT, Boussy T, Fernandez-Armenta J, De Caralt TM, Perea RJet al. . Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation. Eur Heart J 2014;35:1316&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">24394378</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu D, Ortiz-Perez JT, Fernandez-Armenta J, Guiu E, Acosta J, Prat-Gonzalez Set al. . 3D delayed-enhanced magnetic resonance sequences improve conducting channel delineation prior to ventricular tachycardia ablation. Europace 2015;17:938&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">25616406</ArticleId></ArticleIdList></Reference><Reference><Citation>Piers SRD, Tao Q, Silva M DR, Siebelink HM, Schalij MJ, Van Der Geest RJet al. . CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia. JACC Cardiovasc Imaging 2014;7:774&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25051947</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez-Calvo S, Casanovas JM, Garre P, Ferr&#xf3; E, S&#xe1;nchez-Somonte P, Quinto Let al. . Evolution of deceleration zones during ventricular tachycardia ablation and relation with cardiac magnetic resonance. JACC Clin Electrophysiol 2023;9:779&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">37380313</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu D, Penela D, Acosta J, Perea RJ, Soto-iglesias D, De Caralt TMet al. . Cardiac magnetic resonance&#x2013;aided scar dechanneling: influence on acute and long-term outcomes. Heart Rhythm 2017;14:1121&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28760258</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Luque I, Rivas-Gandara N, Francisco-Pascual J, Rodriguez-Sanchez J, Cuellar-Calabria H, Rodriguez-Palomares Jet al. . Preprocedural imaging to guide transcoronary ethanol ablation for refractory septal ventricular tachycardia. J Cardiovasc Electrophysiol 2019;30:448&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">30556327</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinto L, Sanchez-Somonte P, Alarc&#xf3;n F, Garre P, Castillo &#xc0;, San Antonio Ret al. . Ventricular tachycardia burden reduction after substrate ablation: predictors of recurrence. Heart Rhythm 2021;18:896&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">33639298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15826268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhuva AN, Kellman P, Graham A, Ramlall M, Boubertakh R, Feuchter Pet al. . Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices. Int J Cardiol 2019;279:72&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30642645</ArticleId></ArticleIdList></Reference><Reference><Citation>Do DH, Eyvazian V, Bayoneta AJ, Hu P, Finn JP, Brad JSet al. . Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices. Heart Rhythm 2018;15:218&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823604</ArticleId><ArticleId IdType="pubmed">29017930</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbert S, Weber A, Nehrke K, Bornert P, Schnackenburg B, Oebel Set al. . Artefact-free late gadolinium enhancement imaging in patients with implanted cardiac devices using a modified broadband sequence: current strategies and results from a real-world patient cohort. Europace 2018;20:801&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28431009</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Luque I, Van Breukelen A, Alarcon F, Garre P, Tolosana JM, Borras Ret al. . Ventricular scar channel entrances identified by new wideband cardiac magnetic resonance sequence to guide ventricular tachycardia ablation in patients with cardiac defibrillators. Europace 2020;22:598&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">32101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafoori E, Kholmovski E, Thomas S, Silvernagel J, Nathan A, Nan Het al. . Characterization of gadolinium contrast enhancement of radiofrequency ablation lesions in predicting edema and chronic lesion size. Circ Arrhythm Electrophysiol 2017;10:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693314</ArticleId><ArticleId IdType="pubmed">29079664</ArticleId></ArticleIdList></Reference><Reference><Citation>Celik H, Ramanan V, Barry J, Ghate S, Leber V, Oduneye Set al. . Intrinsic contrast for characterization of acute radiofrequency ablation lesions. Circ Arrhythm Electrophysiol 2014;7:718&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">24988893</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabbagh GS, Ghannam M, Siontis KC, Attili A, Cochet H, Jais Pet al. . Magnetic resonance mapping of cathter ablation lesions after post-infarction ventricular tachycardia ablation. JACC Cardiovasc Imaging 2021;14:588&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33248970</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Vice-chair E, Chen Met al. . 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. EP Europace 2019;21:1143&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967791</ArticleId><ArticleId IdType="pubmed">31075787</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz Z, Shatz D, Raiman M, Upadhyay GA, Beaser AD, Besser SAet al. . Targeted ablation of ventricular tachycardia guided by wavefront discontinuities during sinus rhythm: a new functional substrate mapping strategy. Circulation 2019;140:1383&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">31533463</ArticleId></ArticleIdList></Reference><Reference><Citation>De Chillou C, Groben L, Magnin-poull I, Abdelaal A, Ammar S, Sellal Jet al. . Localizing the critical isthmus of postinfarct ventricular tachycardia : the value of pace-mapping during sinus rhythm. Heart Rhythm 2014;11:175&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">24513915</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Armenta J, Berruezo A, Andreu D, Camara O, Silva E, Serra Let al. . Three-dimensional architecture of scar and conducting channels based on high resolution ce-CMR insights for ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 2013;6:528&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">23685537</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Somonte P, Quinto L, Garre P, Zaraket F, Alarc&#xf3;n F, Borr&#xe0;s Ret al. . Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention. Heart Rhythm 2021;18:1336&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">33892202</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Bijl P, Delgado V, Bax JJ. Sudden cardiac death: the role of imaging. Int J Cardiol 2017;237:15&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28284506</ArticleId></ArticleIdList></Reference><Reference><Citation>Linhart M, Alarcon F, Borr&#xe0;s R, Benito EM, Chipa F, Cozzari Jet al. . Delayed gadolinium enhancement magnetic resonance imaging detected anatomic gap length in wide circumferential pulmonary vein ablation lesions is associated with recurrence of atrial fibrillation. Circ Arrhythm Electrophysiol 2018;11:e006659:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30562102</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinov B, Oebel S, Hilbert S, Loebe S, Arya A. Characteristics of the ablation lesions in cardiac magnetic resonance imaging after radiofrequency ablation of ventricular arrhythmias in relation to the procedural success. Am Heart J 2018;204:68&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">30077835</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickfield T, Kato R, Zviman MM, Lai S, Meininger G, Lardo ACet al. . Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2006;47:370&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2943962</ArticleId><ArticleId IdType="pubmed">16412863</ArticleId></ArticleIdList></Reference><Reference><Citation>Vunnam R, Ghzally Y, Mbbs JBM, See V, Maheshwari V, Imanli Het al. . Ventricular arrhythmia ablation lesions detectability. Pacing Clin Electrophysiol 2020;43:314&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">32052461</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39326671</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin Microbiol Infect</ISOAbbreviation></Journal><ArticleTitle>Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study.</ArticleTitle><Pagination><StartPage>1559</StartPage><EndPage>1568</EndPage><MedlinePgn>1559-1568</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmi.2024.09.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1198-743X(24)00443-9</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Hospital-acquired bloodstream infections (HA-BSI) in the intensive care unit (ICU) are common life-threatening events. We aimed to investigate the association between early adequate antibiotic therapy and 28-day mortality in ICU patients who survived at least 1&#xa0;day after the onset of HA-BSI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used individual data from a prospective, observational, multicentre, and intercontinental cohort study (Eurobact2). We included patients who were followed for &#x2265;1&#xa0;day and for whom time-to-appropriate treatment was available. We used an adjusted frailty Cox proportional-hazard model to assess the effect of time-to-treatment-adequacy on 28-day mortality. Infection- and patient-related variables identified as confounders by the Directed Acyclic Graph were used for adjustment. Adequate therapy within 24&#xa0;hours was used for the primary analysis. Secondary analyses were performed for adequate therapy within 48 and 72&#xa0;hours and for identified patient subgroups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 2418 patients included in 330 centres worldwide, 28-day mortality was 32.8% (n&#xa0;=&#xa0;402/1226) in patients who were adequately treated within 24&#xa0;hours after HA-BSI onset and 40% (n&#xa0;=&#xa0;477/1192) in inadequately treated patients (p&#xa0;&lt;&#xa0;0.01). Adequacy within 24&#xa0;hours was more common in young, immunosuppressed patients, and with HA-BSI due to Gram-negative pathogens. Antimicrobial adequacy was significantly associated with 28-day survival (adjusted Hazard Ratio (aHR), 0.83; 95% CI, 0.72-0.96; p 0.01). The estimated population attributable fraction of 28-day mortality of inadequate therapy was 9.15% (95% CI, 1.9-16.2%).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">In patients with HA-BSI admitted to the ICU, the population attributable fraction of 28-day mortality of inadequate therapy within 24&#xa0;hours was 9.15%. This estimate should be used when hypothesizing the possible benefit of any intervention aiming at reducing the time-to-appropriate antimicrobial therapy in HA-BSI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loiodice</LastName><ForeName>Ambre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OUTCOMEREA Research Group, Drancy, France; ICURESEARCH&#x2122;, 26 rue Garibaldi, Fontaine, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailly</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Grenoble Alpes University, Institut National de la Sant&#xe9; et de la Recherche Medicale 1300, HP2 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruckly</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>OUTCOMEREA Research Group, Drancy, France; Institut National de la Sant&#xe9; et de la Recherche Medicale, Infection Antimicrobial Modelisation Evolution, U1137, Team Decision Science in Infectious Diseases, Paris, France; ICURESEARCH&#x2122;, 26 rue Garibaldi, Fontaine, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buetti</LastName><ForeName>Niccol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institut National de la Sant&#xe9; et de la Recherche Medicale, Infection Antimicrobial Modelisation Evolution, U1137, Team Decision Science in Infectious Diseases, Paris, France; Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Service PCI, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbier</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre Hospitalier R&#xe9;gional d'Orl&#xe9;ans, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staiquly</LastName><ForeName>Quentin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>ICURESEARCH&#x2122;, 26 rue Garibaldi, Fontaine, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabah</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Queensland University of Technology (QUT), Brisbane, Queensland, Australia; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia; Intensive Care Unit, Redcliffe Hospital, Redcliffe, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timsit</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>OUTCOMEREA Research Group, Drancy, France; Institut National de la Sant&#xe9; et de la Recherche Medicale, Infection Antimicrobial Modelisation Evolution, U1137, Team Decision Science in Infectious Diseases, Paris, France; Assistance Publique H&#xf4;pitaux de Paris, Bichat hospital, Medical and infectious diseases ICU, F75018, Paris France. Electronic address: Jean-francois.timsit@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP) and the OUTCOMEREA Network</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="Y">Cross Infection</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="Y">Bacteremia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adequacy</Keyword><Keyword MajorTopicYN="N">Critically ill</Keyword><Keyword MajorTopicYN="N">Directed acyclic Graph</Keyword><Keyword MajorTopicYN="N">Hospital-acquired bloodstream infection</Keyword><Keyword MajorTopicYN="N">Mediation analysis</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Time-to-antibiotic</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Tabah</LastName><ForeName>Alexis</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lipman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tabah</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Redcliffe Hospital, Intensive Care Unit, Australia; Alfred Hospital, Department of Intensive Care and Hyperbaric Medicine, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pollock</LastName><ForeName>Hamish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Redcliffe Hospital, Intensive Care Unit, Australia; Alfred Hospital, Department of Intensive Care and Hyperbaric Medicine, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ben Margetts</LastName><AffiliationInfo><Affiliation>Redcliffe Hospital, Intensive Care Unit, Australia; Alfred Hospital, Department of Intensive Care and Hyperbaric Medicine, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Udy</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alfred Hospital, Department of Intensive Care and Hyperbaric Medicine, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Young</LastName><ForeName>Meredith</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alfred Hospital, Department of Intensive Care and Hyperbaric Medicine, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bhadange</LastName><ForeName>Neeraj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Ipswich Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tyler</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ipswich Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ledtischke</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mater Hospital, And Mater Research Institute - The University of Queensland, Mater Misericordiae Limited, The Department of Intensive Care, Australia; Mater Private Hospital, And Mater Research Institute - The University of Queensland, Mater Misericordiae, The Department of Intensive Care, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Finnis</LastName><ForeName>Mackenzie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mater Hospital, And Mater Research Institute - The University of Queensland, Mater Misericordiae Limited, The Department of Intensive Care, Australia; Mater Private Hospital, And Mater Research Institute - The University of Queensland, Mater Misericordiae, The Department of Intensive Care, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dwivedi</LastName><ForeName>Jyotsna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bankstown-Lidcombe Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saxena</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bankstown-Lidcombe Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Biradar</LastName><ForeName>Vishwanath</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Lyell Mcewin Hospital, Lyell Mcewin Hospital Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soar</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Lyell Mcewin Hospital, Lyell Mcewin Hospital Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sarode</LastName><ForeName>Vineet</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cabrini Hospital, Intensive Care, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brewster</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cabrini Hospital, Intensive Care, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Regli</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St John Of God Murdoch Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Weeda</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>St John Of God Murdoch Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Samiul</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Brisbane and Women S Hospital, Intensive Care Services, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fourie</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Royal Brisbane and Women S Hospital, Intensive Care Services, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Laupland</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Royal Brisbane and Women S Hospital, Intensive Care Services, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ramanan</LastName><ForeName>Mahesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Prince Charles Hospital, Adult Intensive Care Services, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Walsham</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Princess Alexandra Hospital, Intensive Care, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meyer</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Princess Alexandra Hospital, Intensive Care, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Litton</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fiona Stanley Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maria Palermo</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fiona Stanley Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yap</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fiona Stanley Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Eroglu</LastName><ForeName>Ege</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fiona Stanley Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>George Attokaran</LastName><ForeName>Antony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rockhampton Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jaramillo</LastName><ForeName>C'havala</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Rockhampton Hospital, Intensive Care Unit, Australia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nafees</LastName><ForeName>Khalid Mk</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nafees</LastName><ForeName>Khalid Mahmood Khan</ForeName><Initials>KMK</Initials><AffiliationInfo><Affiliation>Ripas Hospital, Icu 3, Brunei.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aqilah Haji Abd Rashid</LastName><ForeName>Nurhikmahtul</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Raja Isteri Pengiran Anak Saleha Hospital, Icu1, Brunei.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Adi Muhamad Ibnu Walid</LastName><ForeName>Haji</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Raja Isteri Pengiran Anak Saleha Hospital, Icu1, Brunei.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mon</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gleneagles Jpmc, Icu, Brunei.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dhakshina Moorthi</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Gleneagles Jpmc, Icu, Brunei.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sudhirchandra</LastName><ForeName>Shah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Suri Seri Begawan Hospital, Intensive Care Unit, Brunei.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sridharan</LastName><ForeName>Dhadappa Damodar</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Suri Seri Begawan Hospital, Intensive Care Unit, Brunei.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Haibo</LastName><ForeName>Qiu</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xie</LastName><ForeName>Jianfeng</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haibo</LastName><ForeName>Qiu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Zhongda Hospital, Southeast University, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jianfeng</LastName><ForeName>Xie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Zhongda Hospital, Southeast University, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wei-Hua</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Yijishan Hospital, First Affiliated Hospital of Wannan Medical College, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhen</LastName><ForeName>Wang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Yijishan Hospital, First Affiliated Hospital of Wannan Medical College, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Qian</LastName><ForeName>Chuanyun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>First Affiliate Hospital of Kunming Medical University, Micu/Eicu, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Luo</LastName><ForeName>Jili</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>First Affiliate Hospital of Kunming Medical University, Micu/Eicu, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaomei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Qilu Hospital of Shandong University, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Qilu Hospital of Shandong University, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hebei Petrochina Central Hospital, Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hebei Petrochina Central Hospital, Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wusi</LastName><ForeName>Qiu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Hangzhou Second Hospital, Affiliated Hospital of Hangzhou Normal University, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mingmin</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hangzhou Second Hospital, Affiliated Hospital of Hangzhou Normal University, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Xu</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Tianjin Third Central Hospital, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yin</LastName><ForeName>Chengfen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Tianjin Third Central Hospital, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Ruilan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Department Of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinfeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Department Of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yin</LastName><ForeName>Yongjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Hospital of Jilin University, Department Of Critical Care, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Second Hospital of Jilin University, Department Of Critical Care, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ye</LastName><ForeName>Jilu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Taizhou People S Hospital, Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Chungfang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Taizhou People S Hospital, Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>Suming</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanjing Medical University, Department Of Geriatrics Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanjing Medical University, Department Of Geriatrics Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yan</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Zhejiang Hospital, Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Zhejiang Hospital, Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Qin</LastName><ForeName>Bingyu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Henan Provincial People S Hospital, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ye</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Henan Provincial People S Hospital, Department of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Weifeng</LastName><ForeName>Xie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Qingdao Municipal Hospital, Intensive Care Unit, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Peije</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Second Hospital of Lanzhou University, Department Of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Geng</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Second Hospital of Lanzhou University, Department Of Critical Care Medicine, China.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ling</LastName><ForeName>Lowell</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Chinese University of Hong Kong, Prince of Wales Hospital, Department Of Anaesthesia And Intensive Care, Hong Kong.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Yoshiro</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Yoshiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Kameda Medical Center, Department of Intensive Care Medicine, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karumai</LastName><ForeName>Toshiyuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kameda Medical Center, Department of Intensive Care Medicine, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yamasaki</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Kyoto Prefectural University of Medicine, Intensive Care Unit, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Kyoto Prefectural University of Medicine, Intensive Care Unit, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hosokawa</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hiroshima University Hospital, ICU, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Makino</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yokosuka General Hospital Uwamachi, Critical Care Medicine, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Matsuyoshi</LastName><ForeName>Takeo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tokyo Metropolitan Tama Medical Center, Emergency and Critical Care Center, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kuriyama</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kurashiki Central Hospital, Emergency Intensive Care Unit, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Shigemitsu</LastName><ForeName>Hidenobu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Tokyo Medical and Dental University, Department of Intensive Care Medicine, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mishima</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tokyo Medical and Dental University, Department of Intensive Care Medicine, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nagashima</LastName><ForeName>Michio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tokyo Medical and Dental University, Department of Intensive Care Medicine, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>St. Marianna University School of Medicine Hospital, Mixed ICU, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fujitani</LastName><ForeName>Shigeki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St. Marianna University School of Medicine Hospital, Mixed ICU, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Omori</LastName><ForeName>Koichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Osaka City General Hospital, Emergency and Critical Care Medical Hospital, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rinka</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Osaka City General Hospital, Emergency and Critical Care Medical Hospital, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saito</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Mixed ICU, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Atobe</LastName><ForeName>Kaori</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Mixed ICU, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kato</LastName><ForeName>Hideaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yokohama City University Hospital, Infection Prevention and Control Department, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Takaki</LastName><ForeName>Shunsuke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Yokohama City University Hospital, Intensive Care Department, Japan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sulaiman</LastName><ForeName>Helmi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shahnaz Hasan</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Malaya Medical Centre, Department of Anaesthesiology and Intensive Care, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fadhil Hadi Jamaluddin</LastName><ForeName>Muhamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Malaya Medical Centre, Department of Anaesthesiology and Intensive Care, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pheng</LastName><ForeName>Lee See</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Hospital Tengku Ampuan Rahimah, Anaesthesia and Intensive Care, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Visvalingam</LastName><ForeName>Sheshendrasurian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Tengku Ampuan Rahimah, Anaesthesia and Intensive Care, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Thing Liew</LastName><ForeName>Mun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Sarikei, Anaesthesiology &amp; Intensive Care Unit, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ling Danny Wong</LastName><ForeName>Siong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Sarikei, Anaesthesiology &amp; Intensive Care Unit, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khang Fong</LastName><ForeName>Kean</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Queen Elizabeth 1 Hospital, Department of Anaesthesiology and Intensive Care, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bt Abdul Rahman</LastName><ForeName>Hamizah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Queen Elizabeth 1 Hospital, Department of Anaesthesiology and Intensive Care, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Md Noor</LastName><ForeName>Zuraini</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Hospital Serdang, Cardiothoracic and Perfusion Unit, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Kok Tong</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Hospital Serdang, Cardiothoracic and Perfusion Unit, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hamid Azman</LastName><ForeName>Abd</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Tuanku Fauziah, Intensive Care Unit, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zulfakar Mazlan</LastName><ForeName>Mohd</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School Of Medical Sciences Universiti Sains Malaysia, Department of Anaesthesiology and Intensive Care, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ali</LastName><ForeName>Saedah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Universiti Sains Malaysia, Department of Anaesthesiology and Intensive Care, Malaysia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Aaron Mark</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abello</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Medical City Ortigas, Intensive Care Unit, Philippines.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jeon</LastName><ForeName>Kyeongman</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jeon</LastName><ForeName>Kyeongman</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Samsung Medical Center, Medical Icu, Republic of Korea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Seoul National University Hospital, Medical Icu, Republic of Korea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Sunghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hallym University Sacred Heart Hospital, Micu, Republic of Korea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Seung Yong</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Micu, Chonbuk National University Hospital, Republic of Korea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yoon Lim</LastName><ForeName>Sung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Seoul National University Bundang Hospital, Medical Icu, Republic of Korea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kwa</LastName><ForeName>Andrea Lay Hoon</ForeName><Initials>ALH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yuan Goh</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yuan Goh</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Singapore General Hospital, Surgical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Shin Yi</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Singapore General Hospital, Surgical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>An Lie</LastName><ForeName>Sui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Singapore General Hospital, Neurosurgical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kwa</LastName><ForeName>Andrea Lay Hoon</ForeName><Initials>ALH</Initials><AffiliationInfo><Affiliation>Singapore General Hospital, Neurosurgical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Junyang Goh</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Singapore General Hospital, Medical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yunkai Li</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National University Hospital System Medical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ong</LastName><ForeName>Caroline Yu Ming</ForeName><Initials>CYM</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Surgical Intensive Care Unit, Neurological Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yan Lim</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Surgical Intensive Care Unit, Neurological Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lishan Quah</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Changi General Hospital, Medical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Kangqi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Changi General Hospital, Medical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Xiang Long Ng</LastName><ForeName>Louis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Changi General Hospital, Surgical Intensive Care Unit, Singapore.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yeh</LastName><ForeName>Tony Yu-Chang</ForeName><Initials>TY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chang Yeh</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Taiwan University Hospital, Sicu, Taiwan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chou</LastName><ForeName>Nai-Kuan</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>National Taiwan University Hospital, Sicu, Taiwan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cia</LastName><ForeName>Cong-Tat</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>National Cheng Kung University Hospital, Division of Critical Care Medicine, Department of Internal Medicine, Taiwan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Ting-Yu</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Mackay Memorial Hospital, Department of Critical Care Medicine, Taiwan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kuo</LastName><ForeName>Li-Kuo</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Mackay Memorial Hospital, Department of Critical Care Medicine, Taiwan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ku</LastName><ForeName>Shih-Chi</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>National Taiwan University Hospital, Department of Internal Medicine, Micu, Taiwan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wongsurakiat</LastName><ForeName>Phunsup</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wongsurakiat</LastName><ForeName>Phunsup</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Siriraj Hospital, Mahidol University, Critical Respitarory Care Unit, Department of Medicine, Thailand.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Apichatbutr</LastName><ForeName>Yutthana</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Vajira Hospital, Department of Internal Medicine, Thailand.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chiewroongroj</LastName><ForeName>Supattra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vajira Hospital, Department of Internal Medicine, Thailand.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alsisi</LastName><ForeName>Adel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadeem</LastName><ForeName>Rashid</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dubai Hospital, Icu Department, Dubai.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>El Houfi</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dubai Hospital, Icu Department, Dubai.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alsisi</LastName><ForeName>Adel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alsisi</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cairo University Hospital (Qasr Al Ainy), Critical Care Department, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Elhadidy</LastName><ForeName>Amr</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cairo University Hospital (Qasr Al Ainy), Critical Care Department, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barsoum</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cairo University Hospital (Qasr Al Ainy), Critical Care Department, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Osman</LastName><ForeName>Nermin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Research Institute, Alexandria University, Biomedical Informatics and Medical Statistics (Icu), Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mostafa</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tanta University Hospital, Anaesthesia and Critical Care Department, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Elbahnasawy</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tanta University Faculty of Medicine, Emergency Medicine and Traumatology Department, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saber</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tanta University Emergency Hospital, Emergency, And Traumatology Department Critical Care Unit, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aldhalia</LastName><ForeName>Amer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nasr City Health Insurance Hospital, Medical Icu, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Elmandouh</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Wingat Royal Hospital, Wingat Icu, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Elsayed</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Elsahel Teaching Hospital, Icu, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Elbadawy</LastName><ForeName>Merihan A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Ain Shams University Hospitals, Department of General Surgery, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Awad</LastName><ForeName>Ahmed K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Ain Shams University Hospitals, Department of General Surgery, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hemead</LastName><ForeName>Hanan M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Alexandria Faculty of Medicine, Dialysis Intensive Care Unit, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zand</LastName><ForeName>Farid</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zand</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Shiraz University of Medical Sciences, Anesthesiology and Critical Care Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ouhadian</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shiraz University of Medical Sciences, Anesthesiology and Critical Care Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hamid Borsi</LastName><ForeName>Seyed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical Sciences, Air Pollution and Respiratory Diseases Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mehraban</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical Sciences, Air Pollution and Respiratory Diseases Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kashipazha</LastName><ForeName>Davood</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical Sciences, Neurology Department, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ahmadi</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical Sciences, Infectious and Tropical Diseases Research Center, Health Research Institute, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Savaie</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical, Pain Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soltani</LastName><ForeName>Farhad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical, Pain Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rashidi</LastName><ForeName>Mahboobeh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical, Pain Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baghbanian</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical, Pain Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Javaherforoosh</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical, Pain Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Amiri</LastName><ForeName>Fereshteh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical, Pain Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kiani</LastName><ForeName>Arash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical Sciences, Neurosurgery Department, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Amin Zargar</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ahvaz Jundishapur University of Medical Sciences, General Surgery Department, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mahmoodpoor</LastName><ForeName>Ata</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tabriz University of Medical Sciences, Research Center for Integrative Medicine in Aging, Aging Research Institute, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aalinezhad</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Jahrom University of Medical Sciences, Peimanieh Hospital, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dabiri</LastName><ForeName>Gholamreza</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Shiraz University of Medical Sciences, Shahid Rajaee Trauma Hospital, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sabetian</LastName><ForeName>Golnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Shiraz University of Medical Sciences, Trauma Research Center, Shahid Rajaee Hospital, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sarshad</LastName><ForeName>Hakimeh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shiraz University of Medical Sciences, Trauma Research Center, Shahid Rajaee Hospital, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Masjedi</LastName><ForeName>Mansoor</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shiraz University of Medical Sciences, Anesthesiology and Critical Care Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tajvidi</LastName><ForeName>Ramin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Shiraz University of Medical Sciences, Anesthesiology and Critical Care Research Center, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nasirodin S M N Tabatabaei</LastName><ForeName>Dr Seyed Mohammad</ForeName><Initials>DSM</Initials><AffiliationInfo><Affiliation>Zahedan University of Medical Sciences, Anesthesiology and Critical Care Department, Iran.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Abdullah Khudhur</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Ibn Zuhur Hospital, Icu, Iraq.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Singer</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singer</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Rabin Medical Center Beilinson Hospital, General Intensive Care, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kagan</LastName><ForeName>Ilya</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Rabin Medical Center Beilinson Hospital, General Intensive Care, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rigler</LastName><ForeName>Merav</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rabin Medical Center Beilinson Hospital, General Intensive Care, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Belman</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shaare Zedek Medical Center, Intensive Care Unit, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Levin</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Shaare Zedek Medical Center, Intensive Care Unit, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Harara</LastName><ForeName>Belal</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Abdali Hospital, Icu, Jordan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Diab</LastName><ForeName>Adei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Abdali Hospital, Icu, Jordan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abillama</LastName><ForeName>Fayez</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abilama</LastName><ForeName>Fayez</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Lebanese American University Medical Center Rizk Hospital, Intensive Care, Lebanon.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Lebanese American University Medical Center Rizk Hospital, Intensive Care, Lebanon.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fares</LastName><ForeName>Aya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lebanese American University Medical Center Rizk Hospital, Intensive Care, Lebanon.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Elhadi</LastName><ForeName>Muhammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buimsaedah</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aljalla Benghazi Center, Micu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gamra</LastName><ForeName>Marwa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Almokhtar Clinic, Intensive Care Unit, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aqeelah</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Althawra Central Hospital, Intensive Care Unit, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ali Mohammed Ali</LastName><ForeName>Almajdoub</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Brega General Hospital Bgh Libya, Icu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gaber Sadik Homaidan</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Brega General Hospital Bgh Libya, Icu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Almiqlash</LastName><ForeName>Bushray</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Heart Institute, Micu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bilkhayr</LastName><ForeName>Hala</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Heart Institute, Micu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bouhuwaish</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tobruk Medical Centre, Medical Icu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sa Taher</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tobruk Medical Centre, Medical Icu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abdulwahed</LastName><ForeName>Eman</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Tripoli Central Hospital, Icu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abousnina</LastName><ForeName>Fathi A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Tripoli Central Hospital, Icu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khaled Hdada</LastName><ForeName>Aisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tripoli Central Hospital, Icu, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jobran</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Tripoli Central Hospital, Unit C, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ben Hasan</LastName><ForeName>Hayat</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Zliten Medical Center, Icu of Zliten Medical Center, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Shaban Ben Hasan</LastName><ForeName>Rabab</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Zliten Medical Center, Icu of Zliten Medical Center, Libya.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khalid Abidi</LastName></Investigator><Investigator ValidYN="Y"><LastName>Serghini</LastName><ForeName>Issam</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Avicenne Military Hospital, Icu, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Seddiki</LastName><ForeName>Rachid</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Avicenne Military Hospital, Icu, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Boukatta</LastName><ForeName>Brahim</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CHU Hassan II F&#xe8;sIntensive Care Unit A4, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kanjaa</LastName><ForeName>Nabil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CHU Hassan II F&#xe8;sIntensive Care Unit A4, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mouhssine</LastName><ForeName>Doumiri</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital Of Specialties, Critical Care Unit of Neurology and Neurosurgery, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ahmed Wajdi</LastName><ForeName>Maazouzi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Of Specialties, Critical Care Unit of Neurology and Neurosurgery, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dendane</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Ibn Sina University Hospital, faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Medical Icu, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ali Zeggwagh</LastName><ForeName>Amine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ibn Sina University Hospital, faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Medical Icu, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Housni</LastName><ForeName>Brahim</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mohammed VI University Hospital of Oujda, Faculty Of Medicine and Pharmacy Oujda, Mohammed Premier University, Anesthesia and Resuscitation Department, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Younes</LastName><ForeName>Oujidi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Mohammed VI University Hospital of Oujda, Faculty Of Medicine and Pharmacy Oujda, Mohammed Premier University, Anesthesia and Resuscitation Department, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hachimi</LastName><ForeName>Abdelhamid</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mohammed VI University Hospital, Medical Icu, Marrakech, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ghannam</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Institute of Oncology of Rabat, Intensive Care Unit, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Belkhadir</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Institute of Oncology of Rabat, Intensive Care Unit, Morocco.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abu Jayyab</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ICU, Alia governmental hospital, Hebron / West Bank, Palestine: Dr. Sarah Amro. Gaza city, Alshifaa hospital, Gaza, Palestine.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aithssain</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lance</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hamad General Hospital, Medical Icu: Dr Ali Ait Hssain, Dr Abdurahaman Elbuzidi. Al Wakrah Hospital, Critical Care: Dr Edin Karic. Hamad General Hospital, Sicu, Qatar.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nissar</LastName><ForeName>Shaikh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hamad General Hospital, Medical Icu: Dr Ali Ait Hssain, Dr Abdurahaman Elbuzidi. Al Wakrah Hospital, Critical Care: Dr Edin Karic. Hamad General Hospital, Sicu, Qatar.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sallam</LastName><ForeName>Hend</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp;Research Center, Adult Critical Care Medicine, Saudi Arabia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Elrabi</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Prince Sultan Medical Military Center, Intensive Care Unit, Saudi Arabia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Almekhlafi</LastName><ForeName>Ghaleb A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Prince Sultan Medical Military Center, Intensive Care Unit, Saudi Arabia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Awad</LastName><ForeName>Maher</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Security Force Hospital - Riyadh, Critical Care Unit, Saudi Arabia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aljabbary</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Security Force Hospital - Riyadh, Critical Care Unit, Saudi Arabia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karam Chaaban</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Al Mouwasat University Hospital, Icu, Syria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abu-Sayf</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Assad University Hospital, Neurological Intensive Care Unit, Syria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Al-Jadaan</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Damascus University Cardiac Surgery Hospital Near Al-Mouwasat University Hospital, Mazzeh Kiwan, Cardiac Surgery Icu, Syria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bakr</LastName><ForeName>Lubna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Damascus University Cardiac Surgery Hospital Near Al-Mouwasat University Hospital, Mazzeh Kiwan, Cardiac Surgery Icu, Syria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mounir Bouaziz</LastName></Investigator><Investigator ValidYN="Y"><LastName>Bouaziz</LastName><ForeName>Mounir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Habib Bourguiba University Hospital, Department of Intensive Care, Tunisia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Turki</LastName><ForeName>Olfa</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Habib Bourguiba University Hospital, Department of Intensive Care, Tunisia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sellami</LastName><ForeName>Walid</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Military Hospital of Tunis, Department of Anesthesiology And Intensive Care Unit, Lr12dn01Tunisia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vidal</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Centeno</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hcas Cuenca Alta, Terapia Intensiva, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Morvillo</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hcas Cuenca Alta, Terapia Intensiva, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oscar Acevedo</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Central De Formosa, Servicio De Terapia Intensiva, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mabel Lopez</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Central De Formosa, Servicio De Terapia Intensiva, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fern&#xe1;ndez</LastName><ForeName>Rub&#xe9;n</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Espa&#xf1;ol De Mendoza, Terapia Intensiva De Adultos, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Segura</LastName><ForeName>Mat&#xed;as</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Espa&#xf1;ol De Mendoza, Terapia Intensiva De Adultos, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aparicio</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Zatti, Ucia, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alonzo</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hospital Zatti, Ucia, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nuccetelli</LastName><ForeName>Yanina</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Instituto De Diagnostico De La Plata, Unidad De Terapia Intensiva, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Montefiore</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Instituto De Diagnostico De La Plata, Unidad De Terapia Intensiva, Argentina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arias</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Felipe Reyes</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinica Universidad De La Sabana, Critical Care Unit, Colombia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Felipe Reyes</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universidad De La Sabana, Infectious Diseases Department, Colombia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>&#xd1;amendys-Silva</LastName><ForeName>Silvio A</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>&#xd1;amendys-Silva</LastName><ForeName>Silvio A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Hospital Medica Sur, Department of Critical Care Medicine, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Romero-Gonzalez</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Hospital Medica Sur, Department of Critical Care Medicine, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hermosillo</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centenario Hospital Miguel Hidalgo, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alejandro Castillo</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centenario Hospital Miguel Hidalgo, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nicol&#xe1;s Pantoja Leal</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital General De Zona 14, Intensive Care Unit, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Garcia Aguilar</LastName><ForeName>Candy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital General De Zona 14, Intensive Care Unit, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ocotlan Gonzalez Herrera</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital General Regional No.1, IMSS Tlaxcala, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vladimir Espinoza Villafuerte</LastName><ForeName>Missael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital General Regional No.1, IMSS Tlaxcala, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lomeli-Teran</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital H+ Queretaro, Unidad De Terapia Intensiva Adultos, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dominguez-Cherit</LastName><ForeName>Jose G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Division of Pulmonary, Anesthesia and Critical Care Medicine, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Davalos-Alvarez</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Division of Pulmonary, Anesthesia and Critical Care Medicine, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>&#xd1;amendys-Silva</LastName><ForeName>Silvio A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Division of Pulmonary, Anesthesia and Critical Care Medicine, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>S&#xe1;nchez-Hurtado</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UMAE Hospital de Especialidades Antonio Fraga Mouret, Centro M&#xe9;dico Nacional La RazaIMSS, Terapia Intensiva Hospital de Especialidades CMN La Raza, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tejeda-Huezo</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>UMAE Hospital de Especialidades Antonio Fraga Mouret, Centro M&#xe9;dico Nacional La RazaIMSS, Terapia Intensiva Hospital de Especialidades CMN La Raza, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Perez-Nieto</LastName><ForeName>Orlando R</ForeName><Initials>OR</Initials><AffiliationInfo><Affiliation>Hospital General San Juan del Rio, Unidad de Terapia Intensiva de Adultos, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Deloya Tomas</LastName><ForeName>Ernesto</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital General San Juan del Rio, Unidad de Terapia Intensiva de Adultos, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Bus</LastName><ForeName>Liesbet</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Waele</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francois</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Bus</LastName><ForeName>Liesbet</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Intensive Care Unit, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Waele</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Intensive Care Unit, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hollevoet</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>A.S.Z., Iz, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Denys</LastName><ForeName>Wouter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Az Nikolaas, Icu, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bourgeois</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Az Sint-Jan Av Brugge - Oostende Campus Brugge, Icu, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vanderhaeghen</LastName><ForeName>Sofie F M</ForeName><Initials>SFM</Initials><AffiliationInfo><Affiliation>Az Sint-Lucas, Department of Intensive Care, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mesland</LastName><ForeName>Jean-Baptiste</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Jolimont, Soins Intensifs, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Henin</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Jolimont, Soins Intensifs, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Haentjens</LastName><ForeName>Lionel</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Chu Ambroise Par&#xe9;, Unit&#xe9; Des Soins Intensifs, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Biston</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chu Charleroi, Medico-Surgical Icu, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Noel</LastName><ForeName>Cind&#xe9;rella</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chu Charleroi, Medico-Surgical Icu, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Layos</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chu Li&#xe8;ge, Soins Intensifs, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Misset</LastName><ForeName>Beno&#xee;t</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Chu Li&#xe8;ge, Soins Intensifs, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Schryver</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinique Saint-Pierre, Intensive Care Unit, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Serck</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinique Saint-Pierre, Intensive Care Unit, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wittebole</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cliniques Universitaires Saint-Luc, UCLouvain, Soins Intensifs, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Waele</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Uzbrussel, Intensieve Zorgen, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Opdenacker</LastName><ForeName>Godelive</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Uzbrussel, Intensieve Zorgen, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kovacevic</LastName><ForeName>Pedja</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kovacevic</LastName><ForeName>Pedja</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Clinical Centre of The Republic Of Srpska, Medical Intensive Care Unit, Bosnia And Herzegovina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zlojutro</LastName><ForeName>Biljana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University Clinical Centre of The Republic Of Srpska, Medical Intensive Care Unit, Bosnia And Herzegovina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ina</LastName><ForeName>Filipovic-Grcic</ForeName><Initials>FG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Custovic</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Hospital Dubrovnik, Anesthesiology, And Intensive Care, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Filipovic-Grcic</LastName><ForeName>Ina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>General Hospital Dubrovnik, Anesthesiology, And Intensive Care, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Radonic</LastName><ForeName>Radovan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University Hospital Centre Zagreb, Medical Intensive Care Unit, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vujaklija Brajkovic</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Centre Zagreb, Medical Intensive Care Unit, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Persec</LastName><ForeName>Jasminka</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital Dubrava, Clinical Department of Anesthesiology, Reanimatology and Intensive Care, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sakan</LastName><ForeName>Sanja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Dubrava, Clinical Department of Anesthesiology, Reanimatology and Intensive Care, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nikolic</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Dubrava, Clinical Department of Anesthesiology, Reanimatology and Intensive Care, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lasic</LastName><ForeName>Hrvoje</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Hospital Dubrava, Clinical Department of Anesthesiology, Reanimatology and Intensive Care, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Leone</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Timsit</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruppe</LastName><ForeName>Etienne</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruckly</LastName><ForeName>Stephane</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montravers</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leone</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Nord, R&#xe9;animation Polyvalente et Traumatologique, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arbelot</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Nord, R&#xe9;animation Polyvalente et Traumatologique, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Timsit</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Bichat Claude Bernard, R&#xe9;animation M&#xe9;dicale et Infectieuse, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Patrier</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bichat Claude Bernard, R&#xe9;animation M&#xe9;dicale et Infectieuse, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zappela</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Bichat-Claude Bernard Hospital, Ap-Hp, Anesthesiology And Critical Care Medicine Department, Dmu Parabol, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Montravers</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Bichat-Claude Bernard Hospital, Ap-Hp, Anesthesiology And Critical Care Medicine Department, Dmu Parabol, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dulac</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Bigorre, Service De R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Castanera</LastName><ForeName>J&#xe9;r&#xe9;my</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Bigorre, Service De R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Auchabie</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Cholet, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Le Meur</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Cholet, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marchalot</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Dieppe, M&#xe9;decine Intensive R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Beuzelin</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Dieppe, M&#xe9;decine Intensive R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Massri</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Pau, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Guesdon</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre Hospitalier De Pau, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Escudier</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ch Annecy Genevois, R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mateu</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ch De Charleville-M&#xe9;zi&#xe8;res, M&#xe9;decine Intensive R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rosman</LastName><ForeName>J&#xe9;r&#xe9;my</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ch De Charleville-M&#xe9;zi&#xe8;res, M&#xe9;decine Intensive R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Leroy</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Ch Tourcoing, Service De Reanimation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alfandari</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ch Tourcoing, Service De Reanimation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nica</LastName><ForeName>Alexandru</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Chu Compiegne Noyon, R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Souweine</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Chu Gabriel Montpied, M&#xe9;decine Intensive Et R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coupez</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Chu Gabriel Montpied, M&#xe9;decine Intensive Et R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Duburcq</LastName><ForeName>Thibault</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Chu Lille, H&#xf4;pital Roger Salengro, P&#xf4;le De R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kipnis</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Chu Lille, Surgical Critical Care, Department of Anesthesiology and Critical Care, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bortolotti</LastName><ForeName>Perrine</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chu Lille, Surgical Critical Care, Department of Anesthesiology and Critical Care, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Le Souhaitier</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chu Rennes, Service De Maladies Infectieuses Et R&#xe9;animation M&#xe9;dicale, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mira</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Cochin, Medecine Intensive Reanimation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Garcon</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ghef Site De Marne-La-Vall&#xe9;e, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Duprey</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ghef Site De Marne-La-Vall&#xe9;e, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Thyrault</LastName><ForeName>Martial</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Nord Essonne - Site Longjumeau, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Paulet</LastName><ForeName>R&#xe9;mi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Nord Essonne - Site Longjumeau, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Philippart</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Paris Saint Joseph, M&#xe9;decine Intensive et R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tran</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Paris Saint Joseph, M&#xe9;decine Intensive et R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bruel</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Paris Saint Joseph, M&#xe9;decine Intensive et R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Weiss</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Beaujon, Department of Anesthesiology and Critical Care, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Janny</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Beaujon, Department of Anesthesiology and Critical Care, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Foucrier</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Beaujon, Department of Anesthesiology and Critical Care, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Perrigault</LastName><ForeName>Pierre-Fran&#xe7;ois</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Hopital De Gui De Chauliac, Departement Anesthesie Reanimation Gui De Chauliac, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Djanikian</LastName><ForeName>Flora</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hopital De Gui De Chauliac, Departement Anesthesie Reanimation Gui De Chauliac, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barbier</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>H&#xf4;pital De La Source, Centre Hospitalier R&#xe9;gional D'orl&#xe9;ans, M&#xe9;decine Intensive &amp; R&#xe9;animation (Medical Icu), France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gainnier</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>H&#xf4;pital De La Timone, M&#xe9;decine Intensive R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bourenne</LastName><ForeName>J&#xe9;r&#xe9;my</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>H&#xf4;pital De La Timone, M&#xe9;decine Intensive R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Louis</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hopital De Mercy, Chr Metz-Thionville, Service De R&#xe9;animation Polyvalente Et Usc, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Smonig</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hopital Du Scorff, Service De R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Argaud</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Edouard Herriot, M&#xe9;decine Intensive-R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baudry</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Edouard Herriot, M&#xe9;decine Intensive-R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mekonted Dessap</LastName><ForeName>Armand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Henri Mondor, Service De R&#xe9;animation M&#xe9;dicale, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Razazi</LastName><ForeName>Keyvan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Henri Mondor, Service De R&#xe9;animation M&#xe9;dicale, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kalfon</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Pasteur, R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Badre</LastName><ForeName>Ga&#xeb;tan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Pasteur, R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Larcher</LastName><ForeName>Romaric</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montpellier University Hospital, Intensive Care Medicine Lapeyronie Hospital, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lefrant</LastName><ForeName>Jean-Yves</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Nimes University Hospital, Service Des R&#xe9;animations, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roger</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nimes University Hospital, Service Des R&#xe9;animations, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sarton</LastName><ForeName>Benjamine</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Purpan, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Silva</LastName><ForeName>Stein</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Purpan, R&#xe9;animation Polyvalente, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Demeret</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sorbonne Universite Pitie Salpetriere, M&#xe9;decine Intensive Et R&#xe9;animation Neurologique, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Le Guennec</LastName><ForeName>Lo&#xef;c</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sorbonne Universite Pitie Salpetriere, M&#xe9;decine Intensive Et R&#xe9;animation Neurologique, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Siami</LastName><ForeName>Shidasp</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sud Essonne Hospital, Department of Intensive Care Medicine, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aparicio</LastName><ForeName>Christelle</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sud Essonne Hospital, Department of Intensive Care Medicine, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Voiriot</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Tenon Hospital, Service De M&#xe9;decine Intensive R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fartoukh</LastName><ForeName>Muriel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tenon Hospital, Service De M&#xe9;decine Intensive R&#xe9;animation, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dahyot-Fizelier</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Of Poitiers, Surgical And Neuro Intensive Care Units, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Imzi</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University Hospital Of Poitiers, Surgical And Neuro Intensive Care Units, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Klouche</LastName><ForeName>Kada</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Of Montpellier, Phymedexp Inserm Cnrs, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bracht</LastName><ForeName>Hendrik</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bracht</LastName><ForeName>Hendrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Hospital Ulm, Icu G1, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hoheisen</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Ulm, Icu G1, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bloos</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Dept. Of Anesthesiology and Intensive Care Medicine, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Thomas-Rueddel</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Dept. Of Anesthesiology and Intensive Care Medicine, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Petros</LastName><ForeName>Sirak</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Leipzig, Medical Icu, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pasieka</LastName><ForeName>Bastian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Leipzig, Medical Icu, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dubler</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Heidelberg, Station 13 Iopsis, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospital Heidelberg, Station 13 Iopsis, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gottschalk</LastName><ForeName>Antje</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wempe</LastName><ForeName>Carola</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lepper</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital of Saarland, Dept. Of Internal Medicine V - Pneumology, Allergology and Critical Care Medicine, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Metz</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital of Saarland, Dept. Of Internal Medicine V - Pneumology, Allergology and Critical Care Medicine, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Viderman</LastName><ForeName>Dmitriy</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viderman</LastName><ForeName>Dmitriy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Medical Center, National Research Oncology Center, Intensive Care Unit, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Umbetzhanov</LastName><ForeName>Yerlan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University Medical Center, National Research Oncology Center, Intensive Care Unit, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mugazov</LastName><ForeName>Miras</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karaganda Medical University, Department of Emergency Medicine, Anesthesiology and Resuscitation Non-Commercial Joint-Stock Company, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bazhykayeva</LastName><ForeName>Yelena</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Karaganda Medical University, Department of Emergency Medicine, Anesthesiology and Resuscitation Non-Commercial Joint-Stock Company, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kaligozhin</LastName><ForeName>Zhannur</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Medical Center Hospital of The President's Affairs Administration of The Republic of Kazakhstan, Intensive Care Unit, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Babashev</LastName><ForeName>Baurzhan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Center Hospital of The President's Affairs Administration of The Republic of Kazakhstan, Intensive Care Unit, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Merenkov</LastName><ForeName>Yevgeniy</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Research Oncology Center, Department of Oncohematological Resuscitation, Resuscitation, Intensive Care, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Temirov</LastName><ForeName>Talgat</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Research Oncology Center, Department of Oncohematological Resuscitation, Resuscitation, Intensive Care, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arvaniti</LastName><ForeName>Kostoula</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arvaniti</LastName><ForeName>Kostoula</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Papageorgiou Hospital, Intensive Care Unit, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Smyrniotis</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Papageorgiou Hospital, Intensive Care Unit, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Psallida</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Agioi Anargiroi Hospital, Agioi Anargiroi Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fildisis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Agioi Anargiroi Hospital, Agioi Anargiroi Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soulountsi</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>G Papanikolaou General Hospital, 1st Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kaimakamis</LastName><ForeName>Evangelos</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>G Papanikolaou General Hospital, 1st Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Iasonidou</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>G Papanikolaou General Hospital, B Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Papoti</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>G Papanikolaou General Hospital, B Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Renta</LastName><ForeName>Foteini</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>General Hospital G. Gennhmatas, Gnth "G Gennhmatas", Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vasileiou</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>General Hospital G. Gennhmatas, Gnth "G Gennhmatas", Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Romanou</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>General Hospital of Athens G. Gennimatas, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koutsoukou</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>General Hospital of Athens G. Gennimatas, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kristina Matei</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gh Imathia Veria, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moldovan</LastName><ForeName>Leora</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Gh Imathia Veria, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karaiskos</LastName><ForeName>Ilias</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Icu, Hygeia General Hospital, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Paskalis</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Icu, Hygeia General Hospital, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marmanidou</LastName><ForeName>Kyriaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, General Hospital of Giannitsa, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Papanikolaou</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hippocration General Hospital Of Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kampolis</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hippocration General Hospital Of Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oikonomou</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Katerini General Hospital, Gnk Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kogkopoulos</LastName><ForeName>Evangelos</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Katerini General Hospital, Gnk Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nikolaou</LastName><ForeName>Charikleia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Konstantopoulion-Patision Hospital, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sakkalis</LastName><ForeName>Anastasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Konstantopoulion-Patision Hospital, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chatzis</LastName><ForeName>Marinos</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mediterraneo Hospital, Icu/Hdu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Georgopoulou</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mediterraneo Hospital, Icu/Hdu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Efthymiou</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chantziara</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sakagianni</LastName><ForeName>Aikaterini</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sismanogleio Hospital, Sismanogleion Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Athanasa Athanassa</LastName><ForeName>Zoi Zoe</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>Sismanogleio Hospital, Sismanogleion Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Papageorgiou</LastName><ForeName>Eirini</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Theageneio Anticancer Hospital, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ali</LastName><ForeName>Fadi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Theageneio Anticancer Hospital, Icu, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dimopoulos</LastName><ForeName>Georges</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Hospital Attikon, National And Kapodistrian University Of Athens, Department Of Critical Care, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Panagiota Almiroudi</LastName><ForeName>Mariota</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Attikon, National And Kapodistrian University Of Athens, Department Of Critical Care, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Malliotakis</LastName><ForeName>Polychronis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital Heraklion, Department of Intensive Care, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marouli</LastName><ForeName>Diamantina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital Heraklion, Department of Intensive Care, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Theodorou</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University Hospital of Alexandroupolis, Department Of Intensive Care, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Retselas</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Hospital of Alexandroupolis, Department Of Intensive Care, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kouroulas</LastName><ForeName>Vasilios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University Hospital of Ioannina, Intensive Care Unit, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Papathanakos</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Hospital of Ioannina, Intensive Care Unit, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bassetti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giacobbe</LastName><ForeName>Daniele</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montrucchio</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Citt&#xe0; Della Salute E Della Scienza - Molinette, Anestesia E Rianimazione Universitaria, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sales</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Citt&#xe0; Della Salute E Della Scienza - Molinette, Anestesia E Rianimazione Universitaria, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Pascale</LastName><ForeName>Gennaro</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli Irccs. Universita Cattolica Del Sacro Cuore. Italy, Uoc Di Anestesia, Rianimazione, Terpia Intensiva E Tossicologia Clinica, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maria Montini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli Irccs. Universita Cattolica Del Sacro Cuore. Italy, Uoc Di Anestesia, Rianimazione, Terpia Intensiva E Tossicologia Clinica, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carelli</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli Irccs. Universita Cattolica Del Sacro Cuore. Italy, Uoc Di Anestesia, Rianimazione, Terpia Intensiva E Tossicologia Clinica, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vargas</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli Irccs. Universita Cattolica Del Sacro Cuore. Italy, Uoc Di Anestesia, Rianimazione, Terpia Intensiva E Tossicologia Clinica, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Di Gravio</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli Irccs. Universita Cattolica Del Sacro Cuore. Italy, Uoc Di Anestesia, Rianimazione, Terpia Intensiva E Tossicologia Clinica, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roberto Giacobbe</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Irccs Ospedale Policlinico San Martino, U.O. Anestesia E Rianimazione, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gratarola</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Irccs Ospedale Policlinico San Martino, U.O. Anestesia E Rianimazione, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Porcile</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Irccs Ospedale Policlinico San Martino, U.O. Anestesia E Rianimazione, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mirabella</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Irccs Ospedale Policlinico San Martino, U.O. Anestesia E Rianimazione, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Daroui</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Irccs Sacro Cuore Don Calabria, Terapia Intensiva, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lodi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Irccs Sacro Cuore Don Calabria, Terapia Intensiva, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zuccaro</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Madonna Delle Grazie, U.O.C. Anestesia E Rianimazione, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grazia Schlevenin</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Madonna Delle Grazie, U.O.C. Anestesia E Rianimazione, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ospedale Policlinico San Martino, Irccs Per L'oncologia E Le Neuroscienze, Uo Clinica Anestesiologica E Terapia Intensiva, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Battaglini</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ospedale Policlinico San Martino, Irccs Per L'oncologia E Le Neuroscienze, Uo Clinica Anestesiologica E Terapia Intensiva, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Policlino Paolo Giaccone, Universit&#xe0; Degli Studi Di Palermo, Terapia Intensiva Polivalente, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ippolito</LastName><ForeName>Mariachiara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Policlino Paolo Giaccone, Universit&#xe0; Degli Studi Di Palermo, Terapia Intensiva Polivalente, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bellina</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Policlino Paolo Giaccone, Universit&#xe0; Degli Studi Di Palermo, Terapia Intensiva Polivalente, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Di Guardo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Policlino Paolo Giaccone, Universit&#xe0; Degli Studi Di Palermo, Terapia Intensiva Polivalente, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pelagalli</LastName><ForeName>Lorella</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Regina Elena National Cancer Institute of Rome, Anesthesia and Intensive Care Department, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Covotta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Regina Elena National Cancer Institute of Rome, Anesthesia and Intensive Care Department, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rocco</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sant'andrea Hospital Sapienza University of Rome, Department of Medical And Surgical Science And Translational Medicine Intensive Care Unit, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fiorelli</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sant'andrea Hospital Sapienza University of Rome, Department of Medical And Surgical Science And Translational Medicine Intensive Care Unit, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cotoia</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital O.O.R.R., Department of Anesthesia And Intensive Care, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chiara Rizzo</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital O.O.R.R., Department of Anesthesia And Intensive Care, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Adam Mikstacki</LastName></Investigator><Investigator ValidYN="Y"><LastName>Mikstacki</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital In Puszczykowo, Poznan University of Medical Sciences, Department of Anaesthesiology and Intensive Therapy, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tamowicz</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital In Puszczykowo, Poznan University of Medical Sciences, Department of Anaesthesiology and Intensive Therapy, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kaptur Komorowska</LastName><ForeName>Irmina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Oddzial Kliniczny Anestezjologii I Intensywnej Terapii, 10 Wojskowy Szpital Kliniczny, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Szczesniak</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oddzial Kliniczny Anestezjologii I Intensywnej Terapii, 10 Wojskowy Szpital Kliniczny, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bojko</LastName><ForeName>Jozef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Szpital Wojewodzki W Opolu, Oddzial Anestezjologii I Intensywnej Terapii, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kotkowska</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Szpital Wojewodzki W Opolu, Oddzial Anestezjologii I Intensywnej Terapii, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Walczak-Wieteska</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Uck Wum, Oddzial Intensywnej Terapii (Icu), Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wasowska</LastName><ForeName>Dominika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Uck Wum, Oddzial Intensywnej Terapii (Icu), Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nowakowski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Wojewodzki Szpital Zespolony, Oddzial Anestezjologii I Intensywnej Terapii, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Broda</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Wojewodzki Szpital Zespolony, Oddzial Anestezjologii I Intensywnej Terapii, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mariusz Peichota</LastName><ForeName>Assoc</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wss Im. Wl. Bieganskiego, Oddzial Anestezjologii I Intensywnej Terapii - Osrodek Pozaustrojowych Technik Wspomagania Czynnosci Nerek I W&#x105;troby, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pietraszek-Grzywaczewska</LastName><ForeName>Iwona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Wss Im. Wl. Bieganskiego, Oddzial Anestezjologii I Intensywnej Terapii - Osrodek Pozaustrojowych Technik Wspomagania Czynnosci Nerek I W&#x105;troby, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martin-Loeches</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bisanti</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Jame's Hospital, Intensive Care Unit: Prof Ignacio Martin-Loeches, Republic of Ireland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Paiva</LastName><ForeName>Jos&#xe9; Artur</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>P&#xf3;voa</LastName><ForeName>Pedro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cartoze</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Medio Tejo - Unidade Abrantes, Ucip, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pereira</LastName><ForeName>Tiago</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Medio Tejo - Unidade Abrantes, Ucip, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Guimar&#xe3;es</LastName><ForeName>N&#xe1;dia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Universit&#xe1;rio do Porto, Sci 1, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alves</LastName><ForeName>Madalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Universit&#xe1;rio do Porto, Sci 1, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Josefina Pinheiro Marques</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Vila Nova De Gaia/Espinho, Unidade De Cuidados Intensivos Polivalente, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rios Pinto</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Vila Nova De Gaia/Espinho, Unidade De Cuidados Intensivos Polivalente, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Krystopchuk</LastName><ForeName>Andriy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHUA Faro, Smi-1, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Teresa</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHUA Faro, Smi-1, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Manuel Pereira de Figueiredo</LastName><ForeName>Ant&#xf3;nio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital De Cascais Dr Jose De Almeida, Unidade de Cuidados Intensivos, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Botelho</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hospital De Cascais Dr Jose De Almeida, Unidade de Cuidados Intensivos, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Duarte</LastName><ForeName>Tiago</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hospital Curry Cabral, Intensive Care Medicine Department, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Costa</LastName><ForeName>Vasco</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Sao Francisco Xavier, CHLO, Unidade De Cuidados Intensivos Polivalente, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pedro Cunha</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Sao Francisco Xavier, CHLO, Unidade De Cuidados Intensivos Polivalente, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Molinos</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Pedro Hispano, Servi&#xe7;o De Medicina Intensiva, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tito da Costa</LastName><AffiliationInfo><Affiliation>Hospital Pedro Hispano, Servi&#xe7;o De Medicina Intensiva, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ledo</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CHULC, Hospital Sao Jos&#xe9;, Unidade de Urg&#xea;ncia M&#xe9;dica, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Queir&#xf3;</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CHULC, Hospital Sao Jos&#xe9;, Unidade de Urg&#xea;ncia M&#xe9;dica, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pascoalinho</LastName><ForeName>Dulce</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>ULS Litoral Alentejano, Servi&#xe7;o de Medicina Intensiva, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nunes</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ULS Nordeste, Unidade de Cuidados Intensivost, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pedro Moura</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ULSAM, UCI, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pereira</LastName><ForeName>&#xc9;nio</ForeName><Initials>&#xc9;</Initials><AffiliationInfo><Affiliation>ULSAM, UCI, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carvalho Mendes</LastName><ForeName>Ant&#xf3;nio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ULS Baixo Alentejo, Unidade Cuidados Intensivos Polivalente, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Valeanu</LastName><ForeName>Liana</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valeanu</LastName><ForeName>Liana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Emergency Institute for Cardiovascular Diseases Prof. Dr. C. C. Iliescu, 1st Anesthesia and Intensive Care Department, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bubenek-Turconi</LastName><ForeName>Serban</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Institute for Cardiovascular Diseases Prof. Dr. C. C. Iliescu, 1st Anesthesia and Intensive Care Department, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marina Grintescu</LastName><ForeName>Ioana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical Emergency Hospital Bucharest, Anesthesia and Intensive Care Department, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cobilinschi</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Emergency Hospital Bucharest, Anesthesia and Intensive Care Department, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carmen Filipescu</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emergency Institute for Cardiovascular Diseases Prof. Dr. C. C. Iliescu, 2nd Anesthesia and Intensive Care Department, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Elena Predoi</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Institute for Cardiovascular Diseases Prof. Dr. C. C. Iliescu, 2nd Anesthesia and Intensive Care Department, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tomescu</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, 3rd Department of Anesthesia and Intensive Care, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Popescu</LastName><ForeName>Mihai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, 3rd Department of Anesthesia and Intensive Care, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marcu</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, 3rd Department of Anesthesia and Intensive Care, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grigoras</LastName><ForeName>Ioana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Of Medicine and Pharmacy "Grigore T Popa", Anesthesia and Intensive Care Department, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lungu</LastName><ForeName>Olguta</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University Of Medicine and Pharmacy "Grigore T Popa", Anesthesia and Intensive Care Department, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gritsan</LastName><ForeName>Alexey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gritsan</LastName><ForeName>Alexey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk Regional Clinical Hospital, Dep. Anaesthesiology and Intensive Care #3, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Anderzhanova</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>City Clinical N.I.Pirogov Hospital, Clinical Pharmacology, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meleshkina</LastName><ForeName>Yulia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>City Clinical N.I.Pirogov Hospital, Clinical Pharmacology, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Magomedov</LastName><ForeName>Marat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>City Clinical N.I.Pirogov Hospital, Icu, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zubareva</LastName><ForeName>Nadezhda</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>E.A. Vagner Perm State Medical University, Intensive Care Unit, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tribulev</LastName><ForeName>Maksim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>E.A. Vagner Perm State Medical University, Intensive Care Unit, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gaigolnik</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Krasnoyarsk Regional Clinical Hospital, Dep. Anaesthesiology and Intensive Care #3, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Eremenko</LastName><ForeName>Aleksandr</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Petrovsky National Research Centre of Surgery, Intensive Care, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vistovskaya</LastName><ForeName>Natala</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Petrovsky National Research Centre of Surgery, Intensive Care, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chukina</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Petrovsky National Research Centre of Surgery, Intensive Care, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Belskiy</LastName><ForeName>Vladislav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Privolzhskiy District Medical Center, Department Anesthesiology and Intensive Care, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Furman</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Privolzhskiy District Medical Center, Department Anesthesiology and Intensive Care, Russian Federation.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ferrer Rocca</LastName><ForeName>Ricard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrer Rocca</LastName><ForeName>Ricard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vall D'herbon, Intensive Care Medicine, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martinez</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vall D'herbon, Intensive Care Medicine, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Casares</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Vall D'herbon, Intensive Care Medicine, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mellado Artigas</LastName><ForeName>Ricard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Clinic De Barcelona, Surgical Icu, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vera</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital De La Santa Creu I Sant Pau, Intensive Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Flores</LastName><ForeName>Matias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital De La Santa Creu I Sant Pau, Intensive Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Amador Amerigo</LastName><ForeName>Joaquin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital De Terrassa, Medicina Intensiva, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gracia Arnillas</LastName><ForeName>Maria Pilar</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Hospital Del Mar, Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Munoz Bermudez</LastName><ForeName>Rosana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Del Mar, Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Armestar</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Germans Trias I Pujol, Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Catalan</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital Germans Trias I Pujol, Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roig</LastName><ForeName>Regina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Germans Trias I Pujol, Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Raguer</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Germans Trias I Pujol, Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dolores Quesada</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Germans Trias I Pujol, Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Diaz Santos</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Parc Tauli, Icu, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gom&#xe0;</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Parc Tauli, Icu, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ubeda</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Punta De Europa, Intensive Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Salgado</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Punta De Europa, Intensive Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Forcelledo Espina</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Universitario Central De Asturia, Uci-Huca, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Garcia Prieto</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Universitario Central De Asturia, Uci-Huca, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Asensio</LastName><ForeName>Mj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, Intensive Care Unit, Servicio De Medicina Intensiva, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, Intensive Care Unit, Servicio De Medicina Intensiva, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maseda</LastName><ForeName>Dr Emilio</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, Surgical Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Suarez De La Rica</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, Surgical Critical Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ignacio Ayestaran</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitarion Son Espases, Unidad De Cuidados Intensivos, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Novo</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitarion Son Espases, Unidad De Cuidados Intensivos, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Blasco-Navalpotro</LastName><ForeName>Miguel Angel</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>University Hospital Severo Ochoa, Intensive Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Orejas Gallego</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Severo Ochoa, Intensive Care Unit, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sjovall</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sj&#xf6;vall</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Skane University Hospital, Intensive- And Perioperative Care, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Spahic</LastName><ForeName>Dzana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Skane University Hospital, Intensive- And Perioperative Care, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Johan Svensson</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ostra Sjukhuset Sahlgrenska University Hospital, Anopiva, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Haney</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ume&#xe5; University, Anesthesiology and Intensive Care Medicine, Surgical and Perioperative Sciences, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Edin</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ume&#xe5; University, Anesthesiology and Intensive Care Medicine, Surgical and Perioperative Sciences, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>&#xc5;kerlund</LastName><ForeName>Joyce</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universitetssjukhuset I Linkoping, Anopiva, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Geer</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universitetssjukhuset I Linkoping, Anopiva, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Prazak</LastName><ForeName>Josef</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buetti</LastName><ForeName>Niccol&#xf2;</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prazak</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Inselspital, Bern University Hospital, Department of Intensive Care Medicine, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jakob</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Inselspital, Bern University Hospital, Department of Intensive Care Medicine, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pagani</LastName><ForeName>Jl</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chuv, Service De M&#xe9;decine Intensive Adulte, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abed-Maillard</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chuv, Service De M&#xe9;decine Intensive Adulte, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Akova</LastName><ForeName>Murat</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aslan</LastName><ForeName>Abdullah Tar&#x131;k</ForeName><Initials>AT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akova</LastName><ForeName>Murat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hacettepe University of Faculty of Medicine, Intensive Care Unit(ICU), Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aslan</LastName><ForeName>Abdullah Tarik</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Hacettepe University of Faculty of Medicine, Intensive Care Unit(ICU), Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Timuroglu</LastName><ForeName>Arif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Anesthesiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kocagoz</LastName><ForeName>Sesin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Acibadem Fulya Hospital, Infectious Diseases, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kusoglu</LastName><ForeName>Hulya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Acibadem Fulya Hospital, Infectious Diseases, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mehtap</LastName><ForeName>Selcuk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Acibadem Kadikoy Hospital, ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ceyhun</LastName><ForeName>Solako&#x11f;lu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Acibadem Kadikoy Hospital, ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Altintas</LastName><ForeName>Dr Neriman Defne</ForeName><Initials>DND</Initials><AffiliationInfo><Affiliation>Ankara University Faculty Medicine Ibni Sina Hospital, Medical ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Talan</LastName><ForeName>Leyla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ankara University Faculty Medicine Ibni Sina Hospital, Medical ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kayaaslan</LastName><ForeName>Bircan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Ankara Yildirim Beyazit University, Ankara City Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kaya Kalem</LastName><ForeName>Ay&#x15f;e</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ankara Yildirim Beyazit University, Ankara City Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kurt</LastName><ForeName>Dr Ibrahim</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Aydin Adnan Menderes University Research Hospital, Anesthesia and Reanimation ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Telli</LastName><ForeName>Murat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aydin Adnan Menderes University Research Hospital, Anesthesia and Reanimation ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ozturk</LastName><ForeName>Barcin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Aydin Adnan Menderes University Research Hospital, Anesthesia and Reanimation ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Erol</LastName><ForeName>&#xc7;i&#x11f;dem</ForeName><Initials>&#xc7;</Initials><AffiliationInfo><Affiliation>Baskent University Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dindar Demiray</LastName><ForeName>Emine Kubra</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Bitlis Goverment Central Hospital, Bitlis Icu, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>&#xc7;olak</LastName><ForeName>Sait</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bitlis Goverment Central Hospital, Bitlis Icu, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Akbas</LastName><ForeName>T&#xfc;rkay</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Duzce University Hospital, Medical ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dr Kursat Gundogan</LastName><AffiliationInfo><Affiliation>Erciyes University, ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sari</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Erciyes University, ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Agalar</LastName><ForeName>Canan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fatih Sultan Mehmet Research and Training Hospital, Infection Diseases, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>&#xc7;olak</LastName><ForeName>Onur</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Fatih Sultan Mehmet Research and Training Hospital, Infection Diseases, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baykam</LastName><ForeName>Nurcan N</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Hitit University Erol Olcok Education and Research Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Akdogan</LastName><ForeName>Ozlem O</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>Hitit University Erol Olcok Education and Research Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yilmaz</LastName><ForeName>Mesut</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istanbul Medipol University, Kosuyolu Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tunay</LastName><ForeName>Burcu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Istanbul Medipol University, Kosuyolu Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cakmak</LastName><ForeName>Rumeysa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Istanbul Medipol University, Kosuyolu Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saltoglu</LastName><ForeName>Nese</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Sadi Sun ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karaali</LastName><ForeName>Ridvan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Sadi Sun ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Iftihar Koksal</LastName><AffiliationInfo><Affiliation>Karadeniz Technical University Faculty of Medicine, Infectious Disease and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Firdevs Aksoy</LastName><AffiliationInfo><Affiliation>Karadeniz Technical University Faculty of Medicine, Infectious Disease and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Eroglu</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Karadeniz Technical University Farabi Hospital, Anesthesia ICU 1, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tolga Saracoglu</LastName><ForeName>Kemal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Kartal Dr. Lutfi Kirdar Training and Research Hospital, ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bilir</LastName><ForeName>Yeliz</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Kartal Dr. Lutfi Kirdar Training and Research Hospital, ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Guzeldag</LastName><ForeName>Seda</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kayseri City Hospital, ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ersoz</LastName><ForeName>Gulden</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Mersin University Hospital, Department of Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Evik</LastName><ForeName>Guliz</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Mersin University Hospital, Department of Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sungurtekin</LastName><ForeName>Hulya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Pamukkale Univ, Anesthesiology and Reanimation, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ozgen</LastName><ForeName>Cansu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pamukkale Univ, Anesthesiology and Reanimation, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Erdo&#x11f;an</LastName><ForeName>Cem</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School Of Medicine, Medipol Mega University Hospitals Complex, Department of Anesthesiology and Reanimation, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>G&#xfc;rb&#xfc;z</LastName><ForeName>Yunus</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, The Department of Infectious Diseases and Clinical Microbiology and ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Altin</LastName><ForeName>Nilg&#xfc;n</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, The Department of Infectious Diseases and Clinical Microbiology and ICU, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bayindir</LastName><ForeName>Yasar</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Turgut Ozal Medical Center, Department of Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ersoy</LastName><ForeName>Yasemin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Turgut Ozal Medical Center, Department of Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Goksu</LastName><ForeName>Senay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Health Sciences Istanbul Umraniye Training and Research Hospital, Anaestesia and Reanimation, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Akyol</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Health Sciences Istanbul Umraniye Training and Research Hospital, Anaestesia and Reanimation, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dr</LastName><ForeName>Kartal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Health Sciences, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Batirel</LastName><ForeName>Ayse</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lutfi Kirdar Training and Research Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cagan Aktas</LastName><ForeName>Sabahat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Lutfi Kirdar Training and Research Hospital, Infectious Diseases and Clinical Microbiology, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Andrew Conway</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conway Morris</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Addenbrookes Hospital, John V Farman Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Routledge</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Addenbrookes Hospital, John V Farman Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Conway Morris</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Addenbrookes Hospital, Neurocritical Care Unit (NCCU), United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ercole</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Addenbrookes Hospital, Neurocritical Care Unit (NCCU), United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Antcliffe</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Charing Cross Hospital - Imperial College NHS Trust, Intensive Care Unit, Level 11, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rojo</LastName><ForeName>Roceld</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Charing Cross Hospital - Imperial College NHS Trust, Intensive Care Unit, Level 11, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tizard</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Countess Of Chester Foundation Trust, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Faulkner</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Countess Of Chester Foundation Trust, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cowton</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Darlington Memorial Hospital Intensive Care Unit, County Durham and Darlington NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kent</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Darlington Memorial Hospital Intensive Care Unit, County Durham and Darlington NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Raj</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Croydon University Hospital, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zormpa</LastName><ForeName>Artemis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Croydon University Hospital, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tinaslanidis</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Croydon University Hospital, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khade</LastName><ForeName>Reena</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Croydon University Hospital, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Torlinski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department Of Anaesthetics and Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mulhi</LastName><ForeName>Randeep</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department Of Anaesthetics and Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Goyal</LastName><ForeName>Shraddha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department Of Anaesthetics and Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bajaj</LastName><ForeName>Manan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department Of Anaesthetics and Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soltan</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department Of Anaesthetics and Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yonan</LastName><ForeName>Aimee</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Of Anaesthetics and Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dolan</LastName><ForeName>Rachael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department Of Anaesthetics and Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Aimee</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Of Microbiology, Queen Elizabeth Hospital Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Macfie</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Freeman Hospital, ICCU 37, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lennard</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Freeman Hospital, ICCU 37, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Templeton</LastName><ForeName>Maie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hammersmith Hospital - Imperial College NHS Trust, Intensive Care Unit, Level 11, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sousa Arias</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hammersmith Hospital - Imperial College NHS Trust, Intensive Care Unit, Level 11, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Franke</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>James Cook University Hospital, Icu2/3, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hugill</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>James Cook University Hospital, Icu2/3, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Angell</LastName><ForeName>Hollie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Medway Maritime Hospital, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Benjamin J Parcell</LastName><AffiliationInfo><Affiliation>Ninewells Hospital and Medical School NHS Tayside, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cobb</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Ninewells Hospital and Medical School NHS Tayside, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cole</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ninewells Hospital and Medical School NHS Tayside, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>North Cumbria University Hospitals NHS Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Graham</LastName><ForeName>Clive</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>North Cumbria University Hospitals NHS Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cerman</LastName><ForeName>Jaroslav</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>North Manchester General Hospital, Critical Care Ward, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Keegan</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>North Manchester General Hospital, Critical Care Ward, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ritzema</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Gateshead Health NHS Foundation Trust, Critical Care Department, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sanderson</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Gateshead Health NHS Foundation Trust, Critical Care Department, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roshdy</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Szakmany</LastName><ForeName>Tamas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Royal Gwent Hospital, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baumer</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Royal Gwent Hospital, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Longbottom</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal London Hospital, Adult Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hall</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Royal London Hospital, Adult Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tatham</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Royal Marsden NHS Foundation Trust, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Loftus</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Marsden NHS Foundation Trust, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Husain</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Royal Marsden NHS Foundation Trust, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Black</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Royal Marsden NHS Foundation Trust, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jhanji</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Marsden NHS Foundation Trust, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rao Baikady</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal Marsden NHS Foundation Trust, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mcguigan</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal Victoria Hospital, Regional Intensive Care Unit, Belfast, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mckee</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal Victoria Hospital, Regional Intensive Care Unit, Belfast, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kannan</LastName><ForeName>Santhana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sandwell And West Birmingham Hospitals NHS Trust, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Antrolikar</LastName><ForeName>Supriya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sandwell And West Birmingham Hospitals NHS Trust, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marsden</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sandwell And West Birmingham Hospitals NHS Trust, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Della Torre</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>St Mary's Hospital - Imperial College NHS Trust, Intensive Care Unit, Level 11, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Banach</LastName><ForeName>Dorota</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St Mary's Hospital - Imperial College NHS Trust, Intensive Care Unit, Level 11, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zaki</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stepping Hill Hospital, Stepping Hill ICU, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stepping Hill Hospital, Stepping Hill ICU, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chikungwa</LastName><ForeName>Moses</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospitals of North Midlands, Critical Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Attwood</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Warwick Hospital, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Warwick Hospital, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rebecca E Tilley</LastName><AffiliationInfo><Affiliation>West Suffolk NHS Foundation Trust, Critical Care, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Sally K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>West Suffolk NHS Foundation Trust, Critical Care, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jean Renaud</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Wirral University Teaching Hospital, Intensive Care Unit, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sokhan</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kharkiv Clinical Infectious Diseases Hospital, Intensive Care, Ukraine.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Burma</LastName><ForeName>Yaroslava</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Kharkiv Clinical Infectious Diseases Hospital, Intensive Care, Ukraine.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sligl</LastName><ForeName>Wendy</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sligl</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University of Alberta Hospital, General Systems Intensive Care Unit (Gsicu), Canada.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baig</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Alberta Hospital, General Systems Intensive Care Unit (Gsicu), Canada.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>McCoshen</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Alberta Hospital, General Systems Intensive Care Unit (Gsicu), Canada.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kutsogiannis</LastName><ForeName>Demetrios J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Royal Alexandra Hospital, General Systems Intensive Care Unit (Gsicu), Canada.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sligl</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Royal Alexandra Hospital, General Systems Intensive Care Unit (Gsicu), Canada.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal Alexandra Hospital, General Systems Intensive Care Unit (Gsicu), Canada.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hewer</LastName><ForeName>Tayne</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Royal Alexandra Hospital, General Systems Intensive Care Unit (Gsicu), Canada.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rabbani</LastName><ForeName>Raihan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rabbani</LastName><ForeName>Raihan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>General Icu, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Huq</LastName><ForeName>Shihan Mahmud Redwanul</ForeName><Initials>SMR</Initials><AffiliationInfo><Affiliation>General Icu, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hasan</LastName><ForeName>Rajib</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Asgar Ali Hospital, Critical Care Medicine, Bangladesh.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Motiul Islam</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Asgar Ali Hospital, Critical Care Medicine, Bangladesh.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gurjar</LastName><ForeName>Mohan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gurjar</LastName><ForeName>Mohan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Department of Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baronia</LastName><ForeName>Arvind</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Department of Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kothari</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>All India Institute of Medical Sciences (AIIMS) Jodhpur, Department of Anaesthesiology &amp; Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Ankur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>All India Institute of Medical Sciences (AIIMS) Jodhpur, Department of Anaesthesiology &amp; Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karmakar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>All India Institute of Medical Sciences (AIIMS), Pulmonary Medicine ICU, Department of Pulmonary Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>All India Institute of Medical Sciences (AIIMS), Pulmonary Medicine ICU, Department of Pulmonary Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nimbolkar</LastName><ForeName>Janardan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Breach Candy Hospital Trust, SICU, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Samdani</LastName><ForeName>Pratit</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Breach Candy Hospital Trust, SICU, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vaidyanathan</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cauvery Heart And Multi-Speciality Hospital, MICU, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ahmedi Rubina</LastName><ForeName>Noor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cauvery Heart And Multi-Speciality Hospital, MICU, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jain</LastName><ForeName>Nikhilesh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CHL Hospitals, Dept of Critical Care Services, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pahuja</LastName><ForeName>Madhumati</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHL Hospitals, Dept of Critical Care Services, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Indira Gandhi Institute of Medical Sciences, Trauma &amp; Emergency, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Shekhar</LastName><ForeName>Saurav</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Indira Gandhi Institute of Medical Sciences, Trauma &amp; Emergency, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Syed</LastName><ForeName>Nabeel Muzaffar</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>King George's Medical University, Department of Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ozair</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King George's Medical University, Department of Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sarwar Siddiqui</LastName><ForeName>Suhail</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King George's Medical University, Department of Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bose</LastName><ForeName>Payel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medica Superspecialty Hospital, Medica Institute of Critical Care, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Datta</LastName><ForeName>Avijatri</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medica Superspecialty Hospital, Medica Institute of Critical Care, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rathod</LastName><ForeName>Darshana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sir H N Reliance Foundation Hospital, Critical Care Unit, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Mayur</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sir H N Reliance Foundation Hospital, Critical Care Unit, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mk</LastName><ForeName>Renuka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sri Ramachandra Institute of Higher Education and Research, Department of Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sailaja</LastName><ForeName>K Baby</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Sri Ramachandra Institute of Higher Education and Research, Department of Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dsilva</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>St Johns Medical College Hospital, Department of Critical Care Medicine, MICU, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chandran</LastName><ForeName>Jagadish</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St Johns Medical College Hospital, Department of Critical Care Medicine, MICU, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Pralay</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Tata Medical Center, Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Sudipta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tata Medical Center, Critical Care Medicine, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sheshala</LastName><ForeName>Kaladhar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Yashoda Hospital, Somajiguda, Hyderabad, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chandra Misra</LastName><ForeName>Krushna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Yashoda Hospital, Somajiguda, Hyderabad, India.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Adekola</LastName><ForeName>Oyebola O</ForeName><Initials>OO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yusuf Yakubu</LastName><ForeName>Saidu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ahmadu Bello University Teaching Hospital Shika Zaria Abuth Zari, Icu Abuth Zaria, Nigeria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mgbosoro Ugwu</LastName><ForeName>Euphemia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ahmadu Bello University Teaching Hospital Shika Zaria Abuth Zari, Icu Abuth Zaria, Nigeria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Olatosi</LastName><ForeName>John O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Lagos University Teaching Hospital, Department of Anaesthesia And Intensive Care, Nigeria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Desalu</LastName><ForeName>Ibironke</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Lagos University Teaching Hospital, Department of Anaesthesia And Intensive Care, Nigeria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Asiyanbi</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>One Life Hospital, One Life Intensive Care Unit, Nigeria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oladimeji</LastName><ForeName>Motunrayo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>One Life Hospital, One Life Intensive Care Unit, Nigeria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Idowu</LastName><ForeName>Olusola</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University College Hospital, Anaesthesia, Nigeria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Adeola</LastName><ForeName>Fowotade</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University College Hospital, Anaesthesia, Nigeria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mer</LastName><ForeName>Mervyn</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mer</LastName><ForeName>Mervyn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Charlotte Maxeke Johannesburg Academic Hospital, Ward 576, South Africa.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mc Cree</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Charlotte Maxeke Johannesburg Academic Hospital, Ward 576, South Africa.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>El Sanousi</LastName><ForeName>Dr Bashir</ForeName><Initials>DB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adil Ali Karar</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Al-Rajhi Hospital, Medicine, Sudan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saidahmed</LastName><ForeName>Elfayadh</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>East Nile Hospital, Intensive Care Unit, Sudan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hamid</LastName><ForeName>Hytham K S</ForeName><Initials>HKS</Initials><AffiliationInfo><Affiliation>East Nile Hospital, Intensive Care Unit, Sudan.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>21</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>19</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39326671</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2024.09.011</ArticleId><ArticleId IdType="pii">S1198-743X(24)00443-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37093571</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2771-1897</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Urogynecology (Philadelphia, Pa.)</Title><ISOAbbreviation>Urogynecology (Phila)</ISOAbbreviation></Journal><ArticleTitle>Voiding Trial Outcomes After Prolapse Surgery: Before Versus During the COVID-19 Pandemic.</ArticleTitle><Pagination><StartPage>836</StartPage><EndPage>843</EndPage><MedlinePgn>836-843</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SPV.0000000000001352</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Coronavirus disease 2019 (COVID-19) has changed practice patterns resulting in same-day discharge after most urogynecologic surgical procedures.</AbstractText><AbstractText Label="OBJECTIVE">We aimed to determine if COVID-19 practice patterns changed patients' voiding trial (VT) results after surgery.</AbstractText><AbstractText Label="STUDY DESIGN">This is a retrospective cohort study of women undergoing urogynecologic surgery at an academic tertiary care center. We compared patients who had surgery between January 1, 2019, and February 28, 2020, (pre-COVID, discharged on postoperative day [POD] 1) with those who underwent surgery between January 1, 2021, and February 28, 2022, (during COVID, discharged on POD 0 or POD 1). Demographics, surgical characteristics, and VT results were compared using nonparametric tests. A logistic regression was performed to adjust for confounders. P value &lt;0.05 was considered statistically significant.</AbstractText><AbstractText Label="RESULTS">A total of 237 patients were included. Patients were mostly White, older than 65 years (interquartile range, 56-73 years), and had a median parity of 2 (interquartile range, 2-3). Approximately 31% of patients in the pre-COVID group failed their VT, whereas 38% in the during-COVID group failed ( P = 0.275). Moreover, 40.5% of women discharged the day of surgery failed their VT ( P = 0.172). Compared with the pre-COVID group, more patients in the during-COVID group and those discharged on POD 0 contacted their surgeons with questions postoperatively (20.5% vs 35.0% and 35.4%, P = 0.014 and 0.022, respectively). Rates of urinary tract infection were similar by period and discharge day ( P &gt; 0.05). There was no statistical association between day of discharge or the COVID-19 pandemic and VT results.</AbstractText><AbstractText Label="CONCLUSIONS">Neither day of discharge nor the presence of the COVID-19 pandemic had a significant effect on postoperative outcomes, including urinary retention, after urogynecologic surgery. Same-day discharge is appropriate for most patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American Urogynecologic Society. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Courtepatte</LastName><ForeName>Alexa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Division of Urogynecology, Department of OB/GYN, Brigham and Women's Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranne</LastName><ForeName>Jeannine M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Tayler</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Maura</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Minassian</LastName><ForeName>Vatche A</ForeName><Initials>VA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Urogynecology (Phila)</MedlineTA><NlmUniqueID>9918452588006676</NlmUniqueID><ISSNLinking>2771-1897</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056887" MajorTopicYN="Y">Pelvic Organ Prolapse</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016055" MajorTopicYN="Y">Urinary Retention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>J.M.M. is an advisor for Attn: Grace. The rest of authors have declared they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>11</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37093571</ArticleId><ArticleId IdType="doi">10.1097/SPV.0000000000001352</ArticleId><ArticleId IdType="pii">02273501-202310000-00007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dreijer B, Moller MH, Bartholdy J. Post-operative urinary retention in a general surgical population. Eur J Anaesthesiol 2011;28(3):190&#x2013;194. doi:10.1097/EJA.0b013e328341ac3b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328341ac3b</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf8;dker B, Lose G. Postoperative urinary retention in gynecologic patients. Int Urogynecol J Pelvic Floor Dysfunct 2003;14(2):94&#x2013;97. doi.org/10.1007/s00192-003-1038-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00192-003-1038-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao L, Mansuria S. Postoperative bladder filling after outpatient laparoscopic hysterectomy and time to discharge: a randomized controlled trial. Obstet Gynecol 2019;133(5):879&#x2013;887. doi:10.1097/AOG.0000000000003191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000003191</ArticleId></ArticleIdList></Reference><Reference><Citation>Beninato T, Laird AM, Graves CE, et al. Impact of the COVID-19 pandemic on the practice of endocrine surgery. Am J Surg 2022;223(4):670&#x2013;675. doi.org/10.1016/j.amjsurg.2021.07.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2021.07.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarac BA, Schoenbrunner AR, Wilson SC, et al. The impact of COVID-19-based suspension of surgeries on plastic surgery practices: a survey of ACAPS members. Plast Reconstr Surg Glob Open 2020;8(8):e3119. doi.org/10.1097%2FGOX.0000000000003119 .</Citation></Reference><Reference><Citation>Abaza R, Kogan P, Martinez O. Impact of the COVID-19 crisis on same-day discharge after robotic urologic surgery. Urology 2021;149:40&#x2013;45. doi.org/10.1016/j.urology.2021.01.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2021.01.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter-Brooks CM, Zyczynski HM, Moalli PA, et al. Early catheter removal after pelvic floor reconstructive surgery: a randomized trial. Int Urogynecol J 2018;29(8):1203&#x2013;1212. doi.org/10.1007/s00192-018-3641-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00192-018-3641-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan P, Raghavan SS, Sharma D. Study comparing 3 hour and 24 hour post-operative removal of bladder catheter and vaginal pack following vaginal surgery: a randomised controlled trial. BMC Womens Health 2017;17(1):78. doi.org/10.1186/s12905-017-0431-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12905-017-0431-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie N, Hu Z, Ye Z, et al. A systematic review comparing early with late removal of indwelling urinary catheters after pelvic organ prolapse surgery. Int Urogynecol J 2021;32(6):1361&#x2013;1372. doi.org/10.1007/s00192-020-04522-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00192-020-04522-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Gonzalez S, Franco EM, Martinez-Cumplido R, et al. Reducing postoperative catheterisation after anterior colporrhaphy from 48 to 24 h: a randomised controlled trial. Int Urogynecol J 2019;30(11):1897&#x2013;1902. Available at: doi.org/10.1007/s00192-018-3818-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00192-018-3818-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabh-Patel V, Popiel P, Salamon C. Indwelling versus immediate removal of transurethral catheter after robotic sacrocolpopexy: a randomized clinical trial. Female Pelvic Med Reconstr Surg 2020;26(10):617&#x2013;621. doi:10.1097/SPV.0000000000000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SPV.0000000000000646</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons. COVID-19: Guidance for Triage of Non-Emergent Surgical Procedures Mar 17, 2020. Available at: https://www.facs.org/for-medical-professionals/covid-19/clinical-guidance/triage/ . Accessed August 10, 2022.</Citation></Reference><Reference><Citation>Dieter AA, Conklin JL, Willis-Gray MG, et al. A systematic review of randomized trials investigating methods of postoperative void trials following benign gynecologic and Urogynecologic surgeries. J Minim invasive Gynecol 2021;28(6):1160&#x2013;1170.e2. doi.org/10.1016/j.jmig.2021.01.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmig.2021.01.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Czeisler M&#xc9;, Marynak K, Clarke KEN, et al. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020. MMWR Morb Mortal Wkly Rep 2020;69(36):1250&#x2013;1257. Published 2020 Sep 11. doi:10.15585/mmwr.mm6936a4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6936a4</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35404130</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9034</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of laparoendoscopic &amp; advanced surgical techniques. Part A</Title><ISOAbbreviation>J Laparoendosc Adv Surg Tech A</ISOAbbreviation></Journal><ArticleTitle>Valveless Trocar Versus Standard Pneumoperitoneum Insufflation System in Minimally Invasive Surgery: Impact on Postoperative Pain. A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>978</StartPage><EndPage>986</EndPage><MedlinePgn>978-986</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/lap.2022.0022</ELocationID><Abstract><AbstractText><b><i>Background:</i></b> The benefits of a valid pneumoperitoneum in laparoscopic surgery are counterbalanced by the possible negative effects of increased abdominal pressure and carbon dioxide (CO<sub>2</sub>) insufflation, which are crucial factors in causing postoperative pain. The purpose of this work is to evaluate the effectiveness of the valveless trocar (VT) insufflation system in decreasing postoperative pain and influencing operative time, compared to a standard insufflation system. <b><i>Methods:</i></b> A systematic research was performed using MEDLINE, EMBASE, Central Cochrane Library, and CINAHL Plus for studies published up to June 2020. Randomized controlled trials (RCTs) on adult population evaluating the effects of VT versus a standard insufflation system in laparoscopic surgery and reporting postoperative pain level and operative time were included in the analysis. Data and study quality indicators were extracted independently by 2 authors using a standardized form. Statistical analysis was based on a random effect model, using the inverse variance method. <b><i>Results:</i></b> We identified 3 RCTs for a total of 245 patients. The meta-analysis showed a statistically significant reduction in shoulder pain with the use of VT at 24 hours: mean difference (MD) -7.9% (95% confidence interval [95% CI]: -1.29 to 0.29; <i>z</i>&#x2009;=&#x2009;3.08; <i>P</i>&#x2009;=&#x2009;.002) and a nonstatistically significant increase in operation time: MD 5.80 (95% CI: -8.93 to 20.54; <i>P</i>&#x2009;=&#x2009;.44). <b><i>Conclusion:</i></b> Our study suggests a better shoulder pain control at 24 hours postoperation using new-generation VT for laparoscopic surgery compared to standard insufflation system. Weak evidence of increased operating time with the VT was observed considering only two of the three RCTs. PROSPERO registration number: CRD42020191835.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Claroni</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3323-616X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morettini</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Research Institute on Sustainable Economic Growth of the National Research Council of Italy, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tola</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covotta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forastiere</LastName><ForeName>Ester</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torregiani</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Laparoendosc Adv Surg Tech A</MedlineTA><NlmUniqueID>9706293</NlmUniqueID><ISSNLinking>1092-6429</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007327" MajorTopicYN="Y">Insufflation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011027" MajorTopicYN="Y">Pneumoperitoneum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020069" MajorTopicYN="N">Shoulder Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013525" MajorTopicYN="N">Surgical Instruments</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">insufflation system</Keyword><Keyword MajorTopicYN="N">laparoscopic surgery</Keyword><Keyword MajorTopicYN="N">operative time</Keyword><Keyword MajorTopicYN="N">pneumoperitoneum</Keyword><Keyword MajorTopicYN="N">postoperative pain</Keyword><Keyword MajorTopicYN="N">valveless trocar</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>11</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35404130</ArticleId><ArticleId IdType="doi">10.1089/lap.2022.0022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30678785</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Catheter Ablation of Ventricular Tachycardia in Patients With a Ventricular Assist Device: A&#xa0;Systematic Review of Procedural Characteristics and&#xa0;Outcomes.</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>51</EndPage><MedlinePgn>39-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2018.08.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(18)30671-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This is a systematic review summarizing the procedural characteristics and outcomes of ventricular assist device (VAD)-related ventricular tachycardia (VT) ablation.</AbstractText><AbstractText Label="BACKGROUND">Drug-refractory VT refractory commonly develops post-VAD implantation. Procedural and outcome data come from small series or case reports.</AbstractText><AbstractText Label="METHODS">An electronic search was performed using major databases. Primary outcomes were VT recurrence, mortality, and cardiac transplantation. Secondary endpoints were acute procedural success and procedural complications.</AbstractText><AbstractText Label="RESULTS">Eighteen studies were included, with a total of 110 patients (mean age 59.6 &#xb1; 11 years, 89% men; VT storm 34%). Scar-related re-entry was the predominant mechanism of VT (90.3%) and cannula-related VT in 19.3% cases. Electroanatomical mapping interference occurred in 1.8% of cases; there were no reports of catheter entrapment. Noninducibility of clinical VT was achieved in 77.9%; procedural complications occurred in 9.4%. At a mean follow-up of 263.5 &#xb1; 267.0 days, VT recurred in 43.6%, 23.4% underwent cardiac transplant, and 48.1% died. There were no procedural-related deaths and no death was directly related to ventricular arrhythmia. In follow-up, there was a significant reduction in implantable cardioverter-defibrillator therapies or shocks (57.1% vs. 23.8%). Ablation allowed VT storm termination in 90% of patients.</AbstractText><AbstractText Label="CONCLUSIONS">VAD-related VT is predominantly related to pre-existing intrinsic myocardial scar rather than inflow cannula site insertion. Catheter ablation is a reasonable treatment strategy, albeit with expectedly high rate of recurrence, transplantation, and mortality related to severe underlying disease.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2019. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohaib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayward</LastName><ForeName>Christopher S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Heart Failure and Transplant Unit, Department of Cardiology, St. Vincent's Hospital, Darlinghurst, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muthiah</LastName><ForeName>Kavitha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Heart Failure and Transplant Unit, Department of Cardiology, St. Vincent's Hospital, Darlinghurst, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalman</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, Australia; Department of Cardiology, Westmead Applied Research Centre, University of Sydney, Westmead, Australia. Electronic address: saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2019 Jan;5(1):52-54. doi: 10.1016/j.jacep.2018.09.011.</RefSource><PMID Version="1">30678786</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016027" MajorTopicYN="N">Heart Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BIVAD</Keyword><Keyword MajorTopicYN="N">LVAD</Keyword><Keyword MajorTopicYN="N">RVAD</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">mechanical support</Keyword><Keyword MajorTopicYN="N">radiofrequency ablation</Keyword><Keyword MajorTopicYN="N">ventricular assist device</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30678785</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2018.08.009</ArticleId><ArticleId IdType="pii">S2405-500X(18)30671-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27574120</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>12</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Substrate-Based Ablation Versus Ablation Guided by Activation and Entrainment Mapping for Ventricular Tachycardia: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1437</StartPage><EndPage>1447</EndPage><MedlinePgn>1437-1447</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.13088</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Substrate-based ablation for scar-related ventricular tachycardia (VT) has gained prominence: however, there is limited data comparing it to ablation guided predominantly by activation and entrainment mapping of inducible and hemodynamically tolerated VTs. We compared the acute procedural efficacy and outcomes of predominantly substrate-based ablation versus ablation guided predominantly by activation and entrainment mapping.</AbstractText><AbstractText Label="METHODS AND RESULTS">Database searches through April 2016 identified 6 eligible studies (enrolling 403 patients, with 1 randomized study) comparing the 2 strategies. The relative risk of VT recurrence at follow-up was assessed as the primary outcome using a random-effects meta-analysis. Secondary endpoints of acute success (based on noninducibility of VT), procedural complications, and mortality were assessed using weighted mean difference with the random effects model. At a median follow-up of 18 months, the relative risk (RR) of VT recurrence was not significantly different with substrate-based versus activation/entrainment guided VT ablation (0.72, 95% confidence interval [CI] 0.44-1.18), P = 0.2). Acute success (RR 1.02, 95% CI 0.95-1.1, P = 0.6), procedural complications (RR 0.8, 95% CI 0.35-1.82, P = 0.5) cardiovascular mortality and total mortality did not differ significantly (RR 0.83, 95% CI 0.38-1.79, P = 0.6 and RR 0.76, 95% CI 0.36-1.59, P = 0.5, respectively).</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis demonstrates similar acute procedural efficacy, and complications, VT recurrence and mortality rates when comparing a predominantly substrate-based ablation strategy to a strategy guided predominantly by activation and entrainment mapping of inducible and hemodynamically tolerated VTs.</AbstractText><CopyrightInformation>&#xa9; 2016 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldinger</LastName><ForeName>Samuel H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Bern University Hospital and University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahida</LastName><ForeName>Saagar N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedrow</LastName><ForeName>Usha B</ForeName><Initials>UB</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>William G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">activation mapping</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">entrainment mapping</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">substrate mapping</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27574120</ArticleId><ArticleId IdType="doi">10.1111/jce.13088</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40381757</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-6280</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Current problems in cardiology</Title><ISOAbbreviation>Curr Probl Cardiol</ISOAbbreviation></Journal><ArticleTitle>Incidence and outcomes of acute myocardial infarction with arrhythmic onset: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>103077</StartPage><MedlinePgn>103077</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cpcardiol.2025.103077</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0146-2806(25)00099-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Patients with acute coronary syndrome (ACS) have concomitant ventricular arrhythmic events (VA). Literature data are conflicting regarding short- and long-term prognosis. International guidelines do not recommend defibrillator (ICD) implantation in the first 40 days after a myocardial infarction. However, some patients may have an increased arrhythmic risk and deserve closer monitoring.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of our study was to define the incidence of arrhythmic events in a population of patients admitted for ACS to the Cardiac Intensive Care Unit (CICU) of a tertiary center and to determine the short- and long-term prognosis in patients with arrhythmic onset compared with patients without arrhythmic onset.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a single-center retrospective cohort data analysis of 1587 consecutive patients admitted with a diagnosis of ACS to the CICU of Niguarda Hospital of Milan, from 2014 to 2022. We classified the patients into two groups according to the arrhythmias at presentation: VA (sustained VT or VF) and no-VA. Kaplan-Meier (KM) estimated the probability of remaining event free in the time after ACS and were compared between VA and no-VA groups, using the log-rank test. Cox regression analysis was used to explore the association of specific variables with the occurrence of cardiac events in univariate and multivariate analysis. Statistical analyses were performed with R 42.0 statistical package (R Core Team, Vienna, Austria).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 1587 ASC patients, 4.6 % had arrhythmic onset (4.0 had a diagnosis of VF and 0.6 % of VT). Patients with VA were significantly younger (63 y. vs 67 y., p = 0.026) and had a lower incidence of cardiovascular risk factors, such as hypertension and dyslipidemia, compared with no-VA group. VA group had a higher risk of arrhythmias during the hospitalization (9.6 % vs 1.3 %, p &lt; 0.001) and had a clinical course characterized by a significantly higher use of mechanical support with intra-aortic balloon pumps (IABP, 35.6 % vs. 6.8 %, p &lt; 0.001) and a greater use of inotropic drugs (34 % vs. 9 %, p &lt; 0.001). We observed in VA group a six-fold increase in-hospital mortality (23 % vs 4 %, p &lt; 0.001), identifying arrhythmic presentation as a marker of worse in-hospital prognosis in patients admitted with ACS. Likewise, mortality at 40 days after the acute event was higher in the VA group than in the no-VA group (22 % vs. 5 %, p &lt; 0.001). Conversely, during a median follow-up of 5.9 years, VA onset did not affect long-term mortality in patients discharged alive.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this long-term follow-up retrospective registry involving a large cohort of patients with ACS admitted to the CICU, concomitant VA at admission was found to be linked with an increase in in-hospital arrhythmic complications and in-hospital mortality. The mortality rate at 40 days post-ACS was also notably higher in the VA group. This study underscores the complexity of arrhythmic presentation in ACS patients, emphasizing the critical need for vigilant monitoring throughout their hospitalization and particularly in the initial 6 weeks following the event index. This heightened surveillance is justified by the documented elevated levels of morbidity and mortality during this phase.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varrenti</LastName><ForeName>Marisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solfanelli</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa, 1035-1039, 00189 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernasconi</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bicocca Bioinformatics Biostatistics and Bioimaging Center, School of Medicine and Surgery, University of Milano-Bicocca, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regazzetti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy; Department of Medicine and Surgery, Bicocca University, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galasso</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy; Department of Medicine and Surgery, Bicocca University, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preda</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbonaro</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baroni</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gigli</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracini</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargiu</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavecchia</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viola</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villanova</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oreglia</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannattasio</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy; Department of Medicine and Surgery, Bicocca University, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzone</LastName><ForeName>Patrizio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy. Electronic address: Patrizio.mazzone@ospedaleniguarda.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacco</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Probl Cardiol</MedlineTA><NlmUniqueID>7701802</NlmUniqueID><ISSNLinking>0146-2806</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Sudden death</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmia</Keyword></KeywordList><CoiStatement>Declaration of competing interest There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>12</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>18</Day><Hour>17</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>17</Day><Hour>19</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40381757</ArticleId><ArticleId IdType="doi">10.1016/j.cpcardiol.2025.103077</ArticleId><ArticleId IdType="pii">S0146-2806(25)00099-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29680972</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>207</StartPage><EndPage>215</EndPage><MedlinePgn>207-215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-018-0376-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Catheter ablation is proven to be an effective strategy for drug refractory ventricular tachycardia (VT) in ischemic cardiomyopathy. However, the appropriate timing of VT ablation and identifying the group of patients that may receive the greatest benefit remains uncertain. There is limited data on the effect on prophylactic catheter ablation (PCA) in the prevention of implantable cardioverter defibrillator (ICD) therapy, electrical storm, and mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a comprehensive literature search through November 1, 2017, for all eligible studies comparing PCA + ICD versus ICD only in eligible patients with ischemic cardiomyopathy. Clinical outcomes included all ICD therapies including ICD shocks and electrical storm. Additional outcomes included all-cause mortality, cardiovascular mortality, and complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three randomized controlled trials (RCTs) (N&#x2009;=&#x2009;346) met inclusion criteria. PCA was associated with a significantly lower ICD therapies (OR 0.49; CI 0.28 to 0.87; p&#x2009;=&#x2009;0.01) including ICD shocks [OR 0.38; CI 0.22 to 0.64; p&#x2009;=&#x2009;0.0003) and electrical storm (OR 0.55; CI 0.30 to 1.01; p&#x2009;=&#x2009;0.05) when compared with ICD only. There was no significant difference in all-cause mortality (OR 0.77; CI 0.41 to 1.46; p&#x2009;=&#x2009;0.42), cardiovascular mortality (OR 0.49; CI 0.16 to 1.50; p&#x2009;=&#x2009;0.21), and major adverse events (OR 1.45; CI 0.52 to 4.01; p&#x2009;=&#x2009;0.47) between two groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results suggest prophylactic catheter ablation decreases ICD therapies, including shocks and electrical storm with no improvement in overall mortality. There is a need for future carefully designed randomized clinical trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Atti</LastName><ForeName>Varunsiri</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0151-1545</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Michigan State University, East Lansing, MI, USA. varunsiri7@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuddanda</LastName><ForeName>Venkat</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turagam</LastName><ForeName>Mohit K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Helmsley Electrophysiology Center, Mount Sinai School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vemula</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Sparrow Hospital, Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Zubair</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagam</LastName><ForeName>Himakar</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yandrapalli</LastName><ForeName>Srikanth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, New York Medical College, Valhalla, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jazayeri</LastName><ForeName>Mohammad-Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute, Kansas University Hospital, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koerber</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Medical University of South Carolina, Columbia, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Juan Viles</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Center, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Helmsley Electrophysiology Center, Mount Sinai School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute, Kansas University Hospital, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011322" MajorTopicYN="N">Primary Prevention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electrical storm</Keyword><Keyword MajorTopicYN="N">ICD shock</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia ablation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29680972</ArticleId><ArticleId IdType="doi">10.1007/s10840-018-0376-5</ArticleId><ArticleId IdType="pii">10.1007/s10840-018-0376-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heart Rhythm. 2016 Aug;13(8):1748-54</Citation><ArticleIdList><ArticleId IdType="pubmed">27050910</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18387436</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Clin Electrophysiol. 2017 Jul;3(7):767-778</Citation><ArticleIdList><ArticleId IdType="pubmed">29759543</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2011 Oct;22(10):1123-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21539642</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1997 Nov 27;337(22):1576-83</Citation><ArticleIdList><ArticleId IdType="pubmed">9411221</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2001 Aug 7;104(6):664-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11489772</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Jul 14;375(2):111-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cardiovasc Med. 2017 Oct;27(7):506-513</Citation><ArticleIdList><ArticleId IdType="pubmed">28625728</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2014 Jun;7(3):424-35</Citation><ArticleIdList><ArticleId IdType="pubmed">24833642</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Clin Electrophysiol. 2018 Mar;4(3):374-382</Citation><ArticleIdList><ArticleId IdType="pubmed">30089564</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2015 Sep;12(9):1997-2007</Citation><ArticleIdList><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Jan 11;295(2):165-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2017 Mar;10(3):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 2;375(9708):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Mar 21;346(12):877-83</Citation><ArticleIdList><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2009 Jun;11(6):771-817</Citation><ArticleIdList><ArticleId IdType="pubmed">19443434</ArticleId></ArticleIdList></Reference><Reference><Citation>Card Electrophysiol Clin. 2017 Mar;9(1):153-165</Citation><ArticleIdList><ArticleId IdType="pubmed">28167083</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2000 Mar 21;101(11):1288-96</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1991 Oct;18(4):1005-14</Citation><ArticleIdList><ArticleId IdType="pubmed">1894846</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrhythm Electrophysiol Rev. 2015 Dec;4(3):177-83</Citation><ArticleIdList><ArticleId IdType="pubmed">26835122</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2014 Jan 21;129(3):e28-e292</Citation><ArticleIdList><ArticleId IdType="pubmed">24352519</ArticleId></ArticleIdList></Reference><Reference><Citation>J Arrhythm. 2015 Jun;31(3):122-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26336545</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrhythm Electrophysiol Rev. 2017 Aug;6(3):125-128</Citation><ArticleIdList><ArticleId IdType="pubmed">29018520</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Sep 4;359(10):1009-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2012 Oct 23;126(17):2146-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23008437</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2018 Mar;15(3):355-362</Citation><ArticleIdList><ArticleId IdType="pubmed">29030235</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2015 Dec 29;66(25):2872-2882</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Lung Circ. 2012 Jun;21(6-7):402-12</Citation><ArticleIdList><ArticleId IdType="pubmed">22237136</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2012 Jul 10;60(2):132-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22766340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2010 May 25;55(21):2366-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20488308</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Oct;11(10):e166-96</Citation><ArticleIdList><ArticleId IdType="pubmed">25179489</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2012 Aug;9(8):1192-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22465295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 Aug 18;151(4):264-9, W64</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 2009 Mar;84(3):289-97</Citation><ArticleIdList><ArticleId IdType="pubmed">19252119</ArticleId></ArticleIdList></Reference><Reference><Citation>Card Electrophysiol Clin. 2017 Mar;9(1):25-46</Citation><ArticleIdList><ArticleId IdType="pubmed">28167084</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2016 Jul;13(7):1552-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26961297</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Nov;11(11):2056-63</Citation><ArticleIdList><ArticleId IdType="pubmed">25016150</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Jan 29;117(4):462-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18172038</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2010 Jul;21(7):799-803</Citation><ArticleIdList><ArticleId IdType="pubmed">20132389</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Oct 18;343:d5928</Citation><ArticleIdList><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2002 Aug;144(2):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12177646</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2007 Nov;4(11):1395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">17954398</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1144-51</Citation><ArticleIdList><ArticleId IdType="pubmed">25262159</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35578170</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative low tidal volume ventilation and the risk of ICD-10 coded delirium and the use for antipsychotic medications.</ArticleTitle><Pagination><StartPage>149</StartPage><MedlinePgn>149</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">149</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-022-01689-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Low tidal volume (V<sub>T</sub>) ventilation and its associated increase in arterial carbon dioxide (PaCO<sub>2</sub>) may affect postoperative neurologic function. We aimed to test the hypothesis that intraoperative low V<sub>T</sub> ventilation affect the incidence of postoperative ICD-10 coded delirium and/or the need for antipsychotic medications.</AbstractText><AbstractText Label="METHODS">This is a post-hoc analysis of a large randomized controlled trial evaluating low vs. conventional V<sub>T</sub> ventilation during major non-cardiothoracic, non-intracranial surgery. The primary outcome was the incidence of ICD-10 delirium and/or the use of antipsychotic medications during hospital stay, and the absolute difference with its 95% confidence interval (CI) was calculated.</AbstractText><AbstractText Label="RESULTS">We studied 1206 patients (median age of 64 [55-72] years, 59.0% males, median ARISCAT of 26 [19-37], and 47.6% of ASA 3). ICD-10 coded delirium and /or antipsychotic medication use was diagnosed in 11.2% with similar incidence between low and conventional V<sub>T</sub> ventilation (11.1% vs. 11.3%; absolute difference, -0.24 [95%CI, -3.82 to 3.32]; p&#x2009;=&#x2009;0.894). There was no interaction between allocation group and type of surgery.</AbstractText><AbstractText Label="CONCLUSION">In adult patients undergoing major surgery, low V<sub>T</sub> ventilation was not associated with increased risk of ICD-10 delirium and/or the use of antipsychotic medications during hospital stay.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ANZCTR Identifier: ACTRN12614000790640 .</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karalapillai</LastName><ForeName>Dharshi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia. dharshi.karalapillai@austin.org.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia. dharshi.karalapillai@austin.org.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia. dharshi.karalapillai@austin.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>Ary Serpa</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellard</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearce</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oughton</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galtieri</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appu</LastName><ForeName>Sree</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastwood</LastName><ForeName>Glenn</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Daryl A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ANZCTR</DataBankName><AccessionNumberList><AccessionNumber>ACTRN12614000790640</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="Y">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="N">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delirium</Keyword><Keyword MajorTopicYN="N">Postoperative</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Tidal volume</Keyword></KeywordList><CoiStatement>The original trial was investigator-initiated research funded by Australian and New Zealand College of Anaesthetists grant ANZAC16/008. Dr Peyton reported receipt of personal fees from Maquet Critical Care outside of the submitted work. Dr Wilson reported receipt of personal fees from Fisher Paykel outside of the submitted work. Dr Serpa Neto reported receiving personal fees from Dr&#xe4;ger outside of the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35578170</ArticleId><ArticleId IdType="pmc">PMC9109306</ArticleId><ArticleId IdType="doi">10.1186/s12871-022-01689-3</ArticleId><ArticleId IdType="pii">10.1186/s12871-022-01689-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, Ellard L, Hu R, Pearce B, et al. Effect of Intraoperative Low Tidal Volume vs Conventional Tidal Volume on Postoperative Pulmonary Complications in Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2020;324:848&#x2013;858. doi: 10.1001/jama.2020.12866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="pubmed">32870298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kety SS, Schmidt CF. The effects of active and passive hyperventilation on cerebral blood flow, cerebral oxygen consumption, cardiac output, and blood pressure of normal young men. J Clin Invest. 1946;25:107&#x2013;119. doi: 10.1172/JCI101680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI101680</ArticleId><ArticleId IdType="pubmed">21016304</ArticleId></ArticleIdList></Reference><Reference><Citation>Kety SS, Schmidt CF. The Effects of Altered Arterial Tensions of Carbon Dioxide and Oxygen on Cerebral Blood Flow and Cerebral Oxygen Consumption of Normal Young Men. J Clin Invest. 1948;27:484&#x2013;492. doi: 10.1172/JCI101995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI101995</ArticleId><ArticleId IdType="pmc">PMC439519</ArticleId><ArticleId IdType="pubmed">16695569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, et al. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med. 2017;43:1075&#x2013;1084. doi: 10.1007/s00134-017-4807-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4807-z</ArticleId><ArticleId IdType="pubmed">28466149</ArticleId></ArticleIdList></Reference><Reference><Citation>Eastwood GM, Schneider AG, Suzuki S, Peck L, Young H, Tanaka A, et al. Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial) Resuscitation. 2016;104:83&#x2013;90. doi: 10.1016/j.resuscitation.2016.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2016.03.023</ArticleId><ArticleId IdType="pubmed">27060535</ArticleId></ArticleIdList></Reference><Reference><Citation>Young GB, DeRubeis DA. Coma and impaired consciousness: a clinical perspective. In: Young GB, Ropper AH, Bolton CF, editors. Metabolic encephalopathies. New York (US): McGraw- Hill Companies; 1998. p. 307e92.</Citation></Reference><Reference><Citation>Kilburn K. Neurologic manifestations of respiratory failure. Arch Intern Med. 1965;116:409e15. doi: 10.1001/archinte.1965.03870030089015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1965.03870030089015</ArticleId><ArticleId IdType="pubmed">14325915</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q, Li L, Yang M, Sun L, Li R, Huang R, et al. Moderate hypercapnia may not contribute to postoperative delirium in patients undergoing bronchoscopic intervention. Medicine (Baltimore) 2019;98:e15906. doi: 10.1097/MD.0000000000015906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000015906</ArticleId><ArticleId IdType="pmc">PMC6709007</ArticleId><ArticleId IdType="pubmed">31145352</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q, Li L, Duomao L, Duomao L, Renjiao L, et al. Effects of acute hypercapnia on cognitive function in patients undergoing bronchoscope intervention. J Thorac Dis. 2019;11:1065&#x2013;1071. doi: 10.21037/jtd.2018.12.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2018.12.15</ArticleId><ArticleId IdType="pmc">PMC6462695</ArticleId><ArticleId IdType="pubmed">31019796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li Z, Yu Y, Li B, Shao G, Wang Q, et al. Risk factors contributing to postoperative delirium in geriatric patients postorthopedic surgery. Asia Pac Psychiatry. 2015;7:375&#x2013;382. doi: 10.1111/appy.12193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/appy.12193</ArticleId><ArticleId IdType="pubmed">26097170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C, Churilov L, Cowie D, Tan CO, Hu R, Tremewen D, et al. Randomised controlled trial to investigate the relationship between mild hypercapnia and cerebral oxygen saturation in patients undergoing major surgery. BMJ Open. 2020;10:e029159. doi: 10.1136/bmjopen-2019-029159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-029159</ArticleId><ArticleId IdType="pmc">PMC7045198</ArticleId><ArticleId IdType="pubmed">32066598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazemi AK, Gowd AK, Carmouche JJ, Kates SL, Albert TJ, Behrend CJ. Prevention and Management of Postoperative Delirium in Elderly Patients Following Elective Spinal Surgery. Clin Spine Surg. 2017;30:112&#x2013;119. doi: 10.1097/BSD.0000000000000467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BSD.0000000000000467</ArticleId><ArticleId IdType="pubmed">28141603</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Lu Y, Liu M, Zou Z, Wang L, Xu FY, et al. Strategies for prevention of postoperative delirium: a systematic review and meta-analysis of randomized trials. Crit Care. 2013;17:R47. doi: 10.1186/cc12566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12566</ArticleId><ArticleId IdType="pmc">PMC3672487</ArticleId><ArticleId IdType="pubmed">23506796</ArticleId></ArticleIdList></Reference><Reference><Citation>Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443&#x2013;451. doi: 10.1001/jama.2010.1013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1013</ArticleId><ArticleId IdType="pubmed">20664045</ArticleId></ArticleIdList></Reference><Reference><Citation>Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, et al. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012;367:30&#x2013;39. doi: 10.1056/NEJMoa1112923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1112923</ArticleId><ArticleId IdType="pmc">PMC3433229</ArticleId><ArticleId IdType="pubmed">22762316</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK. One-year health care costs associated with delirium in the elderly population. Arch Intern Med. 2008;168:27&#x2013;32. doi: 10.1001/archinternmed.2007.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2007.4</ArticleId><ArticleId IdType="pmc">PMC4559525</ArticleId><ArticleId IdType="pubmed">18195192</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner LA. Postoperative delirium. part 2: detection, prevention and treatment. Eur J Anaesthesiol. 2011;28:723&#x2013;32. doi: 10.1097/EJA.0b013e328349b7db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328349b7db</ArticleId><ArticleId IdType="pubmed">21912241</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, Ellard L, Hu R, Pearce B, et al. Low tidal volume ventilation during anaesthesia for major surgery: protocol and statistical analysis plan. Crit Care Resusc. 2019;21:243&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">31778630</ArticleId></ArticleIdList></Reference><Reference><Citation>Danivas V, Venkatasubramanian G. Current perspectives on chlorpromazine equivalents: Comparing apples and oranges! Indian Journal of Psychiatry. 2013;55:207&#x2013;208. doi: 10.4103/0019-5545.105522.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5545.105522</ArticleId><ArticleId IdType="pmc">PMC3696254</ArticleId><ArticleId IdType="pubmed">23825865</ArticleId></ArticleIdList></Reference><Reference><Citation>Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 2015;69:440&#x2013;447. doi: 10.1111/pcn.12275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.12275</ArticleId><ArticleId IdType="pubmed">25601291</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369:428&#x2013;437. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D, Matalanis G, Martensson J, Robbins R, Shaw M, Seevanayagam S. Predictors and outcomes of cardiac surgery-associated delirium. A single centre retrospective cohort study. Heart Lung Circ. 2019;28:455&#x2013;463. doi: 10.1016/j.hlc.2018.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2018.01.007</ArticleId><ArticleId IdType="pubmed">29454582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta F, Lauretta MP, Borozdina A, Mizikov VM, Rosa G. Postoperative delirium: risk factors, diagnosis and perioperative care. Minerva Anestesiol. 2013;79:1066&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pubmed">23511351</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner LA. Postoperative delirium. Part 1: pathophysiology and risk factors. Eur J Anaesthesiol. 2011;28:628&#x2013;36. doi: 10.1097/EJA.0b013e328349b7f5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328349b7f5</ArticleId><ArticleId IdType="pubmed">21785356</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Hu J, Ma D. Postoperative delirium: perioperative assessment, risk reduction, and management. Br J Anaesth. 2020;125:492&#x2013;504. doi: 10.1016/j.bja.2020.06.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.06.063</ArticleId><ArticleId IdType="pubmed">32798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutch WAC, El-Gabalawy R, Girling L, Kilborn K, Jacobsohn E. End-Tidal Hypocapnia Under Anesthesia Predicts Postoperative Delirium. Front Neurol. 2018;9:678. doi: 10.3389/fneur.2018.00678.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00678</ArticleId><ArticleId IdType="pmc">PMC6108130</ArticleId><ArticleId IdType="pubmed">30174647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendlebury ST, Lovett NG, Thomson RJ, Smith SC. Impact of a system-wide multicomponent intervention on administrative diagnostic coding for delirium and other cognitive frailty syndromes: observational prospective study. Clin Med (Lond) 2020;20(5):454&#x2013;464. doi: 10.7861/clinmed.2019-0470.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2019-0470</ArticleId><ArticleId IdType="pmc">PMC7539726</ArticleId><ArticleId IdType="pubmed">32934037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Lee J, Kim CA, Huybrechts KF, Bateman BT, Patorno E, Marcantonio ER. Evaluation of algorithms to identify delirium in administrative claims and drug utilization database. Pharmacoepidemiol Drug Saf. 2017;&#xa0;26(8):945&#x2013;953. doi: 10.1002/pds.4226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4226</ArticleId><ArticleId IdType="pmc">PMC5583076</ArticleId><ArticleId IdType="pubmed">28485014</ArticleId></ArticleIdList></Reference><Reference><Citation>Iamaroon A, Wongviriyawong T, Sura-arunsumrit P, Wiwatnodom N, Rewuri N, Chaiwat O. Incidence of and risk factors for postoperative delirium in older adult patients undergoing noncardiac surgery: a prospective study. BMC Geriatr. 2020;20:40. doi: 10.1186/s12877-020-1449-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-1449-8</ArticleId><ArticleId IdType="pmc">PMC6998823</ArticleId><ArticleId IdType="pubmed">32013872</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941&#x2013;8. doi: 10.7326/0003-4819-113-12-941.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-113-12-941</ArticleId><ArticleId IdType="pubmed">2240918</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon K, Inouye MD MPH. Confusion assessment method: training manual and coding guide, Copyright 2003.</Citation></Reference><Reference><Citation>Bilotta F, Rosa G. General anesthesia and postoperative cognitive dysfunction. J Alzheimer Dis Parkinsonism. 2012;2:e113.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33357646</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-3763</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Indian heart journal</Title><ISOAbbreviation>Indian Heart J</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation of scar based ventricular tachycardia - Procedural characteristics and outcomes.</ArticleTitle><Pagination><StartPage>563</StartPage><EndPage>569</EndPage><MedlinePgn>563-569</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ihj.2020.09.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0019-4832(20)30232-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ventricular tachycardia (VT) is a major cause of morbidity in patients with cardiomyopathy. Radiofrequency ablation has emerged as the mainstay of the management of recurrent sustained VT in these patients. We describe the clinical characteristics, procedural and medium term outcomes of patients undergoing ablation of scar VT in a tertiary care center in India.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a single-center descriptive cohort study. All patients who underwent ablation for scar related VT were included. Endpoints were immediate procedural success, procedural complications and recurrence during follow up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 72 patients with scar VT underwent ablation with electroanatomic mapping. Previous myocardial infarction (MI) was the commonest etiology (69.4%) with arrhythmogenic right ventricular cardiomyopathy (ARVC) being the next common (19.4%). Acute procedural success was achieved in 69.4% patients, partial success in 9.7% and failure in 1 patient (1.4%). Outcome was labeled indeterminate in 19.4% who did not undergo post ablation VT induction. Procedural complications were seen in 4%. Follow up data was available in 95% of the patients with a mean follow up of 28.9&#xa0;&#xb1;&#xa0;22.8 months. At one year, freedom from VT was 83.8% and mortality was 13.2%. Overall mortality during follow up was 22.1% while VT recurrence was seen in 35.3%. Recurrence rate was higher in ARVC as compared to previous MI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Ablation of scar VT has high acute success rates. Ablation is safe with low risk of major complications. Rates of recurrence are higher in patients with ARVC as compared to post MI VT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Ashutosh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramasamy</LastName><ForeName>Sakthivel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodore</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anantharaj</LastName><ForeName>Avinash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>Ajith Ananthakrishna</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satheesh</LastName><ForeName>Santhosh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvaraj</LastName><ForeName>Raja J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Electronic address: raja.selvaraj@jipmer.edu.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian Heart J</MedlineTA><NlmUniqueID>0374675</NlmUniqueID><ISSNLinking>0019-4832</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Electroanatomic mapping</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>28</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33357646</ArticleId><ArticleId IdType="pmc">PMC7772601</ArticleId><ArticleId IdType="doi">10.1016/j.ihj.2020.09.009</ArticleId><ArticleId IdType="pii">S0019-4832(20)30232-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Bakker J.M., van Capelle F.J., Janse M.J. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988 Mar;77(3):589&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">3342490</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchlinski F.E., Callans D.J., Gottlieb C.D. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000 Mar 21;101(11):1288&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;s P., Maury P., Khairy P. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012;125(18):2184&#x2013;2196. doi: 10.1161/CIRCULATIONAHA.111.043216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.043216</ArticleId><ArticleId IdType="pubmed">22492578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck K.-H., Schaumann A., Eckardt L. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet Lond Engl. 2010 Jan 2;375(9708):31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson W.G., Wilber D.J., Natale A. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008 Dec 16;118(25):2773&#x2013;2782.</Citation><ArticleIdList><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy V.Y., Reynolds M.R., Neuzil P. Prophylactic catheter ablation for the prevention of defibrillator therapy. N&#xa0;Engl J Med. 2007 Dec 27;357(26):2657&#x2013;2665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390777</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinov B., Fiedler L., Sch&#xf6;nbauer R. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation. 2014 Feb 18;129(7):728&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">24211823</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A., Kilicaslan F., Schweikert R.A. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation. 2005 Jun 21;111(24):3209&#x2013;3216.</Citation><ArticleIdList><ArticleId IdType="pubmed">15956125</ArticleId></ArticleIdList></Reference><Reference><Citation>Berruezo A., Fern&#xe1;ndez-Armenta J., Mont L. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012 Feb;5(1):111&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22205683</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Biase L., Burkhardt J.D., Lakkireddy D. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial. J&#xa0;Am Coll Cardiol. 2015 Dec 29;66(25):2872&#x2013;2882.</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Armenta J., Andreu D., Penela D. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014 May;11(5):747&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561159</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda M., Kojodjojo P., Tung S. Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. J&#xa0;Am Heart Assoc. 2013 May 31;2(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3698765</ArticleId><ArticleId IdType="pubmed">23727700</ArticleId></ArticleIdList></Reference><Reference><Citation>Berte B., Sacher F., Venlet J. VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study. J&#xa0;Cardiovasc Electrophysiol. 2016 Jan;27(1):80&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">26471955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp J.L., Wells G.A., Parkash R. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N&#xa0;Engl J Med. 2016 Jul 14;375(2):111&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32416063</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1916-7075</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Canadian journal of cardiology</Title><ISOAbbreviation>Can J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Mortality and Ventricular Tachycardia in Patients With Repaired Tetralogy of Fallot: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>1815</StartPage><EndPage>1825</EndPage><MedlinePgn>1815-1825</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjca.2020.01.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0828-282X(20)30059-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with repaired tetralogy of Fallot (rTOF) have increased risk for mortality, sudden cardiac death, and ventricular tachycardia (VT). The aim of this systematic review and meta-analysis is to offer an updated analysis of risk factors following significant changes in surgical and perioperative management.</AbstractText><AbstractText Label="METHODS">A meta-analysis based on the published literature between 2008 and 2018 was conducted. Endpoints were VT, cardiac mortality/VT, and all-cause mortality/VT. Studies with &#x2265;100 patients and &#x2265;10 events were included.</AbstractText><AbstractText Label="RESULTS">Fifteen studies including 7218 patients (average age 27.5 years) were analyzed. Risk factors for VT included older age (per 1 year, odds ratio [OR]: 1.039; 95% confidence interval [CI]: 1.025-1.053), older age at corrective surgery (per 1 year, OR: 1.034; CI: 1.017-1.051), previous palliative shunt (OR: 3.063; CI: 1.525-6.151), number of thoracotomies (OR: 1.416; CI: 1.249-1.604), longer QRS duration (per 1 ms, OR: 1.031; CI: 1.008-1.055), and at least moderate right-ventricular dysfunction (OR: 2.160; CI_ 1.311-3.560). Additional risk factors for cardiac death/VT were previous ventriculotomy (OR: 2.269; CI: 1.226-4.198), lower left-ventricular ejection fraction (per 1%, OR: 1.049; CI: 1.029-1.071), and higher right-ventricular end diastolic volume (per 1 mL/m<sup>2</sup>, OR: 1.009; CI: 1.002-1.016). Supraventricular tachycardia/atrial fibrillation was an additional risk factor for all-cause mortality/VT (OR: 1.939; CI: 1.088-3.457).</AbstractText><AbstractText Label="CONCLUSIONS">The study highlights the importance of preservation of biventricular systolic function on late outcomes. Ventricular function appears to have a greater impact on outcomes than the severity of pulmonary regurgitation alone in this patient population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Possner</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Stephanie Y</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alahdab</LastName><ForeName>Fares</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Mayo Evidence-based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokma</LastName><ForeName>Jouke P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Academic Medical Center Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lubert</LastName><ForeName>Adam M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khairy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Montr&#xe9;al Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>M Hassan</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Mayo Evidence-based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Ali</LastName><ForeName>Walid</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, CHU-ME Sainte Justine and the Montr&#xe9;al Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokop</LastName><ForeName>Larry J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czosek</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldtman</LastName><ForeName>Gruschen R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA; Adult Congenital Heart Disease, Heart Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsaied</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA. Electronic address: Tarek.Alsaied@cchmc.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Cardiol</MedlineTA><NlmUniqueID>8510280</NlmUniqueID><ISSNLinking>0828-282X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013771" MajorTopicYN="N">Tetralogy of Fallot</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32416063</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2020.01.023</ArticleId><ArticleId IdType="pii">S0828-282X(20)30059-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33929590</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-702X</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie</Title><ISOAbbreviation>Graefes Arch Clin Exp Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Central visual field change after fornix-based trabeculectomy in Japanese normal-tension glaucoma patients managed under 15&#xa0;mmHg.</ArticleTitle><Pagination><StartPage>2309</StartPage><EndPage>2316</EndPage><MedlinePgn>2309-2316</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00417-021-05215-y</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate how the central visual field would be changed after fornix-based trabeculectomy with mitomycin C in Japanese normal-tension glaucoma (NTG) patients monitored for more than 10&#xa0;years including before surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective cohort study. We identified twenty-eight eyes of 28 NTG cases regularly monitored for more than 5&#xa0;years and examined static visual field (VF) tests for more than five times before and after fornix-based trabeculectomy (including combined surgery). Based on preoperative data for 6.3&#xa0;years, we evaluated postoperative changes for 6.0&#xa0;years in 10-2 VF and 30-2 VF.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Six patients were male and 22 females, the mean age was 57.9&#xa0;years, and the mean deviation was&#x2009;-&#x2009;13.7 decibels. After surgery, mean IOP decreased from 13.9 to 9.0&#xa0;mmHg (P&#x2009;&#x2264;&#x2009;0.01), and medication score also did. The rate of 10-2 VF deterioration was significantly suppressed from&#x2009;-&#x2009;1.0&#xa0;dB/year preoperatively to&#x2009;-&#x2009;0.4&#xa0;dB/year postoperatively (P&#x2009;&#x2264;&#x2009;0.01). And when 30-2 VF was divided into six relevant sectors, the rate of deterioration at cecocentral and arcuate areas of the superior hemifield was suppressed postoperatively (P&#x2009;&#x2264;&#x2009;0.01 and P&#x2009;=&#x2009;0.042, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Based on long-term preoperative data, a significant positive change in 10-2 VF was observed after fornix-based trabeculectomy with mitomycin C in Japanese NTG patients with a mean IOP of 13.9&#xa0;mmHg. Central vision could be expected to be maintained for NTG patients even if its preoperative IOP is low after successful trabeculectomy.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Kosuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Showa General Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakata</LastName><ForeName>Rei</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1411-1476</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan. reisakata-tky@umin.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yotsuya Shirato Eye Clinic, Tokyo, Japan. reisakata-tky@umin.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueda</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Asahi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujishiro</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yotsuya Shirato Eye Clinic, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honjo</LastName><ForeName>Megumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yotsuya Shirato Eye Clinic, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirato</LastName><ForeName>Shiroaki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Yotsuya Shirato Eye Clinic, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aihara</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yotsuya Shirato Eye Clinic, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Graefes Arch Clin Exp Ophthalmol</MedlineTA><NlmUniqueID>8205248</NlmUniqueID><ISSNLinking>0721-832X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>50SG953SK6</RegistryNumber><NameOfSubstance UI="D016685">Mitomycin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057066" MajorTopicYN="Y">Low Tension Glaucoma</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016685" MajorTopicYN="N">Mitomycin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012590" MajorTopicYN="N">Sclera</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="Y">Trabeculectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Central visual field</Keyword><Keyword MajorTopicYN="N">Fornix-based</Keyword><Keyword MajorTopicYN="N">Japanese</Keyword><Keyword MajorTopicYN="N">Normal-tension glaucoma</Keyword><Keyword MajorTopicYN="N">Trabeculectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33929590</ArticleId><ArticleId IdType="doi">10.1007/s00417-021-05215-y</ArticleId><ArticleId IdType="pii">10.1007/s00417-021-05215-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, Inoue Y, Kitazawa Y (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111:1641&#x2013;1648. https://doi.org/10.1016/j.ophtha.2004.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2004.03.029</ArticleId><ArticleId IdType="pubmed">15350316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernest PJ, Schouten JS, Beckers HJ, Hendrikse F, Prins MH, Webers CA (2013) An evidence-based review of prognostic factors for glaucomatous visual field progression. Ophthalmology 120:512&#x2013;519. https://doi.org/10.1016/j.ophtha.2012.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2012.09.005</ArticleId><ArticleId IdType="pubmed">23211636</ArticleId></ArticleIdList></Reference><Reference><Citation>No authors listed (1998) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126:487&#x2013;497.&#xa0; https://doi.org/10.1016/S0002-9394(98)00223-2</Citation></Reference><Reference><Citation>Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S (1999) Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma 8:117&#x2013;123</Citation></Reference><Reference><Citation>Tomita G, Araie M, Kitazawa Y, Tsukahara S (2004) A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Eye (Lond) 18:984&#x2013;989. https://doi.org/10.1038/sj.eye.6701373</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.eye.6701373</ArticleId></ArticleIdList></Reference><Reference><Citation>Araie M, Shirato S, Yamazaki Y, Kitazawa Y, Ohashi Y (2010) Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study. Jpn J Ophthalmol 54:278&#x2013;285. https://doi.org/10.1007/s10384-010-0815-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10384-010-0815-z</ArticleId><ArticleId IdType="pubmed">20700793</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T (2012) Risk factors for visual field progression in the low-pressure glaucoma treatment study. Am J Ophthalmol 154:702&#x2013;711. https://doi.org/10.1016/j.ajo.2012.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2012.04.015</ArticleId><ArticleId IdType="pubmed">22835512</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata R, Aihara M, Murata H, Mayama C, Tomidokoro A, Iwase A, Araie M (2013) Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment. J Glaucoma 22:250&#x2013;254. https://doi.org/10.1097/IJG.0b013e31823298fb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IJG.0b013e31823298fb</ArticleId><ArticleId IdType="pubmed">23059475</ArticleId></ArticleIdList></Reference><Reference><Citation>Komori S, Ishida K, Yamamoto T (2014) Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up. Graefes Arch Clin Exp Ophthalmol 252:1963&#x2013;1970. https://doi.org/10.1007/s00417-014-2767-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-014-2767-3</ArticleId><ArticleId IdType="pubmed">25128961</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Kong M, Kim J, Kee C (2014) Comparison of visual field progression between relatively low and high intraocular pressure groups in normal tension glaucoma patients. J Glaucoma 23:553&#x2013;560. https://doi.org/10.1097/IJG.0b013e31829484c6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IJG.0b013e31829484c6</ArticleId><ArticleId IdType="pubmed">23751927</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DR, Drance SM, Schulzer M (2001) Natural history of normal-tension glaucoma. Ophthalmology 108:247&#x2013;253.&#xa0; https://doi.org/10.1016/S0161-6420(00)00518-2</Citation></Reference><Reference><Citation>Heijl A, Bengtsson B, Hyman L, Leske MC (2009) Natural history of open-angle glaucoma. Ophthalmology 116:2271&#x2013;2276. https://doi.org/10.1016/j.ophtha.2009.06.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2009.06.042</ArticleId><ArticleId IdType="pubmed">19854514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata R, Yoshitomi T, Iwase A, Matsumoto C, Higashide T, Shirakashi M, Aihara M, Sugiyama K, Araie M (2019) Factors associated with progression of Japanese open-angle glaucoma with lower normal intraocular pressure. Ophthalmology 126:1107&#x2013;1116. https://doi.org/10.1016/j.ophtha.2018.12.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2018.12.029</ArticleId><ArticleId IdType="pubmed">30605741</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson SM, Schultz SK, Shi W, Feuer WJ, Greenfield DS (2016) Effectiveness of single-digit IOP targets on decreasing global and localized visual field progression after filtration surgery in eyes with progressive normal-tension glaucoma. J Glaucoma 25:408&#x2013;414. https://doi.org/10.1097/ijg.0000000000000240</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ijg.0000000000000240</ArticleId><ArticleId IdType="pubmed">25719235</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz SK, Iverson SM, Shi W, Greenfield DS (2016) Safety and efficacy of achieving single-digit intraocular pressure targets with filtration surgery in eyes with progressive normal-tension glaucoma. J Glaucoma 25:217&#x2013;222. https://doi.org/10.1097/ijg.0000000000000145</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ijg.0000000000000145</ArticleId><ArticleId IdType="pubmed">25264998</ArticleId><ArticleId IdType="pmc">4375069</ArticleId></ArticleIdList></Reference><Reference><Citation>Koseki N, Araie M, Shirato S, Yamamoto S (1997) Effect of trabeculectomy on visual field performance in central 30 degrees field in progressive normal-tension glaucoma. Ophthalmology 104:197&#x2013;201.&#xa0; https://doi.org/10.1016/S0161-6420(97)30334-0</Citation></Reference><Reference><Citation>Shigeeda T, Tomidokoro A, Araie M, Koseki N, Yamamoto S (2002) Long-term follow-up of visual field progression after trabeculectomy in progressive normal-tension glaucoma. Ophthalmology 109:766&#x2013;770.&#xa0; https://doi.org/10.1016/S0161-6420(01)01009-0</Citation></Reference><Reference><Citation>Mataki N, Murata H, Sawada A, Yamamoto T, Shigeeda T, Araie M (2014) Visual field progressive rate in normal tension glaucoma before and after trabeculectomy: a subfield-based analysis. Asia Pac J Ophthalmol (Phila) 3:263&#x2013;266. https://doi.org/10.1097/apo.0000000000000020</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/apo.0000000000000020</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugeliene L, Yamamoto T, Kitazawa Y (1998) Effect of trabeculectomy on visual field in progressive normal-tension glaucoma. Jpn J Ophthalmol 42:286&#x2013;292.&#xa0; https://doi.org/10.1016/S0021-5155(98)00013-6</Citation></Reference><Reference><Citation>Koseki N, Araie M, Suzuki Y, Yamagami J (1995) Visual field damage proximal to fixation in normal- and high-tension glaucoma eyes. Jpn J Ophthalmol 39:274&#x2013;283</Citation></Reference><Reference><Citation>Suzuki Y, Araie M, Ohashi Y (1993) Sectorization of the central 30 degrees visual field in glaucoma. Ophthalmology 100:69&#x2013;75. https://doi.org/10.1016/S0161-6420(93)31691-X</Citation></Reference><Reference><Citation>Naito T, Fujiwara M, Miki T, Araki R, Fujiwara A, Shiode Y, Morizane Y, Nagayama M, Shiraga F (2017) Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure &lt; 15 mmHg. PLoS ONE 12:e0184096. https://doi.org/10.1371/journal.pone.0184096</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184096</ArticleId><ArticleId IdType="pubmed">28850613</ArticleId><ArticleId IdType="pmc">5574552</ArticleId></ArticleIdList></Reference><Reference><Citation>Folgar FA, de Moraes CG, Prata TS, Teng CC, Tello C, Ritch R, Liebmann JM (2010) Glaucoma surgery decreases the rates of localized and global visual field progression. Am J Ophthalmol 149:258-264.e252. https://doi.org/10.1016/j.ajo.2009.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2009.09.010</ArticleId><ArticleId IdType="pubmed">20103054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand V, Fieuws S, Stalmans I, Zeyen T (2014) Rates of visual field loss before and after trabeculectomy. Acta Ophthalmol 92:116&#x2013;120. https://doi.org/10.1111/aos.12073</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.12073</ArticleId><ArticleId IdType="pubmed">23551517</ArticleId></ArticleIdList></Reference><Reference><Citation>Baril C, Vianna JR, Shuba LM, Rafuse PE, Chauhan BC, Nicolela MT (2017) Rates of glaucomatous visual field change after trabeculectomy. Br J Ophthalmol 101:874&#x2013;878. https://doi.org/10.1136/bjophthalmol-2016-308948</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2016-308948</ArticleId><ArticleId IdType="pubmed">27811280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan BC, Garway-Heath DF, Goni FJ, Rossetti L, Bengtsson B, Viswanathan AC, Heijl A (2008) Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 92:569&#x2013;573. https://doi.org/10.1136/bjo.2007.135012</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.2007.135012</ArticleId><ArticleId IdType="pubmed">18211935</ArticleId></ArticleIdList></Reference><Reference><Citation>Diestelhorst M, Khalili MA, Krieglstein GK (1998) Trabeculectomy: a retrospective follow-up of 700 eyes. Int Ophthalmol 22:211&#x2013;220. https://doi.org/10.1023/a:1006238624072</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1006238624072</ArticleId><ArticleId IdType="pubmed">10674865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilensky JT, Chen TC (1996) Long-term results of trabeculectomy in eyes that were initially successful. Trans Am OphthalmolSoc 94:147&#x2013;159.&#xa0; https://doi.org/10.1016/s0002-9394(14)70163-1</Citation></Reference><Reference><Citation>Molteno AC, Bosma NJ, Kittelson JM (1999) Otago glaucoma surgery outcome study: long-term results of trabeculectomy&#x2014;1976 to 1995. Ophthalmology 106:1742&#x2013;1750. https://doi.org/10.1016/s0161-6420(99)90351-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0161-6420(99)90351-2</ArticleId><ArticleId IdType="pubmed">10485545</ArticleId></ArticleIdList></Reference><Reference><Citation>Landers J, Martin K, Sarkies N, Bourne R, Watson P (2012) A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119:694&#x2013;702. https://doi.org/10.1016/j.ophtha.2011.09.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2011.09.043</ArticleId><ArticleId IdType="pubmed">22196977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevin TH, Molteno AC, Herbison P (2008) Otago glaucoma surgery outcome study: long-term results of 841 trabeculectomies. Clin Exp Ophthalmol 36:731&#x2013;737. https://doi.org/10.1111/j.1442-9071.2008.01896.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-9071.2008.01896.x</ArticleId><ArticleId IdType="pubmed">19128377</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama A, Ishida K, Sawada A, Yamamoto T (2010) Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma. Jpn J Ophthalmol 54:117&#x2013;123. https://doi.org/10.1007/s10384-009-0779-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10384-009-0779-z</ArticleId><ArticleId IdType="pubmed">20401559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi I, Shirato S, Matsumoto S, Araie M (2003) The relationship between visual disability and visual field in patients with glaucoma. Ophthalmology 110:332&#x2013;339. https://doi.org/10.1016/s0161-6420(02)01742-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0161-6420(02)01742-6</ArticleId><ArticleId IdType="pubmed">12578777</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata H, Hirasawa H, Aoyama Y, Sugisaki K, Araie M, Mayama C, Aihara M, Asaoka R (2013) Identifying areas of the visual field important for quality of life in patients with glaucoma. PLoS ONE 8:e58695. https://doi.org/10.1371/journal.pone.0058695</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058695</ArticleId><ArticleId IdType="pubmed">23520528</ArticleId><ArticleId IdType="pmc">3592814</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwase A, Araie M (2019) Primary open-angle glaucoma with initial visual field damage in the superior and inferior hemifields: comparison in a population-based setting. J Glaucoma 28:493&#x2013;497. https://doi.org/10.1097/ijg.0000000000001241</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ijg.0000000000001241</ArticleId><ArticleId IdType="pubmed">30908347</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34187530</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative protective ventilation in patients undergoing major neurosurgical interventions: a randomized clinical trial.</ArticleTitle><Pagination><StartPage>184</StartPage><MedlinePgn>184</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">184</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-021-01404-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Post-operative pulmonary complications (PPC) can develop in up to 13% of patients undergoing neurosurgical procedures and may adversely affect clinical outcome. The use of intraoperative lung protective ventilation (LPV) strategies, usually including the use of a low V<sub>t</sub>, low PEEP and low plateau pressure, seem to reduce the risk of PPC and are strongly recommended in almost all surgical procedures. Nonetheless, feasibility of LPV strategies in neurosurgical patients are still debated because the use of low Vt during LPV might result in hypercapnia with detrimental effects on cerebrovascular physiology. Aim of our study was to determine whether LPV strategies would be feasible compared with a control group in adult patients undergoing cranial or spinal surgery.</AbstractText><AbstractText Label="METHODS">This single-centre, pilot randomized clinical trial was conducted at the University Hospital "Maggiore della Carit&#xe0;" (Novara, Italy). Adult patients undergoing major cerebral or spinal neurosurgical interventions with risk index for pulmonary post-operative complications &gt;&#x2009;2 and not expected to need post-operative intensive care unit (ICU) admission were considered eligible. Patients were randomly assigned to either LPV (Vt&#x2009;=&#x2009;6&#x2009;ml/kg of ideal body weight (IBW), respiratory rate initially set at 16 breaths/min, PEEP at 5 cmH2O and application of a recruitment manoeuvre (RM) immediately after intubation and at every disconnection from the ventilator) or control treatment (Vt&#x2009;=&#x2009;10&#x2009;ml/kg of IBW, respiratory rate initially set at 6-8 breaths/min, no PEEP and no RM). Primary outcomes of the study were intraoperative adverse events, the level of cerebral tension at dura opening and the intraoperative control of PaCO<sub>2.</sub> Secondary outcomes were the rate of pulmonary and extrapulmonary complications, the number of unplanned ICU admissions, ICU and hospital lengths of stay and mortality.</AbstractText><AbstractText Label="RESULTS">A total of 60 patients, 30 for each group, were randomized. During brain surgery, the number of episodes of intraoperative hypercapnia and grade of cerebral tension were similar between patients randomized to receive control or LPV strategies. No difference in the rate of intraoperative adverse events was found between groups. The rate of postoperative pulmonary and extrapulmonary complications and major clinical outcomes were similar between groups.</AbstractText><AbstractText Label="CONCLUSIONS">LPV strategies in patients undergoing major neurosurgical intervention are feasible. Larger clinical trials are needed to assess their role in postoperative clinical outcome improvements.</AbstractText><AbstractText Label="TRIAL REGISTRATION">registered on the Australian New Zealand Clinical Trial Registry ( www.anzctr.org.au ), registration number ACTRN12615000707561.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, University Hospital of Padua, Via Giustiniani 2, Padova, Italy. laurapasin1704@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montagnini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konrad</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murabito</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelaia</LastName><ForeName>Corrado</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rondi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellapiazza</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Sant'Andrea Hospital, ASL VC, Vercelli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cammarota</LastName><ForeName>Gianmaria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaschetto</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, University Hospital of Padua, Via Giustiniani 2, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mechanical ventilation</Keyword><Keyword MajorTopicYN="N">Neurosurgery</Keyword><Keyword MajorTopicYN="N">Postoperative pulmonary complications</Keyword></KeywordList><CoiStatement>No conflict related to the present work. Dr. Navalesi&#x2019;s research laboratory has received equipment and grants from Maquet Critical Care, Draeger and Intersurgical S.p.A. He also received honoraria/speaking fees from Maquet Critical Care, Orionpharma, Philips, Resmed, MSD and Novartis. Dr. Navalesi contributed to the development of the helmet Next, whose licence for patent belongs to Intersurgical S.P.A., and receives royalties for that invention. Dr. Longhini and Dr. Navalesi contributed to the development of a new device not discussed in the present study (European Patent number 3320941, released on 5th August 2020). The remaining authors have no conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34187530</ArticleId><ArticleId IdType="pmc">PMC8241565</ArticleId><ArticleId IdType="doi">10.1186/s12871-021-01404-8</ArticleId><ArticleId IdType="pii">10.1186/s12871-021-01404-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372(9633):139&#x2013;144. doi: 10.1016/S0140-6736(08)60878-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60878-8</ArticleId><ArticleId IdType="pubmed">18582931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Bustamante A, Frendl G, Sprung J, Kor DJ, Subramaniam B, Martinez Ruiz R, Lee JW, Henderson WG, Moss A, Mehdiratta N, Colwell MM, Bartels K, Kolodzie K, Giquel J, Vidal Melo MF. Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the perioperative research network investigators. JAMA Surg. 2017;152(2):157&#x2013;166. doi: 10.1001/jamasurg.2016.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4065</ArticleId><ArticleId IdType="pmc">PMC5334462</ArticleId><ArticleId IdType="pubmed">27829093</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Hemmes SNT, Serpa Neto A, Bluth T, Canet J, Hiesmayr M, Hollmann MW, Mills GH, Vidal Melo MF, Putensen C, et al. Intraoperative ventilator settings and their association with postoperative pulmonary complications in neurosurgical patients: post-hoc analysis of LAS VEGAS study. BMC Anesthesiol. 2020;20(1):73. doi: 10.1186/s12871-020-00988-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-00988-x</ArticleId><ArticleId IdType="pmc">PMC7114790</ArticleId><ArticleId IdType="pubmed">32241266</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SN, Barbas CS, Beiderlinden M, Fernandez-Bustamante A, Futier E, Gajic O, El-Tahan MR, Ghamdi AA, Gunay E, et al. Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med. 2016;4(4):272&#x2013;280. doi: 10.1016/S2213-2600(16)00057-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00057-6</ArticleId><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Young CC, Harris EM, Vacchiano C, Bodnar S, Bukowy B, Elliott RRD, Migliarese J, Ragains C, Trethewey B, Woodward A, Gama de Abreu M, Girard M, Futier E, Mulier JP, Pelosi P, Sprung J. Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations. Br J Anaesth. 2019;123(6):898&#x2013;913. doi: 10.1016/j.bja.2019.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.08.017</ArticleId><ArticleId IdType="pubmed">31587835</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazo V, Sabate S, Canet J, Gallart L, de Abreu MG, Belda J, Langeron O, Hoeft A, Pelosi P. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology. 2014;121(2):219&#x2013;231. doi: 10.1097/ALN.0000000000000334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000334</ArticleId><ArticleId IdType="pubmed">24901240</ArticleId></ArticleIdList></Reference><Reference><Citation>LAS VEGAS investigators Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS - an observational study in 29 countries. Eur J Anaesthesiol. 2017;34(8):492&#x2013;507. doi: 10.1097/EJA.0000000000000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000646</ArticleId><ArticleId IdType="pmc">PMC5502122</ArticleId><ArticleId IdType="pubmed">28633157</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Gelb AW. Regulation of cerebral autoregulation by carbon dioxide. Anesthesiology. 2015;122(1):196&#x2013;205. doi: 10.1097/ALN.0000000000000506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000506</ArticleId><ArticleId IdType="pubmed">25401418</ArticleId></ArticleIdList></Reference><Reference><Citation>Komjati K, Greenberg JH, Reivich M, Sandor P. Interactions between the endothelium-derived relaxing factor/nitric oxide system and the endogenous opiate system in the modulation of cerebral and spinal vascular CO2 responsiveness. J Cereb Blood Flow Metab. 2001;21(8):937&#x2013;944. doi: 10.1097/00004647-200108000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004647-200108000-00006</ArticleId><ArticleId IdType="pubmed">11487729</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock AK, Opalak CF, Workman KG, Broaddus WC. Safety outcomes following spine and cranial neurosurgery: evidence from the National Surgical Quality Improvement Program. J Neurosurg Anesthesiol. 2018;30(4):328&#x2013;336. doi: 10.1097/ANA.0000000000000474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000474</ArticleId><ArticleId IdType="pubmed">29135700</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh S, Shim JK, Ha Y, Kim YS, Lee H, Kwak YL. Ventilation with high or low tidal volume with PEEP does not influence lung function after spinal surgery in prone position: a randomized controlled trial. J Neurosurg Anesthesiol. 2018;30(3):237&#x2013;245. doi: 10.1097/ANA.0000000000000428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000428</ArticleId><ArticleId IdType="pubmed">28338504</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663&#x2013;694. doi: 10.7326/0003-4819-134-8-200104170-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-134-8-200104170-00012</ArticleId><ArticleId IdType="pubmed">11304107</ArticleId></ArticleIdList></Reference><Reference><Citation>Arozullah AM, Khuri SF, Henderson WG, Daley J. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med. 2001;135(10):847&#x2013;857. doi: 10.7326/0003-4819-135-10-200111200-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-135-10-200111200-00005</ArticleId><ArticleId IdType="pubmed">11712875</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, Marret E, Beaussier M, Gutton C, Lefrant JY, Allaouchiche B, Verzilli D, Leone M, de Jong A, Bazin JE, Pereira B, Jaber S. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428&#x2013;437. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Severgnini P, Selmo G, Lanza C, Chiesa A, Frigerio A, Bacuzzi A, Dionigi G, Novario R, Gregoretti C, de Abreu MG, Schultz MJ, Jaber S, Futier E, Chiaranda M, Pelosi P. Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function. Anesthesiology. 2013;118(6):1307&#x2013;1321. doi: 10.1097/ALN.0b013e31829102de.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31829102de</ArticleId><ArticleId IdType="pubmed">23542800</ArticleId></ArticleIdList></Reference><Reference><Citation>Citerio G, Pesenti A, Latini R, Masson S, Barlera S, Gaspari F, Franzosi MG. A multicentre, randomised, open-label, controlled trial evaluating equivalence of inhalational and intravenous anaesthesia during elective craniotomy. Eur J Anaesthesiol. 2012;29(8):371&#x2013;379. doi: 10.1097/EJA.0b013e32835422db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32835422db</ArticleId><ArticleId IdType="pubmed">22569025</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, de la Brutel Riviere A, Van Meeteren NL. preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA. 2006;296(15):1851&#x2013;1857. doi: 10.1001/jama.296.15.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.296.15.1851</ArticleId><ArticleId IdType="pubmed">17047215</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Hemmes SN, Barbas CS, Beiderlinden M, Biehl M, Binnekade JM, Canet J, Fernandez-Bustamante A, Futier E, Gajic O, et al. Protective versus conventional ventilation for surgery: a systematic review and individual patient data meta-analysis. Anesthesiology. 2015;123(1):66&#x2013;78. doi: 10.1097/ALN.0000000000000706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000706</ArticleId><ArticleId IdType="pubmed">25978326</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M, Diaper J, Villiger Y, Spiliopoulos A, Licker V, Robert J, Tschopp JM. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi: 10.1186/cc7762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7762</ArticleId><ArticleId IdType="pmc">PMC2689485</ArticleId><ArticleId IdType="pubmed">19317902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundar S, Novack V, Jervis K, Bender SP, Lerner A, Panzica P, Mahmood F, Malhotra A, Talmor D. Influence of low tidal volume ventilation on time to extubation in cardiac surgical patients. Anesthesiology. 2011;114(5):1102&#x2013;1110. doi: 10.1097/ALN.0b013e318215e254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318215e254</ArticleId><ArticleId IdType="pmc">PMC3500383</ArticleId><ArticleId IdType="pubmed">21430518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Dionne S, Simard S, Bussieres J, Dagenais F. High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology. 2012;116(5):1072&#x2013;1082. doi: 10.1097/ALN.0b013e3182522df5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182522df5</ArticleId><ArticleId IdType="pubmed">22450472</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, Ellard L, Hu R, Pearce B, Tan CO, Story D, O'Donnell M, Hamilton P, et al. Effect of intraoperative low tidal volume vs conventional tidal volume on postoperative pulmonary complications in patients undergoing major surgery: a randomized clinical trial. JAMA. 2020;324(9):848&#x2013;858. doi: 10.1001/jama.2020.12866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="pubmed">32870298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014;384(9942):495&#x2013;503. doi: 10.1016/S0140-6736(14)60416-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60416-5</ArticleId><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluth T, Serpa Neto A, Schultz MJ, Pelosi P, Gama de Abreu M, Bobek I, Canet JC, Cinnella G, de Baerdemaeker L, Gregoretti C, et al. Effect of intraoperative high positive end-expiratory pressure (PEEP) with recruitment maneuvers vs low PEEP on postoperative pulmonary complications in obese patients: a randomized clinical trial. JAMA. 2019;321(23):2292&#x2013;2305. doi: 10.1001/jama.2019.7505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.7505</ArticleId><ArticleId IdType="pmc">PMC6582260</ArticleId><ArticleId IdType="pubmed">31157366</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis SG, Bombardieri AM, Ma Y, Girardi FP. The effect of low versus high tidal volume ventilation on inflammatory markers in healthy individuals undergoing posterior spine fusion in the prone position: a randomized controlled trial. J Clin Anesth. 2012;24(4):263&#x2013;269. doi: 10.1016/j.jclinane.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2011.08.003</ArticleId><ArticleId IdType="pmc">PMC3288806</ArticleId><ArticleId IdType="pubmed">22001758</ArticleId></ArticleIdList></Reference><Reference><Citation>Brian JE., Jr Carbon dioxide and the cerebral circulation. Anesthesiology. 1998;88(5):1365&#x2013;1386. doi: 10.1097/00000542-199805000-00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199805000-00029</ArticleId><ArticleId IdType="pubmed">9605698</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E, Wilcox ME, Brower RG, Stewart TE, Mehta S, Lapinsky SE, Meade MO, Ferguson ND. Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med. 2008;178(11):1156&#x2013;1163. doi: 10.1164/rccm.200802-335OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200802-335OC</ArticleId><ArticleId IdType="pubmed">18776154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SC, Adams AB, Simonson DA, Dries DJ, Broccard AF, Hotchkiss JR, Marini JJ. Transient hemodynamic effects of recruitment maneuvers in three experimental models of acute lung injury. Crit Care Med. 2004;32(12):2378&#x2013;2384. doi: 10.1097/01.CCM.0000147444.58070.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000147444.58070.72</ArticleId><ArticleId IdType="pubmed">15599139</ArticleId></ArticleIdList></Reference><Reference><Citation>Canfran S, Gomez de Segura IA, Cediel R, Garcia-Fernandez J. Effects of fluid load on cardiovascular function during stepwise lung recruitment manoeuvre in healthy dogs. Vet J. 2013;197(3):800&#x2013;805. doi: 10.1016/j.tvjl.2013.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvjl.2013.05.013</ArticleId><ArticleId IdType="pubmed">23791733</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouz K, Hoppe P, Briesenick L, Saugel B. Intraoperative hypotension: pathophysiology, clinical relevance, and therapeutic approaches. Indian J Anaesth. 2020;64(2):90&#x2013;96. doi: 10.4103/ija.IJA_939_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_939_19</ArticleId><ArticleId IdType="pmc">PMC7017666</ArticleId><ArticleId IdType="pubmed">32139925</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold GE, Tange M, Jensen TM, Ottesen S. &#x2018;Subdural&#x2019; pressure measurement during craniotomy. Correlation with tactile estimation of dural tension and brain herniation after opening of dura. Br J Neurosurg. 1996;10(1):69&#x2013;75. doi: 10.1080/02688699650040548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02688699650040548</ArticleId><ArticleId IdType="pubmed">8672261</ArticleId></ArticleIdList></Reference><Reference><Citation>Hol L, Nijbroek S, Schultz MJ. Perioperative lung protection: clinical implications. Anesth Analg. 2020;131(6):1721&#x2013;1729. doi: 10.1213/ANE.0000000000005187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005187</ArticleId><ArticleId IdType="pubmed">33186160</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32478430</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2022</StartPage><EndPage>2031</EndPage><MedlinePgn>2022-2031</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.14593</ELocationID><Abstract><AbstractText Label="BACKGROUND">The pathologic process of ARVC (arrhythmogenic right ventricular cardiomyopathy) typically originates in the epicardium or subepicardial layers with progression toward endocardium. However, in the most recent ARVC international task force consensus statement, epicardial ventricular tachycardia (VT) ablation is recommended as a Class I indication only in patients with at least one failed endocardial VT ablation attempt.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this meta-analysis is to assess the outcomes of ARVC patients undergoing combined endo-epicardial VT ablation, as compared to endocardial ablation alone.</AbstractText><AbstractText Label="METHODS">A systematic review of PubMed, Embase, and Cochrane was performed for studies reporting clinical outcomes of endo-epicardial VT ablation vs endocardial-only VT ablation in patients with ARVC. Fixed-Effect model was used if I<sub>2</sub> &lt; 25 and the Random-Effects Model was used if I<sub>2</sub> &#x2265; 25%.</AbstractText><AbstractText Label="RESULTS">Nine studies consisting of 452 patients were included (mean age 42.3&#x2009;&#xb1;&#x2009;5.7&#x2009;years; 70% male). After a mean follow-up of 48.1&#x2009;&#xb1;&#x2009;21.5&#x2009;months, endo-epicardial ablation was associated with 42% relative risk reduction in VA recurrence as opposed to endocardial ablation alone (risk ratio [RR], 0.58; 95% confidence interval [CI], 0.45-0.75; P&#x2009;&lt;&#x2009;.0001). No significant differences were noted between endo-epicardial and endocardial VT ablation groups in terms of all-cause mortality (RR, 1.19; 95% CI, 0.03-47.08; P&#x2009;=&#x2009;.93) and acute procedural complications (RR, 5.39; 95% CI, 0.60-48.74; P&#x2009;=&#x2009;.13).</AbstractText><AbstractText Label="CONCLUSIONS">Our findings suggest that in patients with ARVC, endo-epicardial VT ablation is associated with a significant reduction in VA recurrence as opposed to endocardial ablation alone, without a significant difference in all-cause mortality or acute procedural complications.</AbstractText><CopyrightInformation>&#xa9; 2020 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6420-8669</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Kavisha</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6416-5910</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briceno</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3962-1248</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alviz</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5417-9777</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabr</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7129-5550</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivedi</LastName><ForeName>Chintan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Sanghamitra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6601-944X</Identifier><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Rocca</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ahmad</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ruike</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Henan Provincial People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rios</LastName><ForeName>Saul</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6774-5849</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerna</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Xianfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantino</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9770-8675</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Dong</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1492-2693</Identifier><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute, HCA Midwest Health, Kansas City, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5487-0728</Identifier><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6508-4047</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019571" MajorTopicYN="Y">Arrhythmogenic Right Ventricular Dysplasia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004699" MajorTopicYN="N">Endocardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010496" MajorTopicYN="N">Pericardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmogenic right ventricular cardiomyopathy</Keyword><Keyword MajorTopicYN="N">endocardial ablation</Keyword><Keyword MajorTopicYN="N">endocardial-epicardial ablation</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia recurrence</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32478430</ArticleId><ArticleId IdType="doi">10.1111/jce.14593</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Te Riele AS, James CA, Philips B, et al. Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol. 2013;24(12):1311-1320.</Citation></Reference><Reference><Citation>Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94(5):983-991.</Citation></Reference><Reference><Citation>Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2009;120(5):366-375.</Citation></Reference><Reference><Citation>Bai R, Di Biase L, Shivkumar K, et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4(4):478-485.</Citation></Reference><Reference><Citation>Berruezo A, Fern&#xe1;ndez-Armenta J, Mont L, et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012;5(1):111-121.</Citation></Reference><Reference><Citation>Philips B, te Riele AS, Sawant A, et al. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2015;12(4):716-725.</Citation></Reference><Reference><Citation>Romero J, Cerrud-Rodriguez RC, Di Biase L, et al. Combined endocardial-epicardial versus endocardial catheter ablation alone for ventricular tachycardia in structural heart disease: a systematic review and meta-analysis. JACC Clin Electrophysiol. 2019;5(1):13-24.</Citation></Reference><Reference><Citation>Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Eur Heart J. 2015;36(46):3227-3237.</Citation></Reference><Reference><Citation>Berte B, Sacher F, Venlet J, et al. VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study. J Cardiovasc Electrophysiol. 2016;27(1):80-87.</Citation></Reference><Reference><Citation>Mahida S, Venlet J, Saguner AM, et al. Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: results from a multicenter study. Heart Rhythm. 2019;16(4):536-543.</Citation></Reference><Reference><Citation>Mathew S, Saguner AM, Schenker N, et al. Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: a sequential approach. J Am Heart Assoc. 2019;8(5):e010365.</Citation></Reference><Reference><Citation>M&#xfc;ssigbrodt A, Efimova E, Knopp H, et al. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation? J Interv Card Electrophysiol. 2017;48(2):193-199.</Citation></Reference><Reference><Citation>Philips B, Madhavan S, James C, et al. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol. 2012;5(3):499-505.</Citation></Reference><Reference><Citation>Santangeli P, Zado ES, Supple GE, et al. Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8(6):1413-1421.</Citation></Reference><Reference><Citation>Santangeli P, Tung R, Xue Y, et al. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry. JACC Clin Electrophysiol. 2019;5(1):55-65.</Citation></Reference><Reference><Citation>Wei W, Liao H, Xue Y, et al. Long-term outcomes of radio-frequency catheter ablation on ventricular tachycardias due to arrhythmogenic right ventricular cardiomyopathy: a single center experience. PLOS One. 2017;12(1):e0169863.</Citation></Reference><Reference><Citation>Dalal D, Jain R, Tandri H, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2007;50(5):432-440.</Citation></Reference><Reference><Citation>Verma A, Kilicaslan F, Schweikert RA, et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation. 2005;111(24):3209-3216.</Citation></Reference><Reference><Citation>Souissi Z, Boul&#xe9; S, Hermida JS, et al. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry. Europace. 2018;20(2):362-369.</Citation></Reference><Reference><Citation>Romero J, Shivkumar K, Di Biase L, et al. Mastering the art of epicardial access in cardiac electrophysiology. Heart Rhythm. 2019;16(11):1738-1749.</Citation></Reference><Reference><Citation>Orgeron GM, James CA, Te Riele A, et al. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia/cardiomyopathy: predictors of appropriate therapy, outcomes, and complications. J Am Heart Assoc. 2017;6(6):e006242.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40456161</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1539-3704</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of internal medicine</Title><ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal><ArticleTitle>Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>909</StartPage><EndPage>920</EndPage><MedlinePgn>909-920</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7326/ANNALS-24-02841</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Perioperative hemodynamic abnormalities have been associated with neurocognitive outcomes after noncardiac surgery.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To compare the effects of perioperative hypotension-avoidance versus hypertension-avoidance strategies on delirium and 1-year cognitive decline after noncardiac surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Randomized controlled trial. (ClinicalTrials.gov: NCT03505723).</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">54 centers, 19 countries.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">2603 high-vascular-risk patients undergoing noncardiac surgery, receiving 1 or more chronic antihypertensive medications (mean age, 70 years).</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="UNASSIGNED">In the hypotension-avoidance strategy, the intraoperative mean arterial pressure (MAP) target was 80 mm Hg or greater; before and for 2 days after surgery, renin-angiotensin-aldosterone system inhibitors were withheld, and other chronic antihypertensive medications were administered for systolic blood pressures of 130 mm Hg or greater following an algorithm. In the hypertension-avoidance strategy, the intraoperative MAP target was 60 mm Hg or greater; all chronic antihypertensive medications were continued perioperatively.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="UNASSIGNED">Delirium on postoperative day 1 to 3 (primary outcome); decline of 2 points or more at the Montreal Cognitive Assessment (MoCA) 1 year after surgery compared with baseline (secondary outcome).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">95 of 1310 patients (7.3%) in the hypotension-avoidance and 90 of 1293 patients (7.0%) in the hypertension-avoidance group had delirium (relative risk [RR], 1.04 [95% CI, 0.79 to 1.38]). Among 701 patients who completed 1-year MoCA (full or telephone version), 129 of 347 (37.2%) in the hypotension-avoidance and 117 of 354 (33.1%) in the hypertension-avoidance group had a decline of 2 or more points (RR, 1.13 [CI, 0.92 to 1.38]). Nineteen percent in the hypotension-avoidance and 27% in the hypertension-avoidance strategy had hypotension requiring an intervention (RR, 0.63 [CI, 0.52 to 0.76]), mostly intraoperatively; only 5%, in both groups, had hypotension postoperatively.</AbstractText><AbstractText Label="LIMITATION" NlmCategory="UNASSIGNED">The COVID-19 pandemic challenged site participation in the substudy; although large, the sample size was lower than expected.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">There was no evidence of a difference in neurocognitive outcomes between the hypotension-avoidance and hypertension-avoidance strategies.</AbstractText><AbstractText Label="PRIMARY FUNDING SOURCE" NlmCategory="UNASSIGNED">Canadian Institutes of Health Research, Canada; National Health and Medical Research Council, Australia; Research Grant Council, Hong Kong SAR, China.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Maura</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8468-7991</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario, Canada; Clinical Epidemiology and Research Centre, Humanitas University &amp; IRCCS Humanitas Research Hospital, Milan, Italy; and Department of Health Research Methods, McMaster University, Hamilton, Ontario, Canada (M.Marcucci).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MTV</Initials><Identifier Source="ORCID">0000-0002-3574-7855</Identifier><AffiliationInfo><Affiliation>The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China (M.T.V.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Painter</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Acute Care Medicine, The University of Adelaide, Adelaide, South Australia, Australia (T.W.P.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Efremov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5581-9169</Identifier><AffiliationInfo><Affiliation>Saint Petersburg State University Hospital, Saint Petersburg, Russia (S.E.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguado</LastName><ForeName>Hector J</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0002-0371-520X</Identifier><AffiliationInfo><Affiliation>Trauma &amp; Orthopaedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain (H.J.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astrakov</LastName><ForeName>Sergey V</ForeName><Initials>SV</Initials><Identifier Source="ORCID">0000-0001-5251-5362</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Novosibirsk State University, Novosibirsk, Russia (S.V.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinlugtenbelt</LastName><ForeName>Ydo V</ForeName><Initials>YV</Initials><Identifier Source="ORCID">0000-0002-9332-1086</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Ameen</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9338-2815</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada (A.P., V.T., D.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cata</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>MD Anderson Cancer Center, Houston, Texas (J.P.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amir</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4726-5674</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Shifa International Hospital and Shifa Tameer-e-Millat University, Islamabad, Pakistan (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirov</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4375-3374</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Northern State Medical University, Arkhangelsk, Russia (M.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia (K.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1457-2945</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario, Canada; and Department of Medicine, Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada (E.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges</LastName><ForeName>Flavia K</ForeName><Initials>FK</Initials><Identifier Source="ORCID">0000-0001-5377-7612</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario; Department of Health Research Methods, McMaster University, Hamilton, Ontario; and Department of Medicine, McMaster University, Hamilton, Ontario, Canada (F.K.B., D.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Nadal</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4559-2463</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain (M.d.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada (A.P., V.T., D.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8594-5980</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan; and Vita-Salute San Raffaele University, Milan, Italy (G.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery V</ForeName><Initials>VV</Initials><Identifier Source="ORCID">0000-0002-5442-6950</Identifier><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute FRCC RR, Moscow, Russia (V.V.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Centre, Novosibirsk, Russia; and Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania (V.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><Identifier Source="ORCID">0000-0001-9932-3077</Identifier><AffiliationInfo><Affiliation>Center for Outcomes Research and Department of Anesthesiology, UTHealth, Houston, Texas (D.I.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Zapata</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-5836-1138</Identifier><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Public Health and Clinical Epidemiology Service, Institut de Recerca Sant Pau, CIBERESP, Barcelona, Spain (M.J.M.-Z.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xavier</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St. John's Medical College, Bangalore, India (D.X.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna, Austria (E.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chew Yin</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0002-9066-3830</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia (C.Y.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-4885-4609</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark (C.S.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wittmann</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4786-7712</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2908-6365</Identifier><AffiliationInfo><Affiliation>Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, Santiago, Chile (D.T.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Highton</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Princess Alexandra Hospital, Woolloongabba, Queensland, Australia (D.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacka</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesiology and Critical Care, University of Alberta, Edmonton, Alberta, Canada (M.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B</LastName><ForeName>Vishwanath</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Nanjappa Hospital, Karnataka, India (V.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarnke</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Calgary, Calgary, Alberta, Canada (K.Z.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sidhu</LastName><ForeName>Ravinder Singh</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Sidhu Hospital Doraha Ludhiana, Ludhiana, India (R.S.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriani</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0002-2113-4115</Identifier><AffiliationInfo><Affiliation>IRCCS Galeazzi Sant'Ambrogio (OGSA), Site Istituto San Siro, Milan, Italy (G.O.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6728-9297</Identifier><AffiliationInfo><Affiliation>Outcome Research Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio (S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minear</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0006-2354-3472</Identifier><AffiliationInfo><Affiliation>Cleveland Clinic Florida, Weston, Florida (S.Minear).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>Tristan E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>The Ohio State University Wexner Medical Center, Columbus, Ohio (T.E.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0467-1736</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Ordensklinikum Linz, Linz, Austria (K.R.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brusasco</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Medicine, Galliera Hospital, Genova, Italy (C.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parlow</LastName><ForeName>Joel L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-4461-5934</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, Ontario, Canada (J.L.P., T.G.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maxwell</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0007-9427-5652</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Auckland City Hospital, Auckland, New Zealand (E.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine, Winston Salem, North Carolina (S.Miller).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mrkobrada</LastName><ForeName>Marko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Western University, London, Ontario, Canada (M.Mrkobrada).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Keyur Suresh Chandra</ForeName><Initials>KSC</Initials><Identifier Source="ORCID">0000-0002-1734-4577</Identifier><AffiliationInfo><Affiliation>Surat Institution, Surat, India (K.S.C.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahate</LastName><ForeName>Prashant</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5075-8245</Identifier><AffiliationInfo><Affiliation>Rahate Surgical Hospital, Nagpur, India (P.R.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowark</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7433-8675</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany; and University Hospital RWTH Aachen, Aachen, Germany (A.Kowark).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Blasio</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Galeazzi Orthopedic Institute, Milan, Italy (G.D.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ofori</LastName><ForeName>Sandra N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0002-1691-0979</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario; and Department of Medicine, McMaster University, Hamilton, Ontario, Canada (S.N.O., M.K.W., M.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conen</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2459-5251</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario; Department of Health Research Methods, McMaster University, Hamilton, Ontario; and Department of Medicine, McMaster University, Hamilton, Ontario, Canada (F.K.B., D.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinathan</LastName><ForeName>Sadeesh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4972-3619</Identifier><AffiliationInfo><Affiliation>Section of Thoracic Surgery, Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada (S.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-1349-1123</Identifier><AffiliationInfo><Affiliation>Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland (W.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayaram</LastName><ForeName>Raja</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7861-9546</Identifier><AffiliationInfo><Affiliation>Department of Anaesthetics, Clinical Neurosciences, University of Oxford, Oxford University Hospitals NHS Trust, Oxford, United Kingdom (R.J.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellerkmann</LastName><ForeName>Richard K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Klinikum Dortmund, University Witten-Herdecke, Dortmund, Germany (R.K.E.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Momeni</LastName><ForeName>Mona</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1965-2335</Identifier><AffiliationInfo><Affiliation>Cliniques Universitaires Saint-Luc, Brussels, Belgium (M.Momeni).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Copland</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario, Canada (I.C., J.V., K.B., Z.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2356-8876</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario, Canada (I.C., J.V., K.B., Z.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balasubramanian</LastName><ForeName>Kumar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario, Canada (I.C., J.V., K.B., Z.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuoru</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario, Canada (I.C., J.V., K.B., Z.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Michael Ke</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario; and Department of Medicine, McMaster University, Hamilton, Ontario, Canada (S.N.O., M.K.W., M.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Deyang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada (A.P., V.T., D.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGillion</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario; and School of Nursing, McMaster University, Hamilton, Ontario, Canada (M.H.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5887-3099</Identifier><AffiliationInfo><Affiliation>Outcome Research Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio; and Department of General Anesthesiology, Emergency and Intensive Care Medicine, Medical University of Graz, Graz, Austria (A.Kurz).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Mukul</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario; and Department of Medicine, McMaster University, Hamilton, Ontario, Canada (S.N.O., M.K.W., M.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Short</LastName><ForeName>Timothy G</ForeName><Initials>TG</Initials><Identifier Source="ORCID">0000-0001-9374-1710</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, Ontario, Canada (J.L.P., T.G.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0003-2935-637X</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario; and Department of Health Research Methods, McMaster University, Hamilton, Ontario, Canada (P.J.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>cogPOISE-3 Trial Investigators and Study Groups</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03505723</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Intern Med</MedlineTA><NlmUniqueID>0372351</NlmUniqueID><ISSNLinking>0003-4819</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="Y">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079690" MajorTopicYN="Y">Postoperative Cognitive Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Disclosures:</b> Disclosure forms are available with the article online.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Maura</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MTV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Painter</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Efremov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguado</LastName><ForeName>Hector J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Astrakov</LastName><ForeName>Sergey V</ForeName><Initials>SV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleinlugtenbelt</LastName><ForeName>Ydo V</ForeName><Initials>YV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Ameen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cata</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amir</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirov</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borges</LastName><ForeName>Flavia K</ForeName><Initials>FK</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Nadal</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tandon</LastName><ForeName>Vikas</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mart&#xed;nez-Zapata</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xavier</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Edith</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Chew Yin</ForeName><Initials>CY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wittmann</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torres</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Highton</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacka</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>B</LastName><ForeName>Vishwanath</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zarnke</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sidhu</LastName><ForeName>Ravinder Singh</ForeName><Initials>RS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oriani</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minear</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weaver</LastName><ForeName>Tristan E</ForeName><Initials>TE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brusasco</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parlow</LastName><ForeName>Joel L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maxwell</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mrkobrada</LastName><ForeName>Marko</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Keyur Suresh Chandra</ForeName><Initials>KSC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rahate</LastName><ForeName>Prashant</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kowark</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Blasio</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ofori</LastName><ForeName>Sandra N</ForeName><Initials>SN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conen</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srinathan</LastName><ForeName>Sadeesh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayaram</LastName><ForeName>Raja</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellerkmann</LastName><ForeName>Richard K</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Momeni</LastName><ForeName>Mona</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Copland</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balasubramanian</LastName><ForeName>Kumar</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuoru</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Michael Ke</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Deyang</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGillion</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Mukul</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Timothy G</ForeName><Initials>TG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmartz</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polanczyk</LastName><ForeName>Carisi</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alfonsi</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gross</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roshanov</LastName><ForeName>Pavel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roberts</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fergusson</LastName><ForeName>Dean</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fo&#xeb;x</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>McAlister</LastName><ForeName>Finlay</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guyatt</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yusuf</LastName><ForeName>Salim</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bangdiwala</LastName><ForeName>Shrikant I</ForeName><Initials>SI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Diodato</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Howe</LastName><ForeName>Rosemary</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mastrangelo</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGall</LastName><ForeName>Clare</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mercuri</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molnar</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stillo</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Southall</LastName><ForeName>Trisha</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swanson</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tosh</LastName><ForeName>Makayla</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deng</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marsden</LastName><ForeName>Tamara</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molec</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shestakovska</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Robin</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ormond</LastName><ForeName>Gillian</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Prinse</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lumb</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macklin</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Charlton</LastName><ForeName>Christine S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Somfleth</LastName><ForeName>Johanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>Carolyn M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sivalingam</LastName><ForeName>Palvannan</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kearney</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oishi</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forrester</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pilling</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathew-Kurian</LastName><ForeName>Sibi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cummins</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muller</LastName><ForeName>Juanita</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koerber</LastName><ForeName>Jason P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scotland</LastName><ForeName>Vanessa J</ForeName><Initials>VJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ha</LastName><ForeName>Vi</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kabon</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reiterer</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taschner</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adamowitsch</LastName><ForeName>Nikolas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zotti</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieu</LastName><ForeName>Audrey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Joseph</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Amna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gregus</LastName><ForeName>Krysten</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Dale</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raza</LastName><ForeName>Samir</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haider</LastName><ForeName>Shariq</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chakroborty</LastName><ForeName>Amitabha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zandi</LastName><ForeName>Shervin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wyne</LastName><ForeName>Ahraaz</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>VanHelder</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Leary</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harlock</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panju</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srivaratharajan</LastName><ForeName>Kajenny</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chui</LastName><ForeName>Betty</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Proc</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trombetta</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rapanos</LastName><ForeName>Ted</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pettit</LastName><ForeName>Shirley</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shanthanna</LastName><ForeName>Harsha</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neary</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connolly</LastName><ForeName>Katie</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abdulrahman</LastName><ForeName>Muammar</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wikkerink</LastName><ForeName>Spencer</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quraishi</LastName><ForeName>Faraaz</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nenshi</LastName><ForeName>Rahima</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dumerton</LastName><ForeName>Deborah A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erb</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shelley</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vowotor</LastName><ForeName>Elorm</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Todd</LastName><ForeName>Reegan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peponoulas</LastName><ForeName>Emile</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Joly</LastName><ForeName>Nikola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrier</LastName><ForeName>Francois-Martin</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graham</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greene</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dillane</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bigam</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMurtry</LastName><ForeName>Ella</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaugg</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foerster</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiplagat</LastName><ForeName>Linet</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruzycki</LastName><ForeName>Shannon M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schneider</LastName><ForeName>Prism S</ForeName><Initials>PS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davis</LastName><ForeName>Melinda</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kachra</LastName><ForeName>Rahim</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bosch</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kidane</LastName><ForeName>Biniam</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Funk</LastName><ForeName>Duane</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tan</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dresser</LastName><ForeName>George K</ForeName><Initials>GK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ernst</LastName><ForeName>Jaclyn A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubois</LastName><ForeName>Luc</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Handsor</LastName><ForeName>Stephanie N</ForeName><Initials>SN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fuentes</LastName><ForeName>Maite</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paz</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vasquez</LastName><ForeName>Javiera Paz</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Joynt</LastName><ForeName>Gavin M</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>William K K</ForeName><Initials>WKK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choi</LastName><ForeName>Gordon Y S</ForeName><Initials>GYS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Wai Tat</ForeName><Initials>WT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>Linda M L</ForeName><Initials>LML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Chi-Fai</ForeName><Initials>CF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiu</LastName><ForeName>Philip W Y</ForeName><Initials>PWY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lau</LastName><ForeName>James Y W</ForeName><Initials>JYW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Underwood</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fung</LastName><ForeName>Beaker</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hui</LastName><ForeName>Ka Yan</ForeName><Initials>KY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Chee Sam</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Winnie Wing Sam</ForeName><Initials>WWS</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xf8;gaard</LastName><ForeName>Marlene</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gundel</LastName><ForeName>Ossian</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Diana B</ForeName><Initials>DB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Anne Sofie</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiefer</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pohl</LastName><ForeName>Holger</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amarasekara</LastName><ForeName>Mihiri U</ForeName><Initials>MU</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coburn</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neumann</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Velten</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Puscarevic</LastName><ForeName>Alma</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massoth</LastName><ForeName>Gregor</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossaint</LastName><ForeName>Rolf</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ziemann</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gr&#xfc;&#xdf;er</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallqvist</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kowark</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bach</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rao</LastName><ForeName>Mangala</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xavier</LastName><ForeName>Freeda</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Subbin</LastName><ForeName>Susan Maria</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mangukiya</LastName><ForeName>Dhaval</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Jignesh</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kachhadiya</LastName><ForeName>Daxa</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thumar</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parekh</LastName><ForeName>Viral</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sachin</LastName><ForeName>D N B</ForeName><Initials>DNB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gopal</LastName><ForeName>Veena</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shivaraj</LastName><ForeName>D M</ForeName><Initials>DM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ajay</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veena</LastName><ForeName>T S</ForeName><Initials>TS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sidhu</LastName><ForeName>Gursaran Kaur</ForeName><Initials>GK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laiker</LastName><ForeName>Naveen</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sidhu</LastName><ForeName>Abhitej Singh</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patankar</LastName><ForeName>Suresh B</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khaladkar</LastName><ForeName>Suparn K</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padsalgi</LastName><ForeName>Gururaj A</ForeName><Initials>GA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sengupta</LastName><ForeName>Shantanu P</ForeName><Initials>SP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mungulmare</LastName><ForeName>Kunda</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menon</LastName><ForeName>Prem Haridas</ForeName><Initials>PH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amma</LastName><ForeName>Rajeev Damodaran Nair Sarojini</ForeName><Initials>RDNS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sigamani</LastName><ForeName>Alen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stephen</LastName><ForeName>Manesh</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guhabiswas</LastName><ForeName>Rahul</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nisi</LastName><ForeName>Francesco G</ForeName><Initials>FG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valsecchi</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Donato</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrara</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerrerio</LastName><ForeName>Tancredi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donarini</LastName><ForeName>Cesare</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iacurti</LastName><ForeName>Marisa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghanem</LastName><ForeName>Georges</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orefice</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corradi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gandini</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosa</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Maio</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zagra</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perazzo</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colombo</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marra</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Tyng Yan</ForeName><Initials>TY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheong</LastName><ForeName>Chao Chia</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yeow</LastName><ForeName>Ri Qi</ForeName><Initials>RQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choy</LastName><ForeName>Yang Qun</ForeName><Initials>YQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Xue Lin</ForeName><Initials>XL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gan</LastName><ForeName>Choo Kian</ForeName><Initials>CK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sari</LastName><ForeName>Nor Ashikin Md</ForeName><Initials>NAM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landman</LastName><ForeName>Ellie B M</ForeName><Initials>EBM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cobben</LastName><ForeName>Jan-Hein M G</ForeName><Initials>JMG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Staffhorst</LastName><ForeName>Bas</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mes</LastName><ForeName>Roel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elskamp-Meijerman</LastName><ForeName>Hannie</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voskamp-Wierik Te</LastName><ForeName>Monique</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dijkgraaf</LastName><ForeName>Rochel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welberg</LastName><ForeName>Kim M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Postmus</LastName><ForeName>Judith J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campbell</LastName><ForeName>Douglas</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McAllister</LastName><ForeName>Davina</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Vikrant</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Leanda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dandy</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zahid</LastName><ForeName>Tehreem</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azam</LastName><ForeName>Sumeyya</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sohail</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassan</LastName><ForeName>Yumna</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aimon</LastName><ForeName>Sibgha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uneeb</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yusufi</LastName><ForeName>Maaz Ahmed</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nazir</LastName><ForeName>Zia</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Awan</LastName><ForeName>Sundus Ayub</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sandeela</LastName><ForeName>Faisal Aziz</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Qazi</LastName><ForeName>Wara</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chwala</LastName><ForeName>Maciej</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>W&#x142;udarczyk</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kudli&#x144;ski</LastName><ForeName>Bartosz</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zawisza</LastName><ForeName>Jaros&#x142;aw</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wirtek</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kulikov</LastName><ForeName>Alexey Y</ForeName><Initials>AY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alexeev</LastName><ForeName>Mikhail A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trukhin</LastName><ForeName>Konstantin S</ForeName><Initials>KS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cherednichenko</LastName><ForeName>Andrey A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andrianova</LastName><ForeName>Irina A</ForeName><Initials>IA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mikhailova</LastName><ForeName>Svetlana S</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sorokin</LastName><ForeName>Andrey A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leonova</LastName><ForeName>Elizaveta A</ForeName><Initials>EA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuleshov</LastName><ForeName>Oleg V</ForeName><Initials>OV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Safronov</LastName><ForeName>Alexander A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nepomnyaschaya</LastName><ForeName>Svetlana L</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kotova</LastName><ForeName>Anna S</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stoliarov</LastName><ForeName>Maxim S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shmatov</LastName><ForeName>Dmitry V</ForeName><Initials>DV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shkarupa</LastName><ForeName>Dmitry D</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shirshova</LastName><ForeName>Elena A</ForeName><Initials>EA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neporada</LastName><ForeName>Elena L</ForeName><Initials>EL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kungurtsev</LastName><ForeName>Konstantin N</ForeName><Initials>KN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhukov</LastName><ForeName>Vyacheslav V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Werner</LastName><ForeName>Ilya G</ForeName><Initials>IG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chudnovets</LastName><ForeName>Igor Yu</ForeName><Initials>IY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karpenko</LastName><ForeName>Andrey A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ismoilov</LastName><ForeName>Samandar M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deryagin</LastName><ForeName>Mikhail N</ForeName><Initials>MN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomivorotova</LastName><ForeName>Liudmila V</ForeName><Initials>LV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cherniavskiy</LastName><ForeName>Alexander M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moroz</LastName><ForeName>Gleb B</ForeName><Initials>GB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osinsky</LastName><ForeName>Roman V</ForeName><Initials>RV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuzkov</LastName><ForeName>Vsevolod V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hussain</LastName><ForeName>Ayyaz</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smetkin</LastName><ForeName>Alexey A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carionova</LastName><ForeName>Darja V</ForeName><Initials>DV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ilyina</LastName><ForeName>Yana Y</ForeName><Initials>YY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volkov</LastName><ForeName>Dmitrii A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fot</LastName><ForeName>Evgenia V</ForeName><Initials>EV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sokolova</LastName><ForeName>Maria M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veshnyakova</LastName><ForeName>Maria V</ForeName><Initials>MV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lochekhina</LastName><ForeName>Evgenia B</ForeName><Initials>EB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ovezov</LastName><ForeName>Alexey M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berikashvili</LastName><ForeName>Levan B</ForeName><Initials>LB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerasimenko</LastName><ForeName>Oleg N</ForeName><Initials>ON</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berrocal-Cuadrado</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mateos-&#xc1;lvarez</LastName><ForeName>Elvira</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pereda-Manso</LastName><ForeName>Adela</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santiago-Maniega</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fern&#xe1;ndez-Collantes</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodr&#xed;guez-Cer&#xf3;n</LastName><ForeName>Gema</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bragado-Gonz&#xe1;lez</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poves-&#xc1;lvarez</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Prada-Mart&#xed;n</LastName><ForeName>Blanca</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herrero</LastName><ForeName>Roc&#xed;o L&#xf3;pez</ForeName><Initials>RL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verdugo</LastName><ForeName>Mercedes Hernando</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinez-Municio</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noriega</LastName><ForeName>David C</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cano</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasini</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galan</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madrid</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camio</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Miguel</LastName><ForeName>Marcos</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chocron</LastName><ForeName>Ivette</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Susana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butron</LastName><ForeName>Dina</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidal</LastName><ForeName>Gemma</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Maria T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thayaparan</LastName><ForeName>Surendini</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kopyeva</LastName><ForeName>Tatyana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cywinski</LastName><ForeName>Jacek B</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keebler</LastName><ForeName>Allen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritzman</LastName><ForeName>Stacy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machado</LastName><ForeName>Sandra B</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manlapaz</LastName><ForeName>Mariel R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turan</LastName><ForeName>Alparslan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ekrami</LastName><ForeName>Elyad</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bravo</LastName><ForeName>Mauro</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agudelo-Jimenez</LastName><ForeName>Ruben</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niazi</LastName><ForeName>Azfar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volio</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Daniel D</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Araujo-Duran</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mena</LastName><ForeName>Gabriel E</ForeName><Initials>GE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsai</LastName><ForeName>January</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vachhani</LastName><ForeName>Shital</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moon-Calderon</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwater</LastName><ForeName>Piotr</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lasala</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thakar</LastName><ForeName>Dilip</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wright</LastName><ForeName>Crystal</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ifeanyi</LastName><ForeName>Ifeyinwa</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potylchanski</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Camila</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nasim</LastName><ForeName>Syed</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noguera</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pimentel</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raut</LastName><ForeName>Snehal</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baral</LastName><ForeName>Sameep</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergese</LastName><ForeName>Sergio D</ForeName><Initials>SD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uribe</LastName><ForeName>Alberto A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borrell-Vega</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hatten</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dada</LastName><ForeName>Olufunke</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKeown</LastName><ForeName>Johnny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorda-Diaz</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Echeverria-Villalobos</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Essandoh</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cusson</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Lynne</ForeName><Initials>L</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>2</Day><Hour>18</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>2</Day><Hour>17</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40456161</ArticleId><ArticleId IdType="doi">10.7326/ANNALS-24-02841</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34139353</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-8769</ISSN><JournalIssue CitedMedium="Internet"><Volume>153</Volume><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>World neurosurgery</Title><ISOAbbreviation>World Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Association Between Bone Cement Augmentation and New Vertebral Fractures in Patients with Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>98</StartPage><EndPage>108.e3</EndPage><MedlinePgn>98-108.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2021.06.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-8750(21)00851-2</ELocationID><Abstract><AbstractText Label="PURPOSE">To investigate the association between bone cement augmentation and new vertebral fractures (VF) in patients with osteoporotic vertebral compression fractures (OVCFs).</AbstractText><AbstractText Label="METHODS">A literature search of PubMed, EMBASE, and the Cochrane Library was conducted from 1987 to December 31, 2020, to identify randomized controlled trials that compared bone cement augmentation with non-bone cement treatments in patients with OVCFs. The clinical incidence of new VF and the risk of new adjacent vertebral fractures (AVF) after treatment were calculated. The indexes of the risk ratio or odds ratio, and 95% confidence intervals were determined with RevMan 5.2 software.</AbstractText><AbstractText Label="RESULTS">A total of 13 randomized controlled trials involving 1949 participants were included in the final quantitative analysis. There was no significant association between bone cement augmentation and the clinical incidence of new VF during the 6-month and 12-month follow-ups or the whole follow-up period. However, there was a significantly lower clinical incidence of new VF in patients who received bone cement augmentation compared with non-bone cement treatments during 24 months or more of follow-up. Pooled data from the relevant trials demonstrated that the risk of new AVF in bone cement augmentation was significantly higher than that in non-bone cement treatments.</AbstractText><AbstractText Label="CONCLUSIONS">Although the use of bone cement augmentation in OVCFs significantly increased the risk of new AVF compared with non-bone cement treatments, it was not significantly associated with a higher clinical incidence of new VF.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Qinghua</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China; Department of Osteoporosis, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Osteoporosis, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Keliang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiaosheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Osteoporosis, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, P. R. China. Electronic address: lxshengtcm@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World Neurosurg</MedlineTA><NlmUniqueID>101528275</NlmUniqueID><ISSNLinking>1878-8750</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001843" MajorTopicYN="N">Bone Cements</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050815" MajorTopicYN="N">Fractures, Compression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cement augmentation</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">New vertebral fractures</Keyword><Keyword MajorTopicYN="N">Osteoporotic vertebral compression fractures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>17</Day><Hour>20</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34139353</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2021.06.023</ArticleId><ArticleId IdType="pii">S1878-8750(21)00851-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34480562</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-535X</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>The journals of gerontology. Series A, Biological sciences and medical sciences</Title><ISOAbbreviation>J Gerontol A Biol Sci Med Sci</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Nonresilient Outcomes in Older Adults After Total Knee Replacement.</ArticleTitle><Pagination><StartPage>1915</StartPage><EndPage>1922</EndPage><MedlinePgn>1915-1922</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/gerona/glab257</ELocationID><Abstract><AbstractText Label="BACKGROUND">Total knee replacement (TKR) is a common procedure in older adults. Physical resilience may be a useful construct to explain variable outcomes. We sought to define a simple measure of physical resilience and identify risk factors for nonresilient patient outcomes.</AbstractText><AbstractText Label="METHODS">Secondary analysis of Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement (FORCE-TJR) cohort study, a prospective registry of total joint replacement. The analysis included 7&#x2009;239 adults aged 60 or older who underwent TKR between 2011 and 2015. Measures included sociodemographic and health factors. Outcomes were categorized as physically resilient versus nonresilient based on the change from baseline to 1-year follow-up for 3 patient-reported outcomes: the physical component summary (PCS), bodily pain (BP), and vitality (VT) from the Short Form-36 subcomponent scores, at preop and 1-year postprocedure. Associations were expressed as relative risk (RR) of physically nonresilient outcomes using generalized linear regression models, with Poisson distribution and log link.</AbstractText><AbstractText Label="RESULTS">Age, body mass index, and Charlson Comorbidity Index (CCI) were associated with increased risk of physically nonresilient outcomes across PCS, BP, and VT: age, per 5 years for PCS (RR = 1.18 [1.12-1.23]), BP (RR = 1.06 [1.01-1.11), and VT (RR = 1.09 [1.06-1.12]); body mass index, per 5 kg/m2, for PCS (RR = 1.13 [1.07-1.19]), BP (RR = 1.06 [1.00-1.11]), and VT (RR = 1.08 [1.04-1.11]); and CCI for PCS CCI = 1 (RR = 1.38 [1.20-1.59]), CCI = 2-5 (RR = 1.59 [1.35-1.88]), CCI &#x2265;6 (RR = 1.55 [1.31-1.83]. Household income &gt;$45 000 associated with lower risk for PCS (RR = 0.81 [0.70-0.93]), BP (RR = 0.80 [0.69-0.91]), and VT (RR = 0.86 [0.78-0.93]).</AbstractText><AbstractText Label="CONCLUSIONS">We operationalized physical resilience and identified factors predicting resilience after TKR. This approach may aid clinical risk stratification, guide further investigation of causes, and ultimately aid patients through the design of interventions to enhance physical resilience.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laskow</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0173-1588</Identifier><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jiafeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buta</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0752-2456</Identifier><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oni</LastName><ForeName>Julius</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Johns Hopkins Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sieber</LastName><ForeName>Frederick</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandeen-Roche</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walston</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franklin</LastName><ForeName>Patricia D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Institute for Public Health and Medicine at Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varadhan</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8434-1034</Identifier><AffiliationInfo><Affiliation>Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 HS018910</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG058527</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AG056933</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 AG056933</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol A Biol Sci Med Sci</MedlineTA><NlmUniqueID>9502837</NlmUniqueID><ISSNLinking>1079-5006</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Knee arthroplasty</Keyword><Keyword MajorTopicYN="N">Resilience</Keyword><Keyword MajorTopicYN="N">SF-36</Keyword><Keyword MajorTopicYN="N">Surgical risk</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>4</Day><Hour>12</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34480562</ArticleId><ArticleId IdType="pmc">PMC9434465</ArticleId><ArticleId IdType="doi">10.1093/gerona/glab257</ArticleId><ArticleId IdType="pii">6364031</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kane RL, Saleh KJ, Wilt TJ, Bershadsky B. The functional outcomes of total knee arthroplasty. J Bone Joint Surg Am. 2005;87(8):1719&#x2013;1724. doi:10.2106/JBJS.D.02714</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.D.02714</ArticleId><ArticleId IdType="pubmed">16085610</ArticleId></ArticleIdList></Reference><Reference><Citation>Skou ST, Roos EM, Laursen MB, et al. . A randomized, controlled trial of total knee replacement. N Engl J Med. 2015;373(17):1597&#x2013;1606. doi:10.1056/NEJMoa1505467</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1505467</ArticleId><ArticleId IdType="pubmed">26488691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780&#x2013;785. doi:10.2106/JBJS.F.00222</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.F.00222</ArticleId><ArticleId IdType="pubmed">17403800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018;100(17):1455&#x2013;1460. doi:10.2106/JBJS.17.01617</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.17.01617</ArticleId><ArticleId IdType="pubmed">30180053</ArticleId></ArticleIdList></Reference><Reference><Citation>Wylde V, Blom AW, Whitehouse SL, Taylor AH, Pattison GT, Bannister GC. Patient-reported outcomes after total hip and knee arthroplasty: comparison of midterm results. J Arthroplasty. 2009;24(2):210&#x2013;216. doi:10.1016/j.arth.2007.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2007.12.001</ArticleId><ArticleId IdType="pubmed">18534427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuperman EF, Schweizer M, Joy P, Gu X, Fang MM. The effects of advanced age on primary total knee arthroplasty: a meta-analysis and systematic review. BMC Geriatr. 2016;16:41. doi:10.1186/s12877-016-0215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-016-0215-4</ArticleId><ArticleId IdType="pmc">PMC4750247</ArticleId><ArticleId IdType="pubmed">26864215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkland JL, Stout MB, Sierra F. Resilience in aging mice. J Gerontol A Biol Sci Med Sci. 2016;71(11):1407&#x2013;1414. doi:10.1093/gerona/glw086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glw086</ArticleId><ArticleId IdType="pmc">PMC5865545</ArticleId><ArticleId IdType="pubmed">27535963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadley EC, Kuchel GA, Newman AB; Workshop Speakers and Participants . Report: NIA Workshop on measures of physiologic resiliencies in human aging. J Gerontol A Biol Sci Med Sci. 2017;72(7):980&#x2013;990. doi:10.1093/gerona/glx015</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glx015</ArticleId><ArticleId IdType="pmc">PMC5861884</ArticleId><ArticleId IdType="pubmed">28475732</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadhan R, Walston JD, Bandeen-Roche K. Can a link be found between physical resilience and frailty in older adults by studying dynamical systems? J Am Geriatr Soc. 2018;66(8):1455&#x2013;1458. doi:10.1111/jgs.15409</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15409</ArticleId><ArticleId IdType="pmc">PMC6133741</ArticleId><ArticleId IdType="pubmed">29727469</ArticleId></ArticleIdList></Reference><Reference><Citation>Col&#xf3;n-Emeric C, Pieper CF, Schmader KE, et al. . Two approaches to classifying and quantifying physical resilience in longitudinal data. J Gerontol A Biol Sci Med Sci. 2020;75(4):731&#x2013;738. doi:10.1093/gerona/glz097</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glz097</ArticleId><ArticleId IdType="pmc">PMC7328208</ArticleId><ArticleId IdType="pubmed">30993327</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitson HE, Duan-Porter W, Schmader KE, Morey MC, Cohen HJ, Col&#xf3;n-Emeric CS. Physical resilience in older adults: systematic review and development of an emerging construct. J Gerontol A Biol Sci Med Sci. 2016;71(4):489&#x2013;495. doi:10.1093/gerona/glv202</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glv202</ArticleId><ArticleId IdType="pmc">PMC5014191</ArticleId><ArticleId IdType="pubmed">26718984</ArticleId></ArticleIdList></Reference><Reference><Citation>Col&#xf3;n-Emeric C, Whitson HE, Pieper CF, et al. . Resiliency groups following hip fracture in older adults. J Am Geriatr Soc. 2019;67(12):2519&#x2013;2527. doi:10.1111/jgs.16152</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16152</ArticleId><ArticleId IdType="pmc">PMC6898748</ArticleId><ArticleId IdType="pubmed">31469411</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A-M, Ross-Adjie G, McPhail SM, et al. . Incidence, risk factors and the healthcare cost of falls postdischarge after elective total hip and total knee replacement surgery: protocol for a prospective observational cohort study. BMJ Open. 2016;6:11139. doi:10.1136/bmjopen-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016</ArticleId><ArticleId IdType="pmc">PMC4947758</ArticleId><ArticleId IdType="pubmed">27412102</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Wang F, Shi L, Xue Q. Interleukin-6 serum concentration in the elderly undergoing total knee arthroplasty: a potential predictor of the early postoperative knee joint range of motion. J Back Musculoskelet Rehabil. 2020;33(1):35&#x2013;40. doi:10.3233/BMR-181460</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BMR-181460</ArticleId><ArticleId IdType="pubmed">31282401</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan HY, Sultana R, Yeo SJ, Chia SL, Pang HN, Lo NN. Comparison of outcome measures from different pathways following total knee arthroplasty. Singapore Med J. 2018;59(9):476&#x2013;486. doi:10.11622/smedj.2018011</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2018011</ArticleId><ArticleId IdType="pmc">PMC6158141</ArticleId><ArticleId IdType="pubmed">29372260</ArticleId></ArticleIdList></Reference><Reference><Citation>Bade MJ, Wolfe P, Zeni JA, Stevens-Lapsley JE, Snyder-Mackler L. Predicting poor physical performance after total knee arthroplasty. J Orthop Res. 2012;30(11):1805&#x2013;1810. doi:10.1002/jor.22140</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.22140</ArticleId><ArticleId IdType="pmc">PMC3417156</ArticleId><ArticleId IdType="pubmed">22539338</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M, Noiseux N, Linson E, Cram P. The effect of advancing age on total joint replacement outcomes. Geriatr Orthop Surg Rehabil. 2015;6(3):173&#x2013;179. doi:10.1177/2151458515583515</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151458515583515</ArticleId><ArticleId IdType="pmc">PMC4536505</ArticleId><ArticleId IdType="pubmed">26328232</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsdotter AK, Toksvig-Larsen S, Roos EM. Knee arthroplasty: are patients&#x2019; expectations fulfilled? A prospective study of pain and function in 102 patients with 5-year follow-up. Acta Orthop. 2009;80(1):55&#x2013;61. doi:10.1080/17453670902805007</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17453670902805007</ArticleId><ArticleId IdType="pmc">PMC2823230</ArticleId><ArticleId IdType="pubmed">19234886</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmallah RD, Jauregui JJ, Cherian JJ, Pierce TP, Harwin SF, Mont MA. Effect of age on postoperative outcomes following total knee arthroplasty. J Knee Surg. 2016;29(8):673&#x2013;678. doi:10.1055/s-0036-1571428</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0036-1571428</ArticleId><ArticleId IdType="pubmed">26838967</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebs TR, Herzberg W, Roth-Kroeger AM, R&#xfc;ther W, Hassenpflug J. Women recover faster than men after standard knee arthroplasty. Clin Orthop Relat Res. 2011;469(10):2855&#x2013;2865. doi:10.1007/s11999-011-1921-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-011-1921-z</ArticleId><ArticleId IdType="pmc">PMC3171538</ArticleId><ArticleId IdType="pubmed">21698485</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsonga T, Michalopoulou M, Kapetanakis S, et al. . Risk factors for fear of falling in elderly patients with severe knee osteoarthritis before and one year after total knee arthroplasty. J Orthop Surg (Hong Kong). 2016;24(3):302&#x2013;306. doi:10.1177/1602400306</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1602400306</ArticleId><ArticleId IdType="pubmed">28031495</ArticleId></ArticleIdList></Reference><Reference><Citation>Laucis NC, Hays RD, Bhattacharyya T. Scoring the SF-36 in orthopaedics: a brief guide. J Bone Joint Surg Am. 2015;97(19):1628&#x2013;1634. doi:10.2106/JBJS.O.00030</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.O.00030</ArticleId><ArticleId IdType="pmc">PMC5029523</ArticleId><ArticleId IdType="pubmed">26446970</ArticleId></ArticleIdList></Reference><Reference><Citation>Busija L, Osborne RH, Nilsdotter A, Buchbinder R, Roos EM. Magnitude and meaningfulness of change in SF-36 scores in four types of orthopedic surgery. Health Qual Life Outcomes. 2008;6:55. doi:10.1186/1477-7525-6-55</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-6-55</ArticleId><ArticleId IdType="pmc">PMC2527304</ArticleId><ArticleId IdType="pubmed">18667085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward MM, Guthrie LC, Alba MI. Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness. Arthritis Care Res (Hoboken). 2014;66(12):1783&#x2013;1789. doi:10.1002/acr.22392</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22392</ArticleId><ArticleId IdType="pmc">PMC4245332</ArticleId><ArticleId IdType="pubmed">24980417</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin PD, Allison JJ, Ayers DC. Beyond joint implant registries: a patient-centered research consortium for comparative effectiveness in total joint replacement. JAMA. 2012;308(12):1217&#x2013;1218. doi:10.1001/jama.2012.12568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.12568</ArticleId><ArticleId IdType="pmc">PMC5474677</ArticleId><ArticleId IdType="pubmed">23011710</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivec R, Issa K, Given K, et al. . A prospective, longitudinal study of patient satisfaction following total knee arthroplasty using the Short-Form 36 (SF-36) survey stratified by various demographic and comorbid factors. J Arthroplasty. 2015;30(3):374&#x2013;378. doi:10.1016/j.arth.2014.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2014.10.013</ArticleId><ArticleId IdType="pubmed">25453625</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;383. doi:10.1016/0021-9681(87)90171-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>
Zeileis A. Object-Oriented Computation of Sandwich Estimators. Vol 16. Foundation for open access statistics;2006. http://www.jstatsoft.org/</Citation></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. R foundation for statistical computing;2020.</Citation></Reference><Reference><Citation>Ultee KHJ, Tjeertes EKM, Bastos Gon&#xe7;alves F, et al. . The relation between household income and surgical outcome in the Dutch setting of equal access to and provision of healthcare. PLoS One. 2018;13(1):e0191464. doi:10.1371/journal.pone.0191464</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0191464</ArticleId><ArticleId IdType="pmc">PMC5777644</ArticleId><ArticleId IdType="pubmed">29357383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzobon D, Ferreira PH, Blyth FM, Machado GC, Ferreira ML. Can obesity and physical activity predict outcomes of elective knee or hip surgery due to osteoarthritis? A meta-analysis of cohort studies. BMJ Open. 2018;8(2):e017689. doi:10.1136/bmjopen-2017-017689</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017689</ArticleId><ArticleId IdType="pmc">PMC5855486</ArticleId><ArticleId IdType="pubmed">29487072</ArticleId></ArticleIdList></Reference><Reference><Citation>Podmore B, Hutchings A, van der Meulen J, Aggarwal A, Konan S. Impact of comorbid conditions on outcomes of hip and knee replacement surgery: a systematic review and meta-analysis. BMJ Open. 2018;8(7):e021784. doi:10.1136/bmjopen-2018-021784</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-021784</ArticleId><ArticleId IdType="pmc">PMC6082478</ArticleId><ArticleId IdType="pubmed">29997141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorner JB, Wallenstein GV, Martin MC, et al. . Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin. 2007;23(4):731&#x2013;739. doi:10.1185/030079907x178757</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/030079907x178757</ArticleId><ArticleId IdType="pubmed">17407629</ArticleId></ArticleIdList></Reference><Reference><Citation>Elboim-Gabyzon M, Rozen N, Laufer Y. Gender differences in pain perception and functional ability in subjects with knee osteoarthritis. ISRN Orthop. 2012;2012:413105. doi:10.5402/2012/413105</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2012/413105</ArticleId><ArticleId IdType="pmc">PMC4063163</ArticleId><ArticleId IdType="pubmed">24977076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishawi M, Hattler B, Almassi GH, et al. ; VA #517 Randomized On/Off Bypass (ROOBY) Study Group . Preoperative factors associated with worsening in health-related quality of life following coronary artery bypass grafting in the Randomized On/Off Bypass (ROOBY) trial. Am Heart J. 2018;198:33&#x2013;38. doi:10.1016/j.ahj.2017.12.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2017.12.014</ArticleId><ArticleId IdType="pubmed">29653645</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijnhart-De Jong H, Haenen J, Bol Raap G, et al. . Determinants of non-recovery in physical health-related quality of life one year after cardiac surgery: a prospective single centre observational study. J Cardiothorac Surg. 2020;15:234. doi:10.1186/s13019-020-01273-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01273-1</ArticleId><ArticleId IdType="pmc">PMC7466488</ArticleId><ArticleId IdType="pubmed">32873336</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu YK, Maddick IH, Griffiths GS, Gilthorpe MS. Mathematical coupling can undermine the statistical assessment of clinical research: illustration from the treatment of guided tissue regeneration. J Dent. 2004;32(2):133&#x2013;142. doi:10.1016/j.jdent.2003.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdent.2003.10.001</ArticleId><ArticleId IdType="pubmed">14749085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes RJ. Methods for assessing whether change depends on initial value. Stat Med. 1988;7(9):915&#x2013;927. doi:10.1002/sim.4780070903</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780070903</ArticleId><ArticleId IdType="pubmed">3175391</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40237657</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0974-5181</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of cardiac anaesthesia</Title><ISOAbbreviation>Ann Card Anaesth</ISOAbbreviation></Journal><ArticleTitle>Sedation Versus General Anesthesia for Ablation of Ventricular Arrhythmias: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>119</StartPage><EndPage>127</EndPage><MedlinePgn>119-127</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/aca.aca_229_24</ELocationID><Abstract><AbstractText>Ventricular arrhythmias (VA), including ventricular tachycardia and fibrillation, are critical cardiac conditions that are often managed by catheter ablation among those unresponsive to pharmacologic therapy. The choice of anesthesia and sedation regimens for VA ablations may impact arrhythmia inducibility and hemodynamic stability, which can affect procedural success and complication rates. This systematic review and meta-analysis aimed to compare the efficacy and safety of sedation versus general anesthesia (GA) among patients undergoing VA ablation. The review was prospectively registered on PROSPERO (CRD42023441553). Database searches were conducted across five major databases from inception to March 9, 2024 to identify randomized trials or observational studies including adult patients undergoing ablations for VA. Screening and data extraction were completed in duplicate. Risk-of-bias assessments were conducted using ROBINS-I as all included studies were observational, and the quality of evidence was evaluated using the GRADE framework. Six observational studies (N = 16,435) were included. No significant differences were found between sedation and GA for total procedure time (MD: -14.16 minutes; 95%CI: -38.61 to 10.29 minutes), arrhythmia non-inducibility (RR: 0.73; 95% CI: 0.33-1.58), acute ablation success (RR: 1.06; 95% CI: 0.65-1.71), or procedural complications (RR: 0.72; 95% CI: 0.28-1.85). However, sedation was associated with significantly lower intraprocedural hemodynamic instability (RR: 0.28; 95% CI: 0.12-0.70). These findings indicate that while sedation and GA have comparable outcomes, sedation may be associated with less hemodynamic instability during VA ablation. However, more high-quality studies are needed to confirm these results.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Annals of Cardiac Anaesthesia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Shubh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jiawen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zubair</LastName><ForeName>Areeba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heybati</LastName><ForeName>Kiyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Alix School of Medicine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heybati</LastName><ForeName>Shayan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Oswin</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>UBC Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Umaima</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry (Windsor), Western University, Windsor, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahir</LastName><ForeName>Umair</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramaraju</LastName><ForeName>Harikrishnaa B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>VCU School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Chi Y</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Michael G. DeGroote School of Medicine (Waterloo Regional Campus), McMaster University, Kitchener, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhivagaran</LastName><ForeName>Thanansayan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry (Windsor), Western University, Windsor, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rayner</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krever</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Research, Sinai Health System, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woelber</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowlgi</LastName><ForeName>Gurukripa N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramakrishna</LastName><ForeName>Harish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Ann Card Anaesth</MedlineTA><NlmUniqueID>9815987</NlmUniqueID><ISSNLinking>0971-9784</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">sedation</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>14</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>14</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40237657</ArticleId><ArticleId IdType="pmc">PMC12058075</ArticleId><ArticleId IdType="doi">10.4103/aca.aca_229_24</ArticleId><ArticleId IdType="pii">00660469-202504000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace. 2019;21:1143&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967791</ArticleId><ArticleId IdType="pubmed">31075787</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MA, Dukkipati SR, Mittnacht AJ, Chinitz JS, Belliveau L, Koruth JS, et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. J Am Coll Cardiol. 2011;58:1363&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">21920266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel JE, Hutchinson MD, Marchlinski FE. Remifentanil-midazolam sedation provides hemodynamic stability and comfort during epicardial ablation of ventricular tachycardia. J Cardiovasc Electrophysiol. 2011;22:464&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20812933</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti S, Sabatino F, Cascino A, Ferrara G, Sgarito G. Dexmedetomidine for sedation during epicardial ablation for ventricular tachycardia: A single-center experience. J Interv Card Electrophysiol. 2023;66:79&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">36018425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wutzler A, Rolf S, Huemer M, Parwani AS, Boldt LH, Herberger E, et al. Safety aspects of deep sedation during catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012;35:38&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">22054234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazawa S, Sieira J, Bala G, Miraglia V, Al Housari M, Strazdas A, et al. Impact of anesthetic management on catheter ablation for premature ventricular complexes: Insights during the COVID-19 outbreak. J Interv Card Electrophysiol. 2023;66:2135&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10182347</ArticleId><ArticleId IdType="pubmed">37178190</ArticleId></ArticleIdList></Reference><Reference><Citation>Newstead B, Bradburn S, Appelboam A, Reuben A, Harris A, Hudson A, et al. Propofol for adult procedural sedation in a UK emergency department: Safety profile in 1008 cases. Br J Anaesth. 2013;111:651&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23661404</ArticleId></ArticleIdList></Reference><Reference><Citation>Servatius H, Hoefeler T, Hoffmann BA, Sultan A, L&#xfc;ker J, Sch&#xe4;ffer B, et al. Propofol sedation administered by cardiologists without assisted ventilation is safe for patients undergoing catheter ablation for ventricular tachycardia. Europace. 2013;6(15):ii189.</Citation><ArticleIdList><ArticleId IdType="pubmed">27247017</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc; F, Lin J, Benditt DG. Conscious sedation and anesthesia in the cardiac electrophysiology laboratory. J Cardiovasc Electrophysiol. 2013;24:237&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">23130937</ArticleId></ArticleIdList></Reference><Reference><Citation>Wutzler A, Mueller A, Loehr L, Huemer M, Parwani AS, Attanasio P, et al. Minimal and deep sedation during ablation of ventricular tachycardia. Int J Cardiol. 2014;172:161&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24447761</ArticleId></ArticleIdList></Reference><Reference><Citation>Nof E, Reichlin T, Enriquez AD, Ng J, Nagashima K, Tokuda M, et al. Impact of general anesthesia on initiation and stability of VT during catheter ablation. Heart Rhythm. 2015;12:2213&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26072026</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021;18:e1003583. doi:10.1371/journal.pmed.1003583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007028</ArticleId><ArticleId IdType="pubmed">33780438</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. The Cochrane Collaboration. Chichester, UK; 2021. editors: Cochrane Handbook for Systematic Reviews of Interventions (v6.2)</Citation></Reference><Reference><Citation>Schiavo JH. PROSPERO: An International Register of Systematic Review Protocols. Med Ref Serv Q. 2019;38:171&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">31173570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellermeyer L, Harnke B, Knight S. Covidence and Rayyan. J Med Libr Assoc University Library System, University of Pittsburgh, 1062018.  Retrieved from:https://jmla.pitt.edu/ojs/jmla/article/view/513 .</Citation></Reference><Reference><Citation>Shi J, Luo D, Wan X, Liu Y, Liu J, Bian Z, et al. Detecting the skewness of data from the five-number summary and its application in meta-analysis. Stat Methods Med Res. 2023;32:1338&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">37161735</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai S, Zhou J, Pan J. Estimating the sample mean and standard deviation from order statistics and sample size in meta-analysis. Stat Methods Med Res. 2021;30:2701&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">34668458</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath S, Katzenschlager S, Zimmer AJ, Seitel A, Steele R, Benedetti A. Standard error estimation in meta-analysis of studies reporting medians. Stat Methods Med Res. 2023;32:373&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">36412105</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A DEPRESsion Screening Data (DEPRESSD) Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2020;29:2520&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390706</ArticleId><ArticleId IdType="pubmed">32292115</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: A practical tutorial. Evid Based Ment Health. 2019;22:153&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing?Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53:1119&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">11106885</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med. 2003;22:2113&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">12820277</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L, Brignardello-Petersen R, Hultcrantz M, Mustafa RA, Murad MH, Iorio A, Traversy G, et al. GRADE Guidance 34: Update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol. 2022;150:216&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">35934265</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol. 2011;64:1283&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009;1:51&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256489</ArticleId><ArticleId IdType="pubmed">22263004</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines:1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Dada R, McGuire JA, Hayanga JWA. Anesthetic management for ventricular tachycardia ablation: A national anesthesia clinical outcomes registry analysis. Anesth Analg. 2022;134:137&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">38233244</ArticleId></ArticleIdList></Reference><Reference><Citation>Dada RS, McGuire JA, Hayanga JWA, Thibault D, Schwartzman D, Ellison M, et al. Anesthetic management for ventricular tachycardia ablation: A national anesthesia clinical outcomes registry analysis. J Cardiothorac Vasc Anesth. 2024;38:675&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">38233244</ArticleId></ArticleIdList></Reference><Reference><Citation>Woelber T, Dhawan R, Killu AM, Heybati K, Desimone CV, Deshmukh AJ, et al. A comparison of general anesthesia versus monitored anesthesia care during catheter ablation for ventricular tachycardia. Eur Heart J. 2023;44(Suppl_2):ehad655&#x2013;383.</Citation></Reference><Reference><Citation>Ballout JA, Wazni OM, Tarakji KG, Saliba WI, Kanj M, Diab M, et al. Catheter ablation in patients with cardiogenic shock and refractory ventricular tachycardia. Circ Arrhythm Electrophysiol. 2020;13:e007669. doi:10.1161/CIRCEP. 119.007669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7285871</ArticleId><ArticleId IdType="pubmed">32281407</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Bella P, Radinovic A, Limite LR, Baratto F. Mechanical circulatory support in the management of life-threatening arrhythmia. Europace. 2021;23:1166&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">33382868</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto F, Pappalardo F, Oloriz T, Bisceglia C, Vergara P, Silberbauer J, et al. Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2016;9:e004492. doi:10.1161/CIRCEP. 116.004492.</Citation><ArticleIdList><ArticleId IdType="pubmed">27932426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39941531</PMID><DateRevised><Year>2025</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Quantitative Analysis of Propofol Dosage in Cannabis Users: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">858</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14030858</ELocationID><Abstract><AbstractText><b>Background</b>: Rising cannabis use poses significant challenges in the administration of general anesthetics, particularly propofol, due to potential alterations in pharmacodynamics caused by tetrahydrocannabinol and its interactions with central nervous system receptors. This systematic review and meta-analysis aims to consolidate the existing literature to quantify propofol requirements in cannabis users, highlighting the complex relationship between cannabis use and anesthetic management. <b>Methods</b>: A systematic search of English-language literature was conducted to identify studies with data on propofol dosing in adult cannabis users. Propofol requirements were defined as the total intraoperative dose needed to achieve and maintain adequate sedation or anesthesia, assessed using parameters like monitoring and procedural tolerance. A random-effects model was used with DerSimonian-Laird estimations for pooled effect sizes and 95% confidence intervals. Heterogeneity was assessed using I<sup>2</sup> and Cochran's Q statistics, and sensitivity analysis was conducted by grouping publications by design, size, and quality. <b>Results</b>: Eight qualified studies were identified with 2268 patients included. Patients who used cannabis were typically younger and more likely to smoke tobacco than non-users. Propofol requirements were significantly higher in cannabis users, who required an average additional dose of 47.33 mg compared to non-users. Subgroup analyses revealed that cannabis users undergoing general anesthesia needed an additional 30.57 mg intraoperatively, while those undergoing sedation for endoscopic procedures required an additional 53.02 mg. <b>Conclusions</b>: These results underscore the need for personalized anesthetic plans to accommodate physiological variations in cannabis users. However, the lack of standardized definitions for propofol requirements and the heterogeneity across studies necessitate caution in interpretation. The observed increase in propofol requirements suggests altered central nervous system sensitivities and receptor changes in cannabis users, emphasizing the need for further research to establish clear definitions, elucidate underlying mechanisms, and refine clinical guidelines for anesthetic management in this population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Maxwell B</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0003-1191-4134</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Larner College of Medicine, University of Vermont, Burlington, VT 054052, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binda</LastName><ForeName>Dhanesh D</ForeName><Initials>DD</Initials><Identifier Source="ORCID">0000-0002-5490-2013</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Montefiore Einstein Medical Center, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nozari</LastName><ForeName>Ala</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5755-6347</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Joseph M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Larner College of Medicine, Burlington, VT 05405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dienes</LastName><ForeName>Erin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0001-5912-3414</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>William E</ForeName><Initials>WE</Initials><Identifier Source="ORCID">0000-0002-4915-2553</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Larner College of Medicine, Burlington, VT 05405, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthetic dosage</Keyword><Keyword MajorTopicYN="N">anesthetic management</Keyword><Keyword MajorTopicYN="N">cannabis use</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">pharmacological interactions</Keyword><Keyword MajorTopicYN="N">propofol</Keyword><Keyword MajorTopicYN="N">tetrahydrocannabinol</Keyword></KeywordList><CoiStatement>Ala Nozari served as a consultant for Third Pole Therapeutics and the Takeda Pharmaceutical Company. No conflicts of interest are relevant to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>13</Day><Hour>11</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>13</Day><Hour>11</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>13</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39941531</ArticleId><ArticleId IdType="pmc">PMC11818839</ArticleId><ArticleId IdType="doi">10.3390/jcm14030858</ArticleId><ArticleId IdType="pii">jcm14030858</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chiu R.G., Patel S., Siddiqui N., Nunna R.S., Mehta A.I. Cannabis Abuse and Perioperative Complications Following Inpatient Spine Surgery in the United States. Spine. 2021;46:734&#x2013;743. doi: 10.1097/BRS.0000000000004035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000004035</ArticleId><ArticleId IdType="pubmed">33769411</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipari R.N. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. SAMHSA; Rockville, MD, USA: 2018.</Citation></Reference><Reference><Citation>2021 NSDUH Annual National Report|CBHSQ Data.  [(accessed on 6 December 2024)]; Available online:  https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report.</Citation></Reference><Reference><Citation>National Institute on Drug Abuse  Marijuana and Hallucinogen Use, Binge Drinking Reached Historic Highs Among Adults 35 to 50|National Institute on Drug Abuse (NIDA)  [(accessed on 6 December 2024)]; Available online:  https://nida.nih.gov/news-events/news-releases/2023/08/marijuana-and-hallucinogen-use-binge-drinking-reached-historic-highs-among-adults-35-to-50.</Citation></Reference><Reference><Citation>Khelemsky Y., Goldberg A.T., Hurd Y.L., Winkel G., Ninh A., Qian L., Oprescu A., Ciccone J., Katz D.J. Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana (Cannabinoids) for Treatment of Pain: A Prospective Population Survey. Reg. Anesth. Pain Med. 2017;42:652&#x2013;659. doi: 10.1097/AAP.0000000000000654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0000000000000654</ArticleId><ArticleId IdType="pubmed">28796754</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapani G.M., Altomare C., Sanna E., Biggio G., Liso G. Propofol in Anesthesia. Mechanism of Action, Structure-Activity Relationships, and Drug Delivery. Curr. Med. Chem. 2000;7:249&#x2013;271. doi: 10.2174/0929867003375335.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867003375335</ArticleId><ArticleId IdType="pubmed">10637364</ArticleId></ArticleIdList></Reference><Reference><Citation>Habchi K.M., Li M.T., Mallard C.A., Baker M., Ortega R. The Anesthesiologist&#x2019;s Armamentarium: From Recreation to Medication and Back. J. Anesth. Hist. 2020;6:17&#x2013;26. doi: 10.1016/j.janh.2019.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.janh.2019.04.002</ArticleId><ArticleId IdType="pubmed">32473762</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.H., Sideris A., Ladha K.S., Johnson R.L., Wu C.L. Cannabis and Cannabinoids in the Perioperative Period. Anesthesia Analg. 2024;138:16&#x2013;30. doi: 10.1213/ANE.0000000000006070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006070</ArticleId><ArticleId IdType="pubmed">35551150</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand P.-A., Paris A., Bein B., Meybohm P., Scholz J., Ohnesorge H., Tonner P.H. Propofol sedation is reduced by delta9-tetrahydrocannabinol in mice. Anesth. Analg. 2008;107:102&#x2013;106. doi: 10.1213/ane.0b013e318173287a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318173287a</ArticleId><ArticleId IdType="pubmed">18635473</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslonka M.A., Schertz A.R., Markowski L.M., Miller P.J. Sedation challenges in patients with E-cigarette, or vaping, product use-associated lung injury (EVALI) BMJ Case Rep. 2020;13:e233866. doi: 10.1136/bcr-2019-233866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-233866</ArticleId><ArticleId IdType="pmc">PMC7470641</ArticleId><ArticleId IdType="pubmed">32878850</ArticleId></ArticleIdList></Reference><Reference><Citation>Farasatinasab M., Nasiripour S., Aghabiklooei A. Effect of cannabis use on propofol requirement for ICU sedation. Anaesthesiol. Intensive Ther. 2022;54:344&#x2013;345. doi: 10.5114/ait.2022.121002.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2022.121002</ArticleId></ArticleIdList></Reference><Reference><Citation>Richtig G., Bosse G., Arlt F., von Heymann C. Cannabis consumption before surgery may be associated with increased tolerance of anesthetic drugs: A case report. Int. J. Case Rep. Images. 2015;6:436&#x2013;439. doi: 10.5348/ijcri-201573-CR-10534.</Citation><ArticleIdList><ArticleId IdType="doi">10.5348/ijcri-201573-CR-10534</ArticleId></ArticleIdList></Reference><Reference><Citation>Symons I.E. Cannabis smoking and anaesthesia. Anaesthesia. 2002;57:1142&#x2013;1143. doi: 10.1046/j.1365-2044.2002.288312.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2044.2002.288312.x</ArticleId><ArticleId IdType="pubmed">12392470</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker F., Baric A., Sekharan L., James E., Farook F., Itrat Q., Jagadheesan K. Anaesthetic safety with undisclosed substance misuse during electroconvulsive therapy. Australas. Psychiatry. 2022;30:278&#x2013;279. doi: 10.1177/10398562211057076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10398562211057076</ArticleId><ArticleId IdType="pubmed">35073783</ArticleId></ArticleIdList></Reference><Reference><Citation>Twardowski M.A., Link M.M., Twardowski N.M. Effects of Cannabis Use on Sedation Requirements for Endoscopic Procedures. J. Am. Osteopat. Assoc. 2019;119:307&#x2013;311. doi: 10.7556/jaoa.2019.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.7556/jaoa.2019.052</ArticleId><ArticleId IdType="pubmed">30985870</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangwani P., Lillian D., Dobbins J., Feng C., Vorrasi J., Kolokythas A. Is Recreational Marijuana Use Associated With Changes in the Vital Signs or Anesthetic Requirements During Intravenous Sedation? J. Oral Maxillofac. Surg. 2023;81:527&#x2013;535. doi: 10.1016/j.joms.2023.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joms.2023.01.007</ArticleId><ArticleId IdType="pubmed">36746375</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung B.G., Ma M.W., Scolaro J.A., Nelson A.M. Cannabis Exposure Decreases Need for Blood Pressure Support During General Anesthesia in Orthopedic Trauma Surgery. Cannabis Cannabinoid Res. 2022;7:328&#x2013;335. doi: 10.1089/can.2021.0009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/can.2021.0009</ArticleId><ArticleId IdType="pmc">PMC9225405</ArticleId><ArticleId IdType="pubmed">34227872</ArticleId></ArticleIdList></Reference><Reference><Citation>Flisberg P., Paech M., Shah T., Ledowski T., Kurowski I., Parsons R. Induction dose of propofol in patients using cannabis. Eur. J. Anaesthesiol. 2009;26:192&#x2013;195. doi: 10.1097/EJA.0b013e328319be59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328319be59</ArticleId><ArticleId IdType="pubmed">19237981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.-X.B., Bean B.P. Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels. J. Neurosci. 2021;41:6371&#x2013;6387. doi: 10.1523/JNEUROSCI.3216-20.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3216-20.2021</ArticleId><ArticleId IdType="pmc">PMC8318087</ArticleId><ArticleId IdType="pubmed">34131037</ArticleId></ArticleIdList></Reference><Reference><Citation>Laudanski K., Wain J. Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. J. Clin. Med. 2022;11:558. doi: 10.3390/jcm11030558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030558</ArticleId><ArticleId IdType="pmc">PMC8836924</ArticleId><ArticleId IdType="pubmed">35160010</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander J.C., Joshi G.P. A review of the anesthetic implications of marijuana use. Proc. Bayl. Univ. Med. Cent. 2019;32:364&#x2013;371. doi: 10.1080/08998280.2019.1603034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08998280.2019.1603034</ArticleId><ArticleId IdType="pmc">PMC6650211</ArticleId><ArticleId IdType="pubmed">31384188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha K.S., Manoo V., Virji A.-F., Hanlon J.G., Mclaren-Blades A., Goel A., Wijeysundera D.N., Kotra L.P., Ibarra C., Englesakis M., et al. The Impact of Perioperative Cannabis Use: A Narrative Scoping Review. Cannabis Cannabinoid Res. 2019;4:219&#x2013;230. doi: 10.1089/can.2019.0054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/can.2019.0054</ArticleId><ArticleId IdType="pmc">PMC6922064</ArticleId><ArticleId IdType="pubmed">31872058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosirog J., Bouvette C., Pannu J., Gondal J., Madhoun M. Marijuana and endoscopy: The effects of marijuana on sedation. Gastrointest. Endosc. 2024;100:177&#x2013;182. doi: 10.1016/j.gie.2024.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2024.01.013</ArticleId><ArticleId IdType="pubmed">38215858</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J., Bossuyt P., Boutron I., Hoffmann T., Mulrow C., Shamseer L., Tetzlaff J., Aki E., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>R: The R Project for Statistical Computing.  [(accessed on 29 March 2024)].  Available online:  https://www.r-project.org/</Citation></Reference><Reference><Citation>Aleissa M.M., Ahern K.L., Stern G.M. Peri-operative opioid and sedation requirements in patients who use marijuana and are undergoing total knee or total hip arthroplasty: A retrospective study. J. Clin. Anesth. 2020;66:109953. doi: 10.1016/j.jclinane.2020.109953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2020.109953</ArticleId><ArticleId IdType="pubmed">32619794</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmen I.C., Beach J.P., Kaizer A.M., Gumidyala R. The association between preoperative cannabis use and intraoperative inhaled anesthetic consumption: A retrospective study. J. Clin. Anesth. 2020;67:109980. doi: 10.1016/j.jclinane.2020.109980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2020.109980</ArticleId><ArticleId IdType="pubmed">32653758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.S., Nagra N., La Selva D., Kozarek R.A., Ross A., Weigel W., Beecher R., Chiorean M., Gluck M., Boden E., et al. Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult to Sedate. Clin. Gastroenterol. Hepatol. 2021;19:180&#x2013;188. doi: 10.1016/j.cgh.2020.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.09.018</ArticleId><ArticleId IdType="pubmed">32931961</ArticleId></ArticleIdList></Reference><Reference><Citation>Imasogie N., Rose R.V., Wilson A. High quantities: Evaluating the association between cannabis use and propofol anesthesia during endoscopy. PLoS ONE. 2021;16:e0248062. doi: 10.1371/journal.pone.0248062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248062</ArticleId><ArticleId IdType="pmc">PMC7932135</ArticleId><ArticleId IdType="pubmed">33661987</ArticleId></ArticleIdList></Reference><Reference><Citation>King D.D., Stewart S.A., Collins-Yoder A., Fleckner T., Price L.L. Anesthesia for Patients Who Self-Report Cannabis (Marijuana) Use Before Esophagogastroduodenoscopy: A Retrospective Review. AANA J. 2021;89:205&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8764743</ArticleId><ArticleId IdType="pubmed">34042571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripperger D., Atte A., Ritto F. Cannabis Users Require More Anesthetic Agents for General Anesthesia in Ambulatory Oral and Maxillofacial Surgery Procedures. J. Oral Maxillofac. Surg. 2023;81:1460&#x2013;1465. doi: 10.1016/j.joms.2023.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joms.2023.09.008</ArticleId><ArticleId IdType="pubmed">37783364</ArticleId></ArticleIdList></Reference><Reference><Citation>Huson H.B., Granados T.M., Rasko Y. Surgical considerations of marijuana use in elective procedures. Heliyon. 2018;4:e00779. doi: 10.1016/j.heliyon.2018.e00779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2018.e00779</ArticleId><ArticleId IdType="pmc">PMC6139487</ArticleId><ArticleId IdType="pubmed">30225378</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhing M.R., Beno D.W.A., Jiyamapa-Serna V.A., Chen Y., Galinsky R.E., Hall S.D., Kimura R.E. the effect of anesthesia and surgery on CYP3A activity in rats. Drug Metab. Dispos. 2004;32:1325&#x2013;1330. doi: 10.1124/dmd.104.000927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/dmd.104.000927</ArticleId><ArticleId IdType="pubmed">15319324</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelling G., Hauer D., Azad S.C., Schmoelz M., Chouker A., Schmidt M., Hornuss C., Rippberger M., Briegel J., Thiel M., et al. Effects of General Anesthesia on Anandamide Blood Levels in Humans. Anesthesiology. 2006;104:273&#x2013;277. doi: 10.1097/00000542-200602000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200602000-00012</ArticleId><ArticleId IdType="pubmed">16436846</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal H., Awad H.H., Ghali J.K. Role of cannabis in cardiovascular disorders. J. Thorac. Dis. 2017;9:2079&#x2013;2092. doi: 10.21037/jtd.2017.06.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2017.06.104</ArticleId><ArticleId IdType="pmc">PMC5542986</ArticleId><ArticleId IdType="pubmed">28840009</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu P., Boulanger A., Desroches J., Clark A.J. Medical cannabis: Considerations for the anesthesiologist and pain physician. Can. J. Anaesth. 2016;63:608&#x2013;624. doi: 10.1007/s12630-016-0598-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-016-0598-x</ArticleId><ArticleId IdType="pubmed">26850063</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S., Schwenk E.S., Sondekoppam R.V., Clarke H., Zakowski M., Rzasa-Lynn R.S., Yeung B., Nicholson K., Schwartz G., Hooten W.M., et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg. Anesth. Pain Med. 2023;48:97&#x2013;117. doi: 10.1136/rapm-2022-104013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2022-104013</ArticleId><ArticleId IdType="pubmed">36596580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C.J., Galettis P., Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br. J. Clin. Pharmacol. 2018;84:2477&#x2013;2482. doi: 10.1111/bcp.13710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.13710</ArticleId><ArticleId IdType="pmc">PMC6177698</ArticleId><ArticleId IdType="pubmed">30001569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetrault J.M., Crothers K., Moore B.A., Mehra R., Concato J., Fiellin D.A. Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review. Arch. Intern. Med. 2007;167:221&#x2013;228. doi: 10.1001/archinte.167.3.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.3.221</ArticleId><ArticleId IdType="pmc">PMC2720277</ArticleId><ArticleId IdType="pubmed">17296876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong G.T.C., Irwin M.G. Poisoning with illicit substances: Toxicology for the anaesthetist. Anaesthesia. 2013;68((Suppl. S1)):117&#x2013;124. doi: 10.1111/anae.12053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12053</ArticleId><ArticleId IdType="pubmed">23210561</ArticleId></ArticleIdList></Reference><Reference><Citation>Combined Beta-Agonists and Anticholinergics Compared to Beta-Agonists Alone for Adults with Asthma Treated in Emergency Departments.  [(accessed on 6 December 2024)].  Available online:  https://www.cochrane.org/CD001284/AIRWAYS_combined-beta-agonists-and-anticholinergics-compared-beta-agonists-alone-adults-asthma-treated.</Citation></Reference><Reference><Citation>Echeverria-Villalobos M., Todeschini A.B., Stoicea N., Fiorda-Diaz J., Weaver T., Bergese S.D. Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations. J. Clin. Anesth. 2019;57:41&#x2013;49. doi: 10.1016/j.jclinane.2019.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2019.03.011</ArticleId><ArticleId IdType="pubmed">30852326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan T.J., Belani K.G., Bergese S., Chung F., Diemunsch P., Habib A.S., Jin Z., Kovac A.L., Meyer T.A., Urman R.D., et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth. Analg. 2020;131:411&#x2013;448. doi: 10.1213/ANE.0000000000004833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004833</ArticleId><ArticleId IdType="pubmed">32467512</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenne J., Burney E., Mauer K., Orina J., Philipp T., Yoo J. Risks associated with chronic cannabis use on opioid use, length of stay, and revision rate for patients undergoing posterior lumbar interbody fusion. Spine J. 2024;24:851&#x2013;857. doi: 10.1016/j.spinee.2024.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2024.01.011</ArticleId><ArticleId IdType="pubmed">38309626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekrami E., Sari S., Kopac O., Wang D., Mascha E.J., Stamper S., Esa W.A.S., Nair H., Ruetzler K., Turan A. Association Between Cannabis Use and Opioid Consumption, Pain, and Respiratory Complications After Surgery: A Retrospective Cohort Analysis. Anesth. Analg. 2024;139:724&#x2013;733. doi: 10.1213/ANE.0000000000006785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006785</ArticleId><ArticleId IdType="pubmed">38190341</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumrak K. In the Weeds: Nation&#x2019;s First Guidelines for Management of Perioperative Patients on Cannabis. ASA Monit. 2024;88:30&#x2013;33. doi: 10.1097/01.ASM.0001008300.88901.d7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASM.0001008300.88901.d7</ArticleId></ArticleIdList></Reference><Reference><Citation>Potnuru P.P., Jonna S., Williams G.W. Cannabis Use Disorder and Perioperative Complications. JAMA Surg. 2023;158:935&#x2013;944. doi: 10.1001/jamasurg.2023.2403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2023.2403</ArticleId><ArticleId IdType="pmc">PMC10323761</ArticleId><ArticleId IdType="pubmed">37405729</ArticleId></ArticleIdList></Reference><Reference><Citation>King D.D., Gill C.J., Cadieux C.S., Singh N. The role of stigma in cannabis use disclosure: An exploratory study. Harm Reduct. J. 2024;21:21. doi: 10.1186/s12954-024-00929-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12954-024-00929-8</ArticleId><ArticleId IdType="pmc">PMC10811895</ArticleId><ArticleId IdType="pubmed">38273362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicket M.C., Stone E.M., McGinty E.E. Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs. JAMA Netw. Open. 2023;6:e2249797. doi: 10.1001/jamanetworkopen.2022.49797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.49797</ArticleId><ArticleId IdType="pmc">PMC9857553</ArticleId><ArticleId IdType="pubmed">36607641</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanoski K., Pauly B., Inglis D., Cameron F., Haddad T., Phillips J., Phillips P., Rosen C., Schlotter G., Hartney E., et al. Defining culturally safe primary care for people who use substances: A participatory concept mapping study. BMC Health Serv. Res. 2020;20:1060. doi: 10.1186/s12913-020-05915-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-05915-x</ArticleId><ArticleId IdType="pmc">PMC7685616</ArticleId><ArticleId IdType="pubmed">33228650</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M.B., Liu E.C., Bully M.A., Hsieh A., Nozari A., Tuler M., Binda D.D. Overcoming Barriers: A Comprehensive Review of Chronic Pain Management and Accessibility Challenges in Rural America. Healthcare. 2024;12:1765. doi: 10.3390/healthcare12171765.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare12171765</ArticleId><ArticleId IdType="pmc">PMC11394986</ArticleId><ArticleId IdType="pubmed">39273789</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco C.M., Gaylord S.A., Faurot K., Weinberg J.M., Gardiner P., Roth I., Barnhill J.L., Thomas H.N., Dhamne S.C., Lathren C., et al. The design and methods of the OPTIMUM study: A multisite pragmatic randomized clinical trial of a telehealth group mindfulness program for persons with chronic low back pain. Contemp. Clin. Trials. 2021;109:106545. doi: 10.1016/j.cct.2021.106545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2021.106545</ArticleId><ArticleId IdType="pmc">PMC8691659</ArticleId><ArticleId IdType="pubmed">34455111</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M.B., Hsieh A., Gupta V., Kim Y., Merriel M., Nozari A., Binda D. The Color of Climate Change: Can Choice of Anesthetic Be Institutionally Racist? Anesth. Analg. 2024;138:1154&#x2013;1158. doi: 10.1213/ANE.0000000000006809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006809</ArticleId><ArticleId IdType="pubmed">38771597</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhre W., O&#x2019;Reilly-Shah V., Van Cleve W. Cannabis use is associated with a small increase in the risk of postoperative nausea and vomiting: A retrospective machine-learning causal analysis. BMC Anesthesiol. 2020;20:115. doi: 10.1186/s12871-020-01036-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01036-4</ArticleId><ArticleId IdType="pmc">PMC7236204</ArticleId><ArticleId IdType="pubmed">32423445</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahan A., Hooten W.M., Furnish T. Cannabis Use and Anesthesia. Adv. Anesth. 2024;42:85&#x2013;96. doi: 10.1016/j.aan.2024.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aan.2024.07.007</ArticleId><ArticleId IdType="pubmed">39443052</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel A., McGuinness B., Jivraj N.K., Wijeysundera D.N., Mittleman M.A., Bateman B.T., Clarke H., Kotra L.P., Ladha K.S. Cannabis Use Disorder and Perioperative Outcomes in Major Elective Surgeries: A Retrospective Cohort Analysis. Anesthesiology. 2020;132:625&#x2013;635. doi: 10.1097/ALN.0000000000003067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003067</ArticleId><ArticleId IdType="pubmed">31789638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Chung T., Dey A., Bae S.W. Exploring Algorithmic Explainability: Generating Explainable AI Insights for Personalized Clinical Decision Support Focused on Cannabis Intoxication in Young Adults; Proceedings of the 2024 International Conference on Activity and Behavior Computing (ABC); Oita, Japan; Kitakyushu, Japan. 29&#x2013;31 May 2024;</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/abc61795.2024.10652070</ArticleId><ArticleId IdType="pmc">PMC11586775</ArticleId><ArticleId IdType="pubmed">39600343</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton J.E., Bolen S.D., Mascha E.J. Publication Bias: The Elephant in the Review. Anesth. Analg. 2016;123:812&#x2013;813. doi: 10.1213/ANE.0000000000001596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001596</ArticleId><ArticleId IdType="pmc">PMC5482177</ArticleId><ArticleId IdType="pubmed">27636569</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zt&#xfc;rk E., Aydo&#x11f;an M.S., Karaaslan K., Do&#x11f;an Z., Topuz U. Does smoking increase the anesthetic requirement? Turk. J. Med Sci. 2019;49:1271&#x2013;1276. doi: 10.3906/sag-1602-57.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-1602-57</ArticleId><ArticleId IdType="pmc">PMC7018217</ArticleId><ArticleId IdType="pubmed">31648428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajdeya R., Rouhizadeh M., Cook R.L., Ison R.L., Bai C., Jugl S., Gao H., Mardini M.T., Zandbiglari K., Adiba F.I. Cannabis Use and Inhalational Anesthesia Administration in Older Adults: A Propensity-matched Retrospective Cohort Study. Anesthesiology. 2024;141:870&#x2013;880. doi: 10.1097/ALN.0000000000005146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000005146</ArticleId><ArticleId IdType="pmc">PMC11461122</ArticleId><ArticleId IdType="pubmed">38980341</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30678778</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for&#xa0;Ventricular Tachycardia in Structural&#xa0;Heart Disease: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>24</EndPage><MedlinePgn>13-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2018.08.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(18)30672-8</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study sought to determine whether combined endocardial-epicardial (endo-epi) ablation was superior to endocardial only ablation in patients with scar-related ventricular tachycardia (VT).</AbstractText><AbstractText Label="BACKGROUND">Limited single-center studies suggest that combined endo-epi ablation strategy may be superior to endocardial ablation (endo) alone in patients with nonischemic cardiomyopathy (NICM) and arrhythmogenic right ventricular cardiomyopathy (ARVC), and ischemic cardiomyopathy (ICM).</AbstractText><AbstractText Label="METHODS">A systematic review of Medline, Cochrane, and Embase databases was performed for studies that reported outcomes comparing endo-epi with endo VT ablation alone.</AbstractText><AbstractText Label="RESULTS">Seventeen studies consisting of 975 patients were included (mean 56 &#xb1; 10 years of age; 79% male; NICM in 36.6%; ICM in 32.8%; and ARVC in 30.6%). After a mean follow-up of 27 &#xb1; 21 months, endo-epi ablation was associated with a 35% reduction in risk of VT recurrence compared with endocardial ablation alone (risk ratio [RR]: 0.65; 95% confidence interval [CI]: 0.55 to 0.78; p&#xa0;&lt; 0.001). Sensitivity analysis showed lower risk of VT recurrence in ICM (RR: 0.43; 95% CI: 0.28 to 0.67; p&#xa0;= 0.0002) and ARVC (RR: 0.59; 95% CI: 0.43 to 0.82; p&#xa0;= 0.0002), with a nonsignificant trend in NICM (RR: 0.87; 95% CI: 0.70 to 1.08; p&#xa0;= 0.20). Endo-epi, compared with endo ablation, was associated with reduced all-cause mortality (RR: 0.56; 95% CI: 0.32 to 0.97; p&#xa0;= 0.04). Acute procedural complications were higher with the endo-epi approach (RR: 2.62; 95% CI: 0.91 to 7.52; p&#xa0;= 0.07).</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis suggests that a combined endo-epi ablation is associated with a lower risk of VT&#xa0;recurrence and subsequent mortality than endo only VT ablation in patients with scar-related VT. Procedural complications, however, are higher with the endo-epi approach.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2019. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerrud-Rodriguez</LastName><ForeName>Roberto C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alviz</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grupposo</LastName><ForeName>Vito</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerna</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avendano</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedrow</LastName><ForeName>Usha</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Cardiac Arrhythmia Service, Heart and Vascular Center, Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Roderick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Arrhythmia Care, Heart and Vascular Center, Pritzker School of Medicine, The University of Chicago Medicine, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Applied Research Centre, University of Sydney, Sydney, New South Wales, Australia. Electronic address: Saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2019 Jan;5(1):25-27. doi: 10.1016/j.jacep.2018.09.003.</RefSource><PMID Version="1">30678783</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VT recurrence</Keyword><Keyword MajorTopicYN="N">arrhythmogenic right ventricular cardiomyopathy</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">endocardial ablation</Keyword><Keyword MajorTopicYN="N">epicardial ablation</Keyword><Keyword MajorTopicYN="N">ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">nonischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">structural heart disease</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30678778</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2018.08.010</ArticleId><ArticleId IdType="pii">S2405-500X(18)30672-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23450544</PMID><DateCompleted><Year>2013</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2013</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Lung protective ventilation strategy for the acute respiratory distress syndrome.</ArticleTitle><Pagination><StartPage>CD003844</StartPage><MedlinePgn>CD003844</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD003844</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD003844.pub4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with acute respiratory distress syndrome and acute lung injury require mechanical ventilatory support. Acute respiratory distress syndrome and acute lung injury are further complicated by ventilator-induced lung injury. Lung protective ventilation strategies may lead to improved survival. This systematic review is an update of a Cochrane review originally published in 2003 and updated in 2007.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the effects of ventilation with lower tidal volume on morbidity and mortality in patients aged 16 years or older affected by acute respiratory distress syndrome and acute lung injury. A secondary objective was to determine whether the comparison between low and conventional tidal volume was different if a plateau airway pressure of greater than 30 to 35 cm H20 was used.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">In our previous 2007 updated review, we searched databases from inception until 2006. In this third updated review, we searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL and the Web of Science from 2006 to September 2012. We also updated our search of databases of ongoing research and of reference lists from 2006 to September 2012.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We included randomized controlled trials comparing ventilation using either a lower tidal volume (Vt) or low airway driving pressure (plateau pressure 30 cm H2O or less), resulting in a tidal volume of 7 ml/kg or less, versus ventilation that used Vt in the range of 10 to 15 ml/kg in adults (16 years old or older) with acute respiratory distress syndrome and acute lung injury.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">We independently assessed trial quality and extracted data. Wherever appropriate, results were pooled. We applied fixed-effect and random-effects models.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We did not find any new study which were eligible for inclusion in this update. The total number of studies remained unchanged, six trials involving 1297 patients. Five trials had a low risk of bias. One trial had an unclear risk of bias. Mortality at day 28 was significantly reduced by lung-protective ventilation with a relative risk (RR) of 0.74 (95% confidence interval (CI) 0.61 to 0.88); hospital mortality was reduced with a RR of 0.80 (95% CI 0.69 to 0.92). Overall mortality was not significantly different if a plateau pressure less than or equal to 31 cm H2O in the control group was used (RR 1.13, 95% CI 0.88 to 1.45). There was insufficient evidence for morbidity and long-term outcomes.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical heterogeneity, such as different lengths of follow up and higher plateau pressure in control arms in two trials, makes the interpretation of the combined results difficult. Mortality was significantly reduced at day 28 and at the end of the hospital stay. The effects on long-term mortality are unknown, although the possibility of a clinically relevant benefit cannot be excluded. Ventilation with lower tidal volumes is becoming a routine strategy of treatment of acute respiratory distress syndrome and acute lung injury, stopping investigators from carrying out additional trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petrucci</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Azienda Ospedaliera Desenzano, Desenzano, Italy.nicola.petrucci.1@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Feo</LastName><ForeName>Carlo</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003844. doi: 10.1002/14651858.CD003844.pub3.</RefSource><PMID Version="1">17636739</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D055371" MajorTopicYN="N">Acute Lung Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None known</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>2</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23450544</ArticleId><ArticleId IdType="pmc">PMC6517299</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD003844.pub4</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Amato 1998 {published data only}</Title><Reference><Citation>Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Paula Pinto Schettino G, et al. Effect of a protective&#x2010;ventilation strategy on mortality in the acute respiratory distress syndrome. New England Journal of Medicine 1998;338:347&#x2010;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">9449727</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ARDS Network 2000 {published data only}</Title><Reference><Citation>The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New England Journal of Medicine 2000;342:1301&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brochard 1998 {published data only}</Title><Reference><Citation>Brochard L, Roudot&#x2010;Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez&#x2010;Mondejar E, et al. Tidal volume reduction for prevention of ventilator induced lung injury in acute respiratory distress syndrome. The multicenter trial group on tidal volume reduction in ARDS. American Journal of Respiratory and Critical Care Medicine 1998;158:1831&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9847275</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brower 1999 {published data only}</Title><Reference><Citation>Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P Jr, Wiener CM, et al. Prospective, randomized controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Critical Care Medicine 1999;27:1492&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10470755</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stewart 1998 {published data only}</Title><Reference><Citation>Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, et al. Evaluation of a ventilation strategy to prevent barotrauma in patient at high risk for acute respiratory distress syndrome. Pressure and volume limited ventilation strategy group. New England Journal of Medicine 1998;338:355&#x2010;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">9449728</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Villar 2006 {published data only}</Title><Reference><Citation>Villar J, Kacmarek RM, Perez&#x2010;Mendez L, Aguirre&#x2010;Jaime A. A high positive end&#x2010;expiration pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Critical Care Medicine 2006;34(5):1311&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16557151</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Brower 2004 {published data only}</Title><Reference><Citation>Brower RG, Lanken PN, MacIntyre N. Higher versus lower positive end&#x2010;expiratory pressures in patients with the acute respiratory distress syndrome. New England Journal of Medicine 2004;351:327&#x2010;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">15269312</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Esteban 2000 {published data only}</Title><Reference><Citation>Esteban A, Alia I, Gordo F, Pablo R, Suarez J, Gonzales G, et al. Prospective randomized trial comparing pressure&#x2010;controlled ventilation and volume&#x2010;controlled ventilation in ARDS. For the Spanish Lung Failure Collaborative Group. Chest 2000;117:1690&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10858404</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meade 2008 {published data only}</Title><Reference><Citation>Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end&#x2010;expiratory pressure for acute lung injury and acute respiratory distress syndrome. JAMA 2008;299(6):637&#x2010;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">18270352</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mercat 2008 {published data only}</Title><Reference><Citation>Mercat A, Richard JCM, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end&#x2010;expiratory pressure setting in adult with acute lung injury and acute respiratory distress syndrome. JAMA 2008;299(6):646&#x2010;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18270353</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ranieri 1999 {published data only}</Title><Reference><Citation>Ranieri VM, Suter PM, Tortorella C, Tullio R, Dayer JM, Brienza A, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. JAMA 1999;282:54&#x2010;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">10404912</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rappaport 1994 {published data only}</Title><Reference><Citation>Rappaport SH, Shpiner R, Yoshihara G, Wright J, Chang P, Abraham E. Randomized, prospective trial of pressure&#x2010;limited versus volume&#x2010;controlled ventilation in severe respiratory failure. Critical Care Medicine 1994;22:22&#x2010;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">8124968</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Artigas 1998</Title><Reference><Citation>Artigas A, Bernard GR, Carlet J. The American&#x2010;European Consensus Conference on ARDS, Part 2. Intensive Care Medicine 1998;24:378&#x2010;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">9609420</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bernard 1994</Title><Reference><Citation>Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American&#x2010;European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine 1994;149:818&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">7509706</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cooper 1999</Title><Reference><Citation>Cooper AB, Ferguson ND, Hanly PJ, Meade MO, Kachura JR, Granton JT, et al. Long&#x2010;term follow up of survivors of acute lung injury: lack of effect of a ventilation strategy to prevent barotrauma. Critical Care Medicine 1999;27:2616&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10628599</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Davidson 1999</Title><Reference><Citation>Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically control patients. JAMA 1999;281:354&#x2010;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">9929089</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Deeks 2001</Title><Reference><Citation>Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta&#x2010;analysis. In: Egger M, Smith GD, Altman DG editor(s). Systematc Reviews. London: BMJ Books, 2001:285&#x2010;312.</Citation></Reference></ReferenceList><ReferenceList><Title>Dowdy 2006</Title><Reference><Citation>Dowdy DW, Eid MP, Dennison CR, Mendez&#x2010;Tellez PA, Herridge MS, Guallar E, et al. Quality of life after acute respiratory distress syndrome: a meta&#x2010;analysis. Intensive Care Medicine 2006;32:1115&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">16783553</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dreyfuss 1998</Title><Reference><Citation>Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume and positive end&#x2010;expiratory pressure. American Review of Respiratory Diseases 1998;137:1159&#x2010;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">3057957</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Eichacker 2002</Title><Reference><Citation>Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C. Meta&#x2010;analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. American Journal of Respiratory and Critical Care Medicine 2002;166:1510&#x2010;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12406836</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Esteban 2008</Title><Reference><Citation>Esteban A, Ferguson ND, Meade MO, Frutos&#x2010;Vivar F, Apezteguia C, Brochard L, et al. Evolution of mechanical ventilation in response to clinical research. American Journal of Respiratory and Critical Care Medicine 2008;177:170&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17962636</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Feihl 1994</Title><Reference><Citation>Feihl F, Perret C. Permissive hypercapnia: how permissive should we be?. American Journal of Respiratory and Critical Care Medicine 1994;150:1722&#x2010;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">7952641</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Frutos&#x2010;Vivar 2004</Title><Reference><Citation>Frutos&#x2010;Vivar F, Nin N, Esteban A. Epidemiology of acute lung injury and acute respiratory distress syndrome. Current Opinion in Critical Care 2004;10:1&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15166842</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gattinoni 1995</Title><Reference><Citation>Gattinoni L, Pelosi P, Crotti S, Valenza F. Effects of positive end&#x2010;expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 1995;151:1807&#x2010;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">7767524</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gattinoni 2002</Title><Reference><Citation>Gattinoni L, Chiumello D, Russo R. Reduced tidal volumes and lung protective ventilatory strategy: where do we go from here?. Current Opinion in Critical Care 2002;8:45&#x2010;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">12205406</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hickling 1990</Title><Reference><Citation>Hickling KG, Henderson SJ, Jackson R. Low mortality associated with volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Medicine 1990;16:372&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2246418</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hickling 1994</Title><Reference><Citation>Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low&#x2010;volume, pressure limited ventilation with permissive hypercapnia: a prospective study. Critical Care Medicine 1994;22:1568&#x2010;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">7924367</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2002</Title><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta&#x2010;analysis. Statistics in Medicine 2002;21:1539&#x2010;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Knaus 1985</Title><Reference><Citation>Knaus WA, Wagner DP, Draper EA, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985;13:818&#x2010;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Knaus 1991</Title><Reference><Citation>Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619&#x2010;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">1959406</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marini 1990</Title><Reference><Citation>Marini JJ. Lung mechanics in the adult respiratory distress syndrome. Clinical Chest Medicine 1990;11:673&#x2010;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">2268995</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Monchi 1998</Title><Reference><Citation>Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. American Journal of Respiratory and Critical Care Medicine 1998;158:1076&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">9769263</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Murray 1988</Title><Reference><Citation>Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. American Review of Respiratory Diseases 1988;138:720&#x2010;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3202424</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Orme 2003</Title><Reference><Citation>Orme J, Romney JS, Hopkins RO, Pope D, Chan KJ, Thomsen G, et al. Pulmonary function and health related quality of life in survivors of ARDS. American Journal of Respiratory and Critical Care Medicine 2003;167:690&#x2010;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12493646</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrucci 2003</Title><Reference><Citation>Petrucci N. Tidal volumes in ARDS and meta&#x2010;analysis. American Journal of Respiratory and Critical Care Medicine 2003;167:935&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12653110</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ranieri 1997</Title><Reference><Citation>Ranieri VM, Brienza N, Santostasi S, Puntillo F, Mascia L. Impairment of lung and chest wall mechanics in patients with acute respiratory distress syndrome. Role of abdominal distension. American Journal of Respiratory and Critical Care Medicine 1997;156:1082&#x2010;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">9351606</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ranieri 2012</Title><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012;307(23):2526&#x2010;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Roupie 1999</Title><Reference><Citation>Roupie E, Lepage E, Wysocki M, Fagon JY, Chastre J, Dreyfuss D, et al. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. SRLF Collaborative group on mechanical ventilation. Societe de Reanimation de Langue Francaise. Intensive Care Medicine 1999;25:920&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10501746</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Petrucci 2004a</Title><Reference><Citation>Petrucci N, Iacovelli W. Ventilation with lower tidal volume versus traditional tidal volumes in adult for acute lung injury and acute respiratory distress syndrome. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003844]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003844</ArticleId><ArticleId IdType="pubmed">15106222</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrucci 2004b</Title><Reference><Citation>Petrucci N, Iacovelli W. Ventilation with lower tidal volume. A quantitative systematic review of randomized controlled trials. Anesthesia and Analgesia 2004;99:193&#x2010;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">15281529</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrucci 2004c</Title><Reference><Citation>Petrucci N, Icovelli W. Ventilation with lower tidal volume versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003844.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003844.pub2</ArticleId><ArticleId IdType="pubmed">15106222</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrucci 2007</Title><Reference><Citation>Petrucci N, Iacovelli W. Lung protection ventilation strategy for the acute respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003844.pub3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003844.pub3</ArticleId><ArticleId IdType="pubmed">17636739</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30089564</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Early Versus Late Referral for Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease: A Systematic Review and Meta-Analysis of Clinical Outcomes.</ArticleTitle><Pagination><StartPage>374</StartPage><EndPage>382</EndPage><MedlinePgn>374-382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2017.12.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(17)31250-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This was a meta-analysis of published studies to examine the impact of early referral on outcomes after catheter ablation for ventricular tachycardia (VT) in patients with structural heart disease.</AbstractText><AbstractText Label="BACKGROUND">Patients are frequently referred for VT ablation after failure of antiarrhythmic drugs to control VT. Some studies have suggested that early referral might confer better outcomes.</AbstractText><AbstractText Label="METHODS">An electronic search was performed using major databases. The primary outcomes were long-term VT recurrence and total mortality. Secondary outcomes were acute procedural success and acute complications.</AbstractText><AbstractText Label="RESULTS">Three studies were included with a total of 980 patients (mean age 64 &#xb1; 12 years, 71% males). Mean follow-up was 29 &#xb1; 27 months. Early referral for VT ablation was associated with decreased VT recurrence and acute complications compared with late referral (relative risk: 0.69 [95% confidence interval: 0.58 to 0.82], p&#xa0;&lt; 0.0001 and relative risk: 0.50 [95% confidence interval: 0.27 to 0.93], p&#xa0;= 0.03, respectively). There was no significant difference between early and late referral for total mortality and acute success.</AbstractText><AbstractText Label="CONCLUSIONS">Late referral for VT ablation was associated with worse outcomes (VT recurrence and acute complications)&#xa0;in patients with structural heart disease, which suggests that early referral for VT ablation might be a reasonable consideration in this patient population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 American College of Cardiology Foundation. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quispe</LastName><ForeName>Renato</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Xianfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ningbo First Hospital, Zhejiang Sheng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briceno</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avendano</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedrow</LastName><ForeName>Usha</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital Heart &amp; Vascular Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Roy M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaud</LastName><ForeName>Gregory F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>William G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital Heart &amp; Vascular Center, Harvard Medical School, Boston, Massachusetts; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital Heart &amp; Vascular Center, Harvard Medical School, Boston, Massachusetts; Department of Cardiology, Westmead Hospital, Westmead Applied Research Centre, University of Sydney, Westmead, New South Wales, Australia. Electronic address: saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2018 Mar;4(3):383-385. doi: 10.1016/j.jacep.2018.01.002.</RefSource><PMID Version="1">30089565</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VT recurrence</Keyword><Keyword MajorTopicYN="N">acute complications</Keyword><Keyword MajorTopicYN="N">antiarrhythmic drugs</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">early referral</Keyword><Keyword MajorTopicYN="N">ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">nonischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30089564</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2017.12.008</ArticleId><ArticleId IdType="pii">S2405-500X(17)31250-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26695501</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>111</StartPage><EndPage>117</EndPage><MedlinePgn>111-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-015-0083-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with ischemic heart disease may have implantable cardioverter defibrillators (ICDs) implanted for primary or secondary prevention of sudden cardiac death. Although ICD shocks can be life saving, in some patients, they have been associated with increased mortality and/or morbidity. Several studies have suggested that catheter ablation may be superior to non-ablative strategies at preventing ICD shocks delivered for ventricular arrhythmias; however, this is still controversial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a meta-analysis of randomized controlled trials (RCTs) comparing catheter ablation with non-ablative strategies in treatment of ventricular tachycardia (VT) in patients with ischemic heart disease and an ICD. The primary endpoints of interest were recurrent episodes of VT and death. We used a binary random effects method to calculate the cumulative odds ratios (OR) for recurrent VT and deaths.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of a total of 643 potential citations, our search yielded three citations that met our inclusion and exclusion criteria. In the three trials, a total of 262 patients were randomized to ablation (n&#x2009;=&#x2009;129) or non-ablative interventions (beta-blockers&#x2009;&#xb1;&#x2009;use of antiarrhythmics) (n&#x2009;=&#x2009;133) group. The cumulative OR for recurrent VT was 0.471 (95% confidence interval (CI)&#x2009;=&#x2009;0.176-1.257) for catheter ablation compared with non-ablative strategies, and for death, it was 0.766 (95% CI&#x2009;=&#x2009;0.351-1.674). Excluding one study for being appreciably smaller than the other two, the OR for recurrent VT was 0.298 (95% CI&#x2009;=&#x2009;0.164-0.543).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this meta-analysis, the rate of recurrent VT was lower with VT catheter ablation compared with non-ablative strategies. There was not a significant difference in rate of death among patients receiving catheter ablation versus non-ablative strategies for management of VT. Given the lack of adequately powered RCTs comparing ablation versus medical management of VT in patients with ischemic heart disease and an ICD, larger studies with longer follow-up are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Divyang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasselblad</LastName><ForeName>Vic</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pokorney</LastName><ForeName>Sean D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daubert</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Khatib</LastName><ForeName>Sana M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA. alkha001@dm.duke.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA. alkha001@dm.duke.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">Ischemic heart disease</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26695501</ArticleId><ArticleId IdType="doi">10.1007/s10840-015-0083-4</ArticleId><ArticleId IdType="pii">10.1007/s10840-015-0083-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Circulation. 2004 Dec 21;110(25):3760-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15583079</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2003 Oct;5(4):381-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14753636</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2010 Jan;21(1):47-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19656251</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1997 Nov 27;337(22):1576-83</Citation><ArticleIdList><ArticleId IdType="pubmed">9411221</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1993 Feb;87(2):363-72</Citation><ArticleIdList><ArticleId IdType="pubmed">8425285</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2014 Feb 18;129(7):728-36</Citation><ArticleIdList><ArticleId IdType="pubmed">24211823</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Jan 11;295(2):165-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 2;375(9708):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Mar 21;346(12):877-83</Citation><ArticleIdList><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2009 Jun;11(6):771-817</Citation><ArticleIdList><ArticleId IdType="pubmed">19443434</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Sep 4;359(10):1009-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2015 Feb;26(2):151-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25332150</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 1993 Sep;14 Suppl E:120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8223748</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jun 29;342(26):1937-45</Citation><ArticleIdList><ArticleId IdType="pubmed">10874061</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1992 May;85(5):1666-74</Citation><ArticleIdList><ArticleId IdType="pubmed">1572025</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2011 Apr;8(4):503-10</Citation><ArticleIdList><ArticleId IdType="pubmed">21147263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kardiol Pol. 2009 Feb;67(2):123-7; discussion 128-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19288374</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Apr;11(4):533-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24333283</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2007 Nov 12;167(20):2226-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17998496</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2000 Jun;35(7):1905-14</Citation><ArticleIdList><ArticleId IdType="pubmed">10841242</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Dec 16;118(25):2773-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Feb 5;105(5):589-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11827924</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2002 Aug;144(2):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12177646</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2013 May;24(5):525-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23350967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30089555</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Multicenter Study of Ischemic Ventricular&#xa0;Tachycardia Ablation With&#xa0;Decrement-Evoked Potential (DEEP)&#xa0;Mapping With Extra Stimulus.</ArticleTitle><Pagination><StartPage>307</StartPage><EndPage>315</EndPage><MedlinePgn>307-315</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2017.12.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(17)31242-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The authors conducted a multicenter study of decrement-evoked potential (DEEP)-based functional ventricular tachycardia (VT) substrate modification to evaluate if such a mechanistic and physiological strategy is feasible and efficient in clinical practice and provides reduction in the VT burden.</AbstractText><AbstractText Label="BACKGROUND">Only a fraction of the myocardium targeted in current VT substrate modification procedures is involved in the initiation and perpetuation of VT. The physiological basis of the DEEP strategy for identification of areas of initiation and maintenance of VT was recently established.</AbstractText><AbstractText Label="METHODS">We included 20 consecutive patients with ischemic cardiomyopathy. During substrate mapping, fractionated and late potentials (LPs) were tagged, and an extra stimulus was performed to determine which LPs displayed decrement&#xa0;(DEEPs). All patients underwent DEEP-focused ablation: elimination of DEEP&#xa0;+ further radiofrequency (RF) if VT was still inducible. Patients were followed during 6 months.</AbstractText><AbstractText Label="RESULTS">Patients were predominantly male (95%), and their mean age was 64.6 &#xb1; 17.1 years. Mean left ventricular ejection fraction was 33.4 &#xb1; 11.4%. Mean ablation time was 30.6 &#xb1; 20.4 min. Specificity of DEEPs&#xa0;to detect the isthmus of VT was better than that of LPs (0.97 [95% confidence interval [CI]: 0.95 to 0.98] vs. 0.82 [95% CI: 0.73 to 0.89]), without significant differences in terms of sensitivity (0.61 [95% CI: 0.52 to 0.69] vs. 0.60&#xa0;[95% CI: 0.44 to 0.74], respectively). Fifteen of 20 (75%) patients were free of any VT after DEEP-RF at 6 months of follow-up and there was a strong reduction in VT burden compared to 6 months pre-ablation.</AbstractText><AbstractText Label="CONCLUSIONS">In a multicenter prospective study, DEEP substrate mapping identified the functional substrate critical to the VT circuit with high specificity. DEEP-guided VT ablation, by its physiological nature, may enable greater access&#xa0;to&#xa0;focused ablation therapy for patients requiring VT treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Porta-S&#xe1;nchez</LastName><ForeName>Andreu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Department de Medicina, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>John Hunter Hospital, Newcastle, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukac</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>&#xc5;rhus University Hospital, Skejby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kristiansen</LastName><ForeName>Steen Buus</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>&#xc5;rhus University Hospital, Skejby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Jan Moller</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>&#xc5;rhus University Hospital, Skejby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gizurarson</LastName><ForeName>Sigfus</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mass&#xe9;</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labos</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>McGill University, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viswanathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Andrew C T</ForeName><Initials>ACT</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Downar</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanthakumar</LastName><ForeName>Kumaraswamy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada. Electronic address: kumar.nanthakumar@uhn.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2018 Mar;4(3):328-330. doi: 10.1016/j.jacep.2018.02.004.</RefSource><PMID Version="1">30089557</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025321" MajorTopicYN="N">Surgery, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">mapping</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">nonischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">substrate ablation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30089555</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2017.12.005</ArticleId><ArticleId IdType="pii">S2405-500X(17)31242-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28069835</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study.</ArticleTitle><Pagination><StartPage>512</StartPage><EndPage>519</EndPage><MedlinePgn>512-519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euw406</ELocationID><Abstract><AbstractText Label="AIMS">Ventricular tachycardia (VT) substrate ablation is based on detailed electroanatomical maps (EAM). This study analyses whether high-density multielectrode mapping (MEM) is superior to conventional point-by-point mapping (PPM) in guiding VT substrate ablation procedures.</AbstractText><AbstractText Label="METHODS AND RESULTS">This was a randomized controlled study (NCT02083016). Twenty consecutive ischemic patients undergoing VT substrate ablation were randomized to either group A [n&#x2009;=&#x2009;10; substrate mapping performed first by PPM (Navistar) and secondly by MEM (PentaRay) ablation guided by PPM] or group B [n&#x2009;=&#x2009;10; substrate mapping performed first by MEM and second by PPM ablation guided by MEM]. Ablation was performed according to the scar-dechanneling technique. Late potential (LP) pairs were defined as a Navistar-LP and a PentaRay-LP located within a three-dimensional distance of&#x2009;&#x2264;&#x2009;3&#x2009;mm. Data obtained from EAM, procedure time, radiofrequency time, and post-ablation VT inducibility were compared between groups. Larger bipolar scar areas were obtained with MEM (55.7&#xb1;31.7 vs. 50.5&#xb1;26.6&#x2009;cm2; P&#x2009;=&#x2009;0.017). Substrate mapping time was similar with MEM (19.7&#xb1;7.9&#x2009;minutes) and PPM (25&#xb1;9.2&#x2009;minutes); P&#x2009;=&#x2009;0.222. No differences were observed in the number of LPs identified within the scar by MEM vs. PPM (73&#xb1;50 vs. 76&#xb1;52 LPs per patient, respectively; P&#x2009;=&#x2009;0.965). A total of 1104 LP pairs were analysed. Using PentaRay, far-field/LP ratio was significantly lower (0.58&#xb1;0.4 vs. 1.64&#xb1;1.1; P&#x2009;=&#x2009;0.01) and radiofrequency time was shorter [median (interquartile range) 12 (7-20) vs. 22 (17-33) minutes; P&#x2009;=&#x2009;0.023]. No differences were observed in VT inducibility after procedure.</AbstractText><AbstractText Label="CONCLUSION">MEM with PentaRay catheter provided better discrimination of LPs due to a lower sensitivity for far-field signals. Ablation guided by MEM was associated with a shorter radiofrequency time.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penela</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreu</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlosena</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassanelli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarc&#xf3;n</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soto-Iglesias</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korshunov</LastName><ForeName>Viatcheslav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borras</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linhart</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Mikel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Armenta</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mont</LastName><ForeName>Lluis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berruezo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="N">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062906" MajorTopicYN="N">Cardiac Catheters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="Y">Electrophysiologic Techniques, Cardiac</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28069835</ArticleId><ArticleId IdType="doi">10.1093/europace/euw406</ArticleId><ArticleId IdType="pii">euw406</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24570557</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2014</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1816-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Asian cardiovascular &amp; thoracic annals</Title><ISOAbbreviation>Asian Cardiovasc Thorac Ann</ISOAbbreviation></Journal><ArticleTitle>Ventricular tachyarrhythmia after coronary bypass surgery: incidence and outcome.</ArticleTitle><Pagination><StartPage>551</StartPage><EndPage>557</EndPage><MedlinePgn>551-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0218492312462225</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ventricular tachyarrhythmia after coronary artery bypass graft is common and the occurrence has been described, but the incidence and risk factors are not well defined.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the incidence of arrhythmias and to detect high-risk populations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective study, 856 consecutive patients undergoing coronary artery bypass graft were monitored for new-onset ventricular tachyarrhythmias: non-sustained monomorphic ventricular tachyarrhythmia, sustained monomorphic ventricular tachyarrhythmia, sustained polymorphic ventricular tachyarrhythmia, and ventricular fibrillation. Detailed analyses of the clinical, demographic, echocardiographic, and surgical findings and arrhythmias occurrence was carried out during 6 months of follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of ventricular tachyarrhythmia was 26.6% (17.6% non-sustained monomorphic ventricular tachycardia, 5.5% sustained monomorphic ventricular tachycardia, 0.8% sustained polymorphic ventricular tachycardia, and 2.7% ventricular fibrillation). The strongest degrees of statistical significance were for low ejection fraction (p&#x2009;=&#x2009;0.01) and ischemic heart disease (p&#x2009;=&#x2009;0.02). The incidence of ventricular fibrillation (61%) was greatest in the first 48&#x2009;h after surgery. Postoperative myocardial infarction (p&#x2009;=&#x2009;0.03) and hemodynamic instability (p&#x2009;=&#x2009;0.05) were also predictors of arrhythmia occurrence. Recurrence of arrhythmia was highest in the ventricular fibrillation group (52%). The correlations between tachyarrhythmia, age, sex, electrolyte disorders, body mass index, and systemic or pulmonary hypertension were not significant.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In view of the strong relationship between ventricular arrhythmias and low ejection fraction, ischemic heart disease, coronary artery disease severity, postoperative myocardial infection, and hemodynamic impairment, continuous monitoring is necessary, especially in the first 48&#x2009;h after coronary artery bypass surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadr-Ameli</LastName><ForeName>Mohammad Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alizadeh</LastName><ForeName>Abolfath</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ghasemi</LastName><ForeName>Valiollah</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Heidarali</LastName><ForeName>Mona</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Asian Cardiovasc Thorac Ann</MedlineTA><NlmUniqueID>9503417</NlmUniqueID><ISSNLinking>0218-4923</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmias</Keyword><Keyword MajorTopicYN="N">coronary artery bypass</Keyword><Keyword MajorTopicYN="N">intra-aortic balloon pump</Keyword><Keyword MajorTopicYN="N">ischemic heart disease</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24570557</ArticleId><ArticleId IdType="doi">10.1177/0218492312462225</ArticleId><ArticleId IdType="pii">0218492312462225</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29114888</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>May</Month></PubDate></JournalIssue><Title>The Laryngoscope</Title><ISOAbbreviation>Laryngoscope</ISOAbbreviation></Journal><ArticleTitle>Cricothyroid joint type as predictor for vocal fold elongation in professional singers.</ArticleTitle><Pagination><StartPage>1176</StartPage><EndPage>1181</EndPage><MedlinePgn>1176-1181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.26984</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Vocal fold (VF) elongation vocal folds depends on two factors: the activity of the laryngeal muscles and the cricothyroid joint (CTJ). The aim of the study was to show the influence of the CTJ on VF elongation while singing a sustained vowel at different pitches.</AbstractText><AbstractText Label="STUDY DESIGN">Prospective study.</AbstractText><AbstractText Label="METHODS">Forty-nine female professional singers (25 sopranos, 24 altos) were recruited. Three-dimensional images of the larynx derived from high-resolution computed tomography scanning were obtained at the mean speaking fundamental frequency (F0) and one (F1) and two octaves (F2) above this pitch.</AbstractText><AbstractText Label="RESULTS">From F0 to F1, all three CTJ types showed equal elongation of the VF (type A: 14%, type B/C: 13%). From F1 to F2, VF elongation was 8% in singers with type A and 4% in those with type B/C (P &lt; 0.0001).</AbstractText><AbstractText Label="CONCLUSION">The stability of the CTJ directly influences VF during singing. This is the first study to show this relationship in vivo.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">4. Laryngoscope, 128:1176-1181, 2018.</AbstractText><CopyrightInformation>&#xa9; 2017 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Storck</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2187-8181</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Division of Phoniatrics, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unteregger</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Division of Phoniatrics, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Laryngoscope</MedlineTA><NlmUniqueID>8607378</NlmUniqueID><ISSNLinking>0023-852X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003413" MajorTopicYN="N">Cricoid Cartilage</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007821" MajorTopicYN="N">Laryngeal Muscles</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011857" MajorTopicYN="N">Radiographic Image Interpretation, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063346" MajorTopicYN="N">Singing</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013957" MajorTopicYN="N">Thyroid Cartilage</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014827" MajorTopicYN="N">Vocal Cords</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014833" MajorTopicYN="N">Voice Quality</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3D</Keyword><Keyword MajorTopicYN="N">Larynx</Keyword><Keyword MajorTopicYN="N">MIMICS</Keyword><Keyword MajorTopicYN="N">biomechanics</Keyword><Keyword MajorTopicYN="N">cricothyroid joint</Keyword><Keyword MajorTopicYN="N">singer</Keyword><Keyword MajorTopicYN="N">three-dimensional</Keyword><Keyword MajorTopicYN="N">vocal fold elongation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29114888</ArticleId><ArticleId IdType="doi">10.1002/lary.26984</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28575378</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>104</StartPage><EndPage>115</EndPage><MedlinePgn>104-115</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/eux109</ELocationID><Abstract><AbstractText Label="AIMS">To compare the long-term outcomes of standard ablation of stable ventricular tachycardia (VT) vs. substrate modification, and of complete vs. incomplete substrate modification in patients with structural heart disease (SHD) presenting with VT.</AbstractText><AbstractText Label="METHODS AND RESULTS">An electronic search was performed using major databases. The main outcomes were a composite of long-term ventricular arrhythmia (VA) recurrence and all-cause mortality of standard ablation of stable VT vs. substrate modification, and long-term VA recurrence in complete vs. incomplete substrate modification. Six studies were included for the comparison of standard ablation of stable VT vs. substrate modification, with a total of 396 patients (mean age 63 &#xb1; 10 years, 87% males), and seven studies were included to assess the impact of extensive substrate modification, with a total of 391 patients (mean age 64 &#xb1; years, 90% males). More than 70% of all the patients included had ischaemic cardiomyopathy. Substrate modification was associated with decreased composite VA recurrence/all-cause mortality compared to standard ablation of stable VTs [risk ratio (RR) 0.57, 95% confidence interval (CI) 0.40-0.81]. Complete substrate modification was associated with decreased VA recurrence as compared to incomplete substrate modification (RR 0.39, 95% CI 0.27-0.58).</AbstractText><AbstractText Label="CONCLUSION">In patients with SHD who had VT related mainly to ischaemic substrates, there was a significantly lower risk of the composite primary outcome of long-term VA recurrence and all-cause mortality among those undergoing substrate modification compared to standard ablation. Long-term success is improved when performing complete substrate modification.</AbstractText><CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. &#xa9; The Author 2017. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brice&#xf1;o</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villablanca</LastName><ForeName>Pedro A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Londo&#xf1;o</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maraj</LastName><ForeName>Ilir</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batul</LastName><ForeName>Syeda Atiqa</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madan</LastName><ForeName>Nidhi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Jignesh</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagannath</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Sanghamitra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Prasant</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianni</LastName><ForeName>Carola</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Rocca</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabri</LastName><ForeName>Ahlam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Soo G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, 107 W. Dean Keeton, BME Building, 78712, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Stanford Arrhythmia Service, Stanford University, 300 Pasteur Drive, 94305 Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Case Western Reserve University, University Hospitals of Cleveland, 11100 Euclid Avenue, 44106-5038 Cleveland, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interventional Electrophysiology, Department of Cardiology, Scripps Clinic, 10666 N Torrey Pines Road, 92037, La Jolla, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dell Medical School, 1501 Red River St, Austin, TX 78701, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arrhythmia Services California Pacific Medical Center, 2100 Webster Street, 94115, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University of Foggia, viale L Pinto, 1, 71100, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, 107 W. Dean Keeton, BME Building, 78712, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University of Foggia, viale L Pinto, 1, 71100, Foggia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D055011" MajorTopicYN="Y">Ablation Techniques</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Activation/entrainment mapping</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Substrate modification</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28575378</ArticleId><ArticleId IdType="doi">10.1093/europace/eux109</ArticleId><ArticleId IdType="pii">3855685</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35427808</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0849</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European journal of medical genetics</Title><ISOAbbreviation>Eur J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: An international retrospective cohort study.</ArticleTitle><Pagination><StartPage>104503</StartPage><MedlinePgn>104503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejmg.2022.104503</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1769-7212(22)00084-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Heritable thoracic aortic diseases (HTAD), typically entailing aortic complications, can be caused by pathogenic variants or likely pathogenic variants (PV/LPVs) in several genes, including fibrillin1 (FBN1), Actin Alpha2 (ACTA2) and genes encoding components of the transforming growth factor (TGF)-&#x3b2; signaling pathway. In addition to aortic complications, non-aortic cardiac disease such as impaired myocardial function and/or arrhythmia have been increasingly reported, mainly in Marfan syndrome with underlying FBN1 PV/LPVs and are acknowledged as additional causes of morbidity and mortality. The prevalence of these manifestations in the various HTAD entities is largely unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This international multicentre retrospective study collected data on patients with HTAD presenting non-aortic cardiac disease. A total of 9 centers from 7 different countries participated. Patients 12 years or older carrying a PV/LPV in one of the following genes: FBN1, TGFBR1, TGFBR2, TGFB2, TGFB3, SMAD3 and ACTA2 were screened. Non-aortic cardiac disease included impaired myocardial function and/or arrhythmia. Impaired myocardial function was defined as (a)symptomatic reduced ejection fraction (EF&lt;50%). Arrhythmias included atrial fibrillation (AF), atrial flutter (AFL), ventricular tachycardia (VT), ventricular fibrillation (VF) and (aborted) sudden cardiac death (presumed arrhythmogenic) (SCD).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Medical records of 3219 patients with HTAD were screened (2761, 385 and 73 carrying a PV/LPV in FBN1, in a TGF-&#x3b2; signaling gene and in ACTA2 respectively). Non-aortic cardiac disease was reported 142 times in 101 patients (3.1%) (age 37 [range 12-77] years, 39% female): 88 patients carrying an FBN1 PV/LPV and 13 carrying a PV/LPV in one of the TGF-&#x3b2; signaling genes. Neither impaired myocardial function nor arrhythmia was reported in screened patients carrying a PV/LPV in ACTA2. Among the 142 reported non-aortic cardiac diseases, 68 (48%) were impaired myocardial function, 47 (33%) were AF/AFL and 27 (19%) were VT/VF/SCD. Among the patients with non-aortic cardiac disease, prior cardiac surgery was noted in 80% and severe valvular disease (valvular surgery or severe valvular regurgitation) in 58%, while 18% of the patients developed non-aortic cardiac disease in the absence of any of the latter.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with HTAD, arrhythmia and impaired myocardial function was reported in patients with PV/LPVs in FBN1 and in the TGF-&#x3b2; signaling genes and not in patients harboring PV/LPVs in ACTA2. Though infrequent, non-aortic cardiac disease should be acknowledged as potentially severe, also occurring in young patients with no underlying significant valvular or aortic disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Demolder</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium; Department of Cardiology, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianco</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pediatric Cardiology Department, Universitat Aut&#xf2;noma Barcelona, Hospital Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caruana</LastName><ForeName>Maryanne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Mater Dei Hospital, Birkirkara Bypass, Malta; VASCERN HTAD Affiliated Partner Centre, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervi</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evangelista</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, CIBER-CV, Spain; VASCERN HTAD European Reference Centre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jondeau</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>VASCERN HTAD European Reference Centre, Belgium; Centre de r&#xe9;f&#xe9;rence pour le syndrome de Marfan et apparent&#xe9;s, AP-HP, H&#xf4;pital Bichat, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buttigieg</LastName><ForeName>Lisa Lauren</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Mater Dei Hospital, Birkirkara Bypass, Malta; VASCERN HTAD Affiliated Partner Centre, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Sainz</LastName><ForeName>&#xc1;ngela</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, CIBER-CV, Spain; VASCERN HTAD European Reference Centre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delm&#xe1;s</LastName><ForeName>Elena Monta&#xf1;&#xe9;s</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Instituto Pedi&#xe1;trico del Coraz&#xf3;n, Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pini</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Genetic Centre, IRCCS Policlinico San Donato, San Donato Milanese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabat&#xe9;-Rot&#xe9;s</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Cardiology Department, Universitat Aut&#xf2;noma Barcelona, Hospital Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sz&#xf6;cs</LastName><ForeName>Katalin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>VASCERN HTAD European Reference Centre, Belgium; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Hospital Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tchitchinadze</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>VASCERN HTAD European Reference Centre, Belgium; Centre de r&#xe9;f&#xe9;rence pour le syndrome de Marfan et apparent&#xe9;s, AP-HP, H&#xf4;pital Bichat, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixid&#xf3;-Tura</LastName><ForeName>Gisela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, CIBER-CV, Spain; VASCERN HTAD European Reference Centre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Kodolitsch</LastName><ForeName>Yskert</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>VASCERN HTAD European Reference Centre, Belgium; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Hospital Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mui&#xf1;o-Mosquera</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium; VASCERN HTAD European Reference Centre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Backer</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium; VASCERN HTAD European Reference Centre, Belgium; Department of Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium; Department of Cardiology, Ghent University Hospital, Ghent, Belgium. Electronic address: Julie.DeBacker@UGent.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Med Genet</MedlineTA><NlmUniqueID>101247089</NlmUniqueID><ISSNLinking>1769-7212</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000199">Actins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000199" MajorTopicYN="N">Actins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001018" MajorTopicYN="Y">Aortic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008382" MajorTopicYN="Y">Marfan Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35427808</ArticleId><ArticleId IdType="doi">10.1016/j.ejmg.2022.104503</ArticleId><ArticleId IdType="pii">S1769-7212(22)00084-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32268210</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2763</ISSN><JournalIssue CitedMedium="Internet"><Volume>136</Volume><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Bone</Title><ISOAbbreviation>Bone</ISOAbbreviation></Journal><ArticleTitle>Identification of prevalent vertebral fractures using Vertebral Fracture Assessment (VFA) in asymptomatic postmenopausal women: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>115358</StartPage><MedlinePgn>115358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bone.2020.115358</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S8756-3282(20)30138-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Vertebral fracture (VF) is the most common osteoporotic fracture in postmenopausal women, although most VFs are subclinical. Prevalent VFs are a significant predictor of subsequent fracture and therefore, identification of VF improves the identification of those with high fracture risk. The aim of present study was to systematically review the literature that assessed the prevalence of VF in asymptomatic postmenopausal women, using Vertebral Fracture Assessment (VFA) by dual-energy X-ray absorptiometry.</AbstractText><AbstractText Label="METHOD">Medline, Web of Science and Cochrane databases were searched between Jan 1st, 2000 and Jan 31st, 2018, for publications in English that reported the prevalence of VFA-detected VF in asymptomatic postmenopausal women. We also searched for reports, conference papers and grey literature. Reviewers screened studies for eligibility and extracted data for included studies. Random effects meta-analyses were performed to calculate the prevalence of VF. The presence of publication bias was assessed using funnel plots by precision and Egger's Test of the Intercept.</AbstractText><AbstractText Label="RESULTS">A total of 1777 articles were identified, 94 studies were fully reviewed and 28 studies (n&#xa0;=&#xa0;25,418) met the inclusion criteria and were analyzed. More than two thirds of the studies were cross-sectional and the sample size varied widely across the studies (from 63 to 5156). The mean age ranged from 59.5 to 86.2&#xa0;years old. The prevalence of osteoporosis and osteopenia varied between 6-57.0% and 25.1-58.9%, respectively. However, among women who had prevalent VFs, up to 43% had osteopenia and as many as 32% had normal bone density. The weighted pooled prevalence of VFA-detected VF in asymptomatic women was 28% (95% CI: 23%-32%).</AbstractText><AbstractText Label="CONCLUSION">VFA is able to identify prevalent VF in asymptomatic postmenopausal women. The use of VFA identified an average of 28% of asymptomatic women with VFs, many of whom did not have a diagnosis of osteoporosis. Implementation of VFA as a routine screening tool may detect high risk women. Detection of VF might lead to pharmacological treatment in individuals who may not otherwise be treated.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jingyan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Social and Economic Research and Policy (ISERP), Columbia University, New York, NY, USA; Patient Health and Impact, Pfizer Inc., New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Yushan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, The Affiliated Hospital of Medical School, Ningbo University, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieves</LastName><ForeName>Jeri W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; Hospital for Special Surgery, New York, NY, USA. Electronic address: jwn5@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bone</MedlineTA><NlmUniqueID>8504048</NlmUniqueID><ISSNLinking>1873-2763</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015663" MajorTopicYN="Y">Osteoporosis, Postmenopausal</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="Y">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Postmenopausal women</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Vertebral Fracture Assessment</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32268210</ArticleId><ArticleId IdType="doi">10.1016/j.bone.2020.115358</ArticleId><ArticleId IdType="pii">S8756-3282(20)30138-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31724106</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-187X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>American journal of cardiovascular drugs : drugs, devices, and other interventions</Title><ISOAbbreviation>Am J Cardiovasc Drugs</ISOAbbreviation></Journal><ArticleTitle>Dexmedetomidine Reduces Atrial Fibrillation After Adult Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>281</EndPage><MedlinePgn>271-281</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40256-019-00380-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dexmedetomidine has been shown to have antiarrhythmic effects by exhibiting sympatholytic properties and activating the vagus nerve in preclinical studies. Results from clinical trials of dexmedetomidine on atrial fibrillation (AF) following adult cardiac surgery are controversial.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We searched EMBASE, PubMed and Cochrane CENTRAL databases for randomized controlled trials (RCTs) comparing the antiarrhythmic effect of dexmedetomidine versus placebo or other anesthetic drugs in adult patients undergoing cardiac surgery. The primary outcome was the incidence of AF. The secondary outcomes were ventricular arrhythmias [ventricular fibrillation (VF), ventricular tachycardia (VT)], mechanical ventilation (MV) duration, intensive care unit (ICU) length of stay, and hospital length of stay, and all-cause mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen trials with a total of 1684 study patients were selected. Compared with controls, dexmedetomidine significantly reduced the incidence of postoperative AF [odds ratio (OR) 0.75; 95% confidence interval (CI) 0.58-0.97; P = 0.03] and VT (OR 0.23; 95% CI 0.11-0.48; P &lt; 0.0001). No significant difference for the incidence of VF existed (OR 0.80; 95% CI 0.21-3.03; P = 0.74). There was no significant difference between groups in MV duration [weighted mean difference (WMD) -&#x2009;0.10; 95% CI -&#x2009;0.42 to 0.21; P = 0.52], postoperative ICU stay (WMD -&#x2009;0.49; 95% CI -&#x2009;2.64 to 1.66; P = 0.65), hospital stay (WMD -&#x2009;0.01; 95% CI -&#x2009;0.16 to 0.13; P = 0.88) and mortality (OR 0.59; 95% CI 0.15-2.37; P = 0.46).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative administration of dexmedetomidine in adult patients undergoing cardiac surgery reduced the incidence of postoperative AF and VT. But there was no significant difference in incidence of VF, MV duration, ICU stay, hospital stay and mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of anesthesiology, Beijing Daxing Maternal and Child Care Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Suozhu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Feiping</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhen</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China. heart2008whu@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Am J Cardiovasc Drugs</MedlineTA><NlmUniqueID>100967755</NlmUniqueID><ISSNLinking>1175-3277</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31724106</ArticleId><ArticleId IdType="doi">10.1007/s40256-019-00380-2</ArticleId><ArticleId IdType="pii">10.1007/s40256-019-00380-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25796995</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1570</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Resuscitation</Title><ISOAbbreviation>Resuscitation</ISOAbbreviation></Journal><ArticleTitle>Effects of in-hospital low targeted temperature after out of hospital cardiac arrest: A systematic review with meta-analysis of randomized clinical trials.</ArticleTitle><Pagination><StartPage>8</StartPage><EndPage>18</EndPage><MedlinePgn>8-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resuscitation.2015.02.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0300-9572(15)00123-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We performed this systematic review to evaluate the effectiveness of in-hospital low targeted temperature in adult patients after out of hospital cardiac arrest on survival and neurologic performance.</AbstractText><AbstractText Label="DATA SOURCE" NlmCategory="METHODS">We systematically searched MEDLINE and PUBMED from inception to April 2014.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Citations were screened for studies evaluating the effect of in-hospital low targeted temperature in patients following out of hospital cardiac arrest.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">We analyzed randomized control trials (RCTs) that included adult patients resuscitated from out of hospital cardiac arrest, reporting mortality at hospital discharge and comparing in-hospital low targeted temperature with a control group.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">This meta-analysis included 6 RCTs and 1418 adult patients. In-hospital low targeted (low T) temperature was associated to a reduction in mortality at hospital discharge and at 6 months when compared with in-hospital targeted and not targeted temperature while there was no reduction in mortality comparing low and high targeted temperature. In patients with initial ventricular fibrillation/ventricular tachycardia rhythm of out of hospital cardiac arrest, low T was associated with a reduction in short and long-term mortality when compared with no targeted temperature while not when compared to high targeted temperature. Low T was associated with good neurologic performance at hospital discharge compared with in-hospital high or not targeted temperature.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In-hospital low targeted temperature (&lt;4 &#xb0;C) improved short and long-term mortality when compared to no targeted temperature. In contrast, low T did not improve outcome compared with a slightly higher targeted temperature (&#x2248; 36 &#xb0;C).</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive and Odonthostomatological Sciences, University of Naples "Federico II", Naples, Italy. Electronic address: vargas.maria82@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Servillo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive and Odonthostomatological Sciences, University of Naples "Federico II", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutherasan</LastName><ForeName>Yuda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Gonz&#xe1;lez</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research Unit, Hospital Universitario Dr. Negr&#xed;n, Las Palmas de Gran Canaria, Spain; Critical Patient Translational Research Group, Department of Anesthesiology, Intensive Care and Pain Management, Hospital Cl&#xed;nico Universitario, Instituto de Investigaci&#xf3;n Sanitaria (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunetti</LastName><ForeName>Iole</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>AOU IRCCS San Martino-IST, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, AOU IRCCS San Martino-IST, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Resuscitation</MedlineTA><NlmUniqueID>0332173</NlmUniqueID><ISSNLinking>0300-9572</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="N">Emergency Medical Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="N">Hypothermia, Induced</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058687" MajorTopicYN="N">Out-of-Hospital Cardiac Arrest</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">In hospital</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Neurologic performance</Keyword><Keyword MajorTopicYN="N">Targeted temperature</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25796995</ArticleId><ArticleId IdType="doi">10.1016/j.resuscitation.2015.02.038</ArticleId><ArticleId IdType="pii">S0300-9572(15)00123-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38996090</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>28</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Oral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia: An observational study.</ArticleTitle><Pagination><StartPage>e38839</StartPage><MedlinePgn>e38839</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38839</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000038839</ELocationID><Abstract><AbstractText>Left ventricular assist devices (LVADs) are widely used as end-stage therapy in patients with advanced heart failure, whereas implantation increases the risks of development of sustained ventricular tachycardia at the later postimplantation stage. Therefore, this study aimed to evaluate the clinical efficacy of orally administered amiodarone and propranolol in 3 patients with ventricular tachycardia (VT) after LVAD implantation who were resistant to initial anti-antiarrhythmic drugs. This retrospective cohort study consisted of the initial evaluation of the clinical data of 14 adult patients who underwent implantation of LVAD between January 2019 and March 2021. A total of 3 patients with resistant VT were finally included. In all cases, the patients were initially administered amiodarone in the different doses intravenously to stabilize the critical condition, whereas its oral form along with that of propranolol was used as maintenance therapy in the first 2 cases. In the third case, amiodarone was withdrawn because of the risk of development of hyperthyroidism, while oral propranolol was used in the treatment. The assessment in the 16-month follow-up period after discharge did not show presence of non-sustained and sustained VT in all 3 cases. In the ventricular arrhythmia-free group, the total mortality rate within the follow-up period was 11.1&#x2005;&#xb1;&#x2005;7.78 months in the 3 patients. We suggest that maintenance oral therapy of propranolol and amiodarone can significantly decrease the risks of complications in patients with VT after implantation of ventricular assist device in the long term.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arslan</LastName><ForeName>Abdulla</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2355-3524</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zkaya</LastName><ForeName>&#xd6;yk&#xfc; G&#xfc;lmez</ForeName><Initials>&#xd6;G</Initials><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aytemiz</LastName><ForeName>Fatih</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiology Department, Manisa State Hospital, Manisa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altay</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zcan</LastName><ForeName>Emin Evren</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Cardiology Department, Dokuz Eyl&#xfc;l University Izmir Medical and Research Center, Bal&#xe7;ova/Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;&#xe7;&#xfc;kaksu</LastName><ForeName>Deniz S&#xfc;ha</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakuy</LastName><ForeName>Vedat</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozan</LastName><ForeName>&#xd6;mer</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pehlivano&#x11f;lu</LastName><ForeName>Se&#xe7;kin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber><NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9Y8NXQ24VQ</RegistryNumber><NameOfSubstance UI="D011433">Propranolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000638" MajorTopicYN="Y">Amiodarone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011433" MajorTopicYN="Y">Propranolol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="Y">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>15</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38996090</ArticleId><ArticleId IdType="pmc">PMC11245262</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000038839</ArticleId><ArticleId IdType="pii">00005792-202407120-00003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boruah P, Saqib N, Barooah J, et al. . Left ventricular assist device: what the internist needs to know. A review of the literature. Cureus. 2019;11:e4399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6559676</ArticleId><ArticleId IdType="pubmed">31245189</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoruk A, Sherazi S, Massey HT, et al. . Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device. Heart Rhythm. 2016;13:1052&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26829113</ArticleId></ArticleIdList></Reference><Reference><Citation>Markham DW, Fu Q, Palmer MD, et al. . Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and non-pulsatile left ventricular assist devices. Circ Heart Fail. 2013;6:293&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23250982</ArticleId></ArticleIdList></Reference><Reference><Citation>Welp H, Rukosujew A, Tjan TD, et al. . Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin&#x2013;angiotensin system in patients with end-stage heart failure. Thorac Cardiovasc Surg. 2010;58:S185&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20101537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasin T, Matsuzawa Y, Guddeti RR, et al. . Attenuation in peripheral endothelial function after continuous flow left ventricular assist device therapy is associated with cardiovascular adverse events. Circ J. 2015;79:770&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25739569</ArticleId></ArticleIdList></Reference><Reference><Citation>Starling RC, Naka Y, Boyle AJ, et al. . Results of the Post-U.S. food and drug administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;57:1890&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21545946</ArticleId></ArticleIdList></Reference><Reference><Citation>Efimova E, Fischer J, Bertagnolli L, et al. . Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study. Heart Rhythm. 2017;14:1812&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28756099</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;im&#x15f;ek E, &#xd6;zcan EE, Demir E, et al. . Sol Ventrik&#xfc;l Destek Cihazi Olan Bir Hastada Ventrik&#xfc;ler Ta&#x15f;ikardi Ablasyonu ablation of ventricular tachycardia in a patient with a left ventricular assist device. Turk Kardiyol Dern Ars. 2020;48:58&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">31974318</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenyo A, Rao M, Koneru S, et al. . Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol. 2012;23:515&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">22081967</ArticleId></ArticleIdList></Reference><Reference><Citation>Greet BD, Pujara D, Burkland D, et al. . Incidence, predictors, and significance of ventricular arrhythmias in patients with continuous-flow left ventricular assist devices: a 15-year institutional experience. JACC Clin Electrophysiol. 2018;4:257&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">29749947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzidou S, Kontogiannis C, Tsilimigras DI, et al. . Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator. J Am Coll Cardiol. 2018;71:1897&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">29699616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatano M, Jimba T, Fujiwara T, et al. . Late-Onset right ventricular failure after continuous-flow left ventricular assist device implantation: case presentation and review of the literature. J Cardiol. 2022;80:110&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">34974940</ArticleId></ArticleIdList></Reference><Reference><Citation>Refaat M, Chemaly E, Lebeche D, et al. . Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol. 2008;31:1246&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752870</ArticleId><ArticleId IdType="pubmed">18811803</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss JD, Flatley EE, Beaser AD, et al. . Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience. JACC Clin Electrophysiol. 2017;3:1412&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">29759673</ArticleId></ArticleIdList></Reference><Reference><Citation>Slaughter MS, Pagani FD, Rogers JG, et al. .; HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced HF. J Heart Lung Transplant. 2010;29(Suppl):S1&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">20181499</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SJ, Milano CA, Tatooles AJ, et al. .; HeartMate II Clinical Investigators. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5:241&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22282104</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourque D, Daoust R, Huard V, et al. . Beta-Blockers for the treatment of cardiac arrest from ventricular fibrillation? Resuscitation. 2007;75:434&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">17764805</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ferrari GM, Landolina M, Mantica M, et al. . Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction. Am Heart J. 1995;130:473&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">7661063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bristow MR, Ginsburg R, Umans V, et al. . Beta 1- and Beta 2-Adrenergic-Receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">2876788</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson JL, Rodier HE, Green LS. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol. 1983;51:1196&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">6132549</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JD, Piacentino V, Rothman S, et al. . Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail. 2005;11:227&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15812752</ArticleId></ArticleIdList></Reference><Reference><Citation>Margulies KB. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail. 2002;8(Suppl):S500&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12555165</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedi M, Kormos R, Winowich S, et al. . Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">17437746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziv O, Dizon J, Thosani A, et al. . Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45:1428&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">15862414</ArticleId></ArticleIdList></Reference><Reference><Citation>Oswald H, Schultz-Wildelau C, Gardiwal A, et al. . Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010;12:593&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20406799</ArticleId></ArticleIdList></Reference><Reference><Citation>Garan AR, Yuzefpolskaya M, Colombo PC, et al. . Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol. 2013;61:2542&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23643502</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantillon DJ, Tarakji KG, Kumbhani DJ, et al. . Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7:466&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">20178869</ArticleId></ArticleIdList></Reference><Reference><Citation>Raasch H, Jensen BC, Chang PP, et al. . Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164:373&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22980304</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray KT, Reilly C, Koshakji RP, et al. . Suppression of ventricular arrhythmias in man by d-propranolol independent of betaadrenergic receptor blockade. J Clin Invest. 1990;85:836&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC296501</ArticleId><ArticleId IdType="pubmed">2155929</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28385642</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1570</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Resuscitation</Title><ISOAbbreviation>Resuscitation</ISOAbbreviation></Journal><ArticleTitle>Outcome among VF/VT patients in the LINC (LUCAS IN cardiac arrest) trial-A randomised, controlled trial.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>162</EndPage><MedlinePgn>155-162</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resuscitation.2017.04.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0300-9572(17)30156-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The LINC trial evaluated two ALS-CPR algorithms for OHCA patients, consisting of 3min' mechanical chest compression (LUCAS) cycles with defibrillation attempt through compressions vs. 2min' manual compressions with compression pause for defibrillation. The PARAMEDIC trial, using 2min' algorithm found worse outcome for patients with initial VF/VT in the LUCAS group and they received more adrenalin compared to the manual group. We wanted to evaluate if these algorithms had any outcome effect for patients still in VF/VT after the initial defibrillation and how adrenalin timing impacted it.</AbstractText><AbstractText Label="METHOD">Both groups received manual chest compressions first. Based on non-electronic CPR process documentation, outcome, neurologic status and its relation to CPR duration prior to the first detected return of spontaneous circulation (ROSC), time to defibrillation and adrenalin given were analysed in the subgroup of VF/VT patients.</AbstractText><AbstractText Label="RESULTS">Seven hundred and fifty-seven patients had still VF/VT after initial chest compressions combined with a defibrillation attempt (374 received mechanical CPR) or not (383 received manual CPR). No differences were found for ROSC (mechanical CPR 58.3% vs. manual CPR 58.6%, p=0.94), or 6-month survival with good neurologic outcome (mechanical CPR 25.1% vs. manual CPR 23.0%, p=0.50). A significant difference was found regarding the time from start of manual chest compression to the first defibrillation (mechanical CPR: 4 (2-5) min vs manual CPR 3 (2-4) min, P&lt;0.001). The time from the start of manual chest compressions to ROSC was longer in the mechanical CPR group.</AbstractText><AbstractText Label="CONCLUSIONS">No difference in short- or long-term outcomes was found between the 2 algorithms for patients still in VF/VT after the initial defibrillation. The time to the 1st defibrillation and the interval between defibrillations were longer in the mechanical CPR group without impacting the overall outcome. The number of defibrillations required to achieve ROSC or adrenalin doses did not differ between the groups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hardig</LastName><ForeName>Bjarne Madsen</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Physio-Control, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindgren</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences/Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;stlund</LastName><ForeName>Ollie</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herlitz</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Health Sciences, Research Centre PreHospen, University of Bor&#xe5;s, The Prehospital Research Centre of Western Sweden, Bor&#xe5;s, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsten</LastName><ForeName>Rolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences/Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubertsson</LastName><ForeName>Sten</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences/Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden. Electronic address: sten.rubertsson@akademiska.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Resuscitation</MedlineTA><NlmUniqueID>0332173</NlmUniqueID><ISSNLinking>0300-9572</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YKH834O4BH</RegistryNumber><NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="N">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004554" MajorTopicYN="N">Electric Countershock</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058687" MajorTopicYN="N">Out-of-Hospital Cardiac Arrest</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adrenaline</Keyword><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Defibrillation</Keyword><Keyword MajorTopicYN="N">Mechanical chest compressions</Keyword><Keyword MajorTopicYN="N">Outcome</Keyword><Keyword MajorTopicYN="N">Ventricular fibrillation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28385642</ArticleId><ArticleId IdType="doi">10.1016/j.resuscitation.2017.04.005</ArticleId><ArticleId IdType="pii">S0300-9572(17)30156-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40294736</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes (BRAVE).</ArticleTitle><Pagination><StartPage>1975</StartPage><EndPage>1983</EndPage><MedlinePgn>1975-1983</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2025.04.033</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(25)02381-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Catheter ablation has emerged as a promising treatment to prevent ventricular fibrillation (VF) in Brugada syndrome (BrS). However, evidence from a prospective, randomized clinical trial is lacking.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes trial is a prospective, multicenter, 2-arm, randomized (1:1), open-label clinical study designed to evaluate the efficacy and safety of ablation therapy in patients with symptomatic BrS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled patients with symptomatic BrS with an implantable cardioverter-defibrillator. Patients were randomized to ablation therapy or control groups. Ablation targeted arrhythmogenic areas identified through electroanatomical mapping, predominantly at the right ventricular epicardium. The primary outcome was the first occurrence of VF or death. One interim analysis was planned after 50 patients were randomized.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 67 patients screened, 52 were randomized (25 to ablation, 25 to control, 2 withdrawals), and 15 declined randomizations but remained in a registry (10 chose ablation, 5 opted against ablation). After 3 years of follow-up, the ablation group had significantly fewer VF events than the control group (hazard ratio, 0.288; P = .0184). At the interim analysis, the Data Safety Monitoring Board recommended early trial termination. Among all ablation recipients (including crossovers and registry participants), 83% remained VF free after a single procedure and 90% after a repeat ablation. Complications of ablation included 1 hemopericardium without a long-term sequel.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Epicardial substrate ablation significantly reduces VF recurrence in patients with symptomatic BrS with implantable cardioverter-defibrillators and seems safe, supporting its potential role as a first-line therapy to prevent recurrent VF in patients with symptomatic BrS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nademanee</LastName><ForeName>Koonlawee</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Heart Institute, Bumrungrad Hospital, Bangkok, Thailand; Pacific Rim Electrophysiology Research Institute, Las Vegas, Nevada. Electronic address: wee@pacificrimep.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wongcharoen</LastName><ForeName>Wanwarang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chimparlee</LastName><ForeName>Nitinan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chokesuwattanaskul</LastName><ForeName>Ronpichai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annueypol</LastName><ForeName>Montawatt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phusunti</LastName><ForeName>Keerapa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Maharat Nakhon Ratchasima Hospital, Nakorn Ratchasima, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahasatas</LastName><ForeName>Dujdao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prechawat</LastName><ForeName>Somchai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasertwitayakij</LastName><ForeName>Narawudt</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makarawate</LastName><ForeName>Pattarapong</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutjaporn</LastName><ForeName>Boosamas</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilde</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands; Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drew</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pacific Rim Electrophysiology Research Institute, Las Vegas, Nevada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Postema</LastName><ForeName>Pieter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands; Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngarmukos</LastName><ForeName>Tachapong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardhanabhuti</LastName><ForeName>Saran</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pacific Rim Electrophysiology Research Institute, Las Vegas, Nevada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veerakul</LastName><ForeName>Gumpanart</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Bangkok Heart Hospital, Bangkok General Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wandee</LastName><ForeName>Pharawee</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauleekoonphairoj</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poovorawan</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khongphatthanyaothin</LastName><ForeName>Apichai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053840" MajorTopicYN="Y">Brugada Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="N">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Brugada syndrome</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter-defibrillator</Keyword><Keyword MajorTopicYN="N">Sudden death</Keyword><Keyword MajorTopicYN="N">Ventricular fibrillation</Keyword></KeywordList><CoiStatement>Disclosures Dr Nademanee receives a research grant and royalty from Biosense Webster Inc, and all other coauthors have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>29</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>19</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40294736</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2025.04.033</ArticleId><ArticleId IdType="pii">S1547-5271(25)02381-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39849420</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>The effect of anesthesia on postoperative cognitive dysfunction in adults undergoing cataract surgery: a systematic review.</ArticleTitle><Pagination><StartPage>35</StartPage><MedlinePgn>35</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">35</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-025-02897-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">We systematically reviewed the evidence on the effect of anesthetic methods and drugs on the incidence of postoperative cognitive dysfunction (POCD) after cataract surgery.</AbstractText><AbstractText Label="METHODS">The Web of Science, PubMed, and Scopus databases were searched for relevant English reports published from 2000 to August 2024. After full-text screening and checking the quality assessment of each article using the JBI checklist, 9 relevant articles were included in this study. The included articles were reviewed to explain how different anesthetic modalities and drugs may affect the incidence of POCD after cataract surgery. Our study aimed to systematically investigate the relationship between various methods of anesthesia and POCD for people undergoing cataract surgery.</AbstractText><AbstractText Label="RESULTS">We included 9 clinical trials with 1014 participants, which analyzed the incidence of POCD after anesthetic interventions. Four articles compared the effect of anesthetic modality interventions on POCD and five studies compared the effect of anesthetic drugs on POCD. The studies used various cognitive measurement scales, including the Mini-Mental State Examination, Neurobehavioral Rating Scale, Blessed Orientation-Memory-Concentration Test, Iowa Satisfaction with Anesthesia scale, PALT, and VF test. All articles that compared local and topical anesthesia found no statistically significant difference in the incidence of cognitive dysfunction at postop days 1 and 7. General anesthesia may cause POCD approximately twofold than local anesthesia. Ketamine, Midazolam, or Dexmedetomidine seemed to reduce postoperative cognitive complications compared to the control group&#x200c;&#x200c;.</AbstractText><AbstractText Label="CONCLUSIONS">This systematic review investigates how different anesthetic techniques and drugs may affect the incidence of POCD. The available literature is far from being conclusive and further studies are needed to reach any significant conclusions. It is necessary to adopt an appropriate anesthesia method for elderly and high-risk patients, especially people who have a history of cognitive problems&#x200c;&#x200c; undergoing elective cataract surgery, to reduce cognitive complications after surgery.&#x200c;.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Foroughi</LastName><ForeName>Elaheh</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brogi</LastName><ForeName>Etrusca</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroscience Intensive Care Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. etrusca.brogi@ospedaleniguarda.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forfori</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universita di Pisa, Medical, Molecular, and Critical Area Pathology, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashemi</LastName><ForeName>Seyyed Taghi</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Isfahan University of Medical Sciences, Isfahan, Iran. st_hashemi@med.mui.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002387" MajorTopicYN="Y">Cataract Extraction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079690" MajorTopicYN="Y">Postoperative Cognitive Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Anesthetic modalities</Keyword><Keyword MajorTopicYN="N">Cataract surgery</Keyword><Keyword MajorTopicYN="N">Cognition complications</Keyword><Keyword MajorTopicYN="N">Postoperative cognitive dysfunction (POCD)</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: IRB Information: not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>24</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39849420</ArticleId><ArticleId IdType="pmc">PMC11755816</ArticleId><ArticleId IdType="doi">10.1186/s12871-025-02897-3</ArticleId><ArticleId IdType="pii">10.1186/s12871-025-02897-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Urits I, Orhurhu V, Jones M, Hoyt D, Seats A,Viswanath OJTjoa, et al. Current perspectives on postoperative cognitive dysfunction in the ageing population. 2019;47(6):439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6886822</ArticleId><ArticleId IdType="pubmed">31828240</ArticleId></ArticleIdList></Reference><Reference><Citation>Poorzamany Nejat Kermany M, Dahi M, Yamini Sharif R, Radpay B. Comparison of the effects of dexmedetomidine and remifentanil on cognition state after cataract surgery. Anesth Pain Med. 2016;6(3):e33448. 10.5812/aapm.33448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018133</ArticleId><ArticleId IdType="pubmed">27642574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S-H, Ji M-H, Gao D-P, Li W-Y. Yang J-JJUjoms. Association between perioperative blood transfusion and early postoperative cognitive dysfunction in aged patients following total hip replacement surgery. 2014;119(3):262&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4116766</ArticleId><ArticleId IdType="pubmed">24345210</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Gara BP, Mueller A, Gasangwa DVI, Patxot M, Shaefi S, Khabbaz K, Banner-Goodspeed V, Pascal-Leone A, Marcantonio ER, Subramaniam B. Prevention of Early Postoperative Decline: A Randomized, Controlled Feasibility Trial of Perioperative Cognitive Training. Anesth Analg. 2020;130(3):586&#x2013;95. 10.1213/ANE.0000000000004469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154961</ArticleId><ArticleId IdType="pubmed">31569161</ArticleId></ArticleIdList></Reference><Reference><Citation>Li WX, Luo RY, Chen C, Li X, Ao JS, Liu Y, Yin YQ. Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: a randomized controlled preliminary trial. Chin Med J (Engl). 2019;132(4):437-45. 10.1097/CM9.0000000000000098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6595716</ArticleId><ArticleId IdType="pubmed">30707179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancelin M-L, DeRoquefeuil G, Scali J, Bonnel F, Adam J-F, Cheminal J-C, et al. Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents. 2010;22(s3):S105&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078520</ArticleId><ArticleId IdType="pubmed">20858969</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Lu W, Jiang X, Xiong C, Chai H, Cai L, et al. Current progress on neuroinflammation-mediated postoperative cognitive dysfunction: an update. 2023;23(10):1077&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">36411553</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges J, Moreira J, Moreira A, Santos A. Abelha FJJRBdA. Impact of postoperative cognitive decline in quality of life: a prospective study. 2017;67(4):362&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28412051</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK. Delirium in older persons. N Engl J Med. 2006;354(11):1157-65. 10.1056/NEJMra052321. Erratum in: N Engl J Med. 2006;354(15):1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">16540616</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiner S, Silverstein JH. Postoperative delirium and cognitive dysfunction. Br J Anaesth. 2009;103 Suppl 1(Suppl 1):i41-46. 10.1093/bja/aep291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791855</ArticleId><ArticleId IdType="pubmed">20007989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall TA, McGwin G Jr. Owsley CJJotAGS. Effect of cataract surgery on cognitive function in older adults. 2005;53(12):2140&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16398899</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorofeeva GJMP. The influence of the chosen method of anesthesia on the severity of postoperative cognitive dysfunction in patients with ophthalmic surgery. 2021;26(1):122.</Citation></Reference><Reference><Citation>Smith GT, Chen TJ, Shah NM, Agrest B. Grotticelli JJFiA. Anesthesia-mediated neuroinflammatory sequelae in post operative cognitive dysfunction: mechanisms and therapeutic implications. 2024;3:1281034.</Citation></Reference><Reference><Citation>Karhunen U, J&#xf6;nn G. A comparison of memory function following local and general anaesthesia for extraction of senile cataract. Acta Anaesthesiol Scand. 1982;26(4):291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7124302</ArticleId></ArticleIdList></Reference><Reference><Citation>Naghibi K, Shafa A, Hirmanpour A. Sabaghi BJJoIMS. The impact of general anesthesia vs local anesthesia with intravenous sedation on the incidence of postoperative cognitive dysfunction after cataract surgery in elderly patients. 2016;34(372):134&#x2013;42.</Citation></Reference><Reference><Citation>Zhang Y, Shan G-J, Zhang Y-X, Cao S-J, Zhu S-N, Li H-J, et al. Propofol compared with sevoflurane general anaesthesia is associated with decreased delayed neurocognitive recovery in older adults. 2018;121(3):595&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">30115258</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathy W, Hussein M, Khalil H. Comparative effect of local anesthesia with lidocaine 2% versus topical anesthesia on cognitive function in ophthalmic surgery. Anesthesiol Pain Med. 2019;9(6):e97172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118683</ArticleId><ArticleId IdType="pubmed">32280618</ArticleId></ArticleIdList></Reference><Reference><Citation>Oriby ME, Elrashidy AA, Elsharkawy A, Ahmed SA. Effects of ketamine or dexmedetomidine on postoperative cognitive dysfunction after cataract surgery: A randomized controlled trial. Indian J Anaesth. 2023;67(2):186&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10121090</ArticleId><ArticleId IdType="pubmed">37091455</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#x131;l&#x131;&#xe7; Y, Bilge&#xe7; MD, Sar&#x131;o&#x11f;lan BT, Kayhan GE, G&#xfc;le&#xe7; MS, &#xd6;zer AJEMJ. Impact of topical and local anesthesia on postoperative cognitive functions in geriatrics undergoing cataract surgery. 2021;111&#x2013;7.</Citation></Reference><Reference><Citation>Elsaid MA. Elgazar AFJTSJoMS. Ketamine versus Dexmedetomidine for Postoperative Cognitive Dysfunction after Cataract Surgery: A retrospective Study. 2021;2021(1):23&#x2013;8.</Citation></Reference><Reference><Citation>K&#x131;l&#x131;&#xe7; Y, Bilge&#xe7; M, Sar&#x131;o&#x11f;lan B, Kayhan GE, G&#xfc;le&#xe7; M,&#xd6;zer AJJoS, et al. Role of anesthesia type on cognitive functions in adults undergoing cataract surgery. 2020;4(12):1112&#x2013;5.</Citation></Reference><Reference><Citation>Mansouri N, Nasrollahi K, Shetabi H. Prevention of Cognitive Dysfunction after Cataract Surgery with Intravenous Administration of Midazolam and Dexmedetomidine in Elderly Patients Undergoing Cataract Surgery. Adv Biomed Res. 2019;8(1):6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6385669</ArticleId><ArticleId IdType="pubmed">30820427</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathy W, Hussein M, Khalil H. Effect of local anesthesia (with lidocaine vs bupivacaine) on cognitive function in patients undergoing elective cataract surgery. Local Reg Anesth. 2018;12:1-6. 10.2147/LRA.S185367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6318706</ArticleId><ArticleId IdType="pubmed">30643450</ArticleId></ArticleIdList></Reference><Reference><Citation>Naghibi K, Shetabi H, Nasrollahi K. Mansouri NJJoIMS. The effect of intravenous midazolam and dexmedetomidine on prevention of cognitive dysfunction after cataract surgery in the elderly patients under general anesthesia compared with the control group. 2018;36(504):1395&#x2013;400.</Citation></Reference><Reference><Citation>Askarianfard N, Nasrollahi K, Shetabi H. Naghibi KJJoIMS. A Comparative Study of the Effects of Two Different Levels of End-Tidal Carbon Dioxide Pressure on Cognitive Dysfunction in Elderly Patients, after Cataract Surgery under General Anesthesia. 2019;37(533):747&#x2013;53.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, medicine PGJAoi. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. World Alzheimer Report 2015. The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends: Alzheimer&#x2019;s Disease International; 2015.</Citation></Reference><Reference><Citation>Suraarunsumrit P, Srinonprasert V, Kongmalai T, Suratewat S, Chaikledkaew U, Rattanasiri S, et al. Outcomes associated with postoperative cognitive dysfunction: a systematic review and meta-analysis. 2024;53(7):afae160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11277860</ArticleId><ArticleId IdType="pubmed">39058915</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P, Blumenthal J, Hoffman B, Davis RD. Palmer SJAJoT. Postoperative cognitive dysfunction and mortality following lung transplantation. 2018;18(3):696&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5820215</ArticleId><ArticleId IdType="pubmed">29087035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zywiel MG, Prabhu A, Perruccio AV, Gandhi RJCO. Research&#xae; R. The influence of anesthesia and pain management on cognitive dysfunction after joint arthroplasty: a systematic review. 2014;472:1453&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3971229</ArticleId><ArticleId IdType="pubmed">24186470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Basu M, Kirtania J, Sarbapalli D, Pal R, Kar S, et al. Impact of general versus epidural anesthesia on early post-operative cognitive dysfunction following hip and knee surgery. 2011;4(1):23&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3097574</ArticleId><ArticleId IdType="pubmed">21633563</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason SE, Noel-Storr A. Ritchie CWJJoAsD. The impact of general and regional anesthesia on the incidence of post-operative cognitive dysfunction and post-operative delirium: a systematic review with meta-analysis. 2010;22(s3):S67&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">20858956</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Liu L, Zhao B, Wang Y, Yu S, Wang HJJCPSP. Effect of general and non-general anesthesia on postoperative cognitive dysfunction. 2020;30(4):407&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32513362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudetz J, Iqbal Z, Gandhi S, Patterson K, Byrne A, Hudetz A, et al. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. 2009;53(7):864&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">19422355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou N, Chen C, Liu Y, Yu Z, Chen Y. Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis. Ther Adv Psychopharmacol. 2023;13:20451253231200260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10617260</ArticleId><ArticleId IdType="pubmed">37915364</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasc&#xf3;n-Mart&#xed;nez DM, Fres&#xe1;n-Orellana A, Ochar&#xe1;n-Hern&#xe1;ndez ME, Genis-Zarate JH, Castellanos-Olivares AJA. Analgesia. The effects of ketamine on cognitive function in elderly patients undergoing ophthalmic surgery: a pilot study. 2016;122(4):969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">26771268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell RFJP. Ketamine for chronic non-cancer pain. 2009;141(3):210&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19128879</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Xu S, Zhang Y, Huang YJB. Behavior. Effects of anesthetic adjunctive agents on postoperative cognitive dysfunction in elderly patients undergoing noncardiac surgery: A Bayesian network meta-analysis. 2023;13(8): e3149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10454282</ArticleId><ArticleId IdType="pubmed">37431799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamperti M, Romero CS, Guarracino F, Cammarota G, Vetrugno L, Tufegdzic B, et al. Preoperative assessment of adults undergoing elective noncardiac surgery: Updated guidelines from the European Society of Anaesthesiology and Intensive Care. 2025;42(1):1&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">39492705</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecorella G, De Rosa F, Licchelli M, Panese G, Carugno JT, Morciano A, et al. Postoperative cognitive disorders and delirium in gynecologic surgery: Which surgery and anesthetic techniques to use to reduce the risk? 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38557928</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaput AJ. Bryson GLJCJoAJcda. Postoperative delirium: risk factors and management: continuing professional development. 2012;59(3):304&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">22311257</ArticleId></ArticleIdList></Reference><Reference><Citation>Contin A, Perez-Jara J, Alonso-Contin A, Enguix A, Ramos FJIjogp. Postoperative delirium after elective orthopedic surgery. 2005;20(6).</Citation><ArticleIdList><ArticleId IdType="pubmed">15962354</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31856983</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4502</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cataract and refractive surgery</Title><ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation></Journal><ArticleTitle>Long-term outcome of cataract surgery: 20-year results from a population-based prospective study.</ArticleTitle><Pagination><StartPage>1732</StartPage><EndPage>1737</EndPage><MedlinePgn>1732-1737</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2019.07.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0886-3350(19)30555-3</ELocationID><Abstract><AbstractText Label="PURPOSE">To report the longitudinal visual functional outcome after cataract surgery over 20 years.</AbstractText><AbstractText Label="SETTING">Eye clinic, Norrlands University Hospital, Sweden.</AbstractText><AbstractText Label="DESIGN">Prospective population-based cohort study.</AbstractText><AbstractText Label="METHODS">One hundred fourteen patients (86% of survivors) who had cataract surgery during a 1-year period (1997 to 1998) answered the same Visual Function Index-14 questionnaire (VF-14) preoperatively, 2 to 4&#xa0;months postoperatively, and at 5, 10, 15, and 20&#xa0;years after surgery. Most patients (100 [88%] of 114; 75% of survivors) also had a routine ocular examination, including corrected distance visual acuity (CDVA).</AbstractText><AbstractText Label="RESULTS">The mean age of the114 patients in the study was 60.6&#xa0;years (range 36 to 80&#xa0;years) at the time of surgery. Twenty years after surgery, the median CDVA in the operated eye had deteriorated from Snellen acuity 20/20 (logarithm of the minimum angle of resolution [logMAR] 0.0) postoperatively to 20/23 (logMAR 0.07) (P&#xa0;=&#xa0;.001). Patients aged 70&#xa0;years or older at surgery had the largest loss of CDVA at 20&#xa0;years compared with younger patients. At 20&#xa0;years, 63 (55%) of the 114 patients had no deterioration in subjective visual function and most patients (82 [72%]) had 10 points decline or less. Patients who were older at surgery had a more pronounced decline in VF-14 total score over 20&#xa0;years (P&#xa0;=&#xa0;.002). Fifty-six (58%) of 96 patients had never been treated for posterior capsule opacification.</AbstractText><AbstractText Label="CONCLUSIONS">This prospective 20-year follow-up study provided estimates of longitudinal visual results. Cataract surgery also offered excellent long-term visual rehabilitation for the majority, especially younger patients, after 20&#xa0;years, with a low requirement for Nd:YAG laser capsulotomy. The results in this study are of value for counseling younger patients with cataract and patients considering refractive lens surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xf6;nestam</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences/Ophthalmology, Faculty of Medicine, Ume&#xe5; University, Ume&#xe5;, Sweden. Electronic address: eva.monestam@regionvasterbotten.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cataract Refract Surg</MedlineTA><NlmUniqueID>8604171</NlmUniqueID><ISSNLinking>0886-3350</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002387" MajorTopicYN="N">Cataract Extraction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="Y">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="Y">Visual Acuity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31856983</ArticleId><ArticleId IdType="doi">10.1016/j.jcrs.2019.07.026</ArticleId><ArticleId IdType="pii">S0886-3350(19)30555-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38837212</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of orthopaedic trauma</Title><ISOAbbreviation>J Orthop Trauma</ISOAbbreviation></Journal><ArticleTitle>The Intermalleolar Method for Intraoperative Rotational Assessment of the Tibia-A Prospective Clinical Validation Study.</ArticleTitle><Pagination><StartPage>e245</StartPage><EndPage>e251</EndPage><MedlinePgn>e245-e251</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BOT.0000000000002819</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To determine the accuracy of the intermalleolar method, an intraoperative fluoroscopic method for assessing tibial rotation in patients undergoing intramedullary nail fixation for tibial shaft fractures, by comparing it with the gold standard computed tomography (CT).</AbstractText><AbstractText Label="DESIGN">Prospective cohort study.</AbstractText><AbstractText Label="SETTING">Academic Level 1 trauma center.</AbstractText><AbstractText Label="PATIENT SELECTION CRITERIA">Consecutive patients, aged 18 years and older, with unilateral tibial shaft fractures who underwent intramedullary fixation from September 2021 to January 2023.</AbstractText><AbstractText Label="OUTCOME MEASURES AND COMPARISONS">Intraoperatively, tibial rotation measurements were obtained using the intermalleolar method on both the uninjured and injured limbs. Postoperatively, patients underwent bilateral low-dose lower extremity rotational CT scans. CT measurements were made by 4 blinded observers. Mean absolute rotational differences and standard errors were calculated to compare the injured and uninjured limbs. Subgroup analysis was performed assessing accuracy relating to injured versus uninjured limbs, body mass index, OTA/AO fracture pattern, tibial and fibular fracture location, and distal articular fracture extension requiring fixation.</AbstractText><AbstractText Label="RESULTS">Of the 20 tibia fractures, the mean patient age was 43.4 years. The intermalleolar method had a mean absolute rotational difference of 5.1 degrees (standard error 0.6, range 0-13.7) compared with CT. Sixty percent (24/40) of the measurements were within 5 degrees, 90% (36/40) of the measurements were within 10 degrees, and 100% (40/40) were within 15 degrees of the CT. No patients were revised for malrotation postoperatively.</AbstractText><AbstractText Label="CONCLUSIONS">The intermalleolar method is accurate and consistently provides intraoperative tibial rotation measurements within 10 degrees of the mean CT measurement for adult patients undergoing intramedullary nail fixation for unilateral tibial shaft fractures. This method may be employed in the operating room to accurately quantify tibial rotation and assist with intraoperative rotational corrections.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-7495-9893</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine at The University of Vermont, Burlington, VT; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conroy</LastName><ForeName>Jordan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine at The University of Vermont, Burlington, VT; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeSarno</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Statistics, University of Vermont, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankstein</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine at The University of Vermont, Burlington, VT; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>Jesse C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine at The University of Vermont, Burlington, VT; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Craig S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine at The University of Vermont, Burlington, VT; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schottel</LastName><ForeName>Patrick C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine at The University of Vermont, Burlington, VT; and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OTA Grant ID#6259</GrantID><Agency>Orthopaedic Trauma Association</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Orthop Trauma</MedlineTA><NlmUniqueID>8807705</NlmUniqueID><ISSNLinking>0890-5339</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013978" MajorTopicYN="Y">Tibial Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005594" MajorTopicYN="Y">Fracture Fixation, Intramedullary</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005471" MajorTopicYN="N">Fluoroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012399" MajorTopicYN="N">Rotation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013977" MajorTopicYN="N">Tibia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>5</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>5</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>5</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38837212</ArticleId><ArticleId IdType="doi">10.1097/BOT.0000000000002819</ArticleId><ArticleId IdType="pii">00005131-202407000-00011</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Coles CP, Gross M. Closed tibial shaft fractures: management and treatment complications. A review of the prospective literature. Can J Surg. 2000;43:256&#x2013;262.</Citation></Reference><Reference><Citation>Littenberg B, Weinstein LP, McCarren M, et al. Closed fractures of the tibial shaft. A meta-analysis of three methods of treatment. J Bone Joint Surg Am. 1998;80:174&#x2013;183.</Citation></Reference><Reference><Citation>Puloski S, Romano C, Buckley R, et al. Rotational malalignment of the tibia following reamed intramedullary nail fixation. J Orthop Trauma. 2004;18:397&#x2013;402.</Citation></Reference><Reference><Citation>Say F, Bulbul M. Findings related to rotational malalignment in tibial fractures treated with reamed intramedullary nailing. Arch Orthop Trauma Surg. 2014;134:1381&#x2013;1386.</Citation></Reference><Reference><Citation>Jaarsma RL, Pakvis DFM, Verdonschot N, et al. Rotational malalignment after intramedullary nailing of femoral fractures. J Orthop Trauma. 2004;18:403&#x2013;409.</Citation></Reference><Reference><Citation>Theriault B, Turgeon AF, Pelet S. Functional impact of tibial malrotation following intramedullary nailing of tibial shaft fractures. J Bone Joint Surg Am. 2012;94:2033&#x2013;2039.</Citation></Reference><Reference><Citation>Clementz BG. Assessment of tibial torsion and rotational deformity with a new fluoroscopic technique. Clin Orthop Relat Res. 1989:199&#x2013;209.</Citation></Reference><Reference><Citation>Clementz BG, Magnusson A. Fluoroscopic measurement of tibial torsion in adults. A comparison of three methods. Arch Orthop Trauma Surg. 1989;108:150&#x2013;153.</Citation></Reference><Reference><Citation>Clementz BG, Magnusson A. Assessment of tibial torsion employing fluoroscopy, computed tomography and the cryosectioning technique. Acta Radiol. 1989;30:75&#x2013;80.</Citation></Reference><Reference><Citation>Larsson KBB, van der Linden W, Aittenberg B. A New Method for Measuring Tibio-Fibular Torsion. Sweden: Uppsala University; 1983.</Citation></Reference><Reference><Citation>Bleeker NJ, Doornberg JN, Duis KT, et al. Intraoperative fluoroscopic protocol to avoid rotational malalignment after nailing of tibia shaft fractures: introduction of the &#x2018;C-Arm Rotational View (CARV)&#x2019;. Eur J Trauma Emerg Surg. 2023;49:2329&#x2013;2336.</Citation></Reference><Reference><Citation>Eckardt HM, Morgenstern M, Cadosch D, et al. Fluoroscopic control of tibial torsion after intramedullary nailing: a technical trick. J Orthop Trauma. 2021;35:e507&#x2013;e510.</Citation></Reference><Reference><Citation>Roberts MS, Haimes MA, Vacek P, et al. A novel fluoroscopic method for assessing rotational malalignment of the tibia. J Orthop Trauma. 2022;36:e12&#x2013;e17.</Citation></Reference><Reference><Citation>Reikeras O, Hoiseth A. Torsion of the leg determined by computed tomography. Acta Orthop Scand. 1989;60:330&#x2013;333.</Citation></Reference><Reference><Citation>Court-Brown CM, Caesar B. Epidemiology of adult fractures: a review. Injury. 2006;37:691&#x2013;697.</Citation></Reference><Reference><Citation>Cain ME, Hendrickx LAM, Bleeker NJ, et al. Prevalence of rotational malalignment after intramedullary nailing of tibial shaft fractures: can we reliably use the contralateral uninjured side as the reference standard? J Bone Joint Surg Am. 2020;102:582&#x2013;591.</Citation></Reference><Reference><Citation>Jakob RP, Haertel M, Stussi E. Tibial torsion calculated by computerised tomography and compared to other methods of measurement. J Bone Joint Surg Br. 1980;62-B:238&#x2013;242.</Citation></Reference><Reference><Citation>Gallo MC, Tucker DW, Reddy A, et al. Large individual bilateral differences in tibial torsion impact accurate contralateral templating and the evaluation of rotational malalignment. J Orthop Trauma. 2021;35:e277&#x2013;e282.</Citation></Reference><Reference><Citation>Sayli U, B&#xf6;l&#xfc;kbasi S, Atik OS, et al. Determination of tibial torsion by computed tomography. J Foot Ankle Surg. 1994;33:144&#x2013;147.</Citation></Reference><Reference><Citation>Madadi F, Madadi F, Maleki A, et al. A new method for tibial torsion measurement by computerized tomography. J Orthop. 2016;13:43&#x2013;47.</Citation></Reference><Reference><Citation>Volkmar AJ, Stinner DJ, Pennings J, et al. Prevalence of individual differences in tibial torsion: a CT-based study. J Am Acad Orthop Surg. 2022;30:e199&#x2013;e203.</Citation></Reference><Reference><Citation>Purcell KF, Bergin PF, Russell GV, et al. Tibial shaft and pilon fractures with associated syndesmotic injury: a matched cohort assessment. J Orthop Trauma. 2022;36:157&#x2013;162.</Citation></Reference><Reference><Citation>Kagan BD, Roberts MS, Haimes MA, et al. Intraoperative comparative femoral rotation imaging: do not overlook parallax. J Orthop Trauma. 2022;36:420&#x2013;425.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15281529</PMID><DateCompleted><Year>2004</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-2999</ISSN><JournalIssue CitedMedium="Print"><Volume>99</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Ventilation with smaller tidal volumes: a quantitative systematic review of randomized controlled trials.</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>200</EndPage><MedlinePgn>193-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/01.ANE.0000118102.93688.97</ELocationID><Abstract><AbstractText>In this quantitative systematic review we assessed the effects of ventilation with smaller tidal volume (VT) on morbidity and mortality in patients aged 16 yr or older affected by acute lung injury and acute respiratory distress syndrome. Five randomized trials (1202 patients) comparing ventilation using smaller VT and/or low airway driving pressure (plateau pressure 30 cm H2O or less), resulting in VT of 7 mL/kg or less versus ventilation that uses VT in the range of 10 to 15 mL/kg, were identified after a systematic search of The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, databases of current research, reference lists, and "gray literature." Mortality at day 28 was significantly reduced by lung-protective ventilation (relative risk [RR], 0.74; confidence interval [CI], 0.61-0.88), whereas beneficial effect on long-term mortality was uncertain (RR, 0.84; CI, 0.68-1.05). The comparison between small and conventional VT was not significantly different if a plateau pressure less than or equal to 31 cm H2O in the control group was used (RR, 1.13; CI, 0.88-1.45). Clinical heterogeneity, such as different lengths of follow-up and higher plateau pressures in control arms in two trials, make the interpretation of the combined results difficult.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petrucci</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia &amp; Intensive Care, Azienda Ospedaliera Desenzano, Desenzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacovelli</LastName><ForeName>Walter</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="N">Lung Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>39</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>8</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15281529</ArticleId><ArticleId IdType="doi">10.1213/01.ANE.0000118102.93688.97</ArticleId><ArticleId IdType="pii">00000539-200407000-00039</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roupie E, Lepage E, Wysocki M, et al. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. Intensive Care Med 1999;25:920&#x2013;9.</Citation></Reference><Reference><Citation>Lewandowski K. Epidemiological data challenge ARDS/ALI. Intensive Care Med 1999;25:884&#x2013;6.</Citation></Reference><Reference><Citation>Davidson TA, Caldwell ES, Curtis JR. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999;281:354&#x2013;60.</Citation></Reference><Reference><Citation>Marini JJ. Lung mechanics in the adult respiratory distress syndrome. Clinical Chest Med 1990;11:673&#x2013;90.</Citation></Reference><Reference><Citation>Parker JC, Hernandez LA, Peevy KJ. Mechanism of ventilator induced lung injury. Crit Care Med 1993;21:131&#x2013;43.</Citation></Reference><Reference><Citation>Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume and positive end-expiratory pressure. Am Rev Respir Dis 1998;137:1159&#x2013;64.</Citation></Reference><Reference><Citation>Hickling KG, Henderson SJ, Jackson R. Low mortality associated with volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990;16:372&#x2013;7.</Citation></Reference><Reference><Citation>Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 1994;22:1568&#x2013;78.</Citation></Reference><Reference><Citation>Artigas A, Bernard GR, Carlet J. The American-European consensus conference on ARDS, part 2. Intensive Care Med 1998; 24:378&#x2013;98.</Citation></Reference><Reference><Citation>Roupie E, Dambrosio M, Servillo G, et al. Titration of tidal volume and induced hypercapnia in acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:121&#x2013;8.</Citation></Reference><Reference><Citation>Feihl F, Perret C. Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994;150:1722&#x2013;37.</Citation></Reference><Reference><Citation>Eichacker PQ, Gerstenberger EP, Banks SM, et al. Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002;166:1510&#x2013;4.</Citation></Reference><Reference><Citation>Steinbrook R. Trial design and patient safety. The debate continues. N Engl J Med 2003;349:620&#x2013;30.</Citation></Reference><Reference><Citation>Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818&#x2013;24.</Citation></Reference><Reference><Citation>Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720&#x2013;3.</Citation></Reference><Reference><Citation>Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986;7:267&#x2013;75.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539&#x2013;58.</Citation></Reference><Reference><Citation>Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, eds. Systematc reviews. London: BMJ books, 2001:285&#x2013;312.</Citation></Reference><Reference><Citation>Rappaport SH, Shpiner R, Yoshihara G, et al. Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med 1994;22:22&#x2013;32.</Citation></Reference><Reference><Citation>Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. JAMA 1999;282:54&#x2013;77.</Citation></Reference><Reference><Citation>Esteban A, Alia I, Gordo F, et al. Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS. Chest 2000;117:1690&#x2013;6.</Citation></Reference><Reference><Citation>Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338:347&#x2013;54.</Citation></Reference><Reference><Citation>Brochard L, Roudot-Thoraval F, Roupie E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:1831&#x2013;8.</Citation></Reference><Reference><Citation>Stewart TE, Meade MO, Cook DJ, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome: pressure and volume limited ventilation strategy group. N Engl J Med 1998;338:355&#x2013;61.</Citation></Reference><Reference><Citation>Brower RG, Shanholtz CB, Fessler HE, et al. Prospective, randomized controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999;27:1492&#x2013;8.</Citation></Reference><Reference><Citation>The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301&#x2013;8.</Citation></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818&#x2013;29.</Citation></Reference><Reference><Citation>Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619&#x2013;36.</Citation></Reference><Reference><Citation>Gattinoni L, Pelosi P, Crotti S, Valenza F. Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:1807&#x2013;14.</Citation></Reference><Reference><Citation>Ranieri VM, Mascia L, Fiore T, et al. Cardiorespiratory effects of positive end-expiratory pressure during progressive tidal volume reduction (permissive hypercapnia) in patients with acute respiratory distress syndrome. Anesthesiology 1995;83:710&#x2013;20.</Citation></Reference><Reference><Citation>Glasziou PP, Irwing LM. An evidence-based approach to individualising treatment. BMJ 1995;311:1356&#x2013;9.</Citation></Reference><Reference><Citation>Cooper AB, Ferguson ND, Hanly PJ, et al. Long-term follow up of survivors of acute lung injury: lack of effect of a ventilation strategy to prevent barotrauma. Crit Care Med 1999;27:2616&#x2013;21.</Citation></Reference><Reference><Citation>Orme J, Romney JS, Hopkins RO, et al. Pulmonary function and health related quality of life in survivors of ARDS. Am J Respir Crit Care Med 2003;167:690&#x2013;4.</Citation></Reference><Reference><Citation>Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. BMJ 313:735&#x2013;8.</Citation></Reference><Reference><Citation>Ranieri VM, Brienza N, Santostasi S, et al. Impairment of lung and chest wall mechanics in patients with acute respiratory distress syndrome: role of abdominal distension. Am J Respir Crit Care Med 1997;156:1082&#x2013;91.</Citation></Reference><Reference><Citation>Steinbrook R. How best to ventilate? N Engl J Med 2003;348:1393&#x2013;401.</Citation></Reference><Reference><Citation>Gattinoni L, Chiumello D, Russo R. Reduced tidal volumes and lung protective ventilatory strategies: where do we go from here? Curr Opin Crit Care 2002;8:45&#x2013;50.</Citation></Reference><Reference><Citation>Monchi M, Bellenfant F, Cariou A, et al. Early predictive factors of survival in the acute respiratory distress syndrome: a multivariate analysis. Am J Respir Crit Care Med 1998;158:1076&#x2013;81.</Citation></Reference><Reference><Citation>Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993;341:418&#x2013;22.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33784987</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Lung-protective mechanical ventilation for patients undergoing abdominal laparoscopic surgeries: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>95</StartPage><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">95</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-021-01318-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pneumoperitoneum and Trendelenburg position in laparoscopic surgeries could contribute to postoperative pulmonary dysfunction. In recent years, intraoperative lung-protective mechanical ventilation (LPV) has been reportedly able to attenuate ventilator-induced lung injuries (VILI). Our objectives were to test the hypothesis that LPV could improve intraoperative oxygenation function, pulmonary mechanics and early postoperative atelectasis in laparoscopic surgeries.</AbstractText><AbstractText Label="METHODS">In this randomized controlled clinical trial, 62 patients indicated for elective abdominal laparoscopic surgeries with an expected duration of greater than 2&#x2009;h were randomly assigned to receive either lung-protective ventilation (LPV) with a tidal volume (Vt) of 7&#x2009;ml&#x2009;kg<sup>-&#x2009;1</sup> ideal body weight (IBW), 10 cmH<sub>2</sub>O positive end-expiratory pressure (PEEP) combined with regular recruitment maneuvers (RMs) or conventional ventilation (CV) with a Vt of 10&#x2009;ml&#x2009;kg<sup>-&#x2009;1</sup> IBW, 0 cmH<sub>2</sub>O in PEEP and no RMs. The primary endpoints were the changes in the ratio of PaO<sub>2</sub> to FiO<sub>2</sub> (P/F). The secondary endpoints were the differences between the two groups in PaO<sub>2</sub>, alveolar-arterial oxygen gradient (A-aO<sub>2</sub>), intraoperative pulmonary mechanics and the incidence of atelectasis detected on chest x-ray on the first postoperative day.</AbstractText><AbstractText Label="RESULTS">In comparison to CV group, the intraoperative P/F and PaO<sub>2</sub> in LPV group were significantly higher while the intraoperative A-aO<sub>2</sub> was clearly lower. C<sub>dyn</sub> and C<sub>stat</sub> at all the intraoperative time points in LPV group were significantly higher compared to CV group (p&#x2009;&lt;&#x2009;0.05). There were no differences in the incidence of atelectasis on day one after surgery between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS">Lung protective mechanical ventilation significantly improved intraoperative pulmonary oxygenation function and pulmonary compliance in patients experiencing various abdominal laparoscopic surgeries, but it could not ameliorate early postoperative atelectasis and oxygenation function on the first day after surgery.</AbstractText><AbstractText Label="TRIAL REGISTRATION">https://www.clinicaltrials.gov/identifier: NCT04546932 (09/05/2020).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Trung Kien</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0002-2451-5397</Identifier><AffiliationInfo><Affiliation>Center of Emergency, Critical Care Medicine and Clinical Toxicology, 103 Military Hospital, Vietnam Military Medical University, 261 Phung Hung road, Ha Dong District, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Viet Luong</ForeName><Initials>VL</Initials><Identifier Source="ORCID">0000-0003-1456-8177</Identifier><AffiliationInfo><Affiliation>Critical Care Unit, National Burn Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Truong Giang</ForeName><Initials>TG</Initials><Identifier Source="ORCID">0000-0002-0166-0778</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic surgery, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>Duc Hanh</ForeName><Initials>DH</Initials><Identifier Source="ORCID">0000-0002-4912-5088</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Ngoc Quynh</ForeName><Initials>NQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, Vietnam National Cancer Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>The Anh</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0002-6748-720X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam. qy.theanh@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Anh Nguyet</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0003-3976-6399</Identifier><AffiliationInfo><Affiliation>Department of Urology, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Quang Huy</ForeName><Initials>QH</Initials><Identifier Source="ORCID">0000-0001-7008-8229</Identifier><AffiliationInfo><Affiliation>Center of Emergency, Critical Care Medicine and Clinical Toxicology, 103 Military Hospital, Vietnam Military Medical University, 261 Phung Hung road, Ha Dong District, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Chi Tue</ForeName><Initials>CT</Initials><Identifier Source="ORCID">0000-0001-9817-1219</Identifier><AffiliationInfo><Affiliation>Center of Emergency, Critical Care Medicine and Clinical Toxicology, 103 Military Hospital, Vietnam Military Medical University, 261 Phung Hung road, Ha Dong District, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Dang Thu</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04546932</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001261" MajorTopicYN="N">Pulmonary Atelectasis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055397" MajorTopicYN="N">Ventilator-Induced Lung Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Low tidal volume</Keyword><Keyword MajorTopicYN="N">Lung-protective ventilation</Keyword><Keyword MajorTopicYN="N">Positive end-expiratory pressure</Keyword><Keyword MajorTopicYN="N">Recruitment maneuvers</Keyword></KeywordList><CoiStatement>No author has any conflict of interest regarding the publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33784987</ArticleId><ArticleId IdType="pmc">PMC8008676</ArticleId><ArticleId IdType="doi">10.1186/s12871-021-01318-5</ArticleId><ArticleId IdType="pii">10.1186/s12871-021-01318-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duggan M, Kavanagh BP. Pulmonary atelectasis: a pathogenic perioperative entity. Anesthesiology. 2005;102(4):838&#x2013;854. doi: 10.1097/00000542-200504000-00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200504000-00021</ArticleId><ArticleId IdType="pubmed">15791115</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson L, Spahn DR. New concepts of atelectasis during general anaesthesia. Br J Anaesth. 2003;91(1):61&#x2013;72. doi: 10.1093/bja/aeg085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeg085</ArticleId><ArticleId IdType="pubmed">12821566</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso S, Terragni P, Mascia L, Fanelli V, Quintel M, Herrmann P, et al. Airway pressure-time curve profile (stress index) detects tidal recruitment/hyperinflation in experimental acute lung injury. Crit Care Med. 2004;32(4):1018&#x2013;1027. doi: 10.1097/01.CCM.0000120059.94009.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000120059.94009.AD</ArticleId><ArticleId IdType="pubmed">15071395</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedenstierna G, Edmark L. The effects of anesthesia and muscle paralysis on the respiratory system. Intensive Care Med. 2005;31(10):1327&#x2013;1335. doi: 10.1007/s00134-005-2761-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2761-7</ArticleId><ArticleId IdType="pubmed">16132894</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, et al. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009;111(5):979&#x2013;987. doi: 10.1097/ALN.0b013e3181b87edb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181b87edb</ArticleId><ArticleId IdType="pubmed">19809292</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi G, Wolthuis EK, Bresser P, Levi M, van der Poll T, Dzoljic M, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology. 2006;105(4):689&#x2013;695. doi: 10.1097/00000542-200610000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200610000-00013</ArticleId><ArticleId IdType="pubmed">17006066</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolthuis EK, Choi G, Dessing MC, Bresser P, Lutter R, Dzoljic M, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology. 2008;108(1):46&#x2013;54. doi: 10.1097/01.anes.0000296068.80921.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000296068.80921.10</ArticleId><ArticleId IdType="pubmed">18156881</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusman G, Bohm SH, Warner DO, Sprung J. Atelectasis and perioperative pulmonary complications in high-risk patients. Curr Opin Anaesthesiol. 2012;25(1):1&#x2013;10. doi: 10.1097/ACO.0b013e32834dd1eb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e32834dd1eb</ArticleId><ArticleId IdType="pubmed">22113182</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaber S, Coisel Y, Chanques G, Futier E, Constantin JM, Michelet P, et al. A multicentre observational study of intra-operative ventilatory management during general anaesthesia: tidal volumes and relation to body weight. Anaesthesia. 2012;67(9):999&#x2013;1008. doi: 10.1111/j.1365-2044.2012.07218.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2012.07218.x</ArticleId><ArticleId IdType="pubmed">22708696</ArticleId></ArticleIdList></Reference><Reference><Citation>Haliloglu M, Bilgili B, Ozdemir M, Umuroglu T, Bakan N. Low tidal volume positive end-expiratory pressure versus high tidal volume zero-positive end-expiratory pressure and postoperative pulmonary functions in robot-assisted laparoscopic radical prostatectomy. Med Princ Pract. 2017;26(6):573&#x2013;578. doi: 10.1159/000484693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484693</ArticleId><ArticleId IdType="pmc">PMC5848477</ArticleId><ArticleId IdType="pubmed">29131002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen JK, Anthony DG, Li L, Wheeler D, Sessler DI, Bashour CA. Comparison of positive end-expiratory pressure of 8 versus 5 cm H2O on outcome after cardiac operations. J Intensive Care Med. 2015;30(6):338&#x2013;343. doi: 10.1177/0885066613519571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066613519571</ArticleId><ArticleId IdType="pubmed">24488037</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Miranda D, Gommers D, Struijs A, Dekker R, Mekel J, Feelders R, et al. Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg. 2005;28(6):889&#x2013;895. doi: 10.1016/j.ejcts.2005.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.10.007</ArticleId><ArticleId IdType="pubmed">16271479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusman G, Bohm SH, Suarez-Sipmann F, Turchetto E. Alveolar recruitment improves ventilatory efficiency of the lungs during anesthesia. Can J Anaesth. 2004;51(7):723&#x2013;727. doi: 10.1007/BF03018433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03018433</ArticleId><ArticleId IdType="pubmed">15310643</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428&#x2013;437. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Maracaja-Neto LF, Vercosa N, Roncally AC, Giannella A, Bozza FA, Lessa MA. Beneficial effects of high positive end-expiratory pressure in lung respiratory mechanics during laparoscopic surgery. Acta Anaesthesiol Scand. 2009;53(2):210&#x2013;217. doi: 10.1111/j.1399-6576.2008.01826.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2008.01826.x</ArticleId><ArticleId IdType="pubmed">19175578</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Ravagnan I, Giurati G, Panigada M, Bottino N, Tredici S, et al. Positive end-expiratory pressure improves respiratory function in obese but not in normal subjects during anesthesia and paralysis. Anesthesiology. 1999;91(5):1221&#x2013;1231. doi: 10.1097/00000542-199911000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199911000-00011</ArticleId><ArticleId IdType="pubmed">10551570</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinnella G, Grasso S, Spadaro S, Rauseo M, Mirabella L, Salatto P, et al. Effects of recruitment maneuver and positive end-expiratory pressure on respiratory mechanics and transpulmonary pressure during laparoscopic surgery. Anesthesiology. 2013;118(1):114&#x2013;122. doi: 10.1097/ALN.0b013e3182746a10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182746a10</ArticleId><ArticleId IdType="pubmed">23196259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouadma L, Dreyfuss D, Ricard JD, Martet G, Saumon G. Mechanical ventilation and hemorrhagic shock-resuscitation interact to increase inflammatory cytokine release in rats. Crit Care Med. 2007;35(11):2601&#x2013;2606. doi: 10.1097/01.CCM.0000286398.78243.CE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000286398.78243.CE</ArticleId><ArticleId IdType="pubmed">17828032</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsten J, Luepschen H, Grossherr M, Bruch HP, Leonhardt S, Gehring H, et al. Effect of PEEP on regional ventilation during laparoscopic surgery monitored by electrical impedance tomography. Acta Anaesthesiol Scand. 2011;55(7):878&#x2013;886. doi: 10.1111/j.1399-6576.2011.02467.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2011.02467.x</ArticleId><ArticleId IdType="pubmed">21658014</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009;37(9):2642&#x2013;2647. doi: 10.1097/CCM.0b013e3181a590da.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181a590da</ArticleId><ArticleId IdType="pubmed">19602972</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Le Manach Y, Hofer CK, Goarin JP, Lehot JJ, Vallet B, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a &#x201c;gray zone&#x201d; approach. Anesthesiology. 2011;115(2):231&#x2013;241. doi: 10.1097/ALN.0b013e318225b80a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318225b80a</ArticleId><ArticleId IdType="pubmed">21705869</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, de Courson H, Lanchon R, Pereira B, Bardonneau G, Griton M, et al. Mini-fluid challenge of 100 ml of crystalloid predicts fluid responsiveness in the operating room. Anesthesiology. 2017;127(3):450&#x2013;456. doi: 10.1097/ALN.0000000000001753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001753</ArticleId><ArticleId IdType="pubmed">28640019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu AL, Cai XZ, Gao XJ, Zhang ZW, Ma ZS, Ma LL, et al. Determinants of immediate extubation in the operating room after total thoracoscopic closure of congenital heart defects. Med Princ Pract. 2013;22(3):234&#x2013;238. doi: 10.1159/000345844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000345844</ArticleId><ArticleId IdType="pmc">PMC5586751</ArticleId><ArticleId IdType="pubmed">23296121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung J, Whalen FX, Comfere T, Bosnjak ZJ, Bajzer Z, Gajic O, et al. Alveolar recruitment and arterial desflurane concentration during bariatric surgery. Anesth Analg. 2009;108(1):120&#x2013;127. doi: 10.1213/ane.0b013e31818db6c7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e31818db6c7</ArticleId><ArticleId IdType="pubmed">19095839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YH. Randomised controlled trials (RCTs)--sample size: the magic number? Singap Med J. 2003;44(4):172&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">12952027</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi X, Cui Y, Wang C, Guo L, Sun B, Shi J, et al. Low tidal volume with PEEP and recruitment expedite the recovery of pulmonary function. Int J Clin Exp Pathol. 2015;8(11):14305&#x2013;14314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4713532</ArticleId><ArticleId IdType="pubmed">26823746</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung J, Whalley DG, Falcone T, Wilks W, Navratil JE, Bourke DL. The effects of tidal volume and respiratory rate on oxygenation and respiratory mechanics during laparoscopy in morbidly obese patients. Anesth Analg. 2003;97(1):268&#x2013;274. doi: 10.1213/01.ANE.0000067409.33495.1F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000067409.33495.1F</ArticleId><ArticleId IdType="pubmed">12818980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung J, Whalley DG, Falcone T, Warner DO, Hubmayr RD, Hammel J. The impact of morbid obesity, pneumoperitoneum, and posture on respiratory system mechanics and oxygenation during laparoscopy. Anesth Analg. 2002;94(5):1345&#x2013;1350. doi: 10.1097/00000539-200205000-00056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200205000-00056</ArticleId><ArticleId IdType="pubmed">11973218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazebroek EJ, Haitsma JJ, Lachmann B, Bonjer HJ. Mechanical ventilation with positive end-expiratory pressure preserves arterial oxygenation during prolonged pneumoperitoneum. Surg Endosc. 2002;16(4):685&#x2013;689. doi: 10.1007/s00464-001-8174-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-001-8174-y</ArticleId><ArticleId IdType="pubmed">11972215</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusman G, Bohm SH, De Anda GV, do Campo JL, Lachmann B. &#x2018;Alveolar recruitment strategy&#x2019; improves arterial oxygenation during general anaesthesia. Br J Anaesth. 1999;82(1):8&#x2013;13. doi: 10.1093/bja/82.1.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/82.1.8</ArticleId><ArticleId IdType="pubmed">10325828</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang CK, Yap J, Chen PP. The effect of an alveolar recruitment strategy on oxygenation during laparascopic cholecystectomy. Anaesth Intensive Care. 2003;31(2):176&#x2013;180. doi: 10.1177/0310057X0303100206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X0303100206</ArticleId><ArticleId IdType="pubmed">12712781</ArticleId></ArticleIdList></Reference><Reference><Citation>Whalen FX, Gajic O, Thompson GB, Kendrick ML, Que FL, Williams BA, et al. The effects of the alveolar recruitment maneuver and positive end-expiratory pressure on arterial oxygenation during laparoscopic bariatric surgery. Anesth Analg. 2006;102(1):298&#x2013;305. doi: 10.1213/01.ane.0000183655.57275.7a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000183655.57275.7a</ArticleId><ArticleId IdType="pubmed">16368847</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SJ. In: AS. T. Advances in respiratory life support. Hoyt JW, editor. Philadelphia: WB Saunders; 1991.</Citation></Reference><Reference><Citation>Liu J, Meng Z, Lv R, Zhang Y, Wang G, Xie J. Effect of intraoperative lung-protective mechanical ventilation on pulmonary oxygenation function and postoperative pulmonary complications after laparoscopic radical gastrectomy. Braz J Med Biol Res. 2019;52(6):e8523. doi: 10.1590/1414-431x20198523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431x20198523</ArticleId><ArticleId IdType="pmc">PMC6556971</ArticleId><ArticleId IdType="pubmed">31166383</ArticleId></ArticleIdList></Reference><Reference><Citation>Feihl F, Perret C. Permissive hypercapnia. How permissive should we be? Am J Respir Crit Care Med. 1994;150(6 Pt 1):1722&#x2013;1737. doi: 10.1164/ajrccm.150.6.7952641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.150.6.7952641</ArticleId><ArticleId IdType="pubmed">7952641</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenza F, Chevallard G, Fossali T, Salice V, Pizzocri M, Gattinoni L. Management of mechanical ventilation during laparoscopic surgery. Best Pract Res Clin Anaesthesiol. 2010;24(2):227&#x2013;241. doi: 10.1016/j.bpa.2010.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2010.02.002</ArticleId><ArticleId IdType="pubmed">20608559</ArticleId></ArticleIdList></Reference><Reference><Citation>Strang CM, Hachenberg T, Freden F, Hedenstierna G. Development of atelectasis and arterial to end-tidal PCO2-difference in a porcine model of pneumoperitoneum. Br J Anaesth. 2009;103(2):298&#x2013;303. doi: 10.1093/bja/aep102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep102</ArticleId><ArticleId IdType="pubmed">19443420</ArticleId></ArticleIdList></Reference><Reference><Citation>Perilli V, Sollazzi L, Bozza P, Modesti C, Chierichini A, Tacchino RM, et al. The effects of the reverse trendelenburg position on respiratory mechanics and blood gases in morbidly obese patients during bariatric surgery. Anesth Analg. 2000;91(6):1520&#x2013;1525. doi: 10.1097/00000539-200012000-00041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200012000-00041</ArticleId><ArticleId IdType="pubmed">11094011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong CM, Xu DZ, Lu Q, Cheng Y, Pisarenko V, Doucet D, et al. Low tidal volume and high positive end-expiratory pressure mechanical ventilation results in increased inflammation and ventilator-associated lung injury in normal lungs. Anesth Analg. 2010;110(6):1652&#x2013;1660. doi: 10.1213/ANE.0b013e3181cfc416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181cfc416</ArticleId><ArticleId IdType="pubmed">20103541</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Duggal NM, Likosky DS, Haft JW, Douville NJ, Vaughn MT, et al. Intraoperative mechanical ventilation and postoperative pulmonary complications after cardiac surgery. Anesthesiology. 2019;131(5):1046&#x2013;1062. doi: 10.1097/ALN.0000000000002909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002909</ArticleId><ArticleId IdType="pmc">PMC6800803</ArticleId><ArticleId IdType="pubmed">31403976</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundquist H, Hedenstierna G, Strandberg A, Tokics L, Brismar B. CT-assessment of dependent lung densities in man during general anaesthesia. Acta Radiol. 1995;36(6):626&#x2013;632. doi: 10.3109/02841859509176761.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02841859509176761</ArticleId><ArticleId IdType="pubmed">8519574</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Goldner M, McKibben A, Adams A, Eccher G, Caironi P, et al. Recruitment and derecruitment during acute respiratory failure: an experimental study. Am J Respir Crit Care Med. 2001;164(1):122&#x2013;130. doi: 10.1164/ajrccm.164.1.2007010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.164.1.2007010</ArticleId><ArticleId IdType="pubmed">11435250</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce CJ, Williams AB. Kinetics of absorption atelectasis during anesthesia: a mathematical model. J Appl Physiol (1985) 1999;86(4):1116&#x2013;1125. doi: 10.1152/jappl.1999.86.4.1116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1999.86.4.1116</ArticleId><ArticleId IdType="pubmed">10194192</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothen HU, Sporre B, Engberg G, Wegenius G, Hogman M, Hedenstierna G. Influence of gas composition on recurrence of atelectasis after a reexpansion maneuver during general anesthesia. Anesthesiology. 1995;82(4):832&#x2013;842. doi: 10.1097/00000542-199504000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199504000-00004</ArticleId><ArticleId IdType="pubmed">7717553</ArticleId></ArticleIdList></Reference><Reference><Citation>Juno J, Marsh HM, Knopp TJ, Rehder K. Closing capacity in awake and anesthetized-paralyzed man. J Appl Physiol Respir Environ Exerc Physiol. 1978;44(2):238&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">632164</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, Gong H, Zhang L, Wang Y, Tian Y. Effect of low tidal volume ventilation on atelectasis in patients during general anesthesia: a computed tomographic scan. J Clin Anesth. 2007;19(2):125&#x2013;129. doi: 10.1016/j.jclinane.2006.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2006.08.008</ArticleId><ArticleId IdType="pubmed">17379125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusca M, Proietti S, Schnyder P, Frascarolo P, Hedenstierna G, Spahn DR, et al. Prevention of atelectasis formation during induction of general anesthesia. Anesth Analg. 2003;97(6):1835&#x2013;1839. doi: 10.1213/01.ANE.0000087042.02266.F6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000087042.02266.F6</ArticleId><ArticleId IdType="pubmed">14633570</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh D, Kurosawa S, Kirino W, Wagatsuma T, Ejima Y, Yoshida A, et al. Impact of changes of positive end-expiratory pressure on functional residual capacity at low tidal volume ventilation during general anesthesia. J Anesth. 2012;26(5):664&#x2013;669. doi: 10.1007/s00540-012-1411-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-012-1411-9</ArticleId><ArticleId IdType="pmc">PMC3468745</ArticleId><ArticleId IdType="pubmed">22584817</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Guttmann J, Moller K. Adaptive SLICE method: an enhanced method to determine nonlinear dynamic respiratory system mechanics. Physiol Meas. 2012;33(1):51&#x2013;64. doi: 10.1088/0967-3334/33/1/51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0967-3334/33/1/51</ArticleId><ArticleId IdType="pubmed">22155927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregoretti C, Pelosi P. A physiologically oriented approach to the perioperative period: the role of the anaesthesiologist. Best Pract Res Clin Anaesthesiol. 2010;24(2):vii&#x2013;viii. doi: 10.1016/j.bpa.2010.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2010.03.001</ArticleId><ArticleId IdType="pubmed">20608552</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33179155</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>First-line ablation of ventricular tachycardia in ischemic cardiomyopathy: stratification of outcomes by left ventricular function.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>400</EndPage><MedlinePgn>391-400</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-020-00912-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">First-line catheter ablation of ventricular tachycardia/ventricular fibrillation (VT/VF) in patients with ischemic cardiomyopathy (ICM) has been associated with improved outcomes; however, most benefit seems to be in patients with moderately depressed left ventricular ejection fraction (LVEF). Herein, outcomes were stratified based on LVEF.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A meta-analysis of randomized controlled trials (RCTs) evaluating first-line ablation versus medical therapy in patients with VT and ICM was performed. Risk estimates and 95% confidence intervals (CI) were measured.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four RCTs with a total of 505 patients (mean age 66&#x2009;&#xb1;&#x2009;9&#xa0;years, 89% male, 80% with previous revascularization) were included. Mean LVEF was 35&#x2009;&#xb1;&#x2009;8%. At a mean follow-up of 24&#x2009;&#xb1;&#x2009;9&#xa0;months, a significant benefit in survival-free from appropriate implantable cardioverter-defibrillator (ICD) therapies was observed in all patients undergoing first-line catheter ablation compared with medical management (RR 0.70, 95% CI 0.56-0.86). In patients with moderately depressed LVEF (&gt;&#x2009;30-50%), first-line VT ablation was associated with a statistically significant reduction in the composite endpoint of survival free from VT/VF and appropriate ICD therapies (HR 0.52, 95% CI 0.36-0.76), whereas there was no difference in patients with severely depressed LVEF (&#x2264;30%) (HR 0.56, 95% CI 0.24-1.32). Funnel plots did not show asymmetry suggesting lack of bias.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with ICM and VT undergoing first-line ablation have a significantly lower rate of appropriate ICD therapies without a mortality difference compared with patients receiving an initial approach based on medical therapy. The beneficial effect of a first-line ablation approach was only observed in patients with moderately depressed LVEF (&gt;&#x2009;30-50%).</AbstractText><CopyrightInformation>&#xa9; 2020. Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brice&#xf1;o</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Kavisha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaqat</LastName><ForeName>Wasla</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Dong</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alviz</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ruike</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Henan Provincial People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute, Overland Park, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocca</LastName><ForeName>Domenico Della</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantino</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopinathannair</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute, Overland Park, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6508-4047</Identifier><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA. dibbia@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, USA. dibbia@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>12</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33179155</ArticleId><ArticleId IdType="doi">10.1007/s10840-020-00912-w</ArticleId><ArticleId IdType="pii">10.1007/s10840-020-00912-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Bakker JM, van Capelle FJ, Janse MJ, Wilde AA, Coronel R, Becker AE, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77:589&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.77.3.589</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020;17:e2&#x2013;e154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA. 2006;295:165&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.2.165</ArticleId></ArticleIdList></Reference><Reference><Citation>Briceno DF, Romero J, Villablanca PA, et al. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. Europace. 2018;20:104&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eux109</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr&#xe9;taz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61755-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou WS, et al. Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol. 2017;69:2105&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.02.044</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa071098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041489</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1513614</ArticleId></ArticleIdList></Reference><Reference><Citation>Haqqani HM, Kalman JM, Roberts-Thomson KC, Balasubramaniam RN, Rosso R, Snowdon RL, et al. Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia. J Am Coll Cardiol. 2009;54:166&#x2013;73.</Citation></Reference><Reference><Citation>Romero J, Di Biase L, Diaz JC, et al. Early versus late referral for catheter ablation of ventricular tachycardia in patients with structural heart disease: a systematic review and meta-analysis of clinical outcomes. JACC Clin Electrophysiol. 2018;4:374&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2017.12.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an international VT ablation center collaborative group study. Heart Rhythm. 2015;12:1997&#x2013;2007.</Citation></Reference><Reference><Citation>Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (substrate modification study). Circ Arrhythm Electrophysiol. 2017;10:e004422. https://doi.org/10.1161/CIRCEP.116.004422 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.116.004422</ArticleId><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems S, Tilz RR, Steven D, K&#xe4;&#xe4;b S, Wegscheider K, Gell&#xe9;r L, et al. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141:1057&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043400</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschabrunn CM, Roujol S, Nezafat R, Faulkner-Jones B, Buxton AE, Josephson ME, et al. A swine model of infarct-related reentrant ventricular tachycardia: electroanatomic, magnetic resonance, and histopathological characterization. Heart Rhythm. 2016;13:262&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.07.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenal A, Perez-David E, Avila P, et al. Noninvasive identification of epicardial ventricular tachycardia substrate by magnetic resonance-based signal intensity mapping. Heart Rhythm. 2014;11:1456&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2014.04.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero J, Cerrud-Rodriguez RC, Di Biase L, et al. Combined endocardial-epicardial versus endocardial catheter ablation alone for ventricular tachycardia in structural heart disease: a systematic review and meta-analysis. JACC Clin Electrophysiol. 2019;5:13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2018.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, et al. Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm. 2018;15:355&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2017.10.009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16490088</PMID><DateCompleted><Year>2006</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1155-5645</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2006</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Randomized controlled trial comparing the laryngeal tube and the laryngeal mask in pediatric patients.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>257</EndPage><MedlinePgn>251-7</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The laryngeal tube (LT) is a supraglottic ventilatory device used in adults. However, there is limited information about LT use in pediatric patients. This randomized controlled study compares LT with laryngeal mask (LMA) for airway management during spontaneous or assisted ventilation and during fiberoptic laryngoscopy in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirty children under 10-years old, ASA I-II, scheduled for minor general surgery, Mallampati score I-II, fasted and premedicated were included. Patients with upper respiratory infection, craniofacial malformation, intracranial hypertension, emergency surgery were excluded. The primary outcome measure was the proportion of patients in whom effective spontaneous or assisted ventilation [Vt &gt; or = 4 ml.kg(-1), SpO2 &gt; or = 95% with FiO2 0.4, P(E)CO2 &lt; or = 7.2 kPa (55 mmHg)] was achieved after 3 min of LT or LMA cuff inflation. The secondary endpoint was the proportion of patients in whom fiberoptic laryngoscopy resulted in identification of the vocal cords.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven children with LMA and two children in LT group had adequate spontaneous or assisted ventilation after initial positioning (P &lt; 0.01). After head extension or device repositioning 15 of 15 patients in LMA group had adequate ventilation compared with 11 of 15 patients in LT group (P &lt; 0.05). The vocal cords could be observed with fiberoptic laryngoscopy in 11 LMA group patients compared with no patients in the LT group (P &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The LT is less effective than the LMA to allow adequate spontaneous or assisted ventilation and for fiberoptic evaluation of the airway in children under 10 years old.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bortone</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Azienda Ospedaliera di Parma, Parma, Italy. lbortone@ao.pr.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingelmo</LastName><ForeName>Pablo M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>De Ninno</LastName><ForeName>Ges&#xf9;</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Tosi</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Caffini</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Trenchi</LastName><ForeName>Juna</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mergoni</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Martorana</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007828" MajorTopicYN="N">Laryngoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>2</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>2</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16490088</ArticleId><ArticleId IdType="doi">10.1111/j.1460-9592.2005.01756.x</ArticleId><ArticleId IdType="pii">PAN1756</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22879631</PMID><DateCompleted><Year>2012</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1945-7197</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>10</Issue><PubDate><Year>2012</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The Journal of clinical endocrinology and metabolism</Title><ISOAbbreviation>J Clin Endocrinol Metab</ISOAbbreviation></Journal><ArticleTitle>Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women.</ArticleTitle><Pagination><StartPage>3807</StartPage><EndPage>3814</EndPage><MedlinePgn>3807-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1210/jc.2012-2346</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Although sphingosine 1-phosphate (S1P) plays diverse roles in bone metabolism, the most prominent role seems to be the augmentation of bone resorption.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of the study was to investigate the possibility of using S1P as a predictor for osteoporotic vertebral fracture (VF) risk.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">This was a case-control study conducted in a clinical unit in Korea.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Sixty-nine cases having radiological VF and 69 age- and body mass index-matched controls among 460 eligible postmenopausal women participated in the study.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Lateral thoracolumbar radiographs, bone mineral density (BMD), bone turnover markers, and plasma S1P levels were obtained from all subjects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">S1P levels were markedly higher in subjects with VF (7.49&#xb1;3.44 &#x3bc;mol/liter) than in those without VF (5.58&#xb1;2.01 &#x3bc;mol/liter; P=0.001) and increased in a dose-response manner as the number of VF increased (P for the trend&lt;0.001), even after adjustment for lumbar spine BMD and potential confounders. The odds ratio for VF was markedly higher in subjects in the highest S1P quartile category compared with those in the lowest S1P quartile category after adjustment for confounders (odds ratio 9.33, 95% confidence interval 2.68-32.49). S1P levels were inversely correlated with BMD at various sites (P=0.015 to 0.044), whereas they were positively correlated with bone resorption markers (P=0.016 to 0.098).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings suggest that plasma S1P may be a potential biomarker for the risk of VF, independent of BMD, in postmenopausal women.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Beom-Jun</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap2-Dong, Songpa-Gu, Seoul 138-736, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Jung-Min</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sun-Young</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Young-Sun</ForeName><Initials>YS</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Hun</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Kyeong-Hye</ForeName><Initials>KH</Initials></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Eun-Hee</ForeName><Initials>EH</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sang-Wook</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae-Ho</ForeName><Initials>TH</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Shin-Yoon</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ghi Su</ForeName><Initials>GS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Endocrinol Metab</MedlineTA><NlmUniqueID>0375362</NlmUniqueID><ISSNLinking>0021-972X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008246">Lysophospholipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>26993-30-6</RegistryNumber><NameOfSubstance UI="C060506">sphingosine 1-phosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>NGZ37HRE42</RegistryNumber><NameOfSubstance UI="D013110">Sphingosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008246" MajorTopicYN="N">Lysophospholipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015663" MajorTopicYN="N">Osteoporosis, Postmenopausal</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013110" MajorTopicYN="N">Sphingosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013904" MajorTopicYN="N">Thoracic Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22879631</ArticleId><ArticleId IdType="doi">10.1210/jc.2012-2346</ArticleId><ArticleId IdType="pii">jc.2012-2346</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39198875</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-8090</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of cardiothoracic surgery</Title><ISOAbbreviation>J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Immediate effects of upper limb exercises with and without deep breathing on lung function after cardiac surgery - a randomized crossover trial.</ArticleTitle><Pagination><StartPage>503</StartPage><MedlinePgn>503</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">503</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13019-024-03007-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Open heart surgery, involving median sternotomy, may cause diminished chest wall motion and restrictive pulmonary function in the early postoperative period. Thoracic and upper extremity range of motion (ROM) exercises are often recommended after surgery but have not been evaluated regarding effect on lung volumes and oxygenation. The objective of this study was to evaluate the immediate effect of upper limb elevations, with or without simultaneous deep breathing, on lung function after cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a randomized 2&#x2009;&#xd7;&#x2009;2 crossover trial, 22 adult patients (&gt;&#x2009;18 years old) were assessed during one of the first days after surgery in the spring of 2022 at &#xd6;rebro University Hospital, Sweden. Exercises involving five bilateral upper limb elevations, performed either with simultaneous deep breathing (ROM-DB) or without (ROM), while sitting in an upright position at the edge of the bed, were evaluated. Peripheral oxygen saturation (Rad-5v; Masimo, Irvine, USA) was the primary outcome. Tidal volume and respiratory rate were recorded continuously during the exercises (Spiropalm; Cosmed, Rome, Italy). Heart rate, pain, exertion and dyspnoea were evaluated before and after the exercises.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both ROM-DB and ROM momentarily increased peripheral oxygen saturation (+&#x2009;1% &#xb1; 1, p&#x2009;=&#x2009;0.004 and +&#x2009;1% &#xb1; 1, p&#x2009;&lt;&#x2009;0.001, respectively), with no significant differences between these exercises (p&#x2009;=&#x2009;0.525). ROM-DB significantly increased the V<sub>T</sub> compared with ROM (798&#x2009;&#xb1;&#x2009;316 vs. 602 mL&#x2009;&#xb1;&#x2009;176, p&#x2009;=&#x2009;0.004). However, ROM-DB induced more pronounced pain (p&#x2009;=&#x2009;0.012), exertion (p&#x2009;=&#x2009;0.035) and dyspnoea (p&#x2009;=&#x2009;0.013) than ROM.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Upper limb elevations improved oxygenation momentarily, both performed with and without simultaneous deep breathing, with no significant differences between these exercises. The additive deep breathing improved tidal volume compared with upper limb elevations alone, but induced more pain, exertion and dyspnoea during the performance of exercise.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov (NCT05278819).</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reinhart</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1222-4741</Identifier><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, SE- 70185, Sweden. michael.reinhart@regionorebrolan.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Division of Prevention, Rehabilitation and Community Medicine, Unit of Physiotherapy, Link&#xf6;ping University, Link&#xf6;ping, SE-58183, Sweden. michael.reinhart@regionorebrolan.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonsson</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8186-8562</Identifier><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, SE- 70185, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enthoven</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3707-5869</Identifier><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Division of Prevention, Rehabilitation and Community Medicine, Unit of Physiotherapy, Link&#xf6;ping University, Link&#xf6;ping, SE-58183, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westerdahl</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8363-1662</Identifier><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, SE- 70185, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Health Care Research Center, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, SE-70185, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05278819</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>OLL-973688</GrantID><Agency>Nyckelfonden</Agency><Country/></Grant><Grant><GrantID>OLL-973688</GrantID><Agency>Nyckelfonden</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cardiothorac Surg</MedlineTA><NlmUniqueID>101265113</NlmUniqueID><ISSNLinking>1749-8090</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="Y">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="Y">Upper Extremity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001945" MajorTopicYN="N">Breathing Exercises</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breathing exercises</Keyword><Keyword MajorTopicYN="N">Exercise therapy</Keyword><Keyword MajorTopicYN="N">Physical therapy modalities</Keyword><Keyword MajorTopicYN="N">Respiratory function tests</Keyword><Keyword MajorTopicYN="N">Thoracic surgery</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39198875</ArticleId><ArticleId IdType="pmc">PMC11350993</ArticleId><ArticleId IdType="doi">10.1186/s13019-024-03007-z</ArticleId><ArticleId IdType="pii">10.1186/s13019-024-03007-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Katijjahbe MA, Granger CL, Denehy L, et al. Standard restrictive sternal precautions and modified sternal precautions had similar effects in people after cardiac surgery via median sternotomy (&#x2018;SMART&#x2019; trial): a randomised trial. Physiotherapy. 2018;64:97&#x2013;106. 10.1016/j.jphys.2018.02.013.10.1016/j.jphys.2018.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2018.02.013</ArticleId><ArticleId IdType="pubmed">29602750</ArticleId></ArticleIdList></Reference><Reference><Citation>Milgrom LB, Brooks JA, Qi R, Bunnell K, et al. Pain levels experienced with activities after cardiac surgery. Am J Crit Care. 2004;13:116&#x2013;25. 10.4037/ajcc2004.13.2.116. 10.4037/ajcc2004.13.2.116</Citation><ArticleIdList><ArticleId IdType="doi">10.4037/ajcc2004.13.2.116</ArticleId><ArticleId IdType="pubmed">15043239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller XM, Tinguely F, Tevaearai HT et al. Pain location, distribution, and intensity after cardiac surgery. Chest 2000118:391&#x2013;6. 10.1378/chest.118.2.391</Citation><ArticleIdList><ArticleId IdType="pubmed">10936130</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgarten MCDS, Garcia GK, Frantzeski MH, et al. Pain and pulmonary function in patients submitted to heart surgery via sternotomy. Rev Bras Cir Cardiovasc. 2009;24:497&#x2013;505. 10.1590/s0102-76382009000500011. 10.1590/s0102-76382009000500011</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0102-76382009000500011</ArticleId><ArticleId IdType="pubmed">20305923</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenkman Z, Shir Y, Weiss Y, et al. The effects of cardiac surgery on early and late pulmonary functions. Acta Anaesthesiol Scand. 1997;41:1193&#x2013;9. 10.1111/j.1399-6576.1997.tb04865.x. 10.1111/j.1399-6576.1997.tb04865.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.1997.tb04865.x</ArticleId><ArticleId IdType="pubmed">9366943</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins SC, Soutar SA, MoxhamJ. The effects of posture on lung volumes in normal subjects and in patients pre- and post-coronary artery surgery. Physiotherapy. 1988;74:492&#x2013;6. 10.1016/S0031-9406(10)63381-0.10.1016/S0031-9406(10)63381-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-9406(10)63381-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonmarker C, Nordstr&#xf6;m L, Werner O. Changes in functional residual capacity during cardiac surgery. Br J Anaesth. 1986;58:428&#x2013;32. 10.1093/bja/58.4.428. 10.1093/bja/58.4.428</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/58.4.428</ArticleId><ArticleId IdType="pubmed">3485439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Ding X, Su Y, et al. Incidence, risk factors, and outcomes of severe hypoxemia after cardiac surgery. Front Cardiovasc Med. 2022;9:e934533. 10.3389/fcvm.2022.934533.10.3389/fcvm.2022.934533</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.934533</ArticleId><ArticleId IdType="pmc">PMC9273816</ArticleId><ArticleId IdType="pubmed">35837609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Ballotta A, La Rovere MT, Castelvecchio S, Surgical, Clinical Outcome Research (SCORE) Group. Postoperative hypoxia and length of intensive care unit stay after cardiac surgery: the underweight paradox? PLoS ONE. 2014;9:e93992. 10.1371/journal.pone.0093992. 10.1371/journal.pone.0093992</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093992</ArticleId><ArticleId IdType="pmc">PMC3978074</ArticleId><ArticleId IdType="pubmed">24709952</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerdahl E, Jonsson M, Emtner M. Pulmonary function and health-related quality of life 1-year follow up after cardiac surgery. J Cardiothorac Surg. 2016;11:99. 10.1186/s13019-016-0491-2. 10.1186/s13019-016-0491-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-016-0491-2</ArticleId><ArticleId IdType="pmc">PMC4938995</ArticleId><ArticleId IdType="pubmed">27390849</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw DK, Deutsch DT, Bowling RJ. Efficacy of shoulder range of motion exercise in hospitalized patients after coronary artery bypass graft surgery. Heart Lung. 1989;18:364&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2787309</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerdahl E, M&#xf6;ller M. Physiotherapy-supervised mobilization and exercise following cardiac surgery: a national questionnaire survey in Sweden. J Cardiothorac Surg. 2010;5:67. 10.1186/1749-8090-5-67. 10.1186/1749-8090-5-67</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-5-67</ArticleId><ArticleId IdType="pmc">PMC2936289</ArticleId><ArticleId IdType="pubmed">20738852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cline M, Adams J. Early upper-body exercise in cardiac rehabilitation after coronary artery bypass grafting. J Cardiopulm Rehabil. 2006;26:41&#x2013;3. 10.1097/00008483-200601000-00009. 10.1097/00008483-200601000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008483-200601000-00009</ArticleId><ArticleId IdType="pubmed">16617227</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbay SR, Hayes K, Holland AE. Physiotherapy for patients following coronary artery bypass graft (CABG) surgery: limited uptake of evidence into practice. Physiother Theory Pract. 2012;28:178&#x2013;87. 10.3109/09593985.2011.582231. 10.3109/09593985.2011.582231</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09593985.2011.582231</ArticleId><ArticleId IdType="pubmed">21823991</ArticleId></ArticleIdList></Reference><Reference><Citation>Overend TJ, Anderson CM, Jackson J, et al. Physical therapy management for adult patients undergoing cardiac surgery: a Canadian practice survey. Physiother Can. 2010;62:215&#x2013;21. 10.3138/physio.62.3.215. 10.3138/physio.62.3.215</Citation><ArticleIdList><ArticleId IdType="doi">10.3138/physio.62.3.215</ArticleId><ArticleId IdType="pmc">PMC2909859</ArticleId><ArticleId IdType="pubmed">21629599</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeve J, Ewan S. The physiotherapy management of the coronary artery bypass graft patient: a survey of current practice throughout the United Kingdom. J Assoc Chart Physiother Respir Care. 2005;37:35&#x2013;45.</Citation></Reference><Reference><Citation>Westerdahl E, Lindmark B, Eriksson T, et al. The immediate effects of deep breathing exercises on atelectasis and oxygenation after cardiac surgery. Scand Cardiovasc J. 2003;37:363&#x2013;7. 10.1080/14017430310014984. 10.1080/14017430310014984</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14017430310014984</ArticleId><ArticleId IdType="pubmed">14668188</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerdahl E, Lindmark B, Eriksson T, et al. Deep-breathing exercises reduce atelectasis and improve pulmonary function after coronary artery bypass surgery. Chest. 2005;128:3482&#x2013;8. 10.1378/chest.128.5.3482. 10.1378/chest.128.5.3482</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.5.3482</ArticleId><ArticleId IdType="pubmed">16304303</ArticleId></ArticleIdList></Reference><Reference><Citation>Urell C, Emtner M, Hedenstr&#xf6;m H, et al. Deep breathing exercises with positive expiratory pressure at a higher rate improve oxygenation in the early period after cardiac surgery &#x2014; a randomised controlled trial. Eur J Cardiothorac Surg. 2011;40:162&#x2013;7. 10.1016/j.ejcts.2010.10.018. 10.1016/j.ejcts.2010.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.10.018</ArticleId><ArticleId IdType="pubmed">21146420</ArticleId></ArticleIdList></Reference><Reference><Citation>Mans CM, Reeve JC, Elkins MR. Postoperative outcomes following preoperative inspiratory muscle training in patients undergoing cardiothoracic or upper abdominal surgery: a systematic review and meta analysis. Clin Rehabil. 2015;29:426&#x2013;38. 10.1177/0269215514545350. 10.1177/0269215514545350</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269215514545350</ArticleId><ArticleId IdType="pubmed">25160007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Souza AC, da Silva Barbosa L, Nascimento Cruz SDC, et al. Pilates method on pulmonary function and range of motion after coronary artery bypass grafting: a clinical trial. J Bodyw Mov Ther. 2021;28:552&#x2013;6. 10.1016/j.jbmt.2021.09.006. 10.1016/j.jbmt.2021.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbmt.2021.09.006</ArticleId><ArticleId IdType="pubmed">34776194</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjerbaek A, Westerdahl E, Andreasen JJ, et al. Change of position from a supine to a sitting position increases pulmonary function early after cardiac surgery. Eur J Physiother. 2019;22:313&#x2013;7. 10.1080/21679169.2019.1617778.10.1080/21679169.2019.1617778</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21679169.2019.1617778</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellek S, Blettner M. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2012;109:276&#x2013;81. 10.3238/arztebl.2012.0276. 10.3238/arztebl.2012.0276</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2012.0276</ArticleId><ArticleId IdType="pmc">PMC3345345</ArticleId><ArticleId IdType="pubmed">22567063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrman JK, Kerrigan DJ, Keteyian SJ. Advanced Exercise Physiology: essential concepts and applications. Champaign, IL: Human Kinetics; 2018.</Citation></Reference><Reference><Citation>Kirkeby-Garstad I, Wisl&#xf8;ff U, Skogvoll E, et al. The marked reduction in mixed venous oxygen saturation during early mobilization after cardiac surgery: the effect of posture or exercise? Anesth Analg. 2006;102:1609&#x2013;16. 10.1213/01.ANE.0000219589.03633.BF. 10.1213/01.ANE.0000219589.03633.BF</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000219589.03633.BF</ArticleId><ArticleId IdType="pubmed">16717296</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bosch OFC, Alvarez-Jimenez R, Stam MMH, et al. Variations in respiratory rate do not reflect changes in tidal volume or minute ventilation after major abdominal surgery. J Clin Monit Comput. 2021;35:787&#x2013;96. 10.1007/s10877-020-00538-3. 10.1007/s10877-020-00538-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-020-00538-3</ArticleId><ArticleId IdType="pmc">PMC8286957</ArticleId><ArticleId IdType="pubmed">32488678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallett S, Toro F, Ashurst JV, Physiology TV. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK482502/</Citation></Reference><Reference><Citation>Gilbert R, Auchincloss JH Jr, Brodsky J, Boden W. Changes in tidal volume, frequency, and ventilation induced by their measurement. J Appl Physiol. 1972;33:252&#x2013;4. 10.1152/jappl.1972.33.2.252. 10.1152/jappl.1972.33.2.252</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1972.33.2.252</ArticleId><ArticleId IdType="pubmed">5054434</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27687346</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Comparison of volume-controlled ventilation and pressure-controlled ventilation volume guaranteed during laparoscopic surgery in Trendelenburg position.</ArticleTitle><Pagination><StartPage>55</StartPage><EndPage>61</EndPage><MedlinePgn>55-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2016.03.053</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(16)30089-7</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">To analyze the effects of pressure-controlled ventilation-volume guaranteed (PCV-VG) and volume controlled ventilation (VCV) on airway pressures and respiratory and circulatory indicators during laparoscopic surgery in Trendelenburg position.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective randomized comparative clinical study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Tertiary hospital.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Forty ASA physical status 1 and 2 patients who underwent elective laparoscopic surgery in Trendelenburg position.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomly allocated to either VCV group (n=20) or the PCV-VG group (n=20). After induction of anesthesia, for both modes of ventilation, the target tidal volume (VT) was 8mL/kg and the respiratory rate was adjusted to avoid hypercarbia.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The peak and mean inspiratory pressures, dynamic compliance, exhaled VT, oxygenation index and physiological dead space were calculated and recorded at T1, 5minutes after induction of anesthesia in supine position, T2, 5minutes after stabilization of pneumoperitoneum, T3 and T4, 15 and 60minutes after 30&#xb0; Trendelenburg position with pneumoperitoneum respectively.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">PCV-VG group had significantly lower peak inspiratory pressure and greater dynamic compliance than VCV group (P&lt;.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients who underwent laparoscopic surgery in Trendelenburg position, PCV-VG was superior to VCV in its ability to provide ventilation with lower peak inspiratory pressure and greater dynamic compliance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Assad</LastName><ForeName>Osama M</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: osamaasaad72@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Sayed</LastName><ForeName>Ayman A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Mohamed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="N">Blood Gas Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018475" MajorTopicYN="N">Head-Down Tilt</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="N">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="Y">Respiratory Mechanics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Laparoscopic surgery</Keyword><Keyword MajorTopicYN="N">Mechanical ventilation</Keyword><Keyword MajorTopicYN="N">Trendelenburg position</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27687346</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2016.03.053</ArticleId><ArticleId IdType="pii">S0952-8180(16)30089-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30566903</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1479-683X</ISSN><JournalIssue CitedMedium="Internet"><Volume>180</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of endocrinology</Title><ISOAbbreviation>Eur J Endocrinol</ISOAbbreviation></Journal><ArticleTitle>Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study.</ArticleTitle><Pagination><StartPage>201</StartPage><EndPage>211</EndPage><MedlinePgn>201-211</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1530/EJE-18-0881</ELocationID><ELocationID EIdType="pii" ValidYN="Y">EJE-18-0881</ELocationID><Abstract><AbstractText>Introduction Impaired bone microarchitecture is involved in vertebral fracture (VF) development among acromegaly patients. Aim of the study Comparison of DXA-derived bone parameters, areal BMD (aBMD), trabecular bone score (TBS) and 3D-SHAPER parameters in acromegaly patients with healthy controls. Methods This cross-sectional study evaluated acromegaly patients and a control group of healthy subjects. In all subjects, a single measurement of pituitary axis hormone levels, bone turnover markers, aBMD, (total hip (TH) and lumbar spine (LS)), TBS and 3D-SHAPER of the proximal femur region was performed. All subjects underwent DXA assessment of VF using the semiquantitative approach. Results One hundred six patients with acromegaly (mean age 56.6 years, BMI 30.2 kg/m2) and 104 control subjects (mean age 54.06 years, 28.4 BMI kg/m2) were included. After adjustment for weight, LS aBMD, TBS and TH trabecular volumetric BMD (vBMD) remained lower (P = 0.0048, &lt;0.0001 and &lt;0.0001, respectively) while cortical thickness (Cth) at TH and neck remained thicker (P = 0.006) in acromegaly patients compared with controls. The best multivariate model (model 1) discriminating patients with and without acromegaly included TBS, TH trabecular vBMD and TH Cth parameters (all P &lt; 0.05). Twenty-two VFs (13 acromegaly subjects) were recognized. In these subjects after adjustment for age, FN aBMD, TH cortical sBMD and TH cortical vBMD remained significantly associated with the prevalent VF (OR = 2.69 (1.07-6.78), 2.84 (1.24-6.51) and 2.38 (1.11-5.10) for neck aBMD, TH cortical sBMD and TH cortical vBMD respectively)). The AUCs were similar for each parameter in this model. Conclusions Acromegaly patients, regardless of VF presence, have lower trabecular bone quantitative parameters, but those with VFs had decreased cortical density.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ku&#x17e;ma</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital Bratislava, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Va&#x148;uga</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Institute of Endocrinology and Diabetology, Lubochna, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;gov&#xe1;</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Comenius University Jessenius Faculty of Medicine, th Department of Internal Medicine, University Hospital Martin, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe1;vai</LastName><ForeName>Du&#x161;an</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Institute of Endocrinology and Diabetology, Lubochna, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackuliak</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital Bratislava, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Killinger</LastName><ForeName>Zdenko</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital Bratislava, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binkley</LastName><ForeName>Neil C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winzenrieth</LastName><ForeName>Renaud</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Galgo Medical, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genant</LastName><ForeName>Harry K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Payer</LastName><ForeName>Juraj</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital Bratislava, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Endocrinol</MedlineTA><NlmUniqueID>9423848</NlmUniqueID><ISSNLinking>0804-4643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="Y">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000172" MajorTopicYN="N">Acromegaly</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001842" MajorTopicYN="N">Bone and Bones</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007006" MajorTopicYN="N">Hypogonadism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30566903</ArticleId><ArticleId IdType="doi">10.1530/EJE-18-0881</ArticleId><ArticleId IdType="pii">EJE-18-0881</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39709297</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1424-3911</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</Title><ISOAbbreviation>Pancreatology</ISOAbbreviation></Journal><ArticleTitle>Trends and impact of endoscopic ultrasound utilization for suspected intraductal papillary mucinous neoplasms.</ArticleTitle><Pagination><StartPage>353</StartPage><EndPage>358</EndPage><MedlinePgn>353-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pan.2024.12.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1424-3903(24)00828-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Multiple management guidelines for intraductal papillary mucinous neoplasms (IPMNs) have been published to improve risk stratification and resource utilization. This study aims to evaluate trends in endoscopic ultrasound (EUS) use and agreement between cross-sectional imaging and EUS for specific pancreas cystic lesion (PCL) features.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included consecutive adults undergoing EUS for suspected IPMN detected with cross-sectional imaging (CT/MRCP) between 2013 and 2015 (Cohort 1) and 2018-2020 (Cohort 2). Clinical, radiographic, EUS, cytologic, and outcomes data were collected. IPMN were defined as high-risk/worrisome (having any Fukuoka high risk (HR) or worrisome feature (WF)), low risk (cyst size 10-29.9 mm, without Fukuoka HR or WF), or very low risk (cyst size &lt;10 mm, without Fukuoka HR or WF). Chi-square, Fisher's exact test, Wilcoxon rank-sum test and Kappa statistics were used. Impact of the COVID-19 pandemic was assessed via post-hoc sensitivity analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 711 patients, 292 (41.1 %) were in Cohort 1. More patients in Cohort 1 underwent EUS for non-high risk/non-worrisome PCL on pre-EUS imaging (65.8 % vs. 54.9 %, P &lt; 0.01). Good agreement between pre-EUS imaging and EUS for WF (84.1 %) and HR (96.6 %) was seen. EUS-FNA impacted surveillance and surgical referral in 29.5 % (P = 0.51). Median surveillance duration was 917 days (IQR 367, 1439 days), during which pancreatic ductal adenocarcinoma (PDAC) was diagnosed in 7.5 % (P = 0.11).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this series EUS over-utilization for low risk IPMN improved over time reflecting more conservative guidelines, without changing PDAC diagnosis rates. There was good agreement between cross-sectional imaging and EUS for specific PCL features.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 IAP and EPC. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lillian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vatsavayi</LastName><ForeName>Priyanka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majumder</LastName><ForeName>Shounak</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleeson</LastName><ForeName>Ferga C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajan</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu Dayyeh</LastName><ForeName>Barham K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storm</LastName><ForeName>Andrew C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umar</LastName><ForeName>Shifa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velaga</LastName><ForeName>Saran T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmsen</LastName><ForeName>William S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vege</LastName><ForeName>Santhi S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandrasekhara</LastName><ForeName>Vinay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Electronic address: Chandrasekhara.vinay@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pancreatology</MedlineTA><NlmUniqueID>100966936</NlmUniqueID><ISSNLinking>1424-3903</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019160" MajorTopicYN="Y">Endosonography</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="Y">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077779" MajorTopicYN="Y">Pancreatic Intraductal Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021441" MajorTopicYN="Y">Carcinoma, Pancreatic Ductal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endoscopic ultrasound</Keyword><Keyword MajorTopicYN="N">Intraductal papillary mucinous neoplasm</Keyword><Keyword MajorTopicYN="N">Pancreatic cystic lesions</Keyword></KeywordList><CoiStatement>Declaration of interests S.M. is listed as an inventor under an intellectual property development agreement between Mayo Clinic and Exact Sciences and could share potential future royalties as employee of Mayo Clinic, and is on the Editorial Board for Pancreatology. E.R. consults for Olympus and J&amp;J and has intellectual property with Medtronic and Ruhoff. B.A. consults for and receives research support from Boston Scientific and Medtronic; consults for Olympus; and receives research support from ERBE and Endogastric solutions. A.C.S. consults for and receives research support from Boston Scientific; consults for Intuitive, Medtronic, Microtech, and Olympus; and receives research support from Apollo Endosurgery, Endogenex, Endo-TAGSS, Enterasense, Onepass, and SofTac. S.S.V. was the first author of the 2015 AGA guidelines for the diagnosis and management of asymptomatic neoplastic pancreatic cysts, and is an Associate Editor for Pancreatology. V.C. consults for Covidien LP and Boston Scientific, receives research support from Microtech Endoscopy, and is a shareholder of Nevakar Corporation. The following authors and co-authors have no conflicts of interest to disclose: L.W., P.V., F.C.G., S.U., S.T.V., and W.S.H.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>22</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>21</Day><Hour>21</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39709297</ArticleId><ArticleId IdType="doi">10.1016/j.pan.2024.12.001</ArticleId><ArticleId IdType="pii">S1424-3903(24)00828-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36858681</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Neuromodulation for the Treatment of Refractory Ventricular Arrhythmias.</ArticleTitle><Pagination><StartPage>161</StartPage><EndPage>169</EndPage><MedlinePgn>161-169</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2022.08.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(22)00742-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Neuromodulation is increasingly recognized as a therapeutic strategy for patients with refractory ventricular arrhythmias (VAs). Percutaneous stellate ganglion blockade (SGB), transcutaneous magnetic stimulation (TcMS), and surgical cardiac sympathetic denervation (CSD) have all been utilized in this setting.</AbstractText><AbstractText Label="OBJECTIVES">This study sought to characterize contemporary use and outcomes of these neuromodulation techniques for patients with refractory VA.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study included all patients at the Hospital of the University of Pennsylvania with antiarrhythmic drug (AAD)-refractory VA from 2019 to 2021 who were treated with SGB, TcMS, or CSD.</AbstractText><AbstractText Label="RESULTS">A total of 34 patients (age 61 &#xb1; 14 years, 15 polymorphic VAs [44%], refractory to 1.8 &#xb1; 0.8 AADs) met inclusion criteria. SGB was performed on 11 patients (32%), TcMS on 19 (56%), and CSD on 7 (21%). Neuromodulation was associated with a reduction in the number of episodes of sustained VAs from 7 [IQR: 4-12] episodes in the 24 hours before the initial neuromodulation strategy to 0 [IQR: 0-1] episodes in the subsequent 24 hours (P&#xa0;&lt; 0.001). During 1.2 &#xb1; 1.1 years of follow-up, 21 (62%) experienced recurrent VAs, and among those patients, the median time to recurrence was 3 [IQR: 1-25] days. Outcomes were similar among patients with monomorphic and polymorphic VAs. Among patients who had an acute myocardial infarction within 30&#xa0;days before neuromodulation, the burden of VAs decreased from 11 [IQR: 7-12] episodes to 0 episodes in the 24 hours after treatment.</AbstractText><AbstractText Label="CONCLUSIONS">Autonomic neuromodulation with SGB, TcMS, or CSD in patients with AAD-refractory VAs is safe and results in substantial acute reduction of VA although recurrent arrhythmias are common, and not all patients experience a reduction in arrhythmia burden.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American College of Cardiology Foundation. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Markman</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: timothy.markman@pennmedicine.upenn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gugger</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arkles</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riley</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixit</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guandalini</LastName><ForeName>Gustavo S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frankel</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epstein</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callans</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singhal</LastName><ForeName>Sunil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Thoracic Surgery Division, Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchlinski</LastName><ForeName>Francis E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazarian</LastName><ForeName>Saman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2023 Feb;9(2):170-172. doi: 10.1016/j.jacep.2022.11.002.</RefSource><PMID Version="1">36858682</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001340" MajorTopicYN="Y">Autonomic Nerve Block</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac sympathetic denervation</Keyword><Keyword MajorTopicYN="N">neuromodulation</Keyword><Keyword MajorTopicYN="N">stellate ganglion block</Keyword><Keyword MajorTopicYN="N">transcutaneous magnetic stimulation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures Dr Frankel is a consultant for Biosense Webster, Boston Scientific, Medtronic, and Stryker. Dr Epstein serves on the advisory board or events committees for Abbott, Boston Scientific, Medtronic, and Zoll. Dr Callans has served as a consultant for Abbott Medical, Boston Scientific, and Medtronic. Dr Marchlinski has served as a consultant for Abbott Medical, Biosense Webster, Biotronik, Boston Scientific, and Medtronic; and receives research funding from Biosense Webster and the Leducq Foundation. Dr Nazarian is a consultant for CardioSolv and Circle CVI; and principal investigator for research funding from Biosense Webster, ImriCor, Siemens, ADAS software, and the US National Institutes of Health. The University of Pennsylvania Conflict of Interest Committee manages all commercial arrangements. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>20</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36858681</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2022.08.031</ArticleId><ArticleId IdType="pii">S2405-500X(22)00742-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40037766</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1468-201X</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>18</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Heart (British Cardiac Society)</Title><ISOAbbreviation>Heart</ISOAbbreviation></Journal><ArticleTitle>Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registry.</ArticleTitle><Pagination><StartPage>885</StartPage><EndPage>892</EndPage><MedlinePgn>885-892</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e324811</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/heartjnl-2024-324811</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Japanese Hypertrophic Cardiomyopathy Registry Study was designed to provide comprehensive, real-world insights into the clinical characteristics and management of hypertrophic cardiomyopathy (HCM) in Japan.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This multicentre, prospective study enrolled consecutive patients with HCM from 24 referral hospitals across Japan starting in 2016. The baseline characteristics of 1485 patients enrolled by December 2019 are presented in this analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The median ages at registration and diagnosis were 69 and 60 years, respectively, with men accounting for 54% of the cohort. Familial HCM was confirmed in 18% of cases. Of the cohort, 36% had hypertrophic obstructive cardiomyopathy (HOCM), while 8% had mid-ventricular obstruction, 14% had apical HCM and 4% were in the end-stage phase. Atrial fibrillation was observed in 27% of patients, though the majority were asymptomatic or had mild symptoms at registration. Adverse outcomes included prior sustained ventricular tachycardia or fibrillation (6%), heart failure requiring hospitalisation (11%) and embolic events (5%). Defibrillator implantation was performed in 11% of patients. Differences in the defibrillator indications for primary prevention in the current three guidelines and status of defibrillator deployment at registration were clarified: the percentages of class IIa recommendation in the whole cohort and of patients with defibrillator implantation in class IIa were 22% and 19% in the Japanese guidelines, 4% and 39% in the European guidelines and 28% and 22% in the American guidelines, respectively. Beta blockers were prescribed to 90% of patients with HOCM, while 51% received cibenzoline. Septal reduction therapies were performed in 22% of patients with HOCM, with 6% undergoing surgical myectomy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As the first large-scale, prospective HCM registry in Japan, this study provides valuable baseline data on the clinical characteristics and management of HCM. These findings will help address gaps between current practice and guideline recommendations, improving the care of patients with HCM.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Toru</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5681-8854</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan jm-kubotoru@kochi-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugiura</LastName><ForeName>Kenta</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokita</LastName><ForeName>Yukichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Nippon Medical School Hospital, Bunkyo-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takano</LastName><ForeName>Hitoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Nippon Medical School Hospital, Bunkyo-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takamisawa</LastName><ForeName>Itaru</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sakakibara Heart Institute, Fuchu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takayama</LastName><ForeName>Morimasa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sakakibara Heart Institute, Fuchu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doi</LastName><ForeName>Yoshinori L</ForeName><Initials>YL</Initials><Identifier Source="ORCID">0000-0002-2851-7568</Identifier><AffiliationInfo><Affiliation>Cardiomyopathy Institute, Chikamori Hospital, Kochi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minami</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6126-4112</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirotani</LastName><ForeName>Shota</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebato</LastName><ForeName>Mio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Showa University Fujigaoka Hospital, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsujiuchi</LastName><ForeName>Miki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Nippon Medical School Hospital, Bunkyo-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nabeta</LastName><ForeName>Takeru</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4671-7667</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Kitasato University School of Medicine, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inomata</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Niigata University School of Medical and Dental Sciences, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Takao</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8213-7999</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okamoto</LastName><ForeName>Ryuji</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dohi</LastName><ForeName>Kaoru</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takei</LastName><ForeName>Yasuyoshi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tokyo Medical University, Shinjuku-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chikamori</LastName><ForeName>Taishiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tokyo Medical University, Shinjuku-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Eiichi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Fujita Health University Bantane Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furugen</LastName><ForeName>Azusa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hokkaido Cardiovascular Hospital, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doi</LastName><ForeName>Hirosato</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Sapporo Shiroishi Memorial Hospital, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akita</LastName><ForeName>Keitaro</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-5395-1887</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maekawa</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogimoto</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Uwajima City Hospital, Uwajima, Ehime, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tada</LastName><ForeName>Norio</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiology, Sendai Kousei Hospital, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokota</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Shuntaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Ehime, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Ehime, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izumiya</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibata</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takashio</LastName><ForeName>Seiji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsujita</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maejima</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujino</LastName><ForeName>Noboru</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nomura</LastName><ForeName>Akihiro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akasaki</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higuchi</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Shuichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoshiga</LastName><ForeName>Masaaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiraishi</LastName><ForeName>Yasuyuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ieda</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyamoto</LastName><ForeName>Yuya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitaoka</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heart</MedlineTA><NlmUniqueID>9602087</NlmUniqueID><ISSNLinking>1355-6037</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="Y">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="N">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiomyopathy, Hypertrophic</Keyword><Keyword MajorTopicYN="N">Cohort Studies</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>7</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>4</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40037766</ArticleId><ArticleId IdType="pmc">PMC12418554</ArticleId><ArticleId IdType="doi">10.1136/heartjnl-2024-324811</ArticleId><ArticleId IdType="pii">heartjnl-2024-324811</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maron BJ, Desai MY, Nishimura RA, et al. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2022;79:372&#x2013;89. doi: 10.1016/j.jacc.2021.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.002</ArticleId><ArticleId IdType="pubmed">35086660</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P. Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative. Eur Heart J. 2021;42:3945&#x2013;7. doi: 10.1093/eurheartj/ehab608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab608</ArticleId><ArticleId IdType="pubmed">34514508</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BJ. Clinical Course and Management of Hypertrophic Cardiomyopathy. N Engl J Med. 2018;379:655&#x2013;68. doi: 10.1056/NEJMra1710575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1710575</ArticleId><ArticleId IdType="pubmed">30110588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitaoka H, Tsutsui H, Kubo T, et al. JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies. Circ J. 2021;85:1590&#x2013;689. doi: 10.1253/circj.CJ-20-0910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-20-0910</ArticleId><ArticleId IdType="pubmed">34305070</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44:3503&#x2013;626. doi: 10.1093/eurheartj/ehad194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad194</ArticleId><ArticleId IdType="pubmed">37622657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen SR, Ho CY, Asif IM, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1239&#x2013;311. doi: 10.1161/CIR.0000000000001250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001250</ArticleId><ArticleId IdType="pubmed">38718139</ArticleId></ArticleIdList></Reference><Reference><Citation>Charron P, Elliott PM, Gimeno JR, et al. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Eur Heart J. 2018;39:1784&#x2013;93. doi: 10.1093/eurheartj/ehx819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx819</ArticleId><ArticleId IdType="pubmed">29378019</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer S, Kolm P, Ho CY, et al. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry. J Am Coll Cardiol. 2019;74:2333&#x2013;45. doi: 10.1016/j.jacc.2019.08.1057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.08.1057</ArticleId><ArticleId IdType="pmc">PMC6905038</ArticleId><ArticleId IdType="pubmed">31699273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo T, Hirota T, Baba Y, et al. Patients&#x2019; Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort&#x3000;- Results From Kochi RYOMA Study. Circ J. 2018;82:824&#x2013;30. doi: 10.1253/circj.CJ-17-0845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-17-0845</ArticleId><ArticleId IdType="pubmed">29332907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho CY, Day SM, Ashley EA, et al. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) Circulation. 2018;138:1387&#x2013;98. doi: 10.1161/CIRCULATIONAHA.117.033200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.033200</ArticleId><ArticleId IdType="pmc">PMC6170149</ArticleId><ArticleId IdType="pubmed">30297972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitaoka H, Doi Y, Casey SA, et al. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003;92:1183&#x2013;6. doi: 10.1016/j.amjcard.2003.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2003.07.027</ArticleId><ArticleId IdType="pubmed">14609593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo T, Kitaoka H, Okawa M, et al. Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Results from Kochi RYOMA Study. Circ J. 2009;73:1599&#x2013;605. doi: 10.1253/circj.cj-09-0140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.cj-09-0140</ArticleId><ArticleId IdType="pubmed">19590139</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada M, Shigematsu Y, Ikeda S, et al. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 1997;96:1520&#x2013;4. doi: 10.1161/01.cir.96.5.1520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.96.5.1520</ArticleId><ArticleId IdType="pubmed">9315541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo I, Mizushige K, Nozaki S, et al. Effect of cibenzoline on regional left ventricular function in hypertrophic obstructive cardiomyopathy. Clin Cardiol. 2000;23:689&#x2013;96. doi: 10.1002/clc.4960230911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.4960230911</ArticleId><ArticleId IdType="pmc">PMC6654909</ArticleId><ArticleId IdType="pubmed">11016020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajimoto K, Imai T, Minami Y, et al. Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline. Am J Cardiol. 2010;106:1307&#x2013;12. doi: 10.1016/j.amjcard.2010.06.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2010.06.059</ArticleId><ArticleId IdType="pubmed">21029829</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherrid MV, Shetty A, Winson G, et al. Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With &#x3b2;-Blockade or Verapamil. Circ: Heart Failure. 2013;6:694&#x2013;702. doi: 10.1161/CIRCHEARTFAILURE.112.000122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.112.000122</ArticleId><ArticleId IdType="pubmed">23704138</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron MS, Ommen SR. Exploring New and Old Therapies for Obstructive Hypertrophic Cardiomyopathy. Circulation. 2021;143:1181&#x2013;3. doi: 10.1161/CIRCULATIONAHA.120.051330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.051330</ArticleId><ArticleId IdType="pubmed">33750209</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivotto I, Oreziak A, Barriales-Villa R, et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020;396:759&#x2013;69. doi: 10.1016/S0140-6736(20)31792-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31792-X</ArticleId><ArticleId IdType="pubmed">32871100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitaoka H, Ieda M, Ebato M, et al. Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy &#x2015; The HORIZON-HCM Study. Circ J. 2024;89:130&#x2013;8. doi: 10.1253/circj.CJ-24-0501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-24-0501</ArticleId><ArticleId IdType="pubmed">39505542</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hanlon R, Grasso A, Roughton M, et al. Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2010;56:867&#x2013;74. doi: 10.1016/j.jacc.2010.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.05.010</ArticleId><ArticleId IdType="pubmed">20688032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130:484&#x2013;95. doi: 10.1161/CIRCULATIONAHA.113.007094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.007094</ArticleId><ArticleId IdType="pubmed">25092278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima Y, Kubo T, Sugiura K, et al. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy. Circ J. 2020;84:1846&#x2013;53. doi: 10.1253/circj.CJ-20-0027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-20-0027</ArticleId><ArticleId IdType="pubmed">32830170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo T, Kitaoka H. Genetic Testing for Cardiomyopathy in Japan 2022: Current Status and Issues of Precision Medicine. J Card Fail. 2023;29:805&#x2013;14. doi: 10.1016/j.cardfail.2022.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2022.11.017</ArticleId><ArticleId IdType="pubmed">37169422</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26047468</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Abdominal Functional Electrical Stimulation to Assist Ventilator Weaning in Acute Tetraplegia: A Cohort Study.</ArticleTitle><Pagination><StartPage>e0128589</StartPage><MedlinePgn>e0128589</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0128589</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0128589</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe impairment of the major respiratory muscles resulting from tetraplegia reduces respiratory function, causing many people with tetraplegia to require mechanical ventilation during the acute stage of injury. Abdominal Functional Electrical Stimulation (AFES) can improve respiratory function in non-ventilated patients with sub-acute and chronic tetraplegia. The aim of this study was to investigate the clinical feasibility of using an AFES training program to improve respiratory function and assist ventilator weaning in acute tetraplegia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">AFES was applied for between 20 and 40 minutes per day, five times per week on four alternate weeks, with 10 acute ventilator dependent tetraplegic participants. Each participant was matched retrospectively with a ventilator dependent tetraplegic control, based on injury level, age and sex. Tidal Volume (VT) and Vital Capacity (VC) were measured weekly, with weaning progress compared to the controls.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compliance to training sessions was 96.7%. Stimulated VT was significantly greater than unstimulated VT. VT and VC increased throughout the study, with mean VC increasing significantly (VT: 6.2 mL/kg to 7.8 mL/kg VC: 12.6 mL/kg to 18.7 mL/kg). Intervention participants weaned from mechanical ventilation on average 11 (sd: &#xb1; 23) days faster than their matched controls.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this study indicate that AFES is a clinically feasible technique for acute ventilator dependent tetraplegic patients and that this intervention may improve respiratory function and enable faster weaning from mechanical ventilation.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT02200393.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCaughey</LastName><ForeName>Euan J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Centre for Rehabilitation Engineering, School of Engineering, University of Glasgow, University Avenue, Glasgow, United Kingdom; Centre for Excellence in Rehabilitation Research, Biomedical Engineering, University of Strathclyde, Glasgow, United Kingdom; Centre for Health Systems and Safety Research, Australia Institute of Health Innovation, Macquarie University, North Ryde, Australia; Scottish Centre for Innovation in Spinal Cord Injury, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>Helen R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Centre for Excellence in Rehabilitation Research, Biomedical Engineering, University of Strathclyde, Glasgow, United Kingdom; Scottish Centre for Innovation in Spinal Cord Injury, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLean</LastName><ForeName>Alan N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Queen Elizabeth National Spinal Injuries Unit, Southern General Hospital, Glasgow, United Kingdom; Scottish Centre for Innovation in Spinal Cord Injury, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allan</LastName><ForeName>David B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Queen Elizabeth National Spinal Injuries Unit, Southern General Hospital, Glasgow, United Kingdom; Scottish Centre for Innovation in Spinal Cord Injury, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gollee</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Rehabilitation Engineering, School of Engineering, University of Glasgow, University Avenue, Glasgow, United Kingdom; Scottish Centre for Innovation in Spinal Cord Injury, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02200393</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004558" MajorTopicYN="N">Electric Stimulation</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011782" MajorTopicYN="N">Quadriplegia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015300" MajorTopicYN="N">Ventilator Weaning</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014797" MajorTopicYN="N">Vital Capacity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26047468</ArticleId><ArticleId IdType="pmc">PMC4457912</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0128589</ArticleId><ArticleId IdType="pii">PONE-D-14-55655</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Claxton AR, Wong DT, Chung F, Fehlings MG. (1998) Predictors of hospital mortality and mechanical ventilation in patients with cervical spinal cord injury. Can J Anaesth 45: 144&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">9512849</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin MJ. (2001) Advances in mechanical ventilation. N Engl J Med 344: 1986&#x2013;1996.</Citation><ArticleIdList><ArticleId IdType="pubmed">11430329</ArticleId></ArticleIdList></Reference><Reference><Citation>Gay PC. (2013) Counterpoint: Should phrenic nerve stimulation be the treatment of choice for spinal cord injury? No. Chest 143: 1203&#x2013;1206. 10.1378/chest.13-0219</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.13-0219</ArticleId><ArticleId IdType="pubmed">23648903</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause JS, Devivo MJ, Jackson AB. (2004) Health status, community integration, and economic risk factors for mortality after spinal cord injury. Arch Phys Med Rehabil 85:1764&#x2013;1773.</Citation><ArticleIdList><ArticleId IdType="pubmed">15520971</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlifue S, Apple D, Burns SP, Chen D, Cuthbert JP, Donovan WH, et al. (2011) Mechanical ventilation, health, and quality of life following spinal cord injury. Arch Phys Med Rehabil 92: 457&#x2013;463. 10.1016/j.apmr.2010.07.237</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2010.07.237</ArticleId><ArticleId IdType="pubmed">21353827</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, McLaughlin TP, Mody SH, Piech CT. (2005) Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med 33: 1266&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pubmed">15942342</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheffler LR, Chae J. (2007) Neuromuscular electrical stimulation in neurorehabilitation. Muscle Nerve 35: 562&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">17299744</ArticleId></ArticleIdList></Reference><Reference><Citation>Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, et al. (2010) Electrical muscle stimulation prevents critical illness polyneuromyopathy: A randomized parallel intervention trial. Crit Care 14: R74 10.1186/cc8987</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8987</ArticleId><ArticleId IdType="pmc">PMC2887197</ArticleId><ArticleId IdType="pubmed">20426834</ArticleId></ArticleIdList></Reference><Reference><Citation>McBain RA, Boswell-Ruys CL, Lee BB, Gandevia SC, Butler JE. (2013) Abdominal muscle training can enhance cough after spinal cord injury. Neurorehabil Neural Repair 27: 834&#x2013;843. 10.1177/1545968313496324</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968313496324</ArticleId><ArticleId IdType="pubmed">23884017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditunno JF, Formal CS. (1994) Chronic spinal cord injury. N Engl J Med 330: 550&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">8302323</ArticleId></ArticleIdList></Reference><Reference><Citation>McLachlan AJ, McLean AN, Allan DB, Gollee H. (2013) Changes in pulmonary function measures following a passive abdominal functional electrical stimulation training program. J Spinal Cord Med 36: 97&#x2013;103. 10.1179/2045772312Y.0000000031</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/2045772312Y.0000000031</ArticleId><ArticleId IdType="pmc">PMC3595974</ArticleId><ArticleId IdType="pubmed">23809523</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BB, Boswell-Ruys CL, Butler JE, Gandevia SC. (2008) Surface functional electrical stimulation of the abdominal muscles to enhance cough and assist tracheostomy decannulation after high-level spinal cord injury. J Spinal Cord Med 31: 78&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2435038</ArticleId><ArticleId IdType="pubmed">18533416</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo T, Watt JW, Soni BM, Sett PK. (1999) Delayed diaphragm recovery in 12 patients after high cervical spinal cord injury. a retrospective review of the diaphragm status of 107 patients ventilated after acute spinal cord injury. Spinal Cord 37: 117&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">10065750</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban A, Frutos F, Tobin MJ, Al&#xed;a I, Solsona JF, Valverd&#xfa; I, et al. (1995) A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med 332: 345&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">7823995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditunno JF, Little JW, Tessler A, Burns AS. (2004) Spinal shock revisited: A four-phase model. Spinal Cord 42: 383&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">15037862</ArticleId></ArticleIdList></Reference><Reference><Citation>Queen Elizabeth National Spinal Injuries Unit: Annual Report 2012&#x2013;13. (2013) Queen Elizabeth National Spinal Injuries Unit</Citation></Reference><Reference><Citation>Atito-Narh E, Pieri-Davies S, Watt JWH. (2008) Slow ventilator weaning after cervical spinal cord injury. Brit J Intensive Care Autumn: 95&#x2013;102.</Citation></Reference><Reference><Citation>Chiodo AE, Scelza W, Forchheimer M. (2008) Predictors of ventilator weaning in individuals with high cervical spinal cord injury. J Spinal Cord Med 31: 72&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2435030</ArticleId><ArticleId IdType="pubmed">18533415</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson WP, Barbalata L, Brooks CA, Gerhart KA, Mellick DC, Whiteneck GG. (1999) The effect of tidal volumes on the time to wean persons with high tetraplegia from ventilators. Spinal Cord 37: 284&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">10338350</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. (2005) Standardisation of spirometry. Eur Respir J 26: 319&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra SK. (1998) Forced vital capacity, slow vital capacity, or inspiratory vital capacity: which is the best measure of vital capacity? J Asthma 35: 361&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">9669830</ArticleId></ArticleIdList></Reference><Reference><Citation>McCaughey EJ, McLean AN, Allan DB, Gollee H. (2014) Detection of the motor points of the abdominal muscles. Eur J Appl Physiol 114: 2483&#x2013;2489. 10.1007/s00421-014-2966-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-014-2966-y</ArticleId><ArticleId IdType="pubmed">25113093</ArticleId></ArticleIdList></Reference><Reference><Citation>McCaughey EJ, McLachlan AJ, Gollee H. (2014) Non-intrusive real-time breathing pattern detection and classification for automatic abdominal functional electrical stimulation. Med Eng Phys 36: 1057&#x2013;1061. 10.1016/j.medengphy.2014.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medengphy.2014.04.005</ArticleId><ArticleId IdType="pubmed">24894029</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorli J, Kandare F, Jaeger RJ, Stanic U. (1996) Ventilatory assistance using electrical stimulation of abdominal muscles. IEEE Trans Rehabil Eng 4: 1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8798066</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanic U, Kandare F, Jaeger R, Sorli J. (2000) Functional electrical stimulation of abdominal muscles to augment tidal volume in spinal cord injury. IEEE Trans Rehabil Eng 8: 30&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">10779105</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng P, Chen C, Wang C, Chung C. (2006) Effect of neuromuscular electrical stimulation on cough capacity and pulmonary function in patients with acute cervical cord injury. J Rehab Med 38: 32&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">16548084</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw M, Lin M, Cheng P, Wong MA, Tang F. (2000) Resistive inspiratory muscle training: Its effectiveness in patients with acute complete cervical cord injury. Arch Phys Med Rehabil 81: 752&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">10857519</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor PN, Burridge JH, Dunkerley AL, Wood DE, Norton JA, Singleton C, et al. (1999) Clinical use of the Odstock dropped foot stimulator: Its effect on the speed and effort of walking. Arch Phys Med Rehabil 80: 1577&#x2013;1583.</Citation><ArticleIdList><ArticleId IdType="pubmed">10597809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottink AIR, Hermens HJ, Nene AV, Tenniglo MJ, Groothuis-Oudshoorn CG, IJzerman MJ. (2008) Therapeutic effect of an implantable peroneal nerve stimulator in subjects with chronic stroke and footdrop: A randomized controlled trial. Phys Ther 88: 437&#x2013;448. 10.2522/ptj.20070035</Citation><ArticleIdList><ArticleId IdType="doi">10.2522/ptj.20070035</ArticleId><ArticleId IdType="pubmed">18218825</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper NJ, Greer R, Conway D. (2001) Neuromuscular monitoring in intensive care patients: Milliamperage requirements for supramaximal stimulation. Br J Anaesth 87: 625&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">11878733</ArticleId></ArticleIdList></Reference><Reference><Citation>Shade SK. (1985) Use of transcutaneous electrical nerve stimulation for a patient with a cardiac pacemaker. A case report. Phys Ther 65: 206&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">3871530</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson AB, Groomes TE. (1994) Incidence of respiratory complications following spinal cord injury. Arch Phys Med Rehabil 75: 270&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">8129577</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38168502</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Prevalence, incidence of and risk factors for vertebral fracture in the community: the Vietnam Osteoporosis Study.</ArticleTitle><Pagination><StartPage>32</StartPage><MedlinePgn>32</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">32</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-50145-w</ELocationID><Abstract><AbstractText>The epidemiology of vertebral fractures (VF) in underrepresented populations is not well-documented. This cohort study was part of a longitudinal osteoporosis research project with the aim of determining the prevalence, incidence, and risk factors for VF. 401 individuals (155 men) aged 50&#xa0;years and older without a clinical diagnosis of VF were took radiographs at baseline and 2&#xa0;years later. VF were ascertained using the Genant's semi-quantitative method. Bone mineral density (BMD) of femoral neck and lumbar spine were measured by dual-energy X-ray absorptiometry (Hologic Inc). The association between VF and risk factors was analyzed by the multiple logistic regression. The 95% confidence interval for prevalence and incidence was estimated by exact Poisson test. At baseline, the prevalence of VF was 12.2% (n&#x2009;=&#x2009;49, 95% CI 9.0-16.2%) and increased with advancing age with one-fifth of those aged 70 and older having a VF. During the follow-up period, we observed 6 new VF, making the incidence of 6.6/1000 person-years (n&#x2009;=&#x2009;6, 95% CI 2.4-14.3). The risk of prevalent VF was associated with male gender (OR: 2.67; 95% CI 1.28-5.87) and T-score at the femoral neck (OR per one SD decrease: 1.1; 1.03-1.17). These data indicate that VF is common among adults, and that lower femoral neck BMD was a risk factor for VF.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Hoa T</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Can Tho University of Medicine and Pharmacy, Faculty of Medicine, Can Tho, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saigon Precision Medicine Research Center, Ho Chi Minh City, 70000, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Bao T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Can Tho University of Medicine and Pharmacy, Faculty of Medicine, Can Tho, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thai</LastName><ForeName>Thi H Nhung</ForeName><Initials>THN</Initials><AffiliationInfo><Affiliation>Can Tho University of Medicine and Pharmacy, Faculty of Medicine, Can Tho, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>An V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Can Tho University of Medicine and Pharmacy, Faculty of Medicine, Can Tho, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Tan T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Can Tho University of Medicine and Pharmacy, Faculty of Medicine, Can Tho, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vo</LastName><ForeName>Tam</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>Linh D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Biomedicine Research Center Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saigon Precision Medicine Research Center, Ho Chi Minh City, 70000, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bone and Muscle Research Group Ton Duc Thang University, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Thach S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Saigon Precision Medicine Research Center, Ho Chi Minh City, 70000, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering, University of Technology Sydney, Ultimo, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Tuan V</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Tam Anh Research Institute, Tam Anh Hospital, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering, University of Technology Sydney, Ultimo, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho-Pham</LastName><ForeName>Lan T</ForeName><Initials>LT</Initials><Identifier Source="ORCID">0000-0001-8382-5080</Identifier><AffiliationInfo><Affiliation>Biomedicine Research Center Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam. lan.hopham@saigonmec.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saigon Precision Medicine Research Center, Ho Chi Minh City, 70000, Vietnam. lan.hopham@saigonmec.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bone and Muscle Research Group Ton Duc Thang University, Ho Chi Minh City, Vietnam. lan.hopham@saigonmec.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FOSTECT.2014.BR.09</GrantID><Agency>Foundation for Science and Technology Development of Ton Duc Thang University (FOSTECT)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014744" MajorTopicYN="N" Type="Geographic">Vietnam</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="Y">Osteoporosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>3</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38168502</ArticleId><ArticleId IdType="pmc">PMC10761939</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-50145-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-50145-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ross PD. Clinical consequences of vertebral fractures. Am. J. Med. 1997;103:30&#x2013;43. doi: 10.1016/s0002-9343(97)90025-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9343(97)90025-5</ArticleId><ArticleId IdType="pubmed">9302895</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson L, et al. Decreased physical health-related quality of life-a persisting state for older women with clinical vertebral fracture. Osteoporos. Int. 2019;30:1961&#x2013;1971. doi: 10.1007/s00198-019-05044-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-019-05044-0</ArticleId><ArticleId IdType="pmc">PMC6795611</ArticleId><ArticleId IdType="pubmed">31227884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kado DM, et al. Vertebral fractures and mortality in older women: A prospective study. Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 1999;159:1215&#x2013;1220. doi: 10.1001/archinte.159.11.1215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.159.11.1215</ArticleId><ArticleId IdType="pubmed">10371229</ArticleId></ArticleIdList></Reference><Reference><Citation>Pongchaiyakul C, et al. Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: A long-term prospective study. J. Bone. Miner. Res. 2005;20:1349&#x2013;1355. doi: 10.1359/JBMR.050317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/JBMR.050317</ArticleId><ArticleId IdType="pubmed">16007332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay R, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285:320&#x2013;323. doi: 10.1001/jama.285.3.320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.3.320</ArticleId><ArticleId IdType="pubmed">11176842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos. Int. 2017;28:1531&#x2013;1542. doi: 10.1007/s00198-017-3909-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-017-3909-3</ArticleId><ArticleId IdType="pubmed">28168409</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761&#x2013;1767. doi: 10.1016/S0140-6736(02)08657-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)08657-9</ArticleId><ArticleId IdType="pubmed">12049882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensrud KE, Schousboe JT. Clinical practice. Vertebral fractures. N. Engl. J. Med. 2011;364:1634&#x2013;1642. doi: 10.1056/NEJMcp1009697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp1009697</ArticleId><ArticleId IdType="pubmed">21524214</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark P, et al. The prevalence of radiographic vertebral fractures in Latin American countries: The Latin American Vertebral Osteoporosis Study (LAVOS) Osteoporos. Int. 2009;20:275&#x2013;282. doi: 10.1007/s00198-008-0657-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-008-0657-4</ArticleId><ArticleId IdType="pubmed">18584111</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SA, Tenenhouse A, Robertson L. Vertebral fracture definition from population-based data: Preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos) Osteoporos. Int. 2000;11:680&#x2013;687. doi: 10.1007/s001980070066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001980070066</ArticleId><ArticleId IdType="pubmed">11095171</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neill TW, et al. The prevalence of vertebral deformity in european men and women: The European Vertebral Osteoporosis Study. J. Bone. Miner. Res. 1996;11:1010&#x2013;1018. doi: 10.1002/jbmr.5650110719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.5650110719</ArticleId><ArticleId IdType="pubmed">8797123</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin CS, et al. The prevalence and risk factors of vertebral fractures in Korea. J. Bone. Miner. Metab. 2012;30:183&#x2013;192. doi: 10.1007/s00774-011-0300-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-011-0300-x</ArticleId><ArticleId IdType="pubmed">21773702</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho-Pham LT, Mai LD, Pham HN, Nguyen ND, Nguyen TV. Reference ranges for vertebral heights and prevalence of asymptomatic (undiagnosed) vertebral fracture in Vietnamese men and women. Arch. Osteoporos. 2012;7:257&#x2013;266. doi: 10.1007/s11657-012-0106-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-012-0106-z</ArticleId><ArticleId IdType="pubmed">23132647</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenberg D, et al. Incidence of vertebral fracture in europe: Results from the European Prospective Osteoporosis Study (EPOS) J. Bone. Miner. Res. 2002;17:716&#x2013;724. doi: 10.1359/jbmr.2002.17.4.716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2002.17.4.716</ArticleId><ArticleId IdType="pubmed">11918229</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenspan SL, Von Stetten E, Emond SK, Jones L, Parker RA. Instant vertebral assessment: A noninvasive dual x-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. J. Clin. Densitom. 2001;4:373&#x2013;380. doi: 10.1385/jcd:4:4:373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/jcd:4:4:373</ArticleId><ArticleId IdType="pubmed">11748342</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ., 3rd Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985&#x2013;1989. J. Bone. Miner. Res. 1992;7:221&#x2013;227. doi: 10.1002/jbmr.5650070214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.5650070214</ArticleId><ArticleId IdType="pubmed">1570766</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink HA, et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J. Bone. Miner. Res. 2005;20:1216&#x2013;1222. doi: 10.1359/JBMR.050314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/JBMR.050314</ArticleId><ArticleId IdType="pubmed">15940375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al. Prevalence of osteoporosis and fracture in China: The China osteoporosis prevalence study. JAMA Netw. Open. 2021;4:e2121106. doi: 10.1001/jamanetworkopen.2021.21106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.21106</ArticleId><ArticleId IdType="pmc">PMC8369359</ArticleId><ArticleId IdType="pubmed">34398202</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai K, Twu S, Chieng P, Yang R, Lee T. Prevalence of vertebral fractures in chinese men and women in urban Taiwanese communities. Calcif. Tissue. Int. 1996;59:249&#x2013;253. doi: 10.1007/s002239900118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002239900118</ArticleId><ArticleId IdType="pubmed">8781047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho-Pham LT, Nguyen ND, Vu BQ, Pham HN, Nguyen TV. Prevalence and risk factors of radiographic vertebral fracture in postmenopausal Vietnamese women. Bone. 2009;45:213&#x2013;217. doi: 10.1016/j.bone.2009.04.199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2009.04.199</ArticleId><ArticleId IdType="pubmed">19376279</ArticleId></ArticleIdList></Reference><Reference><Citation>Oei L, et al. Osteoporotic vertebral fracture prevalence varies widely between qualitative and quantitative radiological assessment methods: The Rotterdam study. J. Bone. Miner. Res. 2018;33:560&#x2013;568. doi: 10.1002/jbmr.3220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3220</ArticleId><ArticleId IdType="pubmed">28719143</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty S, John B, Mohan S, Paul TV. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis. Arch. Osteoporos. 2020;15:25. doi: 10.1007/s11657-020-0688-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-020-0688-9</ArticleId><ArticleId IdType="pubmed">32095943</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboudiab M, et al. Vertebral fracture assessment (VFA) in patients over 50 years of age with a non-severe peripheral fracture. Osteoporos. Int. 2020;31:1477&#x2013;1486. doi: 10.1007/s00198-020-05400-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-020-05400-5</ArticleId><ArticleId IdType="pubmed">32266434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lems WF, et al. Vertebral fracture: Epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services. Osteoporos. Int. 2021;32:399&#x2013;411. doi: 10.1007/s00198-020-05804-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-020-05804-3</ArticleId><ArticleId IdType="pmc">PMC7929949</ArticleId><ArticleId IdType="pubmed">33475820</ArticleId></ArticleIdList></Reference><Reference><Citation>Pongchaiyakul C, et al. Prevalence of asymptomatic radiographic vertebral fracture in postmenopausal Thai women. Arch. Osteoporos. 2020;15:78. doi: 10.1007/s11657-020-00762-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-020-00762-z</ArticleId><ArticleId IdType="pubmed">32447475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YK, et al. Mortality after vertebral fracture in Korea: Analysis of the National Claim Registry. Osteoporos. Int. 2012;23:1859&#x2013;1865. doi: 10.1007/s00198-011-1833-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-011-1833-5</ArticleId><ArticleId IdType="pubmed">22109741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippuner K, Johansson H, Kanis JA, Rizzoli R. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos. Int. 2009;20:1131&#x2013;1140. doi: 10.1007/s00198-008-0779-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-008-0779-8</ArticleId><ArticleId IdType="pubmed">18974918</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA. The incidence of vertebral fractures in men and women: The Rotterdam Study. J. Bone. Miner. Res. 2002;17:1051&#x2013;1056. doi: 10.1359/jbmr.2002.17.6.1051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2002.17.6.1051</ArticleId><ArticleId IdType="pubmed">12054160</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001;29:517&#x2013;522. doi: 10.1016/S8756-3282(01)00614-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S8756-3282(01)00614-7</ArticleId><ArticleId IdType="pubmed">11728921</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara S, et al. Fracture prediction from bone mineral density in Japanese men and women. J. Bone. Miner. Res. 2003;18:1547&#x2013;1553. doi: 10.1359/jbmr.2003.18.8.1547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2003.18.8.1547</ArticleId><ArticleId IdType="pubmed">12929946</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TV, Center JR, Eisman JA. Femoral neck bone loss predicts fracture risk independent of baseline BMD. J. Bone. Miner. Res. 2005;20:1195&#x2013;1201. doi: 10.1359/JBMR.050215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/JBMR.050215</ArticleId><ArticleId IdType="pubmed">15940372</ArticleId></ArticleIdList></Reference><Reference><Citation>Alajlouni D, et al. Nonstandard lumbar region in predicting fracture risk. J. Clin. Densitom. 2018;21:220&#x2013;226. doi: 10.1016/j.jocd.2017.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2017.05.014</ArticleId><ArticleId IdType="pubmed">28689879</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauley JA, et al. Bone mineral density and prevalent vertebral fractures in men and women. Osteoporos. Int. 2004;15:32&#x2013;37. doi: 10.1007/s00198-003-1462-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-003-1462-8</ArticleId><ArticleId IdType="pubmed">14628107</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho-Pham LT, Nguyen TV. The Vietnam Osteoporosis Study: Rationale and design. Osteoporos. Sarcopenia. 2017;3:90&#x2013;97. doi: 10.1016/j.afos.2017.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.afos.2017.06.001</ArticleId><ArticleId IdType="pmc">PMC6372769</ArticleId><ArticleId IdType="pubmed">30775510</ArticleId></ArticleIdList></Reference><Reference><Citation>Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J. Bone. Miner. Res. 1993;8:1137&#x2013;1148. doi: 10.1002/jbmr.5650080915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.5650080915</ArticleId><ArticleId IdType="pubmed">8237484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho-Pham LT, Nguyen UD, Pham HN, Nguyen ND, Nguyen TV. Reference ranges for bone mineral density and prevalence of osteoporosis in Vietnamese men and women. BMC. Musculoskelet. Disord. 2011;12:182. doi: 10.1186/1471-2474-12-182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-12-182</ArticleId><ArticleId IdType="pmc">PMC3163638</ArticleId><ArticleId IdType="pubmed">21831301</ArticleId></ArticleIdList></Reference><Reference><Citation>R Development Core Team. R: A language and environment for statistical computing. 2.8.1 ed. (R Foundation for Statistical Computing, 2008).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27377285</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Genetic risk factors for venous thrombosis in the elderly in a case-control study.</ArticleTitle><Pagination><StartPage>1759</StartPage><EndPage>1764</EndPage><MedlinePgn>1759-64</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.13409</ELocationID><Abstract><AbstractText Label="UNLABELLED">Essentials Risk of venous thrombosis (VT) related to common genetic variants in those aged 70+ is unknown. We studied Factor V Leiden, prothrombin mutation, non-O blood group and family history (FH) of VT. Risk of VT was increased 2.2-, 1.4-, 1.3- and 2.1-fold respectively. FH is easy to obtain and can be implemented in clinical decision rules of VT risk in the elderly. Click to hear Prof. Reitsma discuss genetic risk factors of arterial and venous thrombosis</AbstractText><AbstractText Label="SUMMARY">Background As the incidence of venous thrombosis (VT) increases steeply with age and the number of elderly people is on the rise, studies of VT in this age group are important. Objectives We aimed to study the associations of common genetic risk factors (i.e. the factor V Leiden and prothrombin G20210A mutations, non-O blood group and family history of VT) with risk of a first VT in older age (&gt; 70 years). Methods Four hundred and one consecutive cases with a first-time thrombosis and 431 controls (all &#x2265; 70 years) were included in the AT-AGE case-control study. Information on risk factors for VT, including family history of VT in first-degree relatives, was obtained by interview. Unprovoked VT was defined as thrombosis not related to surgery, fracture, plaster cast or immobility within 3 months prior to VT. Results The risk of VT was 2.2-fold increased in factor V Leiden carriers (95% confidence interval [CI], 1.2-3.9), 1.4-fold increased in prothrombin mutation carriers (95% CI, 0.5-3.9), and 1.3-fold increased in those with non-O blood group (95% CI, 1.0-1.8). Positive family history of VT was associated with a 2.1-fold increased risk of VT (95% CI, 1.5-3.1). The highest risk of VT was found in individuals who had both a positive family history and were carriers of one of the two prothrombotic mutations. Conclusions Genetic factors clearly related to VT in younger populations were also risk factors in older age and a positive family history was also important in this age group.</AbstractText><CopyrightInformation>&#xa9; 2016 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karasu</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engbers</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cushman</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Cardiovascular Research Institute, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosendaal</LastName><ForeName>F R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Thrombosis and Haemostasis Research Center, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Hylckama Vlieg</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. A.van_hylckama_vlieg@lumc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000017">ABO Blood-Group System</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C095381">factor V Leiden</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-24-5</RegistryNumber><NameOfSubstance UI="D005165">Factor V</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-26-7</RegistryNumber><NameOfSubstance UI="D011516">Prothrombin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000017" MajorTopicYN="N">ABO Blood-Group System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="N">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005165" MajorTopicYN="N">Factor V</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005192" MajorTopicYN="N">Family Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011516" MajorTopicYN="N">Prothrombin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ABO blood-group system</Keyword><Keyword MajorTopicYN="N">aged</Keyword><Keyword MajorTopicYN="N">factor V Leiden</Keyword><Keyword MajorTopicYN="N">prothrombin</Keyword><Keyword MajorTopicYN="N">venous thrombosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27377285</ArticleId><ArticleId IdType="doi">10.1111/jth.13409</ArticleId><ArticleId IdType="pii">S1538-7836(22)03573-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36093646</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-7401</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Technology and health care : official journal of the European Society for Engineering and Medicine</Title><ISOAbbreviation>Technol Health Care</ISOAbbreviation></Journal><ArticleTitle>Intraoperative lung-protective ventilation adjusting tidal volume to a plateau pressure restriction in elderly patients: A randomized controlled clinical trial.</ArticleTitle><Pagination><StartPage>539</StartPage><EndPage>551</EndPage><MedlinePgn>539-551</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/THC-220144</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lung-protective ventilation (LPV) strategies have been considered as best practice in the care of critically patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to investigate the effects individualized perioperative LPV with a positive end-expiratory pressure (PEEP) and low tidal volumes (VT) based on a target airway plateau pressure (Pplat) in patients during and after an operation compared with conventional ventilation in elderly patients during abdominal surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty-one elderly patients with American Society of Anesthesiologists (ASA) I to III undergoing open abdominal surgery received either conventional ventilation (8 ml/kg-1VT; CV group) or LPV (VT was adjusted to a target Pplat [&#x2a7d; 20 cm H2O]) in the volume-controlled mode with PEEP (9 cm H2O; LPV group) ventilation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in the LPV group showed significantly lower pH values (7.30 &#xb1; 0.07 vs. 7.38 &#xb1; 0.05, P&lt; 0.001) and respiratory indexes than that of CV group (0.806 &#xb1; 0.339 vs. 0.919 &#xb1; 0.300, P= 0.043) at the end of surgery. Compared with the CV group, the dynamic lung compliance (33.39 &#xb1; 3.163 vs. 30.15 &#xb1; 2.572, P&lt; 0.001) was significantly higher, and the body temperature remained significantly more favorable in the LPV group (35.9 &#xb1; 0.3 vs. 35.1 &#xb1; 0.4, P&lt; 0.001). Patients in the LPV group had significantly faster postoperative recovery than that of the CV group (P&lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study showed that LPV could be beneficial for ventilation, core body temperature, and postoperative recovery in elderly patients with healthy lungs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Chunshan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Peng</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiang</ForeName><Initials>X</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Technol Health Care</MedlineTA><NlmUniqueID>9314590</NlmUniqueID><ISSNLinking>0928-7329</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Tidal volume</Keyword><Keyword MajorTopicYN="N">airway plateau pressure</Keyword><Keyword MajorTopicYN="N">lung function</Keyword><Keyword MajorTopicYN="N">positive end-expiratory pressure</Keyword><Keyword MajorTopicYN="N">postoperative recovery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>12</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36093646</ArticleId><ArticleId IdType="doi">10.3233/THC-220144</ArticleId><ArticleId IdType="pii">THC220144</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38391186</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>In-hospital safety outcomes of left atrial appendage occlusion in octogenarians and nonagenarians.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">euae055</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euae055</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Data on safety outcomes of left atrial appendage occlusion (LAAO) in elderly patients are limited. This study aimed to compare the outcomes of LAAO between octogenarians (age 80-89) and nonagenarians (age &#x2265;90) vs. younger patients (age &#x2264;79).</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We conducted a retrospective cohort study using the National Inpatient Sample database to identify patients hospitalized for LAAO from 2016 to 2020 and to compare in-hospital safety outcomes in octogenarians and nonagenarians vs. younger patients. The primary outcome was a composite of in-hospital all-cause mortality or stroke. Secondary outcomes included procedural complications, length of stay (LOS), and total costs. Outcomes were determined using logistic regression models. Among 84 140 patients hospitalized for LAAO, 32.9% were octogenarians, 2.8% were nonagenarians, and 64.3% were &#x2264;79 years of age. Over the study period, the volume of LAAO increased in all age groups (all Ptrend &lt; 0.01). After adjustment for clinical and demographic factors, octogenarians and nonagenarians had similar odds of in-hospital all-cause mortality or stroke [adjusted odds ratio (aOR) 1.41, 95% confidence interval (CI) 0.93-2.13 for octogenarians; aOR 1.69, 95% CI 0.67-3.92 for nonagenarians], cardiac tamponade, acute kidney injury, major bleeding, and blood transfusion, in addition to similar LOS and total costs compared with younger patients (all P &gt; 0.05). However, octogenarians and nonagenarians had higher odds of vascular complications compared with younger patients (aOR 1.47, 95% CI 1.08-1.99 for octogenarians; aOR 1.60, 95% CI 1.18-2.97 for nonagenarians).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Octogenarians and nonagenarians undergoing LAAO have a similar safety profile compared with clinically similar younger patients except for higher odds of vascular complications.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ismayl</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9033-7835</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Hasaan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0004-7825-8252</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Creighton University School of Medicine, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldsweig</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-2952-7837</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Baystate Medical Center, Springfield, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>James V</ForeName><Initials>JV</Initials><Identifier Source="ORCID">0000-0002-4614-6879</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkhouli</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088642" MajorTopicYN="N">Nonagenarians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087742" MajorTopicYN="N">Octogenarians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020517" MajorTopicYN="Y">Atrial Appendage</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">LAAO</Keyword><Keyword MajorTopicYN="N">Nonagenarians</Keyword><Keyword MajorTopicYN="N">Octogenarians</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword></KeywordList><CoiStatement>Conflict of interest: A.M.G. reports speaking fees from Edwards Lifesciences and Philips and consulting fees from Philips and Inari Medical. J.V.F. reports salary support from the American College of Cardiology National Cardiovascular Data Registry and the NHLBI and consulting/advisory board fees from Boston Scientific, Medtronic, Janssen Pharmaceuticals, Biosense Webster, and Pacemate and equity from Pacemate. The remaining authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>9</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38391186</ArticleId><ArticleId IdType="pmc">PMC10927254</ArticleId><ArticleId IdType="doi">10.1093/europace/euae055</ArticleId><ArticleId IdType="pii">7613083</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mou &#xa0;L, Norby &#xa0;FL, Chen &#xa0;LY, O'Neal &#xa0;WT, Lewis &#xa0;TT, Loehr &#xa0;LR &#xa0;et al. &#xa0;Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol &#xa0;2018;11:e006350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053683</ArticleId><ArticleId IdType="pubmed">30002066</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini &#xa0;C, De Santis &#xa0;F, Sacco &#xa0;S, Russo &#xa0;T, Olivieri &#xa0;L, Totaro &#xa0;R &#xa0;et al. &#xa0;Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke &#xa0;2005;36:1115&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15879330</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackshear &#xa0;JL, Odell &#xa0;JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg &#xa0;1996;61:755&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8572814</ArticleId></ArticleIdList></Reference><Reference><Citation>Savelieva &#xa0;I, Fumagalli &#xa0;S, Kenny &#xa0;RA, Anker &#xa0;S, Benetos &#xa0;A, Boriani &#xa0;G &#xa0;et al. &#xa0;EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace &#xa0;2023;25:1249&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10105859</ArticleId><ArticleId IdType="pubmed">37061780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks &#xa0;G, Potpara &#xa0;T, Dagres &#xa0;N, Arbelo &#xa0;E, Bax &#xa0;JJ, Blomstr&#xf6;m-Lundqvist &#xa0;C &#xa0;et al. &#xa0;2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J &#xa0;2021;42:373&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Joglar &#xa0;JA, Chung &#xa0;MK, Armbruster &#xa0;AL, Benjamin &#xa0;EJ, Chyou &#xa0;JY, Cronin &#xa0;EM &#xa0;et al. &#xa0;2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation &#xa0;2024;149:e1&#x2013;156. Erratum in: Circulation 2024; 149:e167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11095842</ArticleId><ArticleId IdType="pubmed">38033089</ArticleId></ArticleIdList></Reference><Reference><Citation>Saw &#xa0;J, Holmes &#xa0;DR, Cavalcante &#xa0;JL, Freeman &#xa0;JV, Goldsweig &#xa0;AM, Kavinsky &#xa0;CJ &#xa0;et al. &#xa0;SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure. Heart Rhythm &#xa0;2023;20:e1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">36990925</ArticleId></ArticleIdList></Reference><Reference><Citation>

Caplan &#xa0;Z. &#x201c;U.S. older population grew from 2010 to 2020 at fastest rate since 1880 to 1890.&#x201d;  Census.Gov, 25 May 2023, www.census.gov/library/stories/2023/05/2020-census-united-states-older-population-grew.html.</Citation></Reference><Reference><Citation>Fukuda &#xa0;N, Imamura &#xa0;T, Tanaka &#xa0;S, Kataoka &#xa0;N, Ushijima &#xa0;R, Ueno &#xa0;H &#xa0;et al. &#xa0;Mid-term feasibility of percutaneous left atrial appendage occlusion in elderly patients with non-valvular atrial fibrillation. J Clin Med &#xa0;2023;12:6024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10531715</ArticleId><ArticleId IdType="pubmed">37762964</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurshid &#xa0;S, Ashburner &#xa0;JM, Ellinor &#xa0;PT, McManus &#xa0;DD, Atlas &#xa0;SJ, Singer &#xa0;DE &#xa0;et al. &#xa0;Prevalence and incidence of atrial fibrillation among older primary care patients. JAMA Netw Open &#xa0;2023;6:e2255838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11015386</ArticleId><ArticleId IdType="pubmed">36780164</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview of the National (Nationwide) Inpatient Sample. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality (AHRQ). Accessed December 15, 2023. https://www.hcup-us.ahrq.gov/nisoverview.jsp.</Citation></Reference><Reference><Citation>World Health Organization . International statistical classification of diseases, tenth revision (ICD-10), clinical modification: World Health Organization; 1992.</Citation></Reference><Reference><Citation>Khera &#xa0;R, Angraal &#xa0;S, Couch &#xa0;T, Welsh &#xa0;JW, Nallamothu &#xa0;BK, Girotra &#xa0;S &#xa0;et al. &#xa0;Adherence to methodological standards in research using the national inpatient sample. JAMA &#xa0;2017;318:2011&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5742631</ArticleId><ArticleId IdType="pubmed">29183077</ArticleId></ArticleIdList></Reference><Reference><Citation>NIS description of data elements. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality (AHRQ). Accessed December 15, 2023. https://hcup-us.ahrq.gov/db/vars/race/nisnote.jsp.</Citation></Reference><Reference><Citation>Ismayl &#xa0;M, Abbasi &#xa0;MA, Al-Abcha &#xa0;A, El-Am &#xa0;E, Walters &#xa0;RW, Goldsweig &#xa0;AM &#xa0;et al. &#xa0;Racial and ethnic disparities in the use and outcomes of transcatheter mitral valve replacement: analysis from the national inpatient sample database. J Am Heart Assoc &#xa0;2023;12:e028999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10122911</ArticleId><ArticleId IdType="pubmed">36974752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismayl &#xa0;M, Ahmed &#xa0;H, Freeman &#xa0;JV, Alkhouli &#xa0;M, Lakkireddy &#xa0;D, Goldsweig &#xa0;AM. Safety and efficacy of combining left atrial appendage occlusion with another cardiac procedure. JACC Cardiovasc Interv &#xa0;2024;17:262&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">38267141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismayl &#xa0;M, Abbasi &#xa0;MA, Al-Abcha &#xa0;A, Robertson &#xa0;S, El-Am &#xa0;E, Goldsweig &#xa0;AM &#xa0;et al. &#xa0;Outcomes of transcatheter aortic valve implantation in nonagenarians and octogenarians (analysis from the National Inpatient Sample database). Am J Cardiol &#xa0;2023;199:59&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">37257370</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Bureau of Labor Statistics. CPI inflation calculator. United States Bureau of Labor Statistics. Accessed December 15, 2023. https://www.bls.gov/data/inflation_calculator.htm.</Citation></Reference><Reference><Citation>Data use agreement for the nationwide databases from the Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality (AHRQ). Available at: https://www.hcup-us.ahrq.gov/team/NationwideDUA.jsp. Accessed December 15, 2023.</Citation></Reference><Reference><Citation>Shrestha &#xa0;B, Poudel &#xa0;B, Poudel &#xa0;D, Diaz Fraga &#xa0;J. National yearly trend of utilization and procedural complication of the Watchman device in the United States. Cureus &#xa0;2022;14:e25567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9249046</ArticleId><ArticleId IdType="pubmed">35784996</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil &#xa0;F, Arora &#xa0;S, Killu &#xa0;AM, Tripathi &#xa0;B, DeSimone &#xa0;CV, Egbe &#xa0;A &#xa0;et al. &#xa0;Utilization and procedural adverse outcomes associated with Watchman device implantation. Europace &#xa0;2021;23:247&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929501</ArticleId></ArticleIdList></Reference><Reference><Citation>Munir &#xa0;MB, Khan &#xa0;MZ, Darden &#xa0;D, Asad &#xa0;ZUA, Choubdar &#xa0;PA, Din &#xa0;MTU &#xa0;et al. &#xa0;Association of advanced age with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the National Inpatient Sample of 36,065 procedures. J Interv Card Electrophysiol &#xa0;2022;65:219&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9550678</ArticleId><ArticleId IdType="pubmed">35731328</ArticleId></ArticleIdList></Reference><Reference><Citation>Daimee &#xa0;UA, Wang &#xa0;Y, Masoudi &#xa0;FA, Varosy &#xa0;PD, Friedman &#xa0;DJ, Du &#xa0;C &#xa0;et al. &#xa0;Indications for left atrial appendage occlusion in the United States and associated in-hospital outcomes: results from the NCDR LAAO registry. Circ Cardiovasc Qual Outcomes &#xa0;2022;15:e008418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388561</ArticleId><ArticleId IdType="pubmed">35959677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf &#xa0;M, Allaqaband &#xa0;SQ, Bajwa &#xa0;T, Mortada &#xa0;ME, Sra &#xa0;J, Jan &#xa0;MF. Age-based trends in the outcomes of percutaneous left atrial appendage occlusion: insights from a real-world database. Am J Cardiol &#xa0;2023;207:322&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37774473</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen &#xa0;J, Kragholm &#xa0;KH, Christensen &#xa0;SB, Johannessen &#xa0;A, Torp-Pedersen &#xa0;C, Kristiansen &#xa0;SB &#xa0;et al. &#xa0;Periprocedural complications and one-year outcomes after catheter ablation for treatment of atrial fibrillation in elderly patients: a nationwide Danish cohort study. J Geriatr Cardiol &#xa0;2021;18:897&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8648543</ArticleId><ArticleId IdType="pubmed">34908927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulaiman &#xa0;S, Roy &#xa0;K, Wang &#xa0;H, de Backer &#xa0;O, Alloco &#xa0;D, Reddy &#xa0;VY &#xa0;et al. &#xa0;Left atrial appendage occlusion in the elderly: insights from PROTECT-AF, PREVAIL, and Continuous Access Registries. JACC Clin Electrophysiol &#xa0;2023;9:669&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">36890047</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Rocca &#xa0;DG, Magnocavallo &#xa0;M &#xa0;Van Niekerk &#xa0;CJ, Gilhofer &#xa0;T, Ha &#xa0;G, D'Ambrosio &#xa0;G &#xa0;et al. &#xa0;Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion. Europace &#xa0;2023; 25:euad315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10653166</ArticleId><ArticleId IdType="pubmed">37889200</ArticleId></ArticleIdList></Reference><Reference><Citation>Munir &#xa0;MB, Khan &#xa0;MZ, Darden &#xa0;D, Asad &#xa0;A, Osman &#xa0;ZU, Singh &#xa0;M &#xa0;et al. &#xa0;Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the national inpatient sample of 62 980 procedures. Europace &#xa0;2022;24:1451&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35613020</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir &#xa0;T, Rawasia &#xa0;WF, Uddin &#xa0;M, Sheikh &#xa0;M, Munir &#xa0;MB, Balla &#xa0;S. Left atrial appendage closure device outcomes among cirrhosis patients with atrial fibrillation: a United States national cohort study. Europace &#xa0;2023;25:1408&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10105884</ArticleId><ArticleId IdType="pubmed">36857522</ArticleId></ArticleIdList></Reference><Reference><Citation>Messele &#xa0;LF, Khan &#xa0;MZ, Darden &#xa0;D, Agarwal &#xa0;S, Krishan &#xa0;S, Pasupula &#xa0;DK &#xa0;et al. &#xa0;Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk. Europace &#xa0;2023;25:1415&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10105852</ArticleId><ArticleId IdType="pubmed">36881781</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhuarrat &#xa0;MAD, Pargaonkar &#xa0;S, Rahgozar &#xa0;K, Safiriyu &#xa0;I, Zhang &#xa0;X, Faillace &#xa0;RT &#xa0;et al. &#xa0;Comparison of in-hospital outcomes and complications of left atrial appendage closure with the Watchman device between males and females. Europace &#xa0;2023;25:euad228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10445300</ArticleId><ArticleId IdType="pubmed">37503957</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbaz-Greener &#xa0;G, Rahamim &#xa0;E, Abu Ghosh &#xa0;Z, Carasso &#xa0;S, Yarkoni &#xa0;M, Radhakrishnan &#xa0;S &#xa0;et al. &#xa0;Sex difference and outcome trends following transcatheter aortic valve replacement. Front Cardiovasc Med &#xa0;2022; 9:1013739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9623151</ArticleId><ArticleId IdType="pubmed">36329995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjoy &#xa0;SS, Choi &#xa0;YH, Sparrow &#xa0;RT, Jneid &#xa0;H, Dawn Abbott &#xa0;J, Nombela-Franco &#xa0;L &#xa0;et al. &#xa0;Outcomes of elderly patients undergoing left atrial appendage closure. J Am Heart Assoc &#xa0;2021;10:e021973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8649147</ArticleId><ArticleId IdType="pubmed">34558289</ArticleId></ArticleIdList></Reference><Reference><Citation>Piayda &#xa0;K, Afzal &#xa0;S, Nielsen-Kudsk &#xa0;JE, Schmidt &#xa0;B, Mazzone &#xa0;P, Berti &#xa0;S &#xa0;et al. &#xa0;Length of stay following percutaneous left atrial appendage occlusion: data from the prospective, multicenter Amplatzer amulet occluder observational study. PLoS One &#xa0;2021;16:e0255721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354446</ArticleId><ArticleId IdType="pubmed">34375347</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33142996</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>21</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>30</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Blood Pressure Changes While Hiking at Moderate Altitudes: A Prospective Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7978</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph17217978</ELocationID><Abstract><AbstractText>Recreational hiking in the mountains is a common activity, whether for a single day or for several days in a row. We sought to measure blood pressure (BP) response during a 10-day trek at moderate-altitude elevation (6500-13,000 feet) and observe for uncontrolled hypertension and/or adverse cardiovascular outcomes. A total of 1279 adult participants completed an observational study of resting BP during a 10-day trek in the Sangre de Cristo mountains. Following initial recruitment, participants were issued a trail data card to record BP measurements at day 0 (basecamp), day 3, day 6 and day 9. BP was measured using a sphygmomanometer and auscultation. Demographic data, height, weight, home altitude, daily water and sports drink intake, existence of pre-arrival hypertension and BP medication class were also recorded. We observed a rise in mean blood pressure for the cohort during all exposures to moderate altitudes. The increases were greatest for individuals with pre-existing hypertension and/or obesity. There were no observed life-threatening cardiovascular events for participants. We conclude that for individuals with a modestly controlled blood pressure of 160/95 mmHg, hiking at a moderate altitude is a safe activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stoltzfus</LastName><ForeName>Ky B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas, KS 66160, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naylor</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas, KS 66160, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cattermole</LastName><ForeName>Tessa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Vermont Medical Center, Burlington, VT 05401, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ankeney</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of South Carolina, Prisma Health Richland, Columbia, SC 29203, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mount</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas, KS 66160, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Rong</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6502-3081</Identifier><AffiliationInfo><Affiliation>Khoury College of Computer Sciences, Northeastern University, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>Cheryl A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas, KS 66160, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000064" MajorTopicYN="N">Acclimatization</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000531" MajorTopicYN="Y">Altitude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009051" MajorTopicYN="N">Mountaineering</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">altitude</Keyword><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">hiking</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">mountaineering</Keyword><Keyword MajorTopicYN="N">recreation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>4</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33142996</ArticleId><ArticleId IdType="pmc">PMC7663232</ArticleId><ArticleId IdType="doi">10.3390/ijerph17217978</ArticleId><ArticleId IdType="pii">ijerph17217978</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schobersberger W., Leichtfried V., Mueck-Weymann M., Humpeler E. Austrian Moderate Altitude Studies (AMAS): Benefits of exposure to moderate altitudes (1500&#x2013;2500 m) Sleep Breath. 2010;14:201&#x2013;207. doi: 10.1007/s11325-009-0286-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11325-009-0286-y</ArticleId><ArticleId IdType="pubmed">19669819</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtscher M. Risk of cardiovascular events during mountain activities. Adv. Exp. Med. Biol. 2007;618:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">18269184</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulhaber M., Flatz M., Gatterer H., Schobersberger W., Burtscher M. Prevalence of cardiovascular diseases among alpine skiers and hikers in the Austrian Alps. High Alt. Med. Biol. 2007;8:245&#x2013;252. doi: 10.1089/ham.2007.1005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ham.2007.1005</ArticleId><ArticleId IdType="pubmed">17824825</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulhaber M., Gatterer H., Burtscher M. Preexisting cardiovascular diseases among high-altitude mountaineers in the alps. J. Travel Med. 2011;18:355&#x2013;357. doi: 10.1111/j.1708-8305.2011.00536.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1708-8305.2011.00536.x</ArticleId><ArticleId IdType="pubmed">21896101</ArticleId></ArticleIdList></Reference><Reference><Citation>Parati G., Agostoni P., Basnyat B., Bilo G., Brugger H., Coca A., Festi L., Giardini G., Lironcurti A., Luks A.M., et al. Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine. Eur. Heart J. 2018;39:1546&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5930248</ArticleId><ArticleId IdType="pubmed">29340578</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilo G., Caldara G., Styczkiewicz K., Revera M., Lombardi C., Giglio A., Zambon A., Corrao G., Faini A., Valentini M., et al. Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. J. Hypertens. 2011;29:380&#x2013;387. doi: 10.1097/HJH.0b013e3283409014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0b013e3283409014</ArticleId><ArticleId IdType="pubmed">21045724</ArticleId></ArticleIdList></Reference><Reference><Citation>Parati G., Revera M., Giuliano A., Faini A., Bilo G., Gregorini F., Lisi E., Salerno S., Lombardi C., Ramos Becerra C.G., et al. Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. Eur. Heart J. 2013;34:759&#x2013;766. doi: 10.1093/eurheartj/ehs140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs140</ArticleId><ArticleId IdType="pubmed">22711752</ArticleId></ArticleIdList></Reference><Reference><Citation>Parati G., Bilo G., Faini A., Bilo B., Revera M., Giuliano A., Lombardi C., Caldara G., Gregorini F., Styczkiewicz K., et al. Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial. Eur. Heart J. 2014;35:3113&#x2013;3122. doi: 10.1093/eurheartj/ehu275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu275</ArticleId><ArticleId IdType="pubmed">25161182</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyes L.E., Sallade T.D., Duke C., Starling J., Sheets A., Pant S., Young D.S., Twillman D., Regmi N., Phelan B., et al. Blood Pressure and Altitude: An Observational Cohort Study of Hypertensive and Nonhypertensive Himalayan Trekkers in Nepal. High Alt. Med. Biol. 2017;18:267&#x2013;277. doi: 10.1089/ham.2017.0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ham.2017.0001</ArticleId><ArticleId IdType="pubmed">28787190</ArticleId></ArticleIdList></Reference><Reference><Citation>Imray C., Booth A., Wright A., Bradwell A. Acute altitude illnesses. BMJ Clin. Res. Ed. 2011;343:4943. doi: 10.1136/bmj.d4943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4943</ArticleId><ArticleId IdType="pubmed">21844157</ArticleId></ArticleIdList></Reference><Reference><Citation>Luks A.M. Should travelers with hypertension adjust their medications when traveling to high altitude? High Alt. Med. Biol. 2009;10:11&#x2013;15. doi: 10.1089/ham.2008.1076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ham.2008.1076</ArticleId><ArticleId IdType="pubmed">19278350</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilo G., Villafuerte F.C., Faini A., Anza-Ram&#xed;rez C., Revera M., Giuliano A., Caravita S., Gregorini F., Lombardi C., Salvioni E., et al. Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: The High Altitude Cardiovascular Research-Andes study. Hypertension. 2015;65:1266&#x2013;1272. doi: 10.1161/HYPERTENSIONAHA.114.05003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.114.05003</ArticleId><ArticleId IdType="pubmed">25895588</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33270043</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1479-683X</ISSN><JournalIssue CitedMedium="Internet"><Volume>184</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of endocrinology</Title><ISOAbbreviation>Eur J Endocrinol</ISOAbbreviation></Journal><ArticleTitle>Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus.</ArticleTitle><Pagination><StartPage>299</StartPage><EndPage>310</EndPage><MedlinePgn>299-310</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1530/EJE-20-0507</ELocationID><ELocationID EIdType="pii" ValidYN="Y">EJE-20-0507</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate the metformin effect on the risk of osteoporosis (OS) and/or vertebral fracture (VF).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled 14 611 pairs of metformin ever and never users matched on propensity score (PS) from Taiwan's National Health Insurance database. All patients had new-onset type 2 diabetes mellitus (T2DM) during 1999-2005 and were free from OS and/or any fracture at the start of follow-up on January 1, 2006. They were followed up until December 31, 2011 for the incidence of OS/VF. Cox regression incorporated with the inverse probability of treatment weighting using PS was used in the main analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">New-onset OS/VF was diagnosed in 1757 never users (median follow-up 5.0 years) and 1143 ever users (median follow-up 5.3 years). The respective incidence rates were 2870.97 and 1713.20 per 100 000 person-years. Two-thirds of the incident cases had OS without VF and the other third had VF. In main analyses, the hazard ratio for ever vs never users was 0.592 (95% CI: 0.550-0.638). In either sex, a dose-response pattern was noted and metformin therapy &gt; 2 years was consistently associated with a lower risk. The protective effect attenuated with increasing age but remained significant in patients aged &#x2265; 80 years. In sensitivity analyses, metformin significantly reduced the risk of both OS and VF (with or without a prior OS) by 30-40%. Additional analyses showed a null association for other antidiabetic drugs, but significant interactions between metformin and insulin, sulfonylurea and pioglitazone, respectively, were noted.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Metformin use is associated with a lower risk of OS/VF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chin-Hsiao</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0001-9545-7123</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Environmental Health and Occupational Medicine of the National Health Research Institutes, Zhunan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Endocrinol</MedlineTA><NlmUniqueID>9423848</NlmUniqueID><ISSNLinking>0804-4643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9100L32L2N</RegistryNumber><NameOfSubstance UI="D008687">Metformin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>12</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33270043</ArticleId><ArticleId IdType="doi">10.1530/EJE-20-0507</ArticleId><ArticleId IdType="pii">EJE-20-0507</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38336516</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Pathological findings associated with the updated European Society of Cardiology 2022 guidelines for preoperative cardiac testing: an observational cohort modelling study.</ArticleTitle><Pagination><StartPage>675</StartPage><EndPage>684</EndPage><MedlinePgn>675-684</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2023.12.036</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(24)00012-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In 2022, the European Society of Cardiology updated guidelines for preoperative evaluation. The aims of this study were to quantify: (1) the impact of the updated recommendations on the yield of pathological findings compared with the previous guidelines published in 2014; (2) the impact of preoperative B-type natriuretic peptide (NT-proBNP) use for risk estimation on the yield of pathological findings; and (3) the association between 2022 guideline adherence and outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a secondary analysis of MET-REPAIR, an international, prospective observational cohort study (NCT03016936). Primary endpoints were reduced ejection fraction (EF&lt;40%), stress-induced ischaemia, and major adverse cardiovascular events (MACE). The explanatory variables were class of recommendations for transthoracic echocardiography (TTE), stress imaging, and guideline adherence. We conducted second-order Monte Carlo simulations and multivariable regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 15,529 patients (39% female, median age 72 [inter-quartile range: 67-78] yr) were included. The 2022 update changed the recommendation for preoperative TTE in 39.7% patients, and for preoperative stress imaging in 12.9% patients. The update resulted in missing 1 EF &lt;40% every 3 fewer conducted TTE, and in 4 additional stress imaging per 1 additionally detected ischaemia events. For cardiac stress testing, four more investigations were performed for every 1 additionally detected ischaemia episodes. Use of NT-proBNP did not improve the yield of pathological findings. Multivariable regression analysis failed to find an association between adherence to the updated guidelines and MACE.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The 2022 update for preoperative cardiac testing resulted in a relevant increase in tests receiving a stronger recommendation. The updated recommendations for TTE did not improve the yield of pathological cardiac testing.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stroda</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Hospital D&#xfc;sseldorf, Heinrich Heine University, D&#xfc;sseldorf, Germany. Electronic address: Alexandra.stroda@med.uni-duesseldorf.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauermann</LastName><ForeName>Eckhard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ionescu</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krak&#xf3;w, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Hert</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Peri-operative Medicine, Ghent University Hospital, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipovic</LastName><ForeName>Miodrag</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Anaesthesiology, Intensive Care, Rescue and Pain Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beck Schimmer</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadaro</LastName><ForeName>Savino</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matute</LastName><ForeName>Purificaci&#xf3;n</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Hospital Clinic of Barcelona, Universidad de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganter</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Klinik Hirslanden, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ovezov</LastName><ForeName>Alexey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Moscow Regional Research Clinical Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turhan</LastName><ForeName>Sanem C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and ICU, Ankara University Medical School, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Waes</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagarto</LastName><ForeName>Filipa</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Hospital Beatriz &#xc2;ngelo, Loures, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodoraki</LastName><ForeName>Kassiani</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aretaieion University Hospital National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care, Karolinska Hospital and Institution for Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillmann</LastName><ForeName>Hans-J&#xf6;rg</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzzetti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Department, University Hospital, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotfis</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Therapy and Pain Management, Pomeranian Medical University, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larmann</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corneci</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Department III, Carol Davila University of Medicine and Pharmacy Bucharest, Central Military Emergency University Hospital "Dr. Carol Davila Bucharest", Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buggy</LastName><ForeName>Donal J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Mater University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howell</LastName><ForeName>Simon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lurati Buse</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Hospital D&#xfc;sseldorf, Heinrich Heine University, D&#xfc;sseldorf, Germany; CARID, Cardiovascular Research Institute D&#xfc;sseldorf, Medical Faculty and University Hospital D&#xfc;sseldorf, Heinrich-Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>MET-REPAIR investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>114471-18-0</RegistryNumber><NameOfSubstance UI="D020097">Natriuretic Peptide, Brain</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002309" MajorTopicYN="Y">Cardiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020097" MajorTopicYN="N">Natriuretic Peptide, Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NT-proBNP</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">ejection fraction</Keyword><Keyword MajorTopicYN="N">guideline adherence</Keyword><Keyword MajorTopicYN="N">major adverse cardiovascular events</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">stress echocardiography</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Kemper</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kohaupt</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Witzler</LastName><ForeName>Jette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tuzhikov</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roth</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stroda</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>M'Pembele</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tenge</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schultze</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Verbarg</LastName><ForeName>Nele</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gehrke</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Klemann</LastName><ForeName>Anna Katharina</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hageb&#xf6;lling</LastName><ForeName>Friederike</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Albrecht</LastName><ForeName>Svenja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Marburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stroeder</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital Marburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schubert</LastName><ForeName>Ann-Kristin</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>University Hospital Marburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Espeter</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Heidelberg University Hospital, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Russe</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Heidelberg University Hospital, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Weigand</LastName><ForeName>Markus A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Heidelberg University Hospital, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bergmann</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University Hospital Knappschaftskrankenhaus Bochum, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Unterberg</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Knappschaftskrankenhaus Bochum, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bischoff</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Marien Hospital Herne, Ruhr University Bochum, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pirzer</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Augsburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rach</LastName><ForeName>Patric Rene</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Augsburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ott</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Augsburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zarbock</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kowark</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital RWTH Aachen, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Neumann</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marchand</LastName><ForeName>Bahareh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sponholz</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rueffert</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Helios Klinik Schkeuditz, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kramer</LastName><ForeName>Mira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Witten / Herdecke - Hospital Center Merheim Cologne, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zacharowski</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospital Frankfurt, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meybohm</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital Frankfurt, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lindau</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Frankfurt, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meybohm</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carollo</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Novazzi</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Toso</LastName><ForeName>Fiorenza</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bacuzzi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ragazzi</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arcispedale Sant'Anna Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Volta</LastName><ForeName>Carlo Alberto</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Arcispedale Sant'Anna Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Giorgi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arcispedale Sant'Anna Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bacer</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Azienda USL Di Bologna, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Federico</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Azienda USL Di Bologna, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chiumello</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vetrugno</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Asuiud, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Castella</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ospedale San Raffaele IRCCS, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tesoro</LastName><ForeName>Simonetta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Perugia Hospital Santa Maria della Misericordia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cotoia</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital of Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bignami</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliero universitaria di Parma, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bellissima</LastName><ForeName>Agrippino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arnas Garibaldi, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Policlinico P. Giaccone, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Crisman</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Azienda Sanitaria Universitaria Integrata di Trieste, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Toninelli</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASST Spedali Civili Brescia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Piazza</LastName><ForeName>Ornella</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University of Salerno-AOU San Giovanni di Dio e Ruggi D'Aragona, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mirabella</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bossolasco</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ASL CN1, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bona</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>FPO IRCCS CANDIOLO, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Perdomo</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nic. UB. Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coca-Martinez</LastName><ForeName>Miquel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nic. UB. Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carrami&#xf1;ana</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nic. UB. Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Serv&#xe9;n</LastName><ForeName>Marta Gin&#xe9;</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Hospital de la Santa Creu i Sant Pau, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Astrid Batalla</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Hospital de la Santa Creu i Sant Pau, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gil S&#xe1;nchez</LastName><ForeName>Jos&#xe9; Maria</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital de la Santa Creu i Sant Pau, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Becerra-Bola&#xf1;os</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Gran Canaria Doctor Negrin, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rodr&#xed;guez-P&#xe9;rez</LastName><ForeName>Aurelio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Gran Canaria Doctor Negrin, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soler</LastName><ForeName>Anna Artigas</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Corporacio sanitaria Parc Tauli, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Basso</LastName><ForeName>Morena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Corporacio sanitaria Parc Tauli, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Font</LastName><ForeName>Anna Peig</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Corporacio sanitaria Parc Tauli, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vernetta</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundacion Puigvert, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Julia Hernando</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Princesa, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Enrique Alday</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Princesa, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Olivares</LastName><ForeName>Mercedes Cabellos</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>University Hospital of Guadalajara, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marco</LastName><ForeName>Gregorio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Santa Maria, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lopez</LastName><ForeName>Maria Bermudez</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Hospital Universitario Lucus Augusti, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barrio</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitari Doctor Peset, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>For&#xe9;s</LastName><ForeName>Mar&#xed;a Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Hospital Arnau De Vilanova-Lliria, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Boix</LastName><ForeName>Estefan&#xed;a</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Arnau De Vilanova-Lliria, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ayuso</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario Pr&#xed;ncipe de Asturias, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Petre</LastName><ForeName>Bogdan Sorel</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Central Military University Emergency Hospital From Romania, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oprea</LastName><ForeName>Ioana Sorina</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Central Military University Emergency Hospital From Romania, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lati&#x219;</LastName><ForeName>Mihai Dan</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Central Military University Emergency Hospital From Romania, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Margarit</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Regional Institute of Gastroenterology and Hepatology "Prof Dr Octavian Fodor" Cluj Napoca, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vasian</LastName><ForeName>Horatiu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Regional Institute of Gastroenterology and Hepatology "Prof Dr Octavian Fodor" Cluj Napoca, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tomescu</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>C&#xee;ndea</LastName><ForeName>Iulia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Constanta County Emergency Clinical Hospital, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dirzu</LastName><ForeName>Dan Sebastian</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Emergency county hospital cluj, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Copotoiu</LastName><ForeName>Sanda-Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Spital Clinic Judetean de Urgenta Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moise</LastName><ForeName>Alida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Prof Dr Gerota Hospital, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bubenek-Turconi</LastName><ForeName>Serban</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Institute for CardioVascular Diseases Prof. Dr. C.C.Iliescu, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Valeanu</LastName><ForeName>Liana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Emergency Institute for CardioVascular Diseases Prof. Dr. C.C.Iliescu, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wanner</LastName><ForeName>Patrick Mark</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Kantonsspital St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Djurdjevic</LastName><ForeName>Mirjana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kantonsspital St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nuth</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kantonsspital St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Seeberger</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Basel University Hospital, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Goettel</LastName><ForeName>Nicolai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Basel University Hospital, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kamber</LastName><ForeName>Firmin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Basel University Hospital, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ganter</LastName><ForeName>Michael Thomas</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Kantonsspital Winterthur, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gerber</LastName><ForeName>Thomas Jan</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Kantonsspital Winterthur, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schneebeli</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kantonsspital Winterthur, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pregernig</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Zurich, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grape</LastName><ForeName>Sina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H&#xf4;pital du Valais, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tomala</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Bernardo Bollen</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>&#x17b;ukowski</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pomeranian Medical University, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zegan-Bara&#x144;ska</LastName><ForeName>Ma&#x142;gorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pomeranian Medical University, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karolak</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pomeranian Medical University, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Krzych</LastName><ForeName>Lukasz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical University of Silesia, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Czajka</LastName><ForeName>Szymon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical University of Silesia, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Studzi&#x144;ska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St John Grande Hospital, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kluzik</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Heliodor Swiecicki Clinical Hospital at Poznan University of Medical Sciences, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koszel</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Heliodor Swiecicki Clinical Hospital at Poznan University of Medical Sciences, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pabja&#x144;czyk</LastName><ForeName>Izabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>The University Hospital in Krakow, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gajdosz</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St. Raphael Hospital, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Erkoc</LastName><ForeName>Suheyla Karadag</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Ankara University Medical School, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meco</LastName><ForeName>Basak Ceyda</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Ankara University Medical School, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koltka</LastName><ForeName>Ahmet Kemalettin</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Istanbul University Istanbul Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dincer</LastName><ForeName>Muserref Beril</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Istanbul University Istanbul Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ekmek&#xe7;i</LastName><ForeName>Perihan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ufuk University Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Kemal Tolga</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Kocaeli Derince Training and Research Hospital, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Solmaz</LastName><ForeName>Filiz Alkaya</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Suleyman Demirel University School of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ozcelik</LastName><ForeName>Menekse</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ankara University School of Medicine Cebeci Hospital, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arun</LastName><ForeName>Oguzhan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Selcuk University Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dilmen</LastName><ForeName>Ozlem Korkmaz</ForeName><Initials>OK</Initials><AffiliationInfo><Affiliation>Istanbul University- Cerrahpasa, Cerrahpasa Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Preckel</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, location AMC, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hollmann</LastName><ForeName>Markus W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, location AMC, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hazen</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University Medical Center Utrecht, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Donald de Boer</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Martini General Hospital Groningen, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Epema</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Medical Center Groningen (UMCG), Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koopman</LastName><ForeName>Seppe</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Maasstad Hospital, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Van Lier</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Erasmus MC, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Beatriz &#xc2;ngelo, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carr&#xe3;o</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Beatriz &#xc2;ngelo, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital Beatriz &#xc2;ngelo, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mour&#xe3;o</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coelho</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Baixo Vouga, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Losa</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Vila Nova de Gaia / Espinho, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hospital de Santo Esp&#xed;rito da Ilha Terceira, E.P.E.R., Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cabral</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital de Santo Esp&#xed;rito da Ilha Terceira, E.P.E.R., Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Afonso</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Entre Douro e Vouga, EPE, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zenha</LastName><ForeName>S&#xe9;rgio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Central do Funchal, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ramos</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital de Sta. Marta, CHLC, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hip&#xf3;lito</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital de Braga, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vasilaki</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>General Hospital of Athens "G. Gennimatas", Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Andreeva</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Hospital of Athens "G. Gennimatas", Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zaimi</LastName><ForeName>Donika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>General Hospital of Thessaloniki "Ippokratio", Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chalkias</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tzaneio General Hospital of Piraeus, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Spyraki</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital of Patras, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rekatsina</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aretaieion University Hospital, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tsaousi</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ahepa University Hospital, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wrightington, Wigan and Leigh NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meier</LastName><ForeName>Sonja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Guys and St Thomas NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Madhuri</LastName><ForeName>Thumuluru Kavitha</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Royal Surrey NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Latham</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Bolton Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Knock</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>York Teaching Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Drummond</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Royal Oldham Hospital - The Pennine Acute Hospitals NHS Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ramsden</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Queen Victoria Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kubisz-Pudelko</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Yeovil Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal Bournemouth Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moppett</LastName><ForeName>Iain</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Nottingham University Hospital, Queen's Medical Centre, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>St James' University Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stockport NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Reschreiter</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Poole Hospital NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Innes</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Musgrove Park Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Link&#xf6;ping University Hospital, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kalman</LastName><ForeName>Sigridur</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Karolinska University Hospital and Karolinska Institutet, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wallden</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sundsvall Hospital, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schening</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Karolinska Institute Physiology and Pharmacology, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jonikaite</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Uppsala University Hospital, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Enlund</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Uppsala University, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Baerdemaeker</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Morrison</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Antwerp University Hospital, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rex</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospitals Leuven, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alexis</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Saint-Pierre, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khoronenko</LastName><ForeName>Viktoria E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>P.A. Herzen Moscow Cancer Research Institute, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ovezov</LastName><ForeName>Alexey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Moscow Regional Research Clinical Institute, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Belskii</LastName><ForeName>Vladislav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Privolzhskiy District Medical Center, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kaznacheeva</LastName><ForeName>Kseniya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Privolzhskiy District Medical Center, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gritsan</LastName><ForeName>Alexey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Krasnoyrask Regional Clinical Hospital; Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kuzmanovska</LastName><ForeName>Biljana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinic for Anesthesiology, Reanimation and Intensive Care medicine, Republic of North Macedonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Malinovska-Nikolovska</LastName><ForeName>Liljana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>GOB 8-mi Septemvri, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barisin</LastName><ForeName>Stjepan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Dubrava, J.J. Strossmayer University of Osijek, Faculty of Medicine, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Poredos</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Medical Centre Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arabadzhieva</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital Kaneff Ruse, Bulgaria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Unic-Stojanovic</LastName><ForeName>Dragana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Institute Dedinje, Serbia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Golubovi&#x107;</LastName><ForeName>Mladjan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Center Nis, Serbia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kotzinger</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Klinikum Wels Grieskirchen, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Des Deserts</LastName><ForeName>Marc Danguy</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Military Teaching Hospital Clermont Tonnerre, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ducrocq</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinique du Mill&#xe9;naire, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Buggy</LastName><ForeName>Donal J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Mater University Hospital, University College Dublin, Ireland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bonnet</LastName><ForeName>Jean Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Mater University Hospital, University College Dublin, Ireland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cusack</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mater University Hospital, University College Dublin, Ireland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Calleja</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Malta.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hasani</LastName><ForeName>Antigona</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Prishtina, Faculty of Medicine, Kosovo.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nallbani</LastName><ForeName>Rajmonda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Prishtina, Faculty of Medicine, Kosovo.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>21</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38336516</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2023.12.036</ArticleId><ArticleId IdType="pii">S0007-0912(24)00012-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27180621</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Substrate modification or ventricular tachycardia induction, mapping, and ablation as the first step? A randomized study.</ArticleTitle><Pagination><StartPage>1589</StartPage><EndPage>1595</EndPage><MedlinePgn>1589-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2016.05.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(16)30275-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">The role and optimal sequence of ventricular tachycardia (VT) induction, mapping, and ablation when combined with substrate modification is unclear.</AbstractText><AbstractText Label="OBJECTIVE">The purpose of this study was to test the benefits of starting the scar-related VT ablation procedure with substrate modification vs the standard protocol of VT induction, mapping, and ablation as the first step.</AbstractText><AbstractText Label="METHODS">Forty-eight consecutive patients with structural heart disease and clinical VTs were randomized to simplified substrate ablation procedure with scar dechanneling as the first step (group 1, n = 24) or standard procedure with VT induction, mapping, and ablation followed by scar dechanneling (group 2, n = 24). Procedure and fluoroscopy times, the need for external cardioversion, acute results, and VT recurrence during follow-up were compared between groups.</AbstractText><AbstractText Label="RESULTS">Thirty-seven patients had ischemic cardiomyopathy, 10 nonischemic cardiomyopathy, and 1 arrhythmogenic cardiomyopathy. Before substrate ablation, 32 VTs were induced and targeted for ablation in 23 patients of group 2. Procedure time (209 &#xb1; 70 minutes vs 262 &#xb1; 63 minutes; P = .009), fluoroscopy time (14 &#xb1; 6 minutes vs 21&#xb1; 9 minutes; P = .005), and electrical cardioversion (25% vs 54%; P = .039) were lower in group 1. After substrate ablation, 16 patients (66%) of group 1 and 12 patients (50%) of group 2 were noninducible (P = .242). End-procedure success (after residual inducible VT ablation) was achieved in 87.5% and 70.8% of patients, respectively (P = .155). There were no differences in VT recurrence rate between groups during a mean follow-up of 22 &#xb1; 14 months (log rank, P = .557).</AbstractText><AbstractText Label="CONCLUSION">VT induction and mapping before substrate ablation prolongs the procedure, radiation exposure, and the need for electrical cardioversion without improving acute results and long-term ablation outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Armenta</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penela</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreu</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evertz</LastName><ForeName>Reinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korshunov</LastName><ForeName>Viatcheslav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassanelli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Mikel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guasch</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbelo</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mar&#xed;a Tolosana</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mont</LastName><ForeName>Lluis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berruezo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain. Electronic address: berruezo@clinic.ub.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018780" MajorTopicYN="N">Body Surface Potential Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Nonischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Substrate ablation</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27180621</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2016.05.013</ArticleId><ArticleId IdType="pii">S1547-5271(16)30275-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37250262</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0970-9185</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>Journal of anaesthesiology, clinical pharmacology</Title><ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The respiratory and hemodynamic effects of alveolar recruitment in cirrhotic patients undergoing liver resection surgery: A randomized controlled trial.</ArticleTitle><Pagination><StartPage>113</StartPage><EndPage>120</EndPage><MedlinePgn>113-120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/joacp.joacp_188_21</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="UNASSIGNED">Extensive surgical retraction combined with general anesthesia increase alveolar collapse. The primary aim of our study was to investigate the effect of alveolar recruitment maneuver (ARM) on arterial oxygenation tension (PaO<sub>2</sub>). The secondary aim was to observe its effect on hemodynamics parameters in hepatic patients during liver resection, to investigate its impact on blood loss, postoperative pulmonary complications (PPC), remnant liver function tests, and on the outcome.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">Adult patients scheduled for liver resection were randomized into two groups: ARM (<i>n</i> = 21) and control (C) (<i>n</i> = 21). Stepwise ARM was initiated after intubation and was repeated post-retraction. Pressure-control ventilation mode was adjusted to deliver a tidal volume (<i>V<sub>t</sub></i>) of 6 mL/kg and an inspiratory-to-expiratory time (<i>I:E</i>) ratio of 1:2 with an optimal positive end-expiratory pressure (PEEP) for the ARM group. In the C group, a fixed PEEP (5 cmH<sub>2</sub>O) was applied. Invasive intra-arterial blood pressure (IBP), central venous pressure (CVP), electrical cardiometry (EC), alanine transaminase (ALT, U/L), and aspartate aminotransferase (AST, U/L) blood levels were monitored.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">ARM increased PEEP, dynamic compliances, and arterial oxygenation, but reduced ventilator driving pressure compared to group C <i>(P</i> &lt; 0.01). IBP, cardiac output (CO), and stroke volume variation were not affected by the higher PEEP in the ARM group (<i>P</i> &gt; 0.05) but the CVP increased significantly (<i>P</i> = 0.001). Blood loss was not different between the ARM and C groups (1700 (1150-2000) mL vs 1110 (900-2400) mL, respectively and <i>P</i> = 0.57). ARM reduced postoperative oxygen desaturation; however, it did not affect the increase in remnant liver enzymes and was comparable to group C (ALT, <i>P</i> = 0.54, AST, <i>P</i> = 0.41).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">ARM improved intraoperative lung mechanics and reduced oxygen desaturation episodes in recovery, but not PPC or ICU stay. ARM was tolerated with minimal cardiac and systemic hemodynamic effects.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2022 Journal of Anaesthesiology Clinical Pharmacology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halawa</LastName><ForeName>Naglaa Moustafa</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, National Liver Institute, Menoufia University, Sheeben Elkom City, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Sayed</LastName><ForeName>Amani Mamdouh</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, National Liver Institute, Menoufia University, Sheeben Elkom City, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Ezzeldin Saleh</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, Faculty of Medicine, Menoufia University, Sheeben Elkom City, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khater</LastName><ForeName>Yehia H</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yassen</LastName><ForeName>Khaled Ahmed</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, National Liver Institute, Menoufia University, Sheeben Elkom City, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgery Department, College of Medicine, King Faisal University, Al Hasa, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA><NlmUniqueID>9516972</NlmUniqueID><ISSNLinking>0970-9185</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">cardiac</Keyword><Keyword MajorTopicYN="N">cirrhosis</Keyword><Keyword MajorTopicYN="N">hepatectomy</Keyword><Keyword MajorTopicYN="N">liver</Keyword><Keyword MajorTopicYN="N">lung</Keyword><Keyword MajorTopicYN="N">recruitment</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37250262</ArticleId><ArticleId IdType="pmc">PMC10220178</ArticleId><ArticleId IdType="doi">10.4103/joacp.joacp_188_21</ArticleId><ArticleId IdType="pii">JOACP-39-113</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AbdelWahab M, ElHusseiny T, ElHanafy E, El Shobary M, Hamdy E. Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. Langenbecks Arch Surg. 2010;395:625&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">20358380</ArticleId></ArticleIdList></Reference><Reference><Citation>Paugam-Burtz C, Wendon J, Belghiti J, Mantz J. Case scenario:Postoperative liver failure after liver resection in a cirrhotic patient. Anesthesiology. 2012;116:705&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">22293716</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller S, Hillings&#xf8; J, Christensen E, Henriksen JH. Arterial hypoxaemia in cirrhosis:Fact or fiction?Gut. 1998;42:868&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1727147</ArticleId><ArticleId IdType="pubmed">9691928</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhuri AH, Chandra S, Aggarwal G, Uppal R. Predictors of postoperative pulmonary complications after liver resection:Results from a tertiary care intensive care unit. Indian J Crit Care Med. 2014;18:358&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071679</ArticleId><ArticleId IdType="pubmed">24987234</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepere V, Vanier A, Loncar Y, Lemoine L, Vaillant JC, Monsel A, et al. Risk factors for pulmonary complications after hepatic resection:Role of intraoperative. J Crit Care Med. 2014;18:358&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5477742</ArticleId><ArticleId IdType="pubmed">28633644</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Collino F, Maiolo G, Rapetti F, Romitti F, Tonetti T, et al. Positive end-expiratory pressure:How to set it at the individual level. Ann Transl Med. 2017;5:288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5537121</ArticleId><ArticleId IdType="pubmed">28828363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kredel M, Muellenbach RM, Brock RW, Wilckens HH, Brederlau J, Roewer N, et al. Liver dysfunction after lung recruitment manoeuvres during pressure-controlled ventilation in experimental acute respiratory distress. Critical Care. 2007;11:R13. doi:10.1186/cc5674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2151872</ArticleId><ArticleId IdType="pubmed">17261192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Cao R, Li G, Gong T, Ou Y, Huang J. The effect of lung recruitment maneuvers on postoperative pulmonary complications for patients undergoing general anesthesia:A meta-analysis. PLoS One. 2019;14:e0217405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6541371</ArticleId><ArticleId IdType="pubmed">31141541</ArticleId></ArticleIdList></Reference><Reference><Citation>Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P. Continuous positive airway pressure for treatment of postoperative hypoxemia:A randomized controlled trial. JAMA. 2005;293:589&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">15687314</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui N, Arzola C, Teresi J, Fox G, Guerina L, Friedman Z. Predictors of desaturation in the postoperative anesthesia care unit:An observational study. J Clin Anesth. 2013;25:612&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24095886</ArticleId></ArticleIdList></Reference><Reference><Citation>Yassen K, Lotfy M, Miligi A, Sallam A, Hegazi EAR, Afifi M. Patient-controlled analgesia with and without transverse abdominis plane and rectus sheath space block in cirrhotic patients undergoing liver resection. J Anaesthesiol Clin Pharmacol. 2019;35:58&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6495621</ArticleId><ArticleId IdType="pubmed">31057242</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput RS, Das S, Chauhan S, Bisoi AK, Vasdev S. Comparison of cardiac output measurement by noninvasive method with electrical cardiometry and invasive method with thermodilution technique in patients undergoing coronary artery bypass grafting. World J Cardiovasc Surg. 2014;4:123&#x2013;30.</Citation></Reference><Reference><Citation>Abou-Khaber H, El-Mehalawy A, Nasreldin M, El-Far W. Stepwise PEEP elevation with determination of the alveolar collapsing pressure versus sustained lung inflation as a recruitment maneuver in patients with ARDS. J Am Sci. 2011;7:742&#x2013;9.</Citation></Reference><Reference><Citation>Killeen PR. An alternative to null-hypothesis significance tests. Psychol Sci. 2005;16:345&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1473027</ArticleId><ArticleId IdType="pubmed">15869691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial):A multicenter randomised controlled trial. Lancet. 2014;384:495&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C, Suarez-Sipmann F, Tusman G, Le&#xf3;n I, Romero E, Gracia E, et al. Open lung approach versus standard protective strategies:Effects on driving pressure and ventilatory efficiency during anesthesia-A pilot, randomized controlled trial. PLoS One. 2017;12:e0177399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5426745</ArticleId><ArticleId IdType="pubmed">28493943</ArticleId></ArticleIdList></Reference><Reference><Citation>Severgnini P, Selmo G, Lanza C, Chiesa A, Frigerio A, Bacuzzi A, et al. Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function. Anesthesiology. 2013;118:1307&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">23542800</ArticleId></ArticleIdList></Reference><Reference><Citation>Whalen FX, Gajic O, Thompson GB, Kendrick ML, Que FL, Williams BA, et al. The effects of the alveolar recruitment maneuver and positive end-expiratory pressure on arterial oxygenation during laparoscopic bariatric surgery. Anesth Analg. 2006;102:298&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">16368847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Kim WH, Ryu HG, Lee HC, Chung EJ, Yang SM, et al. Stroke volume variation&#x2013;guided versus central venous pressure&#x2013;guided low central venous pressure with milrinone during living donor hepatectomy:A randomized double-blinded clinical trial. Anesth Analg. 2017;125:423&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">28632543</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson CJE, Kosmoliaptsis V, Randle LV, Gimson AE, Brais R, Klinck JR, et al. Normothermic perfusion in the assessment and preservation of declined livers before transplantation:Hyperoxia and vasoplegia-important lessons from the first 12 cases. Transplantation. 2017;101:1084&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642347</ArticleId><ArticleId IdType="pubmed">28437389</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradini SG, Elisei W, De Marco R, Siciliano M, Iappelli M, Pugliese F, et al. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl. 2005;11:140&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">15666381</ArticleId></ArticleIdList></Reference><Reference><Citation>McNally SJ, Revie EJ, Massie LJ, McKeown DW, Parks RW, Garden OJ, et al. Factors in perioperative care that determine blood loss in liver surgery. HPB. 2012;14:236&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3371209</ArticleId><ArticleId IdType="pubmed">22404261</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ES, Hallet J, Hanna SS, Law CH, Coburn NG, Tarshis J, et al. Is central venous pressure still relevant in the contemporary era of liver resection? J Surg Res. 2016;200:139&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">26342837</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack L, Capitanich P, Qui&#xf1;onez E. Liver surgery in the presence of cirrhosis or steatosis:Is morbidity increased? Patient Saf Surg. 2008;2:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390525</ArticleId><ArticleId IdType="pubmed">18439273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackl C, Schlitt HJ, Renner P, Lang SA. Liver surgery in cirrhosis and portal hypertension. World J Gastroenterol. 2016;22:2725&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777995</ArticleId><ArticleId IdType="pubmed">26973411</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Sun YM, Wu FX, Yang LQ, Lu ZJ, Yu WF. Controlled low central venous pressure reduces blood loss and transfusion requirements in hepatectomy. World J Gastroenterol. 2014;20:303&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3886023</ArticleId><ArticleId IdType="pubmed">24415886</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuschwander A, Futier E, Jaber S, Pereira B, Eurin M, Marret E, et al. The effects of intraoperative lung protective ventilation with positive end-expiratory pressure on blood loss during hepatic resection surgery:A secondary analysis of data from a published randomised control trial (IMPROVE) Eur J Anaesthesiol. 2016;33:292&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26716865</ArticleId></ArticleIdList></Reference><Reference><Citation>Halawa NM, Elshafie MA, Fernandez JG, Metwally AA, Yassen KA. Respiratory and hemodynamic effects of prophylactic alveolar recruitment during liver transplant:A randomized controlled trial. Exp Clin Transplant. 2021;19:462&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">33736584</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH. Perioperative lung-protective ventilation strategy reduces postoperative pulmonary complications in patients undergoing thoracic and major abdominal surgery. Korean J Anesthesiol. 2016;69:3&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4754263</ArticleId><ArticleId IdType="pubmed">26885294</ArticleId></ArticleIdList></Reference><Reference><Citation>The PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthiology. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial) multicenter randomized controlled trial. Lancet. 2014;384:495&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38156486</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">0022-9040</ISSN><JournalIssue CitedMedium="Print"><Volume>63</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>26</Day></PubDate></JournalIssue><Title>Kardiologiia</Title><ISOAbbreviation>Kardiologiia</ISOAbbreviation></Journal><ArticleTitle>Effects of Mitral Valve Surgery on Ventricular Arrhythmia in Mitral Valve Prolapse Patients: Five-Year Eollow-up.</ArticleTitle><Pagination><StartPage>22</StartPage><EndPage>30</EndPage><MedlinePgn>22-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18087/cardio.2023.12.n2273</ELocationID><Abstract><AbstractText>Aim&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; To evaluate the effect of mitral valve (MV) repair and replacement on the incidence of ventricular arrhythmias (VA) and to identify risk factors for the persistence of VA in patients with MV prolapse and severe mitral regurgitation (MR) during a mid-term follow-up.Material and methods&#xa0; A single-site observational, prospective study successively enrolled 30 patients (mean age, 55.2&#xb1;9.9 years, 60% men) who underwent MV repair or replacement for severe MR due to MV prolapse or chordal avulsion. Transthoracic echocardiography and Holter monitoring were performed in all patients before and annually after surgery. A pathomorphological study of MV fragments excised during surgery was performed.Results During the five-year follow-up period (144 person-years), one case of sudden cardiac death outside a health care facility was recorded. MR severity progressed in three patients after MV repair. The total number of all VAs decreased during the follow-up period, with a significant decrease in the number of paroxysms of unstable ventricular tachycardia during the first two years after surgery. The presence of VA in the postoperative period was correlated with the severity of postoperative left ventricular (LV) remodeling: end-diastolic volume (EDV) (rs=0.69; p=0.005), LV ejection fraction (EF) (rs = -0.55; p=0.004) and severity of MV myxomatous alterations according to histological study data (r&#x3c4;=0.58; p=0.045). The beta-blocker treatment did not influence the VA frequency and severity (rs= -0.18; p=0.69). According to a univariate regression analysis only EDV (p = 0.001), LVEF &amp;lt;50% (p = 0.003), and myxomatous MV degeneration (p = 0.02) were risk factors for persistent ventricular tachycardia in the postoperative period.Conclusion&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; Surgical intervention on MV in patients with MV prolapse and severe MR decreased the number of cases of malignant VAs and was correlated with the postoperative changes in LV volume and function, as well as the severity of MV myxomatous alterations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malev</LastName><ForeName>E G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>St.-Petersburg State Pediatric Medical University, Saint Petersburg; Almazov National Medical Research Center, St.-Petersburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omelchenko</LastName><ForeName>M Yu</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Center, St.-Petersburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeva</LastName><ForeName>S V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>St.-Petersburg State Pediatric Medical University, Saint Petersburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitrofanova</LastName><ForeName>L B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Center, St.-Petersburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parfenova</LastName><ForeName>N N</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>St.-Petersburg State Pediatric Medical University, Saint Petersburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timofeev</LastName><ForeName>E V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>St.-Petersburg State Pediatric Medical University, Saint Petersburg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>rus</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Russia (Federation)</Country><MedlineTA>Kardiologiia</MedlineTA><NlmUniqueID>0376351</NlmUniqueID><ISSNLinking>0022-9040</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008944" MajorTopicYN="Y">Mitral Valve Insufficiency</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008945" MajorTopicYN="Y">Mitral Valve Prolapse</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011391" MajorTopicYN="N">Prolapse</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>29</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38156486</ArticleId><ArticleId IdType="doi">10.18087/cardio.2023.12.n2273</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31238025</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1891</ISSN><JournalIssue CitedMedium="Internet"><Volume>207</Volume><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>American journal of ophthalmology</Title><ISOAbbreviation>Am J Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Fast Visual Field Progression in Glaucoma.</ArticleTitle><Pagination><StartPage>268</StartPage><EndPage>278</EndPage><MedlinePgn>268-278</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajo.2019.06.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9394(19)30295-8</ELocationID><Abstract><AbstractText Label="PURPOSE">To identify baseline and longitudinal risk factors for fast visual field (VF) decay in patients with open-angle glaucoma.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="METHODS">Patients with open-angle glaucoma with &#x2265;6 VFs and &#x2265;4 years of follow-up were included. VF decay rates were measured with the following methods: mean deviation (MD) rate, VF index (VFI) rate, and the Glaucoma Rate Index (GRI). The relationship between VF rates and clinical variables were investigated with linear mixed models. Logistic regression analysis was performed to determine which factors were associated with fast progression.</AbstractText><AbstractText Label="RESULTS">A total of 1317 eyes of 745 patients with a mean (&#xb1; SD) age of 63.3 (&#xb1;10.9) years and a median (interquartile range) MD&#xa0;-2.4 (-0.7 to&#xa0;-5.6) dB at baseline were analyzed. The median (interquartile range) number of VFs was 12 (9 to 16), and mean follow-up duration was 11.5 (&#xb1;3.7) years. Older age (P &lt; .001), higher peak intraocular pressure (IOP) (P &lt; .001), and glaucoma surgery during the study period (P &lt; .001) were associated with faster rates of progression regardless of the method used. Worse baseline MD was associated with MD rate (P&#xa0;= .02), but neither with VFI rate (P&#xa0;=&#xa0;.37) nor GRI (P&#xa0;= .31); whereas pseudoexfoliative glaucoma was associated with faster rates of progression with MD (P = .008) and VFI (P = .01) rates, but not with GRI. Higher peak IOPs (P&#xa0;= .005) was a significant predictor for fast progression.</AbstractText><AbstractText Label="CONCLUSION">In this cohort, older age, peak IOP, pseudoexfoliative glaucoma, and baseline MD were associated with the rate of glaucomatous VF worsening. Fast progressors had a higher peak IOP than non-fast progressors. The identification and appropriately aggressive treatment of fast progressors would reduce visual disability from glaucoma.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA; Siloam Eye Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabiolo</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA; Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA; Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afifi</LastName><ForeName>Abdelmonem A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouri-Mahdavi</LastName><ForeName>Kouros</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caprioli</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA. Electronic address: caprioli@jsei.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Ophthalmol</MedlineTA><NlmUniqueID>0370500</NlmUniqueID><ISSNLinking>0002-9394</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058609" MajorTopicYN="N">Visual Field Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31238025</ArticleId><ArticleId IdType="doi">10.1016/j.ajo.2019.06.019</ArticleId><ArticleId IdType="pii">S0002-9394(19)30295-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25332150</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.</ArticleTitle><Pagination><StartPage>151</StartPage><EndPage>157</EndPage><MedlinePgn>151-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.12567</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">We conducted this pilot randomized clinical trial to determine the feasibility of a large clinical trial aimed at testing whether early use of catheter ablation of ventricular tachycardia (VT) is superior to antiarrhythmic medications at reducing mortality.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Patients were enrolled at 4 sites if they had ischemic heart disease, an implantable cardioverter defibrillator (ICD), and received &#x2265;1 ICD shock or &#x2265;3 antitachycardia pacing therapies for VT. Patients were randomized to 2 arms: (1) antiarrhythmic medication (n = 14) and (2) catheter ablation (n = 13); patients were followed at 3 and 6 months. Endpoints included recurrent VT, time to first ICD therapy for VT, and death. Of 243 screened patients, 27 were enrolled. Main reasons for screen failures were: (1) patient was already on an antiarrhythmic medication (88 [41%]), (2) VT due to a reversible cause (23 [11%]), and (3) incessant VT (20 [9%]). Fourteen patients had recurrent VT, 8 (62%) in the ablation arm and 6 (43%) in the antiarrhythmic medication arm. Median time to recurrent VT was 75 days (25th, 75th: 51, 89) in the ablation arm and 57 days (30, 145) in the antiarrhythmic arm. Four patients died, 2 in each arm.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This clinical trial shows that most patients in clinical practice have already failed antiarrhythmic drug therapy before catheter ablation is considered, and the VT recurrence rates and death in these patients are high. For a large clinical trial to be feasible, factors limiting early consideration of catheter ablation need to be identified and addressed.</AbstractText><CopyrightInformation>&#xa9; 2014 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Khatib</LastName><ForeName>Sana M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daubert</LastName><ForeName>James P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Anstrom</LastName><ForeName>Kevin J</ForeName><Initials>KJ</Initials></Author><Author ValidYN="Y"><LastName>Daoud</LastName><ForeName>Emile G</ForeName><Initials>EG</Initials></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Saba</LastName><ForeName>Samir</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials></Author><Author ValidYN="Y"><LastName>Reece</LastName><ForeName>Tammy</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Pokorney</LastName><ForeName>Sean D</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Granger</LastName><ForeName>Christopher B</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Paul L</ForeName><Initials>PL</Initials></Author><Author ValidYN="Y"><LastName>Mark</LastName><ForeName>Daniel B</ForeName><Initials>DB</Initials></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>William G</ForeName><Initials>WG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004554" MajorTopicYN="N">Electric Countershock</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CALYPSO</Keyword><Keyword MajorTopicYN="N">antiarrhythmic medications</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">ischemic heart disease</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25332150</ArticleId><ArticleId IdType="doi">10.1111/jce.12567</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15120824</PMID><DateCompleted><Year>2004</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0735-1097</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>9</Issue><PubDate><Year>2004</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Predictors of new malignant ventricular arrhythmias after coronary surgery: a case-control study.</ArticleTitle><Pagination><StartPage>1630</StartPage><EndPage>1638</EndPage><MedlinePgn>1630-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We sought to investigate the relationship between perioperative factors and the occurrence of ventricular tachycardia (VT) and ventricular fibrillation (VF), as well as the impact of VT/VF on early and late mortality.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Both VT and VF are rare but serious complications after coronary artery bypass graft surgery (CABG), and their etiology and implications remain uncertain.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data on 4,411 consecutive patients undergoing CABG (1,154 [25.8%] had off-pump surgery) between April 1996 and September 2001 were extracted from a prospective database and analyzed. Odds ratios (ORs) describing associations between possible risk factors and VT/VF were estimated separately. Factors observed to be significantly associated with VT/VF were further investigated using multivariate logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty-nine patients suffered VT/VF (1.6%). There were 61 (1.4%) in-hospital/30-day deaths, 15 among patients who had postoperative VT/VF (21.7%). Patient factors independently associated with an increase in the odds of VT/VF included age &lt;65 years, female gender, body mass index &lt;25 kg/m(2), unstable angina, moderate or poor ejection fraction, and the need for inotropes and an intra-aortic balloon pump (OR 1.72 to 4.47, p &lt; 0.05). After adjustment, off-pump surgery was associated with a substantial but nonsignificant protective effect against VT/VF (OR 0.53, 95% confidence interval [CI] 0.25 to 1.13; p = 0.10). Actuarial survival at two years was 98.2% among patients who had VT/VF and who survived to discharge/30 days, compared with 97.0% for the control group (adjusted hazard ratio 0.96 (95% CI 0.40 to 2.31, p = 0.92).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of VT/VF is low in patients undergoing coronary surgery but is associated with high in-hospital mortality. The late survival of the discharged VT/VF patients compares favorably with that of controls.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ascione</LastName><ForeName>Raimondo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United Kingdom. R.Ascione@bristol.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeves</LastName><ForeName>Barnaby C</ForeName><Initials>BC</Initials></Author><Author ValidYN="Y"><LastName>Santo</LastName><ForeName>Kirkpatrick</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Nouman</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Angelini</LastName><ForeName>Gianni D</ForeName><Initials>GD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="Y">Coronary Artery Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003327" MajorTopicYN="N">Coronary Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2003</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>5</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>6</Month><Day>21</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>5</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15120824</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2003.11.056</ArticleId><ArticleId IdType="pii">S073510970400350X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40445108</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Ventricular Arrhythmia During Off-Pump Coronary Artery Bypass grafting-Incidence, Risk Factors, and Outcomes.</ArticleTitle><Pagination><StartPage>1738</StartPage><EndPage>1746</EndPage><MedlinePgn>1738-1746</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/wjs.12641</ELocationID><Abstract><AbstractText Label="BACKGROUND">Ventricular arrhythmia (VA) is a critical complication of off-pump coronary artery bypass grafting (OPCABG). However, few studies have explored the impact of VA during operative. This study aimed to determine the incidence, risk factors, and outcomes of intraoperative VA.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study consecutively reviewed patients who underwent isolated OPCABG at the Affiliated Hospital of Qingdao University from January 2016 to January 2021. Based on the occurrence of intraoperative VA, patients were divided into an intraoperative VA group and a non-intraoperative VA group. Multivariate logistic and COX regression models were used to determine the independent risk factors of intraoperative VA and the effect on short-term mortality of intraoperative VA, respectively.</AbstractText><AbstractText Label="RESULTS">A total of 2.4% (44/1829) of the patients experienced intraoperative VA, of whom 43 patients were treated with internal shocks. 22 (50%) patients experienced intraoperative VA during anastomosis. Multivariate logistic regression showed that emergency surgery, heart failure, history of coronary stent implantation, and BMI&#xa0;&lt;&#xa0;25&#xa0;kg/m<sup>2</sup> were independent risk factors of intraoperative VA. Among these factors, emergency surgery was the most important predictive factor. The mortality of the intraoperative VA group was much higher than the control group (18.2% vs. 3.6%, adjusted HR&#xa0;=&#xa0;4.605, 95%CI 2.126-9.978, and P&#xa0;&lt;&#xa0;0.001).</AbstractText><AbstractText Label="CONCLUSION">Emergency surgery, heart failure, history of coronary artery stent implantation, and BMI&#xa0;&lt;&#xa0;25&#xa0;kg/m<sup>2</sup> were independent risk factors of intraoperative VA. Intraoperative VA has a low incidence during OPCABG; however, it significantly increases the risk of short-term mortality.</AbstractText><CopyrightInformation>&#xa9; 2025 International Society of Surgery/Soci&#xe9;t&#xe9; Internationale de Chirurgie (ISS/SIC).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yangyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Wenjie</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Wuhan Asia General Hospital, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, The Affiliated Hospital of Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Linming</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Wuhan Jianjia Rehabilitation Hospital, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Honghui</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0000-4311-7573</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047549" MajorTopicYN="Y">Coronary Artery Bypass, Off-Pump</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">off&#x2010;pump coronary artery bypass grafting</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>18</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40445108</ArticleId><ArticleId IdType="doi">10.1002/wjs.12641</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>R. H. Mehta, A. Z. Starr, R. D. Lopes, et&#xa0;al., &#x201c;Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention,&#x201d; JAMA 301, no. 17 (2009): 1779&#x2013;1789, https://doi.org/10.1001/jama.2009.600.</Citation></Reference><Reference><Citation>R. H. Mehta, K. J. Harjai, L. Grines, et&#xa0;al., &#x201c;Sustained Ventricular Tachycardia or Fibrillation in the Cardiac Catheterization Laboratory Among Patients Receiving Primary Percutaneous Coronary Intervention: Incidence, Predictors, and Outcomes,&#x201d; Journal of the American College of Cardiology 43, no. 10 (2004): 1765&#x2013;1772, https://doi.org/10.1016/j.jacc.2003.09.072.</Citation></Reference><Reference><Citation>J. Ma, H.&#x2010;J. Liao, F.&#x2010;Wu Shi, J.&#x2010;H. An, S.&#x2010;G. Zhao, and Q.&#x2010;Li Ma, &#x201c;Effects of Off&#x2010;Pump Coronary Artery Bypass Graft on the Clinical Efficacy, Surgical Indicators, and Cardiac Function of Patients With Coronary Heart Disease,&#x201d; Annals of Palliative Medicine 10, no. 1 (2021): 597&#x2013;605, https://doi.org/10.21037/apm&#x2010;20&#x2010;2560.</Citation></Reference><Reference><Citation>E. E. Tekin, M.met Ali Ye&#x15f;ilta&#x15f;, and &#x130;. Haberal, &#x201c;Short&#x2010;Term Results of Ivabradine Versus Metoprolol: The Effects on Atrial Fibrillation in Patients Undergoing Off&#x2010;Pump Coronary Artery Bypass Grafting,&#x201d; Brazilian Journal of Cardiovascular Surgery 37, no. 6 (2022), https://doi.org/10.21470/1678&#x2010;9741&#x2010;2021&#x2010;0201.</Citation></Reference><Reference><Citation>E. Mujanovic, E. Kabil, M. Hadziselimovic, M. Softic, A. Azabagic, and J. Bergsland, &#x201c;Conversions in Off&#x2010;Pump Coronary Surgery,&#x201d; Heart Surgery Forum 6, no. 3 (2003): 135&#x2013;137, https://doi.org/10.1532/hsf.885.</Citation></Reference><Reference><Citation>T. Fujimatsu, T. Nitta, H. Osawa, and K. Shimizu, &#x201c;Serial Changes in Epicardial Electrograms During and After a Coronary Artery Occlusion,&#x201d; General Thoracic and Cardiovascular Surgery 58, no. 7 (2010): 323&#x2013;330, https://doi.org/10.1007/s11748&#x2010;010&#x2010;0590&#x2010;2.</Citation></Reference><Reference><Citation>R. Ascione, B. C. Reeves, K. Santo, N. Khan, and G. D. Angelini, &#x201c;Predictors of New Malignant Ventricular Arrhythmias After Coronary Surgery: A Case&#x2010;Control Study,&#x201d; Journal of the American College of Cardiology 43, no. 9 (2004): 1630&#x2013;1638, https://doi.org/10.1016/j.jacc.2003.11.056.</Citation></Reference><Reference><Citation>J.&#x2010;W. Chen, C.&#x2010;H. Lin, and R.&#x2010;B. Hsu, &#x201c;Malignant Ventricular Arrhythmias After Off&#x2010;Pump Coronary Artery Bypass,&#x201d; Journal of the Formosan Medical Association 114, no. 10 (2015): 936&#x2013;942, https://doi.org/10.1016/j.jfma.2014.02.005.</Citation></Reference><Reference><Citation>M. F. El&#x2010;Chami, F. J. Sawaya, P. Kilgo, et&#xa0;al., &#x201c;Ventricular Arrhythmia After Cardiac Surgery: Incidence, Predictors, and Outcomes,&#x201d; Journal of the American College of Cardiology 60, no. 25 (2012): 2664&#x2013;2671, https://doi.org/10.1016/j.jacc.2012.08.1011.</Citation></Reference><Reference><Citation>J. S. Steinberg, A. Gaur, R. Sciacca, and E. Tan, &#x201c;New&#x2010;Onset Sustained Ventricular Tachycardia After Cardiac Surgery,&#x201d; Circulation (New York, N. Y.) 99, no. 7 (1999): 903&#x2013;908, https://doi.org/10.1161/01.cir.99.7.903.</Citation></Reference><Reference><Citation>Y. Zheng, Q. Gu, H.&#x2010;wu Chen, et&#xa0;al., &#x201c;Efficacy of Amiodarone and Lidocaine for Preventing Ventricular Fibrillation After Aortic Cross&#x2010;Clamp Release in Open Heart Surgery: A Meta&#x2010;Analysis of Randomized Controlled Trials,&#x201d; Journal of Zhejiang University &#x2010; Science B 18, no. 12 (2017): 1113&#x2013;1122, https://doi.org/10.1631/jzus.B1700229.</Citation></Reference><Reference><Citation>M. Yilmaz, U. Aydin, Z. I. Arslan, et&#xa0;al., &#x201c;The Effect of Lidocaine and Amiodarone on Prevention of Ventricular Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting,&#x201d; Heart Surgery Forum 17, no. 5 (2014): E245&#x2013;E249, https://doi.org/10.1532/HSF98.2014402.</Citation></Reference><Reference><Citation>W. J. Mauermann, J. N. Pulido, D. W. Barbara, et&#xa0;al., &#x201c;Amiodarone Versus Lidocaine and Placebo for the Prevention of Ventricular Fibrillation After Aortic Crossclamping: A Randomized, Double&#x2010;Blind, Placebo&#x2010;Controlled Trial,&#x201d; Journal of Thoracic and Cardiovascular Surgery 144, no. 5 (2012): 1229&#x2013;1234, https://doi.org/10.1016/j.jtcvs.2012.06.039.</Citation></Reference><Reference><Citation>D. E. Hofsten, K. Wachtell, B. Lund, H. Molgaard, and K. Egstrup, &#x201c;Prevalence and Prognostic Implications of Non&#x2010;Sustained Ventricular Tachycardia in ST&#x2010;Segment Elevation Myocardial Infarction After Revascularization With Either Fibrinolysis or Primary Angioplasty,&#x201d; European Heart Journal 28, no. 4 (2007): 407&#x2013;414, https://doi.org/10.1093/eurheartj/ehl476.</Citation></Reference><Reference><Citation>J.&#x2010;K. Shim, K.&#x2010;S. Kim, P. Couture, et&#xa0;al., &#x201c;Hemodynamic Management During Off&#x2010;Pump Coronary Artery Bypass Surgery: A Narrative Review of Proper Targets for Safe Execution and Troubleshooting,&#x201d; Korean Journal of Anesthesiology 76, no. 4 (2023): 267&#x2013;279, https://doi.org/10.4097/kja.23103.</Citation></Reference><Reference><Citation>B. Simsek, S. Kostantinis, J. Karacsonyi, et&#xa0;al., &#x201c;Body Mass Index and Chronic Total Occlusion Percutaneous Coronary Intervention Outcomes: Is Overweight the New Normal?,&#x201d; Journal of Invasive Cardiology 35, no. 3 (2023): JIC20230113&#x2010;1, https://doi.org/10.25270/jic/22.00033.</Citation></Reference><Reference><Citation>F. &#x15e;ayl&#x131;k, T. &#xc7;&#x131;nar, and M. &#x130;. Hay&#x131;ro&#x11f;lu, &#x201c;Effect of the Obesity Paradox on Mortality in Patients With Acute Coronary Syndrome: A Comprehensive Meta&#x2010;Analysis of the Literature,&#x201d; Balkan Medical Journal 40, no. 2 (2023): 93&#x2013;103, https://doi.org/10.4274/balkanmedj.galenos.2022.2022&#x2010;11&#x2010;56.</Citation></Reference><Reference><Citation>R. Gupta, E. Mahmoudi, A. H. Behnoush, et&#xa0;al., &#x201c;Effect of BMI on Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta&#x2010;Analysis,&#x201d; Progress in Cardiovascular Diseases 78 (2023): 58&#x2013;66: S0033&#x2010;0620(22)00158&#x2010;X, https://doi.org/10.1016/j.pcad.2022.12.006.</Citation></Reference><Reference><Citation>A. Sharma, A. Vallakati, A. J. Einstein, et&#xa0;al., &#x201c;Relationship of Body Mass Index With Total Mortality, Cardiovascular Mortality, and Myocardial Infarction After Coronary Revascularization: Evidence From a Meta&#x2010;Analysis,&#x201d; Mayo Clinic Proceedings 89, no. 8 (2014): 1080&#x2013;1100, https://doi.org/10.1016/j.mayocp.2014.04.020.</Citation></Reference><Reference><Citation>A. Romero&#x2010;Corral, V. M. Montori, V. K. Somers, et&#xa0;al., &#x201c;Association of Bodyweight With Total Mortality and With Cardiovascular Events in Coronary Artery Disease: A Systematic Review of Cohort Studies,&#x201d; Lancet 368, no. 9536 (2006): 666&#x2013;678, https://doi.org/10.1016/S0140&#x2010;6736(06)69251&#x2010;9.</Citation></Reference><Reference><Citation>C. M. Gibson, Y. B. Pride, J. L. Buros, et&#xa0;al., &#x201c;Association of Impaired Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade With Ventricular Tachycardia and Ventricular Fibrillation Following Fibrinolytic Therapy for ST&#x2010;Segment Elevation Myocardial Infarction,&#x201d; Journal of the American College of Cardiology 51, no. 5 (2008): 546&#x2013;551, https://doi.org/10.1016/j.jacc.2007.08.061.</Citation></Reference><Reference><Citation>C. Ueki, G. Sakaguchi, T. Akimoto, T. Shintani, Y. Ohashi, and H. Sato, &#x201c;Influence of Previous Percutaneous Coronary Intervention on Clinical Outcome of Coronary Artery Bypass Grafting: A Meta&#x2010;Analysis of Comparative Studies,&#x201d; Interactive Cardiovascular and Thoracic Surgery 20, no. 4 (2015): 531&#x2013;537, https://doi.org/10.1093/icvts/ivu449.</Citation></Reference><Reference><Citation>G. Mariscalco, S. Rosato, G. F. Serraino, et&#xa0;al., &#x201c;Prior Percutaneous Coronary Intervention and Mortality in Patients Undergoing Surgical Myocardial Revascularization: Results From the E&#x2010;CABG (European Multicenter Study on Coronary Artery Bypass Grafting) With a Systematic Review and Meta&#x2010;Analysis,&#x201d; Circulation: Cardiovascular Interventions 11, no. 2 (2018): e005650, https://doi.org/10.1161/CIRCINTERVENTIONS.117.005650.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15846712</PMID><DateCompleted><Year>2005</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>2</Issue><PubDate><Year>2005</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Medical versus surgical interventions for open angle glaucoma.</ArticleTitle><Pagination><StartPage>CD004399</StartPage><MedlinePgn>CD004399</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Open angle glaucoma (OAG) is the commonest cause of irreversible blindness worldwide.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To study the relative effects of medical and surgical treatment of OAG.</AbstractText><AbstractText Label="SEARCH STRATEGY" NlmCategory="METHODS">We searched the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 1, 2005), MEDLINE (1966 to February 2005), EMBASE (1988 to February 2005), and reference lists of articles. We also contacted researchers in the field.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Randomised controlled trials comparing medications to surgery in adults.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two authors independently assessed trial quality and extracted data. We contacted trial investigators for missing information.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Four trials involving 888 participants with previously untreated OAG were included. Surgery was Scheie's procedure in one trial and trabeculectomy in three trials. In three trials, primary medication was usually pilocarpine, in one trial a beta-blocker. In the most recent trial, participants with mild OAG, progressive visual field (VF) loss, after adjustment for cataract surgery, was not significantly different for medications compared to trabeculectomy (Odds ratio (OR) 0.74; 95% CI 0.54 to 1.01). Reduction of vision, with a higher risk of developing cataract (OR 2.69, 95%% CI 1.64 to 4.42), and more patient discomfort was more likely with trabeculectomy than medication. There is some evidence, from three trials, for people with moderately advanced glaucoma that medication is associated with more progressive VF loss and 6 to 8 mmHg less intraocular pressure (IOP) lowering than surgery, either by a Scheie's procedure or trabeculectomy. There was a trend towards an increased risk of failed IOP control over time for initial pilocarpine treatment compared to trabeculectomy. In the longer-term (two trials) the risk of failure was significantly greater with medication than trabeculectomy (OR 3.90, 95% CI 1.60 to 9.53; HR 7.27, 95% CI 2.23 to 25.71). Medicine and surgery have evolved since these trials were undertaken, and additionally the evidence is potentially subject to detection and attrition bias.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Evidence from one trial suggests, for mild OAG, that VF deterioration up to five-years is not significantly different whether treatment is initiated with medication or trabeculectomy. Reduced vision, cataract and eye discomfort are more likely with trabeculectomy. There is some evidence, for more severe OAG, that initial medication (pilocarpine, now rarely used as first line medication) is associated with greater VF deterioration than surgery. In general, surgery lowers IOP more than medication. There was no evidence to determine the effectiveness of contemporary medication (prostaglandin analogues, alpha2-agonists and topical carbonic anhydrase inhibitors) compared to surgery in severe OAG, and in people of black African ethnic origin who have a greater risk of more severe open angle glaucoma. More research is required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burr</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Services Research Unit, University of Aberdeen, Foresterhill Lea, Aberdeen, UK, AB 2ZD25. j.m.burr@abdn.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azuara-Blanco</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Avenell</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>01MI4Q9DI3</RegistryNumber><NameOfSubstance UI="D010862">Pilocarpine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004399. doi: 10.1002/14651858.CD004399.pub3.</RefSource><PMID Version="1">22972069</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010862" MajorTopicYN="N">Pilocarpine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="N">Trabeculectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>65</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>4</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>7</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>4</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15846712</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD004399.pub2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22201185</PMID><DateCompleted><Year>2012</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Alveolar recruitment improves ventilation during thoracic surgery: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>517</StartPage><EndPage>524</EndPage><MedlinePgn>517-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aer415</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study was conducted to determine whether an alveolar recruitment strategy (ARS) applied during two-lung ventilation (TLV) just before starting one-lung ventilation (OLV) improves ventilatory efficiency.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Subjects were randomly allocated to two groups: (i) control group: ventilation with tidal volume (VT) of 8 or 6 ml kg(-1) for TLV and OLV, respectively, and (ii) ARS group: same ventilatory pattern with ARS consisting of 10 consecutive breaths at a plateau pressure of 40 and 20 cm H(2)O PEEP applied immediately before and after OLV. Volumetric capnography and arterial blood samples were recorded 5 min (baseline) and 20 min into TLV, at 20 and 40 min during OLV, and finally 10 min after re-establishing TLV.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty subjects were included in each group. In all subjects, the airway component of dead space remained constant during the study. Compared with baseline, the alveolar dead space ratio (VD(alv)/VT(alv)) increased throughout the protocol in the control but decreased in the ARS group. Differences in VD(alv)/VT(alv) between groups were significant (P&lt;0.001). Except for baseline, all values in kPa (sd) were higher in the ARS than in the control group (P&lt;0.001), respectively [70 (7) and 55 (9); 33 (9) and 24 (10); 33 (8) and 22 (10); 70 (7) and 55 (10)].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Recruitment of both lungs before instituting OLV not only decreased alveolar dead space but also improved arterial oxygenation and the efficiency of ventilation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Unzueta</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hospital de Sant Pau, Barcelona, Spain. mcunzueta@telefonica.net</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tusman</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Suarez-Sipmann</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>B&#xf6;hm</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Moral</LastName><ForeName>V</ForeName><Initials>V</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>142M471B3J</RegistryNumber><NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019296" MajorTopicYN="N">Capnography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010313" MajorTopicYN="N">Partial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011650" MajorTopicYN="N">Pulmonary Alveoli</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="N">Respiratory Mechanics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22201185</ArticleId><ArticleId IdType="doi">10.1093/bja/aer415</ArticleId><ArticleId IdType="pii">S0007-0912(17)32319-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34236526</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1862-3514</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>Archives of osteoporosis</Title><ISOAbbreviation>Arch Osteoporos</ISOAbbreviation></Journal><ArticleTitle>The aging spine: the effect of vertebral fragility fracture on sagittal alignment.</ArticleTitle><Pagination><StartPage>109</StartPage><MedlinePgn>109</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11657-021-00975-w</ELocationID><Abstract><AbstractText Label="UNLABELLED">Our study investigates the relationship, in the aging population, between vertebral fractures, spinal alignment, and quality of life. Kyphotic fractures were related to more significant disability and impaired spinopelvic alignment. The spinal malalignment was strongly associated with fractures in the thoracolumbar junction vertebrae and the absence of powerful compensatory mechanisms as thoracic hypokyphosis and lower lumbar hyperlordosis.</AbstractText><AbstractText Label="INTRODUCTION">In adult spine deformity (ASD), the sagittal imbalance is defined by the deformity in the sagittal plane that causes the need for greater use of muscle strength to maintain an upright static posture or walking. Fragility vertebral fractures (VF) and ASD are frequent causes of spinal morbidity in the elderly. The prevalence of both ASD and VF increases with aging. Although these two clinical conditions insist on the same population, little is known about the interactions between sagittal imbalance and vertebral fracture (VF) deformity. The aim of our work is to examine the associations between vertebral fractures, sagittal alignment, and their impact on the quality of life scores in elderly patients.</AbstractText><AbstractText Label="METHODS">A retrospective cohort study of 110 patients of both sexes, from a spine surgery waiting list, with at least one VF with&#x2009;&#x2265;&#x2009;5&#xb0; of kyphosis and a full-standing X-ray.</AbstractText><AbstractText Label="INDEPENDENT VARIABLES">the presence of VF with kyphotic deformity&#x2009;&#x2265;&#x2009;10&#xb0;, fracture level, degree of kyphosis (deformity) of the fracture, number of fractures, spinopelvic angular parameters, demographic parameters, and scales of evaluation of the health-related quality of life.</AbstractText><AbstractText Label="RESULTS">A total of 110 patients with mean age 73.8&#x2009;&#xb1;&#x2009;5.2, of which 70 women (63%) were included in the study. Subjects with at least one VF&#x2009;&#x2265;&#x2009;10&#xb0; presented greater disability and an overall worse sagittal spinal alignment (no VF10&#xb0; vs VF10&#xb0;: TPA 21.30&#x2009;&#xb1;&#x2009;11.5 vs 26.51&#x2009;&#xb1;&#x2009;12.6, p&#x2009;=&#x2009;0.041) and more disability (no VF10&#xb0; vs VF10&#xb0;: ODI 41.91&#x2009;&#xb1;&#x2009;16.9 vs 54.67&#x2009;&#xb1;&#x2009;15.8, p&#x2009;&lt;&#x2009;0.001) than patients with less degree of vertebral deformity. Significant compensatory mechanisms involved the thoracic area and the lower lumbar region.</AbstractText><AbstractText Label="CONCLUSION">Kyphotic VFs were associated with severe alterations of sagittal spine alignment and perceived disability. Subjects with sagittal imbalance have a greater degree of deformity in the thoracolumbar junction area. Thoracic hypokyphosis and lower lumbar hyperlordosis are effective compensatory mechanisms in case of lumbar or thoracic fracture, respectively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Langella</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8639-8480</Identifier><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy. Francesco.langella.md@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balestrino</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurosurgery and Neurotraumatology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damilano</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchinato</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biber</LastName><ForeName>Zeno</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Casa Di Cura 'Sileno E Anna Rizzola', San Don&#xe0; di Piave, Venezia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paoletta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iolascon</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamartina</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peretti</LastName><ForeName>Giuseppe M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berjano</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Osteoporos</MedlineTA><NlmUniqueID>101318988</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adult spine deformity</Keyword><Keyword MajorTopicYN="N">Compensatory mechanism</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Sagittal imbalance</Keyword><Keyword MajorTopicYN="N">Spine osteoarthritis</Keyword><Keyword MajorTopicYN="N">Vertebral deformity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34236526</ArticleId><ArticleId IdType="doi">10.1007/s11657-021-00975-w</ArticleId><ArticleId IdType="pii">10.1007/s11657-021-00975-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bess S, Line B, Fu K-M et al (2016) The health impact of symptomatic adult spinal deformity: comparison of deformity types to United States population norms and chronic diseases. Spine 41:224&#x2013;233. https://doi.org/10.1097/BRS.0000000000001202</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000001202</ArticleId><ArticleId IdType="pubmed">26571174</ArticleId><ArticleId IdType="pmc">4718181</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab F, Dubey A, Gamez L et al (2005) Adult scoliosis: prevalence, SF-36, and nutritional parameters in an elderly volunteer population. Spine 30:1082&#x2013;1085. https://doi.org/10.1097/01.brs.0000160842.43482.cd</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.brs.0000160842.43482.cd</ArticleId><ArticleId IdType="pubmed">15864163</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab F, Ungar B, Blondel B et al (2012) Scoliosis research society&#x2014;Schwab adult spinal deformity classification: a validation study. Spine 37:1077&#x2013;1082. https://doi.org/10.1097/BRS.0b013e31823e15e2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e31823e15e2</ArticleId><ArticleId IdType="pubmed">22045006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafage V, Schwab F, Patel A et al (2009) Pelvic tilt and truncal inclination: two key radiographic parameters in the setting of adults with spinal deformity. Spine 34:E599-606. https://doi.org/10.1097/BRS.0b013e3181aad219</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e3181aad219</ArticleId><ArticleId IdType="pubmed">19644319</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CS, Lee CK, Kim YT et al (2001) Dynamic sagittal imbalance of the spine in degenerative flat back: significance of pelvic tilt in surgical treatment. Spine 26:2029&#x2013;2035. https://doi.org/10.1097/00007632-200109150-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200109150-00017</ArticleId><ArticleId IdType="pubmed">11547204</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellis&#xe9; F, Vila-Casademunt A, Issa D et al (2014) Impact on health related quality of life of adult spinal deformity (ASD) compared with other chronic conditions. Eur Spine J 23:S493</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-3036-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnell O, Kanis JA (2004) An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15:897&#x2013;902. https://doi.org/10.1007/s00198-004-1627-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-004-1627-0</ArticleId><ArticleId IdType="pubmed">15490120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, McCloskey EV, Johansson H et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23&#x2013;57. https://doi.org/10.1007/s00198-012-2074-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-012-2074-y</ArticleId><ArticleId IdType="pubmed">23079689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Lee HS, Shin JK et al (2013) Prediction of sagittal balance in patients with osteoporosis using spinopelvic parameters. Eur Spine J 22:1053&#x2013;1058. https://doi.org/10.1007/s00586-013-2672-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-2672-1</ArticleId><ArticleId IdType="pubmed">23354778</ArticleId><ArticleId IdType="pmc">3657054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-L, Shi L-T, Tang P-F et al (2017) Correlation analysis of osteoporotic vertebral compression fractures and spinal sagittal imbalance. Orthopade 46:249&#x2013;255. https://doi.org/10.1007/s00132-016-3359-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00132-016-3359-1</ArticleId><ArticleId IdType="pubmed">28116458</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey JH, Lane JM (1985) Structural scoliosis in osteoporotic women. Clin Orthop Relat Res 195:216&#x2013;223. https://doi.org/10.1097/00003086-198505000-00025</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003086-198505000-00025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismael M, Villafa&#xf1;e JH, Cabitza F et al (2018) Spine surgery registries: hope for evidence-based spinal care? J Spine Surg (Hong Kong) 4:456&#x2013;458. https://doi.org/10.21037/jss.2018.05.19</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jss.2018.05.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairbank JC, Pynsent PB (2000) The Oswestry disability index. Spine 25:2940&#x2013;52. discussion 2952. https://doi.org/10.1097/00007632-200011150-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200011150-00017</ArticleId><ArticleId IdType="pubmed">11074683</ArticleId></ArticleIdList></Reference><Reference><Citation>Langella F, Barletta P, Baroncini A et al (2021) The use of electronic PROMs provides same outcomes as paper version in a spine surgery registry. Results from a prospective cohort study. Eur Spine J. https://doi.org/10.1007/s00586-021-06834-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-021-06834-z</ArticleId><ArticleId IdType="pubmed">34081185</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannion AF, Vila-Casademunt A, Domingo-S&#xe0;bat M et al (2016) The Core Outcome Measures Index (COMI) is a responsive instrument for assessing the outcome of treatment for adult spinal deformity. Eur Spine J 25:2638&#x2013;2648. https://doi.org/10.1007/s00586-015-4292-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-015-4292-4</ArticleId><ArticleId IdType="pubmed">26519374</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert TJ, Purtill J, Mesa J et al (1995) Health outcome assessment before and after adult deformity surgery: a prospective study. Spine 20:2002&#x2013;2005. https://doi.org/10.1097/00007632-199509150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199509150-00009</ArticleId><ArticleId IdType="pubmed">8578376</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjano P, Damilano M, Bozzaro M et al (2013) Standing lateral lumbar spine and pelvis (SLLP) radiograph: a screening, reduced radiation method, for sagittal imbalance. Eur Spine J 22 Suppl 6:S842&#x2013;S846. https://doi.org/10.1007/s00586-013-3026-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-3026-8</ArticleId><ArticleId IdType="pubmed">24072339</ArticleId></ArticleIdList></Reference><Reference><Citation>Langella F, Villafa&#xf1;e JH, Damilano M et al (2017) Predictive accuracy of surgimap surgical planning for sagittal imbalance: a cohort study. Spine 42(22):E1297&#x2013;E1304. https://doi.org/10.1097/BRS.0000000000002230</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000002230</ArticleId><ArticleId IdType="pubmed">28542103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamartina C, Berjano P (2014) Classification of sagittal imbalance based on spinal alignment and compensatory mechanisms. Eur Spine J 23:1177&#x2013;1189. https://doi.org/10.1007/s00586-014-3227-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-014-3227-9</ArticleId><ArticleId IdType="pubmed">24682355</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu DC, Chou D (2007) Flatback syndrome - iatrogenic etiologie through previous fusion. Neurosurg Clin N Am 18:289&#x2013;294</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nec.2007.01.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagrone MO, Bradford DS, Moe JH et al (1988) Treatment of symptomatic flatback after spinal fusion. J Bone Joint Surg Am 70:569&#x2013;580</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-198870040-00014</ArticleId></ArticleIdList></Reference><Reference><Citation>Farcy J-PC, Schwab FJ (1997) Management of flatback and related kyphotic decompensation syndromes. Spine 22:2452&#x2013;2457. https://doi.org/10.1097/00007632-199710150-00025</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199710150-00025</ArticleId><ArticleId IdType="pubmed">9355229</ArticleId></ArticleIdList></Reference><Reference><Citation>Boos N, Weissbach S, Rohrbach H et al (2002) Classification of age-related changes in lumbar intervertebral discs. Spine 27:2631&#x2013;2644. https://doi.org/10.1097/00007632-200212010-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200212010-00002</ArticleId><ArticleId IdType="pubmed">12461389</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelb DEE, Lenke LGG, Bridwell KHH et al (1995) An analysis of sagittal spinal alignment in 100 asymptomatic middle and older aged volunteers. Spine 20:1351&#x2013;1358</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199520120-00005</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkkola R, Kormano M (1992) Lumbar disc and back muscle degeneration on MRI: correlation to age and body mass. J Spinal Disord 5:86&#x2013;92. https://doi.org/10.1097/00002517-199203000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002517-199203000-00011</ArticleId><ArticleId IdType="pubmed">1571617</ArticleId></ArticleIdList></Reference><Reference><Citation>Boden S, Davis D, Dina T et al (1990) Abnormal magnetic-resonance scans of the cervical spine in asymptomatic subjects. J Bone Jt Surg 72:403&#x2013;408</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-199072030-00013</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrey C, Roussouly P, Perrin G, Le Huec JC (2011) Sagittal balance disorders in severe degenerative spine. Can we identify the compensatory mechanisms? Eur Spine J 20:1&#x2013;8. https://doi.org/10.1007/s00586-011-1930-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-011-1930-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Korovessis P, Dimas A, Iliopoulos P, Lambiris E (2002) Correlative analysis of lateral vertebral radiographic variables and medical outcomes study short-form health survey: a comparative study in asymptomatic volunteers versus patients with low back pain. J Spinal Disord Tech 15:384&#x2013;390. https://doi.org/10.1097/00024720-200210000-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024720-200210000-00007</ArticleId><ArticleId IdType="pubmed">12394662</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson RP, Peterson MD, McManus AC, Hales C (1998) Compensatory spinopelvic balance over the hip axis and better reliability in measuring lordosis to the pelvic radius on standing lateral radiographs of adult volunteers and patients. Spine 23:1750&#x2013;1767. https://doi.org/10.1097/00007632-199808150-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199808150-00008</ArticleId><ArticleId IdType="pubmed">9728376</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Huec JC, Aunoble S, Philippe L, Nicolas P (2011) Pelvic parameters: origin and significance. Eur Spine J 20:1&#x2013;8. https://doi.org/10.1007/s00586-011-1940-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-011-1940-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrey C, Jund J, Noseda O, Roussouly P (2007) Sagittal balance of the pelvis-spine complex and lumbar degenerative diseases. A comparative study about 85 cases. Eur Spine J 16:1459&#x2013;1467. https://doi.org/10.1007/s00586-006-0294-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-006-0294-6</ArticleId><ArticleId IdType="pubmed">17211522</ArticleId><ArticleId IdType="pmc">2200735</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson RP, McManus AC (1994) Radiographic analysis of sagittal plane alignment and balance in standing volunteers and patients with low back pain matched for age, sex, and size A prospective controlled clinical study. Spine 19:1611&#x2013;1618</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199407001-00010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafage R, Schwab F, Challier V et al (2016) Defining spino-pelvic alignment thresholds: should operative goals in adult spinal deformity surgery account for age? Spine 41(1):62&#x2013;68. https://doi.org/10.1097/BRS.0000000000001171</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000001171</ArticleId><ArticleId IdType="pubmed">26689395</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnake KJ, Blattert TR, Hahn P et al (2018) Classification of osteoporotic thoracolumbar spine fractures: recommendations of the spine section of the German Society for Orthopaedics and Trauma (DGOU). Glob Spine J 8:46S-49S. https://doi.org/10.1177/2192568217717972</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568217717972</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung HJ, Park Y-S, Seo H-Y et al (2017) Quality of life in patients with osteoporotic vertebral compression fractures. J Bone Metab 24:187. https://doi.org/10.11005/jbm.2017.24.3.187</Citation><ArticleIdList><ArticleId IdType="doi">10.11005/jbm.2017.24.3.187</ArticleId><ArticleId IdType="pubmed">28955695</ArticleId><ArticleId IdType="pmc">5613024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall SE, Criddle RA, Comito TL, Prince RL (1999) A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int 9:508&#x2013;515. https://doi.org/10.1007/s001980050178</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001980050178</ArticleId><ArticleId IdType="pubmed">10624458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29754277</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0827</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Calcified tissue international</Title><ISOAbbreviation>Calcif Tissue Int</ISOAbbreviation></Journal><ArticleTitle>Proton Pump Inhibitor Use, H<sub>2</sub>-Receptor Antagonist Use, and Risk of Incident Clinical Vertebral Fracture in Women.</ArticleTitle><Pagination><StartPage>380</StartPage><EndPage>387</EndPage><MedlinePgn>380-387</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00223-018-0432-2</ELocationID><Abstract><AbstractText>The few prospective studies examining the relation between proton pump inhibitor (PPI) use and risk of vertebral fracture (VF) suggest a higher risk, but the magnitude of the association has been inconsistent. Moreover, no prospective studies have examined the association between substantially longer duration of PPI use and VF risk. Our objective was to determine the association between PPI use, H<sub>2</sub>RA use, and incident clinical VF in women. We conducted a prospective study in 55,545 women participating in the Nurses' Health Study. PPI and H<sub>2</sub>RA use was assessed by questionnaire every 4&#xa0;years. Self-reports of VF were confirmed by medical record. Our analysis included 547 incident VF cases (2002-2014). The multivariate adjusted relative risk (MVRR) of VF for women taking PPIs was 1.29 (95% CI 1.04-1.59) compared with non-users. Longer duration of PPI use was associated with higher VF risk (MVRR 1.16 [0.90-1.49] for &lt;&#x2009;4&#xa0;years; 1.27 [0.93-1.73] for 4-7.9&#xa0;years; 1.64 [1.02-2.64] for &#x2265;&#x2009;8&#xa0;years; p<sub>trend</sub>&#x2009;=&#x2009;0.01). The MVRR of VF for women taking H<sub>2</sub>RAs was 1.22 (0.90-1.67) compared with non-users. Longer duration of H<sub>2</sub>RA use was not associated with VF risk (MVRR 1.16 [0.88-1.53] for &lt;&#x2009;4&#xa0;years; 0.98 [0.60-1.59] for &#x2265;&#x2009;4&#xa0;years; p<sub>trend</sub>&#x2009;=&#x2009;0.72). PPI use is independently associated with a modestly higher risk of VF and the risk increases with longer duration of use. There was no statistically significant association between H<sub>2</sub>RA use and VF risk. Our findings add to the growing evidence suggesting caution with PPI use, particularly with longer duration of use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paik</LastName><ForeName>Julie M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. jmpaik@bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Renal Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. jmpaik@bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA. jmpaik@bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, USA. jmpaik@bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Room 432, Boston, MA, 02115, USA. jmpaik@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>Harold N</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Endocrinology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Adolescent and Transition Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curhan</LastName><ForeName>Gary C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Renal Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 DK100447</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 DK091417</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 CA186107</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Calcif Tissue Int</MedlineTA><NlmUniqueID>7905481</NlmUniqueID><ISSNLinking>0171-967X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006635">Histamine H2 Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054328">Proton Pump Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006635" MajorTopicYN="N">Histamine H2 Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054328" MajorTopicYN="N">Proton Pump Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">H2-receptor antagonist</Keyword><Keyword MajorTopicYN="N">Nurses&#x2019; health study</Keyword><Keyword MajorTopicYN="N">Prospective study</Keyword><Keyword MajorTopicYN="N">Proton pump inhibitor</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList><CoiStatement><b>Conflicts of Interest</b>: All authors state that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29754277</ArticleId><ArticleId IdType="mid">NIHMS967503</ArticleId><ArticleId IdType="pmc">PMC6231994</ArticleId><ArticleId IdType="doi">10.1007/s00223-018-0432-2</ArticleId><ArticleId IdType="pii">10.1007/s00223-018-0432-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Menees SB, Guentner A, Chey SW, Saad R, Chey WD. How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation? Am J Gastroenterol. 2015;110:1516&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pubmed">26054623</ArticleId></ArticleIdList></Reference><Reference><Citation>Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176:473&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024734</ArticleId><ArticleId IdType="pubmed">26998708</ArticleId></ArticleIdList></Reference><Reference><Citation>Riggs BL, Melton LJ., 3rd The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17:505S&#x2013;511S.</Citation><ArticleIdList><ArticleId IdType="pubmed">8573428</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Annals of internal medicine. 1998;128:793&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">9599190</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett-Connor E. The economic and human costs of osteoporotic fracture. The American journal of medicine. 1995;98:3S&#x2013;8S.</Citation><ArticleIdList><ArticleId IdType="pubmed">7709931</ArticleId></ArticleIdList></Reference><Reference><Citation>Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Archives of internal medicine. 1999;159:1215&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pubmed">10371229</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LJ., 3rd Epidemiology of spinal osteoporosis. Spine (Phila Pa 1976) 1997;22:2S&#x2013;11S.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431638</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LJ, 3rd, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol. 1989;129:1000&#x2013;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">2784934</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ., 3rd Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res. 2014;29:581&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929546</ArticleId><ArticleId IdType="pubmed">23959594</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein EM, Liu XS, Nickolas TL, Cohen A, McMahon DJ, Zhou B, Zhang C, Kamanda-Kosseh M, Cosman F, Nieves J, Guo XE, Shane E. Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab. 2012;97:E1918&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674300</ArticleId><ArticleId IdType="pubmed">22821893</ArticleId></ArticleIdList></Reference><Reference><Citation>Genant HK, Delmas PD, Chen P, Jiang Y, Eriksen EF, Dalsky GP, Marcus R, San Martin J. Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int. 2007;18:69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">17028792</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeni YN, Zinno MJ, Yerramshetty JS, Zauel R, Fyhrie DP. Variability of trabecular microstructure is age-, gender-, race- and anatomic site-dependent and affects stiffness and stress distribution properties of human vertebral cancellous bone. Bone. 2011;49:886&#x2013;894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170516</ArticleId><ArticleId IdType="pubmed">21802536</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen BA, Bouxsein ML. Biomechanics of vertebral fractures and the vertebral fracture cascade. Curr Osteoporos Rep. 2010;8:198&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">20838942</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers ER, Wilson SE. Biomechanics of osteoporosis and vertebral fracture. Spine (Phila Pa 1976) 1997;22:25S&#x2013;31S.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431641</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, Seeman E, Turner CH. The biomechanical basis of vertebral body fragility in men and women. J Bone Miner Res. 2001;16:2276&#x2013;2283.</Citation><ArticleIdList><ArticleId IdType="pubmed">11760842</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu EW, Bauer SR, Bain PA, Bauer DC. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med. 2011;124:519&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3101476</ArticleId><ArticleId IdType="pubmed">21605729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Huang Y, Li H, Sun W, Liu J. Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int. 2016;27:339&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">26462494</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili H, Huang ES, Jacobson BC, Camargo CA, Jr, Feskanich D, Chan AT. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. Bmj. 2012;344:e372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3269660</ArticleId><ArticleId IdType="pubmed">22294756</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu EW, Blackwell T, Ensrud KE, Hillier TA, Lane NE, Orwoll E, Bauer DC. Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int. 2008;83:251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2596870</ArticleId><ArticleId IdType="pubmed">18813868</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser LA, Leslie WD, Targownik LE, Papaioannou A, Adachi JD CaMos Research G. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int. 2013;24:1161&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5096922</ArticleId><ArticleId IdType="pubmed">22890365</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947&#x2013;2953.</Citation><ArticleIdList><ArticleId IdType="pubmed">17190895</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int. 2006;79:76&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">16927047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok CS, Yeong JK, Loke YK. Meta-analysis: risk of fractures with acid-suppressing medication. Bone. 2011;48:768&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">21185417</ArticleId></ArticleIdList></Reference><Reference><Citation>Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ. 2008;179:319&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2492962</ArticleId><ArticleId IdType="pubmed">18695179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2011;106:1209&#x2013;1218. quiz 1219.</Citation><ArticleIdList><ArticleId IdType="pubmed">21483462</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye JA, Jick H. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors. Pharmacotherapy. 2008;28:951&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pubmed">18657011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray SL, LaCroix AZ, Larson J, Robbins J, Cauley JA, Manson JE, Chen Z. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med. 2010;170:765&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4240017</ArticleId><ArticleId IdType="pubmed">20458083</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux C, Briot K, Gossec L, Kolta S, Blenk T, Felsenberg D, Reid D, Eastell R, Gl&#xfc;er C. Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int. 2009;84:13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">19023510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J, Heller DA, Ahern FM, Brown TV. The relationship between proton pump inhibitor adherence and fracture risk in the elderly. Calcif Tissue Int. 2014;94:597&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">24706060</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118:778&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pubmed">15989913</ArticleId></ArticleIdList></Reference><Reference><Citation>Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985;313:70&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">4000241</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo MK, Park JJ, Lee BJ, Kim JH, Yeon JE, Kim JS, Byun KS, Bak YT. The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats. Mol Med Rep. 2013;7:1267&#x2013;1272.</Citation><ArticleIdList><ArticleId IdType="pubmed">23426758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizunashi K, Furukawa Y, Katano K, Abe K. Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int. 1993;53:21&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">8102318</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuukkanen J, Vaananen HK. Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro. Calcif Tissue Int. 1986;38:123&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">3006888</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnemo-Persson R, Samuelsson A, Hakanson R, Persson P. Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol, and restricted food intake. Calcif Tissue Int. 1997;61:210&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">9262512</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimm E, Stampfer M, Colditz GA, Chute C, Litin L, Willett W. Validity of self-reported waist and hip circumference in men and women. Epidemiology. 1990;1:466&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">2090285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf A, Hunter D, Colditz G, Manson J, Stampfer M, Corsano K, Rosner B, Kriska A, Willett W. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23:991&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pubmed">7860180</ArticleId></ArticleIdList></Reference><Reference><Citation>Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. American Journal of Epidemiology. 1986;123:894&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">3962971</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">2043016</ArticleId></ArticleIdList></Reference><Reference><Citation>Willett W, Sampson L, Stampfer M, Rosner B, Bain C, Witschi J, Hennekens C, Speizer F. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">4014201</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Spiegelman D, Rimm EB, Rosner BA, Stampfer MJ, Barnett JB, Chavarro JE, Subar AF, Sampson LK, Willett WC. Validity of a Dietary Questionnaire Assessed by Comparison With Multiple Weighed Dietary Records or 24-Hour Recalls. Am J Epidemiol. 2017;185:570&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859994</ArticleId><ArticleId IdType="pubmed">28338828</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedberg DE, Kim LS, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017;152:706&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">28257716</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon DH, Diem SJ, Ruppert K, Lian YJ, Liu CC, Wohlfart A, Greendale GA, Finkelstein JS. Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study. J Bone Miner Res. 2015;30:232&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404624</ArticleId><ArticleId IdType="pubmed">25156141</ArticleId></ArticleIdList></Reference><Reference><Citation>Targownik LE, Lix LM, Leung S, Leslie WD. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology. 2010;138:896&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">19931262</ArticleId></ArticleIdList></Reference><Reference><Citation>Targownik LE, Leslie WD, Davison KS, Goltzman D, Jamal SA, Kreiger N, Josse RG, Kaiser SM, Kovacs CS, Prior JC, Zhou W CaMos Research G. The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos) Am J Gastroenterol. 2012;107:1361&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5104563</ArticleId><ArticleId IdType="pubmed">22777336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24763158</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2014</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2154-4212</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Female pelvic medicine &amp; reconstructive surgery</Title><ISOAbbreviation>Female Pelvic Med Reconstr Surg</ISOAbbreviation></Journal><ArticleTitle>Perioperative anticholinergic medications and risk of catheterization after urogynecologic surgery.</ArticleTitle><Pagination><StartPage>163</StartPage><EndPage>167</EndPage><MedlinePgn>163-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SPV.0000000000000075</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to examine how anticholinergic medication exposure affects the risk of failed postoperative void trial (VT) in women undergoing urogynecologic surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study of women undergoing outpatient prolapse or incontinence surgery. We evaluated perioperative anticholinergic exposure via the validated anticholinergic risk scale (ARS). Total ARS score was calculated by summing the individual ARS for each medication used during the following periods: at home before surgery, in preoperative holding, intraoperatively, and in postoperative recovery. The "low anticholinergic exposure" cohort (total ARS, &#x2264;7) was compared to the "high anticholinergic exposure" cohort (total ARS, &#x2265;8) to assess our primary outcome: failed postoperative VT on day of surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 125 women in the study, 98 (78%) had low anticholinergic exposure and 27 (22%) had high anticholinergic exposure. Overall, 28 (22%) patients failed the postoperative VT. Women in the high anticholinergic group had a significantly higher risk of a failed VT (41% vs 17%, P = 0.01 for high vs low anticholinergic groups, respectively). In logistic regression analysis, adjusting for age, body mass index, diabetes, midurethral sling and anterior repair, high anticholinergic exposure (AOR, 4.15; 95% confidence interval, 1.49-11.57), and anterior repair (AOR, 3.15; 95% CI, 1.15-8.61) remained significantly associated with failed postoperative VT.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Higher exposure to perioperative anticholinergic medications increases the risk of a failed postoperative VT after outpatient urogynecologic surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Paige J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>From the *Department of Obstetrics and Gynecology, Duke University Medical Center, Durham; and &#x2020;Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieter</LastName><ForeName>Alexis A</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>Siddiqui</LastName><ForeName>Nazema Y</ForeName><Initials>NY</Initials></Author><Author ValidYN="Y"><LastName>Weidner</LastName><ForeName>Alison C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Female Pelvic Med Reconstr Surg</MedlineTA><NlmUniqueID>101528690</NlmUniqueID><ISSNLinking>2151-8378</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018680">Cholinergic Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018680" MajorTopicYN="N">Cholinergic Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014546" MajorTopicYN="N">Urinary Catheterization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016055" MajorTopicYN="N">Urinary Retention</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013519" MajorTopicYN="N">Urogenital Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24763158</ArticleId><ArticleId IdType="doi">10.1097/SPV.0000000000000075</ArticleId><ArticleId IdType="pii">01436319-201405000-00008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34964475</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Comparative effectiveness of ventricular tachycardia ablation vs. escalated antiarrhythmic drug therapy by location of myocardial infarction: a sub-study of the VANISH trial.</ArticleTitle><Pagination><StartPage>948</StartPage><EndPage>958</EndPage><MedlinePgn>948-958</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euab298</ELocationID><Abstract><AbstractText Label="AIMS">Complexity of the ventricular tachycardia (VT) substrate and the size and thickness of infarction area border zones differ based on location of myocardial infarctions (MIs). These differences may translate into heterogeneity in the effectiveness of treatments. This study aims to examine the influence of infarct location on the effectiveness of VT ablation in comparison with escalated pharmacological therapy in patients with prior MI and antiarrhythmic drug (AAD)-refractory VT.</AbstractText><AbstractText Label="METHODS AND RESULTS">VANISH trial participants were categorized based on the presence or absence of an inferior MI scar. Inverse probability of treatment weighted Cox models were calculated for each subgroup. Of 259 randomized patients (median age 69.8&#x2009;years, 7.0% women), 135 had an inferior MI and 124 had a non-inferior MI. Among patients with an inferior MI, no statistically significant difference in the composite primary outcome of all-cause mortality, appropriate implantable cardioverter-defibrillator (ICD) shock, and VT storm was detected between treatment arms [adjusted hazard ratio (aHR) 0.80, 95% confidence interval (CI) 0.51-1.20]. In contrast, patients with non-inferior MIs had a statistically significant reduction in the incidence of the primary outcome with ablation (aHR 0.48, 95% CI 0.27-0.86). In a sensitivity analysis of anterior MI patients (n&#x2009;=&#x2009;83), a trend towards a reduction in the primary outcome with ablation was detected (aHR 0.50, 95% CI 0.23-1.09).</AbstractText><AbstractText Label="CONCLUSION">The effectiveness of VT ablation versus escalated AADs varies based on the location of the MI. Patients with MI scars located only in non-inferior regions of the ventricles derive greater benefit from VT ablation in comparison to escalation of AADs in reducing VT-related events.</AbstractText><CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. &#xa9; The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivard</LastName><ForeName>Lena</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1340-0850</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nault</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, Quebec Heart and Lung Institute, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gula</LastName><ForeName>Lorne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Essebag</LastName><ForeName>Vidal</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-0107-5197</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parkash</LastName><ForeName>Ratika</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7630-7795</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Room 2501B Halifax Infirmary, 1796 Summer St, Halifax, Nova Scotia B3H 3A7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterns</LastName><ForeName>Laurence D</ForeName><Initials>LD</Initials><Identifier Source="ORCID">0000-0002-3096-2548</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Royal Jubilee Hospital, Victoria, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khairy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4059-3800</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapp</LastName><ForeName>John L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-9602-2751</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Room 2501B Halifax Infirmary, 1796 Summer St, Halifax, Nova Scotia B3H 3A7, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002921" MajorTopicYN="N">Cicatrix</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiarrhythmic drugs</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34964475</ArticleId><ArticleId IdType="pmc">PMC9282915</ArticleId><ArticleId IdType="doi">10.1093/europace/euab298</ArticleId><ArticleId IdType="pii">6487233</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Priori SG, Blomstr&#xf6;m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm Jet al. . 2015. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 2015;17:1601&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">26837728</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis ABet al. . 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2018;15:e73&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">29097319</ArticleId></ArticleIdList></Reference><Reference><Citation>Deyell MW, AbdelWahab A, Angaran P, Essebag V, Glover B, Gula LJet al. Members of the Secondary Panel . 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease. Can J Cardiol 2020;36:822&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">32536373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri Net al. . 2019. HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 2019;21:1143&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967791</ArticleId><ArticleId IdType="pubmed">31075787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr&#xe9;taz Eet al. . Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PSet al. . Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol 2017;10:e004422.</Citation><ArticleIdList><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin Ket al. . Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390777</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JFet al. . Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016;375:111&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix D, Warembourg H, Klug D, Decoene C, Kacet S.. Intraoperative computerized mapping of ventricular tachycardia: differences between anterior and inferior myocardial infarctions. J Cardiovasc Electrophysiol 1999;10:781&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">10376914</ArticleId></ArticleIdList></Reference><Reference><Citation>Antz M, Berodt K, Bansch D, Ernst S, Chun KJ, Satomi Ket al. . Catheter-ablation of ventricular tachycardia in patients with coronary artery disease: influence of the endocardial substrate size on clinical outcome. Clin Res Cardiol 2008;97:110&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18046530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cesario DA, Vaseghi M, Boyle NG, Fishbein MC, Valderrabano M, Narasimhan Cet al. . Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia. Heart Rhythm 2006;3:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">16399044</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiga Y, Mathew S, Wissner E, Tilz R, Fuernkranz A, Metzner Aet al. . Correlation between substrate location and ablation strategy in patients with ventricular tachycardia late after myocardial infarction. Heart Rhythm 2012;9:1192&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22465295</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascale P, Schlaepfer J, Oddo M, Schaller MD, Vogt P, Fromer M.. Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization. Europace 2009;11:1639&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">19864312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasmer K, Reinecke H, Heitmann M, Dechering DG, Reinke F, Lange PSet al. . Clinical, procedural and long-term outcome of ischemic VT ablation in patients with previous anterior versus inferior myocardial infarction. Clin Res Cardiol 2020;109:1282&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515937</ArticleId><ArticleId IdType="pubmed">32157380</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaniswamy C, Kolte D, Harikrishnan P, Khera S, Aronow WS, Mujib Met al. . Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. Heart Rhythm 2014;11:2056&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">25016150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocock SJ, Hughes MD, Lee RJ.. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med 1987;317:426&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">3614286</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM.. Statistics in medicine&#x2013;reporting of subgroup analyses in clinical trials. N Engl J Med 2007;357:2189&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">18032770</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf S, Wittes J, Probstfield J, Tyroler HA.. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991;266:93&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2046134</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AB, Naylor CD.. Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials. Am Heart J 2000;139:952&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">10827374</ArticleId></ArticleIdList></Reference><Reference><Citation>Assmann SF, Pocock SJ, Enos LE, Kasten LE.. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355:1064&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10744093</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston P, Sauerbrei W.. Multivariable Model-Building: A Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables. England, UK: John Wiley &amp; Sons; 2008.</Citation></Reference><Reference><Citation>Kyle RP, Moodie EE, Klein MB, Abrahamowicz M.. Evaluating flexible modeling of continuous covariates in inverse-weighted estimators. Am J Epidemiol 2019;188:1181&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6545287</ArticleId><ArticleId IdType="pubmed">30649165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunceford JK, Davidian M.. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med 2004;23:2937&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">15351954</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011;46:399&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB.. The central role of the propensity score in observational studies for causal effects. J Biometrika 1983;70:41&#x2013;55.</Citation></Reference><Reference><Citation>Imbens GW. Nonparametric estimation of average treatment effects under exogeneity: a review. J Rev Econ Stat 2004;86:4&#x2013;29.</Citation></Reference><Reference><Citation>Callans DJ, Reynolds M, Zimetbaum PJ.. Electrophysiology's identity crisis: what our clinical trials do and do not say about us. Arrhythm Electrophysiol Rev 2020;9:15&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7330723</ArticleId><ArticleId IdType="pubmed">32637115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentias A, Raza MQ, Barakat AF, Hill E, Youssef D, Krishnaswamy Aet al. . Outcomes of ischaemic mitral regurgitation in anterior versus inferior ST elevation myocardial infarction. Open Heart 2016;3:e000493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5128765</ArticleId><ArticleId IdType="pubmed">27933193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosa E, Scanavacca M, d'Avila A, Oliveira F, Ramires JA.. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol 2000;35:1442&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10807445</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogun F, Desjardins B, Crawford T, Good E, Jongnarangsin K, Oral Het al. . Post-infarction ventricular arrhythmias originating in papillary muscles. J Am Coll Cardiol 2008;51:1794&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">18452787</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TKet al. . Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442229</ArticleId><ArticleId IdType="pubmed">17389270</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Starr AZ, Lopes RD, Hochman JS, Widimsky P, Pieper KSet al. ; APEX AMI Investigators . Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA 2009;301:1779&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">19417195</ArticleId></ArticleIdList></Reference><Reference><Citation>Thames MD, Klopfenstein HS, Abboud FM, Mark AL, Walker JL.. Preferential distribution of inhibitory cardiac receptors with vagal afferents to the inferoposterior wall of the left ventricle activated during coronary occlusion in the dog. Circ Res 1978;43:512&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">688555</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugada J, Berruezo A, Cuesta A, Osca J, Chueca E, Fosch Xet al. . Nonsurgical transthoracic epicardial radiofrequency ablation: an alternative in incessant ventricular tachycardia. J Am Coll Cardiol 2003;41:2036&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">12798578</ArticleId></ArticleIdList></Reference><Reference><Citation>Woie L, Eftestol T, Engan K, Kvaloy JT, Nilsen DW, Orn S.. The heart rate of ventricular tachycardia following an old myocardial infarction is inversely related to the size of scarring. Europace 2011;13:864&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21227951</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchlinski FE, Callans DJ, Gottlieb CD, Zado E.. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000;101:1288&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahara S, Tung R, Ramirez RJ, Gima J, Wiener I, Mahajan Aet al. . Distribution of late potentials within infarct scars assessed by ultra high-density mapping. Heart Rhythm 2010;7:1817&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">20682358</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashikaga H, Sasano T, Dong J, Zviman MM, Evers R, Hopenfeld Bet al. . Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res 2007;101:939&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2842927</ArticleId><ArticleId IdType="pubmed">17916777</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacher F, Roberts-Thomson K, Maury P, Tedrow U, Nault I, Steven Det al. . Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol 2010;55:2366&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">20488308</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34797391</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women: the ROAD study third and fourth surveys.</ArticleTitle><Pagination><StartPage>889</StartPage><EndPage>899</EndPage><MedlinePgn>889-899</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-021-06143-7</ELocationID><Abstract><AbstractText Label="UNLABELLED">This population-based cohort study with a 3-year follow-up revealed that the annual incidence rates of vertebral fracture (VF) and severe VF (sVF) were 5.9%/year and 1.7%/year, respectively. The presence of mild VF at the baseline was a significant risk factor for incident sVF in participants without prevalent sVF.</AbstractText><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">This study aimed to estimate the incidence of morphometric vertebral fracture (VF) and severe VF (sVF) in men and women and clarify whether the presence of a mild VF (mVF) increases the risk of incident sVF.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from the population-based cohort study, entitled the Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study, were analyzed. In total, 1190 participants aged&#x2009;&#x2265;&#x2009;40&#xa0;years (mean age, 65.0&#x2009;&#xb1;&#x2009;11.2) years completed whole-spine lateral radiography both at the third (2012-2013, baseline) and fourth surveys performed 3&#xa0;years later (2015-2016, follow-up). VF was defined using Genant's semi-quantitative (SQ) method: VF as SQ&#x2009;&#x2265;&#x2009;1, mVF as SQ&#x2009;=&#x2009;1, and sVF as SQ&#x2009;&#x2265;&#x2009;2. Cumulative incidence of VF and sVF was estimated. Multivariate logistic regression analyses were performed to evaluate risk factors for incident sVF.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The baseline prevalence of mVF and sVF were 16.8% and 6.0%, respectively. The annual incidence rates of VF and sVF were 5.9%/year and 1.7%/year, respectively. The annual incidence rates of sVF in participants without prevalent VF, with prevalent mVF, and with prevalent sVF were 0.6%/year, 3.8%/year, and 11.7%/year (p&#x2009;&lt;&#x2009;0.001), respectively. Multivariate logistic regression analyses in participants without prevalent sVF showed that the adjusted odds ratios for incident sVF were 4.12 [95% confident interval 1.85-9.16] and 4.53 [1.49-13.77] if the number of prevalent mVF at the baseline was 1 and&#x2009;&#x2265;&#x2009;2, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The annual incidence rates of VF and sVF were 5.9%/year and 1.7%/year, respectively. The presence of prevalent mVF was an independent risk factor for incident sVF.</AbstractText><CopyrightInformation>&#xa9; 2021. International Osteoporosis Foundation and National Osteoporosis Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Horii</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iidaka</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical &amp; Research Center, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muraki</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical &amp; Research Center, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oka</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Research and Management for Musculoskeletal Pain, 22nd Century Medical &amp; Research Center, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asai</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama, 641-8510, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsutsui</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama, 641-8510, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashizume</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama, 641-8510, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama, 641-8510, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama, 641-8510, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawaguchi</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tokyo Neurological Center, 4-1-17, Toranomon, Minato-ku, Tokyo, 105-0001, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Towa Hospital, Towa 4-7-10, Adachi-ku, Tokyo, 120-0003, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akune</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, National Rehabilitation Center for Persons With Disabilities, 4-1 Namiki, Tokorozawa City, Saitama, 359-0042, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oshima</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshimura</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9206-4658</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical &amp; Research Center, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8655, Japan. yoshimuran-ort@h.u-tokyo.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>H25-Choujyu-007</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>JOA-Subsidized Science Project Research 2014-1</GrantID><Agency>the Japanese Orthopaedic Association</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010003" MajorTopicYN="Y">Osteoarthritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="Y">Osteoporosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Risk factor</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>19</Day><Hour>12</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34797391</ArticleId><ArticleId IdType="doi">10.1007/s00198-021-06143-7</ArticleId><ArticleId IdType="pii">10.1007/s00198-021-06143-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Riggs BL, Melton LJ 3rd (1995) The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17:505s&#x2013;511s</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/8756-3282(95)00258-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, Ogikubo O, Hansson T (2009) The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: its relation to fracture level, type of fracture and grade of fracture deformation. Eur Spine J 18:77&#x2013;88</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-008-0847-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockerill W, Lunt M, Silman AJ et al (2004) Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 15:113&#x2013;119</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-003-1547-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, Kanis J (2000) Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 15:1384&#x2013;1392</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2000.15.7.1384</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnell O, Kanis JA, Od&#xe9;n A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, J&#xf6;nsson B (2004) Mortality after osteoporotic fractures. Osteoporos Int 15:38&#x2013;42</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-003-1490-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O, Study EVO (2003) Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int 14:61&#x2013;68</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-002-1316-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Atkinson EJ, O&#x2019;Fallon WM, Melton LJ (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985&#x2013;1989. J Bone Miner Res 7:221&#x2013;227</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.5650070214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross PD, Fujiwara S, Huang C, Davis JW, Epstein RS, Wasnich RD, Kodama K, Melton LJ (1995) Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol 24:1171&#x2013;1177</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/24.6.1171</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara S, Hamaya E, Goto W, Masunari N, Furukawa K, Fukunaga M, Nakamura T, Miyauchi A, Chen P (2011) Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk in Japan. Bone 49:520&#x2013;525</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2011.05.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadowaki E, Tamaki J, Iki M, Sato Y, Chiba Y, Kajita E, Kagamimori S, Kagawa Y, Yoneshima H (2010) Prevalent vertebral deformity independently increases incident vertebral fracture risk in middle-aged and elderly Japanese women: the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 21:1513&#x2013;1522</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-009-1113-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Bank TW (2020) Life expectancy at birth, total (years) - Japan. https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=JP . Accessed 20 Aug 2020</Citation></Reference><Reference><Citation>Chen P, Krege JH, Adachi JD et al (2009) Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res 24:495&#x2013;502</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.081103</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA (2002) The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 17:1051&#x2013;1056</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2002.17.6.1051</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux C, Fechtenbaum J, Kolta S, Briot K, Girard M (2007) Mild prevalent and incident vertebral fractures are risk factors for new fractures. Osteoporos Int 18:1617&#x2013;1624</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-007-0413-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanterewicz E, Puigoriol E, Rodr&#xed;guez Cros JR, Peris P (2019) Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study. Osteoporos Int 30:2141&#x2013;2149</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-019-04962-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LJ, Wenger DE, Atkinson EJ, Achenbach SJ, Berquist TH, Riggs BL, Jiang G, Eastell R (2006) Influence of baseline deformity definition on subsequent vertebral fracture risk in postmenopausal women. Osteoporos Int 17:978&#x2013;985</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-006-0106-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Horii C, Asai Y, Iidaka T et al (2019) Differences in prevalence and associated factors between mild and severe vertebral fractures in Japanese men and women: the third survey of the ROAD study. J Bone Miner Metab 37:844&#x2013;853</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-018-0981-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Szulc P, Munoz F, Marchand F, Delmas PD (2001) Semiquantitative evaluation of prevalent vertebral deformities in men and their relationship with osteoporosis: the MINOS study. Osteoporos Int 12:302&#x2013;310</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001980170120</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura N, Muraki S, Oka H et al (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620&#x2013;628</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-009-0080-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T (2010) Cohort profile: research on Osteoarthritis/Osteoporosis Against Disability study. Int J Epidemiol 39:988&#x2013;995</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyp276</ArticleId></ArticleIdList></Reference><Reference><Citation>Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137&#x2013;1148</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.5650080915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lentle B, Koromani F, Brown JP et al (2019) The Radiology of Osteoporotic Vertebral Fractures Revisited. J Bone Miner Res 34:409&#x2013;418</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3669</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe1;ng YXJ, Deng M, He LC, Che-Nordin N, Santiago FR (2018) Osteoporotic vertebral endplate and cortex fractures: a pictorial review. J Orthop Translat 15:35&#x2013;49</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jot.2018.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Group WS (2007) Assessment of osteoporosis at the primary health care level. Technical Report. Accessed 17 Aug. 2020</Citation></Reference><Reference><Citation>Orimo H, Hayashi Y, Fukunaga M et al (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331&#x2013;337</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007740170001</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Klift M, de Laet CD, Pols HA (2005) Assessment of fracture risk: who should be treated for osteoporosis? Best Pract Res Clin Rheumatol 19:937&#x2013;950</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2005.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnick SL (2006) Osteoporosis in men and women. Clin Cornerstone 8:28&#x2013;39</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1098-3597(06)80063-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Samelson EJ, Hannan MT, Zhang Y, Genant HK, Felson DT, Kiel DP (2006) Incidence and risk factors for vertebral fracture in women and men: 25-year follow-up results from the population-based Framingham study. J Bone Miner Res 21:1207&#x2013;1214</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.060513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanterewicz E, Puigoriol E, Rodriguez Cros JR, Peris P (2019) Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study. Osteoporos Int 30:2141&#x2013;2149</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-019-04962-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenberg D, Silman AJ, Lunt M et al (2002) Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 17:716&#x2013;724</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2002.17.4.716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura N, Kinoshita H, Oka H, Muraki S, Mabuchi A, Kawaguchi H, Nakamura K (2006) Cumulative incidence and changes in the prevalence of vertebral fractures in a rural Japanese community: a 10-year follow-up of the Miyama cohort. Arch Osteoporos 1:43&#x2013;49</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-006-0007-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G, Fukunaga M (2003) Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 18:1547&#x2013;1553</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2003.18.8.1547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health LaW (2012) The report of National Health and Nutrition Survey 2012. https://www.mhlw.go.jp/bunya/kenkou/eiyou/h24-houkoku.html .</Citation></Reference><Reference><Citation>Statistics Breau of Japan (2015) Population Census/Basic Complete Tabulation on Population and Households Japan. https://www.e-stat.go.jp/en/stat-search/files?page=1&amp;layout=datalist&amp;toukei=00200521&amp;tstat=000001080615&amp;cycle=0&amp;tclass1=000001089055&amp;tclass2=000001089056&amp;stat_infid=000031473212 . Accessed 20 Aug 2020</Citation></Reference><Reference><Citation>Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033&#x2013;1046</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-007-0343-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14:821&#x2013;828</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.1999.14.5.821</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LJ, Atkinson EJ, Cooper C, O&#x2019;Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10:214&#x2013;221</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001980050218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendler DL, Bauer DC, Davison KS et al (2016) Vertebral Fractures: Clinical Importance and Management. Am J Med 129:221.e221&#x2013;210</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2015.09.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorin MH, Wihlborg A, &#xc5;kesson K, Gerdhem P (2016) Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years. Osteoporos Int 27:249&#x2013;255</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-015-3290-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Oei L, Koromani F, Breda SJ et al (2018) Osteoporotic vertebral fracture prevalence varies widely between qualitative and quantitative radiological assessment methods: the rotterdam study. J Bone Miner Res 33:560&#x2013;568</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lentle BC, Hg Oei E, Goltzman D et al (2018) Vertebral fractures and morphometric deformities. J Bone Miner Res 33:1544&#x2013;1545</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health, Labour and Welfare. The report of National Health and Nutrition Survey 2012. https://www.mhlw.go.jp/bunya/kenkou/eiyou/h24-houkoku.html . Accessed 8 Feb 2021</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25913000</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2016</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3597</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>18</Issue><PubDate><Year>2015</Year><Month>May</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Predictive value of programmed ventricular stimulation after catheter&#xa0;ablation of post-infarction ventricular tachycardia.</ArticleTitle><Pagination><StartPage>1954</StartPage><EndPage>1959</EndPage><MedlinePgn>1954-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2015.02.058</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-1097(15)00910-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A recent meta-analysis demonstrated a survival benefit in post-infarction patients whose ventricular tachycardia (VT) was rendered noninducible by catheter ablation. Furthermore, patients with noninducible VT had a lower VT recurrence rate than did patients whose VT remained inducible after ablation.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this multicenter cohort study was to assess whether noninducibility after VT ablation is independently associated with improved survival.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from 1,064 patients who underwent VT ablation for post-infarction VT at seven international centers were analyzed. The ablation procedure was considered successful if no VT was inducible at the end of the procedure and unsuccessful if VT remained inducible or if programmed stimulation was not performed at the end of the ablation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median follow-up time was 633 days. Noninducibility was independently associated with lower mortality (adjusted hazard ratio: 0.65; 95% confidence interval: 0.53 to 0.79; p&lt;0.001). Atrial fibrillation, diabetes, and age were other independent predictors of higher mortality. Ablation of only the clinical VT in patients who also had inducible, nonclinical VTs was not associated with improved survival.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Noninducibility after VT ablation in patients with post-infarction VT is independently associated with lower mortality during long-term follow-up.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yokokawa</LastName><ForeName>Miki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyungjin Myra</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baser</LastName><ForeName>Kazim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagashima</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Bella</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergara</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hindricks</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University Hospital, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arya</LastName><ForeName>Arash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University Hospital, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeppenfeld</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Riva Silva</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daoud</LastName><ForeName>Emile G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Division of Cardiology, The Ohio State University, Columbus, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sunil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, The Ohio State University, Columbus, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuck</LastName><ForeName>Karl-Heinz</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Asklepios Klinik St. Georg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tilz</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Asklepios Klinik St. Georg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shibu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Asklepios Klinik St. Georg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghanbari</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latchamsetty</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morady</LastName><ForeName>Fred</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogun</LastName><ForeName>Frank M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Michigan, Ann Arbor, Michigan. Electronic address: fbogun@med.umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2015 May 12;65(18):1960-3. doi: 10.1016/j.jacc.2015.03.037.</RefSource><PMID Version="1">25913001</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2015 Dec 8;66(22):2576-7. doi: 10.1016/j.jacc.2015.09.066.</RefSource><PMID Version="1">26653638</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2015 Dec 8;66(22):2576. doi: 10.1016/j.jacc.2015.08.1127.</RefSource><PMID Version="1">26653639</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004558" MajorTopicYN="N">Electric Stimulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ablation</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25913000</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2015.02.058</ArticleId><ArticleId IdType="pii">S0735-1097(15)00910-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31952885</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-4713</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Ophthalmology</Title><ISOAbbreviation>Ophthalmology</ISOAbbreviation></Journal><ArticleTitle>Predictors of Long-Term Visual Field Fluctuation in Glaucoma Patients.</ArticleTitle><Pagination><StartPage>739</StartPage><EndPage>747</EndPage><MedlinePgn>739-747</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ophtha.2019.11.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0161-6420(19)32302-4</ELocationID><Abstract><AbstractText Label="PURPOSE">To identify predictive factors for visual field (VF) fluctuation in glaucoma patients.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="PARTICIPANTS">A total of 1392 eyes (816 patients) with 6 or more VFs and 3 years or more of follow-up.</AbstractText><AbstractText Label="METHODS">For each eye, the VF mean deviation (MD) and the pointwise sensitivities were regressed against time to model the series trend, and the root mean square error (RMSE) was estimated as a measure of variability. Potential predictors were selected with least absolute shrinkage and selection operator regression and included eye laterality, ethnicity, glaucoma type, intraocular pressure (IOP) fluctuation, baseline best corrected-visual acuity, intervening cataract or glaucoma surgery, length of follow-up, frequency of testing, baseline MD, rates of VF progression, and median false positive (FP) and false negative (FN) responses.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Predictors of global and pointwise VF long-term fluctuation.</AbstractText><AbstractText Label="RESULTS">In the global model, left eye (0.063 dB; P&#xa0;= 0.022), Asian descent (0.265 dB; P&#xa0;= 0.006), larger IOP fluctuation (0.051 dB; P &lt; 0.001), intervening cataract surgery (0.090 dB; P&#xa0;= 0.023), longer follow-up (0.130 dB; P &lt; 0.001), worse baseline MD (-0.145 dB; P &lt; 0.001), faster VF decay rate (-0.090 dB; P &lt; 0.001), and higher FP rate (0.145 dB; P &lt; 0.001) and FN rate (0.220 dB; P &lt; 0.001) were predictors of VF fluctuation. In the pointwise model, larger IOP fluctuation (0.039 dB; P&#xa0;= 0.022), longer follow-up (0.340 dB; P &lt; 0.001), higher VF frequency (0.238 dB; P&#xa0;= 0.002), intervening glaucoma surgery (0.190 dB; P&#xa0;= 0.01), worse baseline MD (-0.535 dB; P &lt; 0.001), faster VF decay rate (-0.340 dB; P &lt; 0.001), and higher FP rate (0.255 dB; P &lt; 0.001) and FN rate (0.395 dB; P &lt; 0.001) were associated with increased fluctuation. The multivariable model explained 57% and 28% of the pointwise and global variances, respectively.</AbstractText><AbstractText Label="CONCLUSIONS">This study identified novel predictors of VF fluctuation, and explains nearly 60% of the pointwise variance. In the presence of factors predictive of high fluctuation, increased frequency of testing and better analytics will help to identify VF progression more accurately.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rabiolo</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Siloam Eye Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afifi</LastName><ForeName>Abdelmonem A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouri-Mahdavi</LastName><ForeName>Kouros</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caprioli</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: caprioli@jsei.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ophthalmology</MedlineTA><NlmUniqueID>7802443</NlmUniqueID><ISSNLinking>0161-6420</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005901" MajorTopicYN="N">Glaucoma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009798" MajorTopicYN="N">Ocular Hypertension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014065" MajorTopicYN="N">Tonometry, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058609" MajorTopicYN="N">Visual Field Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31952885</ArticleId><ArticleId IdType="doi">10.1016/j.ophtha.2019.11.021</ArticleId><ArticleId IdType="pii">S0161-6420(19)32302-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35669688</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Level-Specific Volumetric BMD Threshold Values for the Prediction of Incident Vertebral Fractures Using Opportunistic QCT: A Case-Control Study.</ArticleTitle><Pagination><StartPage>882163</StartPage><MedlinePgn>882163</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">882163</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2022.882163</ELocationID><Abstract><AbstractText Label="PURPOSE">To establish and evaluate the diagnostic accuracy of volumetric bone mineral density (vBMD) threshold values at different spinal levels, derived from opportunistic quantitative computed tomography (QCT), for the prediction of incident vertebral fractures (VF).</AbstractText><AbstractText Label="MATERIALS AND METHODS">In this case-control study, 35 incident VF cases (23 women, 12 men; mean age: 67 years) and 70 sex- and age-matched controls were included, based on routine multi detector CT (MDCT) scans of the thoracolumbar spine. Trabecular vBMD was measured from routine baseline CT scans of the thoracolumbar spine using an automated pipeline including vertebral segmentation, asynchronous calibration for HU-to-vBMD conversion, and correction of intravenous contrast medium (https://anduin.bonescreen.de). Threshold values at T1-L5 were calculated for the optimal operating point according to the Youden index and for fixed sensitivities (60 - 85%) in receiver operating characteristic (ROC) curves.</AbstractText><AbstractText Label="RESULTS">vBMD at each single level of the thoracolumbar spine was significantly associated with incident VFs (odds ratio per SD decrease [OR], 95% confidence interval [CI] at T1-T4: 3.28, 1.66-6.49; at T5-T8: 3.28, 1.72-6.26; at T9-T12: 3.37, 1.78-6.36; and at L1-L4: 3.98, 1.97-8.06), independent of adjustment for age, sex, and prevalent VF. AUC showed no significant difference between vertebral levels and was highest at the thoracolumbar junction (AUC = 0.75, 95%-CI = 0.63 - 0.85 for T11-L2). Optimal threshold values increased from lumbar (L1-L4: 52.0 mg/cm&#xb3;) to upper thoracic spine (T1-T4: 69.3 mg/cm&#xb3;). At T11-L2, T12-L3 and L1-L4, a threshold of 80.0 mg/cm&#xb3; showed sensitivities of 85 - 88%, and specificities of 41 - 49%. To achieve comparable sensitivity (85%) at more superior spinal levels, resulting thresholds were higher: 114.1 mg/cm&#xb3; (T1-T4), 92.0 mg/cm&#xb3; (T5-T8), 88.2 mg/cm&#xb3; (T9-T12).</AbstractText><AbstractText Label="CONCLUSIONS">At all levels of the thoracolumbar spine, lower vBMD was associated with incident VFs in an elderly, predominantly oncologic patient population. Automated opportunistic osteoporosis screening of vBMD along the entire thoracolumbar spine allows for risk assessment of imminent VFs. We propose level-specific vBMD threshold at the thoracolumbar spine to identify individuals at high fracture risk.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Dieckmeyer, L&#xf6;ffler, El Husseini, Sekuboyina, Menze, Sollmann, Wostrack, Zimmer, Baum and Kirschke.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dieckmeyer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;ffler</LastName><ForeName>Maximilian Thomas</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, University Medical Center, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Husseini</LastName><ForeName>Malek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekuboyina</LastName><ForeName>Anjany</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menze</LastName><ForeName>Bjoern</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Image-Based Biomedical Modeling, Department of Computer Science, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sollmann</LastName><ForeName>Nico</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>TUM-Neuroimaging Center, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wostrack</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmer</LastName><ForeName>Claus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baum</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirschke</LastName><ForeName>Jan Stefan</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>TUM-Neuroimaging Center, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="Y">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bone mineral density (BMD)</Keyword><Keyword MajorTopicYN="N">multidetector computed tomography (MDCT)</Keyword><Keyword MajorTopicYN="N">osteoporosis</Keyword><Keyword MajorTopicYN="N">spinal fracture</Keyword><Keyword MajorTopicYN="N">threshold value</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>2</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35669688</ArticleId><ArticleId IdType="pmc">PMC9165054</ArticleId><ArticleId IdType="doi">10.3389/fendo.2022.882163</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Consensus Development Conference: Diagnosis, Prophylaxis, and Treatment of Osteoporosis. Am J Med (1993) 94(6):646&#x2013;50. doi:&#xa0;10.1016/0002-9343(93)90218-e</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(93)90218-e</ArticleId><ArticleId IdType="pubmed">8506892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, et al. . SCOPE 2021: A New Scorecard for Osteoporosis in Europe. Arch Osteo (2021) 16(1):82. doi:&#xa0;10.1007/s11657-020-00871-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-020-00871-9</ArticleId><ArticleId IdType="pmc">PMC8172408</ArticleId><ArticleId IdType="pubmed">34080059</ArticleId></ArticleIdList></Reference><Reference><Citation>Haussler B, Gothe H, Gol D, Glaeske G, Pientka L, Felsenberg D. Epidemiology, Treatment and Costs of Osteoporosis in Germany&#x2013;the BoneEVA Study. Osteo Int (2007) 18(1):77&#x2013;84. doi:&#xa0;10.1007/s00198-006-0206-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-006-0206-y</ArticleId><ArticleId IdType="pubmed">17048064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, et al. . Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden. A Report Prepared in Collaboration With the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (Efpia). Arch Osteo (2013) 8:136. doi:&#xa0;10.1007/s11657-013-0136-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-013-0136-1</ArticleId><ArticleId IdType="pmc">PMC3880487</ArticleId><ArticleId IdType="pubmed">24113837</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosla S, Shane E. A Crisis in the Treatment of Osteoporosis. J Bone Mine Res (2016) 31(8):1485&#x2013;7. doi:&#xa0;10.1002/jbmr.2888</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.2888</ArticleId><ArticleId IdType="pubmed">27335158</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. . Clinician&#x2019;s Guide to Prevention and Treatment of Osteoporosis. Osteo Int (2014) 25(10):2359&#x2013;81. doi:&#xa0;10.1007/s00198-014-2794-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-014-2794-2</ArticleId><ArticleId IdType="pmc">PMC4176573</ArticleId><ArticleId IdType="pubmed">25182228</ArticleId></ArticleIdList></Reference><Reference><Citation>Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL. Dxa Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women. J Clin Densitom (2015) 18(2):145&#x2013;9. doi:&#xa0;10.1016/j.jocd.2015.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2015.01.005</ArticleId><ArticleId IdType="pmc">PMC4420644</ArticleId><ArticleId IdType="pubmed">25700662</ArticleId></ArticleIdList></Reference><Reference><Citation>Iki M, Tamaki J, Kadowaki E, Sato Y, Dongmei N, Winzenrieth R, et al. . Trabecular Bone Score (TBS) Predicts Vertebral Fractures in Japanese Women Over 10 Years Independently of Bone Density and Prevalent Vertebral Deformity: The Japanese Population-Based Osteoporosis (JPOS) Cohort Study. J Bone Mine Res (2014) 29(2):399&#x2013;407. doi:&#xa0;10.1002/jbmr.2048</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.2048</ArticleId><ArticleId IdType="pubmed">23873699</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelke K, Adams JE, Armbrecht G, Augat P, Bogado CE, Bouxsein ML, et al. . Clinical Use of Quantitative Computed Tomography and Peripheral Quantitative Computed Tomography in the Management of Osteoporosis in Adults: The 2007 ISCD Official Positions. J Clin Densitom (2008) 11(1):123&#x2013;62. doi:&#xa0;10.1016/j.jocd.2007.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2007.12.010</ArticleId><ArticleId IdType="pubmed">18442757</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffler MT, Sollmann N, Mei K, Valentinitsch A, Noel PB, Kirschke JS, et al. . X-Ray-Based Quantitative Osteoporosis Imaging at the Spine. Osteo Int (2020) 31(2):233&#x2013;50. doi:&#xa0;10.1007/s00198-019-05212-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-019-05212-2</ArticleId><ArticleId IdType="pubmed">31728606</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadakis AE, Karantanas AH, Papadokostakis G, Petinellis E, Damilakis J. Can Abdominal Multi-Detector CT Diagnose Spinal Osteoporosis? Eur Radiol (2009) 19(1):172&#x2013;6. doi:&#xa0;10.1007/s00330-008-1099-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-008-1099-2</ArticleId><ArticleId IdType="pubmed">18641992</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffler MT, Jacob A, Scharr A, Sollmann N, Burian E, El Husseini M, et al. . Automatic Opportunistic Osteoporosis Screening in Routine CT: Improved Prediction of Patients With Prevalent Vertebral Fractures Compared to DXA. Eur Radiol (2021) 31(8):6069&#x2013;77. doi:&#xa0;10.1007/s00330-020-07655-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-07655-2</ArticleId><ArticleId IdType="pmc">PMC8270840</ArticleId><ArticleId IdType="pubmed">33507353</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffler MT, Jacob A, Valentinitsch A, Rienmuller A, Zimmer C, Ryang YM, et al. . Improved Prediction of Incident Vertebral Fractures Using Opportunistic QCT Compared to DXA. Eur Radiol (2019) 29(9):4980&#x2013;9. doi:&#xa0;10.1007/s00330-019-06018-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-019-06018-w</ArticleId><ArticleId IdType="pmc">PMC6682570</ArticleId><ArticleId IdType="pubmed">30790025</ArticleId></ArticleIdList></Reference><Reference><Citation>Allaire BT, Lu D, Johannesdottir F, Kopperdahl D, Keaveny TM, Jarraya M, et al. . Prediction of Incident Vertebral Fracture Using CT-based Finite Element Analysis. Osteo Int (2019) 30(2):323&#x2013;31. doi:&#xa0;10.1007/s00198-018-4716-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-018-4716-1</ArticleId><ArticleId IdType="pmc">PMC6450770</ArticleId><ArticleId IdType="pubmed">30306225</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelke K. Quantitative Computed Tomography-Current Status and New Developments. J Clin Densitom (2017) 20(3):309&#x2013;21. doi:&#xa0;10.1016/j.jocd.2017.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2017.06.017</ArticleId><ArticleId IdType="pubmed">28712984</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenberg D, Gowin W. [Bone Densitometry by Dual Energy Methods]. Radiologe (1999) 39(3):186&#x2013;93. doi:&#xa0;10.1007/s001170050495</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001170050495</ArticleId><ArticleId IdType="pubmed">10218211</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffler MT, Sekuboyina A, Jacob A, Grau AL, Scharr A, El Husseini M, et al. . A Vertebral Segmentation Dataset With Fracture Grading. Radiol Artif Intell (2020) 2(4):e190138. doi:&#xa0;10.1148/ryai.2020190138</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryai.2020190138</ArticleId><ArticleId IdType="pmc">PMC8082364</ArticleId><ArticleId IdType="pubmed">33937831</ArticleId></ArticleIdList></Reference><Reference><Citation>Therkildsen J, Nissen L, Jorgensen HS, Thygesen J, Ivarsen P, Frost L, et al. . Thoracic Bone Mineral Density Derived From Cardiac Ct Is Associated With Greater Fracture Rate. Radiology (2020) 296(3):499&#x2013;508. doi:&#xa0;10.1148/radiol.2020192706</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020192706</ArticleId><ArticleId IdType="pubmed">32662758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei K, Kopp FK, Bippus R, Kohler T, Schwaiger BJ, Gersing AS, et al. . Is Multidetector CT-based Bone Mineral Density and Quantitative Bone Microstructure Assessment at the Spine Still Feasible Using Ultra-Low Tube Current and Sparse Sampling? Eur Radiol (2017) 27(12):5261&#x2013;71. doi:&#xa0;10.1007/s00330-017-4904-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-017-4904-y</ArticleId><ArticleId IdType="pmc">PMC5674130</ArticleId><ArticleId IdType="pubmed">28639046</ArticleId></ArticleIdList></Reference><Reference><Citation>OECD . Computed Tomography (CT) Scanners (Indicator). (2021). doi:&#xa0;10.1787/bedece12-en</Citation><ArticleIdList><ArticleId IdType="doi">10.1787/bedece12-en</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DI. Epidemiology and Risk Factors for Spine Pain. Neurol Clin (2007) 25(2):353&#x2013;71. doi:&#xa0;10.1016/j.ncl.2007.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2007.01.004</ArticleId><ArticleId IdType="pubmed">17445733</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin (2021) 71(3):209&#x2013;49. doi:&#xa0;10.3322/caac.21660</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Parenteau CS, Lau EC, Campbell IC, Courtney A. Prevalence of Spine Degeneration Diagnosis by Type, Age, Gender, and Obesity Using Medicare Data. Sci Rep (2021) 11(1):5389. doi:&#xa0;10.1038/s41598-021-84724-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84724-6</ArticleId><ArticleId IdType="pmc">PMC7940625</ArticleId><ArticleId IdType="pubmed">33686128</ArticleId></ArticleIdList></Reference><Reference><Citation>
OECD . Computed Tomography (CT) Exams (Indicator)(2021). Available at: https://data.oecd.org/healthcare/computed-tomography-ct-exams.htm.</Citation></Reference><Reference><Citation>Wang X, Sanyal A, Cawthon PM, Palermo L, Jekir M, Christensen J, et al. . Prediction of New Clinical Vertebral Fractures in Elderly Men Using Finite Element Analysis of CT Scans. J Bone Mine Res (2012) 27(4):808&#x2013;16. doi:&#xa0;10.1002/jbmr.1539</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.1539</ArticleId><ArticleId IdType="pmc">PMC3510751</ArticleId><ArticleId IdType="pubmed">22190331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalhoub D, Orwoll ES, Cawthon PM, Ensrud KE, Boudreau R, Greenspan S, et al. . Areal and Volumetric Bone Mineral Density and Risk of Multiple Types of Fracture in Older Men. Bone (2016) 92:100&#x2013;6. doi:&#xa0;10.1016/j.bone.2016.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2016.08.014</ArticleId><ArticleId IdType="pmc">PMC5056840</ArticleId><ArticleId IdType="pubmed">27554426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJ, Graffy PM, Zea RD, Ziemlewicz TJ, Pickhardt PJ. Future Osteoporotic Fracture Risk Related to Lumbar Vertebral Trabecular Attenuation Measured at Routine Body Ct. J Bone Mine Res (2018) 33(5):860&#x2013;7. doi:&#xa0;10.1002/jbmr.3383</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3383</ArticleId><ArticleId IdType="pmc">PMC5935538</ArticleId><ArticleId IdType="pubmed">29314261</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DE, Demissie S, Allaire BT, Bruno AG, Kopperdahl DL, Keaveny TM, et al. . The Associations Between QCT-based Vertebral Bone Measurements and Prevalent Vertebral Fractures Depend on the Spinal Locations of Both Bone Measurement and Fracture. Osteo Int (2014) 25(2):559&#x2013;66. doi:&#xa0;10.1007/s00198-013-2452-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-013-2452-0</ArticleId><ArticleId IdType="pmc">PMC3946739</ArticleId><ArticleId IdType="pubmed">23925651</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannesdottir F, Allaire B, Kopperdahl DL, Keaveny TM, Sigurdsson S, Bredella MA, et al. . Bone Density and Strength From Thoracic and Lumbar CT Scans Both Predict Incident Vertebral Fractures Independently of Fracture Location. Osteo Int (2021) 32(2):261&#x2013;9. doi:&#xa0;10.1007/s00198-020-05528-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-020-05528-4</ArticleId><ArticleId IdType="pmc">PMC8265597</ArticleId><ArticleId IdType="pubmed">32748310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredella MA. Opportunistic Osteoporosis Screening With Cardiac Ct: Can We Predict Future Fractures? Radiology (2020) 296(3):509&#x2013;10. doi:&#xa0;10.1148/radiol.2020202374</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202374</ArticleId><ArticleId IdType="pmc">PMC7457941</ArticleId><ArticleId IdType="pubmed">32667255</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology ACo . ACR&#x2013;SPR&#x2013;SSR Practice Parameter for the Performance of Musculoskeletal Quantitative Computed Tomography (QCT). (2018).</Citation></Reference><Reference><Citation>Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral Fracture Assessment Using a Semiquantitative Technique. J Bone Mine Res (1993) 8(9):1137&#x2013;48. doi:&#xa0;10.1002/jbmr.5650080915</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.5650080915</ArticleId><ArticleId IdType="pubmed">8237484</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazzolla A, Solarino G, Lamartina C, De Giorgi S, Bizzoca D, Berjano P, et al. . Vertebral Bone Marrow Edema (VBME) in Conservatively Treated Acute Vertebral Compression Fractures (Vcfs): Evolution and Clinical Correlations. Spine (Phila Pa 1976) (2015) 40(14):E842&#x2013;8. doi:&#xa0;10.1097/BRS.0000000000000973</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000000973</ArticleId><ArticleId IdType="pubmed">25946722</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedderich DM, Maegerlein C, Baum T, Hapfelmeier A, Ryang YM, Zimmer C, et al. . Differentiation of Acute/Subacute Versus Old Vertebral Fractures in Multislice Detector Computed Tomography: Is Magnetic Resonance Imaging Always Needed? World Neurosurg (2019) 122:e676&#x2013;e83. doi:&#xa0;10.1016/j.wneu.2018.10.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.10.121</ArticleId><ArticleId IdType="pubmed">30385360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer JS, Muller D, Ambekar A, Dobritz M, Matsuura M, Eckstein F, et al. . Detection of Osteoporotic Vertebral Fractures Using Multidetector CT. Osteo Int (2006) 17(4):608&#x2013;15. doi:&#xa0;10.1007/s00198-005-0023-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-005-0023-8</ArticleId><ArticleId IdType="pubmed">16437195</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffler MT, Sollmann N, Burian E, Bayat A, Aftahy K, Baum T, et al. . Opportunistic Osteoporosis Screening Reveals Low Bone Density in Patients With Screw Loosening After Lumbar Semi-Rigid Instrumentation: A Case-Control Study. Front Endocrinol (Lausanne) (2020) 11:552719. doi:&#xa0;10.3389/fendo.2020.552719</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.552719</ArticleId><ArticleId IdType="pmc">PMC7832475</ArticleId><ArticleId IdType="pubmed">33505353</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum T, Muller D, Dobritz M, Rummeny EJ, Link TM, Bauer JS. BMD Measurements of the Spine Derived From Sagittal Reformations of Contrast-Enhanced MDCT Without Dedicated Software. Eur J Radiol (2011) 80(2):e140&#x2013;5. doi:&#xa0;10.1016/j.ejrad.2010.08.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2010.08.034</ArticleId><ArticleId IdType="pubmed">20851544</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum T, Muller D, Dobritz M, Wolf P, Rummeny EJ, Link TM, et al. . Converted Lumbar BMD Values Derived From Sagittal Reformations of Contrast-Enhanced MDCT Predict Incidental Osteoporotic Vertebral Fractures. Calcif Tissue Int (2012) 90(6):481&#x2013;7. doi:&#xa0;10.1007/s00223-012-9596-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-012-9596-3</ArticleId><ArticleId IdType="pubmed">22484555</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwaiger BJ, Gersing AS, Baum T, Noel PB, Zimmer C, Bauer JS. Bone Mineral Density Values Derived From Routine Lumbar Spine Multidetector Row CT Predict Osteoporotic Vertebral Fractures and Screw Loosening. AJNR Am J Neuroradiol (2014) 35(8):1628&#x2013;33. doi:&#xa0;10.3174/ajnr.A3893</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A3893</ArticleId><ArticleId IdType="pmc">PMC7964446</ArticleId><ArticleId IdType="pubmed">24627455</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentinitsch A, Trebeschi S, Alarcon E, Baum T, Kaesmacher J, Zimmer C, et al. . Regional Analysis of Age-Related Local Bone Loss in the Spine of a Healthy Population Using 3D Voxel-Based Modeling. Bone (2017) 103:233&#x2013;40. doi:&#xa0;10.1016/j.bone.2017.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2017.06.013</ArticleId><ArticleId IdType="pubmed">28716553</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentinitsch A, Trebeschi S, Kaesmacher J, Lorenz C, Loffler MT, Zimmer C, et al. . Opportunistic Osteoporosis Screening in Multi-Detector CT Images Via Local Classification of Textures. Osteo Int (2019) 30(6):1275&#x2013;85. doi:&#xa0;10.1007/s00198-019-04910-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-019-04910-1</ArticleId><ArticleId IdType="pmc">PMC6546649</ArticleId><ArticleId IdType="pubmed">30830261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the Assessment of Fracture Probability in Men and Women From the UK. Osteo Int (2008) 19(4):385&#x2013;97. doi:&#xa0;10.1007/s00198-007-0543-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-007-0543-5</ArticleId><ArticleId IdType="pmc">PMC2267485</ArticleId><ArticleId IdType="pubmed">18292978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Su Y, Wang Q, Duanmu Y, Yang M, Yi C, et al. . Validation of Asynchronous Quantitative Bone Densitometry of the Spine: Accuracy, Short-Term Reproducibility, and a Comparison With Conventional Quantitative Computed Tomography. Sci Rep (2017) 7(1):6284. doi:&#xa0;10.1038/s41598-017-06608-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06608-y</ArticleId><ArticleId IdType="pmc">PMC5524691</ArticleId><ArticleId IdType="pubmed">28740145</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JK, Timm W, Bodeen G, Chason A, Perry M, Vernacchia F, et al. . Asynchronously Calibrated Quantitative Bone Densitometry. J Clin Densitom (2017) 20(2):216&#x2013;25. doi:&#xa0;10.1016/j.jocd.2015.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2015.11.001</ArticleId><ArticleId IdType="pubmed">26781430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhling S, Navarro F, Sekuboyina A, El Husseini M, Baum T, Menze B, et al. . Automated Detection of the Contrast Phase in MDCT by an Artificial Neural Network Improves the Accuracy of Opportunistic Bone Mineral Density Measurements. Eur Radiol (2022) 32(3):1465&#x2013;74. doi:&#xa0;10.1007/s00330-021-08284-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-021-08284-z</ArticleId><ArticleId IdType="pmc">PMC8831336</ArticleId><ArticleId IdType="pubmed">34687347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaesmacher J, Liebl H, Baum T, Kirschke JS. Bone Mineral Density Estimations From Routine Multidetector Computed Tomography: A Comparative Study of Contrast and Calibration Effects. J Comput Assist Tomogr (2017) 41(2):217&#x2013;23. doi:&#xa0;10.1097/RCT.0000000000000518</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RCT.0000000000000518</ArticleId><ArticleId IdType="pmc">PMC5359785</ArticleId><ArticleId IdType="pubmed">27798444</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30844953</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of orthopaedic trauma</Title><ISOAbbreviation>J Orthop Trauma</ISOAbbreviation></Journal><ArticleTitle>Nonoperative Geriatric Hip Fracture Treatment Is Associated With Increased Mortality: A Matched Cohort Study.</ArticleTitle><Pagination><StartPage>346</StartPage><EndPage>350</EndPage><MedlinePgn>346-350</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BOT.0000000000001460</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To report the mortality data and life expectancy of geriatric hip fracture patients who underwent nonoperative management and compare that with a matched operative cohort.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Level 1 trauma center.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Geriatric (65 years of age and older) femoral neck or intertrochanteric fracture (OTA/AO 31A and 31B) patients.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Operative treatment with either arthroplasty, cannulated screws, sliding hip screw device, or cephalomedullary nail compared with nonoperative cohort.</AbstractText><AbstractText Label="MAIN OUTCOME MEASUREMENTS" NlmCategory="METHODS">In-hospital, 30-day, and 1-year mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred thirty-one patients, comprising 154 operative and 77 nonoperative patients, were compared. There were no significant differences among age, sex, fracture location, Charlson Comorbidity Index, preinjury living location, dementia, and history of cardiac arrhythmia between the 2 cohorts. Nonoperatively managed patients were found to have a significantly higher percent in-hospital (28.6 vs. 3.9; P &lt; 0.0001), 30-day (63.6 vs. 11.0; &lt;0.0001), and 1-year (84.4 vs. 36.4; P &lt; 0.0001) mortality. The mean life expectancy after a hip fracture for the nonoperative cohort was significantly shorter than the operative group (221 vs. 1024 days; P &lt; 0.0001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Nonoperatively treated hip fracture patients had an 84.4% 1-year mortality that was significantly higher than a matched operative cohort. Our results demonstrate the bleak overall prognosis for nonoperatively treated geriatric hip fractures as well as the associated reduction in mortality with surgical treatment. Our findings offer helpful information by providing updated mortality data when discussing nonoperative hip fracture management with patients and their family.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chlebeck</LastName><ForeName>Jesse D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>St. Luke's Nampa Medical Center, Nampa, ID.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birch</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Alta Orthopaedics, Santa Barbara, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankstein</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine, The University of Vermont, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kristiansen</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine, The University of Vermont, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Craig S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine, The University of Vermont, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schottel</LastName><ForeName>Patrick C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, Larner College of Medicine, The University of Vermont, Burlington, VT.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Orthop Trauma</MedlineTA><NlmUniqueID>8807705</NlmUniqueID><ISSNLinking>0890-5339</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005592" MajorTopicYN="N">Fracture Fixation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015577" MajorTopicYN="N">Geriatric Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30844953</ArticleId><ArticleId IdType="doi">10.1097/BOT.0000000000001460</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30768462</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Randomized Trial Comparing Early and Late Administration of Rocuronium Before and After Checking Mask Ventilation in Patients With Normal Airways.</ArticleTitle><Pagination><StartPage>380</StartPage><EndPage>386</EndPage><MedlinePgn>380-386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000004060</ELocationID><Abstract><AbstractText Label="BACKGROUND">During induction of general anesthesia, it is common practice to delay neuromuscular blockade until the ability to deliver mask ventilation has been confirmed. However, the benefits of this approach have never been scientifically validated. We thus compared the early and late administration of rocuronium before and after checking mask ventilation to investigate the efficiency of mask ventilation and the time to tracheal intubation in patients with normal airways.</AbstractText><AbstractText Label="METHODS">Patients (n = 114) were randomized to receive IV rocuronium either before (early rocuronium group, n = 58) or after (late rocuronium group, n = 56) checking mask ventilation. Expiratory tidal volumes (VTs) were measured at 10, 20, 30, 40, 50, and 60 seconds after apnea during mask ventilation. We graded the ease of mask ventilation and measured the time from apnea to tracheal intubation. The primary outcome was the average of mask VTs measured at 10, 20, 30, 40, 50, and 60 seconds after apnea. The main secondary outcome was the time from apnea to tracheal intubation. STATA was used for statistical analysis.</AbstractText><AbstractText Label="RESULTS">The average of mask VTs measured at 10, 20, 30, 40, 50, and 60 seconds after apnea was larger in the early rocuronium group than in the late rocuronium group (552 mL breath [165 mL breath] vs 393 mL breath [165 mL breath], mean difference, 160 mL breath; 95% CI, 98-221 mL breath; P &lt; .001, unpaired t test). Because the interaction between time and group was significant in mask VTs measured at 10, 20, 30, 40, 50, and 60 seconds after apnea (P &lt; .001, linear mixed effects model), pairwise comparisons were performed at the 6 time points. The differences in VTs between the groups were significant at 10, 20, 30, 40, and 50 seconds after apnea (P &lt; .001 each, contrast statements in STATA). The time from apnea to tracheal intubation was shorter in the early rocuronium group than in the late rocuronium group (116 seconds [42 seconds] vs 195 seconds [41 seconds]; mean difference, -79 seconds; 95% CI, -96 to -64 seconds, P &lt; .001).</AbstractText><AbstractText Label="CONCLUSIONS">The early administration of rocuronium before checking mask ventilation resulted in a larger mask VT and earlier tracheal intubation than the late administration of rocuronium after checking mask ventilation in patients with normal airways.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Se-Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Im</LastName><ForeName>Hyunjae</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, National Cancer Center, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Bo Rim</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Susie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahk</LastName><ForeName>Jae-Hyon</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Jeong-Hwa</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03270696</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003473">Neuromuscular Nondepolarizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>WRE554RFEZ</RegistryNumber><NameOfSubstance UI="D000077123">Rocuronium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2019 Sep;129(3):e103-e104. doi: 10.1213/ANE.0000000000004260.</RefSource><PMID Version="1">31425239</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2019 Sep;129(3):e104. doi: 10.1213/ANE.0000000000004261.</RefSource><PMID Version="1">31425240</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2020 Mar;130(3):e98. doi: 10.1213/ANE.0000000000004603.</RefSource><PMID Version="1">31913909</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2020 Mar;130(3):e98-e99. doi: 10.1213/ANE.0000000000004604.</RefSource><PMID Version="1">31913913</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003473" MajorTopicYN="N">Neuromuscular Nondepolarizing Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077123" MajorTopicYN="N">Rocuronium</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066106" MajorTopicYN="N" Type="Geographic">Seoul</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30768462</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000004060</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40278864</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>Prevalence and incidence of osteoporotic vertebral fractures in community-dwelling European older adults: an observational analysis of the DO-HEALTH trial.</ArticleTitle><Pagination><StartPage>1077</StartPage><EndPage>1088</EndPage><MedlinePgn>1077-1088</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-025-07489-y</ELocationID><Abstract><AbstractText Label="UNLABELLED">We examined vertebral fracture (VF) prevalence, incidence, and treatment among 1488 older adults. VF prevalence and incidence were higher in women, older participants, and those with low bone density. In addition to VFs being underdiagnosed (only 20.7% of VFs clinically recognized), treatment rates were low, underscoring the need for improved screening and management.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To estimate prevalence and incidence of osteoporotic VFs and VF progressions overall and by sex, age, and bone status and to describe the proportion of participants with VFs in&#xa0;reporting osteoporosis (OP) medication&#xa0;use.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This observational analysis of the DO-HEALTH trial, a three-year, randomized, controlled trial among community-dwelling adults age&#x2009;&#x2265;&#x2009;70 years, includes a subsample of participants recruited at four study sites equipped with DXA machines. Prevalence and incidence rates (IR) of VFs and VF progressions were described overall and by subgroups of sex, age, and bone status. Incidence of VFs which were clinically recognized was also estimated. Further, we estimated the proportion of participants on OP medication.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1488 participants were included (mean age 74.9 years, 63.1% women, 77.0% had osteopenia or osteoporosis). One hundred forty-four (9.7%) participants had at least one radiographic VF at baseline and of those 19.4% participants reported OP medication use. Over the three-year follow-up, 50 participants sustained 58 new radiographic VFs (IR 1.4, 95% CI 1.1, 1.9). Of the 58 radiographic VFs, only 12 (20.7%) were clinically recognized. Furthermore, 31 participants sustained 35 VF progressions (N&#x2009;=&#x2009;157; IR 7.7, 95% CI 5.5, 10.7). Prevalence and incidence were significantly higher in women, in older participants and those with osteopenia or osteoporosis compared to those with normal bone density.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study suggests a high prevalence and incidence of VFs in community-dwelling European older adults. Underdiagnosis may be even more prevalent than previously observed, and treatment rates were low.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Albrecht</LastName><ForeName>Andreas P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre On Aging and Mobility, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kistler-Fischbacher</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre On Aging and Mobility, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Godoi Rezende Costa Molino</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre On Aging and Mobility, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armbrecht</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t Zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freystaetter</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre On Aging and Mobility, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Clinic for Aging Medicine, Zurich City Hospital, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theiler</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre On Aging and Mobility, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kressig</LastName><ForeName>Reto W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Dept. of Aging Medicine FELIX PLATTER, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Silva</LastName><ForeName>Jose A P</ForeName><Initials>JAP</Initials><AffiliationInfo><Affiliation>Centro Hospitalar E Universit&#xe1;rio de Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzoli</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanner</LastName><ForeName>Guido A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Spine Clinic and Traumatology, Private Hospital Bethanien, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egli</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre On Aging and Mobility, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawson-Hughes</LastName><ForeName>Bess</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Jean Mayer USDA Human Nutrition Research Center On Aging, Tufts University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bischoff-Ferrari</LastName><ForeName>Heike A</ForeName><Initials>HA</Initials><Identifier Source="ORCID">0000-0002-4554-658X</Identifier><AffiliationInfo><Affiliation>Department of Aging Medicine and Aging Research, University of Zurich, Zurich, Switzerland. HA.bischoff-ferrari@felixplatter.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre On Aging and Mobility, University of Zurich, Zurich, Switzerland. HA.bischoff-ferrari@felixplatter.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept. of Aging Medicine FELIX PLATTER, University of Basel, Basel, Switzerland. HA.bischoff-ferrari@felixplatter.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Basel, Basel, Switzerland. HA.bischoff-ferrari@felixplatter.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>278588</GrantID><Agency>European Union, 7th framework</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050071">Bone Density Conservation Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050071" MajorTopicYN="N">Bone Density Conservation Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057187" MajorTopicYN="N">Independent Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="Y">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DO-HEALTH trial</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: HAB-F reports as the PI of the DO-HEALTH trial, grants from the European Commission, (grant agreement no. 278588) from the University of Zurich, from NESTEC, from PFIZER Consumer Healthcare, from Streuli Pharma, plus non-financial support from DSM Nutritional Products and from Roche Diagnostics. Furthermore, HAB-F reports speaker fees from Wild, Pfizer, Vifor, Mylan, Roche Diagnostics, and independent and investigator initiated grants from Pfizer and from Vifor, outside the submitted work. AA, MK-F, CG, GA, GF, RT, RWK, JAPD, RR, GAW, AE, and BD-H declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>12</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>13</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40278864</ArticleId><ArticleId IdType="pmc">PMC12122559</ArticleId><ArticleId IdType="doi">10.1007/s00198-025-07489-y</ArticleId><ArticleId IdType="pii">10.1007/s00198-025-07489-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Melton LJ 3rd, Lane AW, Cooper C, Eastell R, O&#x2019;Fallon WM, Riggs BL (1993) Prevalence and incidence of vertebral deformities. Osteoporos Int 3(3):113&#x2013;119. 10.1007/bf01623271</Citation><ArticleIdList><ArticleId IdType="pubmed">8481586</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Atkinson EJ, O&#x2019;Fallon WM, Melton LJ 3rd (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985&#x2013;1989. J Bone Miner Res 7(2):221&#x2013;227. 10.1002/jbmr.5650070214</Citation><ArticleIdList><ArticleId IdType="pubmed">1570766</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill TW, Roy DK (2005) How many people develop fractures with what outcome? Best Pract Res Clin Rheumatol 19(6):879&#x2013;895. 10.1016/j.berh.2005.06.003</Citation><ArticleIdList><ArticleId IdType="pubmed">16301185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Johansson H, Od&#xe9;n A, Harvey NC, Gudnason V, Sanders KM et al (2018) Characteristics of recurrent fractures. Osteoporos Int 29(8):1747&#x2013;1757. 10.1007/s00198-018-4502-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6076437</ArticleId><ArticleId IdType="pubmed">29947869</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett-Connor E (1995) The economic and human costs of osteoporotic fracture. Am J Med 98(2a):3s&#x2013;8s. 10.1016/s0002-9343(05)80037-3</Citation><ArticleIdList><ArticleId IdType="pubmed">7709931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasnich RD (1996) Vertebral fracture epidemiology. Bone 18(3 Suppl):179s&#x2013;183s. 10.1016/8756-3282(95)00499-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8777085</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K et al (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128(10):793&#x2013;800. 10.7326/0003-4819-128-10-199805150-00001</Citation><ArticleIdList><ArticleId IdType="pubmed">9599190</ArticleId></ArticleIdList></Reference><Reference><Citation>Klazen CA, Verhaar HJ, Lohle PN, Lampmann LE, Juttmann JR, Schoemaker MC et al (2010) Clinical course of pain in acute osteoporotic vertebral compression fractures. J Vasc Interv Radiol 21(9):1405&#x2013;1409. 10.1016/j.jvir.2010.05.018</Citation><ArticleIdList><ArticleId IdType="pubmed">20800779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M et al (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16(1):82. 10.1007/s11657-020-00871-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172408</ArticleId><ArticleId IdType="pubmed">34080059</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N, Darvishi N, Bartina Y, Larti M, Kiaei A, Hemmati M et al (2021) Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16(1):669. 10.1186/s13018-021-02821-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590304</ArticleId><ArticleId IdType="pubmed">34774085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G (2017) Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int 28(5):1531&#x2013;1542. 10.1007/s00198-017-3909-3</Citation><ArticleIdList><ArticleId IdType="pubmed">28168409</ArticleId></ArticleIdList></Reference><Reference><Citation>Delmas PD, van de Langerijt L, Watts NB, Eastell R, Genant H, Grauer A et al (2005) Underdiagnosis of Vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 20(4):557&#x2013;563. 10.1359/JBMR.041214</Citation><ArticleIdList><ArticleId IdType="pubmed">15765173</ArticleId></ArticleIdList></Reference><Reference><Citation>Schousboe JT (2016) Epidemiology of vertebral fractures. J Clin Densitom 19(1):8&#x2013;22. 10.1016/j.jocd.2015.08.004</Citation><ArticleIdList><ArticleId IdType="pubmed">26349789</ArticleId></ArticleIdList></Reference><Reference><Citation>Samelson EJ, Hannan MT, Zhang Y, Genant HK, Felson DT, Kiel DP (2006) Incidence and risk factors for vertebral fracture in women and men: 25-year follow-up results from the population-based Framingham study. J Bone Miner Res 21(8):1207&#x2013;1214. 10.1359/jbmr.060513</Citation><ArticleIdList><ArticleId IdType="pubmed">16869718</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11(7):1010&#x2013;1018. 10.1002/jbmr.5650110719</Citation><ArticleIdList><ArticleId IdType="pubmed">8797123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman JM (2021) Management of osteoporosis in older men. Aging Clin Exp Res 33(6):1439&#x2013;1452. 10.1007/s40520-021-01845-8</Citation><ArticleIdList><ArticleId IdType="pubmed">33821467</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink HA, Milavetz DL, Palermo L, Nevitt MC, Cauley JA, Genant HK et al (2005) What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res 20(7):1216&#x2013;1222. 10.1359/jbmr.050314</Citation><ArticleIdList><ArticleId IdType="pubmed">15940375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensrud KE, Blackwell TL, Fink HA, Zhang J, Cauley JA, Cawthon PM et al (2016) What proportion of incident radiographic vertebral fractures in older men is clinically diagnosed and vice versa: a prospective study. J Bone Miner Res 31(8):1500&#x2013;1503. 10.1002/jbmr.2831</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065098</ArticleId><ArticleId IdType="pubmed">26969847</ArticleId></ArticleIdList></Reference><Reference><Citation>McCloskey E, Rathi J, Heijmans S, Blagden M, Cortet B, Czerwinski E et al (2021) The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int 32(2):251&#x2013;259. 10.1007/s00198-020-05557-z</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7838133</ArticleId><ArticleId IdType="pubmed">32829471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold LS, Cody RF Jr, Tan WK, Marcum ZA, Meier EN, Sherman KJ et al (2022) Osteoporosis identification among previously undiagnosed individuals with vertebral fractures. Osteoporos Int 33(9):1925&#x2013;1935. 10.1007/s00198-022-06450-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10120403</ArticleId><ArticleId IdType="pubmed">35654855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari HA, de GoRezende Costa Molino C, Rival S, Vellas B, Rizzoli R, Kressig RW, et al (2021) DO-HEALTH: vitamin D3 - omega-3 - home exercise - healthy aging and longevity trial - design of a multinational clinical trial on healthy aging among European seniors. Contemp Clin Trials. 100:106124. 10.1016/j.cct.2020.106124</Citation><ArticleIdList><ArticleId IdType="pubmed">32858228</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, da Silva JAP, Blauth M et al (2020) Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical triaL. JAMA 324(18):1855&#x2013;1868. 10.1001/jama.2020.16909</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7656284</ArticleId><ArticleId IdType="pubmed">33170239</ArticleId></ArticleIdList></Reference><Reference><Citation>Armbrecht G, Blenk T, Chesnut CH 3rd, Gardner JC, von Ingersleben G, Mahoney P et al (2008) Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology. J Clin Densitom 11(2):221&#x2013;231. 10.1016/j.jocd.2007.10.002</Citation><ArticleIdList><ArticleId IdType="pubmed">18158264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistler-Fischbacher M, Armbrecht G, G&#xe4;ngler S, Theiler R, Rizzoli R, Dawson-Hughes B et al (2024) Effects of vitamin D3 omega-3 s and a simple strength training exercise program on bone health: the DO-HEALTH randomized controlled trial. J Bone Miner Res. 10.1093/jbmr/zjae054</Citation><ArticleIdList><ArticleId IdType="pubmed">38613445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49(2):156&#x2013;163. 10.1002/art.10993</Citation><ArticleIdList><ArticleId IdType="pubmed">12687505</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenberg D, Silman AJ, Lunt M, Armbrecht G, Ismail AA, Finn JD et al (2002) Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 17(4):716&#x2013;724. 10.1359/jbmr.2002.17.4.716</Citation><ArticleIdList><ArticleId IdType="pubmed">11918229</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA (2002) The incidence of vertebral fractures in men and women: the Rotterdam study. J Bone Miner Res 17(6):1051&#x2013;1056. 10.1359/jbmr.2002.17.6.1051</Citation><ArticleIdList><ArticleId IdType="pubmed">12054160</ArticleId></ArticleIdList></Reference><Reference><Citation>McCloskey EV, Spector TD, Eyres KS, Fern ED, O&#x2019;Rourke N, Vasikaran S et al (1993) The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3(3):138&#x2013;147. 10.1007/bf01623275</Citation><ArticleIdList><ArticleId IdType="pubmed">8481590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigdon SF, Saldarriaga Y, Oswald KAC, M&#xfc;ller M, Deml MC, Benneker LM et al (2022) Epidemiologic analysis of 8000 acute vertebral fractures: evolution of treatment and complications at 10-year follow-up. J Orthop Surg Res 17(1):270. 10.1186/s13018-022-03147-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107747</ArticleId><ArticleId IdType="pubmed">35568925</ArticleId></ArticleIdList></Reference><Reference><Citation>Geusens P, Kendler DL, Fahrleitner-Pammer A, L&#xf3;pez-Romero P, Marin F (2020) Distribution of prevalent and incident vertebral fractures and their association with bone mineral density in postmenopausal women in the teriparatide versus risedronate VERO clinical trial. Calcif Tissue Int 106(6):646&#x2013;654. 10.1007/s00223-020-00683-6</Citation><ArticleIdList><ArticleId IdType="pubmed">32157334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziebart C, Adachi JD, Ashe MC, Bleakney RR, Cheung AM, Gibbs JC et al (2019) Exploring the association between number, severity, location of fracture, and occiput-to-wall distance. Arch Osteoporos 14(1):27. 10.1007/s11657-019-0582-5</Citation><ArticleIdList><ArticleId IdType="pubmed">30820733</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajasekaran S, Kanna RM, Shetty AP (2015) Management of thoracolumbar spine trauma: an overview. Indian J Orthop 49(1):72&#x2013;82. 10.4103/0019-5413.143914</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4292328</ArticleId><ArticleId IdType="pubmed">25593358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3&#x2013;44. 10.1007/s00198-018-4704-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026233</ArticleId><ArticleId IdType="pubmed">30324412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari S, Lippuner K, Lamy O, Meier C (2020) 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Med Wkly 150:w20352. 10.4414/smw.2020.20352</Citation><ArticleIdList><ArticleId IdType="pubmed">33038260</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL et al (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17(1):58. 10.1007/s11657-022-01061-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8979902</ArticleId><ArticleId IdType="pubmed">35378630</ArticleId></ArticleIdList></Reference><Reference><Citation>Lems WF, Paccou J, Zhang J, Fuggle NR, Chandran M, Harvey NC et al (2021) Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services. Osteoporos Int 32(3):399&#x2013;411. 10.1007/s00198-020-05804-3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929949</ArticleId><ArticleId IdType="pubmed">33475820</ArticleId></ArticleIdList></Reference><Reference><Citation>Papaioannou A, Kennedy CC, Ioannidis G, Gao Y, Sawka AM, Goltzman D et al (2008) The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 19(4):581&#x2013;587. 10.1007/s00198-007-0483-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5104547</ArticleId><ArticleId IdType="pubmed">17924051</ArticleId></ArticleIdList></Reference><Reference><Citation>Malle O, Borgstroem F, Fahrleitner-Pammer A, Svedbom A, Dimai SV, Dimai HP (2021) Mind the gap: incidence of osteoporosis treatment after an osteoporotic fracture - results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS). Bone 142:115071. 10.1016/j.bone.2019.115071</Citation><ArticleIdList><ArticleId IdType="pubmed">31593822</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rnsdottir S, Clarke BL, Mannstadt M, Langdahl BL (2022) Male osteoporosis-what are the causes, diagnostic challenges, and management. Best Pract Res Clin Rheumatol 36(3):101766. 10.1016/j.berh.2022.101766</Citation><ArticleIdList><ArticleId IdType="pubmed">35961836</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe1;ng YXJ, Che-Nordin N, Deng M, Leung JCS, Kwok AWL, He LC, et al (2019) Osteoporotic vertebral deformity with endplate/cortex fracture is associated with higher further vertebral fracture risk: the Ms. OS (Hong Kong) study results. Osteoporos Int. 30(4):897&#x2013;905. 10.1007/s00198-019-04856-4</Citation><ArticleIdList><ArticleId IdType="pubmed">30666373</ArticleId></ArticleIdList></Reference><Reference><Citation>Akeda K, Nakase K, Yamada J, Takegami N, Fujiwara T, Sudo A (2024) Progression of vertebral deformity of prevalent vertebral fractures in the elderly: a population-based study. BMC Musculoskelet Disord 25(1):110. 10.1186/s12891-024-07254-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10840146</ArticleId><ArticleId IdType="pubmed">38317112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamimura M, Nakamura Y, Sugino N, Uchiyama S, Komatsu M, Ikegami S et al (2016) Associations of self-reported height loss and kyphosis with vertebral fractures in Japanese women 60 years and older: a cross-sectional survey. Sci Rep 6(1):29199. 10.1038/srep29199</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933969</ArticleId><ArticleId IdType="pubmed">27381354</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, Ogikubo O, Hansson T (2009) The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: its relation to fracture level, type of fracture and grade of fracture deformation. Eur Spine J 18(1):77&#x2013;88. 10.1007/s00586-008-0847-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615123</ArticleId><ArticleId IdType="pubmed">19082846</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37940953</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Reliability of pulse pressure and stroke volume variation in assessing fluid responsiveness in the operating room: a metanalysis and a metaregression.</ArticleTitle><Pagination><StartPage>431</StartPage><MedlinePgn>431</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">431</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-023-04706-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pulse pressure and stroke volume variation (PPV and SVV) have been widely used in surgical patients as predictors of fluid challenge (FC) response. Several factors may affect the reliability of these indices in predicting fluid responsiveness, such as the position of the patient, the use of laparoscopy and the opening of the abdomen or the chest, combined FC characteristics, the tidal volume (Vt) and the type of anesthesia.</AbstractText><AbstractText Label="METHODS">Systematic review and metanalysis of PPV and SVV use in surgical adult patients. The QUADAS-2 scale was used to assess the risk of bias of included studies. We adopted a metanalysis pooling of aggregate data from 5 subgroups of studies with random effects models using the common-effect inverse variance model. The area under the curve (AUC) of pooled receiving operating characteristics (ROC) curves was reported. A metaregression was performed using FC type, volume, and rate as independent variables.</AbstractText><AbstractText Label="RESULTS">We selected 59 studies enrolling 2,947 patients, with a median of fluid responders of 55% (46-63). The pooled AUC for the PPV was 0.77 (0.73-0.80), with a mean threshold of 10.8 (10.6-11.0). The pooled AUC for the SVV was 0.76 (0.72-0.80), with a mean threshold of 12.1 (11.6-12.7); 19 studies (32.2%) reported the grey zone of PPV or SVV, with a median of 56% (40-62) and 57% (46-83) of patients included, respectively. In the different subgroups, the AUC and the best thresholds ranged from 0.69 and 0.81 and from 6.9 to 11.5% for the PPV, and from 0.73 to 0.79 and 9.9 to 10.8% for the SVV. A high Vt and the choice of colloids positively impacted on PPV performance, especially among patients with closed chest and abdomen, or in prone position.</AbstractText><AbstractText Label="CONCLUSION">The overall performance of PPV and SVV in operating room in predicting fluid responsiveness is moderate, ranging close to an AUC of 0.80 only some subgroups of surgical patients. The grey zone of these dynamic indices is wide and should be carefully considered during the assessment of fluid responsiveness. A high Vt and the choice of colloids for the FC are factors potentially influencing PPV reliability.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO (CRD42022379120), December 2022. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=379120.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy. antonio.messina@humanitas.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy. antonio.messina@humanitas.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caporale</LastName><ForeName>Mariagiovanna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lionetti</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bono</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matronola</LastName><ForeName>Guia Margherita</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunati</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frassanito</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morenghi</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Biomedical and Clinical Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003102">Colloids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2023 Dec 7;27(1):482. doi: 10.1186/s13054-023-04765-3.</RefSource><PMID Version="1">38062505</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2024 Jan 12;28(1):22. doi: 10.1186/s13054-023-04796-w.</RefSource><PMID Version="1">38216947</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009873" MajorTopicYN="Y">Operating Rooms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003102" MajorTopicYN="N">Colloids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fluid responsiveness</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Hemodynamic monitoring</Keyword><Keyword MajorTopicYN="N">Pulse pressure variation</Keyword><Keyword MajorTopicYN="N">Stroke volume variation</Keyword></KeywordList><CoiStatement>Prof. Michelle Chew is a Critical Care journal editor and received travel reimbursements and speaker fees from Edwards Lifesciences and from AOP Health. Dr. Messina received travel expenses and registration for meetings, congresses, and courses and lecture fees from Vygon, Phlips, Edwards; Prof. Cecconi is a consultant for Edwards Lifesciences.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>8</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37940953</ArticleId><ArticleId IdType="pmc">PMC10631038</ArticleId><ArticleId IdType="doi">10.1186/s13054-023-04706-0</ArticleId><ArticleId IdType="pii">10.1186/s13054-023-04706-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thiele RH, Raghunathan K, Brudney CS, Lobo DN, Martin D, Senagore A, Cannesson M, Gan TJ, Mythen MM, Shaw AD, Miller TE. Perioperative quality initiative IW: American society for enhanced recovery (aser) and perioperative quality initiative (poqi) joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Perioper Med. 2016;5:24. doi: 10.1186/s13741-016-0049-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-016-0049-9</ArticleId><ArticleId IdType="pmc">PMC5027098</ArticleId><ArticleId IdType="pubmed">27660701</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, Gan TJ, Kennedy RH, Ljungqvist O, Lobo DN, Miller T, Radtke FF, Ruiz Garces T, Schricker T, Scott MJ, Thacker JK, Ytrebo LM, Carli F. Enhanced recovery after surgery (eras) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016;60:289&#x2013;334. doi: 10.1111/aas.12651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12651</ArticleId><ArticleId IdType="pmc">PMC5061107</ArticleId><ArticleId IdType="pubmed">26514824</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaryus R, Miller TE, Gan TJ. Current concepts of fluid management in enhanced recovery pathways. Br J Anaesth. 2018;120:376&#x2013;383. doi: 10.1016/j.bja.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.10.011</ArticleId><ArticleId IdType="pubmed">29406186</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro LH, Bloomstone JA, Auler JO, Jr, Cannesson M, Rocca GD, Gan TJ, Kinsky M, Magder S, Miller TE, Mythen M, Perel A, Reuter DA, Pinsky MR, Kramer GC. Perioperative fluid therapy: a statement from the international fluid optimization group. Perioper Med. 2015;4:3. doi: 10.1186/s13741-015-0014-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-015-0014-z</ArticleId><ArticleId IdType="pmc">PMC4403901</ArticleId><ArticleId IdType="pubmed">25897397</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Ehrmann S, Mari A, Conte B, Mahjoub Y, Desebbe O, Pottecher J, Lakhal K, Benzekri-Lefevre D, Molinari N, Boulain T, Lefrant JY, Muller L, AzuRea G. Clinical relevance of pulse pressure variations for predicting fluid responsiveness in mechanically ventilated intensive care unit patients: the grey zone approach. Crit Care. 2014;18:587. doi: 10.1186/s13054-014-0587-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0587-9</ArticleId><ArticleId IdType="pmc">PMC4240833</ArticleId><ArticleId IdType="pubmed">25658489</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahjoub Y, Lejeune V, Muller L, Perbet S, Zieleskiewicz L, Bart F, Veber B, Paugam-Burtz C, Jaber S, Ayham A, Zogheib E, Lasocki S, Vieillard-Baron A, Quintard H, Joannes-Boyau O, Plantefeve G, Montravers P, Duperret S, Lakhdari M, Ammenouche N, Lorne E, Slama M, Dupont H. Evaluation of pulse pressure variation validity criteria in critically ill patients: a prospective observational multicentre point-prevalence study. Br J Anaesth. 2014;112:681&#x2013;685. doi: 10.1093/bja/aet442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet442</ArticleId><ArticleId IdType="pubmed">24374504</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Heenen S, Piagnerelli M, Koch M, Vincent JL. Pulse pressure variations to predict fluid responsiveness: influence of tidal volume. Intensive Care Med. 2005;31:517&#x2013;523. doi: 10.1007/s00134-005-2586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2586-4</ArticleId><ArticleId IdType="pubmed">15754196</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Le Manach Y, Hofer CK, Goarin JP, Lehot JJ, Vallet B, Tavernier B. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a "gray zone" approach. Anesthesiology. 2011;115:231&#x2013;241. doi: 10.1097/ALN.0b013e318225b80a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318225b80a</ArticleId><ArticleId IdType="pubmed">21705869</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, Marret E, Beaussier M, Gutton C, Lefrant JY, Allaouchiche B. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Eng J Med. 2013;369(5):428&#x2013;37. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikermann M, Kurth T. Apply protective mechanical ventilation in the operating room in an individualized approach to perioperative respiratory care. Anesthesiology. 2015;123:12&#x2013;14. doi: 10.1097/ALN.0000000000000707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000707</ArticleId><ArticleId IdType="pubmed">25978325</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Pelaia C, Bruni A, Garofalo E, Bonicolini E, Longhini F, Dellara E, Saderi L, Romagnoli S, Sotgiu G, Cecconi M, Navalesi P. Fluid challenge during anesthesia: a systematic review and meta-analysis. Anesth Analg. 2018;127:1353&#x2013;1364. doi: 10.1213/ANE.0000000000003834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003834</ArticleId><ArticleId IdType="pubmed">30300177</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Sotgiu G, Saderi L, Cammarota G, Capuano L, Colombo D, Bennett V, Payen D, Navalesi P, Cecconi M. Does the definition of fluid responsiveness affect passive leg raising reliability? A methodological ancillary analysis from a multicentric study. Minerva Anestesiol. 2021;88(4):272&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">34709017</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Palandri C, De Rosa S, Danzi V, Bonaldi E, Montagnini C, Baino S, Villa F, Sala F, Zito P, Negri K, Della Corte F, Cammarota G, Saderi L, Sotgiu G, Monge Garcia MI, Cecconi M. Pharmacodynamic analysis of a fluid challenge with 4 ml kg(&#x2212;&#xa0;1) over 10 or 20 min: a multicenter cross-over randomized clinical trial. J Clin Monit Comput. 2022;36:1193&#x2013;1203. doi: 10.1007/s10877-021-00756-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-021-00756-3</ArticleId><ArticleId IdType="pmc">PMC8423602</ArticleId><ArticleId IdType="pubmed">34494204</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthelemy R, Kindermans M, Delval P, Collet M, Gaugain S, Cecconi M, Mebazaa A, Chousterman BG. Accuracy of cumulative volumes of fluid challenge to assess fluid responsiveness in critically ill patients with acute circulatory failure: a pharmacodynamic approach. Br J Anaesth. 2022;128:236&#x2013;243. doi: 10.1016/j.bja.2021.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.10.049</ArticleId><ArticleId IdType="pubmed">34895718</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. Group Q&#x2013;Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529&#x2013;536. doi: 10.7326/0003-4819-155-8-201110180-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Dell'Anna A, Baggiani M, Torrini F, Maresca GM, Bennett V, Saderi L, Sotgiu G, Antonelli M, Cecconi M. Functional hemodynamic tests: a systematic review and a metanalysis on the reliability of the end-expiratory occlusion test and of the mini-fluid challenge in predicting fluid responsiveness. Crit Care. 2019;23:264. doi: 10.1186/s13054-019-2545-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2545-z</ArticleId><ArticleId IdType="pmc">PMC6664788</ArticleId><ArticleId IdType="pubmed">31358025</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>de Courson H, Chauvet J, Le Gall L, Georges D, Boyer P, Verchere E, Nouette-Gaulain K, Biais M. Utility of changes in end-tidal carbon dioxide after volume expansion to assess fluid responsiveness in the operating room: a prospective observational study. Br J Anaesth. 2020;125:672&#x2013;679. doi: 10.1016/j.bja.2020.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.07.018</ArticleId><ArticleId IdType="pubmed">32863016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubenek-Turconi SI, Hendy A, Baila S, Dragan A, Chioncel O, Valeanu L, Morosanu B, Iliescu VA. The value of a superior vena cava collapsibility index measured with a miniaturized transoesophageal monoplane continuous echocardiography probe to predict fluid responsiveness compared to stroke volume variations in open major vascular surgery: a prospective cohort study. J Clin Monit Comput. 2020;34:491&#x2013;499. doi: 10.1007/s10877-019-00346-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-019-00346-4</ArticleId><ArticleId IdType="pmc">PMC7223808</ArticleId><ArticleId IdType="pubmed">31278544</ArticleId></ArticleIdList></Reference><Reference><Citation>Joosten A, Boudart C, Vincent JL, Vanden Eynden F, Barvais L, Van Obbergh L, Rinehart J, Desebbe O. Ability of a new smartphone pulse pressure variation and cardiac output application to predict fluid responsiveness in patients undergoing cardiac surgery. Anesth Analg. 2019;128:1145&#x2013;1151. doi: 10.1213/ANE.0000000000003652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003652</ArticleId><ArticleId IdType="pubmed">31094781</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, de Courson H, Lanchon R, Pereira B, Bardonneau G, Griton M, Sesay M, Nouette-Gaulain K. Mini-fluid challenge of 100 ml of crystalloid predicts fluid responsiveness in the operating room. Anesthesiology. 2017;127:450&#x2013;456. doi: 10.1097/ALN.0000000000001753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001753</ArticleId><ArticleId IdType="pubmed">28640019</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Lanchon R, Sesay M, Le Gall L, Pereira B, Futier E, Nouette-Gaulain K. Changes in stroke volume induced by lung recruitment maneuver predict fluid responsiveness in mechanically ventilated patients in the operating room. Anesthesiology. 2017;126:260&#x2013;267. doi: 10.1097/ALN.0000000000001459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001459</ArticleId><ArticleId IdType="pubmed">27922547</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J, Dai S, Tao X, Chen X, Xu L. Corrected flow time and respirophasic variation in blood flow peak velocity of radial artery predict fluid responsiveness in gynecological surgical patients with mechanical ventilation. BMC Anesthesiol. 2022;22:299. doi: 10.1186/s12871-022-01837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01837-9</ArticleId><ArticleId IdType="pmc">PMC9484168</ArticleId><ArticleId IdType="pubmed">36123625</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordstrom J, Hallsjo-Sander C, Shore R, Bjorne H. Stroke volume optimization in elective bowel surgery: a comparison between pulse power wave analysis (lidcorapid) and oesophageal doppler (cardioq) Br J Anaesth. 2013;110:374&#x2013;380. doi: 10.1093/bja/aes399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes399</ArticleId><ArticleId IdType="pubmed">23171725</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Montagnini C, Cammarota G, De Rosa S, Giuliani F, Muratore L, Della Corte F, Navalesi P, Cecconi M. Tidal volume challenge to predict fluid responsiveness in the operating room: an observational study. Eur J Anaesthesiol. 2019;36:583&#x2013;591. doi: 10.1097/EJA.0000000000000998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000998</ArticleId><ArticleId IdType="pubmed">31021879</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Larghi M, Henriot J, de Courson H, Sesay M, Nouette-Gaulain K. End-expiratory occlusion test predicts fluid responsiveness in patients with protective ventilation in the operating room. Anesth Analg. 2017;125:1889&#x2013;1895. doi: 10.1213/ANE.0000000000002322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002322</ArticleId><ArticleId IdType="pubmed">28742783</ArticleId></ArticleIdList></Reference><Reference><Citation>De Broca B, Garnier J, Fischer MO, Archange T, Marc J, Abou-Arab O, Dupont H, Lorne E, Guinot PG. Stroke volume changes induced by a recruitment maneuver predict fluid responsiveness in patients with protective ventilation in the operating theater. Medicine. 2016;95:e4259. doi: 10.1097/MD.0000000000004259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000004259</ArticleId><ArticleId IdType="pmc">PMC4956831</ArticleId><ArticleId IdType="pubmed">27428237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura A, Suehiro K, Juri T, Tanaka K, Mori T. Changes in corrected carotid flow time induced by recruitment maneuver predict fluid responsiveness in patients undergoing general anesthesia. J Clin Monit Comput. 2022;36:1069&#x2013;1077. doi: 10.1007/s10877-021-00736-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-021-00736-7</ArticleId><ArticleId IdType="pubmed">34191254</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Lionetti G, Foti L, Bellotti E, Marcomini N, Cammarota G, Bennett V, Saderi L, Sotgiu G, Della Corte F, Protti A, Monge Garcia MI, Romagnoli S, Cecconi M. Mini fluid challenge and end-expiratory occlusion test to assess fluid responsiveness in the operating room (maneuver study): a multicentre cohort study. Eur J Anaesthesiol. 2021;38:422&#x2013;431. doi: 10.1097/EJA.0000000000001406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000001406</ArticleId><ArticleId IdType="pubmed">33399372</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil G, Motamed C, Eghiaian A, Monnet X, Suria S. Comparison of proaqt/pulsioflex. Anaesth Crit Care Pain Med. 2019;38:153&#x2013;159. doi: 10.1016/j.accpm.2018.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2018.03.011</ArticleId><ArticleId IdType="pubmed">29679768</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil G, Motamed C, Monnet X, Eghiaian A, Le Maho AL. End-expiratory occlusion test to predict fluid responsiveness is not suitable for laparotomic surgery. Anesth Analg. 2020;130:151&#x2013;158. doi: 10.1213/ANE.0000000000004205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004205</ArticleId><ArticleId IdType="pubmed">31846441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura A, Suehiro K, Juri T, Fujimoto Y, Yoshida H, Tanaka K, Mori T, Nishikawa K. Hemodynamic changes via the lung recruitment maneuver can predict fluid responsiveness in stroke volume and arterial pressure during one-lung ventilation. Anesth Analg. 2021;133:44&#x2013;52. doi: 10.1213/ANE.0000000000005375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005375</ArticleId><ArticleId IdType="pubmed">33687175</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun JH, Chung RK, Baik HJ, Chung MH, Hyeon JS, Lee YG, Park SH. The tidal volume challenge improves the reliability of dynamic preload indices during robot-assisted laparoscopic surgery in the trendelenburg position with lung-protective ventilation. BMC Anesthesiol. 2019;19:142. doi: 10.1186/s12871-019-0807-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0807-6</ArticleId><ArticleId IdType="pmc">PMC6686427</ArticleId><ArticleId IdType="pubmed">31390982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlicar M, Novak-Jankovic V, Blagus R, Cecconi M. Predictive values of pulse pressure variation and stroke volume variation for fluid responsiveness in patients with pneumoperitoneum. J Clin Monit Comput. 2018;32:825&#x2013;832. doi: 10.1007/s10877-017-0081-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-017-0081-4</ArticleId><ArticleId IdType="pubmed">29149433</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Shin S, Kim JY, Kim SH, Jo M, Choi YS. Pulse pressure variation and pleth variability index as predictors of fluid responsiveness in patients undergoing spinal surgery in the prone position. Ther Clin Risk Manag. 2018;14:1175&#x2013;1183. doi: 10.2147/TCRM.S170395.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S170395</ArticleId><ArticleId IdType="pmc">PMC6038863</ArticleId><ArticleId IdType="pubmed">30013353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CT, Lee TS, Chiu CT, Teng HC, Cheng HL, Wu CY. Mini-fluid challenge test predicts stroke volume and arterial pressure fluid responsiveness during spine surgery in prone position: a stard-compliant diagnostic accuracy study. Medicine. 2020;99:e19031. doi: 10.1097/MD.0000000000019031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000019031</ArticleId><ArticleId IdType="pmc">PMC7015642</ArticleId><ArticleId IdType="pubmed">32028416</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinot PG, de Broca B, Bernard E, Abou Arab O, Lorne E, Dupont H. Respiratory stroke volume variation assessed by oesophageal doppler monitoring predicts fluid responsiveness during laparoscopy. Br J Anaesth. 2014;112:660&#x2013;664. doi: 10.1093/bja/aet430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet430</ArticleId><ArticleId IdType="pubmed">24366723</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009;37:2642&#x2013;2647. doi: 10.1097/CCM.0b013e3181a590da.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181a590da</ArticleId><ArticleId IdType="pubmed">19602972</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Lu B, Sheng X, Jin N. Accuracy of stroke volume variation in predicting fluid responsiveness: a systematic review and meta-analysis. J Anesth. 2011;25:904&#x2013;916. doi: 10.1007/s00540-011-1217-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-011-1217-1</ArticleId><ArticleId IdType="pubmed">21892779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann M, Feibicke T, Keyl C, Prasser C, Moritz S, Graf BM, Wiesenack C. Accuracy of stroke volume variation compared with pleth variability index to predict fluid responsiveness in mechanically ventilated patients undergoing major surgery. Eur J Anaesthesiol. 2010;27:555&#x2013;561. doi: 10.1097/EJA.0b013e328335fbd1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328335fbd1</ArticleId><ArticleId IdType="pubmed">20035228</ArticleId></ArticleIdList></Reference><Reference><Citation>Aya HD, Ster IC, Fletcher N, Grounds RM, Rhodes A, Cecconi M. Pharmacodynamic analysis of a fluid challenge. Crit Care Med. 2016;44:880&#x2013;891. doi: 10.1097/CCM.0000000000001517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001517</ArticleId><ArticleId IdType="pubmed">26683506</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Calabro L, Pugliese L, Lulja A, Sopuch A, Rosalba D, Morenghi E, Hernandez G, Monnet X, Cecconi M. Fluid challenge in critically ill patients receiving haemodynamic monitoring: a systematic review and comparison of two decades. Crit Care. 2022;26:186. doi: 10.1186/s13054-022-04056-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04056-3</ArticleId><ArticleId IdType="pmc">PMC9210670</ArticleId><ArticleId IdType="pubmed">35729632</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer CK, M&#xfc;ller SM, Furrer L, Klaghofer R, Genoni M, Zollinger A. Stroke volume and pulse pressure variation for prediction of fluid responsiveness in patients undergoing off-pump coronary artery bypass grafting. Chest. 2005;128:848&#x2013;854. doi: 10.1378/chest.128.2.848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.2.848</ArticleId><ArticleId IdType="pubmed">16100177</ArticleId></ArticleIdList></Reference><Reference><Citation>Preisman S, Kogan S, Berkenstadt H, Perel A. Predicting fluid responsiveness in patients undergoing cardiac surgery: functional haemodynamic parameters including the respiratory systolic variation test and static preload indicators. Br J Anaesth. 2005;95:746&#x2013;755. doi: 10.1093/bja/aei262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aei262</ArticleId><ArticleId IdType="pubmed">16286349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Attof Y, Rosamel P, Desebbe O, Joseph P, Metton O, Bastien O, Lehot JJ. Respiratory variations in pulse oximetry plethysmographic waveform amplitude to predict fluid responsiveness in the operating room. Anesthesiology. 2007;106:1105&#x2013;1111. doi: 10.1097/01.anes.0000267593.72744.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000267593.72744.20</ArticleId><ArticleId IdType="pubmed">17525584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Kim JT, Yoon SZ, Lim YJ, Jeon Y, Bahk JH, Kim CS. Evaluation of corrected flow time in oesophageal doppler as a predictor of fluid responsiveness. Br J Anaesth. 2007;99:343&#x2013;348. doi: 10.1093/bja/aem179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aem179</ArticleId><ArticleId IdType="pubmed">17621598</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Slieker J, Desebbe O, Bauer C, Chiari P, Henaine R, Lehot JJ. The ability of a novel algorithm for automatic estimation of the respiratory variations in arterial pulse pressure to monitor fluid responsiveness in the operating room. Anesthesia Analgesia. 2008;106:1195&#x2013;1200. doi: 10.1213/01.ane.0000297291.01615.5c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000297291.01615.5c</ArticleId><ArticleId IdType="pubmed">18349192</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Romano SM, Bonicolini E, Colombo D, Cammarota G, Chiostri M, Della Corte F, Navalesi P, Payen D, Romagnoli S. Cardiac cycle efficiency and dicrotic pressure variations: new parameters for fluid therapy: an observational study. Eur J Anaesthesiol. 2017;34:755&#x2013;763. doi: 10.1097/EJA.0000000000000661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000661</ArticleId><ArticleId IdType="pubmed">28722695</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Desebbe O, Rosamel P, Delannoy B, Robin J, Bastien O, Lehot JJ. Pleth variability index to monitor the respiratory variations in the pulse oximeter plethysmographic waveform amplitude and predict fluid responsiveness in the operating theatre. Br J Anaesth. 2008;101:200&#x2013;206. doi: 10.1093/bja/aen133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen133</ArticleId><ArticleId IdType="pubmed">18522935</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JJ, Kim TK, Lee JH, Park J, Cho HS, Kim WS, Lee YT. Evaluation of augmented pulse pressure variation using the valsalva manoeuvre as a predictor of fluid responsiveness under open-chest conditions: a prospective observational study. Eur J Anaesthesiol. 2017;34:254&#x2013;261. doi: 10.1097/EJA.0000000000000613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000613</ArticleId><ArticleId IdType="pubmed">28207430</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Musard H, Desebbe O, Boucau C, Simon R, H&#xe9;naine R, Lehot JJ. The ability of stroke volume variations obtained with vigileo/flotrac system to monitor fluid responsiveness in mechanically ventilated patients. Anesth Analg. 2009;108:513&#x2013;517. doi: 10.1213/ane.0b013e318192a36b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318192a36b</ArticleId><ArticleId IdType="pubmed">19151280</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong DM, Ahn HJ, Park HW, Yang M, Kim JA, Park J. Stroke volume variation and pulse pressure variation are not useful for predicting fluid responsiveness in thoracic surgery. Anesth Analg. 2017;125:1158&#x2013;1165. doi: 10.1213/ANE.0000000000002056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002056</ArticleId><ArticleId IdType="pubmed">28504996</ArticleId></ArticleIdList></Reference><Reference><Citation>Derichard A, Robin E, Tavernier B, Costecalde M, Fleyfel M, Onimus J, Lebuffe G, Chambon JP, Vallet B. Automated pulse pressure and stroke volume variations from radial artery: evaluation during major abdominal surgery. Br J Anaesth. 2009;103:678&#x2013;684. doi: 10.1093/bja/aep267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep267</ArticleId><ArticleId IdType="pubmed">19797246</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JJ, Lee JH, Hong KY, Choi SJ. Utility of stroke volume variation measured using non-invasive bioreactance as a predictor of fluid responsiveness in the prone position. J Clin Monit Comput. 2017;31:397&#x2013;405. doi: 10.1007/s10877-016-9859-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-016-9859-z</ArticleId><ArticleId IdType="pubmed">26964992</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal EE, Rex S, Kruitwagen CL, Kalkman CJ, Buhre WF. Dynamic preload indicators fail to predict fluid responsiveness in open-chest conditions. Crit Care Med. 2009;37:510&#x2013;515. doi: 10.1097/CCM.0b013e3181958bf7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181958bf7</ArticleId><ArticleId IdType="pubmed">19114886</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Bernard O, Ha JC, Degryse C, Sztark F. Abilities of pulse pressure variations and stroke volume variations to predict fluid responsiveness in prone position during scoliosis surgery. Br J Anaesth. 2010;104:407&#x2013;413. doi: 10.1093/bja/aeq031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq031</ArticleId><ArticleId IdType="pubmed">20190260</ArticleId></ArticleIdList></Reference><Reference><Citation>Suehiro K, Okutani R. Stroke volume variation as a predictor of fluid responsiveness in patients undergoing one-lung ventilation. J Cardiothorac Vasc Anesth. 2010;24:772&#x2013;775. doi: 10.1053/j.jvca.2010.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2010.03.014</ArticleId><ArticleId IdType="pubmed">20638869</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Jeon Y, Bahk JH, Gil NS, Hong DM, Kim JH, Kim HJ. Pulse pressure variation as a predictor of fluid responsiveness during one-lung ventilation for lung surgery using thoracotomy: randomised controlled study. Eur J Anaesthesiol. 2011;28:39&#x2013;44. doi: 10.1097/EJA.0b013e32834089cf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32834089cf</ArticleId><ArticleId IdType="pubmed">21088596</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;iseth L, Hoff IE, Skare O, Kirkeb&#xf8;en KA, Landsverk SA. Photoplethysmographic and pulse pressure variations during abdominal surgery. Acta Anaesthesiol Scand. 2011;55:1221&#x2013;1230. doi: 10.1111/j.1399-6576.2011.02527.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2011.02527.x</ArticleId><ArticleId IdType="pubmed">22092127</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, Stecken L, Ottolenghi L, Roullet S, Quinart A, Masson F, Sztark F. The ability of pulse pressure variations obtained with cnap&#x2122; device to predict fluid responsiveness in the operating room. Anesth Analg. 2011;113:523&#x2013;528. doi: 10.1213/ANE.0b013e3182240054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182240054</ArticleId><ArticleId IdType="pubmed">21642606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Abdullah T, Sabanci PA, Dogan L, Orhan-Sungur M, Akinci IO. Comparison of ability of pulse pressure variation to predict fluid responsiveness in prone and supine position: an observational study. J Clin Monit Comput. 2019;33:573&#x2013;580. doi: 10.1007/s10877-018-0195-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-018-0195-3</ArticleId><ArticleId IdType="pubmed">30117033</ArticleId></ArticleIdList></Reference><Reference><Citation>Suehiro K, Okutani R. Influence of tidal volume for stroke volume variation to predict fluid responsiveness in patients undergoing one-lung ventilation. J Anesth. 2011;25:777&#x2013;780. doi: 10.1007/s00540-011-1200-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-011-1200-x</ArticleId><ArticleId IdType="pubmed">21744128</ArticleId></ArticleIdList></Reference><Reference><Citation>Vistisen ST, Berg JM, Boekel MF, Modestini M, Bergman R, Jainandunsing JS, Mariani MA, Scheeren TWL. Using extra systoles and the micro-fluid challenge to predict fluid responsiveness during cardiac surgery. J Clin Monit Comput. 2019;33:777&#x2013;786. doi: 10.1007/s10877-018-0218-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-018-0218-0</ArticleId><ArticleId IdType="pubmed">30414054</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;iseth L, Hoff IE, Myre K, Landsverk SA, Kirkeb&#xf8;en KA. Dynamic variables of fluid responsiveness during pneumoperitoneum and laparoscopic surgery. Acta Anaesthesiol Scand. 2012;56:777&#x2013;786. doi: 10.1111/j.1399-6576.2011.02641.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2011.02641.x</ArticleId><ArticleId IdType="pubmed">22288953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Aygun E, Abdullah T, Bolsoy-Deveci S, Orhan-Sungur M, Canbaz M, Ozkan Akinci I. A challenge with 5 cmh2o of positive end-expiratory pressure predicts fluid responsiveness in neurosurgery patients with protective ventilation: an observational study. Minerva Anestesiol. 2019;85:1184&#x2013;1192. doi: 10.23736/S0375-9393.19.13721-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.19.13721-2</ArticleId><ArticleId IdType="pubmed">31213047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KM, Gwak MS, Choi SJ, Kim MH, Park MH, Heo BY. Pulse pressure variation and stroke volume variation to predict fluid responsiveness in patients undergoing carotid endarterectomy. Korean J Anesthesiol. 2013;65:237&#x2013;243. doi: 10.4097/kjae.2013.65.3.237.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2013.65.3.237</ArticleId><ArticleId IdType="pmc">PMC3790035</ArticleId><ArticleId IdType="pubmed">24101958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Dorman Y, Abdullah T, Yasa C, Orhan-Sungur M, Akinci IO, Ergin-Ozcan P. Ability of mini-fluid challenge to predict fluid responsiveness in obese patients undergoing surgery in the prone position. Minerva Anestesiol. 2019;85:981&#x2013;988. doi: 10.23736/S0375-9393.19.13276-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.19.13276-2</ArticleId><ArticleId IdType="pubmed">30994311</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo H, Kong YG, Jin SJ, Chin JH, Kim HY, Lee YK, Hwang JH, Kim YK. Dynamic arterial elastance in predicting arterial pressure increase after fluid challenge during robot-assisted laparoscopic prostatectomy: a prospective observational study. Medicine. 2015;94:e1794. doi: 10.1097/MD.0000000000001794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000001794</ArticleId><ArticleId IdType="pmc">PMC4616778</ArticleId><ArticleId IdType="pubmed">26469925</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger K, Francony G, Bouzat P, Halle C, Genty C, Oddoux M, Gay E, Albaladejo P, Payen JF. Prone position affects stroke volume variation performance in predicting fluid responsiveness in neurosurgical patients. Minerva Anestesiol. 2015;81:628&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">25263024</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe R, Suehiro K, Mukai A, Tanaka K, Yamada T, Mori T, Nishikawa K. Changes in stroke volume induced by lung recruitment maneuver can predict fluid responsiveness during intraoperative lung-protective ventilation in prone position. BMC Anesthesiol. 2021;21:303. doi: 10.1186/s12871-021-01527-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01527-y</ArticleId><ArticleId IdType="pmc">PMC8638171</ArticleId><ArticleId IdType="pubmed">34856928</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusman G, Groisman I, Maidana GA, Scandurra A, Arca JM, Bohm SH, Suarez-Sipmann F. The sensitivity and specificity of pulmonary carbon dioxide elimination for noninvasive assessment of fluid responsiveness. Anesth Analg. 2016;122:1404&#x2013;1411. doi: 10.1213/ANE.0000000000001047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001047</ArticleId><ArticleId IdType="pubmed">26505574</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenij LJ, Sonneveld JP, Nierich AP, Buhre WF, de Waal EE. Diagnostic accuracy of stroke volume variation measured with uncalibrated arterial waveform analysis for the prediction of fluid responsiveness in patients with impaired left ventricular function: a prospective, observational study. J Clin Monit Comput. 2016;30:481&#x2013;486. doi: 10.1007/s10877-015-9743-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-015-9743-2</ArticleId><ArticleId IdType="pmc">PMC4960272</ArticleId><ArticleId IdType="pubmed">26227160</ArticleId></ArticleIdList></Reference><Reference><Citation>Flick M, Sand U, Bergholz A, Kouz K, Reiter B, Flotzinger D, Saugel B, Kubitz JC. Right ventricular and pulmonary artery pulse pressure variation and systolic pressure variation for the prediction of fluid responsiveness: an interventional study in coronary artery bypass surgery patients. J Clin Monit Comput. 2022;36:1817&#x2013;1825. doi: 10.1007/s10877-022-00830-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-022-00830-4</ArticleId><ArticleId IdType="pubmed">35233702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30870165</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Relationship between Perioperative Hypotension and Perioperative Cardiovascular Events in Patients with Coronary Artery Disease Undergoing Major Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>756</StartPage><EndPage>766</EndPage><MedlinePgn>756-766</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000002654</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative hypotension is associated with cardiovascular events in patients having noncardiac surgery. It is unknown if the severity of preexisting coronary artery disease determines susceptibility to the cardiovascular risks of perioperative hypotension.</AbstractText><AbstractText Label="METHODS">In this retrospective exploratory analysis of a substudy of an international prospective blinded cohort study, 955 patients 45 yr of age or older with history or risk factors for coronary artery disease underwent coronary computed tomographic angiography before elective inpatient noncardiac surgery. The authors evaluated the potential interaction between angiographic findings and perioperative hypotension (defined as systolic blood pressure less than 90 mmHg for a total of 10&#x2009;min or more during surgery or for any duration after surgery and for which intervention was initiated) on the composite outcome of time to myocardial infarction or cardiovascular death up to 30 days after surgery. Angiography assessors were blinded to study outcomes; patients, treating clinicians, and outcome assessors were blinded to angiography findings.</AbstractText><AbstractText Label="RESULTS">Cardiovascular events (myocardial infarction or cardiovascular death within 30 days after surgery) occurred in 7.7% of patients (74/955), including in 2.7% (8/293) without obstructive coronary disease or hypotension compared to 6.7% (21/314) with obstructive coronary disease but no hypotension (hazard ratio, 2.51; 95% CI, 1.11 to 5.66; P = 0.027), 8.8% (14/159) in patients with hypotension but without obstructive coronary disease (hazard ratio, 3.85; 95% CI, 1.62 to 9.19; P = 0.002), and 16.4% (31/189) with obstructive coronary disease and hypotension (hazard ratio, 7.34; 95% CI, 3.37 to 15.96; P &lt; 0.001). Hypotension was independently associated with cardiovascular events (hazard ratio, 3.17; 95% CI, 1.99 to 5.06; P &lt; 0.001). This association remained in patients without obstructive disease and did not differ significantly across degrees of coronary disease (P value for interaction, 0.599).</AbstractText><AbstractText Label="CONCLUSIONS">In patients having noncardiac surgery, perioperative hypotension was associated with cardiovascular events regardless of the degree of coronary artery disease on preoperative coronary computed tomographic angiography.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roshanov</LastName><ForeName>Pavel S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>From the Lilibeth Caberto London Kidney Clinical Research Unit, London Health Sciences Centre, London, Canada (P.S.R.) the Department of Medicine (P.S.R., T.S., E.D., V.T., P.J.D.) Department of Health Research Methods, Evidence and Impact (P.S.R., E.D., P.J.D.), McMaster University, Hamilton, Canada the Population Health Research Institute, Hamilton, Canada (E.D., P.J.D.) the Division of General Internal Medicine, McGill University Health Center, Montreal, Canada (A.B.) the Department of Anesthesia and Intensive Care, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China (M.T.V.C.) the Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada (C.B.) the Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada (B.J.W.C.) the Department of Radiology, University of Ottawa, Ottawa, Canada (B.J.W.C.) the Department of Anesthesia, University of Toronto, Toronto, Canada (J.S.K).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheth</LastName><ForeName>Tej</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Vikas</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Bessissow</LastName><ForeName>Amal</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MTV</Initials></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Craig</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Benjamin J W</ForeName><Initials>BJW</Initials></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>James S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="N">Computed Tomography Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30870165</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000002654</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33733548</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1742-1241</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International journal of clinical practice</Title><ISOAbbreviation>Int J Clin Pract</ISOAbbreviation></Journal><ArticleTitle>The relationship between gestational week and QT dispersion in cesarean section patients undergoing spinal anaesthesia: A prospective study.</ArticleTitle><Pagination><StartPage>e14154</StartPage><MedlinePgn>e14154</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.14154</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pregnancy affects the cardiovascular system, particularly the cardiac conduction system, thereby increasing the susceptibility of patients towards arrhythmia. QT interval results in ventricular arrhythmias, predominantly polymorphic ventricular tachycardia. The present study was planned to investigate the relationship between a gestational week and QT dispersion in cesarean section patients undergoing spinal anaesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study included 40 patients between the ages of 18 and 45 who had no symptoms of anaemia and undergoing elective cesarean section. The patients were separated into two groups based on the gestational week as Group I &lt;39&#xa0;weeks and Group II &#x2265;39&#xa0;weeks. The patient was given a sitting position and the puncture site was cleansed with 10% povidone-iodine antiseptic solution. After placing a sterile drape on the patient, the subarachnoid space was punctured through an appropriate vertebral space (L3-L4 or L4-L5) using a pencil-point 25G spinal needle, followed by intrathecal injection of 12.5&#xa0;mg (2.5&#xa0;mL) 5% hyperbaric bupivacaine hydrochloride. Electrocardiographic (ECG) records were obtained both preoperatively and at 1, 5, and 10&#xa0;minutes after spinal block, and the QT, QTc, QTd, and corrected QTd (QTcd) intervals were estimated using Bazett's formula.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no significant difference between the two groups within the QT and QTc intervals. QTcd measured after post-operative was significantly higher in Group II (P&#xa0;=&#xa0;.007).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results indicated that spinal anaesthesia may prolong the QTdc interval in patients with a gestational week of &#x2265;39&#xa0;weeks undergoing cesarean section.</AbstractText><CopyrightInformation>&#xa9; 2021 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karahan</LastName><ForeName>Mahmut Alp</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-7210-9481</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Harran University Medical Faculty, Sanliurfa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;y&#xfc;kf&#x131;rat</LastName><ForeName>Evren</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6396-0426</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Harran University Medical Faculty, Sanliurfa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altay</LastName><ForeName>Nuray</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-7111-7893</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Harran University Medical Faculty, Sanliurfa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binici</LastName><ForeName>Orhan</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-3158-8252</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Harran University Medical Faculty, Sanliurfa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyan&#x131;ko&#x11f;lu</LastName><ForeName>Hacer</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0316-4900</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Harran University Medical Faculty, Sanliurfa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Be&#x15f;li</LastName><ForeName>Feyzullah</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-6206-8700</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Harran University Medical Faculty, Sanliurfa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demir</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0130-0254</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, ANKA Hospital, Gaziantep, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Clin Pract</MedlineTA><NlmUniqueID>9712381</NlmUniqueID><ISSNLinking>1368-5031</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>18</Day><Hour>7</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33733548</ArticleId><ArticleId IdType="doi">10.1111/ijcp.14154</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Sharma G, Lindley K, Grodzinsky A. Cardio-obstetrics: developing a niche in maternal cardiovascular health. J Am Coll Cardiol. 2020;75:1355-1359.</Citation></Reference><Reference><Citation>Shapero KS, Desai NR, Elder RW, Lipkind HS, Chou JC, Spatz ES. Cardio-obstetrics: recognizing and managing cardiovascular complications of pregnancy. Cleve Clin J Med. 2020;87:43-52.</Citation></Reference><Reference><Citation>Egawa H, Minami J, Fujii K, Hamaguchi S, Okuda Y, Kitajima T. QT interval and QT dispersion increase in the elderly during laparoscopic cholecystectomy: a preliminary study. Can J Anaesth. 2002;49:805-809.</Citation></Reference><Reference><Citation>Bett GC. Hormones and sex differences: changes in cardiac electrophysiology with pregnancy. Clin Sci. 2016;130(10):747-759.</Citation></Reference><Reference><Citation>Deniz Y, Okyay D, Hanci V, Yurtlu S, Ayo&#x11f;lu H, Turan I&#xd6;. The effect of levobupivacaine and bupivacaine on QT, corrected QT (Qtc), and P wave dispersions in cesarean section. Braz J Anesthesiol. 2013;63:202-208.</Citation></Reference><Reference><Citation>Zamani M, Esmailian M, Yoosefian Z. QT Interval in pregnant and non-pregnant women. Emergency. 2014;2:22-25.</Citation></Reference><Reference><Citation>T&#xf6;r IH, Aksoy M, Aksoy AN, Ah&#x131;skal&#x131;oglu A, Ince I, K&#xfc;rsad H. The effect of colloid preload versus prophylactic ephedrine administration on QTc intervals during cesarean delivery: a randomized controlled study. Niger J Clin Pract. 2016;19:115-120.</Citation></Reference><Reference><Citation>Karahan MA, Incebiyik A, Buyukfirat E, Altay N, Binici O, Besli F. Effect of spinal anesthesia on the QT interval in term and post-term pregnancies scheduled for elective cesarean section: a prospective study. J Matern Fetal Neonatal Med. 2020;33:3147-3151.</Citation></Reference><Reference><Citation>Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175-191.</Citation></Reference><Reference><Citation>Kampman MAM, Valente MAE, van Melle JP, et al. Cardiac adaption during pregnancy in women with congenital heart disease and healthy women. Heart. 2016;102:1302-1308.</Citation></Reference><Reference><Citation>Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol. 2015;12:718-729.</Citation></Reference><Reference><Citation>Vaidya VR, Arora S, Patel N, et al. Burden of arrhythmia in pregnancy. Circulation. 2017;135:619-621.</Citation></Reference><Reference><Citation>Nikoo MH, Khosropanah S, Alborzi S, Aslani A. QT dispersion in young, ideal, and old aged pregnancies. Int Cardiovasc Res J. 2014;8:24-26.</Citation></Reference><Reference><Citation>Lechmanova M, Kittnar O, Mlcek M, et al. QT dispersion and T-loop morphology in late pregnancy and after delivery. Physiol Res. 2002;51:121-129.</Citation></Reference><Reference><Citation>Tanindi A, Akgun N, Pabuccu EG, et al. Electrocardiographic P-wave duration, QT interval, T peak to end interval and Tp-e/QT ratio in pregnancy with respect to trimesters. Ann Noninvasive Electrocardiol. 2016;21:169-174.</Citation></Reference><Reference><Citation>Shen CL, Ho YY, Hung YC, Chen PL. Arrhythmias during spinal anesthesia for cesarean section. Can J Anaesth. 2000;47:393-397.</Citation></Reference><Reference><Citation>Youngs PJ, Littleford J. Arrhythmias during spinal anesthesia. Can J Anaesth. 2000;47:385-390.</Citation></Reference><Reference><Citation>Guillon A, Leyre S, Rem&#xe9;rand F, et al. Modification of Tp-e and QTc intervals during caesarean section under spinal anaesthesia. Anaesthesia. 2010;65:337-342.</Citation></Reference><Reference><Citation>Dogan Z, Yildiz H, Akcay A, et al. The effect of intraspinal bupivacaine versus levobupivacaine on the QTc intervals during caesarean section: a randomized, double-blind, prospective study. Basic Clin Pharmacol Toxicol. 2014;114:248-253.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28464804</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors.</ArticleTitle><Pagination><StartPage>298</StartPage><MedlinePgn>298</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">298</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-017-3290-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">We aimed to evaluate the potential benefits of the Leadership and Coaching for Health (LEACH) program on physical activity (PA), dietary habits, and distress management in cancer survivors.</AbstractText><AbstractText Label="METHODS">We randomly assigned 248 cancer survivors with an allocation ratio of two-to-one to the LEACH program (LP) group, coached by long-term survivors, or the usual care (UC) group. At baseline, 3, 6, and 12&#xa0;months, we used PA scores, the intake of vegetables and fruits (VF), and the Post Traumatic Growth Inventory (PTGI) as primary outcomes and, for secondary outcomes, the Ten Rules for Highly Effective Health Behavior adhered to and quality of life (QOL), the Hospital Anxiety and Depression Scale (HADS), and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30).</AbstractText><AbstractText Label="RESULTS">For primary outcomes, the two groups did not significantly differ in PA scores or VF intake but differed marginally in PTGI. For secondary outcomes, the LP group showed a significantly greater improvement in the HADS anxiety score, the social functioning score, and the appetite loss and financial difficulties scores of the EORTC QLQ-C30 scales from baseline to 3&#xa0;months. From baseline to 12&#xa0;months, the LP group showed a significantly greater decrease in the EORTC QLQ-C30 fatigue score and a significantly greater increase in the number of the Ten Rules for Highly Effective Health Behavior.</AbstractText><AbstractText Label="CONCLUSION">Our findings indicate that the LEACH program, coached by long-term survivors, can provide effective management of the QOL of cancer survivors but not of their PA or dietary habits.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Clinical trial information can be found for the following: NCT01527409 (the date when the trial was registered: February 2012).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Young Ho</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea. lawyun@snu.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Research Institute, Seoul National University Hospital and College of Medicine, Seoul, South Korea. lawyun@snu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Young Ae</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Research Institute and Hospital, National Cancer Center, Goyang, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Myung Kyung</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>College of Nursing, Kyungpook National University, Daegu, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Jin Ah</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nam</LastName><ForeName>Byung-Ho</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, National Cancer Center, Goyang, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sohee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, National Cancer Center, Goyang, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Eun Sook</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Research Institute and Hospital, National Cancer Center, Goyang, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noh</LastName><ForeName>Dong-Young</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Cancer Research Institute, Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jae-Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Bundang, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Si-Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kyung Hee University Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Chi-Heum</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Kyung Hae</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chun</LastName><ForeName>Mison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Soon Nam</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kyong Hwa</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sohee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Promotion, Yonsei University Graduate School of Public Health, Seoul, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01527409</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003376" MajorTopicYN="N">Counseling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005247" MajorTopicYN="Y">Feeding Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Balanced diet</Keyword><Keyword MajorTopicYN="N">Health coaching</Keyword><Keyword MajorTopicYN="N">Health partnership</Keyword><Keyword MajorTopicYN="N">Positive thinking</Keyword><Keyword MajorTopicYN="N">Regular exercise</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28464804</ArticleId><ArticleId IdType="pmc">PMC5412037</ArticleId><ArticleId IdType="doi">10.1186/s12885-017-3290-9</ArticleId><ArticleId IdType="pii">10.1186/s12885-017-3290-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duk Hyoung Lee KP, Hyung Kook Y, Young Ae K, Eun Joo N. National Cancer Center: Ministry of Health and Welfare. 1st 2014. Cancer facts and figures 2014 in the Republic of Korea.</Citation></Reference><Reference><Citation>Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20(10):1996&#x2013;2005. doi: 10.1158/1055-9965.EPI-11-0729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-11-0729</ArticleId><ArticleId IdType="pmc">PMC3422885</ArticleId><ArticleId IdType="pubmed">21980007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun YH, Sim JA, Jung JY, Noh DY, Lee ES, Kim YW, Oh JH, Ro JS, Park SY, Park SJ, et al. The association of self-leadership, health behaviors, and posttraumatic growth with health-related quality of life in patients with cancer. Psychooncology. 2014;</Citation><ArticleIdList><ArticleId IdType="pubmed">24844184</ArticleId></ArticleIdList></Reference><Reference><Citation>Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249(6):751&#x2013;757. doi: 10.1001/jama.1983.03330300035030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1983.03330300035030</ArticleId><ArticleId IdType="pubmed">6823028</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol. 2007;25(17):2345&#x2013;2351. doi: 10.1200/JCO.2006.08.6819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2006.08.6819</ArticleId><ArticleId IdType="pmc">PMC2274898</ArticleId><ArticleId IdType="pubmed">17557947</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9&#x2013;29. doi: 10.3322/caac.21208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21208</ArticleId><ArticleId IdType="pubmed">24399786</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder CF, Frick KD, Kantsiper ME, Peairs KS, Herbert RJ, Blackford AL, Wolff AC, Earle CC. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27(7):1054&#x2013;1061. doi: 10.1200/JCO.2008.18.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2008.18.0950</ArticleId><ArticleId IdType="pmc">PMC5950494</ArticleId><ArticleId IdType="pubmed">19164212</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, Halberg F, Somerfield MR, Davidson NE. American Society of Clinical O: American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091&#x2013;5097. doi: 10.1200/JCO.2006.08.8575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2006.08.8575</ArticleId><ArticleId IdType="pubmed">17033037</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control. A national action plan for cancer survivorship: advancing public health strategies. Atlanta: US Department of Health and Human Services; 2004.</Citation></Reference><Reference><Citation>McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, Wagner EH. Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin. 2011;61(1):50&#x2013;62. doi: 10.3322/caac.20093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.20093</ArticleId><ArticleId IdType="pmc">PMC3058905</ArticleId><ArticleId IdType="pubmed">21205833</ArticleId></ArticleIdList></Reference><Reference><Citation>(IOM) IoM . Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press; 2001.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057539</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams K, editor. Priority areas for National Action: transforming health care quality. Washington, DC: National Academies Press; 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057643</ArticleId></ArticleIdList></Reference><Reference><Citation>Synder DC, Morey MC, Sloane R, Stull V, Cohen HJ, Peterson B, Pieper C, Hartman TJ, Miller PE, Mitchell DC, et al. Reach out to ENhancE wellness in older cancer survivors (RENEW): design, methods and recruitment challenges of a home-based exercise and diet intervention to improve physical function among long-term survivors of breast, prostate, and colorectal cancer. Psycho-Oncol. 2009;18(4):429&#x2013;439. doi: 10.1002/pon.1491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.1491</ArticleId><ArticleId IdType="pmc">PMC2748788</ArticleId><ArticleId IdType="pubmed">19117329</ArticleId></ArticleIdList></Reference><Reference><Citation>Charles P, Giraudeau B, Dechartres A, Baron G, Ravaud P. Reporting of sample size calculation in randomised controlled trials: review. BMJ. 2009;338:b1732. doi: 10.1136/bmj.b1732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b1732</ArticleId><ArticleId IdType="pmc">PMC2680945</ArticleId><ArticleId IdType="pubmed">19435763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009;1(1):51&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256489</ArticleId><ArticleId IdType="pubmed">22263004</ArticleId></ArticleIdList></Reference><Reference><Citation>Covey SR. The Seven habits of highly effective people. 25. New York: US: Simon &amp; Schuster; 1989.</Citation><ArticleIdList><ArticleId IdType="pubmed">1747433</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson FM. The handbook of coaching: a comprehensive resource guide for managers, executives, consultants, and human resource professionals. San Francisco, CA: Jossey-Bass; 1999.</Citation></Reference><Reference><Citation>Yun YH, Lee MK, Bae Y, Shon E-J, Shin B-R, Ko H, Lee ES, Noh D-Y, Lim J-Y, Kim S, et al. Efficacy of a training program for long-term disease-free cancer survivors as health partners: a randomized controlled trial in Korea. Asian Pac J Cancer Prev. 2013;14(12):7229&#x2013;7235. doi: 10.7314/APJCP.2013.14.12.7229.</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2013.14.12.7229</ArticleId><ArticleId IdType="pubmed">24460280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O Brien WL, Bassett DR, Schmitz KH, Emplaincourt PO. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9; SUPP/1):S498&#x2013;S504. doi: 10.1097/00005768-200009001-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005768-200009001-00009</ArticleId><ArticleId IdType="pubmed">10993420</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Sports M. Kenney WL, Humphrey RH, Bryant CX, Mahler DA. ACSM's guidelines for exercise testing and prescription. Baltimore: Williams &amp; Wilkins; 1995.</Citation></Reference><Reference><Citation>Kim WY, Cho MS, Lee HS. Development and validation of mini dietary assessment index for Koreans. Korean Journal of Nutrition. 2003;36(1):83&#x2013;92.</Citation></Reference><Reference><Citation>Lee SY, Shin MH, Sung MK, Paik HY, Park YK, Kim J, Sohn JW, Kim WG, Jung HJ, Ahn YO. Establishment of Korean dietary guidelines for cancer prevention. Korean J Health Promot. 2011;11(3):129&#x2013;143.</Citation></Reference><Reference><Citation>Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, Chun C, Khang YH, Oh K. Data resource profile: the korea national health and nutrition examination survey (knhanes) Int J Epidemiol. 2014;43(1):69&#x2013;77. doi: 10.1093/ije/dyt228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyt228</ArticleId><ArticleId IdType="pmc">PMC3937975</ArticleId><ArticleId IdType="pubmed">24585853</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedeschi RG, Calhoun LG. The posttraumatic growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455&#x2013;471. doi: 10.1002/jts.2490090305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jts.2490090305</ArticleId><ArticleId IdType="pubmed">8827649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim HK, Woo JM, Kim TS, Kim TH, Choi KS, Chung SK, Chee IS, Lee KU, Paik KC, Seo HJ, et al. Reliability and validity of the Korean version of the impact of event scale-Revised. Compr Psychiatry. 2009;50(4):385&#x2013;390. doi: 10.1016/j.comppsych.2008.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.comppsych.2008.09.011</ArticleId><ArticleId IdType="pubmed">19486738</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004;13(4):863&#x2013;868. doi: 10.1023/B:QURE.0000021692.81214.70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:QURE.0000021692.81214.70</ArticleId><ArticleId IdType="pubmed">15129896</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Dehaes JCJM, et al. The European-organization-for-research-and-treatment-of-cancer Qlq-C30 - a quality-of-life instrument for use in international clinical-trials in oncology. J Natl Cancer I. 1993;85(5):365&#x2013;376. doi: 10.1093/jnci/85.5.365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/85.5.365</ArticleId><ArticleId IdType="pubmed">8433390</ArticleId></ArticleIdList></Reference><Reference><Citation>Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess. 1985;49(1):71&#x2013;75. doi: 10.1207/s15327752jpa4901_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15327752jpa4901_13</ArticleId><ArticleId IdType="pubmed">16367493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond ASSR. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705&#x2013;714. doi: 10.1016/0277-9536(91)90150-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0277-9536(91)90150-B</ArticleId><ArticleId IdType="pubmed">2035047</ArticleId></ArticleIdList></Reference><Reference><Citation>Prochaska JO, Velicer WF. The Transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38&#x2013;48. doi: 10.4278/0890-1171-12.1.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.4278/0890-1171-12.1.38</ArticleId><ArticleId IdType="pubmed">10170434</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect". J Clin Epidemiol. 2001;54(3):217&#x2013;224. doi: 10.1016/S0895-4356(00)00305-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(00)00305-X</ArticleId><ArticleId IdType="pubmed">11223318</ArticleId></ArticleIdList></Reference><Reference><Citation>Demark-Wahnefried W, Pinto BM, Gritz ER. Promoting health and physical function among cancer survivors: potential for prevention and questions that remain. J Clin Oncol. 2006;24(32):5125&#x2013;5131. doi: 10.1200/JCO.2006.06.6175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2006.06.6175</ArticleId><ArticleId IdType="pubmed">17093274</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R, et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol. 2007;25(17):2345&#x2013;2351. doi: 10.1200/JCO.2006.08.6819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2006.08.6819</ArticleId><ArticleId IdType="pmc">PMC2274898</ArticleId><ArticleId IdType="pubmed">17557947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28(3):753&#x2013;765. doi: 10.1007/s12032-010-9536-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12032-010-9536-x</ArticleId><ArticleId IdType="pubmed">20411366</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland JC. Managing depression in the patient with cancer. CA Cancer J Clin. 1987;37(6):366&#x2013;371. doi: 10.3322/canjclin.37.6.366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/canjclin.37.6.366</ArticleId><ArticleId IdType="pubmed">3119169</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira MG, Figueiredo AP, Fincham FD. Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: a study with Portuguese patients and their partners. Eur J Oncol Nurs. 2012;16(3):227&#x2013;232. doi: 10.1016/j.ejon.2011.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejon.2011.06.006</ArticleId><ArticleId IdType="pubmed">21783416</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes AL, Chambers SK, Pakenham KI, Patrao TA, Baade PD, Lynch BM, Aitken JF, Meng X, Courneya KS. Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial. J Clin Oncol. 2013;31(18):2313&#x2013;2321. doi: 10.1200/JCO.2012.45.5873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2012.45.5873</ArticleId><ArticleId IdType="pubmed">23690410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Shin MS, Lee HS, Lee ES, Ro JS, Kang HS, Kim SW, Lee WH, Kim HS, Kim CJ, et al. Randomized pilot test of a simultaneous stage-matched exercise and diet intervention for breast cancer survivors. Oncol Nurs Forum. 2011;38(2):E97&#x2013;106. doi: 10.1188/11.ONF.E97-E106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1188/11.ONF.E97-E106</ArticleId><ArticleId IdType="pubmed">21356647</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun YH, Lee KS, Kim YW, Park SY, Lee ES, Noh DY, Kim S, Oh JH, Jung SY, Chung KW, et al. Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol. 2012;30(12):1296&#x2013;1303. doi: 10.1200/JCO.2011.37.2979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2011.37.2979</ArticleId><ArticleId IdType="pubmed">22412149</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun YH, Lee MK, Park S, Lee JL, Park J, Choi YS, Lim YK, Kim SY, Jeong HS, Kang JH, et al. Use of a decision aid to help caregivers discuss terminal disease status with a family member with cancer: a randomized controlled trial. J Clin Oncol. 2011;29(36):4811&#x2013;4819. doi: 10.1200/JCO.2011.35.3870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2011.35.3870</ArticleId><ArticleId IdType="pubmed">22105823</ArticleId></ArticleIdList></Reference><Reference><Citation>Demark-Wahnefried W, Clipp EC, Lipkus IM, Lobach D, Snyder DC, Sloane R, Peterson B, Macri JM, Rock CL, McBride CM, et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol. 2007;25(19):2709&#x2013;2718. doi: 10.1200/JCO.2007.10.7094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2007.10.7094</ArticleId><ArticleId IdType="pubmed">17602076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469&#x2013;2475. doi: 10.1001/jama.288.19.2469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.288.19.2469</ArticleId><ArticleId IdType="pubmed">12435261</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun YH, Lee MK, Bae Y, Shon EJ, Shin BR, Ko H, Lee ES, Noh DY, Lim JY, Kim S, et al. Efficacy of a training program for long-term disease- free cancer survivors as health partners: a randomized controlled trial in Korea. Asian Pac J Cancer Prev. 2013;14(12):7229&#x2013;7235. doi: 10.7314/APJCP.2013.14.12.7229.</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2013.14.12.7229</ArticleId><ArticleId IdType="pubmed">24460280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363(24):2301&#x2013;2309. doi: 10.1056/NEJMoa1010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1010029</ArticleId><ArticleId IdType="pmc">PMC3237394</ArticleId><ArticleId IdType="pubmed">21080835</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36706623</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1465</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Physiotherapy</Title><ISOAbbreviation>Physiotherapy</ISOAbbreviation></Journal><ArticleTitle>Quantification of changes in lung aeration associated with physiotherapy using lung ultrasound in mechanically ventilated patients: a prospective cohort study.</ArticleTitle><Pagination><StartPage>26</StartPage><EndPage>33</EndPage><MedlinePgn>26-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.physio.2022.11.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0031-9406(22)00114-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Lung ultrasound (LUS) is a novel and emerging tool for physiotherapists in ICU and may provide a way of monitoring lung aeration change in response to respiratory physiotherapy treatment during a patient's ICU stay.</AbstractText><AbstractText Label="OBJECTIVE">To measure change in the LUS score associated with a respiratory physiotherapy treatment; to determine whether change in LUS score correlates with other physiological measures.</AbstractText><AbstractText Label="DESIGN AND SETTING">A single-centre prospective cohort study was undertaken in a tertiary teaching hospital in Sydney, Australia.</AbstractText><AbstractText Label="PATIENTS">Adult mechanically ventilated patients in ICU with suspicion of atelectasis.</AbstractText><AbstractText Label="MEASUREMENTS">Primary outcome: pre-post difference in LUS score.</AbstractText><AbstractText Label="SECONDARY OUTCOMES">PaO<sub>2</sub>/FiO<sub>2</sub> (PF) ratio, tidal volume (V<sub>T</sub>), lung auscultation score, driving pressure (DP) and the modified radiological atelectasis score (mRAS) on CXR.</AbstractText><AbstractText Label="RESULTS">43 patients were included. There was a mean improvement in total LUS score after physiotherapy treatment of -&#x202f;2.9 (95%CI -4.4, -1.4), and a mean improvement in LUS of the right and left lungs of -&#x202f;1.6 (-2.5, -0.7) and -&#x202f;1.3 (-2.5, -0.1) respectively. There was a mean improvement in PF ratio, V<sub>T</sub> and auscultation score of 10.4 (-11.89, 32.7), 19 (-7.4, 44.5) and -&#x202f;1.8 (-2.6, -1.0) respectively. There was no improvement in mRAS or DP. There was a weak correlation between change in LUS score compared with change in mRAS score.</AbstractText><AbstractText Label="LIMITATIONS">Limitations included the prospective cohort single site design and the small sample size.</AbstractText><AbstractText Label="CONCLUSIONS">The LUS score can be used to detect changes in lung aeration associated with respiratory physiotherapy treatment for acute lobar atelectasis in mechanically ventilated patients. Australian and New Zealand Clinical Trials Registry Number: ACTRN12619000783123. CONTRIBUTION OF THE PAPER.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hansell</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Physiotherapy Department, Royal North Shore Hospital, St Leonards, Sydney, Australia. Electronic address: Louise.Hansell@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milross</LastName><ForeName>Maree</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. Electronic address: Maree.Milross@sydney.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Malcolm Fisher Department of Intensive Care Medicine, Royal North Shore Hospital, Sydney, Australia; Division of Critical Care, The George Institute for Global Health, University of New South Wales, Sydney, Australia; Northern Clinical School, Faculty of Medicine, The University of Sydney, Sydney, Australia; ANZIC Research Centre, Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia. Electronic address: ADelaney@georgeinstitute.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>Chung Mo</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Radiology, Royal North Shore Hospital, St Leonards, Sydney, Australia; Department of Nuclear Medicine, Royal North Shore Hospital, St Leonard, Sydney, Australia. Electronic address: chungmokoo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Division of Critical Care, The George Institute for Global Health, University of New South Wales, Sydney, Australia; Department of Anaesthesia and Perioperative Medicine, Westmead Hospital, Australia. Electronic address: drdavidtian@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntoumenopoulos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Physiotherapy Department, St Vincent's Hospital, Sydney, Australia. Electronic address: georgentou@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Physiotherapy</MedlineTA><NlmUniqueID>0401223</NlmUniqueID><ISSNLinking>0031-9406</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001261" MajorTopicYN="Y">Pulmonary Atelectasis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026741" MajorTopicYN="N">Physical Therapy Modalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atelectasis</Keyword><Keyword MajorTopicYN="N">Lung ultrasound</Keyword><Keyword MajorTopicYN="N">POCUS</Keyword><Keyword MajorTopicYN="N">Respiratory physiotherapy treatment</Keyword></KeywordList><CoiStatement>Conflict of interests None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>18</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36706623</ArticleId><ArticleId IdType="doi">10.1016/j.physio.2022.11.003</ArticleId><ArticleId IdType="pii">S0031-9406(22)00114-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28671879</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-1921</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of neurosurgical anesthesiology</Title><ISOAbbreviation>J Neurosurg Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Feasibility of Protective Ventilation During Elective Supratentorial Neurosurgery: A Randomized, Crossover, Clinical Trial.</ArticleTitle><Pagination><StartPage>246</StartPage><EndPage>250</EndPage><MedlinePgn>246-250</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ANA.0000000000000442</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Traditional ventilation approaches, providing high tidal volumes (Vt), produce excessive alveolar distention and lung injury. Protective ventilation, employing lower Vt and positive end-expiratory pressure (PEEP), is an attractive alternative also for neuroanesthesia, when prolonged mechanical ventilation is needed. Nevertheless, protective ventilation during intracranial surgery may exert dangerous effects on intracranial pressure (ICP). We tested the feasibility of a protective ventilation strategy in neurosurgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Our monocentric, double-blind, 1:1 randomized, 2&#xd7;2 crossover study aimed at studying the effect size and variability of ICP in patients undergoing elective supratentorial brain tumor removal and alternatively ventilated with Vt 9 mL/kg-PEEP 0 mm Hg and Vt 7 mL/kg-PEEP 5 mm Hg. Respiratory rate was adjusted to maintain comparable end-tidal carbon dioxide between ventilation modes. ICP was measured through a subdural catheter inserted before dural opening.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty patients were enrolled; 8 (15%) were excluded after enrollment. ICP did not differ between traditional and protective ventilation (11.28&#xb1;5.37, 11 [7 to 14.5] vs. 11.90&#xb1;5.86, 11 [8 to 15] mm Hg; P=0.541). End-tidal carbon dioxide (28.91&#xb1;2.28, 29 [28 to 30] vs. 28.00&#xb1;2.17, 28 [27 to 29] mm Hg; P&lt;0.001). Peak airway pressure (17.25&#xb1;1.97, 17 [16 to 18.5] vs. 15.81&#xb1;2.87, 15.5 [14 to 17] mm Hg; P&lt;0.001) and plateau airway pressure (16.06&#xb1;2.30, 16 [14.5 to 17] vs. 14.19&#xb1;2.82, 14 [12.5 to 16] mm Hg; P&lt;0.001) were higher during protective ventilation. Blood pressure, heart rate, and body temperature did not differ between ventilation modes. Dural tension was "acceptable for surgery" in all cases. ICP differences between ventilation modes were not affected by ICP values under traditional ventilation (coefficient=0.067; 95% confidence interval, -0.278 to 0.144; P=0.523).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Protective ventilation is a feasible alternative to traditional ventilation during elective neurosurgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruggieri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Head and Neck Department, Anesthesia and Neuro-Intensive Care Unit, Scientific Institute Hospital San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beretta</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Corno</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Testa</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Enrico A</ForeName><Initials>EA</Initials></Author><Author ValidYN="Y"><LastName>Gemma</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg Anesthesiol</MedlineTA><NlmUniqueID>8910749</NlmUniqueID><ISSNLinking>0898-4921</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="Y">Neurosurgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28671879</ArticleId><ArticleId IdType="doi">10.1097/ANA.0000000000000442</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31868939</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2265</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical endocrinology</Title><ISOAbbreviation>Clin Endocrinol (Oxf)</ISOAbbreviation></Journal><ArticleTitle>Unilateral primary aldosteronism as an independent risk factor for vertebral fracture.</ArticleTitle><Pagination><StartPage>206</StartPage><EndPage>213</EndPage><MedlinePgn>206-213</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cen.14145</ELocationID><Abstract><AbstractText Label="CONTEXT">Primary aldosteronism (PA) is known to increase vertebral fracture (VF), although the detailed mechanism remains to be elucidated. We hypothesized that the PA subtype is associated with VF.</AbstractText><AbstractText Label="OBJECTIVE">To evaluate whether unilateral PA is associated with the prevalence of VF.</AbstractText><AbstractText Label="DESIGN">This was a retrospective cross-sectional study in a single referral centre.</AbstractText><AbstractText Label="PATIENTS">We identified 210 hypertensive patients whose clinical data were available for case-detection results. One hundred and fifty-two patients were diagnosed with PA using captopril challenge tests.</AbstractText><AbstractText Label="MEASUREMENTS">We measured the prevalence of VF, according to PA subtype.</AbstractText><AbstractText Label="RESULTS">One hundred thirteen patients with PA were subtype classified by adrenal vein sampling. Of these, 37 patients had unilateral PA, 76 patients had bilateral PA, 58 patients had non-PA; 39 patients with PA were not subtype-classified. Patients with PA had a higher prevalence of VF (29%, 44/152) than those with non-PA (12%, 7/58; P&#xa0;=&#xa0;.011). Moreover, unilateral PA had a higher prevalence of VF (46%, 17/37) than bilateral PA (20%, 15/76; P&#xa0;=&#xa0;.021). There was no significant difference in the prevalence of VF between bilateral PA and non-PA. Unilateral PA was an independent risk factor for VF after adjusting for age and sex (OR: 3.16, 95% confidence interval: 1.12-8.92; P&#xa0;=&#xa0;.017). Among patients with unilateral PA, serum cortisol concentrations after 1-mg dexamethasone suppression test were higher in those with VF (1.32&#xa0;&#xb1;&#xa0;0.67&#xa0;g/dL) than those without (0.96&#xa0;&#xb1;&#xa0;0.33&#xa0;g/dL; P&#xa0;=&#xa0;.048).</AbstractText><AbstractText Label="CONCLUSIONS">Unilateral PA is an independent risk factor for VF.</AbstractText><CopyrightInformation>&#xa9; 2019 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yokomoto-Umakoshi</LastName><ForeName>Maki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakamoto</LastName><ForeName>Ryuichi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umakoshi</LastName><ForeName>Hironobu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4293-287X</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuda</LastName><ForeName>Yayoi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagata</LastName><ForeName>Hiromi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukumoto</LastName><ForeName>Tazuru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogata</LastName><ForeName>Masatoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Q-AND-A study group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Endocrinol (Oxf)</MedlineTA><NlmUniqueID>0346653</NlmUniqueID><ISSNLinking>0300-0664</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4964P6T9RB</RegistryNumber><NameOfSubstance UI="D000450">Aldosterone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000450" MajorTopicYN="N">Aldosterone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006929" MajorTopicYN="N">Hyperaldosteronism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">osteoporosis</Keyword><Keyword MajorTopicYN="N">unilateral primary aldosteronism</Keyword><Keyword MajorTopicYN="N">vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31868939</ArticleId><ArticleId IdType="doi">10.1111/cen.14145</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Mulatero P, Stowasser M, Loh K-C, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045-1050.</Citation></Reference><Reference><Citation>Monticone S, Burrello J, Tizzani D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811-1820.</Citation></Reference><Reference><Citation>Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293-2300.</Citation></Reference><Reference><Citation>Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285:126-148.</Citation></Reference><Reference><Citation>Akasaka H, Yamamoto K, Rakugi H, et al. Sex difference in the association between subtype distribution and age at diagnosis in patients with primary aldosteronism. Hypertension. 2019;74(2):368-374.</Citation></Reference><Reference><Citation>Salcuni AS, Palmieri S, Carnevale V, et al. Bone involvement in aldosteronism. J Bone Miner Res. 2012;27(10):2217-2222.</Citation></Reference><Reference><Citation>Notsu M, Yamauchi M, Yamamoto M, Nawata K, Sugimoto T. Primary aldosteronism as a risk factor for vertebral fracture. J Clin Endocrinol Metab. 2017;102:1237-1243.</Citation></Reference><Reference><Citation>Wu V-C, Chang C-H, Wang C-Y, et al. Risk of fracture in primary aldosteronism: a population-based cohort study. J Bone Miner Res. 2017;32:743-752.</Citation></Reference><Reference><Citation>Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2019;104:1595-1622.</Citation></Reference><Reference><Citation>Athimulam S, Bancos I. Evaluation of bone health in patients with adrenal tumors. Curr Opin Endocrinol Diabetes Obes. 2019;26(3):125-312.</Citation></Reference><Reference><Citation>Diab DL, Watts NB. Secondary osteoporosis: differential diagnosis and workup. Clin Obstet Gynecol. 2013;56:686-693.</Citation></Reference><Reference><Citation>Salcuni AS, Carnevale V, Battista C, et al. Primary aldosteronism as a cause of secondary osteoporosis. Eur J Endocrinol. 2017;177:431-437.</Citation></Reference><Reference><Citation>Ceccoli L, Ronconi V, Giovannini L, et al. Bone health and aldosterone excess. Oseteoporos Int. 2013;24:2801-2807.</Citation></Reference><Reference><Citation>Mulatero P, Monticone S, Bertello C, et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98:4826-4833.</Citation></Reference><Reference><Citation>Reincke M, Fischer E, Gerum S, et al. Observational study mortality in treated primary aldosteronism: the German Conn's registry. Hypertension. 2012;60:618-624.</Citation></Reference><Reference><Citation>Ohno Y, Sone M, Inagaki N, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension. 2018;71:530-537.</Citation></Reference><Reference><Citation>Nishikawa T, Omura M, Satoh F, et al. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society. Endocr J. 2011;58:711-721.</Citation></Reference><Reference><Citation>Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37:253-390.</Citation></Reference><Reference><Citation>Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889-1916.</Citation></Reference><Reference><Citation>Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, et al. Correlation between lateralization index of adrenal venous sampling and standardized outcome in primary aldosteronism. Journal of Endocr Soc. 2018;2:893-902.</Citation></Reference><Reference><Citation>Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137-1148.</Citation></Reference><Reference><Citation>Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med. 2017;167(3):ITC17-ITC32.</Citation></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x2018;EXR&#x2019; for medical statistics. Bone Marrow Transplant. 2013;48:452-458.</Citation></Reference><Reference><Citation>Nakajima Y, Yamada M, Taguchi R, et al. Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab. 2011;96:2512-2518.</Citation></Reference><Reference><Citation>Chiodini I, Mascia ML, Muscarella S, et al. Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med. 2007;147:541-548.</Citation></Reference><Reference><Citation>Zhukouskaya VV, Eller-Vainicher C, Gaudio A, et al. In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity. J Clin Endocrinol Metab. 2015;100:1417-1425.</Citation></Reference><Reference><Citation>Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M. Patients with prior fractures have an increased risk of future fractures; a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-739.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30625492</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0372</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>6</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Stereotactic and functional neurosurgery</Title><ISOAbbreviation>Stereotact Funct Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Unilateral Thalamic Deep Brain Stimulation for Voice Tremor.</ArticleTitle><Pagination><StartPage>392</StartPage><EndPage>399</EndPage><MedlinePgn>392-399</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000495413</ELocationID><Abstract><AbstractText Label="BACKGROUND">Voice tremor (VT) is the involuntary and rhythmical phonatory instability of the voice. Recent findings suggest that unilateral deep brain stimulation of the ventral intermediate nucleus (Vim-DBS) can sometimes be effective for VT. In this exploratory analysis, we investigated the effect of Vim-DBS on VT and tested the hypothesis that unilateral thalamic stimulation is effective for patients with VT.</AbstractText><AbstractText Label="METHODS">Seven patients with VT and previously implanted bilateral Vim-DBS were enrolled in the study. Each patient was randomized and recorded performing sustained phonation during the following conditions: left thalamic stimulation, right thalamic stimulation, bilateral thalamic stimulation (Bil-ON), and no stimulation (Bil-OFF). Perceptual VT ratings and an acoustic analysis to find the rate of variation of the fundamental frequency measured by the standard deviation of the pitch (f0SD) were performed in a blinded manner. For the purposes of this study, a "dominant" side was defined as one with more than twice as much reduction in VT following Vim-DBS compared to the contralateral side. The Wilcoxon signed-rank test was performed to compare the effect of the dominant side stimulation in the reduction of VT scores and f0SD. The volume of activated tissue (VAT) of the dominant stimulation side was modelled against the degree of improvement in VT to correlate the significant stimulation cluster with thalamic anatomy. Finally, tractography analysis was performed to analyze the connectivity of the significant stimulation cluster.</AbstractText><AbstractText Label="RESULTS">Unilateral stimulation was beneficial in all 7 patients. Five patients clearly had a "dominant" side with either benefit only seen following stimulation of one side or more than twice as much benefit from one side compared to the other. Two patients had similar benefit with unilateral stimulation from either side. The Wilcoxon paired test showed significant differences between unilateral dominant and unilateral nondominant stimulation for VT scores (p = 0.04), between unilateral dominant and Bil-OFF (p = 0.04), and between Bil-ON and unilateral nondominant stimulation (p = 0.04). No significant differences were found between Bil-ON and unilateral dominant condition (p = 0.27), or between Bil-OFF and unilateral nondominant (p = 0.23). The dominant VAT showed that the significant voxels associated with the best VT control were located in the most ventral and medial part of the Vim nucleus and the ventralis caudalis anterior internus nucleus. The connectivity analysis showed significant connectivity with the cortical areas of the speech circuit.</AbstractText><AbstractText Label="CONCLUSIONS">Unilateral dominant-side thalamic stimulation and bilateral thalamic stimulation were equally effective in reducing VT. Nondominant unilateral stimulation alone did not significantly improve VT.</AbstractText><CopyrightInformation>&#xa9; 2019 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Avecillas-Chasin</LastName><ForeName>Josue M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Neurosurgery, The University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poologaindran</LastName><ForeName>Anujan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Neurosurgery, The University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Murray D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Otolaryngology, The University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rammage</LastName><ForeName>Linda A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Otolaryngology, The University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honey</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Neurosurgery, The University of British Columbia, Vancouver, British Columbia, Canada, chris.honey@telus.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Stereotact Funct Neurosurg</MedlineTA><NlmUniqueID>8902881</NlmUniqueID><ISSNLinking>1011-6125</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046690" MajorTopicYN="N">Deep Brain Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014202" MajorTopicYN="N">Tremor</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020651" MajorTopicYN="N">Ventral Thalamic Nuclei</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014832" MajorTopicYN="N">Voice Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep brain stimulation</Keyword><Keyword MajorTopicYN="N">Neuromodulation</Keyword><Keyword MajorTopicYN="N">Ventral intermediate nucleus</Keyword><Keyword MajorTopicYN="N">Voice tremor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30625492</ArticleId><ArticleId IdType="doi">10.1159/000495413</ArticleId><ArticleId IdType="pii">000495413</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16881978</PMID><DateCompleted><Year>2006</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-4327</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2006</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of interventional cardiology</Title><ISOAbbreviation>J Interv Cardiol</ISOAbbreviation></Journal><ArticleTitle>Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.</ArticleTitle><Pagination><StartPage>319</StartPage><EndPage>327</EndPage><MedlinePgn>319-27</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Alcohol septal ablation (ASA) for hypertrophic obstructive cardiomyopathy (HOCM) has emerged as a lesser invasive alternative to surgical myectomy over the past decade. The purpose of this study is to analyze all the published literature on outcomes and complications after ASA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE and PubMed were searched for all available published literature on ASA (June 1996-June 2005) using the terms hypertrophic obstructive cardiomyopathy (HOCM), alcohol septal ablation for hypertrophic obstructive cardiomyopathy, alcohol septal ablation for HOCM, alcohol septal ablation (ASA), transcoronary alcohol septal ablation for hypertrophic obstructive cardiomyopathy (TASH), transcoronary alcohol septal ablation for HOCM, nonsurgical septal reduction therapy (NSRT), and percutaneous transcoronary septal myocardial ablation (PTSMA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 42 published studies (2,959 patients) were analyzed. Mean age was 53.5 (35.4-72) years with a mean male to female ratio of 1.17. Mean follow-up was 12.7 +/- 0.3 months (1.5-43.2). Absolute ethanol (3 mL) was injected in 1.2 septal perforator arteries. On average, serum CK peaked at 964 units. At 12 months, there was a sustained decrease in resting and provoked LVOT gradient (65.3-15.8 and 125.4-31.5 mmHg, respectively) accompanied by reduction in basal septal diameter (20.9-13.9 mm), improvement in NYHA Class (2.9-1.2), and increase in exercise capacity (325.3-437.5 seconds). Early mortality (within 30 days) was 1.5% (0.0-5.0%) and late mortality (beyond 30 days) was 0.5% (0.0-9.3%). Other complications include ventricular fibrillation (2.2%), LAD dissection (1.8%), complete heart block requiring permanent pacemaker (10.5%), and pericardial effusion (0.6%). A repeat ASA was performed on 6.6% of patients and 1.9% of patients underwent surgical myomectomy with resolution of symptoms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Literature to date suggests that ASA results in acute and intermediate-term favorable clinical and echocardiographic outcomes. A randomized controlled trial is needed to compare ASA and myomectomy in order to determine which technique provides maximal benefit.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alam</LastName><ForeName>Mahboob</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine-Cardiology, Houston, Texas 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dokainish</LastName><ForeName>Hisham</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Lakkis</LastName><ForeName>Nasser</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Interv Cardiol</MedlineTA><NlmUniqueID>8907826</NlmUniqueID><ISSNLinking>0896-4327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3K9958V90M</RegistryNumber><NameOfSubstance UI="D000431">Ethanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="N">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000431" MajorTopicYN="N">Ethanol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006346" MajorTopicYN="N">Heart Septum</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>87</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>8</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>8</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16881978</ArticleId><ArticleId IdType="doi">10.1111/j.1540-8183.2006.00153.x</ArticleId><ArticleId IdType="pii">JOIC153</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16760868</PMID><DateCompleted><Year>2006</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0021-9509</ISSN><JournalIssue CitedMedium="Print"><Volume>47</Volume><Issue>3</Issue><PubDate><Year>2006</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of cardiovascular surgery</Title><ISOAbbreviation>J Cardiovasc Surg (Torino)</ISOAbbreviation></Journal><ArticleTitle>General anesthesia with thoracic epidural anesthesia in the cardiopulmonary bypass surgery reduces apoptosis by upregulating antiapoptotic protein Bcl-2.</ArticleTitle><Pagination><StartPage>315</StartPage><EndPage>322</EndPage><MedlinePgn>315-22</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of the paper was to investigate whether thoracic epidural anesthesia (TEA) together with general anaesthesia (GA) play a role on apoptosis in humans before cardiopulmonary bypass (CPB), before aortic cross clamp (ACC) and at 15 min after ACC release (after ischemia and reperfusion).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Eighty patients scheduled for elective CABG were randomized to receive either GA group (n: 40) or TEA+GA group (n: 40). The right atrial biopsy samples were taken before CPB, before ACC and at 15 min after ACC release from all patients. Human heart tissues were obtained from patients of TEA+GA group and GA group. The number of Bcl-2 positive cardiomyocytes was counted in multiple tissue sections of biopsies of 80 patients using light microscopy (magnification x 40) with an ocular micrometer system (Olympus).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the TEA+GA group, the Bcl-2 positive cardiomyocytes were distinctly statistically increased compared to the GA group (P&lt;0.001). In addition, the intensity of the immunostaining was also increased in the TEA+GA compared with the GA group. The number of immunoreactive cardiomyocytes is as follows: before CPB, TEA+GA group 396+/-61, GA group 92+/-41, before ACC, TEA+GA group 333+/-47, GA group 94+/-18, at 15 min after ACC release, TEA+GA group 346+/-68.8, GA group 85+/-9.5. There were statistically significant differences between groups, (P&lt;0.001). Between groups, at 4 h and at 24 h after the end of CPB, in the TEA+GA group, the CI was significantly higher than GA group respectively; (3.4+/-0.8 L/min/m(2) vs 2.5+/-0.8 L/min/m(2); P&lt;0.001), (3.8+/-1.1 L/min/m(2) vs 3.1+/-1.1 L/min/m(2); P&lt;0.008). Within groups, at 4 and 24 h after the end of CPB, in the TEA+GA group, the CI was significantly higher than baseline values, respectively, (3.4+/-0.8 L/min/m(2) vs 2.4+/-0.7 L/min/m(2); P&lt;0.001), (3.8+/-1.1 L/min/m(2) vs 2.4+/-0.7 L/min/m(2); P&lt;0.001). Whereas no difference was found in the GA group respectively, (2.6+/-0.8 L/min/m(2) vs. 2.5+/-0.8 L/min/m(2); P&gt;0.05), (2.6+/-0.8 L/min/m(2) vs. 3.1+/-1.1 L/min/m(2); P&gt;0.05). The number of patients showing ventricular fibrillation (VF), atrial fibrillation or heart block after release of the ACC was 11 of 40 (27.5%) in the TEA+GA group versus 25 of 40 (62.5%) in the GA group. The number of patients showing VF after release of ACC was 9 out of 20 patients (22.5%) in the TEA+GA group which was significantly lower than in the GA group (21 of 40 patients 52.5%); (P&lt;0.006). Sinus rhythm after release of ACC, in the TEA+GA group was observed in 29 of 40 patients (72.5%) and was significantly higher than in the GA group (15 of 40 patients 37.5%); (P&lt;0.002).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The result of the present study indicate that TEA plus GA in coronary surgery had preserved cardiac function during intraoperative and postoperative period by means of reduced apoptosis, improved hemodynamic function and reduced arrhythmias after release of the ACC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kili&#xe7;kan</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Kocaeli University School of Medicine, Kocaeli, Turkey. leventkilickan@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonca</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Dal&#xe7;ik</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Dal&#xe7;ik</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Solak</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bayindir</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>S&#xfc;zer</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Omay</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Calikan</LastName><ForeName>E</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>J Cardiovasc Surg (Torino)</MedlineTA><NlmUniqueID>0066127</NlmUniqueID><ISSNLinking>0021-9509</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019253">Proto-Oncogene Proteins c-bcl-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="Y">Anesthesia, Epidural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002452" MajorTopicYN="N">Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006327" MajorTopicYN="N">Heart Block</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019253" MajorTopicYN="N">Proto-Oncogene Proteins c-bcl-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013525" MajorTopicYN="N">Surgical Instruments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>6</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>9</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>6</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16760868</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20300753</PMID><DateCompleted><Year>2010</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>9</Issue><PubDate><Year>2010</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Polymyalgia rheumatica and vertebral fractures: a 1-year pilot controlled study.</ArticleTitle><Pagination><StartPage>1245</StartPage><EndPage>1247</EndPage><MedlinePgn>1245-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-010-1399-0</ELocationID><Abstract><AbstractText>No data exist about the possibility that vertebral fracture in PMR patients could be independent of steroid therapy. For this reason, we aimed to investigate this topic by a case cohort study with a 1-year follow-up for each patient. We selected ten consecutive patients who experienced vertebral fractures (VF-group) during the first month of 1-year follow-up period and without any other significant associated condition. As a control group we studied ten control patients, without vertebral fractures and with a follow-up of 1 year, randomly selected among a larger group of patients affected by polymyalgia rheumatica. The following data were analysed: eritrosedimention rate (ESR), visual analogical scale score (VAS), methyprednisolone daily dosage. Each patient had been monthly evaluated by the aforementioned clinical and laboratoristic parameters during the 1-year follow-up period. The VF-group resulted with a higher and statistically significant median corticosteroid 12-month total dosage [mean 3,480 mg (95%CI 2,805-3,030) vs. 2,760 mg (2,666.25-3,247.5)]. The VF-group had statistically significant higher ESR and VAS AUC when compared to control group (median ESR AUC, 484.75 vs. 288.25; P = 0.0001; median VAS AUC, 70.75 vs. 43.5 P &lt; 0.0001); ESR at the baseline (cut-off &gt;80 mm) showed a specificity of 90% (95%CI 56-100) and sensitivity of 70% (95%CI 35-93). VAS difference from first to second month (cut-off &lt;or=3) showed a specificity of 90% (95%CI 56-100) and sensitivity of 80% (95% CI 44-97). Our results point out that vertebral fracture might be predicted from commonly used laboratory (ESR) and clinical (VAS) findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dipartimento Biomedico di Medicina Interna e Specialistica, Universit&#xe0; di Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistone</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Arnone</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Colomba</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Amico</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Giacalone</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Vitale</LastName><ForeName>Pietra</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Nicosia</LastName><ForeName>Calogero</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Barone</LastName><ForeName>Eliana</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Scaglione</LastName><ForeName>Rosario</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Licata</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Corrao</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013700" MajorTopicYN="N">Giant Cell Arteritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011111" MajorTopicYN="N">Polymyalgia Rheumatica</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20300753</ArticleId><ArticleId IdType="doi">10.1007/s00296-010-1399-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cochrane Database Syst Rev. 2000;(2):CD000952</Citation><ArticleIdList><ArticleId IdType="pubmed">10796394</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2000;(2):CD001347</Citation><ArticleIdList><ArticleId IdType="pubmed">10796432</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Rheumatol. 1998 Mar;37(3):292-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9566670</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 1984 May;13(4):322-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6729485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1982 Nov;97(5):672-80</Citation><ArticleIdList><ArticleId IdType="pubmed">6982645</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35283084</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-9375</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of the American Medical Directors Association</Title><ISOAbbreviation>J Am Med Dir Assoc</ISOAbbreviation></Journal><ArticleTitle>Traumatic Brain Injury in Older Adults: Characteristics, Outcomes, and Considerations. Results From the American Association for the Surgery of Trauma Geriatric Traumatic Brain Injury (GERI-TBI) Multicenter Trial.</ArticleTitle><Pagination><StartPage>568</StartPage><EndPage>575.e1</EndPage><MedlinePgn>568-575.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jamda.2022.01.085</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1525-8610(22)00163-3</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Describe the epidemiology of a large cohort of older adults with isolated traumatic brain injury (TBI) and identify predictors of mortality, palliative interventions, and discharge to preinjury residence in those presenting with moderate/severe TBI.</AbstractText><AbstractText Label="DESIGN">Prospective observational study of geriatric patients with TBI enrolled across 45 trauma centers.</AbstractText><AbstractText Label="SETTING AND PARTICIPANTS">Inclusion criteria were age &#x2265;40&#xa0;years, and computed tomography (CT)-verified TBI. Exclusion criteria were any other body region abbreviated injury scale score &gt;2 and presentation at enrolling center &gt;24&#xa0;hours after injury.</AbstractText><AbstractText Label="METHODS">The analysis was restricted to individuals aged &#x2265;65 and stratified into 3 age groups: young-old (65-74), middle-old (75-84), and oldest-old (&#x2265;85). Demographic, clinical, and injury data were collected. Predictors of mortality, palliative interventions, and discharge to preinjury residence in the moderate/severe TBI group were identified using Classification and Regression Tree and Generalized Linear Mixed Models.</AbstractText><AbstractText Label="RESULTS">Of the 3081 subjects enrolled in the study, 2028 were &#x2265;65&#xa0;years old. Overall, 339 (16.7%) presented with a moderate/severe TBI and experienced a 64% mortality rate. A Glasgow Coma Scale (GCS) score &lt;9 was the main predictor of mortality, CT worsening (odds ratio [OR]&#xa0;= 1.7, P &lt; .04), cerebral edema (OR&#xa0;= 2.4, P &lt; .04), GCS &lt;9, and age &#x2265;75 (OR&#xa0;= 2.1, P&#xa0;= .007) were predictors for palliative interventions, and an injury severity score &#x2264;24 (OR&#xa0;= 0.087, P&#xa0;= .002) was associated with increased likelihood of discharge to preinjury residence in the moderate/severe TBI group.</AbstractText><AbstractText Label="CONCLUSION AND IMPLICATIONS">In this prospective study of a large cohort of older adults with isolated TBI, comparisons across the older age groups with moderate/severe TBI revealed that survival and favorable discharge disposition were influenced more by severity of injury rather than age itself. Indicating that chronological age alone maybe insufficient to accurately predict outcomes, and increased representation of older adults in TBI research to develop better diagnostic and prognostic tools is warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 AMDA &#x2013; The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghneim</LastName><ForeName>Mira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Trauma, Critical Care and Acute Care Surgery, R Adams Cowley Shock Trauma Center, The University of Maryland Medical Center, Baltimore, MD, USA. Electronic address: mira.ghneim@som.umaryland.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brasel</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vesselinov</LastName><ForeName>Roumen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albrecht</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liveris</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Trauma, Critical Care and Acute Care Surgery, R Adams Cowley Shock Trauma Center, The University of Maryland Medical Center, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watras</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Trauma Services, Inova Fairfax Medical Campus, Falls Church, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michetti</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Trauma Services, Inova Fairfax Medical Campus, Falls Church, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haan</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ascension Via Christi Hospital, Wichita, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lightwine</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ascension Via Christi Hospital, Wichita, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winfield</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Critical Care and Acute Care Surgery, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Sasha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podbielski</LastName><ForeName>Jeanette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armen</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Surgery and Neurosurgery, Penn State Health System, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacko</LastName><ForeName>J Christopher</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Departments of Surgery and Neurosurgery, Penn State Health System, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasrallah</LastName><ForeName>Fady</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trauma Service, Scripps Memorial Hospital La Jolla, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaffer</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trauma Service, Scripps Memorial Hospital La Jolla, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunn</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Medical Center of the Rockies, Loveland, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smoot</LastName><ForeName>Brittany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Medical Center of the Rockies, Loveland, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeppel</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Critical Care and Acute Care Surgery, UC Health Memorial Hospital, Colorado Springs, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stillman</LastName><ForeName>Zachery</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Critical Care and Acute Care Surgery, UC Health Memorial Hospital, Colorado Springs, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Zara</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Trauma, Critical Care and Acute Care Surgery, R Adams Cowley Shock Trauma Center, The University of Maryland Medical Center, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Additional Study Group Members of The American Association for the Surgery of Trauma Geri-TBI Study</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Med Dir Assoc</MedlineTA><NlmUniqueID>100893243</NlmUniqueID><ISSNLinking>1525-8610</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="Y">Brain Injuries, Traumatic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015600" MajorTopicYN="N">Glasgow Coma Scale</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014193" MajorTopicYN="N">Trauma Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Geriatric</Keyword><Keyword MajorTopicYN="N">moderate/severe TBI</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">older adults</Keyword><Keyword MajorTopicYN="N">palliative interventions</Keyword><Keyword MajorTopicYN="N">traumatic brain injury</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Adams</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, Rhode Island Hospital, Providence, RI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lueckelm</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, Rhode Island Hospital, Providence, RI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Murry</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Texas Health Science Center at Tyler, Tyler, TX, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hsu</LastName><ForeName>Cindy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bhatti</LastName><ForeName>Umer</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lissauer</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Rutgers-Robert Wood Johnson Medical School, Clinical Academic Building, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>LaFonte</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Rutgers-Robert Wood Johnson Medical School, Clinical Academic Building, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Najafi</LastName><ForeName>Kaveh</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Honor Health Scottdale Osborn Medical Center, Scottsdale, AZ, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lewandowski</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Honor Health Scottdale Osborn Medical Center, Scottsdale, AZ, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Kaushik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Loma Linda University Medical Center, Loma Linda, CA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Imperio-Lagabon</LastName><ForeName>Kristelle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Loma Linda University Medical Center, Loma Linda, CA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hirsch</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Berry</LastName><ForeName>Cherisse</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Acute Care Surgery, New York University/Bellevue Hospital Center, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Freitas</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Acute Care Surgery, New York University/Bellevue Hospital Center, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cullinane</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, Marshfield Clinic, Marshfield, WI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ramwani</LastName><ForeName>Roshini</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Marshfield Clinic, Marshfield, WI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Truitt</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Methodist Dallas Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pearcy</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, Methodist Dallas Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hashimi</LastName><ForeName>Habiba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of California San Francisco Fresno, Fresno, CA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kaups</LastName><ForeName>Krista</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of California San Francisco Fresno, Fresno, CA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Claridge</LastName><ForeName>Jeffry</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, MetroHealth Medical Center, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Husayn</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, MetroHealth Medical Center, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hartwell</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Indiana University Department of Surgery, IU Health Methodist Hospital, Indianapolis, IN, USA; Department of Surgery, Indiana University at Eskenazi Health, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ballou</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Critical Care and Acute Care Surgery, Oregon Health and Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Croce</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Markle</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ascension Borgess, Kalamazoo, MI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Osserwaarde</LastName><ForeName>Sally</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ascension Borgess, Kalamazoo, MI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Posluszny</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stocker</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hranjec</LastName><ForeName>Tjasa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Acute Care Surgery, Memorial Regional Hospital, Hollywood, FL, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Solomon</LastName><ForeName>Rachele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Acute Care Surgery, Memorial Regional Hospital, Hollywood, FL, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martinek</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>Alok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grabo</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Acute Care Surgery and Surgical Critical Care, West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Uzer</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Acute Care Surgery and Surgical Critical Care, West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tatum</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Our Lady of the Lake Regional Medical Center, Baton Rouge, LA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jacome</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Our Lady of the Lake Regional Medical Center, Baton Rouge, LA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gates</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hartford Hospital, Hartford, CT, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jawani</LastName><ForeName>Alisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hartford Hospital, Hartford, CT, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Berndtson</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Surgical Critical Care, Burn and Acute Care Surgery, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Curry</LastName><ForeName>Terry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Surgical Critical Care, Burn and Acute Care Surgery, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bala</LastName><ForeName>Miklosh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Acute Care Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dultz</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Burn, Trauma and Surgical Critical Care, The University of Texas Southwestern Medical Center, Parkland Hospital, Dallas, TX, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Houshmand</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Burn, Trauma and Surgical Critical Care, The University of Texas Southwestern Medical Center, Parkland Hospital, Dallas, TX, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pieri</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, Maricopa Integrated Health Systems, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zielinski</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Critical Care and General Surgery, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hughes</LastName><ForeName>Joy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Critical Care and General Surgery, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hartwell</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Indiana University at Eskenazi Health, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Malhotra</LastName><ForeName>Ajai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Acute Care Surgery, University of Vermont, Burlington, Burlington, VT, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Acute Care Surgery, University of Vermont, Burlington, Burlington, VT, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Petrone</LastName><ForeName>Patrizio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgery, New York University Winthrop Hospital, Mineola, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Joseph</LastName><ForeName>D'andrea</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, New York University Winthrop Hospital, Mineola, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, Medical Center Plano, Plano, TX, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carrick</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Medical Center Plano, Plano, TX, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pathak</LastName><ForeName>Abhijit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Temple University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Van Zandt</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Temple University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Glass</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, Rutgers Medical School University Hospital, Newark, NJ, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Livingston</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma and Surgical Critical Care, Rutgers Medical School University Hospital, Newark, NJ, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gregg</LastName><ForeName>Shea</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Bridgeport Hospital, Bridgeport, CT, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Webb</LastName><ForeName>Travis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Medical College of Wisconsin, Wauwatosa, WI, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Drumheller</LastName><ForeName>Byron</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Trauma, Critical Care and Acute Care Surgery, R Adams Cowley Shock Trauma Center, The University of Maryland Medical Center, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kozar</LastName><ForeName>Rosemary</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Trauma, Critical Care and Acute Care Surgery, R Adams Cowley Shock Trauma Center, The University of Maryland Medical Center, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barraco</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, University of San Francisco-Lehigh Valley, Allentown, PA, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Joseph</LastName><ForeName>Bellal</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Trauma, Burn and Acute Care Surgery, The University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>14</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35283084</ArticleId><ArticleId IdType="doi">10.1016/j.jamda.2022.01.085</ArticleId><ArticleId IdType="pii">S1525-8610(22)00163-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17636739</PMID><DateCompleted><Year>2007</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>3</Issue><PubDate><Year>2007</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Lung protective ventilation strategy for the acute respiratory distress syndrome.</ArticleTitle><Pagination><StartPage>CD003844</StartPage><MedlinePgn>CD003844</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with acute respiratory distress syndrome and acute lung injury require mechanical ventilatory support. Acute respiratory distress syndrome and acute lung injury are further complicated by ventilator-induced lung injury. Lung-protective ventilation strategies may lead to improved survival.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the effects of ventilation with lower tidal volume on morbidity and mortality in patients aged 16 years or older affected by acute respiratory distress syndrome and acute lung injury. A secondary objective was to determine whether the comparison between low and conventional tidal volume was different if a plateau airway pressure of greater than 30 to 35 cm H20 was used.</AbstractText><AbstractText Label="SEARCH STRATEGY" NlmCategory="METHODS">In our original review, we searched databases from inception until 2003. In this updated review, we searched The Cochrane Central Register of Controlled Trials (CENTRAL), (The Cochrane Library 2006, Issue 3). We updated our search of MEDLINE, EMBASE, CINAHL and the Web of Science from 2003 to 2006. We also updated our search of intensive care journals and conference proceedings; databases of ongoing research, reference lists and 'grey literature' from 2003 to 2006.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We included randomized controlled trials comparing ventilation using either lower tidal volume (Vt) or low airway driving pressure (plateau pressure 30 cm H2O or less), resulting in tidal volume of 7 ml/kg or less versus ventilation that uses Vt in the range of 10 to 15 ml/kg, in adults (16 years old or older).</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">We independently assessed trial quality and extracted data. Wherever appropriate, results were pooled. We applied fixed- and random-effects models.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We found one new study in this update for a total of six trials, involving 1297 patients, which were eligible for inclusion. Mortality at day 28 was significantly reduced by lung-protective ventilation: relative risk (RR) 0.74 (95% confidence interval (CI) 0.61 to 0.88); hospital mortality was reduced: RR 0.80 (95% CI 0.69 to 0.92); overall mortality was not significantly different if a plateau pressure less than or equal to 31 cm H2O in control group was used: RR 1.13 (95% CI 0.88 to 1.45). There was insufficient evidence about morbidity and long term outcomes.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical heterogeneity, such as different lengths of follow up and higher plateau pressure in control arms in two trials, make the interpretation of the combined results difficult. Mortality is significantly reduced at day 28 and at the end of hospital stay. The effects on long-term mortality are unknown, although the possibility of a clinically relevant benefit cannot be excluded.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petrucci</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliera Desenzano, Department of Anaesthesia and Intensive Care, Loc. Montecroce, Desenzano, Italy, 25015. n.petrucci@libero.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacovelli</LastName><ForeName>W</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2004;(2):CD003844. doi: 10.1002/14651858.CD003844.pub2.</RefSource><PMID Version="1">15106222</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2013 Feb 28;(2):CD003844. doi: 10.1002/14651858.CD003844.pub4.</RefSource><PMID Version="1">23450544</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>48</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>7</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>10</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>7</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17636739</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD003844.pub3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23699725</PMID><DateCompleted><Year>2013</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6114</ISSN><JournalIssue CitedMedium="Internet"><Volume>173</Volume><Issue>12</Issue><PubDate><Year>2013</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>JAMA internal medicine</Title><ISOAbbreviation>JAMA Intern Med</ISOAbbreviation></Journal><ArticleTitle>Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery.</ArticleTitle><Pagination><StartPage>1075</StartPage><EndPage>1081</EndPage><MedlinePgn>1075-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2013.714</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Single-site studies have described an association between use of selective serotonin reuptake inhibitors (SSRIs) and adverse outcomes of surgery. Multicenter studies including a broad range of surgical procedures that explore rare outcomes, such as bleeding and mortality, and that account for indications for administration of SSRIs are needed.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether perioperative use of SSRIs is associated with adverse outcomes of surgery in a national sample of patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective study of patients 18 years or older who underwent major surgery from January 1, 2006, through December 31, 2008, at 375 US hospitals. We used multivariable hierarchical models to estimate associations between SSRI use and our outcomes. Pharmacy data were used to determine whether a patient received an SSRI in the perioperative period.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Three hundred seventy-five US hospitals.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Five hundred thirty thousand four hundred sixteen patients 18 years or older.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="METHODS">Perioperative use of SSRIs.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="METHODS">In-hospital mortality, length of stay, readmission at 30 days, bleeding events, transfusions, and incidence of ventricular arrhythmias.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients receiving SSRIs were more likely to have obesity, chronic pulmonary disease, or hypothyroidism (P &lt; .001 for each) and more likely to have depression (41.0% vs 6.2%, P &lt; .001). After adjustment, patients receiving SSRIs had higher odds of in-hospital mortality (adjusted odds ratio, 1.20 [95% CI, 1.07-1.36]), bleeding (1.09 [1.04-1.15]), and readmission at 30 days (1.22 [1.18-1.26]). Similar results were observed in propensity-matched analyses, although the risk of inpatient mortality was attenuated among patients with depression. Sensitivity analyses suggest that, to invalidate our results, an unmeasured covariate would have to have higher prevalence and be more strongly associated with mortality than any covariate included in our models.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Receiving SSRIs in the perioperative period is associated with a higher risk for adverse events. Determining whether patient factors or SSRIs themselves are responsible for elevated risks requires prospective study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Auerbach</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Division of Hospital Medicine, Department of Medicine, University of California, San Francisco, 505 Parnassus Ave, PO Box 0131, San Francisco, CA 94143, USA. ada@medicine.ucsf.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vittinghoff</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Maselli</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Pekow</LastName><ForeName>Penelope S</ForeName><Initials>PS</Initials></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>John Q</ForeName><Initials>JQ</Initials></Author><Author ValidYN="Y"><LastName>Lindenauer</LastName><ForeName>Peter K</ForeName><Initials>PK</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 HL098372</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24HL098372</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Intern Med</MedlineTA><NlmUniqueID>101589534</NlmUniqueID><ISSNLinking>2168-6106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017367">Serotonin Uptake Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Intern Med. 2013 Jun 24;173(12):1082-3. doi: 10.1001/jamainternmed.2013.718.</RefSource><PMID Version="1">23699775</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Evid Based Med. 2014 Apr;19(2):73. doi: 10.1136/eb-2013-101491.</RefSource><PMID Version="1">24065862</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012494" MajorTopicYN="N">Sampling Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017367" MajorTopicYN="N">Selective Serotonin Reuptake Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>12</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23699725</ArticleId><ArticleId IdType="mid">NIHMS535903</ArticleId><ArticleId IdType="pmc">PMC3867199</ArticleId><ArticleId IdType="doi">10.1001/jamainternmed.2013.714</ArticleId><ArticleId IdType="pii">1682366</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schalekamp T, Klungel OH, Souverein PC, de Boer A. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med. 2008 Jan 28;168(2):180&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">18227365</ArticleId></ArticleIdList></Reference><Reference><Citation>Tata LJ, Fortun PJ, Hubbard RB, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther. 2005 Aug 1;22(3):175&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">16091054</ArticleId></ArticleIdList></Reference><Reference><Citation>de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999 Oct 23;319(7217):1106&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC28262</ArticleId><ArticleId IdType="pubmed">10531103</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez PA, Pahissa J. QT alterations in psychopharmacology: proven candidates and suspects. Curr Drug Saf. 2010 Jan;5(1):97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">20210726</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolly K, Gammage MD, Cheng KK, Bradburn P, Banting MV, Langman MJ. Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol. 2009 Nov;68(5):743&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791981</ArticleId><ArticleId IdType="pubmed">19916999</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam G, Kent B, Alsaiwadi T, Baskett R. Serotonin syndrome following cardiac surgery. Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):656&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">18334520</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong GL, Jiang W, Clare RM, et al. Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting. Clin Cardiol. 2010 Jun;33(6):E94&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6653610</ArticleId><ArticleId IdType="pubmed">20552618</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Daskalakis C, Whellan DJ, et al. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol. 2009 May 15;103(10):1391&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">19427434</ArticleId></ArticleIdList></Reference><Reference><Citation>Movig KL, Janssen MW, de Waal Malefijt J, Kabel PJ, Leufkens HG, Egberts AC. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med. 2003 Oct 27;163(19):2354&#x2013;2358.</Citation><ArticleIdList><ArticleId IdType="pubmed">14581256</ArticleId></ArticleIdList></Reference><Reference><Citation>van Haelst IM, Egberts TC, Doodeman HJ, et al. Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiology. 2010 Mar;112(3):631&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">20179499</ArticleId></ArticleIdList></Reference><Reference><Citation>Auerbach AD, Hilton JF, Maselli J, Pekow PS, Rothberg MB, Lindenauer PK. Shop for quality or volume? Volume, quality, and outcomes of coronary artery bypass surgery. Ann Intern Med. 2009 May 19;150(10):696&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4617614</ArticleId><ArticleId IdType="pubmed">19451576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006 Jun 20;144(12):894&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">16785478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in hospital mortality following major noncardiac surgery. JAMA. 2004 May 5;291(17):2092&#x2013;2099.</Citation><ArticleIdList><ArticleId IdType="pubmed">15126437</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005 Jul 28;353(4):349&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">16049209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007 Feb 1;356(5):486&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">17259444</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgical Care Improvement Program   [October 2, 2012];2007   http://www.medqic.org/dcs/ContentServer?cid=1122904930422&amp;pagename=Medqic%2FContent%2FParentShellTemplate&amp;parentName=Topic&amp;c=MQParents.</Citation></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998 Jan;36(1):8&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnason T, Wells PS, van Walraven C, Forster AJ. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res. 2006;118(2):253&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">16081144</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozic KJ, Vail TP, Pekow PS, Maselli JH, Lindenauer PK, Auerbach AD. Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty. 2010 Oct;25(7):1053&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4142798</ArticleId><ArticleId IdType="pubmed">19679434</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang MC, Maselli J, Lurie JD, Lindenauer PK, Pekow PS, Auerbach AD. Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery. J Thromb Haemost. 2011 May 2;</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3129495</ArticleId><ArticleId IdType="pubmed">21535390</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997 Oct 15;127(8 Pt 2):757&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">9382394</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41&#x2013;55.</Citation></Reference><Reference><Citation>Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996 Mar;52(1):249&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">8934595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mago R, Mahajan R, Thase ME. Medically serious adverse effects of newer antidepressants. Curr Psychiatry Rep. 2008 Jun;10(3):249&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">18652794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics. 1998 Sep;54(3):948&#x2013;963.</Citation><ArticleIdList><ArticleId IdType="pubmed">9750244</ArticleId></ArticleIdList></Reference><Reference><Citation>Muluk V. In: Perioperative medication management. UpToDate. Basow D, editor. UpToDate; Waltham, MA: 2012.</Citation></Reference><Reference><Citation>PPH Preoperative Medication Procedure   [October 17, 2012];2010   http://www.pph.org/media/File/Pharmacy/PreopMeds(2).pdf.</Citation></Reference><Reference><Citation>Clinic UoWP. Perioperative medication management. 2010</Citation></Reference><Reference><Citation>Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc. 2010 Apr;58(4):650&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2858360</ArticleId><ArticleId IdType="pubmed">20398147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28630567</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1918-1523</ISSN><JournalIssue CitedMedium="Internet"><Volume>2017</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Pain research &amp; management</Title><ISOAbbreviation>Pain Res Manag</ISOAbbreviation></Journal><ArticleTitle>A Clinical Prospective Observational Cohort Study on the Prevalence and Primary Diagnostic Accuracy of Occult Vertebral Fractures in Aged Women with Acute Lower Back Pain Using Magnetic Resonance Imaging.</ArticleTitle><Pagination><StartPage>9265259</StartPage><MedlinePgn>9265259</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9265259</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2017/9265259</ELocationID><Abstract><AbstractText Label="BACKGROUND">Elderly female patients complaints of acute low back pain (LBP) may involve vertebral fracture (VF), among which occult VF (OVF: early-stage VF without any morphological change) is often missed to be detected by primary X-ray examination. The current study aimed to investigate the prevalence of VF and OVF and the diagnostic accuracy of the initial X-ray in detecting OVF.</AbstractText><AbstractText Label="METHOD">Subjects were elderly women (&gt;70 years old) complaining of acute LBP with an accurate onset date. Subjects underwent lumbar X-ray, magnetic resonance imaging (MRI), and bone mineral density (BMD) measurement at their first visit. The distribution of radiological findings from X-ray and magnetic resonance imaging (MRI) as well as the calculation of the prevalence of VF and OVF are investigated.</AbstractText><AbstractText Label="RESULTS">The prevalence of VF among elderly women with LBP was 76.5% and L1 was the most commonly injured level. Among VF cases, the prevalence of OVF was 33.3%. Furthermore, osteoporotic patients tend to show increased prevalence of VF (87.5%). The predictive values in detecting VF on the initial plain X-ray were as follows: sensitivity, 51.3%; specificity, 75.0%; and accuracy rate, 56.7%.</AbstractText><AbstractText Label="CONCLUSIONS">Acute LBP patients may suffer vertebral injury with almost no morphologic change in X-ray, which can be detected using MRI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Terakado</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kitachiba Spine and Sports Clinic, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orita</LastName><ForeName>Sumihisa</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2676-5469</Identifier><AffiliationInfo><Affiliation>Kitachiba Spine and Sports Clinic, Chiba, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inage</LastName><ForeName>Kazuhide</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0540-4613</Identifier><AffiliationInfo><Affiliation>Kitachiba Spine and Sports Clinic, Chiba, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubota</LastName><ForeName>Go</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanzaki</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kitachiba Spine and Sports Clinic, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Kitachiba Spine and Sports Clinic, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shinohara</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Kitachiba Spine and Sports Clinic, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Junichi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuura</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoki</LastName><ForeName>Yasuchika</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furuya</LastName><ForeName>Takeo</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5378-940X</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koda</LastName><ForeName>Masao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohtori</LastName><ForeName>Seiji</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5738-6184</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pain Res Manag</MedlineTA><NlmUniqueID>9612504</NlmUniqueID><ISSNLinking>1203-6765</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017116" MajorTopicYN="N">Low Back Pain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28630567</ArticleId><ArticleId IdType="pmc">PMC5463094</ArticleId><ArticleId IdType="doi">10.1155/2017/9265259</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pham T., Azulay-Parrado J., Champsaur P., Chagnaud C., Legr&#xe9; V., Lafforgue P. "Occult" osteoporotic vertebral fractures: Vertebral body fractures without radiologic collapse. Spine. 2005;30(21):2430&#x2013;2435. doi: 10.1097/01.brs.0000184303.86932.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.brs.0000184303.86932.77</ArticleId><ArticleId IdType="pubmed">16261121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanchiku T., Taguchi T., Kawai S. Magnetic resonance imaging diagnosis and new classification of the osteoporotic vertebral fracture. Journal of Orthopaedic Science. 2003;8(4):463&#x2013;466. doi: 10.1007/s00776-003-0665-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00776-003-0665-3</ArticleId><ArticleId IdType="pubmed">12898295</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehlbach S. H., Bigelow C., Heimisdottir M., May S., Walker M., Kirkwood J. R. Recognition of vertebral fracture in a clinical setting. Osteoporosis International. 2000;11(7):577&#x2013;582. doi: 10.1007/s001980070078. A journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001980070078</ArticleId><ArticleId IdType="pubmed">11069191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross P. D. Clinical consequences of vertebral fractures. The American Journal of Medicine. 1997;103:30&#x2013;42. doi: 10.1016/S0002-9343(97)90025-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(97)90025-5</ArticleId><ArticleId IdType="pubmed">9302895</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y. F., Teng M. M., Chang C. Y., et al. Imaging manifestations of spinal fractures in ankylosing spondylitis. AJNR: American Journal of Neuroradiology. 2005;26:2067&#x2013;2076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8148850</ArticleId><ArticleId IdType="pubmed">16155161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Z., Harada A., Matsui Y., et al. Can you diagnose for vertebral fracture correctly by plain X-ray? Osteoporosis International. 2006;17(11):1584&#x2013;1591. doi: 10.1007/s00198-006-0123-0. A journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-006-0123-0</ArticleId><ArticleId IdType="pubmed">16917676</ArticleId></ArticleIdList></Reference><Reference><Citation>Milicic A., Jovanovic A., Milankov M., et al. Fractures of the spine in patients with ankylosing spondylitis. Medicinski Pregled. 1995;48:429&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">8643060</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz J. J., Jr., Aulino J. M., Collier B., et al. The early work-up for isolated ligamentous injury of the cervical spine: does computed tomography scan have a role? Journal of Trauma: Injury, Infection and Critical Care. 2005;59(4):897&#x2013;904. doi: 10.1097/01.ta.0000188012.84356.dc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ta.0000188012.84356.dc</ArticleId><ArticleId IdType="pubmed">16374279</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid D. C., Henderson R., Saboe L., et al. Etiology and clinical course of missed spine fractures. The Journal of trauma. 1987;27:980&#x2013;986. doi: 10.1097/00005373-198709000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-198709000-00005</ArticleId><ArticleId IdType="pubmed">3656481</ArticleId></ArticleIdList></Reference><Reference><Citation>Delmas P. D., Van Langerijt L. D., Watts N. B., et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. Journal of Bone and Mineral Research. 2005;20(4):557&#x2013;563. doi: 10.1359/JBMR.041214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/JBMR.041214</ArticleId><ArticleId IdType="pubmed">15765173</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. Southern Medical Journal. 2001;94:569&#x2013;573.  http://www.ncbi.nlm.nih.gov/pubmed/11440324.</Citation><ArticleIdList><ArticleId IdType="pubmed">11440324</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller M. D., Osborne J. R., Gordon W. T., Hinkin D. T., Brinker M. R. The natural history of bone bruises. A prospective study of magnetic resonance imaging-detected trabecular microfractures in patients with isolated medial collateral ligament injuries. American Journal of Sports Medicine. 1998;26(1):15&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">9474396</ArticleId></ArticleIdList></Reference><Reference><Citation>Qaiyum M., Tyrrell P. N. M., McCall I. W., Cassar-Pullicino V. N. MRI detection of unsuspected vertebral injury in acute spinal trauma: incidence and significance. Skeletal Radiology. 2001;30(6):299&#x2013;304. doi: 10.1007/s002560100329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002560100329</ArticleId><ArticleId IdType="pubmed">11465768</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenfeld A. J., Bono C. M., McGuire K. J., Warholic N., Harris M. B. Computed tomography alone versus computed tomography and magnetic resonance imaging in the identification of occult injuries to the cervical spine: a meta-analysis. The Journal of trauma. 2010;68(1):109&#x2013;114. doi: 10.1097/TA.0b013e3181c0b67a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181c0b67a</ArticleId><ArticleId IdType="pubmed">20065765</ArticleId></ArticleIdList></Reference><Reference><Citation>Kepler C. K., Bogner E. A., Herzog R. J., Huang R. C. Anatomy of the psoas muscle and lumbar plexus with respect to the surgical approach for lateral transpsoas interbody fusion. European Spine Journal. 2011;20(4):550&#x2013;556. doi: 10.1007/s00586-010-1593-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-010-1593-5</ArticleId><ArticleId IdType="pmc">PMC3065600</ArticleId><ArticleId IdType="pubmed">20938787</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanucci E., Manenti G., Masala S., et al. Multiparameter characterisation of vertebral osteoporosis with 3-T MR. Radiologia Medica. 2007;112(2):208&#x2013;223. doi: 10.1007/s11547-007-0136-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11547-007-0136-6</ArticleId><ArticleId IdType="pubmed">17361375</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31021879</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Tidal volume challenge to predict fluid responsiveness in the operating room: An observational study.</ArticleTitle><Pagination><StartPage>583</StartPage><EndPage>591</EndPage><MedlinePgn>583-591</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0000000000000998</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pulse pressure variation (PPV) and stroke volume variation (SVV) do not predict fluid responsiveness when using a protective ventilation strategy: the use of functional haemodynamic tests can be useful to overcome this limitation.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We tested the use of a tidal volume challenge (VTC), during 6&#x200a;ml&#x200a;kg [predicted body weight (PBW)] ventilation, and the end-expiratory occlusion test (EEOT) for prediction of fluid responsiveness.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">An interventional prospective study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Supine elective neurosurgical patients.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">The study protocol was, first, the initial EEOT test was performed during baseline 6&#x200a;ml&#x200a;kg PBW ventilation; second, VTC was performed by increasing the VT up to 8&#x200a;ml&#x200a;kg PBW and PPV and SVV changes were recorded after 1&#x200a;min; third, a second EEOT was performed during 8&#x200a;ml&#x200a;kg PBW ventilation; and VT was reduced back to 6&#x200a;ml&#x200a;kg PBW and a third EEOT was performed. Finally, a 250&#x200a;ml fluid challenge was administered over 10&#x200a;min to identify fluid responders (increase in stroke volume index &#x2265;10%).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the 40 patients analysed, PPV and SVV values at baseline and EEOT performed at 6&#x200a;ml&#x200a;kg PBW did not predict fluid responsiveness. A 13.3% increase in PPV after VTC predicted fluid responsiveness with a sensitivity of 94.7% and a specificity of 76.1%, while a 12.1% increase in SVV after VTC predicted fluid responsiveness with a sensitivity of 78.9% and a specificity of 95.2%. After EEOT performed at 8&#x200a;ml&#x200a;kg PBW, a 3.6% increase in cardiac index predicted fluid responsiveness with a sensitivity of 89.4% and a specificity of 85.7%, while a 4.7% increase in stroke volume index (SVI) with a sensitivity of 89.4% and a specificity of 85.7%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The changes in PPV and SVV obtained after VTC are reliable and comparable to the changes in CI and SVI obtained after EEOT performed at 8&#x200a;ml&#x200a;kg PBW in predicting fluid responsiveness in neurosurgical patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ACTRN12618000351213.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas, Humanitas University, Milan (AM, MC), the Department of Anaesthesia and Intensive Care Medicine, Maggiore della Carit&#xe0; University Hospital, Novara (CM, GC, FG, LM, FDC), the Department of Anaesthesiology and Intensive Care, San Bortolo Hospital, Vicenza (SDR), and the Department of Anaesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy (PN).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montagnini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Cammarota</LastName><ForeName>Gianmaria</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>De Rosa</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Giuliani</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Muratore</LastName><ForeName>Lara</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Della Corte</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020896" MajorTopicYN="N">Hypovolemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009873" MajorTopicYN="N">Operating Rooms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31021879</ArticleId><ArticleId IdType="doi">10.1097/EJA.0000000000000998</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40051013</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-799X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of orthopaedic surgery and research</Title><ISOAbbreviation>J Orthop Surg Res</ISOAbbreviation></Journal><ArticleTitle>Orthopedic frailty risk stratification (OFRS): a systematic review of the frailty indices predicting adverse outcomes in orthopedics.</ArticleTitle><Pagination><StartPage>247</StartPage><MedlinePgn>247</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">247</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13018-025-05609-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">With a growing number of elderly patients requiring elective and non-elective procedures, frailty-based preoperative risk stratification is an emerging tool in orthopedic surgery to minimize adverse postoperative outcomes. This paper sought to understand the current literature regarding preoperative Orthopedic Frailty Risk Stratification (OFRS) and describe the disparate frailty indices and their capabilities for discrimination in predicting adverse postoperative outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search was conducted in Pubmed, Cochrane, and Scopus for articles published during or prior to February 2024 assessing frailty following surgery for orthopedic pathologies. Qualitative variables including study characteristics and application of frailty were collected and synthesized. Quantitative meta-analysis was performed for pooled odds ratio (OR) and area under the curve (AUC) of frailty for mortality and complications. All methods were performed in accordance with PRISMA guidelines.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 81 included articles, over half (52%) addressed traumatic orthopedic pathologies with traumatic hip fractures being the most studied in the OFRS (25 studies). Less common categories included oncology, sports, and foot/ankle. Functional status and independence were the most common frailty domain (25, 96.2%) and component across scales (20, 76.9%), respectively. The 5-Item Modified Frailty Index (mFI-5) was the most common frailty index (28 publications). Meta-analysis demonstrated increasing frailty was an independent predictor of mortality (30-day OR: 2.89, 95% CI: 2.00-4.18; 1&#xa0;year OR: 1.81, 95% CI: 1.48-2.22, p&#x2009;&lt;&#x2009;0.001), major complications (OR: 1.63, 95% CI: 1.10-2.41, p&#x2009;=&#x2009;0.02), and Clavien-Dindo IV complications (OR: 3.26, 95% CI: 2.18-4.87, p&#x2009;&lt;&#x2009;0.001). Frailty had good discriminatory accuracy for predicting mortality at 30-days (AUC: 0.71, 95% CI: 0.68-0.74, p&#x2009;&lt;&#x2009;0.001), 3-months (OR: 0.75, 95% CI: 0.65-0.83, p&#x2009;&lt;&#x2009;0.001), and 1-year (OR:0.74, 95% CI: 0.73-0.75, p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The orthopedic surgery frailty literature is extremely heterogeneous, with disparate frailty scales implemented to measure varying outcomes across many orthopedic pathologies. Despite no consensus on exact scales or definitions, various frailty indices have predicted adverse outcomes.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Nithin K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Flint, MI, USA. n_gupta0210@email.campbell.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Campbell University School of Osteopathic Medicine, Leon Levine Hall of Medical Sciences, 4350 US Hwy 421 S, Lillington, NC, USA. n_gupta0210@email.campbell.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunivin</LastName><ForeName>Forrest</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Kansas City University College of Osteopathic Medicine, Joplin, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chmait</LastName><ForeName>Hikmat R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Flint, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Larner College of Medicine at the University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smitterberg</LastName><ForeName>Chase</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Flint, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michigan State University College of Human Medicine, Flint, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buttar</LastName><ForeName>Azhaan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>North Carolina State University, Raleigh, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fazal-Ur-Rehman</LastName><ForeName>Moiz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Louisiana at Lafayette, Lafayette, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manes</LastName><ForeName>Taylor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, OhioHealth Grant Medical Center, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turnow</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, OhioHealth Grant Medical Center, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Tyler K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, University of Texas Health San Antonio, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Benjamin C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, OhioHealth Grant Medical Center, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weick</LastName><ForeName>Jack W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, OhioHealth Grant Medical Center, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowers</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Flint, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hurley Neurological Center, Hurley Medical Center, Flint, MI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Orthop Surg Res</MedlineTA><NlmUniqueID>101265112</NlmUniqueID><ISSNLinking>1749-799X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="Y">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016330" MajorTopicYN="N">Frail Elderly</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015577" MajorTopicYN="N">Geriatric Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">And preoperative risk stratification</Keyword><Keyword MajorTopicYN="N">Comorbidity index</Keyword><Keyword MajorTopicYN="N">Frailty index</Keyword><Keyword MajorTopicYN="N">Modified frailty index (mFI)</Keyword><Keyword MajorTopicYN="N">Orthopedic frailty risk stratification (OFRS)</Keyword><Keyword MajorTopicYN="N">Orthopedic surgery</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: Dr. BCT is a consultant for/lecturer bureau for ZimmerBiomet; consultant for Stryker; consultant for Atricure; royalties from Innomed; editorial board for Orthobullets.com. NKG, FD, HRC, CS, AB, MFR, Dr. TM, Dr. MT, Dr. TKW, Dr. JWW, and Dr. CB report no financial or non-financial competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>7</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>6</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40051013</ArticleId><ArticleId IdType="pmc">PMC11887260</ArticleId><ArticleId IdType="doi">10.1186/s13018-025-05609-2</ArticleId><ArticleId IdType="pii">10.1186/s13018-025-05609-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Belatti DA, Phisitkul P. Trends in orthopedics: an analysis of Medicare claims, 2000&#x2013;2010. Orthopedics. 2013. 10.3928/01477447-20130222-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">23464959</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Census Bureau. An aging nation: the older population in the United States [Internet]. Census.gov: United States Census Bureau; 2014, May [cited 2024 Aug 18]. Available from: https://www.census.gov/content/dam/Census/library/publications/2014/demo/p25-1140.pdf</Citation></Reference><Reference><Citation>Shichman I, Roof M, Askew N, Nherera L, Rozell J, Seyler T, Schwarzkopf R. Projections and epidemiology of primary hip and knee arthroplasty in Medicare patients to 2040&#x2013;2060. JBJS Open Access. 2023. 10.2106/JBJS.OA.22.00112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9974080</ArticleId><ArticleId IdType="pubmed">36864906</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremers HM, Larson DR, Crowson CS, Kremers WK, Washington RE, Steiner CA, Jiranek WA, Berry DJ. Prevalence of total hip and knee replacement in the United States. J Bone Jt Surg. 2015;97(17):1386&#x2013;97. 10.2106/JBJS.N.01141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4551172</ArticleId><ArticleId IdType="pubmed">26333733</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JA, Yu S, Chen L, Cleveland JD. Rates of total joint replacement in the United States: future projections to 2020&#x2013;2040 using the national inpatient sample. J Rheumatol. 2019;46(9):1134&#x2013;40. 10.3899/jrheum.170990.</Citation><ArticleIdList><ArticleId IdType="pubmed">30988126</ArticleId></ArticleIdList></Reference><Reference><Citation>Losina E, Thornhill TS, Rome BN, Wright J, Katz JN. The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Jt Surg. 2012;94(3):201&#x2013;7. 10.2106/JBJS.J.01958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3262184</ArticleId><ArticleId IdType="pubmed">22298051</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones HG, Hathaway I, Glossop S, Bhachoo H, Hoade L, Froud J, Scourfield L, Poacher AT. The clinical frailty scale as a predictor of orthopaedic outcomes: a narrative review. Injury. 2024;55(6):111450. 10.1016/j.injury.2024.111450.</Citation><ArticleIdList><ArticleId IdType="pubmed">38493521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali B, Choi EE, Barlas V, Petersen TR, Morrell NT, McKee RG. Modified Frailty Index (mFI) predicts 30-day complications after microsurgical breast reconstruction. JPHS. 2021;56(4):229&#x2013;35. 10.1080/2000656x.2021.1962333.</Citation><ArticleIdList><ArticleId IdType="pubmed">34431755</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang ZB, Hu FY, Arya S, Gillespie TW, Rajani RR. Preoperative frailty is predictive of complications after major lower extremity amputation. J Vasc Surg. 2017;65(3):804&#x2013;11. 10.1016/j.jvs.2016.10.102.</Citation><ArticleIdList><ArticleId IdType="pubmed">28236922</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang HJ, Chin DK, Park JY, Kuh SU, Kim KS, Cho YE, Kim KH. Influence of frailty on life expectancy in octogenarians after lumbar spine surgery. Neurospine. 2021;18(2):303&#x2013;10. 10.14245/ns.2040688.344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255765</ArticleId><ArticleId IdType="pubmed">33494553</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald VS, Thompson KA, Lewis PR, Sise CB, Sise MJ, Shackford SR. Frailty in trauma: a systematic review of the surgical literature for clinical assessment tools. J Trauma Acute Care Surg. 2016;80(5):824&#x2013;34. 10.1097/ta.0000000000000981.</Citation><ArticleIdList><ArticleId IdType="pubmed">26881488</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinall MC, Arya S, Youk A, Varley P, Shah R, Massarweh NN, Shireman PK, Johanning JM, Brown AJ, Christie NA, Crist L, Curtin CM, Drolet BC, Dhupar R, Griffin J, Ibinson JW, Johnson JT, Kinney S, LaGrange C, Langerman A, Loyd GE, Mady LJ, Mott MP, Patri M, Siebler JC, Stimson CJ, Thorell WE, Vincent SA, Hall DE. Association of preoperative patient frailty and operative stress with postoperative mortality. JAMA Surg. 2020;155(1):e194620. 10.1001/jamasurg.2019.4620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865246</ArticleId><ArticleId IdType="pubmed">31721994</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy BM, Wilson JM, Smith RN, Schenker ML, Gelbard RB. The 5-item modified frailty index predicts adverse outcomes in trauma. J Surg Res. 2020;253:167&#x2013;72. 10.1016/j.jss.2020.03.052.</Citation><ArticleIdList><ArticleId IdType="pubmed">32361611</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver DJ, Malik AT, Jain N, Yu E, Kim J, Khan SN. The modified 5-item frailty index: a concise and useful tool for assessing the impact of frailty on postoperative morbidity following elective posterior lumbar fusions. World Neurosurg. 2019;124(19):e626&#x2013;32. 10.1016/j.wneu.2018.12.168.</Citation><ArticleIdList><ArticleId IdType="pubmed">30639495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorbas KA, Velanovich V, Esnaola NF, Karachristos A. Modified frailty index predicts complications and death after non-bariatric gastrectomies. Transl Gastroenterol Hepatol. 2021;6(10):10. 10.21037/tgh.2020.01.07.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724180</ArticleId><ArticleId IdType="pubmed">33409404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemos JL, Welch JM, Xiao M, Shapiro LM, Adeli E, Kamal RN. Is frailty associated with adverse outcomes after orthopaedic surgery? A systematic review and assessment of definitions. JBJS Rev. 2021. 10.2106/jbjs.rvw.21.00065.</Citation><ArticleIdList><ArticleId IdType="pubmed">34936580</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazniokas J, Gandhi C, Theriault B, Schmidt M, Cole C, Al-Mufti F, Santarelli J, Bowers C. The immense heterogeneity of frailty in neurosurgery: a systematic literature review. Neurosurg Rev. 2020;44:189&#x2013;201. 10.1007/s10143-020-01241-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">31953785</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsamadicy AA, Sayeed S, Sherman J, Craft S, Reeves BC, Lo SL, Shin JH, Sciubba DM. Impact of preoperative frailty on outcomes in patients with cervical spondylotic myelopathy undergoing anterior vs. posterior cervical surgery. J Clin Med. 2024;13(1):114. 10.3390/jcm13010114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10779741</ArticleId><ArticleId IdType="pubmed">38202121</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedro KM, Alvi MA, Hejrati N, Moghaddamjou A, Fehlings MG. Elderly patients show substantial improvement in health-related quality of life after surgery for degenerative cervical myelopathy despite medical frailty: an ambispective analysis of a multicenter, international data set. Neurosurgery. 2024;94(6):1122&#x2013;31. 10.1227/neu.0000000000002818.</Citation><ArticleIdList><ArticleId IdType="pubmed">38197642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson J, Badhiwala JH, Moghaddamjou A, Yee A, Wilson JR, Fehlings MG. Frailty is a better predictor than age of mortality and perioperative complications after surgery for degenerative cervical myelopathy: an analysis of 41,369 patients from the NSQIP database 2010&#x2013;2018. J Clin Med. 2020;9(11):3491. 10.3390/jcm9113491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692707</ArticleId><ArticleId IdType="pubmed">33137985</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson J, Badhiwala JH, Moghaddamjou A, Vaccaro AR, Arnold PM, Bartels R, Barbagallo G, Fehlings MG. Adverse effects of frailty on the outcomes of surgery for degenerative cervical myelopathy: results from a prospective multicenter international data set of 757 patients. J Neurosurg Spine. 2023;39(6):815&#x2013;21. 10.3171/2023.6.spine23461.</Citation><ArticleIdList><ArticleId IdType="pubmed">37728372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan&#x2014;a web and mobile app for systematic reviews. Syst Rev. 2016. 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek W, Park SY, Kim Y. Impact of frailty on the outcomes of patients undergoing degenerative spine surgery: a systematic review and meta-analysis. BMC Geriatr. 2023. 10.1186/s12877-023-04448-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10668507</ArticleId><ArticleId IdType="pubmed">37996826</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V, Wilson JRF, Ravinsky R, Badhiwala J, Jiang F, Anderson M, Yee A, Wilson JR, Fehlings MG. Frailty adversely affects outcomes of patients undergoing spine surgery: a systematic review. Spine J. 2021;21(6):988&#x2013;1000. 10.1016/j.spinee.2021.01.028.</Citation><ArticleIdList><ArticleId IdType="pubmed">33548521</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole KL, Kassicieh AJ, Rumalla K, Kazim SF, Thommen R, Conlon M, Schmidt MH, Bowers CA. Frailty predicts worse outcomes for spine surgery patients with interhospital transfer status: analysis of 295,875 patients from the National Surgical Quality Improvement Program (NSQIP) 2015&#x2013;2019. Clin Neurol Neurosurg. 2023;224:107519. 10.1016/j.clineuro.2022.107519.</Citation><ArticleIdList><ArticleId IdType="pubmed">36436435</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya S, Varley P, Youk A, Borrebach JD, Perez S, Massarweh NN, Johanning JM, Hall DE. Recalibration and external validation of the Risk Analysis Index. Ann Surg. 2019;272(6):996&#x2013;1005. 10.1097/SLA.0000000000003276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785437</ArticleId><ArticleId IdType="pubmed">30907757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JM, Holzgrefe RE, Staley C, Schenker ML, Meals CG. Use of a 5-item modified frailty index for risk stratification in patients undergoing surgical management of distal radius fractures. J Hand Surg. 2018;43(8):701&#x2013;9. 10.1016/j.jhsa.2018.05.029.</Citation><ArticleIdList><ArticleId IdType="pubmed">29980394</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi BC, Gowd AK, Agarwalla A, Chen E, Amin NH, Nicholson GP, Romeo AA, Liu JN. Efficacy of the modified frailty index and the modified Charlson comorbidity index in predicting complications in patients undergoing operative management of proximal humerus fracture. JSES. 2021;30(3):658&#x2013;67. 10.1016/j.jse.2020.06.014.</Citation><ArticleIdList><ArticleId IdType="pubmed">32650081</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, Parik L, Greimel F, Renkawitz T, Grifka J, Weber M. Hospital Frailty Risk Score outperforms current risk stratification models in primary total hip and knee arthroplasty. J Arthroplasty. 2021;36(5):1533&#x2013;42. 10.1016/j.arth.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">33380352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong B, Chan YH, O&#x2019;Neill GK, Murphy D, Merchant RA. Frailty, length of stay and cost in hip fracture patients. Osteoporos Int. 2022;34(1):59&#x2013;68. 10.1007/s00198-022-06553-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">36197493</ArticleId></ArticleIdList></Reference><Reference><Citation>Ondeck NT, Bovonratwet P, Ibe IK, Bohl DD, McLynn RP, Cui JJ, Baumgaertner MR, Grauer JN. Discriminative ability for adverse outcomes after surgical management of hip fractures: a comparison of the charlson comorbidity index, elixhauser comorbidity measure, and modified frailty index. J Orthop Trauma. 2018;32(5):231&#x2013;7. 10.1097/BOT.0000000000001140.</Citation><ArticleIdList><ArticleId IdType="pubmed">29401098</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon M, Thommen R, Kazim SF, Dicpinigaitis AJ, Schmidt MH, McKee RG, Bowers CA. Risk Analysis Index and its recalibrated version predict postoperative outcomes better than 5-factor modified frailty index in traumatic spinal injury. Neurospine. 2022;19(4):1039&#x2013;48. 10.14245/ns.2244326.163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9816576</ArticleId><ArticleId IdType="pubmed">36597640</ArticleId></ArticleIdList></Reference><Reference><Citation>Paiz CC, Owodunni OP, Courville EN, Schmidt M, Alunday R, Bowers CA. Frailty predicts 30-day mortality following major complications in neurosurgery patients: the Risk Analysis Index has superior discrimination compared to modified frailty index-5 and increasing patient age. World Neurosurg X. 2024;23:100286. 10.1016/j.wnsx.2024.100286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10955078</ArticleId><ArticleId IdType="pubmed">38516023</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P, Ghanem T, Stachler R, Hall F, Velanovich V, Rubinfeld I. Frailty as a predictor of morbidity and mortality in inpatient head and neck surgery. JAMA Otolaryngol Head Neck Surg. 2013;139(8):783&#x2013;9. 10.1001/jamaoto.2013.3969.</Citation><ArticleIdList><ArticleId IdType="pubmed">23949353</ArticleId></ArticleIdList></Reference><Reference><Citation>Owodunni OP, Uzoukwu C, Courville EN, Schmidt MH, Bowers CA. The fine line between simplicity and oversimplification: comparing the risk analysis index and 5-factor modified frailty index as frailty assessment tools. Neurospine. 2023;20(2):728&#x2013;30. 10.14245/ns.2346496.248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10323339</ArticleId><ArticleId IdType="pubmed">37401092</ArticleId></ArticleIdList></Reference><Reference><Citation>Covell MM, Roy JM, Rumalla K, Dicpinigaitis AJ, Kazim SF, Hall DE, Schmidt MH, Bowers CA. The limited utility of the Hospital Frailty Risk Score as a frailty assessment tool in neurosurgery: a systematic review. Neurosurgery. 2024;94(2):251&#x2013;62. 10.1227/neu.0000000000002668.</Citation><ArticleIdList><ArticleId IdType="pubmed">37695046</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C, Arora S, Street A, Parker S, Roberts HC, Bardsley M, Conroy S. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391(10132):1775&#x2013;82. 10.1016/S0140-6736(18)30668-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5946808</ArticleId><ArticleId IdType="pubmed">29706364</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin M, Kendzerska T, Inoue J, Aw M, Mardiros L, Pease C, Andrew MK, Pakhale S, Forster AJ, Mulpuru S. Comparing the Hospital Frailty Risk Score and the Clinical Frailty Scale among older adults with chronic obstructive pulmonary disease exacerbation. JAMA Netw Open. 2023;6(2):e2253692. 10.1001/jamanetworkopen.2022.53692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9896302</ArticleId><ArticleId IdType="pubmed">36729458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakra A, Tram MK, Bernasek T, Lyons ST, O&#x2019;Connor CM. Frailty is associated with increased complications, readmissions, and hospitalization costs following primary total knee arthroplasty. J Arthroplasty. 2023. 10.1016/j.arth.2023.02.036.</Citation><ArticleIdList><ArticleId IdType="pubmed">36858131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotzur TM, Singh A, Peng LN, Makhani AA, Seifi A, Moore CC. Comparing common risk assessment tools to predict outcomes in total knee arthroplasty. J Arthroplasty. 2024. 10.1016/j.arth.2024.01.052.</Citation><ArticleIdList><ArticleId IdType="pubmed">38336306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyaw NR, Tram MK, Lakra A, Bernasek TL, Lyons ST, O&#x2019;Connor CM. Patient frailty is correlated with increased adverse events and costs after revision knee arthroplasty. J Arthroplasty. 2024;39(5):1165&#x2013;70. 10.1016/j.arth.2023.12.025.</Citation><ArticleIdList><ArticleId IdType="pubmed">38128625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou Y, Wang H, Yang L, Jiang W. Frailty is associated with an increased risk of postoperative pneumonia in elderly patients following surgical treatment for lower-extremity fractures: a cross-sectional study. Medicine. 2023;102(15):e33557. 10.1097/MD.0000000000033557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10101317</ArticleId><ArticleId IdType="pubmed">37058022</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EX, Kuhataparuks P, Liow ML, Pang H, Tay D, Chia S, Lo N, Yeo S, Chen JY. Clinical Frailty Scale is a better predictor for adverse post-operative complications and functional outcomes than Modified Frailty Index and Charlson Comorbidity Index after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2023;31(8):3186&#x2013;95. 10.1007/s00167-023-07316-z.</Citation><ArticleIdList><ArticleId IdType="pubmed">36795126</ArticleId></ArticleIdList></Reference><Reference><Citation>Moorthy V, Lee M, Ang B, Chen JY, Lie D. Comparing the predictors of functional outcomes after arthroscopic rotator cuff repair: Modified Frailty Index, Clinical Frailty Scale, and Charlson Comorbidity Index. Orthop J Sports Med. 2021. 10.1177/23259671211005091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287367</ArticleId><ArticleId IdType="pubmed">34350299</ArticleId></ArticleIdList></Reference><Reference><Citation>Dicpinigaitis AJ, Kalakoti P, Schmidt M, Gurgel R, Cole C, Carlson A, Pickett B, Sun H, Mukherjee D, Al-Mufti F, Bowers CA. Associations of baseline frailty status and age with outcomes in patients undergoing vestibular schwannoma resection. JAMA Otolaryngol Head Neck Surg. 2021;147(7):608&#x2013;14. 10.1001/jamaoto.2021.0670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8085763</ArticleId><ArticleId IdType="pubmed">33914061</ArticleId></ArticleIdList></Reference><Reference><Citation>Canizares M, MacKay C, Davis AM, Mahomed N, Badley EM. A population-based study of ambulatory and surgical services provided by orthopaedic surgeons for musculoskeletal conditions. BMC Health Serv Res. 2009;9:56. 10.1186/1472-6963-9-56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682488</ArticleId><ArticleId IdType="pubmed">19335904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanlon P, Jani BD, Butterly E, Nicholl B, McAllister DA, Mair FS. An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes. Commun Med. 2021. 10.1038/s43856-021-00029-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9053176</ArticleId><ArticleId IdType="pubmed">35602215</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21600658</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-4713</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>9</Issue><PubDate><Year>2011</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Ophthalmology</Title><ISOAbbreviation>Ophthalmology</ISOAbbreviation></Journal><ArticleTitle>Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.</ArticleTitle><Pagination><StartPage>1766</StartPage><EndPage>1773</EndPage><MedlinePgn>1766-73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ophtha.2011.01.047</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the impact of measures of intraocular pressure (IOP) control on progression of visual field (VF) loss during long-term treatment for open-angle glaucoma (OAG).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Longitudinal, randomized clinical trial.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">We included 607 participants with newly diagnosed OAG.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Study participants were randomly assigned to initial treatment with medications or trabeculectomy, and underwent examination at 6-month intervals. Standardized testing included Goldmann applanation tonometry and Humphrey 24-2 full threshold VFs. Summary measures of IOP control during follow-up included the maximum, mean, standard deviation (SD), range, proportion less than 16, 18, 20, or 22 mmHg, and whether all IOP values were less than each of these 4 cutpoints. Predictive models for VF outcomes were based on the mean deviation (MD) from VF testing, and were adjusted for age, gender, race, baseline VF loss, treatment, and time. Each summary IOP measure was included as a cumulative, time-dependent variable, and its association with subsequent VF loss was assessed from 3 to 9 years postrandomization. Both linear mixed models, to detect shifts in MD levels, and logistic models, to detect elevated odds of substantial worsening (&#x2265;3 dB), were used.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">We measured the MD from Humphrey 24-2 full threshold VF tests.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The effect of the summary IOP measures differed between the medicine and surgery groups in models that addressed the continuous MD outcome. After adjustment for baseline risk factors, in the medicine group larger values of 3 IOP control measures-maximum IOP (P = 0.0003), SD of IOP (P = 0.0056), and range of IOP (P&lt;0.0001)-were significantly associated with lower (worse) MD over the 3- to 9-year period. No IOP summary measure was significantly associated with MD over time in the surgery group. The same 3 IOP summary measures were also significantly associated with substantial worsening of MD; however, the effects were similar in both treatment groups. In models predicting inadequate IOP control, consistently significant predictors of higher maximum, SD, and range of IOP included black race, higher baseline IOP, and clinical center.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results support considering more aggressive treatment when undue elevation or variation in IOP measures is observed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Musch</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan 48105, USA. dmusch@umich.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillespie</LastName><ForeName>Brenda W</ForeName><Initials>BW</Initials></Author><Author ValidYN="Y"><LastName>Niziol</LastName><ForeName>Leslie M</ForeName><Initials>LM</Initials></Author><Author ValidYN="Y"><LastName>Lichter</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials></Author><Author ValidYN="Y"><LastName>Varma</LastName><ForeName>Rohit</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><CollectiveName>CIGTS Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 EY018690</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>EY018690</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ophthalmology</MedlineTA><NlmUniqueID>7802443</NlmUniqueID><ISSNLinking>0161-6420</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014065" MajorTopicYN="N">Tonometry, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="Y">Trabeculectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058609" MajorTopicYN="N">Visual Field Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Musch is a consultant to Glaukos Corporation and AqueSys, Inc. No conflicting relationship exists for Ms. Niziol, Dr. Gillespie, Dr. Lichter, and Dr. Varma.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21600658</ArticleId><ArticleId IdType="mid">NIHMS269616</ArticleId><ArticleId IdType="pmc">PMC3161134</ArticleId><ArticleId IdType="doi">10.1016/j.ophtha.2011.01.047</ArticleId><ArticleId IdType="pii">S0161-6420(11)00081-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798086</ArticleId><ArticleId IdType="pubmed">15078671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon MO, Beiser JA, Brandt JD, et al. Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">12049575</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268&#x2013;1279.</Citation><ArticleIdList><ArticleId IdType="pubmed">12365904</ArticleId></ArticleIdList></Reference><Reference><Citation>Leske MC, Heijl A, Hussein M, et al. Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121:48&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">12523884</ArticleId></ArticleIdList></Reference><Reference><Citation>Leske MC, Heijl A, Hyman L, et al. EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114:1965&#x2013;1972.</Citation><ArticleIdList><ArticleId IdType="pubmed">17628686</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126:498&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">9780094</ArticleId></ArticleIdList></Reference><Reference><Citation>AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">11024415</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch DC, Lichter PR, Guire KE, et al. CIGTS Study Group. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">10201583</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie BW, Musch DC, Guire KE, et al. CIGTS Study Group. The Collaborative Initial Glaucoma Treatment Study: baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci. 2003;44:2613&#x2013;2620.</Citation><ArticleIdList><ArticleId IdType="pubmed">12766064</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch DC, Gillespie BW, Niziol LM, et al. Collaborative Initial Glaucoma Treatment Study Group. Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2008;115:927&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758572</ArticleId><ArticleId IdType="pubmed">17964655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kass MA. Standardizing the measurement of intraocular pressure for clinical research: guidelines from the Eye Care Technology Forum. Ophthalmology. 1996;103:183&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">8628552</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pubmed">7168798</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13&#x2013;22.</Citation></Reference><Reference><Citation>Musch DC, Gillespie BW, Lichter PR, et al. CIGTS Study Investigators. Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors. Ophthalmology. 2009;116:200&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3316491</ArticleId><ArticleId IdType="pubmed">19019444</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddy DM, Billings J. The quality of medical evidence: implications for quality of care. Health Aff (Millwood) 1988;7:19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">3360391</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprioli J. Intraocular pressure fluctuation: an independent risk factor for glaucoma? Arch Ophthalmol. 2007;125:1124&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">17698763</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner EB, Drance SM, Schulzer M. Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol. 1977;95:1374&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pubmed">889512</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien C, Schwartz B, Takamoto T, Wu DC. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol. 1991;111:491&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">2012152</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol. 1993;116:176&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">8352302</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart WC, Kolker AE, Sharpe ED, et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol. 2000;130:274&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">11020404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergea B, Bodin L, Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology. 1999;106:997&#x2013;1004. discussion 1004&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10328403</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Seong GJ, Hong YJ. Long-term intraocular pressure fluctuation and progressive visual field pressures after a triple procedure. Arch Ophthalmol. 2007;125:1010&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">17698746</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PP, Walt JW, Rosenblatt LC, et al. Glaucoma Care Study Group. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol. 2007;144:901&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">17919446</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pubmed">15350314</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprioli J, Coleman AL. Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology. 2008;115:1123&#x2013;1129.</Citation><ArticleIdList><ArticleId IdType="pubmed">18082889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson B, Leske MC, Hyman L, et al. Early Manifest Glaucoma Trial Group. Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114:205&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">17097736</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma R, Hwang LJ, Grunden JW, Bean GW. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials. Am J Ophthalmol. 2008;145:336&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">18222194</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson CA. Standardizing the measurement of visual fields for clinical research: guidelines from the Eye Care Technology Forum. Ophthalmology. 1996;103:186&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">8628553</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz J, Quigley HA, Sommer A. Detection of incident field loss using the glaucoma hemifield test. Ophthalmology. 1996;103:657&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pubmed">8618767</ArticleId></ArticleIdList></Reference><Reference><Citation>Keltner JL, Johnson CA, Quigg JM, et al. Ocular Hypertension Treatment Study Group. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2000;118:1187&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pubmed">10980763</ArticleId></ArticleIdList></Reference><Reference><Citation>Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med. 1993;118:201&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">8417638</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstas AG, Topouzis F, Leliopoulou O, et al. 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology. 2006;113:761&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">16650670</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma R, Hwang LJ, Grunden JW, et al. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range. Am J Ophthalmol. 2009;148:221&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">19427617</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz LJ, Myers JS. Smoothing the intraocular pressure roller coaster: a new goal? Am J Ophthalmol. 2009;148:177&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">19619716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40260705</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2202</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Current eye research</Title><ISOAbbreviation>Curr Eye Res</ISOAbbreviation></Journal><ArticleTitle>Prospective Telemedicine Postoperative Protocol Following Microincision Vitrectomy Surgery (MIVS).</ArticleTitle><Pagination><StartPage>745</StartPage><EndPage>751</EndPage><MedlinePgn>745-751</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/02713683.2025.2490768</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Retrospective studies show a low proportion of postoperative (PO) complications or alterations in management after Microincision Vitrectomy Surgery (MIVS). To our knowledge, this is the first prospective analysis of a telemedicine alternative to the standard practice for PO visits after MIVS. The purpose of this study is to evaluate telemedicine for the management of postoperative visits (POV) following MIVS.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Ongoing randomized, prospective study with 53 patients assigned (1:1) to two arms of POV schedules including Virtual Telemedicine visits (VT) <i>vs.</i> In-person Telemedicine (IP) visits. POV schedules in both groups included visits on the same day after surgery and week(s) 1, 2, 8, and 12. Complete exams with visual acuity, intraocular pressure, and dilated fundus exams of the operative eye were performed by the retina surgeon on day 0, weeks 2 and 12 in both groups. Protocolized focused undilated exams on weeks 1 and 8 either remotely (VT group) or in-person (IP group). Statistical analyses included Mann-Whitney U tests between groups using Microsoft Excel.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Primary outcome, mean POV logMAR BCVA, showed no statistically significant difference (<i>p</i>-value = 0.70) between VT and IP groups. Other pre- and post-surgical comparisons (e.g. IOP, RNFL score) showed no statistical differences. No post-surgical complications have been noted.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Telemedicine-assisted POV may be a safe and convenient alternative for patients undergoing uncomplicated MIVS, but additional and larger studies are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Heun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Oregon Eye Consultants LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cascade Medical Research Institute LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-O'Farrill</LastName><ForeName>Noraliz</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Oregon Eye Consultants LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cascade Medical Research Institute LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Oregon Eye Consultants LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cascade Medical Research Institute LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oregon Eye Consultants LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cascade Medical Research Institute LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Allan A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Oregon Eye Consultants LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cascade Medical Research Institute LLC, Springfield, OR, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Eye Res</MedlineTA><NlmUniqueID>8104312</NlmUniqueID><ISSNLinking>0271-3683</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014821" MajorTopicYN="Y">Vitrectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008866" MajorTopicYN="Y">Microsurgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="Y">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MIVS</Keyword><Keyword MajorTopicYN="N">postoperative management</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword><Keyword MajorTopicYN="N">teleophthalmology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>24</Day><Hour>11</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>22</Day><Hour>16</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40260705</ArticleId><ArticleId IdType="doi">10.1080/02713683.2025.2490768</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31726421</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6744</ISSN><JournalIssue CitedMedium="Internet"><Volume>219</Volume><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>American heart journal</Title><ISOAbbreviation>Am Heart J</ISOAbbreviation></Journal><ArticleTitle>Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.</ArticleTitle><Pagination><StartPage>58</StartPage><EndPage>69</EndPage><MedlinePgn>58-69</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahj.2019.10.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-8703(19)30279-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">It is unknown whether sex-specific differences in mortality observed in HCM are due to older age of women at presentation, or whether women have greater degree of LV myopathy than men.</AbstractText><AbstractText Label="METHODS">We retrospectively compared clinical/imaging characteristics and outcomes between women and men in our overall cohort composed of 728 HCM patients, and in an age-matched subgroup comprised of 400 age-matched patients. We examined sex-specific differences in LV myopathy, and dissected the influence of age and sex on outcomes. LV myopathy was assessed by measuring LV mass, LVEF, global peak longitudinal systolic strain (LV-GLS), diastolic function (E/A, E/e'), late gadolinium enhancement (LV-LGE) and myocardial blood flow (MBF) at rest/stress. The primary endpoint was a composite outcome, comprising heart failure (HF), atrial fibrillation (AFib), ventricular tachycardia/fibrillation (VT/VF) and death; individual outcomes were defined as the secondary endpoint.</AbstractText><AbstractText Label="RESULTS">Women in the overall cohort were older by 6 years. Women were more symptomatic and more likely to have obstructive HCM. Women had smaller LV cavity size, stroke volume and LV mass, higher indexed maximum wall thickness (IMWT), more hyperdynamic LVEF and higher/similar LV-GLS. Women had similar LV-LGE and E/A, but higher E/e' and rest/stress MBF. Female sex was independently associated with the composite outcome in the overall cohort, and with HF in the overall cohort and age-matched subgroup after adjusting for obstructive HCM, LA diameter, LV-GLS.</AbstractText><AbstractText Label="CONCLUSIONS">Our results suggest that sex-specific differences in LV geometry, hyper-contractility and diastolic function, not greater degree of LV myopathy, contribute to a higher, age-independent risk of diastolic HF in women with HCM.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Dai-Yin</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA; Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Public Health, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ventoulis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongyun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudchadkar</LastName><ForeName>Shibani M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenland</LastName><ForeName>Gabriela V</ForeName><Initials>GV</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yalcin</LastName><ForeName>Hulya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontari</LastName><ForeName>Effrosyni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Sagar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corona-Villalobos</LastName><ForeName>Celia P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Radiology, Johns Hopkins University, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vakrou</LastName><ForeName>Styliani</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Stefan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Radiology, Johns Hopkins University, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Theodore P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>M Roselle</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, MD, USA; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, California. Electronic address: Roselle.Abraham@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J</MedlineTA><NlmUniqueID>0370465</NlmUniqueID><ISSNLinking>0002-8703</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>AU0V1LM3JT</RegistryNumber><NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="N">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003326" MajorTopicYN="N">Coronary Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="N">Exercise Tolerance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005682" MajorTopicYN="N">Gadolinium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006334" MajorTopicYN="N">Heart Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006346" MajorTopicYN="N">Heart Septum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017379" MajorTopicYN="N">Hypertrophy, Left Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016555" MajorTopicYN="N">Matched-Pair Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="Y">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020257" MajorTopicYN="N">Ventricular Remodeling</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31726421</ArticleId><ArticleId IdType="doi">10.1016/j.ahj.2019.10.004</ArticleId><ArticleId IdType="pii">S0002-8703(19)30279-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40653208</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6815</ISSN><JournalIssue CitedMedium="Internet"><Volume>209</Volume><PubDate><Year>2025</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Experimental gerontology</Title><ISOAbbreviation>Exp Gerontol</ISOAbbreviation></Journal><ArticleTitle>Sustaining neuromuscular activation after total knee arthroplasty preserves skeletal muscle fiber size, contractility, and innervation in older adults.</ArticleTitle><Pagination><StartPage>112831</StartPage><MedlinePgn>112831</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.exger.2025.112831</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0531-5565(25)00160-3</ELocationID><Abstract><AbstractText>Knee osteoarthritis (OA) is the leading cause of physical disability in older adults. Total knee arthroplasty (TKA) is a common treatment for advanced stage knee OA that alleviates knee pain, but it is associated with precipitous reductions in physical function early after surgery that can take months or years to recover. Sustaining neuromuscular activation after surgery with neuromuscular electrical stimulation (NMES) can improve recovery of physical function, but the mechanisms underlying its benefits are unclear. To examine the unique effects of NMES on skeletal muscle, we randomized older adult patients (70&#xa0;% female) to early NMES (n&#xa0;=&#xa0;11) or no intervention (n&#xa0;=&#xa0;12) for 5&#xa0;weeks after surgery. We measured skeletal muscle (vastus lateralis) fiber size, contractility, mitochondrial content, and mRNA abundance pre-surgery and 5&#xa0;weeks post-surgery. NMES diminished TKA-induced muscle fiber atrophy in fast-twitch, myosin heavy chain (MHC) IIA fibers and improved or preserved single muscle fiber contractility in MHC I and MHC IIA fibers, respectively. In MHC IIA fibers, the beneficial effects of NMES to sustain fiber force production were explained at the molecular level by preservation of strongly bound, myosin-actin crossbridges. Additionally, TKA-induced increases in markers of denervation (CHRNA1 and MYOG) in controls were prevented by NMES. Our results identify beneficial effects of sustaining neuromuscular activation early, post-TKA with NMES on skeletal muscle fiber size and function and potential molecular mechanisms underlying these effects.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toth</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America; Department of Orthopaedics and Rehabilitation, University of Vermont College of Medicine, Burlington, VT, United States of America. Electronic address: michael.toth@uvm.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savage</LastName><ForeName>Patrick D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snoke</LastName><ForeName>Deena B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellefleur</LastName><ForeName>Emma R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Vermont College of Medicine, Burlington, VT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeSarno</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of the Biomedical Statistics Core, University of Vermont College of Medicine, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tourville</LastName><ForeName>Timothy W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, University of Vermont College of Medicine, Burlington, VT, United States of America; Department of Rehabilitation and Movement Science, College of Nursing and Health Science, University of Vermont, Burlington, VT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankstein</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, University of Vermont College of Medicine, Burlington, VT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keeble</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Athletic Training and Clinical Nutrition, College of Health Sciences, University of Kentucky, Lexington, KY, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Velez</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Athletic Training and Clinical Nutrition, College of Health Sciences, University of Kentucky, Lexington, KY, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fry</LastName><ForeName>Christopher S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Athletic Training and Clinical Nutrition, College of Health Sciences, University of Kentucky, Lexington, KY, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens-Lapsley</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, College of Medicine, University of Colorado Anschutz Medical Campus, United States of America; VA Eastern Colorado Geriatric Research Education and Clinical Center, Denver, CO, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelms</LastName><ForeName>Nathaniel J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Rehabilitation, University of Vermont College of Medicine, Burlington, VT, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG050305</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Exp Gerontol</MedlineTA><NlmUniqueID>0047061</NlmUniqueID><ISSNLinking>0531-5565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.1</RegistryNumber><NameOfSubstance UI="D018995">Myosin Heavy Chains</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009119" MajorTopicYN="Y">Muscle Contraction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018485" MajorTopicYN="Y">Muscle Fibers, Skeletal</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004599" MajorTopicYN="Y">Electric Stimulation Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020370" MajorTopicYN="Y">Osteoarthritis, Knee</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052097" MajorTopicYN="Y">Quadriceps Muscle</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018995" MajorTopicYN="N">Myosin Heavy Chains</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Denervation</Keyword><Keyword MajorTopicYN="N">Disablement</Keyword><Keyword MajorTopicYN="N">Myosin</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>31</Day><Hour>20</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>19</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40653208</ArticleId><ArticleId IdType="doi">10.1016/j.exger.2025.112831</ArticleId><ArticleId IdType="pii">S0531-5565(25)00160-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28064433</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>MAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population.</ArticleTitle><Pagination><StartPage>237</StartPage><EndPage>245</EndPage><MedlinePgn>237-245</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-016-0217-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Patients with ischemic cardiomyopathy (ICM) are prone to scar-related ventricular tachycardia (VT). The success of VT ablation depends on accurate arrhythmogenic substrate localization, followed by optimal delivery of energy provided by constant electrode-tissue contact. Current manual and remote magnetic navigation (RMN)-guided ablation strategies aim to identify a reentry circuit and to target a critical isthmus through activation and entrainment mapping during ongoing tachycardia. The MAGNETIC VT trial will assess if VT ablation using the Niobe&#x2122; ES magnetic navigation system results in superior outcomes compared to a manual approach in subjects with ischemic scar VT and low ejection fraction.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This is a randomized, single-blind, prospective, multicenter post-market study. A total of 386 subjects (193 per group) will be enrolled and randomized 1:1 between treatment with the Niobe ES system and treatment via a manual procedure at up to 20 sites. The study population will consist of patients with ischemic cardiomyopathy with left ventricular ejection fraction (LVEF) of &#x2264;35% and implantable cardioverter defibrillator (ICD) who have sustained monomorphic VT. The primary study endpoint is freedom from any recurrence of VT through 12&#xa0;months. The secondary endpoints are acute success; freedom from any VT at 1&#xa0;year in a large-scar subpopulation; procedure-related major adverse events; and mortality rate through 12-month follow-up. Follow-up will consist of visits at 3, 6, 9, and 12&#xa0;months, all of which will include ICD interrogation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The MAGNETIC VT trial will help determine whether substrate-based ablation of VT with RMN has clinical advantages over manual catheter manipulation.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinicaltrials.gov identifier: NCT02637947.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute at St. David's Medical Center, 3000 N. I-35, Suite 720, Austin, TX, 78705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Albert Einstein College of Medicine, at Montefiore Hospital, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Texas, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Roderick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pritzker School of Medicine, University of Chicago Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szili-Torok</LastName><ForeName>Tam&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burkhardt</LastName><ForeName>J David</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute at St. David's Medical Center, 3000 N. I-35, Suite 720, Austin, TX, 78705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center, Murray, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavernier</LastName><ForeName>Rene</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Az Sint-Jan Brugge, Brugge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman</LastName><ForeName>Adam E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Medical College of Georgia, Augusta University, Augusta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wissner</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Advocate Christ Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spear</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Advocate Christ Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neu&#x17e;il</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Nemocnice Na Homolce Hospital, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skoda</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Nemocnice Na Homolce Hospital, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Kansas, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwagten</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>ZNA Middelheim, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lock</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Stereotaxis, Inc., St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute at St. David's Medical Center, 3000 N. I-35, Suite 720, Austin, TX, 78705, USA. dr.natale@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Texas, Austin, TX, USA. dr.natale@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California Pacific Medical Center, San Francisco, CA, USA. dr.natale@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Stanford University, Palo Alto, CA, USA. dr.natale@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Case Western Reserve University, Cleveland, OH, USA. dr.natale@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scripps Clinic, San Diego, CA, USA. dr.natale@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dell Medical School, Austin, TX, USA. dr.natale@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>MAGNETIC VT investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02637947</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018780" MajorTopicYN="N">Body Surface Potential Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008280" MajorTopicYN="N">Magnetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="N">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Robotic magnetic navigation</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28064433</ArticleId><ArticleId IdType="doi">10.1007/s10840-016-0217-3</ArticleId><ArticleId IdType="pii">10.1007/s10840-016-0217-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heart Rhythm. 2013 Aug;10(8):1178-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23692891</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Jul 14;375(2):111-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2015 Jul 20;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">26200478</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1979 Sep;35(3):549-56</Citation><ArticleIdList><ArticleId IdType="pubmed">497341</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2002 Jan 16;39(2):210-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11788209</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Jan 29;105(4):539-42</Citation><ArticleIdList><ArticleId IdType="pubmed">11815441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 2;375(9708):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2010 Aug;7(8):1029-35</Citation><ArticleIdList><ArticleId IdType="pubmed">20434589</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2012 Jul 10;60(2):132-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22766340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interv Card Electrophysiol. 2015 Oct;44(1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26123094</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2011 Jul;13(7):1015-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21508006</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2010 May 25;55(21):2355-65</Citation><ArticleIdList><ArticleId IdType="pubmed">20488307</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2012 Sep;23(9):948-54</Citation><ArticleIdList><ArticleId IdType="pubmed">22554147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34321047</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Static compliance and driving pressure are associated with ICU mortality in intubated COVID-19 ARDS.</ArticleTitle><Pagination><StartPage>263</StartPage><MedlinePgn>263</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">263</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-021-03667-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pathophysiological features of coronavirus disease 2019-associated acute respiratory distress syndrome (COVID-19 ARDS) were indicated to be somewhat different from those described in nonCOVID-19 ARDS, because of relatively preserved compliance of the respiratory system despite marked hypoxemia. We aim ascertaining whether respiratory system static compliance (Crs), driving pressure (DP), and tidal volume normalized for ideal body weight (VT/kg IBW) at the 1st day of controlled mechanical ventilation are associated with intensive care unit (ICU) mortality in COVID-19 ARDS.</AbstractText><AbstractText Label="METHODS">Observational multicenter cohort study. All consecutive COVID-19 adult patients admitted to 25 ICUs belonging to the COVID-19 VENETO ICU network (February 28th-April 28th, 2020), who received controlled mechanical ventilation, were screened. Only patients fulfilling ARDS criteria and with complete records of Crs, DP and VT/kg IBW within the 1st day of controlled mechanical ventilation were included. Crs, DP and VT/kg IBW were collected in sedated, paralyzed and supine patients.</AbstractText><AbstractText Label="RESULTS">A total of 704 COVID-19 patients were screened and 241 enrolled. Seventy-one patients (29%) died in ICU. The logistic regression analysis showed that: (1) Crs was not linearly associated with ICU mortality (p value for nonlinearity&#x2009;=&#x2009;0.01), with a greater risk of death for values &lt;&#x2009;48&#xa0;ml/cmH<sub>2</sub>O; (2) the association between DP and ICU mortality was linear (p value for nonlinearity&#x2009;=&#x2009;0.68), and increasing DP from 10 to 14 cmH<sub>2</sub>O caused significant higher odds of in-ICU death (OR 1.45, 95% CI 1.06-1.99); (3) VT/kg IBW was not associated with a significant increase of the risk of death (OR 0.92, 95% CI 0.55-1.52). Multivariable analysis confirmed these findings.</AbstractText><AbstractText Label="CONCLUSIONS">Crs&#x2009;&lt;&#x2009;48&#xa0;ml/cmH<sub>2</sub>O was associated with ICU mortality, while DP was linearly associated with mortality. DP should be kept as low as possible, even in the case of relatively preserved Crs, irrespective of VT/kg IBW, to reduce the risk of death.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Boscolo</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesia and Intensive Care Unit, Padua University Hospital, via V. Gallucci 13, 35125, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sella</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Padua University School of Medicine, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzoni</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padua University School of Medicine, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettenuzzo</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesia and Intensive Care Unit, Padua University Hospital, via V. Gallucci 13, 35125, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesia and Intensive Care Unit, Padua University Hospital, via V. Gallucci 13, 35125, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretto</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Padua University School of Medicine, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tocco</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Padua University School of Medicine, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamburini</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Padua University School of Medicine, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cassai</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesia and Intensive Care Unit, Padua University Hospital, via V. Gallucci 13, 35125, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Emergency Medical Services, Regional Department, AULSS 3, Venice, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polati</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit B, Verona University Hospital, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donadello</LastName><ForeName>Katia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit B, Verona University Hospital, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottin</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit B, Verona University Hospital, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rosa</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anesthesia and Critical Care Unit, San Bortolo Hospital, Vicenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baratto</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Ospedale Riuniti Padova Sud, Schiavonia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toffoletto</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Ospedali di San Don&#xe0; di Piave e Jesolo, San Don&#xe0; di Piave, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>V Marco</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Medicine, Department of Medical and Surgical Science, Policlinico di Sant'Orsola, Alma Mater Studiorum-Universit&#xe0; di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregori</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padua University School of Medicine, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3733-3453</Identifier><AffiliationInfo><Affiliation>Institute of Anaesthesia and Intensive Care Unit, Padua University Hospital, via V. Gallucci 13, 35125, Padua, Italy. paolo.navalesi@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine (DIMED), Padua University School of Medicine, Padua, Italy. paolo.navalesi@unipd.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>COVID-19 VENETO ICU Network</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007440" MajorTopicYN="N">Intubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Driving pressure</Keyword><Keyword MajorTopicYN="N">Mechanical ventilation</Keyword><Keyword MajorTopicYN="N">Respiratory system compliance</Keyword></KeywordList><CoiStatement>None related to the present work. PN received royalties from Intersurgical for Helmet Next invention and speaking fees from Philips, Resmed, MSD, Drager and Novartis. The other authors have no other competing interests to declare.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Valeri</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andreatta</LastName><ForeName>Giulio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gandolfi</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gadaldi</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brumana</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forin</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Correale</LastName><ForeName>Christelle</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pesenti</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fregolent</LastName><ForeName>Davide</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pirelli</LastName><ForeName>Pier Francesco</ForeName><Initials>PF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchesin</LastName><ForeName>Davide</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perona</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franchetti</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Della Paolera</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simoni</LastName><ForeName>Caterina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Falcioni</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tresin</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schiavolin</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schiavi</LastName><ForeName>Aldo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vathi</LastName><ForeName>Sonila</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sartori</LastName><ForeName>Daria</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sorgato</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pistollato</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linassi</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Serra</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pittarello</LastName><ForeName>Demetrio</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tiberio</LastName><ForeName>Ivo</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bond</LastName><ForeName>Ottavia</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Michieletto</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muraro</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peralta</LastName><ForeName>Arianna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Persona</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petranzan</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zarantonello</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graziano</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piasentini</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernardi</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pianon</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Badii</LastName><ForeName>Flavio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bosco</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agostini</LastName><ForeName>Moreno</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farnia</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peta</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cal&#xf2;</LastName><ForeName>Mauro Antonio</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meggiolaro</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lazzari</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinello</LastName><ForeName>Ivan</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fullin</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papaccio</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonato</LastName><ForeName>Alfeo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sgarabotto</LastName><ForeName>Camilla</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montacciani</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alessandra</LastName><ForeName>Parnigotto</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gagliardi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferraro</LastName><ForeName>Gioconda</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ongaro</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baiocchi</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Danzi</LastName><ForeName>Vinicio</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zanatta</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchiotto</LastName><ForeName>Simonetta</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bassanini</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zamperini</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daroui</LastName><ForeName>Ivan</ForeName><Initials>I</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34321047</ArticleId><ArticleId IdType="pmc">PMC8317138</ArticleId><ArticleId IdType="doi">10.1186/s13054-021-03667-6</ArticleId><ArticleId IdType="pii">10.1186/s13054-021-03667-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, ARDS Definition Task Force et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526&#x2013;2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099&#x2013;1102. doi: 10.1007/s00134-020-06033-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06033-2</ArticleId><ArticleId IdType="pmc">PMC7154064</ArticleId><ArticleId IdType="pubmed">32291463</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E, Beitler JR, Brochard L, Calfee CS, Ferguson ND, Slutsky AS, et al. COVID-19-associated acute respiratory distress syndrome: Is a different approach to management warranted? Lancet Respir Med. 2020;8(8):816&#x2013;821. doi: 10.1016/S2213-2600(20)30304-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30304-0</ArticleId><ArticleId IdType="pmc">PMC7338016</ArticleId><ArticleId IdType="pubmed">32645311</ArticleId></ArticleIdList></Reference><Reference><Citation>Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301&#x2013;1308. doi: 10.1056/NEJM200005043421801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200005043421801</ArticleId><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747&#x2013;755. doi: 10.1056/NEJMsa1410639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1410639</ArticleId><ArticleId IdType="pubmed">25693014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, LUNG SAFE Investigators; ESICM Trials Group et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788&#x2013;800. doi: 10.1001/jama.2016.0291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0291</ArticleId><ArticleId IdType="pubmed">26903337</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP, STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18(6):800&#x2013;804. doi: 10.1097/EDE.0b013e3181577654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181577654</ArticleId><ArticleId IdType="pubmed">18049194</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin L, Sella N, Correale C, Boscolo A, Rosi P, Saia M, et al. Regional COVID-19 network for coordination of SARS-CoV-2 outbreak in Veneto, Italy. J Cardiothorac Vasc Anesth. 2020;34(9):2341&#x2013;2345. doi: 10.1053/j.jvca.2020.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.05.005</ArticleId><ArticleId IdType="pmc">PMC7228700</ArticleId><ArticleId IdType="pubmed">32425461</ArticleId></ArticleIdList></Reference><Reference><Citation>Panwar R, Madotto F, Laffey JG, van Haren FMP. Compliance phenotypes in early acute respiratory distress syndrome before the COVID-19 pandemic. Am J Respir Crit Care Med. 2020;202(9):1244&#x2013;1252. doi: 10.1164/rccm.202005-2046OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-2046OC</ArticleId><ArticleId IdType="pmc">PMC7605177</ArticleId><ArticleId IdType="pubmed">32805143</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox J, Monette G. Generalized collinearity diagnostics. Am Stat Assoc. 1992;87:178&#x2013;183. doi: 10.1080/01621459.1992.10475190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1992.10475190</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson WR, Chen L, Amato MBP, Brochard LJ. Fifty years of research in ARDS. Respiratory mechanics in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;196(7):822&#x2013;833. doi: 10.1164/rccm.201612-2495CI.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201612-2495CI</ArticleId><ArticleId IdType="pubmed">28306327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, Hern&#xe1;ndez M, Gea A, Arruti E, COVID-19 Spanish ICU Network et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020;46(12):2200&#x2013;2211. doi: 10.1007/s00134-020-06192-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06192-2</ArticleId><ArticleId IdType="pmc">PMC7387884</ArticleId><ArticleId IdType="pubmed">32728965</ArticleId></ArticleIdList></Reference><Reference><Citation>Botta M, Tsonas AM, Pillay J, Boers LS, Algera AG, Bos LDJ, PRoVENT-COVID Collaborative Group et al. Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir Med. 2021;9(2):139&#x2013;148. doi: 10.1016/S2213-2600(20)30459-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30459-8</ArticleId><ArticleId IdType="pmc">PMC7584441</ArticleId><ArticleId IdType="pubmed">33169671</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8(12):1201&#x2013;1208. doi: 10.1016/S2213-2600(20)30370-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30370-2</ArticleId><ArticleId IdType="pmc">PMC7834127</ArticleId><ArticleId IdType="pubmed">32861276</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbunder B, Ehrmann S, Piagnerelli M, Sauneuf B, Serck N, Soumagne T, COVADIS study group et al. Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study. Crit Care. 2021;25(1):52. doi: 10.1186/s13054-020-03433-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03433-0</ArticleId><ArticleId IdType="pmc">PMC7868865</ArticleId><ArticleId IdType="pubmed">33557868</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese F, Pezzuto F, Fortarezza F, Boscolo A, Lunardi F, Giraudo C, et al. Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure. J Pathol. 2021 doi: 10.1002/path.5653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5653</ArticleId><ArticleId IdType="pmc">PMC8014445</ArticleId><ArticleId IdType="pubmed">33626204</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a "typical" acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299&#x2013;1300. doi: 10.1164/rccm.202003-0817LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0817LE</ArticleId><ArticleId IdType="pmc">PMC7233352</ArticleId><ArticleId IdType="pubmed">32228035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanspa MJ, Peltan ID, Jacobs JR, Sorensen JS, Carpenter L, Ferraro JP, et al. Driving pressure is not associated with mortality in mechanically ventilated patients without ARDS. Crit Care. 2019;23(1):424. doi: 10.1186/s13054-019-2698-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2698-9</ArticleId><ArticleId IdType="pmc">PMC6935179</ArticleId><ArticleId IdType="pubmed">31881909</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonis FD, Barbas CSV, Artigas-Ravent&#xf3;s A, Canet J, Determann RM, Anstey J, PRoVENT investigators; PROVE Network investigators et al. Potentially modifiable respiratory variables contributing to outcome in ICU patients without ARDS: a secondary analysis of PRoVENT. Ann Intensive Care. 2018;8(1):39. doi: 10.1186/s13613-018-0385-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0385-7</ArticleId><ArticleId IdType="pmc">PMC5862714</ArticleId><ArticleId IdType="pubmed">29564726</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, He H. Why driving pressure is not associated with the mortality in non-ARDS patients? Crit Care. 2020;24(1):147. doi: 10.1186/s13054-020-02845-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02845-2</ArticleId><ArticleId IdType="pmc">PMC7155396</ArticleId><ArticleId IdType="pubmed">32290853</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SN, Barbas CS, Beiderlinden M, Fernandez-Bustamante A, Futier E, PROVE Network Investigators et al. Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med. 2016;4(4):272&#x2013;280. doi: 10.1016/S2213-2600(16)00057-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00057-6</ArticleId><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieco DL, Bongiovanni F, Chen L, Menga LS, Cutuli SL, Pintaudi G, et al. Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies. Crit Care. 2020;24(1):529. doi: 10.1186/s13054-020-03253-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03253-2</ArticleId><ArticleId IdType="pmc">PMC7453378</ArticleId><ArticleId IdType="pubmed">32859264</ArticleId></ArticleIdList></Reference><Reference><Citation>Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327&#x2013;336. doi: 10.1056/NEJMoa032193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa032193</ArticleId><ArticleId IdType="pubmed">15269312</ArticleId></ArticleIdList></Reference><Reference><Citation>Goligher EC, Costa ELV, Yarnell CJ, Brochard LJ, Stewart TE, Tomlinson G, et al. Effect of lowering tidal volume on mortality in ards varies with respiratory system elastance. Am J Respir Crit Care Med. 2021 doi: 10.1164/rccm.202009-3536OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202009-3536OC</ArticleId><ArticleId IdType="pubmed">33439781</ArticleId></ArticleIdList></Reference><Reference><Citation>Dianti J, Matelski J, Tisminetzky M, Walkey AJ, Munshi L, Del Sorbo L, et al. Comparing the effects of tidal volume, driving pressure, and mechanical power on mortality in trials of lung-protective mechanical ventilation. Respir Care. 2021;66(2):221&#x2013;227. doi: 10.4187/respcare.07876.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.07876</ArticleId><ArticleId IdType="pubmed">32843513</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26948774</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4502</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cataract and refractive surgery</Title><ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation></Journal><ArticleTitle>Long-term outcomes of cataract surgery: 15-year results of a prospective study.</ArticleTitle><Pagination><StartPage>19</StartPage><EndPage>26</EndPage><MedlinePgn>19-26</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrs.2015.07.040</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0886-3350(15)01202-X</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To describe the change over a 15-year period in corrected distance visual acuity (CDVA), subjective visual function, and neodymium:YAG (Nd:YAG) frequency after cataract surgery.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Eye Clinic, Norrlands University Hospital, Ume&#xe5;, Sweden.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective longitudinal population-based cohort study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients who had cataract surgery during a 1-year period, 15 years previously (1997 to 1998), were included. All patients answered the same Visual Function-14 (VF-14) questionnaire preoperatively, 4 months postoperatively, and 5, 10, and 15 years after surgery. Most patients (88%; 168/190; 74% of survivors) also had an ocular examination. The CDVA was measured with logMAR charts.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study included 190 patients (83% of survivors). Fifteen years after surgery, the median CDVA in the operated eye had deteriorated from 20/20 postoperatively to 20/25 (P = .0001). Sixty percent of the patients had worsening of CDVA of less than 0.1 logMAR units compared with postoperatively. Fifty-four percent (103/190) had no deterioration in subjective visual function (VF-14), and 79% (150/190) had 10 points of decline or less. Previous Nd:YAG laser capsulotomy was more common in those younger than 65 years at surgery (49% versus 25%) (P = .002).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study confirms the effectiveness of cataract extraction, offering good long-term visual rehabilitation for the majority of the patients. The most common comorbidity causing large functional loss 15 years after surgery was age-related macular degeneration. Fifteen years after surgery, one half of the patients younger than 65 years at surgery had not required a posterior Nd:YAG laser capsulotomy.</AbstractText><AbstractText Label="FINANCIAL DISCLOSURE" NlmCategory="BACKGROUND">The author has no financial or proprietary interest in any method or material mentioned.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xf6;nestam</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Department of Clinical Sciences/Ophthalmology, Faculty of Medicine, Ume&#xe5; University, Ume&#xe5;, Sweden. Electronic address: eva.monestam@vll.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cataract Refract Surg</MedlineTA><NlmUniqueID>8604171</NlmUniqueID><ISSNLinking>0886-3350</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cataract Refract Surg. 2016 Jun;42(6):944. doi: 10.1016/j.jcrs.2016.04.013.</RefSource><PMID Version="1">27373403</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Cataract Refract Surg. 2016 Jun;42(6):944. doi: 10.1016/j.jcrs.2016.04.014.</RefSource><PMID Version="1">27373405</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Cataract Refract Surg. 2020 Feb;46(2):327. doi: 10.1097/j.jcrs.0000000000000056.</RefSource><PMID Version="1">32126054</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053685" MajorTopicYN="N">Laser Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053844" MajorTopicYN="N">Lasers, Solid-State</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019654" MajorTopicYN="Y">Lens Implantation, Intraocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018918" MajorTopicYN="Y">Phacoemulsification</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064727" MajorTopicYN="N">Posterior Capsulotomy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019591" MajorTopicYN="N">Pseudophakia</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018434" MajorTopicYN="N">Sickness Impact Profile</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26948774</ArticleId><ArticleId IdType="doi">10.1016/j.jcrs.2015.07.040</ArticleId><ArticleId IdType="pii">S0886-3350(15)01202-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32673939</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-6968</ISSN><JournalIssue CitedMedium="Internet"><Volume>196</Volume><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical neurology and neurosurgery</Title><ISOAbbreviation>Clin Neurol Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Individualized PEEP ventilation between tumor resection and dural suture in craniotomy.</ArticleTitle><Pagination><StartPage>106027</StartPage><MedlinePgn>106027</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clineuro.2020.106027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0303-8467(20)30370-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Atelectasis, which affects oxygenation, is always occurred after craniotomy under general anesthesia. The commonly used protective ventilation strategy, which includes recruitment maneuver and higher level of positive end-expiratory pressure (PEEP), can effectively reduce atelectasis after heart and abdominal surgery, but increase intracranial pressure and reduce cerebral perfusion in patients undergoing craniotomy. We hypothesized individualized PEEP ventilation between tumor resection and dural suture in craniotomy could effectively reduce postoperative atelectasis, improve PaO<sub>2</sub>/FiO<sub>2</sub> ratio, and without reducing the regional cerebral oxygen saturation (rScO<sub>2</sub>).</AbstractText><AbstractText Label="PATIENTS AND METHODS">96 patients underwent tumor craniotomy in supine position were randomized into the control group (C group) and individualized PEEP group (P group). In the C group, the tidal volume (VT) was set at 8 mL/kg of predicted body weight, but PEEP were not used. In the P group, VT was set at 6 mL/kg of predicted body weight combined with individualized PEEP between tumor resection and dural suture, while in other periods of general anesthesia, VT was set at 8 mL/kg of predicted body weight. PaO<sub>2</sub>/FiO<sub>2</sub> ratio, lung ultrasound score (LUS) and rScO<sub>2</sub> were measured before induction, 1 h and 24 h after extubation.</AbstractText><AbstractText Label="RESULTS">Individual PEEP in the P group was 7.0 (4.0-9.0). The PaO<sub>2</sub>/FiO<sub>2</sub> ratio and rScO<sub>2</sub> in the P group were significantly higher than that of the C group (395 &#xb1; 62 vs. 344 &#xb1; 40, 67 &#xb1; 5 vs. 61 &#xb1; 4, respectively, p&#x202f;&lt;&#x202f;0.05) and the LUS of the experimental group was significantly lower than that of the C group [7.5 (5.3-8.3) vs. 10.0 (9.0-12.0), p&#x202f;&lt;&#x202f;0.05] 1 h after extubation.</AbstractText><AbstractText Label="CONCLUSION">Mechanical ventilation with individualized PEEP between tumor resection and dural suture in craniotomy can reduce atelectasis, improve PaO<sub>2</sub>/FiO<sub>2</sub> ratio and rScO<sub>2</sub> 1 h after extubation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hairui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinlu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yueqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mingxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infection Control, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Peimin</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China. Electronic address: xiehong_sz@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China. Electronic address: dongjun@suda.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Clin Neurol Neurosurg</MedlineTA><NlmUniqueID>7502039</NlmUniqueID><ISSNLinking>0303-8467</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003399" MajorTopicYN="N">Craniotomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001261" MajorTopicYN="N">Pulmonary Atelectasis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015173" MajorTopicYN="N">Supratentorial Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atelectasis</Keyword><Keyword MajorTopicYN="N">Craniotomy</Keyword><Keyword MajorTopicYN="N">Individualized</Keyword><Keyword MajorTopicYN="N">PaO(2)/FiO(2)ratio</Keyword><Keyword MajorTopicYN="N">Positive end-expiratory pressure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32673939</ArticleId><ArticleId IdType="doi">10.1016/j.clineuro.2020.106027</ArticleId><ArticleId IdType="pii">S0303-8467(20)30370-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29582363</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Electrophysiological characteristics and radiofrequency ablation of sustained monomorphic ventricular tachycardia in adult patients with isolated ventricular noncompaction.</ArticleTitle><Pagination><StartPage>117</StartPage><EndPage>125</EndPage><MedlinePgn>117-125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-018-0347-x</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study examined electrophysiological characteristics and outcomes of patients with sustained ventricular tachycardia (VT) in the setting of isolated ventricular noncompaction (IVNC).</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In patients with IVNC, VT has been associated with sudden cardiac death. However, the electrophysiological characteristics and optimal management of these VTs are only incompletely understood.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study assessed arrhythmia characteristics and outcomes in IVNC patients with sustained monomorphic VTs. Data were obtained from five academic centers covering the time period from January 1, 2006, to December 31, 2016, with a median follow-up of 40&#xa0;months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighteen consecutive IVNC patients with sustained VTs (12 males [66%], mean age of 44.4&#x2009;&#xb1;&#x2009;16.9&#xa0;years) were enrolled. Seven (39%) patients underwent VT ablation (five males, mean age of 43.3&#x2009;&#xb1;&#x2009;15.5&#xa0;years) and nine (50%) patients received ICD therapy. Six of 18 patients (33%) died during a median follow-up of 40&#xa0;months. Of these, three had ICDs, two had undergone VT ablation, and one had received only antiarrhythmic drugs. Among the seven patients with prior VT ablation, five VTs in the RV (three RVOT and one tricuspid annulus) and two LV VTs (one anterolateral papillary muscle and one inferolateral wall) were localized by 3-D mapping and successfully ablated. In six of seven ablation cases (85.7%), the VTs were distant from the noncompaction zone. VTs appeared to be focal in 57% (4/7) and macro-reentry in 43% (3/7) of patients based on 3-D mapping and entrainment studies. The success rate of VT ablation was 85.7% with one VT recurrence and two deaths during the mean follow-up of 54 (28-115)&#xa0;months.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">IVNC Patients with sustained VTs appear to have a poor prognosis despite receiving ICD or apparently successful VT ablation therapy. Further, most VTs appear to arise remote from the noncompaction zone. Whether these VTs were "idiopathic" or related to IVNC was uncertain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanhui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Clinical Medicine, Tsinghua University, No. 1, Tsinghua Yuan, Handian District, Beijing, 100084, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Yumei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangzhou Shi, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jianhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Chenyang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zulu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, the General Hospital of Shenyang Military Region, Shenyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbai</LastName><ForeName>Mackenzi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tholakanahalli</LastName><ForeName>Venkatakrishna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benditt</LastName><ForeName>David G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jian-Ming</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-9869-4009</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA. Lixxx261@umn.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Division, University of Minnesota Medical School, Minneapolis, MN, USA. Lixxx261@umn.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Medical Center, One Veterans Drive, Minneapolis, MN, 55417, USA. Lixxx261@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018780" MajorTopicYN="N">Body Surface Potential Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="Y">Imaging, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056830" MajorTopicYN="N">Isolated Noncompaction of the Ventricular Myocardium</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Electroanatomical mapping</Keyword><Keyword MajorTopicYN="N">Noncompaction</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29582363</ArticleId><ArticleId IdType="doi">10.1007/s10840-018-0347-x</ArticleId><ArticleId IdType="pii">10.1007/s10840-018-0347-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Circulation. 2006 Apr 11;113(14):1807-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16567565</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2015 Apr;26(4):464-471</Citation><ArticleIdList><ArticleId IdType="pubmed">25328104</ArticleId></ArticleIdList></Reference><Reference><Citation>J Card Fail. 2011 Sep;17 (9):771-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21872148</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2013 Mar 12;127(10):1165-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23479668</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Comput Tomogr. 2012 Sep-Oct;6(5):346-54</Citation><ArticleIdList><ArticleId IdType="pubmed">22981859</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2011 Aug;22(8):898-904</Citation><ArticleIdList><ArticleId IdType="pubmed">21332865</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Cardiol. 2010 May;31(4):576-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20155258</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2000 Mar 21;101(11):1288-96</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Echocardiogr. 2005 Aug;18(8):865-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16084340</ArticleId></ArticleIdList></Reference><Reference><Citation>Card Electrophysiol Clin. 2015 Jun;7(2):319-30</Citation><ArticleIdList><ArticleId IdType="pubmed">26002396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Noninvasive Electrocardiol. 2017 Mar;22(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">27568851</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Radiol. 2012 Dec;22(12):2699-709</Citation><ArticleIdList><ArticleId IdType="pubmed">22772366</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1996 Mar 1;93(5):841-2</Citation><ArticleIdList><ArticleId IdType="pubmed">8598070</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2015 Aug 4;66(5):578-85</Citation><ArticleIdList><ArticleId IdType="pubmed">26227197</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2009 Sep;11(9):1193-200</Citation><ArticleIdList><ArticleId IdType="pubmed">19589795</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2017 Feb;14 (2):166-175</Citation><ArticleIdList><ArticleId IdType="pubmed">27890738</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2017 Oct 25;:</Citation><ArticleIdList><ArticleId IdType="pubmed">29097296</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 2007 Apr;30(4):544-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17437580</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 2008 Apr;31(4):461-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18373765</ArticleId></ArticleIdList></Reference><Reference><Citation>J Card Fail. 2006 Dec;12(9):726-33</Citation><ArticleIdList><ArticleId IdType="pubmed">17174235</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 1997 Jan;72 (1):26-31</Citation><ArticleIdList><ArticleId IdType="pubmed">9005281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28744600</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.</ArticleTitle><Pagination><StartPage>2573</StartPage><EndPage>2581</EndPage><MedlinePgn>2573-2581</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-017-4096-y</ELocationID><Abstract><AbstractText Label="UNLABELLED">Post-fracture mortality in type 2 diabetes mellitus (T2DM) patients has been poorly studied. We report an absolute and relative excess all-cause mortality following a fracture in these patients compared to non-diabetic patients.</AbstractText><AbstractText Label="INTRODUCTION">T2DM and osteoporotic fractures are independently associated with a reduced lifespan, but it is unknown if T2DM confers an excess post-fracture mortality compared to non-diabetic fracture patients. We report post-fracture all-cause mortality according to T2DM status.</AbstractText><AbstractText Label="METHODS">This is a population-based cohort study using data from the SIDIAP database. All &#x2265;50&#xa0;years old T2DM patients registered in SIDIAP in 2006-2013 and two diabetes-free controls matched on age, gender, and primary care center were selected. Study outcome was all-cause mortality following incident fractures. Participants were followed from date of any fracture (AF), hip fracture (HF), and clinical vertebral fracture (VF) until the earliest of death or censoring. Cox regression was used to calculate mortality according to T2DM status after adjustment for age, gender, body mass index, smoking, alcohol intake, and previous ischemic heart and cerebrovascular disease.</AbstractText><AbstractText Label="RESULTS">We identified 166,106 T2DM patients and 332,212 non-diabetic, of which 11,066 and 21,564, respectively, sustained a fracture and were then included. Post-fracture mortality rates (1000 person-years) were (in T2DM vs non-diabetics) 62.7 vs 49.5 after AF, 130.7 vs 112.7 after HF, and 54.9 vs 46.2 after VF. Adjusted HR (95% CI) for post-AF, post-HF, and post-VF mortality was 1.30 (1.23-1.37), 1.28 (1.20-1.38), and 1.20 (1.06-1.35), respectively, for T2DM compared to non-diabetics.</AbstractText><AbstractText Label="CONCLUSIONS">T2DM patients have a 30% increased post-fracture mortality compared to non-diabetics and a remarkable excess in absolute mortality risk. More research is needed on the causes underlying such excess risk, and on the effectiveness of measures to reduce post-fracture morbi-mortality in T2DM subjects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martinez-Laguna</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>GREMPAL Research Group, Idiap Jordi Gol Primary Care Research Institute, CIBERFES ISCIII, Universitat Autonoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ambit Barcelona, Primary Care Department, Institut Catala de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogues</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Internal Medicine Department IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrahamsen</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Holb&#xe6;k Hospital, Holb&#xe6;k, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OPEN Odense Patient Data Explorative Network, Institute of Clinical Research, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>GREMPAL Research Group, Idiap Jordi Gol Primary Care Research Institute, CIBERFES ISCIII, Universitat Autonoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbonell-Abella</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>GREMPAL Research Group, Idiap Jordi Gol Primary Care Research Institute, CIBERFES ISCIII, Universitat Autonoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ambit Barcelona, Primary Care Department, Institut Catala de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diez-Perez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine Department IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Autonomous University of Barcelona and CIBERFES, ISCIII, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>GREMPAL Research Group, Idiap Jordi Gol Primary Care Research Institute, CIBERFES ISCIII, Universitat Autonoma de Barcelona, Barcelona, Spain. Daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine Department IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Autonomous University of Barcelona and CIBERFES, ISCIII, Barcelona, Catalonia, Spain. Daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Lifecourse Epidemiology Unit, Southampton University, Southampton, UK. Daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Centre, University of Oxford, Oxford, UK. Daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Musculoskeletal Pharmaco and Device Epidemiology, Botnar Research Centre, Nuffield Orthopaedics Centre, Windmill Road, Oxford, OX3 7LD, UK. Daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">General population studies</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Osteoporotic fracture</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28744600</ArticleId><ArticleId IdType="doi">10.1007/s00198-017-4096-y</ArticleId><ArticleId IdType="pii">10.1007/s00198-017-4096-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Bone Miner Res. 2007 Mar;22(3):465-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17144789</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcif Tissue Int. 2014 Sep;95(3):257-66</Citation><ArticleIdList><ArticleId IdType="pubmed">24989776</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2015 Jun;108(3):482-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25869581</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Musculoskelet Disord. 2012 May 28;13:79</Citation><ArticleIdList><ArticleId IdType="pubmed">22639802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2010 Mar 16;152(6):380-90</Citation><ArticleIdList><ArticleId IdType="pubmed">20231569</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Surg (Hong Kong). 2010 Aug;18(2):148-52</Citation><ArticleIdList><ArticleId IdType="pubmed">20808003</ArticleId></ArticleIdList></Reference><Reference><Citation>Climacteric. 2016 Oct;19(5):458-62</Citation><ArticleIdList><ArticleId IdType="pubmed">27397609</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2001 Feb 12;161(3):397-405</Citation><ArticleIdList><ArticleId IdType="pubmed">11176766</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone. 2015 Apr;73:127-31</Citation><ArticleIdList><ArticleId IdType="pubmed">25542156</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2003 Jul;14(7):589-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12827222</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2016 Jan 1;202:490-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26440458</ArticleId></ArticleIdList></Reference><Reference><Citation>Inform Prim Care. 2011;19(3):135-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22688222</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2014 Aug;31(8):954-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24750341</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2012 Jul;23(7):1859-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22109741</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1999 Feb;22(2):233-40</Citation><ArticleIdList><ArticleId IdType="pubmed">10333939</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2012 Feb;27(2):294-300</Citation><ArticleIdList><ArticleId IdType="pubmed">22095911</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2013 May;24(5):1689-96</Citation><ArticleIdList><ArticleId IdType="pubmed">23212281</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Oct 5;6(10 ):e012463</Citation><ArticleIdList><ArticleId IdType="pubmed">27707830</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Oct 29;373(18):1720-32</Citation><ArticleIdList><ArticleId IdType="pubmed">26510021</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Apr;35(4):774-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22344609</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Feb 4;301(5):513-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19190316</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cases Miner Bone Metab. 2016 May-Aug;13(2):123-126</Citation><ArticleIdList><ArticleId IdType="pubmed">27920808</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2015 Jul;26(7):1903-10</Citation><ArticleIdList><ArticleId IdType="pubmed">25910745</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2013 May;24(5):1713-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23052933</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2010 Dec;21(12):2075-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20162259</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Mar;38(3):460-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25552420</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2013 Aug;28(8):1771-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23371035</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2014 Feb;99(2):415-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24276466</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2009 Sep 1;181(5):265-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19654194</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2014 Aug;29(8):1737-44</Citation><ArticleIdList><ArticleId IdType="pubmed">24615695</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone. 2013 Sep;56(1):23-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23684802</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2008 Jan 22;51(3):264-70</Citation><ArticleIdList><ArticleId IdType="pubmed">18206734</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2011 Sep;22(9):2439-48</Citation><ArticleIdList><ArticleId IdType="pubmed">21161507</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 2010 Mar;39(2):203-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20075035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone. 2013 Feb;52(2):562-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23142805</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2013 Apr;24(4):1247-56</Citation><ArticleIdList><ArticleId IdType="pubmed">22872069</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2011 Dec;94(3):311-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcif Tissue Int. 2015 Dec;97(6):535-41</Citation><ArticleIdList><ArticleId IdType="pubmed">26202819</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2015 Dec 10;351:h6246</Citation><ArticleIdList><ArticleId IdType="pubmed">26655876</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Nov;39(11):1987-1995</Citation><ArticleIdList><ArticleId IdType="pubmed">27493134</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2007 Dec;18(12):1583-93</Citation><ArticleIdList><ArticleId IdType="pubmed">17566814</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31813508</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1916-7075</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Canadian journal of cardiology</Title><ISOAbbreviation>Can J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Valve Replacement for Pulmonary Regurgitation in Adults With Tetralogy of Fallot: A Meta-analysis-A Report for the Writing Committee of the 2019 Update of the Canadian Cardiovascular Society Guidelines for the Management of Adults With Congenital Heart Disease.</ArticleTitle><Pagination><StartPage>1772</StartPage><EndPage>1783</EndPage><MedlinePgn>1772-1783</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjca.2019.08.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0828-282X(19)31190-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is no systematic evidence review of the long-term results of surgical pulmonary valve replacement (PVR) dedicated to adults with repaired tetralogy of Fallot (rTOF) and pulmonary regurgitation.</AbstractText><AbstractText Label="METHODS">Our primary objective was to determine whether PVR reduced long-term mortality in adults with rTOF compared with conservative therapy. Secondary objectives were to determine the postoperative incidence rate of death, the changes in functional capacity and in right ventricular (RV) volumes and ejection fraction after PVR, and the postoperative incidence rate of sustained ventricular arrhythmias. A systematic search of multiple databases for studies was conducted without limits.</AbstractText><AbstractText Label="RESULTS">No eligible randomized controlled trial or cohort study compared outcomes of PVR and conservative therapy in adults with rTOF. We selected 10 cohort studies (total 657 patients) reporting secondary outcomes. After PVR, the pooled incidence rate of death was 1% per year (95% confidence interval [CI] 0-1% per year) and the pooled incidence rate of sustained ventricular arrhythmias was 1% per year (95% CI 1%-2% per year). PVR improved symptoms (odds ratio for postoperative New York Heart Association functional class &gt; II 0.08, 95% CI 0.03-0.24). Indexed RV end-diastolic (-61.29 mL/m<sup>2</sup>,&#xa0;-43.64 to&#xa0;-78.94 mL/m<sup>2</sup>) and end-systolic (-37.20 mL/m<sup>2</sup>,&#xa0;-25.58 to&#xa0;-48.82 mL/m<sup>2</sup>) volumes decreased after PVR, but RV ejection fraction did not change (0.19%,&#xa0;-2.36% to 2.74%). The effect of PVR on RV volumes remained constant regardless of functional status.</AbstractText><AbstractText Label="CONCLUSION">Studies comparing PVR and conservative therapy exclusively in adults with rTOF are lacking. After PVR, the incidence rates of death and ventricular tachycardia are both 1 per 100 patient-years. Pooled analyses demonstrated an improved functional status and a reduction in RV volumes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mongeon</LastName><ForeName>Fran&#xe7;ois-Pierre</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Adult Congenital Heart Center, Department of Specialized Medicine, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, Canada. Electronic address: francois-pierre.mongeon@icm-mhi.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Ali</LastName><ForeName>Walid</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of surgery, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khairy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Adult Congenital Heart Center, Department of Specialized Medicine, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouhout</LastName><ForeName>Ismail</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of surgery, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Therrien</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jewish General Hospital, McGill University, Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wald</LastName><ForeName>Rachel M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallaire</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Pediatric and Fetal Cardiology, Centre Hospitalier Universitaire de Sherbrooke, Universit&#xe9; de Sherbrooke, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernier</LastName><ForeName>Pierre-Luc</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of surgery, McGill University Health Center, McGill University, Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poirier</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of surgery, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, Canada; Department of surgery, CHU-Sainte-Justine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dore</LastName><ForeName>Annie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Adult Congenital Heart Center, Department of Specialized Medicine, Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silversides</LastName><ForeName>Candice</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marelli</LastName><ForeName>Ariane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>McGill Adult Unit for Congenital Heart Disease (MAUDE Unit), McGill University, Montr&#xe9;al, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Cardiol</MedlineTA><NlmUniqueID>8510280</NlmUniqueID><ISSNLinking>0828-282X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Can J Cardiol. 2019 Dec;35(12):1620-1622. doi: 10.1016/j.cjca.2019.10.005.</RefSource><PMID Version="1">31813497</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="N">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="N">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011664" MajorTopicYN="N">Pulmonary Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011665" MajorTopicYN="N">Pulmonary Valve Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013771" MajorTopicYN="N">Tetralogy of Fallot</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31813508</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2019.08.031</ArticleId><ArticleId IdType="pii">S0828-282X(19)31190-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">37354175</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>8 Pt 3</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Substrate Imaging Before Catheter Ablation of Ventricular Tachycardia: Risk Prediction for Acute Hemodynamic Decompensation.</ArticleTitle><Pagination><StartPage>1684</StartPage><EndPage>1693</EndPage><MedlinePgn>1684-1693</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2023.03.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(23)00263-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">The PAINESD (Pulmonary disease, Age, Ischemic cardiomyopathy, NYHA functional class, Ejection fraction, Storm, Diabetes mellitus) risk score has been validated as a predictor of periprocedural acute hemodynamic decompensation (AHD) in patients undergoing ventricular tachycardia (VT) ablation. Whether the addition of total scar volume (TSV) determined by preprocedure computed tomography imaging provides additional risk stratification has not been previously investigated.</AbstractText><AbstractText Label="OBJECTIVES">The purpose of this study was to evaluate the impact of TSV on the risk of AHD and its adjunctive benefit to the PAINESD score newly modified as Pulmonary disease, Age, Ischemic cardiomyopathy, NYHA class, Ejection fraction, Storm, Scar volume, Diabetes mellitus (PAINES2D) based on the addition of scar volumes.</AbstractText><AbstractText Label="METHODS">This was a retrospective analysis of all index VT ablations at a quaternary care center from 2017 to 2022. Associations between TSV and AHD were evaluated among patients with structural heart disease.</AbstractText><AbstractText Label="RESULTS">Among 61 patients with TSV data, 13 (21%) had periprocedural AHD. TSV and PAINESD were independently associated with AHD risk. Both TSV and PAINESD were associated with AHD (P&#xa0;=&#xa0;0.016 vs P&#xa0;=&#xa0;0.053, respectively). The highest TSV tertile (&#x2265;37.30&#xa0;mL) showed significant association with AHD (P&#xa0;=&#xa0;0.018; OR: 4.80) compared to the other tertiles. The PAINESD and PAINES2D scores had significant impact on AHD (P&#xa0;=&#xa0;0.046 and P&#xa0;=&#xa0;0.010, respectively). The PAINES2D score had a greater impact on AHD compared to PAINESD (area under the curve: 0.73; P&#xa0;=&#xa0;0.011; 95%&#xa0;CI: 0.56-0.91 and area under the curve: 0.67; P&#xa0;=&#xa0;0.058; 95%&#xa0;CI: 0.49-0.85, respectively).</AbstractText><AbstractText Label="CONCLUSIONS">Addition of TSV to a modified PAINESD score, PAINES2D, enhances risk prediction of AHD. Further prospective study is needed to assess benefit in various cardiomyopathy populations undergoing VT ablation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>John</LastName><ForeName>Leah A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Ian I</ForeName><Initials>II</Initials><AffiliationInfo><Affiliation>Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedford</LastName><ForeName>Ryan J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregoski</LastName><ForeName>Mathew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Payne</LastName><ForeName>Joshua E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoepf</LastName><ForeName>U Joseph</ForeName><Initials>UJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suranyi</LastName><ForeName>Pal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cochet</LastName><ForeName>Hubert</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Bordeaux University Hospital and University of Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ja&#xef;s</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Bordeaux University Hospital and University of Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santangeli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winterfield</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA. Electronic address: winterfj@musc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 3):1694-1696. doi: 10.1016/j.jacep.2023.05.022.</RefSource><PMID Version="1">37498241</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002921" MajorTopicYN="N">Cicatrix</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">hemodynamic decompensation</Keyword><Keyword MajorTopicYN="N">scar volume</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures Dr Tedford has consulting relationships with Medtronic, Abbott Medical, Aria CV Inc, Acceleron, Alleviant, CareDx, Cytokinetics, Itamar, Edwards LifeSciences, Eidos Therapeutics, Lexicon Pharmaceuticals, Gradient, and United Therapeutics; is the national principal investigator for the RIGHT-FLOW clinical trial (Edwards); serves on Steering Committee for Merck and Abbott and a Research Advisory Board for Abiomed; and also does hemodynamic core lab work for Merck. Dr Gold hasconsultation relationships with Medtronic, Boston Scientific, CVRX, EBR, and Abbott Medical. Dr Field has received research funding from Medtronic, Abbott Medical, and Biosense Webster. Dr Schoepf has received institutional research support and honoraria for speaking and consulting from Bayer, ElucidBio, Guerbet, HeartFlow, Inc, Keya Medical, and Siemens Healthineers. Dr Cochet is a cofounder of inHEART Medical. Dr Ja&#xef;s is a cofounder of inHEART Medical. Dr Santangeli has consultation relationships with Boston Scientific, Abbott Medical, and Biosense Webster. Dr Winterfield has received institutional research support from Abbott Medical and Biosense Webster; and has consultation relationships with Abbott Medical, Biosense Webster, Thermedical, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>24</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>24</Day><Hour>10</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37354175</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2023.03.023</ArticleId><ArticleId IdType="pii">S2405-500X(23)00263-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19154568</PMID><DateCompleted><Year>2009</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2036</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>8</Issue><PubDate><Year>2009</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Alimentary pharmacology &amp; therapeutics</Title><ISOAbbreviation>Aliment Pharmacol Ther</ISOAbbreviation></Journal><ArticleTitle>Clinical trial: a randomized, study comparing meperidine (pethidine) and fentanyl in adult gastrointestinal endoscopy.</ArticleTitle><Pagination><StartPage>817</StartPage><EndPage>823</EndPage><MedlinePgn>817-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1365-2036.2009.03943.x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is little evidence to guide choice between meperidine (pethidine) and fentanyl for sedation for gastrointestinal endoscopy.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To compare meperidine with fentanyl in terms of procedure time and analgesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Single centre randomized controlled trial. Patients received narcotic doses and midazolam at the discretion of the attending endoscopist who was unaware of narcotic assignment. Endoscopy and recovery times were then recorded. The main outcome was total procedure time, defined as endoscopy time plus recovery time. Patient discomfort was assessed prior to discharge via visual analogue scale (VAS).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 55 patients were randomized to meperidine [44 colonoscopy and 11 esophagogastroduodenoscopy (EGD)] and 56 to fentanyl (45 colonoscopy and 11 EGD). Total procedure time was shorter for those receiving fentanyl (mean = 87.7 min) than for those receiving meperidine (mean = 102.9 min) (P = 0.05). The difference between the groups was explained by a shorter mean recovery time in the fentanyl group (63.0 min) than in the meperidine group (76.2 min) (P = 0.07). Based on post procedure pain scores, examinations with meperidine (mean = 1.99) were less painful when compared with those receiving fentanyl (mean = 2.86, P = 0.03).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Fentanyl shortened total procedure time by reducing recovery time. A simple change in narcotic choice could increase endoscopy unit efficiency.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>D J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>VA Medical Center, White River Junction, VT 05009, USA. douglas.robertson@med.va.gov</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>D P</ForeName><Initials>DP</Initials></Author><Author ValidYN="Y"><LastName>Mackenzie</LastName><ForeName>T A</ForeName><Initials>TA</Initials></Author><Author ValidYN="Y"><LastName>Oringer</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Rothstein</LastName><ForeName>R I</ForeName><Initials>RI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aliment Pharmacol Ther</MedlineTA><NlmUniqueID>8707234</NlmUniqueID><ISSNLinking>0269-2813</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>9E338QE28F</RegistryNumber><NameOfSubstance UI="D008614">Meperidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Aliment Pharmacol Ther. 2009 Aug;30(3):312-3; author reply 313. doi: 10.1111/j.1365-2036.2009.04030.x.</RefSource><PMID Version="1">19624467</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016099" MajorTopicYN="N">Endoscopy, Gastrointestinal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008614" MajorTopicYN="N">Meperidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>1</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>1</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19154568</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2036.2009.03943.x</ArticleId><ArticleId IdType="pii">APT3943</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16132888</PMID><DateCompleted><Year>2006</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0342-4642</ISSN><JournalIssue CitedMedium="Print"><Volume>31</Volume><Issue>10</Issue><PubDate><Year>2005</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial.</ArticleTitle><Pagination><StartPage>1379</StartPage><EndPage>1387</EndPage><MedlinePgn>1379-87</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine whether postoperative mechanical ventilation with lower tidal volumes (V(T)) has protective effects on inflammatory responses induced by cardiopulmonary bypass (CPB) surgery in smokers and nonsmokers.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">Prospective, randomized, controlled clinical trial in the intensive care unit of a university hospital.</AbstractText><AbstractText Label="PATIENTS AND PARTICIPANTS" NlmCategory="METHODS">We examined 44 patients (22 smokers, 22 nonsmokers) immediately after uncomplicated CPB surgery.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Ventilation was applied for 6 h with either V(T) of either 6 or 12 ml/kg ideal body weight.</AbstractText><AbstractText Label="MEASUREMENTS AND RESULTS" NlmCategory="RESULTS">The time course of serum tumor necrosis factor (TNF) alpha, interleukin (IL) 6, and IL-8 determined 0, 2, 4, and 6 h after randomization did not differ significantly between the ventilatory strategies. By contrast, in bronchoalveolar lavage fluids sampled after 6 h only TNF-alpha levels were significantly higher in the high V(T) group than the low V(T) group (50+/-111 pg/ml vs. 1+/-7 pg/ml). IL-6 and IL-8 concentrations did not differ between groups. Subgroup analysis of patients with serum TNF-alpha level higher than 0 pg/ml after surgery revealed lower TNF-alpha serum levels during lower V(T) ventilation. All observed effects were small, independent of patients' history of smoking, and were not correlated with duration of ventilation and ICU stay.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Ventilation with lower V(T) had no or only minor effect on systemic and pulmonary inflammatory responses in patients with healthy lungs after uncomplicated CPB surgery. Our data do not suggest a clinical benefit of using low V(T) ventilation in these selected patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wrigge</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany. hermann.wrigge@ukb.uni-bonn.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhlig</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Baumgarten</LastName><ForeName>Georg</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Menzenbach</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zinserling</LastName><ForeName>J&#xf6;rg</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ernst</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Dr&#xf6;mann</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Welz</LastName><ForeName>Armin</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Uhlig</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Putensen</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="Y">Coronary Artery Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011659" MajorTopicYN="N">Pulmonary Gas Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>9</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>9</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16132888</ArticleId><ArticleId IdType="doi">10.1007/s00134-005-2767-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anesthesiology. 2000 Dec;93(6):1413-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11149435</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2005 Apr;33(4):867-82</Citation><ArticleIdList><ArticleId IdType="pubmed">15818118</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1993 Nov;104(5):1541-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8222821</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1997 Apr;86(4):809-17</Citation><ArticleIdList><ArticleId IdType="pubmed">9105225</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2005 Jan;33(1):1-6; discussion 230-2</Citation><ArticleIdList><ArticleId IdType="pubmed">15644641</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1995 Mar 22-29;273(12):934-41</Citation><ArticleIdList><ArticleId IdType="pubmed">7884952</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 1999 Jun;27(6):1048-50</Citation><ArticleIdList><ArticleId IdType="pubmed">10397196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2001 Mar;119(3):884-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11243972</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1999 Jul 7;282(1):54-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10404912</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 1999 Dec;25(12):1444-52</Citation><ArticleIdList><ArticleId IdType="pubmed">10660857</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):711-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11254529</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 1997 May;155(5):1793-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9154894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2003 Feb;75(2):534-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12607668</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1998 Feb 5;338(6):347-54</Citation><ArticleIdList><ArticleId IdType="pubmed">9449727</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 1990;16(6):372-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2246418</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 May 4;342(18):1301-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2003 Oct;97(4):944-949</Citation><ArticleIdList><ArticleId IdType="pubmed">14500138</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1998 Feb 5;338(6):355-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9449728</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2004 Mar;98(3):775-81, table of contents</Citation><ArticleIdList><ArticleId IdType="pubmed">14980936</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2004 Apr;30(4):620-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14722635</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2004 Mar 1;169(5):562-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14701713</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1997 May;84(5):950-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9141914</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 1999 Jul;160(1):109-16</Citation><ArticleIdList><ArticleId IdType="pubmed">10390387</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1997 Mar 1;99(5):944-52</Citation><ArticleIdList><ArticleId IdType="pubmed">9062352</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1997 Dec;85(6):1240-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9390587</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1994 Mar;80(3):509-19</Citation><ArticleIdList><ArticleId IdType="pubmed">8141447</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2002 Jul;28(7):817-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12349817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 1996 Jun;61(6):1714-20</Citation><ArticleIdList><ArticleId IdType="pubmed">8651772</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2002 Jul;28(7):834-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12122519</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2003 Apr;31(4):1068-74</Citation><ArticleIdList><ArticleId IdType="pubmed">12682474</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2004 Mar;30(3):347-56</Citation><ArticleIdList><ArticleId IdType="pubmed">14722644</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1995 Dec;81(6):1129-35</Citation><ArticleIdList><ArticleId IdType="pubmed">7486093</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1999 Nov;89(5):1188-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10553832</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2004 Jul 15;170(2):198-9; author reply 199</Citation><ArticleIdList><ArticleId IdType="pubmed">15242856</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1990 Sep;73(3):393-400</Citation><ArticleIdList><ArticleId IdType="pubmed">2393125</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19752361</PMID><DateCompleted><Year>2009</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2009</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>11 Suppl</Issue><PubDate><Year>2009</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>Outcomes of patients undergoing concomitant aortic and mitral valve surgery in northern new England.</ArticleTitle><Pagination><StartPage>S155</StartPage><EndPage>S162</EndPage><MedlinePgn>S155-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.108.843573</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Concomitant aortic (AV) and mitral (MV) valve surgery accounts for 4% of all valve procedures in northern New England. We examined in-hospital and long-term mortality.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This is a report of a prospective study of 1057 patients undergoing concomitant AV and MV surgery from 1989 to 2007. The Social Security Administration Death Master File was used to assess long-term survival. Kaplan-Meier and log-rank tests were performed. In-hospital mortality was 15.5% (11.0% for patients &lt;70 years, 18.0% for 70- to 79-year-olds, and 24% for those &gt; or =80 years). Overall median survival was 7.3 years. Median survival without coronary artery bypass grafting was 9.5 years and with coronary artery bypass grafting was 5.7 years (P&lt;0.001). Survival in women was worse than in men (7.3 versus 9.3, years, P=0.033). Median survival by age was 11.0 years for patients &lt;70 years, 5.4 years for 70- to 79-year-olds, and 4.8 years for those &gt; or =80 years. Median survival was not significantly different for patients &gt; or =80 years compared with those who were 70 to 79 years old (P=0.245).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Double-valve surgery has a high in-hospital mortality rate and a median survival of 7.3 years. After patients have survived surgery, long-term survival is similar between men and women, smaller and larger patients, and those receiving MV repair or replacement. Survival continues to decline after surviving surgery for patients &gt; or =70 years old and those who undergo concomitant coronary artery bypass grafting. In patients &lt;70 years, either mechanical valves in both positions or a tissue AV and mitral repair have the lowest in-hospital mortality and the best long-term survival. In patients &gt; or =70 years, tissue valves in both positions have the best in-hospital and long-term survival.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leavitt</LastName><ForeName>Bruce J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Fletcher Allen Health Care, Burlington, VT 05401-1473, USA. bruce.leavitt@vtmednet.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baribeau</LastName><ForeName>Yvon R</ForeName><Initials>YR</Initials></Author><Author ValidYN="Y"><LastName>DiScipio</LastName><ForeName>Anthony W</ForeName><Initials>AW</Initials></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Cathy S</ForeName><Initials>CS</Initials></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Reed D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Olmstead</LastName><ForeName>Elaine M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Sisto</LastName><ForeName>Donato</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Likosky</LastName><ForeName>Donald S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Cochran</LastName><ForeName>Richard P</ForeName><Initials>RP</Initials></Author><Author ValidYN="Y"><LastName>Clough</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Boss</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Gerald T</ForeName><Initials>GT</Initials></Author><Author ValidYN="Y"><CollectiveName>Northern New England Cardiovascular Disease Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19752361</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.843573</ArticleId><ArticleId IdType="pii">120/11_suppl_1/S155</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34182951</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Effects of intraoperative lung-protective ventilation on clinical outcomes in patients with traumatic brain injury: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>182</StartPage><MedlinePgn>182</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">182</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-021-01402-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">Secondary lung injury is the most common non-neurological complication after traumatic brain injury (TBI). Lung-protective ventilation (LPV) has been proven to improve perioperative oxygenation and lung compliance in some critical patients. This study aimed to investigate whether intraoperative LPV could improve respiratory function and prevent postoperative complications in emergency TBI patients.</AbstractText><AbstractText Label="METHODS">Ninety TBI patients were randomly allocated to three groups (1:1:1): Group A, conventional mechanical ventilation [tidal volume (VT) 10 mL/kg only]; Group B, small VT (8 mL/kg)&#x2009;+&#x2009;positive end-expiratory pressure (PEEP) (5 cmH<sub>2</sub>O); and Group C, small VT (8 mL/kg)&#x2009;+&#x2009;PEEP (5 cmH<sub>2</sub>O)&#x2009;+&#x2009;recruitment maneuvers (RMs). The primary outcome was the incidence of total postoperative pulmonary complications; Secondary outcomes were intraoperative respiratory mechanics parameters and serum levels of brain injury markers, and the incidence of each postoperative pulmonary and neurological complication.</AbstractText><AbstractText Label="RESULTS">Seventy-nine patients completed the final analysis. The intraoperative PaO<sub>2</sub> and dynamic pulmonary compliance of Groups B and C were higher than those of Group A (P&#x2009;=&#x2009;0.028; P&#x2009;=&#x2009;0.005), while their airway peak pressure and plateau pressure were lower than those of group A (P&#x2009;=&#x2009;0.004; P&#x2009;=&#x2009;0.005). Compared to Group A, Groups B and C had decreased 30-day postoperative incidences of total pulmonary complications, hypoxemia, pulmonary infection, and atelectasis (84.0&#x2009;% vs. 57.1&#x2009;% vs. 53.8&#x2009;%, P&#x2009;=&#x2009;0.047; 52.0&#x2009;% vs. 14.3&#x2009;% vs. 19.2&#x2009;%, P&#x2009;=&#x2009;0.005; 84.0&#x2009;% vs. 50.0&#x2009;% vs. 42.3&#x2009;%, P&#x2009;=&#x2009;0.006; 24.0&#x2009;% vs. 3.6&#x2009;% vs. 0.0&#x2009;%, P&#x2009;=&#x2009;0.004). Moreover, intraoperative hypotension was more frequent in Group C than in Groups A and B (P&#x2009;=&#x2009;0.007). At the end of surgery, the serum levels of glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase isozyme L1 in Group B were lower than those in Groups A and C (P&#x2009;=&#x2009;0.002; P&#x2009;&lt;&#x2009;0.001). The postoperative incidences of neurological complications among the three groups were comparable.</AbstractText><AbstractText Label="CONCLUSIONS">Continuous intraoperative administration of small VT&#x2009;+&#x2009;PEEP is beneficial to TBI patients. Additional RMs can be performed with caution to prevent disturbances in the stability of cerebral hemodynamics.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Chinese Clinical Trial Registry (ChiCTR2000038314), retrospectively registered on September 17, 2020.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Lulu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the Second Xiangya Hospital, Central South University, 139# Renmin Central Road, 410011, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, 98# Nantong West Road, 225001, Yangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yujuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangtan Central Hospital, 120# Heping Road, 411100, Xiangtan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the Second Xiangya Hospital, Central South University, 139# Renmin Central Road, 410011, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, 98# Nantong West Road, 225001, Yangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Dahao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, 98# Nantong West Road, 225001, Yangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Keshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, 98# Nantong West Road, 225001, Yangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ju</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, 98# Nantong West Road, 225001, Yangzhou, China. 178201049@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="N">Brain Injuries, Traumatic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="N">Lung Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="N">Respiratory Mechanics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Glial fibrillary acidic protein</Keyword><Keyword MajorTopicYN="N">Lung-protective ventilation</Keyword><Keyword MajorTopicYN="N">Optic nerve sheath diameter</Keyword><Keyword MajorTopicYN="N">Postoperative pulmonary complications</Keyword><Keyword MajorTopicYN="N">Traumatic brain injury</Keyword><Keyword MajorTopicYN="N">Ubiquitin carboxyl-terminal hydrolase isozyme L1</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34182951</ArticleId><ArticleId IdType="pmc">PMC8236740</ArticleId><ArticleId IdType="doi">10.1186/s12871-021-01402-w</ArticleId><ArticleId IdType="pii">10.1186/s12871-021-01402-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maas A, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16(12):987&#x2013;1048. doi: 10.1016/S1474-4422(17)30371-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30371-X</ArticleId><ArticleId IdType="pubmed">29122524</ArticleId></ArticleIdList></Reference><Reference><Citation>Zygun DA, Kortbeek JB, Fick GH, Laupland KB, Doig CJ. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005;33(3):654&#x2013;60. doi: 10.1097/01.CCM.0000155911.01844.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000155911.01844.54</ArticleId><ArticleId IdType="pubmed">15753760</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsoukou A, Katsiari M, Orfanos SE, Kotanidou A, Daganou M, Kyriakopoulou M, et al. Respiratory mechanics in brain injury: A review. World J Crit Care Med. 2016;5(1):65&#x2013;73. doi: 10.5492/wjccm.v5.i1.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.5492/wjccm.v5.i1.65</ArticleId><ArticleId IdType="pmc">PMC4733457</ArticleId><ArticleId IdType="pubmed">26855895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Aguilar J, Quilez ME, Marti-Sistac O, Garcia-Martin C, Fuster G, Puig F, et al. Early physiological and biological features in three animal models of induced acute lung injury. Intensive Care Med. 2010;36(2):347&#x2013;55. doi: 10.1007/s00134-009-1695-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1695-x</ArticleId><ArticleId IdType="pubmed">19841895</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E, Brodie D, Slutsky AS. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018;319(7):698&#x2013;710. doi: 10.1001/jama.2017.21907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.21907</ArticleId><ArticleId IdType="pubmed">29466596</ArticleId></ArticleIdList></Reference><Reference><Citation>Boone MD, Jinadasa SP, Mueller A, Shaefi S, Kasper EM, Hanafy KA, et al. The Effect of Positive End-Expiratory Pressure on Intracranial Pressure and Cerebral Hemodynamics. Neurocrit Care. 2017;26(2):174&#x2013;81. doi: 10.1007/s12028-016-0328-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-016-0328-9</ArticleId><ArticleId IdType="pmc">PMC6613349</ArticleId><ArticleId IdType="pubmed">27848125</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS - an observational study in 29 countries. Eur J Anaesthesiol. 2017;34(8):492&#x2013;507. doi: 10.1097/EJA.0000000000000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000646</ArticleId><ArticleId IdType="pmc">PMC5502122</ArticleId><ArticleId IdType="pubmed">28633157</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirmer-Mikalsen K, Moen KG, Skandsen T, Vik A, Klepstad P. Intensive care and traumatic brain injury after the introduction of a treatment protocol: a prospective study. Acta Anaesthesiol Scand. 2013;57(1):46&#x2013;55. doi: 10.1111/j.1399-6576.2012.02785.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2012.02785.x</ArticleId><ArticleId IdType="pubmed">23095138</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Neurological Perspectives of Neurogenic Pulmonary Edema. Eur Neurol. 2019;81(1&#x2013;2):94&#x2013;102. doi: 10.1159/000500139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000500139</ArticleId><ArticleId IdType="pubmed">31117074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr N, de Rivero Vaccari JP, Dietrich WD, Keane RW. Neural-respiratory inflammasome axis in traumatic brain injury. Exp Neurol. 2020;323:113080. doi: 10.1016/j.expneurol.2019.113080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2019.113080</ArticleId><ArticleId IdType="pmc">PMC6981270</ArticleId><ArticleId IdType="pubmed">31626746</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun ZQ. Estimation of Sample Size. In: Sun ZQ, Xu YY, Ma J, editors. Medical Statistics. 4. Beijing: People&#x2019;s Medical Publishing House; 2014. pp. 573&#x2013;83.</Citation></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428&#x2013;37. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Gara B, Talmor D. Perioperative lung protective ventilation. BMJ. 2018;362:k3030. doi: 10.1136/bmj.k3030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k3030</ArticleId><ArticleId IdType="pmc">PMC6889848</ArticleId><ArticleId IdType="pubmed">30201797</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs J, Tsagogiorgas C, Pelosi P, Rocco PR, Hottenrott M, Sticht C, et al. Open lung approach with low tidal volume mechanical ventilation attenuates lung injury in rats with massive brain damage. Crit Care. 2014;18(2):R59. doi: 10.1186/cc13813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13813</ArticleId><ArticleId IdType="pmc">PMC4056811</ArticleId><ArticleId IdType="pubmed">24693992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascia L, Zavala E, Bosma K, Pasero D, Decaroli D, Andrews P, et al. High tidal volume is associated with the development of acute lung injury after severe brain injury: an international observational study. Crit Care Med. 2007;35(8):1815&#x2013;20. doi: 10.1097/01.CCM.0000275269.77467.DF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000275269.77467.DF</ArticleId><ArticleId IdType="pubmed">17568331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggieri F, Beretta L, Corno L, Testa V, Martino EA, Gemma M. Feasibility of Protective Ventilation During Elective Supratentorial Neurosurgery: A Randomized, Crossover, Clinical Trial. J Neurosurg Anesthesiol. 2018;30(3):246&#x2013;50. doi: 10.1097/ANA.0000000000000442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000442</ArticleId><ArticleId IdType="pubmed">28671879</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiadis D, Schwarz S, Baumgartner RW, Veltkamp R, Schwab S. Influence of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure in patients with acute stroke. Stroke. 2001;32(9):2088&#x2013;92. doi: 10.1161/hs0901.095406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hs0901.095406</ArticleId><ArticleId IdType="pubmed">11546901</ArticleId></ArticleIdList></Reference><Reference><Citation>Bein T, Kuhr LP, Bele S, Ploner F, Keyl C, Taeger K. Lung recruitment maneuver in patients with cerebral injury: effects on intracranial pressure and cerebral metabolism. Intensive Care Med. 2002;28(5):554&#x2013;8. doi: 10.1007/s00134-002-1273-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-002-1273-y</ArticleId><ArticleId IdType="pubmed">12029401</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemer SN, Caldeira JB, Santos RG, Guimaraes BL, Garcia JM, Prado D, et al. Effects of positive end-expiratory pressure on brain tissue oxygen pressure of severe traumatic brain injury patients with acute respiratory distress syndrome: A pilot study. J Crit Care. 2015;30(6):1263&#x2013;6. doi: 10.1016/j.jcrc.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.07.019</ArticleId><ArticleId IdType="pubmed">26307004</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan MC, Tseng JS, Chiu JT, Hsu KH, Shih SJ, Yi CY, et al. Prognostic value of plateau pressure below 30&#xa0;cm H2O in septic subjects with acute respiratory failure. Respir Care. 2015;60(1):12&#x2013;20. doi: 10.4187/respcare.03138.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.03138</ArticleId><ArticleId IdType="pubmed">25249650</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes T, Zochios V, Parhar K. Re-examining Permissive Hypercapnia in ARDS: A Narrative Review. Chest. 2018;154(1):185&#x2013;95. doi: 10.1016/j.chest.2017.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2017.11.010</ArticleId><ArticleId IdType="pubmed">29175086</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015;32(2):88&#x2013;105. doi: 10.1097/EJA.0000000000000118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000118</ArticleId><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW, Wiegers E, Sewalt C, Buki A, Citerio G, De Keyser V, et al. Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study. Lancet Neurol. 2019;18(10):923&#x2013;34. doi: 10.1016/S1474-4422(19)30232-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30232-7</ArticleId><ArticleId IdType="pubmed">31526754</ArticleId></ArticleIdList></Reference><Reference><Citation>Marret E, Cinotti R, Berard L, Piriou V, Jobard J, Barrucand B, et al. Protective ventilation during anaesthesia reduces major postoperative complications after lung cancer surgery: A double-blind randomised controlled trial. Eur J Anaesthesiol. 2018;35(10):727&#x2013;35. doi: 10.1097/EJA.0000000000000804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000804</ArticleId><ArticleId IdType="pubmed">29561278</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelnick LR, Morrison LJ, Devlin SM, Bulger EM, Brasel KJ, Sheehan K, et al. Addressing the challenges of obtaining functional outcomes in traumatic brain injury research: missing data patterns, timing of follow-up, and three prognostic models. J Neurotrauma. 2014;31(11):1029&#x2013;38. doi: 10.1089/neu.2013.3122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2013.3122</ArticleId><ArticleId IdType="pmc">PMC4043258</ArticleId><ArticleId IdType="pubmed">24552494</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteley JR, Taylor J, Henry M, Epperson TI, Hand WR. Detection of elevated intracranial pressure in robot-assisted laparoscopic radical prostatectomy using ultrasonography of optic nerve sheath diameter. J Neurosurg Anesthesiol. 2015;27(2):155&#x2013;9. doi: 10.1097/ANA.0000000000000106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000106</ArticleId><ArticleId IdType="pubmed">25105824</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammarata G, Ristagno G, Cammarata A, Mannanici G, Denaro C, Gullo A. Ocular ultrasound to detect intracranial hypertension in trauma patients. J Trauma. 2011;71(3):779&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">21909008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Menon DK, Kavanagh BP. Impact of Altered Airway Pressure on Intracranial Pressure, Perfusion, and Oxygenation: A Narrative Review. Crit Care Med. 2019;47(2):254&#x2013;63. doi: 10.1097/CCM.0000000000003558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003558</ArticleId><ArticleId IdType="pubmed">30653472</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemer SN, Caldeira JB, Azeredo LM, Garcia JM, Silva RT, Prado D, et al. Alveolar recruitment maneuver in patients with subarachnoid hemorrhage and acute respiratory distress syndrome: a comparison of 2 approaches. J Crit Care. 2011;26(1):22&#x2013;7. doi: 10.1016/j.jcrc.2010.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2010.04.015</ArticleId><ArticleId IdType="pubmed">20646904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon M, Agrawal P, Friez K, Gordon R, Morales I, Fang ZL, et al. Effect of History of Mild Traumatic Brain Injury on Optic Nerve Sheath Diameter Changes after Valsalva Maneuver. J Neurotrauma. 2018;35(4):695&#x2013;702. doi: 10.1089/neu.2017.5164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2017.5164</ArticleId><ArticleId IdType="pubmed">29356623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nylen K, Ost M, Csajbok LZ, Nilsson I, Blennow K, Nellgard B, et al. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci. 2006;240(1&#x2013;2):85&#x2013;91. doi: 10.1016/j.jns.2005.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.09.007</ArticleId><ArticleId IdType="pubmed">16266720</ArticleId></ArticleIdList></Reference><Reference><Citation>Czeiter E, Mondello S, Kovacs N, Sandor J, Gabrielli A, Schmid K, et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma. 2012;29(9):1770&#x2013;8. doi: 10.1089/neu.2011.2127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.2127</ArticleId><ArticleId IdType="pmc">PMC3409455</ArticleId><ArticleId IdType="pubmed">22435839</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon PJ, Panczykowski DM, Yue JK, Puccio AM, Inoue T, Sorani MD, et al. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging. J Neurotrauma. 2015;32(8):527&#x2013;33. doi: 10.1089/neu.2014.3635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2014.3635</ArticleId><ArticleId IdType="pmc">PMC4394160</ArticleId><ArticleId IdType="pubmed">25264814</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Yu C, Sun Y, Li Y. Serum ubiquitin C-terminal hydrolase L1 as a biomarker for traumatic brain injury: a systematic review and meta-analysis. Am J Emerg Med. 2015;33(9):1191&#x2013;6. doi: 10.1016/j.ajem.2015.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2015.05.023</ArticleId><ArticleId IdType="pubmed">26087705</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondello S, Jeromin A, Buki A, Bullock R, Czeiter E, Kovacs N, et al. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma. 2012;29(6):1096&#x2013;104. doi: 10.1089/neu.2011.2092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.2092</ArticleId><ArticleId IdType="pmc">PMC3325554</ArticleId><ArticleId IdType="pubmed">22165978</ArticleId></ArticleIdList></Reference><Reference><Citation>Papa L, Brophy GM, Welch RD, Lewis LM, Braga CF, Tan CN, et al. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury. JAMA Neurol. 2016;73(5):551&#x2013;60. doi: 10.1001/jamaneurol.2016.0039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.0039</ArticleId><ArticleId IdType="pmc">PMC8805143</ArticleId><ArticleId IdType="pubmed">27018834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30051136</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data.</ArticleTitle><Pagination><StartPage>1388</StartPage><EndPage>1399</EndPage><MedlinePgn>1388-1399</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-018-5327-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The soluble receptor for advanced glycation end-products (sRAGE) is a marker of lung epithelial injury and alveolar fluid clearance (AFC), with promising values for assessing prognosis and lung injury severity in acute respiratory distress syndrome (ARDS). Because AFC is impaired in most patients with ARDS and is associated with higher mortality, we hypothesized that baseline plasma sRAGE would predict mortality, independently of two key mediators of ventilator-induced lung injury.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a meta-analysis of individual data from 746 patients enrolled in eight prospective randomized and observational studies in which plasma sRAGE was measured in ARDS articles published through March 2016. The primary outcome was 90-day mortality. Using multivariate and mediation analyses, we tested the association between baseline plasma sRAGE and mortality, independently of driving pressure and tidal volume.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Higher baseline plasma sRAGE [odds ratio (OR) for each one-log increment, 1.18; 95% confidence interval (CI) 1.01-1.38; P&#x2009;=&#x2009;0.04], driving pressure (OR for each one-point increment, 1.04; 95% CI 1.02-1.07; P&#x2009;=&#x2009;0.002), and tidal volume (OR for each one-log increment, 1.98; 95% CI 1.07-3.64; P&#x2009;=&#x2009;0.03) were independently associated with higher 90-day mortality in multivariate analysis. Baseline plasma sRAGE mediated a small fraction of the effect of higher &#x394;P on mortality but not that of higher V<sub>T</sub>.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Higher baseline plasma sRAGE was associated with higher 90-day mortality in patients with ARDS, independently of driving pressure and tidal volume, thus reinforcing the likely contribution of alveolar epithelial injury as an important prognostic factor in ARDS. Registration: PROSPERO (ID: CRD42018100241).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jabaudon</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8121-1680</Identifier><AffiliationInfo><Affiliation>Department of Perioperative Medicine, CHU Clermont-Ferrand, 1 Place Lucie Aubrac, 63003, Clermont-Ferrand Cedex 1, France. mjabaudon@chu-clermontferrand.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS, UMR 6293, INSERM U1103, GReD, Universit&#xe9; Clermont Auvergne, Clermont-Ferrand, France. mjabaudon@chu-clermontferrand.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blondonnet</LastName><ForeName>Raiko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, CHU Clermont-Ferrand, 1 Place Lucie Aubrac, 63003, Clermont-Ferrand Cedex 1, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS, UMR 6293, INSERM U1103, GReD, Universit&#xe9; Clermont Auvergne, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Department of Clinical Research and Innovation (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cartin-Ceba</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtenstern</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauri</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Determann</LastName><ForeName>Rogier M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drabek</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hubmayr</LastName><ForeName>Rolf D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gajic</LastName><ForeName>Ognjen</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhle</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppadoro</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, San Gerardo Hospital, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesenti</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>Marco V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Molinette Hospital, City of Health and Science, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodska</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Clinical Biochemistry and Laboratory Diagnostics, Faculty of Medicine, General University Hospital, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mrozek</LastName><ForeName>S&#xe9;gol&#xe8;ne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital of Toulouse, University Toulouse 3 Paul Sabatier, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapin</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>CNRS, UMR 6293, INSERM U1103, GReD, Universit&#xe9; Clermont Auvergne, Clermont-Ferrand, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Molecular Biology, CHU Clermont-Ferrand, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matthay</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Constantin</LastName><ForeName>Jean-Michel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, CHU Clermont-Ferrand, 1 Place Lucie Aubrac, 63003, Clermont-Ferrand Cedex 1, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS, UMR 6293, INSERM U1103, GReD, Universit&#xe9; Clermont Auvergne, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calfee</LastName><ForeName>Carolyn S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HL51856</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL140026</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 HL051856</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL140026</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL133390</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL051856</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067759">Receptor for Advanced Glycation End Products</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Intensive Care Med. 2018 Sep;44(9):1553-1555. doi: 10.1007/s00134-018-5324-4.</RefSource><PMID Version="1">30141172</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067759" MajorTopicYN="N">Receptor for Advanced Glycation End Products</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014939" MajorTopicYN="N">Work of Breathing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Lung epithelial injury</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Receptor for advanced glycation end-products</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30051136</ArticleId><ArticleId IdType="pmc">PMC6132684</ArticleId><ArticleId IdType="doi">10.1007/s00134-018-5327-1</ArticleId><ArticleId IdType="pii">10.1007/s00134-018-5327-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526&#x2013;2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788&#x2013;800. doi: 10.1001/jama.2016.0291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0291</ArticleId><ArticleId IdType="pubmed">26903337</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2003;167:1027&#x2013;1035. doi: 10.1164/rccm.200208-966WS.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200208-966WS</ArticleId><ArticleId IdType="pubmed">12663342</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis. 1990;142:1250&#x2013;1257. doi: 10.1164/ajrccm/142.6_Pt_1.1250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm/142.6_Pt_1.1250</ArticleId><ArticleId IdType="pubmed">2252240</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay MA. Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit Care Med. 2014;189:1301&#x2013;1308. doi: 10.1164/rccm.201403-0535OE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201403-0535OE</ArticleId><ArticleId IdType="pmc">PMC4098087</ArticleId><ArticleId IdType="pubmed">24881936</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida T, Shirasawa M, Ware LB, et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med. 2006;173:1008&#x2013;1015. doi: 10.1164/rccm.200509-1477OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200509-1477OC</ArticleId><ArticleId IdType="pmc">PMC2662912</ArticleId><ArticleId IdType="pubmed">16456142</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee CS, Ware LB, Eisner MD, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax. 2008;63:1083&#x2013;1089. doi: 10.1136/thx.2008.095588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2008.095588</ArticleId><ArticleId IdType="pmc">PMC2764528</ArticleId><ArticleId IdType="pubmed">18566109</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabaudon M, Blondonnet R, Roszyk L, et al. Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2015;192:191&#x2013;199. doi: 10.1164/rccm.201501-0020OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201501-0020OC</ArticleId><ArticleId IdType="pubmed">25932660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med. 2005;83:876&#x2013;886. doi: 10.1007/s00109-005-0688-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-005-0688-7</ArticleId><ArticleId IdType="pubmed">16133426</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray P, Le Manach Y, Riou B, Houle TT. Statistical evaluation of a biomarker. Anesthesiology. 2010;112:1023&#x2013;1040. doi: 10.1097/ALN.0b013e3181d47604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181d47604</ArticleId><ArticleId IdType="pubmed">20234303</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabaudon M, Futier E, Roszyk L, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med. 2011;39:480&#x2013;488. doi: 10.1097/CCM.0b013e318206b3ca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318206b3ca</ArticleId><ArticleId IdType="pubmed">21220996</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabaudon M, Blondonnet R, Roszyk L, et al. Soluble forms and ligands of the receptor for advanced glycation end-products in patients with acute respiratory distress syndrome: an observational prospective study. PLoS One. 2015;10:e0135857. doi: 10.1371/journal.pone.0135857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135857</ArticleId><ArticleId IdType="pmc">PMC4537285</ArticleId><ArticleId IdType="pubmed">26274928</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee CS, Budev MM, Matthay MA, et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transpl. 2007;26:675&#x2013;680. doi: 10.1016/j.healun.2007.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2007.04.002</ArticleId><ArticleId IdType="pmc">PMC2741136</ArticleId><ArticleId IdType="pubmed">17613396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrozek S, Jabaudon M, Jaber S, et al. Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS: a prospective multicenter study. Chest. 2016;150:998&#x2013;1007. doi: 10.1016/j.chest.2016.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.03.016</ArticleId><ArticleId IdType="pubmed">27018314</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabaudon M, Hamroun N, Roszyk L, et al. Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study. Intensive Care Med. 2015;41:846&#x2013;855. doi: 10.1007/s00134-015-3726-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3726-0</ArticleId><ArticleId IdType="pubmed">25792206</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabaudon M, Blondonnet R, Lutz J, et al. Net alveolar fluid clearance is associated with lung morphology phenotypes in acute respiratory distress syndrome. Anaesth Crit Care Pain Med. 2016;35:81&#x2013;86. doi: 10.1016/j.accpm.2015.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2015.11.006</ArticleId><ArticleId IdType="pubmed">26926951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Pesenti A. The concept of &#x201c;baby lung&#x201d;. Intensive Care Med. 2005;31:776&#x2013;784. doi: 10.1007/s00134-005-2627-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2627-z</ArticleId><ArticleId IdType="pubmed">15812622</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato MBP, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372:747&#x2013;755. doi: 10.1056/NEJMsa1410639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1410639</ArticleId><ArticleId IdType="pubmed">25693014</ArticleId></ArticleIdList></Reference><Reference><Citation>Samary CS, Santos RS, Santos CL, et al. Biological impact of transpulmonary driving pressure in experimental acute respiratory distress syndrome. Anesthesiology. 2015;123:423&#x2013;433. doi: 10.1097/ALN.0000000000000716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000716</ArticleId><ArticleId IdType="pubmed">26039328</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai K, Keele L, Tingley D, Yamamoto T. Unpacking the black box of causality: learning about causal mechanisms from experimental and observational studies. Am Polit Sci Rev. 2011;105:765&#x2013;789. doi: 10.1017/S0003055411000414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0003055411000414</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD Statement. JAMA. 2015;313:1657&#x2013;1665. doi: 10.1001/jama.2015.3656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.3656</ArticleId><ArticleId IdType="pubmed">25919529</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818&#x2013;829. doi: 10.1097/00003246-198510000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-198510000-00009</ArticleId><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619&#x2013;1636. doi: 10.1378/chest.100.6.1619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.100.6.1619</ArticleId><ArticleId IdType="pubmed">1959406</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. on behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics. 1984;40:1079&#x2013;1087. doi: 10.2307/2531158.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2531158</ArticleId><ArticleId IdType="pubmed">6534410</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell FE, Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361&#x2013;387. doi: 10.1002/(SICI)1097-0258(19960229)15:4&lt;361::AID-SIM168&gt;3.0.CO;2-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0258(19960229)15:4&lt;361::AID-SIM168&gt;3.0.CO;2-4</ArticleId><ArticleId IdType="pubmed">8668867</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek MH, Berger DE, Coburn JW. On the inappropriateness of stepwise regression analysis for model building and testing. Eur J Appl Physiol. 2007;101:263&#x2013;264. doi: 10.1007/s00421-007-0485-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-007-0485-9</ArticleId><ArticleId IdType="pubmed">17520270</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002;7:422&#x2013;445. doi: 10.1037/1082-989X.7.4.422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1082-989X.7.4.422</ArticleId><ArticleId IdType="pubmed">12530702</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartin-Ceba R, Hubmayr RD, Qin R, et al. Predictive value of plasma biomarkers for mortality and organ failure development in patients with acute respiratory distress syndrome. J Crit Care. 2015;30(219):e1&#x2013;e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25261280</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodska H, Malickova K, Valenta J, et al. Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis. Scand J Clin Lab Invest. 2013;73:650&#x2013;660. doi: 10.3109/00365513.2013.849357.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365513.2013.849357</ArticleId><ArticleId IdType="pmc">PMC4044864</ArticleId><ArticleId IdType="pubmed">24164543</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri T, Masson S, Pradella A, et al. Elevated plasma and alveolar levels of soluble receptor for advanced glycation end products are associated with severity of lung dysfunction in ARDS patients. Tohoku J Exp Med. 2010;222:105&#x2013;112. doi: 10.1620/tjem.222.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1620/tjem.222.105</ArticleId><ArticleId IdType="pubmed">20877166</ArticleId></ArticleIdList></Reference><Reference><Citation>Determann RM, Royakkers AANM, Haitsma JJ, et al. Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients. BMC Pulm Med. 2010;10:6. doi: 10.1186/1471-2466-10-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2466-10-6</ArticleId><ArticleId IdType="pmc">PMC2841652</ArticleId><ArticleId IdType="pubmed">20158912</ArticleId></ArticleIdList></Reference><Reference><Citation>Krull JL, MacKinnon DP. Multilevel modeling of individual and group level mediated effects. Multivar Behav Res. 2001;36:249&#x2013;277. doi: 10.1207/S15327906MBR3602_06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/S15327906MBR3602_06</ArticleId><ArticleId IdType="pubmed">26822111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;rin C, Papazian L, Reignier J, et al. Effect of driving pressure on mortality in ARDS patients during lung protective mechanical ventilation in two randomized controlled trials. Crit Care. 2016;20:384. doi: 10.1186/s13054-016-1556-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1556-2</ArticleId><ArticleId IdType="pmc">PMC5126997</ArticleId><ArticleId IdType="pubmed">27894328</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators. Cavalcanti AB, Suzumura &#xc9;A, et al. Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs Low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2017;318:1335&#x2013;1345. doi: 10.1001/jama.2017.14171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14171</ArticleId><ArticleId IdType="pmc">PMC5710484</ArticleId><ArticleId IdType="pubmed">28973363</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SNT, Barbas CSV, et al. Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med. 2016;4:272&#x2013;280. doi: 10.1016/S2213-2600(16)00057-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00057-6</ArticleId><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2:611&#x2013;620. doi: 10.1016/S2213-2600(14)70097-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70097-9</ArticleId><ArticleId IdType="pmc">PMC4154544</ArticleId><ArticleId IdType="pubmed">24853585</ArticleId></ArticleIdList></Reference><Reference><Citation>Famous KR, Delucchi K, Ware LB, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195:331&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5328179</ArticleId><ArticleId IdType="pubmed">27513822</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirasawa M, Fujiwara N, Hirabayashi S, et al. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells. 2004;9:165&#x2013;174. doi: 10.1111/j.1356-9597.2004.00712.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1356-9597.2004.00712.x</ArticleId><ArticleId IdType="pubmed">15009093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334&#x2013;1349. doi: 10.1056/NEJM200005043421806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200005043421806</ArticleId><ArticleId IdType="pubmed">10793167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:1376&#x2013;1383. doi: 10.1164/ajrccm.163.6.2004035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.163.6.2004035</ArticleId><ArticleId IdType="pubmed">11371404</ArticleId></ArticleIdList></Reference><Reference><Citation>Briot R, Frank JA, Uchida T, et al. Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest. 2009;135:269&#x2013;275. doi: 10.1378/chest.08-0919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.08-0919</ArticleId><ArticleId IdType="pmc">PMC2714162</ArticleId><ArticleId IdType="pubmed">19017890</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee CS, Janz DR, Bernard GR, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015;147:1539&#x2013;1548. doi: 10.1378/chest.14-2454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.14-2454</ArticleId><ArticleId IdType="pmc">PMC4451708</ArticleId><ArticleId IdType="pubmed">26033126</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33:1&#x2013;6. doi: 10.1097/01.CCM.0000149854.61192.DC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000149854.61192.DC</ArticleId><ArticleId IdType="pubmed">15644641</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo WA, Knight PR, Raghavendran K. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome. Intensive Care Med. 2012;38:1588&#x2013;1598. doi: 10.1007/s00134-012-2624-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2624-y</ArticleId><ArticleId IdType="pubmed">22777515</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee TK, Mukhopadhyay S, Hoidal JR. Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol. 2008;162:210&#x2013;215. doi: 10.1016/j.resp.2008.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2008.07.001</ArticleId><ArticleId IdType="pubmed">18674642</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis. 1988;137:1159&#x2013;1164. doi: 10.1164/ajrccm/137.5.1159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm/137.5.1159</ArticleId><ArticleId IdType="pubmed">3057957</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschumperlin DJ, Oswari J, Margulies AS. Deformation-induced injury of alveolar epithelial cells. Effect of frequency, duration, and amplitude. Am J Respir Crit Care Med. 2000;162:357&#x2013;362. doi: 10.1164/ajrccm.162.2.9807003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.162.2.9807003</ArticleId><ArticleId IdType="pubmed">10934053</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuckton TJ, Alonso JA, Kallet RH, et al. Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med. 2002;346:1281&#x2013;1286. doi: 10.1056/NEJMoa012835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa012835</ArticleId><ArticleId IdType="pubmed">11973365</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28408039</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-4713</ISSN><JournalIssue CitedMedium="Internet"><Volume>124</Volume><Issue>7</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Ophthalmology</Title><ISOAbbreviation>Ophthalmology</ISOAbbreviation></Journal><ArticleTitle>Binocular Measures of Visual Acuity and Visual Field versus Binocular Approximations.</ArticleTitle><Pagination><StartPage>1031</StartPage><EndPage>1038</EndPage><MedlinePgn>1031-1038</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ophtha.2017.02.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0161-6420(16)31327-6</ELocationID><Abstract><AbstractText Label="PURPOSE">To assess the relationship of binocular visual function tests with binocular approximations using data from the Collaborative Initial Glaucoma Treatment Study (CIGTS).</AbstractText><AbstractText Label="DESIGN">Case series based on existing data from a clinical trial.</AbstractText><AbstractText Label="PARTICIPANTS">Six hundred seven patients with newly diagnosed open-angle glaucoma from the CIGTS.</AbstractText><AbstractText Label="METHODS">Monocular visual field (VF) and visual acuity (VA) tests were performed at baseline and every 6 months thereafter. Binocular tests of visual function (Esterman VF score, binocular VA) were added to the CIGTS protocol 3 years into the study. The binocular approximations of binocular visual function were better or worse eye, average eye, better or worse location, and binocular summation or pointwise binocular summation. Associations between binocular tests and binocular approximations to represent binocular visual function were assessed with Pearson's correlations (r), as was the relationship between vision-related quality of life (VR QOL; Visual Activities Questionnaire [VAQ] and the 25-item National Eye Institute Visual Function Questionnaire [NEI&#xa0;VFQ-25]) and binocular tests or binocular approximations of visual function.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Binocular visual function (VF and VA) and VR QOL.</AbstractText><AbstractText Label="RESULTS">Five hundred seventy-five patients underwent at least 1 binocular visual function test. The Esterman score was correlated significantly with all binocular approximations of VF, with r values ranging from 0.31 (worse-eye mean deviation [MD]) to 0.42 (better-eye MD; P &lt; 0.0001 for all). Binocular VA showed stronger correlations with binocular approximations, with r values ranging from 0.65 (worse-eye VA) to 0.80 (binocular summation; P&#xa0;&lt;&#xa0;0.0001 for all). Correlations between the VAQ and Esterman score were stronger in 7 of 9 subscales (r&#xa0;=&#xa0;-0.14 to&#xa0;-0.25; P &lt; 0.05 for all) than correlations with all 7 binocular approximations. In contrast, correlations between the VAQ and binocular VA (r&#xa0;=&#xa0;-0.07 to&#xa0;-0.21) were weaker in all subscales than those with better-eye, average-eye, and binocular summation of VA (r&#xa0;=&#xa0;-0.12 to&#xa0;-0.25), but not different from worse-eye values. These trends also were found in relevant subscales of the NEI VFQ-25.</AbstractText><AbstractText Label="CONCLUSIONS">We found limited benefit in binocular testing of VA in the clinical setting as a means of approximating a patient's reported visual functioning. In contrast, we found some benefit in performing binocular&#xa0;VF testing, because the results correlated more closely with reported functioning than binocular approximations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Musch</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan; Department of Epidemiology, University of Michigan, Ann Arbor, Michigan. Electronic address: dmusch@med.umich.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niziol</LastName><ForeName>Leslie M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillespie</LastName><ForeName>Brenda W</ForeName><Initials>BW</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichter</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janz</LastName><ForeName>Nancy K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00000149</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R21 EY025719</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ophthalmology</MedlineTA><NlmUniqueID>7802443</NlmUniqueID><ISSNLinking>0161-6420</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009883">Ophthalmic Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018463" MajorTopicYN="N">Filtering Surgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009883" MajorTopicYN="N">Ophthalmic Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014787" MajorTopicYN="N">Vision Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015348" MajorTopicYN="N">Vision, Binocular</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015349" MajorTopicYN="N">Vision, Monocular</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="Y">Visual Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>No conflicting relationship exists for any author</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28408039</ArticleId><ArticleId IdType="mid">NIHMS852778</ArticleId><ArticleId IdType="pmc">PMC5483206</ArticleId><ArticleId IdType="doi">10.1016/j.ophtha.2017.02.013</ArticleId><ArticleId IdType="pii">S0161-6420(16)31327-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sloane ME, Ball K, Owsley C, et al. The Visual Activities Questionnaire: developing an instrument for assessing problems in everyday visual tasks. Tech Dig Noninvasive Assess Vis Syst. 1992;1:26&#x2013;9.</Citation></Reference><Reference><Citation>Mangione CM, Lee PP, Gutierez P, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ) Arch Ophthalmol. 2001;119:1050&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11448327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills RP, Janz NK, Wren PA, et al. Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS) J Glaucoma. 2001;10:192&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11442181</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch DC, Lichter PR, Guire KE, et al. The Collaborative Initial Glaucoma Treatment Study (CIGTS): study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">10201583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferris FL, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7091289</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991;98:741&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills RP. Statistical aids to visual field interpretation. J Ocular Pharm. 1991;7:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">2061694</ArticleId></ArticleIdList></Reference><Reference><Citation>Esterman B. Functional scoring of the binocular field. Ophthalmology. 1982;89:1226&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">7155532</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson-Quigg JM, Cello K, Johnson CA. Predicting binocular visual field sensitivity from monocular visual field results. Invest Ophthalmol Vis Sci. 2000;41:2212&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10892865</ArticleId></ArticleIdList></Reference><Reference><Citation>Azen SP, Varma R, Preston-Martin S, et al. Binocular visual acuity summation and inhibition in an ocular epidemiological study: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci. 2002;43:1742&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12036974</ArticleId></ArticleIdList></Reference><Reference><Citation>Jampel HD. Glaucoma patients&#x2019; assessment of their visual function and quality of life. Trans Am Ophthalmol Soc. 2001;99:301&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1359019</ArticleId><ArticleId IdType="pubmed">11797316</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrish RK, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115:1447&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">9366678</ArticleId></ArticleIdList></Reference><Reference><Citation>Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci. 2002;43:1059&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">11923247</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora KS, Boland MV, Friedman DS, et al. The relationship between better-eye and integrated visual field mean deviation and visual disability. Ophthalmology. 2013;120:2476&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3834089</ArticleId><ArticleId IdType="pubmed">23993358</ArticleId></ArticleIdList></Reference><Reference><Citation>McKean-Cowdin R, Wang Y, Wu J, et al. Impact of visual field loss on health-related quality of life in glaucoma. The Los Angeles Latino Eye Study. Ophthalmology. 2008;115:941&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4864605</ArticleId><ArticleId IdType="pubmed">17997485</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen VMF, Crabb DP, White ET, et al. Glaucoma and fitness to drive: using binocular visual fields to predict a milestone to blindness. Invest Ophthalmol Vis Sci. 2008;49:2449&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18515585</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabb DP, Viswanathan AC, McNaught AI, et al. Simulating binocular visual field status in glaucoma. Br J Ophthalmol. 1998;82:1236&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1722423</ArticleId><ArticleId IdType="pubmed">9924324</ArticleId></ArticleIdList></Reference><Reference><Citation>Asaoka R, Crabb DP, Yamashita T, et al. Patients have two eyes!: binocular versus better eye visual field indices. Invest Ophthalmol Vis Sci. 2011;52:7007&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">21810985</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32087356</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: A randomized controlled study.</ArticleTitle><Pagination><StartPage>1510</StartPage><EndPage>1518</EndPage><MedlinePgn>1510-1518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2020.02.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(20)30111-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Epicardial mapping and ablation are frequently necessary to eliminate ventricular tachycardia (VT) in patients with Chagas disease. Nonetheless, there are no randomized controlled trials demonstrating the role of this strategy.</AbstractText><AbstractText Label="OBJECTIVE">We conducted this randomized controlled trial to evaluate the efficacy and safety of combined epicardial ablation in patients with Chagas disease.</AbstractText><AbstractText Label="METHODS">We randomized patients with Chagas disease and VT in a 1:1 fashion to either the endocardial (endo) mapping and ablation group or the combined endocardial/epicardial (endo/epi) mapping and ablation group. The efficacy end points were measured by VT inducibility and all-ventricular arrhythmia recurrence. Safety was assessed by the rate of periprocedural complications.</AbstractText><AbstractText Label="RESULTS">Thirty patients were enrolled, and most were male. The median age was 67 (Q1: 58; Q3: 70) years in the endo group and 58 (Q1: 43; Q3: 66) years in the endo/epi group. The left ventricular ejection fraction was 33.0% &#xb1; 9.5% and 35.2% &#xb1; 11.5%, respectively P = .13. Acute success (non-reinducibility of clinical VT) was obtained in 13 patients (86%) in the endo/epi group and in 6 patients (40%) in the endo-only group (P = .021). There were 12 patients with VT recurrence (80%) in the endo-only group and 6 patients (40%) in the endo/epi group (P = .02) (by intention-to-treat analysis). Epicardial ablation was ultimately performed in 9 patients (60%) in the endo-only group because of an absence of endocardial scar or maintenance of VT inducibility. There was no difference in complications between the groups.</AbstractText><AbstractText Label="CONCLUSION">Combining endo/epi VT catheter ablation in patients with Chagas disease significantly increases short- and long-term freedom from all-ventricular arrhythmias. Epicardial access did not increase periprocedural complication rates.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pisani</LastName><ForeName>Cristiano F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiac Arrhythmia Center, Cardiology Division, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lara</LastName><ForeName>Sissy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chokr</LastName><ForeName>Muhieddine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacilotto</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tan Chen</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darrieux</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hachul</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalil-Filho</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiac Arrhythmia Center, Cardiology Division, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scanavacca</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Heart Institute (InCor), University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil. Electronic address: mauricio.scanavacca@incor.usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02072707</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014355" MajorTopicYN="N">Chagas Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004699" MajorTopicYN="N">Endocardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056149" MajorTopicYN="N">Epicardial Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010496" MajorTopicYN="N">Pericardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Chagas disease</Keyword><Keyword MajorTopicYN="N">Endocardial ablation</Keyword><Keyword MajorTopicYN="N">Epicardial mapping</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32087356</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2020.02.009</ArticleId><ArticleId IdType="pii">S1547-5271(20)30111-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30235487</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2567-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Thrombosis and haemostasis</Title><ISOAbbreviation>Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score.</ArticleTitle><Pagination><StartPage>1823</StartPage><EndPage>1831</EndPage><MedlinePgn>1823-1831</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0038-1670660</ELocationID><Abstract><AbstractText>Patients at high risk for venous thrombosis (VT) following knee arthroscopy could potentially benefit from thromboprophylaxis. We explored the predictive values of environmental, genetic risk factors and levels of coagulation markers to integrate these into a prediction model. Using a population-based case-control study into the aetiology of VT, we developed a <i>Complete</i> (all variables), <i>Screening</i> (easy to use in clinical practice) and <i>Clinical</i> (only environmental risk factors) model. The <i>Clinical</i> model was transformed into the Leiden-Thrombosis Risk Prediction (arthroscopy) score [<i>L-TRiP(ascopy) score</i>]. Model validation was performed both internally and externally in another case-control study. A total of 4,943 cases and 6,294 controls were maintained in the analyses, 107 cases and 26 controls had undergone knee arthroscopy. Twelve predictor variables (8 environmental, 3 haemorheological and 1 genetic) were selected from 52 candidates and incorporated into the <i>Complete</i> model (area under the curve [AUC] of 0.81, 95% confidence interval [CI], 0.76-0.86). The <i>Screening</i> model (9 predictors: environmental factors plus factor VIII activity) reached an AUC of 0.76 (95% CI, 0.64-0.88) and the <i>Clinical</i> (<i>and corresponding L-TRiP</i>(<i>ascopy</i>)) model an AUC of 0.72 (95% CI, 0.60-0.83). In the internal and external validation, the <i>Complete</i> model reached an AUC of 0.78 (95% CI, 0.52-0.98) and 0.75 (95% CI, 0.42-1.00), respectively, while the other models performed slightly less well.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nemeth</LastName><ForeName>Banne</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Adrichem</LastName><ForeName>Raymond A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Hylckama Vlieg</LastName><ForeName>Astrid</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baglin</LastName><ForeName>Trevor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosendaal</LastName><ForeName>Frits R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelissen</LastName><ForeName>Rob G H H</ForeName><Initials>RGHH</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>le Cessie</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cannegieter</LastName><ForeName>Suzanne C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thromb Haemost</MedlineTA><NlmUniqueID>7608063</NlmUniqueID><ISSNLinking>0340-6245</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="Y">Arthroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007717" MajorTopicYN="N">Knee</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30235487</ArticleId><ArticleId IdType="doi">10.1055/s-0038-1670660</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33109807</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">0974-5181</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Season>Oct-Dec</Season></PubDate></JournalIssue><Title>Annals of cardiac anaesthesia</Title><ISOAbbreviation>Ann Card Anaesth</ISOAbbreviation></Journal><ArticleTitle>Myocardial protection in cardiac surgery: Del Nido versus blood cardioplegia.</ArticleTitle><Pagination><StartPage>477</StartPage><EndPage>484</EndPage><MedlinePgn>477-484</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/aca.ACA_153_19</ELocationID><Abstract><AbstractText Label="OBJECTIVES">del Nido cardioplegia which was traditionally used for myocardial protection in pediatric congenital heart surgery is now being extensively utilized in adult cardiac surgery. The aim of this study was to compare the safety and efficacy of del Nido cardioplegia (DNC) with blood cardioplegia (BC).</AbstractText><AbstractText Label="MATERIALS AND METHODS">This is a historical cohort study using secondary data. Two hundred and eighty six patients who underwent coronary artery bypass graft (CABG) or valve surgery were included. They were divided into 2 matched cohorts of which 143 patients received BC and 143 patients received DNC.</AbstractText><AbstractText Label="RESULTS">There was no difference in cardiopulmonary bypass time (P = 0.516) and clamp time (P = 0.650) between the groups. The redosing of cardioplegia was significantly less for DNC (1.13 vs. 2.35, P = &lt;0.001). The post bypass hemoglobin was higher for DNC (9.1 vs. 8.7, P = 0.011). The intraoperative and postoperative blood transfusion was comparable (P = 0.344) (P = 0.40). The incidence of clamp release ventricular fibrillation (P = 0.207) was similar. The creatine kinase-MB isotype levels for the CABG patients were comparable on all 3 days (P = 0.104), (P = 0.106), and (P = 0.158). The postoperative left ventricle ejection fraction was lesser but within normal range in the DNC group (53.4 vs. 56.0, P = &lt;0.001). The duration of ventilation (P = 0.186), ICU days (P = 0.931), and postoperative complications (P = 0.354) were comparable. There was no 30-day mortality or postoperative myocardial infarction in both the groups.</AbstractText><AbstractText Label="CONCLUSION">DNC provides equivalent myocardial protection, efficacy, and surgical workflow and had comparable clinical outcomes to that of BC. This study shows that DNC is a safe alternate to BC in CABG and valve surgeries.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>George</LastName><ForeName>Gladdy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varsha</LastName><ForeName>A V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Madhu Andrew</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vithayathil</LastName><ForeName>Reshma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasan</LastName><ForeName>Dharini</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sneha Princy</LastName><ForeName>F X</ForeName><Initials>FX</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Christian Medical College, Bagayam, Vellore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahajanandan</LastName><ForeName>Raj</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Ann Card Anaesth</MedlineTA><NlmUniqueID>9815987</NlmUniqueID><ISSNLinking>0971-9784</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002314">Cardioplegic Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Card Anaesth. 2022 Apr-Jun;25(2):250. doi: 10.4103/aca.aca_3_21.</RefSource><PMID Version="1">35417988</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Card Anaesth. 2022 Jul-Sep;25(3):378-379. doi: 10.4103/aca.aca_52_22.</RefSource><PMID Version="1">35799577</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002314" MajorTopicYN="Y">Cardioplegic Solutions</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006324" MajorTopicYN="N">Heart Arrest, Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood cardioplegia</Keyword><Keyword MajorTopicYN="N">Del Nido</Keyword><Keyword MajorTopicYN="N">efficacy</Keyword><Keyword MajorTopicYN="N">myocardial protection</Keyword></KeywordList><CoiStatement>None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33109807</ArticleId><ArticleId IdType="pmc">PMC7879885</ArticleId><ArticleId IdType="doi">10.4103/aca.ACA_153_19</ArticleId><ArticleId IdType="pii">AnnCardAnaesth_2020_23_4_477_298523</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gunnes S, Jynge P. Fundamentals of the past: Cardioplegia: The first period revisited. In: Podesser BK, Chambers DJ, editors. New Solutions for the Heart. An Update on Advanced Perioperative Protection. 1st ed. Germany: Springer-Verlag/Wien; 2011. pp. 15&#x2013;40.</Citation></Reference><Reference><Citation>Ali JM, Miles LF, Abu-Omar Y, Galhardo C, Falter F. Global cardioplegia practices: Results from the global cardiopulmonary bypass survey. J Extra Corpor Technol. 2018;50:83&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6002645</ArticleId><ArticleId IdType="pubmed">29921986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, He W, Qu Z, Tang Y, Zhou Q, Zhang B. Cold blood versus crystalloid cardioplegia for myocardial protection in adult cardiac surgery: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth. 2014;28:674&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">24721161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatrath R, Kaul TK, Walker DR. Myocardial protection during cardioplegia in open-heart surgery: A review. Can J Anaesth. 1980;27:381&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">6996794</ArticleId></ArticleIdList></Reference><Reference><Citation>Valooran GJ, Nair SK, Chandrasekharan K, Simon R, Dominic C. del Nido cardioplegia in adult cardiac surgery-Scopes and concerns. Perfusion. 2016;31:6&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26445810</ArticleId></ArticleIdList></Reference><Reference><Citation>Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution at Boston children's hospital. J Extra Corpor Technol. 2012;44:98&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557532</ArticleId><ArticleId IdType="pubmed">23198389</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgy A, Shore-Lesserson L. Del Nido cardioplegia should be used in all adults undergoing cardiac surgery: Con. J Cardiothorac Vasc Anesth. 2019;33:1785&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">30852089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra P, Jadhav RB, Mohapatra CK, Khandekar J, Raut C, Ammannaya GK, et al. Comparison of del Nido cardioplegia and St. Thomas hospital solution &#x2013; Two types of cardioplegia in adult cardiac surgery. Kardiochir Torakochirurgia Pol. 2016;13:295&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233756</ArticleId><ArticleId IdType="pubmed">28096823</ArticleId></ArticleIdList></Reference><Reference><Citation>Engorena MC, Habibb RH, Zachariasb A, Schwannb TA, Riordanb CJ, Durhamb SJ, et al. The association of elevated creatine kinase-myocardial band on mortality after coronary artery bypass grafting surgery is time and magnitude limited. Eur J Cardiothorac Surg. 2005;28:114&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15982595</ArticleId></ArticleIdList></Reference><Reference><Citation>Habertheuer A, Kocher A, Laufer G, Andreas M, Szeto WY, Petzelbauer P, et al. Cardioprotection: A Review of Current Practice in Global Ischemia and Future Translational Perspective. Hindawi Publishing Corporation BioMed Res Int. 2014 Article ID 325725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172998</ArticleId><ArticleId IdType="pubmed">25276778</ArticleId></ArticleIdList></Reference><Reference><Citation>Spellman J. Pro: In favor of more generalized use of del Nido cardioplegia in adult patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2019;33:1785&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">29525190</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi S, Austin N, Totonchi Z, Bakhshandeh H, Hadavand N, Ghavidel AA. Impact of procaine hydrochloride versus lidocaine in cardioplegic solution on reperfusion arrhythmia during coronary artery bypass graft surgery. Multidiscip Cardiovasc Ann. 2018;9:e67749.</Citation></Reference><Reference><Citation>Guajardo Salinas GE, Nutt R, Rodriguez-Araujo G. Del Nido cardioplegia in low risk adults undergoing first time coronary artery bypass surgery. Perfusion. 2017;32:68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">27451052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorabella RA, Akashi H, Yerebakan H, Najjar M, Mannan A, Williams MR, et al. Myocardial protection using del nido cardioplegia solution in adult reoperative aortic valve surgery. J Card Surg. 2014;29:445&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4297647</ArticleId><ArticleId IdType="pubmed">24861160</ArticleId></ArticleIdList></Reference><Reference><Citation>Ad N, Holmes SD, Massimiano PS, Rongione AJ, Fornaresio LM, Fitzgerald D. The use of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial. J Thorac Cardiovasc Surg. 2018;155:1011&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5929134</ArticleId><ArticleId IdType="pubmed">29246552</ArticleId></ArticleIdList></Reference><Reference><Citation>Timek T, Willekes C, Hulme O, Himelhoch B, Nadeau D, Borgman A, et al. Propensity matched analysis of del Nido cardioplegia in adult coronary artery bypass grafting: Initial experience with 100 consecutive patients. Ann Cardiothorac Surg. 2016;101:2237&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">27016843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota T, Yerebakan H, Neely RC, Mongero L, George I, Takayama H, et al. Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution. Perfusion. 2016;31:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">26228274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mick SL, Robich MP, Houghtaling PL, Gillinov AM, Soltesz EG, Johnston DR, et al. Del Nido versus buckberg cardioplegia in adult isolated valve surgery. Ann Cardiothorac Surg. 2015;149:626&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25483897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WK, Kim HR, Kim JB, Jung S, Choo SJ, Chung CH, et al. Del Nido cardioplegia in adult cardiac surgery: Beyond single-valve. Interact Cardiovasc Thorac Surg. 2018;27:81&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29452357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann B, Kaufmann C, Stiller M, Neitzel T, Wienke A, Silber R, et al. Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: A randomized clinical trial. J Cardiothorac Surg. 2018;13:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5963082</ArticleId><ArticleId IdType="pubmed">29784004</ArticleId></ArticleIdList></Reference><Reference><Citation>Teman N, Delavari N, Romano M, Prager R, Yang B, Haft J. Effects of autologous priming on blood conservation after cardiac surgery. Perfusion. 2014;29:333&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24395680</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellevold OFM, Berg EM, Levang OW. Procaine is effective for minimizing postischemic ventricular fibrillation in cardiac surgery. Anesth Analg. 1995;81:932&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7486080</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell C, Wang H, Tran P, Miller S, Shuttleworth P, Boyd JH. Utilization of del Nido cardioplegia in adult coronary artery bypass grafting-a retrospective analysis. Circ J. 2019;83:342&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30531128</ArticleId></ArticleIdList></Reference><Reference><Citation>Buel ST, Striker CW, O&#x2019;Brien JE. Del Nido versus St. Thomas cardioplegia solutions: A single-center retrospective analysis of post cross-clamp defibrillation rates. J Extra Corpor Technol. 2016;48:67&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001523</ArticleId><ArticleId IdType="pubmed">27578896</ArticleId></ArticleIdList></Reference><Reference><Citation>Vistarini N, Laliberte E, Beauchamp P, Bouhout I, Lamarche Y, Cartier R, et al. Del Nido cardioplegia in thesetting of minimally invasive aortic valve surgery. Perfusion. 2017;32:112&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27469246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamad R, Nguyen A, Laliberte E, Bouchard D, Lamarche Y, El-Hamamsy I, et al. Comparison of del Nido cardioplegia with blood cardioplegia in adult combined surgery. Innovations (Phila) 2017;12:356&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">29016380</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerebakan H, Sorabella RA, Najjar M, Castillero E, Mongero L, Beck J, et al. Del Nido cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: A propensity matched comparison. J Cardiothorac Surg. 2014;9:141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4220058</ArticleId><ArticleId IdType="pubmed">25359427</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundry SR, Sequeira A, Coughlin TR, McLaughlin JS. Postoperative conduction disturbances: A comparison of blood and crystalloid cardioplegia. Ann Cardiothorac Surg. 1989;47:384&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">2784664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27670627</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Simultaneous noninvasive recording of skin sympathetic nerve activity and electrocardiogram.</ArticleTitle><Pagination><StartPage>25</StartPage><EndPage>33</EndPage><MedlinePgn>25-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2016.09.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(16)30802-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Sympathetic nerve activity is important to cardiac arrhythmogenesis.</AbstractText><AbstractText Label="OBJECTIVE">The purpose of this study was to develop a method for simultaneous noninvasive recording of skin sympathetic nerve activity (SKNA) and electrocardiogram (ECG) using conventional ECG electrodes. This method (neuECG) can be used to adequately estimate sympathetic tone.</AbstractText><AbstractText Label="METHODS">We recorded neuECG signals from the skin of 56 human subjects. The signals were low-pass filtered to show the ECG and high-pass filtered to show nerve activity. Protocol 1 included 12 healthy volunteers who underwent cold water pressor test and Valsalva maneuver. Protocol 2 included 19 inpatients with epilepsy but without known heart diseases monitored for 24 hours. Protocol 3 included 22 patients admitted with electrical storm and monitored for 39.0 &#xb1; 28.2 hours. Protocol 4 included 3 patients who underwent bilateral stellate ganglion blockade with lidocaine injection.</AbstractText><AbstractText Label="RESULTS">In patients without heart diseases, spontaneous nerve discharges were frequently observed at baseline and were associated with heart rate acceleration. SKNA recorded from chest leads (V<sub>1</sub>-V<sub>6</sub>) during cold water pressor test and Valsalva maneuver (protocol 1) was invariably higher than during baseline and recovery periods (P &lt; .001). In protocol 2, the average SKNA correlated with heart rate acceleration (r = 0.73 &#xb1; 0.14, P &lt; .05) and shortening of QT interval (P &lt; .001). Among 146 spontaneous ventricular tachycardia episodes recorded in 9 patients of protocol 3, 106 episodes (73%) were preceded by SKNA within 30 seconds of onset. Protocol 4 showed that bilateral stellate ganglia blockade by lidocaine inhibited SKNA.</AbstractText><AbstractText Label="CONCLUSION">SKNA is detectable using conventional ECG electrodes in humans and may be useful in estimating sympathetic tone.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doytchinova</LastName><ForeName>Anisiia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassel</LastName><ForeName>Jonathan L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Department of Cardiothoracic Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hongbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Dechun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Department of Cardiology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straka</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Changyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salanova</LastName><ForeName>Vicenta</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meshberger</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lan S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kincaid</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coffey</LastName><ForeName>Arthur C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Shengjing Hospital, China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovacs</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Everett</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Victor</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Heart Institute/Hypertension Center(,) Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cha</LastName><ForeName>Yong-Mei</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shien-Fong</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Institute of Biomedical Engineering, National Chiao-Tung University, Hsin-Chu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Peng-Sheng</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: chenpp@iu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R42 DA043391</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 HL071140</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL078931</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL117983</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL071140</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R41 HL124741</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004566" MajorTopicYN="N">Electrodes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="Y">innervation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013233" MajorTopicYN="N">Stellate Ganglion</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013564" MajorTopicYN="N">Sympathetic Nervous System</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cold water pressor test</Keyword><Keyword MajorTopicYN="N">Microneurography</Keyword><Keyword MajorTopicYN="N">Sympathetic nerve activity</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList><CoiStatement>Shien-Fong Lin and Peng-Sheng Chen have equity interest in Arrhythmotech, LLC. Medtronic, St Jude and Cyberonics Inc. donated research equipment to Dr Chen&#x2019;s research laboratory.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27670627</ArticleId><ArticleId IdType="mid">NIHMS827954</ArticleId><ArticleId IdType="pmc">PMC5182108</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2016.09.019</ArticleId><ArticleId IdType="pii">S1547-5271(16)30802-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kligfield P, Gettes LS, Bailey JJ, et al. Recommendations for the standardization and interpretation of the electrocardiogram. Part I: The electrocardiogram and its technology.A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Heart Rhythm. 2007;4:394&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">17341413</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarthy Marx S, Kumar P, Dhalapathy S, Anitha Marx C. Distribution of sympathetic fiber areas in the sensory nerves of forearm: an immunohistochemical study in cadavers. Rom J Morphol Embryol. 2011;52:605&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">21655650</ArticleId></ArticleIdList></Reference><Reference><Citation>Donadio V, Nolano M, Provitera V, Stancanelli A, Lullo F, Liguori R, Santoro L. Skin sympathetic adrenergic innervation: an immunofluorescence confocal study. Ann Neurol. 2006;59:376&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">16437571</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron R, Janig W, With H. Sympathetic and afferent neurones projecting into forelimb and trunk nerves and the anatomical organization of the thoracic sympathetic outflow of the rat. J Auton Nerv Syst. 1995;53:205&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">7560757</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi T, Morimoto M, Taniguchi Y, Takasaki M, Totoki T. Cutaneous distribution of sympathetic postganglionic fibers from stellate ganglion: A retrograde axonal tracing study using wheat germ agglutinin conjugated with horseradish peroxidase. J Anesth. 1994;8:441&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">28921353</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson EA, Rhee KS, Doytchinova A, et al. Estimating Sympathetic Tone by Recording Subcutaneous Nerve Activity in Ambulatory Dogs. J Cardiovasc Electrophysiol. 2014;26:70&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4289443</ArticleId><ArticleId IdType="pubmed">25091691</ArticleId></ArticleIdList></Reference><Reference><Citation>Doytchinova A, Patel J, Zhou S, Chen H, Lin S-F, Shen C, Everett TH, IV, Lin SF, Chen P-S. Subcutaneous Nerve Activity and Spontaneous Ventricular Arrhythmias in Ambulatory Dogs. Heart Rhythm. 2015;122:612&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4339615</ArticleId><ArticleId IdType="pubmed">25460171</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Zhao Y, Doytchinova A, et al. Using Skin Sympathetic Nerve Activity to Estimate Stellate Ganglion Nerve Activity in Dogs. Heart Rhythm. 2015;12:1324&#x2013;1332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4442039</ArticleId><ArticleId IdType="pubmed">25681792</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor RG, Leimbach WN, Jr, Seals DR, Wallin BG, Mark AL. Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension. 1987;9:429&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">3570420</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmanpour A, Frances MF, Goswami R, Shoemaker JK. Sympathetic neural recruitment patterns during the Valsalva maneuver. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:6951&#x2013;6954.</Citation><ArticleIdList><ArticleId IdType="pubmed">22255937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J, Brili S, Stefanadis CI. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace. 2005;7:184&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">15763536</ArticleId></ArticleIdList></Reference><Reference><Citation>White DW, Shoemaker JK, Raven PB. Methods and considerations for the analysis and standardization of assessing muscle sympathetic nerve activity in humans. Auton Neurosci. 2015;193:12&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658261</ArticleId><ArticleId IdType="pubmed">26299824</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagius J, Karhuvaara S, Sundlof G. The cold pressor test: effects on sympathetic nerve activity in human muscle and skin nerve fascicles. Acta Physiol Scand. 1989;137:325&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">2596327</ArticleId></ArticleIdList></Reference><Reference><Citation>Viskin S, Postema PG, Bhuiyan ZA, et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010;55:1955&#x2013;1961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2862092</ArticleId><ArticleId IdType="pubmed">20116193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114:1500&#x2013;1515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4043633</ArticleId><ArticleId IdType="pubmed">24763467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellyer J, Akingba A, Rhee K-S, Tan AY, Lane KA, Shen C, Patel J, Fishbein M, Chen P-S. Autonomic Nerve Activity and Blood Pressure in Ambulatory Dogs. Heart Rhythm. 2013;11:307&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3918428</ArticleId><ArticleId IdType="pubmed">24275433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol. 1978;274:621&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1282513</ArticleId><ArticleId IdType="pubmed">625012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin BG, Delius W, Sundlof G. Human muscle nerve sympathetic activity in cardiac arrhythmias. Scand J Clin Lab Invest. 1974;34:293&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">4142516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mano T. Microneurographic research on sympathetic nerve responses to environmental stimuli in humans. Jpn J Physiol. 1998;48:99&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">9639545</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallbo AB, Hagbarth KE, Wallin BG. Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. J Appl Physiol. 2004;96:1262&#x2013;1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">15016790</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Chen NX, Shirazi JT, Shen C, Lin SF, Fishbein MC, Moe SM, Chen PS. Subcutaneous nerve activity and mechanisms of sudden death in a rat model of chronic kidney disease. Heart Rhythm. 2015;13:1105&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4851901</ArticleId><ArticleId IdType="pubmed">26744093</ArticleId></ArticleIdList></Reference><Reference><Citation>McAuley JH, Rothwell JC, Marsden CD. Frequency peaks of tremor, muscle vibration and electromyographic activity at 10 Hz, 20 Hz and 40 Hz during human finger muscle contraction may reflect rhythmicities of central neural firing. Exp Brain Res. 1997;114:525&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">9187289</ArticleId></ArticleIdList></Reference><Reference><Citation>Komi PV, Tesch P. EMG frequency spectrum, muscle structure, and fatigue during dynamic contractions in man. Eur J Appl Physiol Occup Physiol. 1979;42:41&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">499196</ArticleId></ArticleIdList></Reference><Reference><Citation>Vongpatanasin W, Mansour Y, Chavoshan B, Arbique D, Victor RG. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation. 1999;100:497&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">10430763</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33557923</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-7241</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>Scandinavian journal of trauma, resuscitation and emergency medicine</Title><ISOAbbreviation>Scand J Trauma Resusc Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome - a retrospective cohort study.</ArticleTitle><Pagination><StartPage>30</StartPage><MedlinePgn>30</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">30</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13049-021-00846-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), an emerging virus, has caused a global pandemic. Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to high hospitalization rates worldwide. Little is known about the occurrence of in-hospital cardiac arrest (IHCA) and high mortality rates have been proposed. The aim of this study was to investigate the incidence, characteristics and outcome of IHCA during the pandemic in comparison to an earlier period.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective analysis of data prospectively recorded during 3-month-periods 2019 and 2020 at the University Medical Centre Hamburg-Eppendorf (Germany). All consecutive adult patients with IHCA were included. Clinical parameters, neurological outcomes and organ failure/support were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period hospital admissions declined from 18,262 (2019) to 13,994 (2020) (-&#x2009;23%). The IHCA incidence increased from 4.6 (2019: 84 IHCA cases) to 6.6 (2020: 93 IHCA cases)/1000 hospital admissions. Median stay before IHCA was 4 (1-9) days. Demographic characteristics were comparable in both periods. IHCA location shifted towards the ICU (56% vs 37%, p&#x2009;&lt;&#x2009;0.01); shockable rhythm (VT/VF) (18% vs 29%, p&#x2009;=&#x2009;0.05) and defibrillation were more frequent in the pandemic period (20% vs 35%, p&#x2009;&lt;&#x2009;0.05). Resuscitation times, rates of ROSC and post-CA characteristics were comparable in both periods. The severity of illness (SAPS II/SOFA), frequency of mechanical ventilation and frequency of vasopressor therapy after IHCA were higher during the 2020 period. Overall, 43 patients (12 with &amp; 31 without COVID-19), presented with respiratory failure at the time of IHCA. The Horowitz index and resuscitation time were significantly lower in patients with COVID-19 (each p&#x2009;&lt;&#x2009;0.01). Favourable outcomes were observed in 42 and 10% of patients with and without COVID-19-related respiratory failure, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Hospital admissions declined during the pandemic, but a higher incidence of IHCA was observed. IHCA in patients with COVID-19 was a common finding. Compared to patients with non-COVID-19-related respiratory failure, the outcome was improved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roedl</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0721-9027</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany. k.roedl@uke.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf6;ffker</LastName><ForeName>Gerold</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Tabea Hospital, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westermann</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Interventional and General Cardiology, University Heart Centre Hamburg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Issleib</LastName><ForeName>Malte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluge</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarczak</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Martinistra&#xdf;e 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Scand J Trauma Resusc Emerg Med</MedlineTA><NlmUniqueID>101477511</NlmUniqueID><ISSNLinking>1757-7241</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Scand J Trauma Resusc Emerg Med. 2021 Nov 3;29(1):159. doi: 10.1186/s13049-021-00965-4.</RefSource><PMID Version="1">34732229</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="N">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004554" MajorTopicYN="N">Electric Countershock</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010343" MajorTopicYN="N">Patient Admission</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary resuscitation</Keyword><Keyword MajorTopicYN="N">Corona virus disease</Keyword><Keyword MajorTopicYN="N">In-hospital cardiac arrest</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Multiple organ failure</Keyword><Keyword MajorTopicYN="N">SARS-COV-2</Keyword></KeywordList><CoiStatement>KR, GS, DF, JM, MI, DW and DJ do not report any conflicts of interest related to this article. SK received research support by Ambu, E.T.View Ltd., Fisher &amp; Paykel, Pfizer and Xenios, lecture honorarium from ArjoHuntleigh, Astellas, Astra, Basilea, Bard, Baxter, Biotest, CSL Behring, Cytosorbents, Fresenius, Gilead, MSD, Orion, Pfizer, Philips, Sedana, Sorin, Xenios and Zoll, and consultant honorarium from AMOMED, Astellas, Baxter, Bayer, Fresenius, Gilead, MSD, Pfizer and Xenios. No other potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33557923</ArticleId><ArticleId IdType="pmc">PMC7868866</ArticleId><ArticleId IdType="doi">10.1186/s13049-021-00846-w</ArticleId><ArticleId IdType="pii">10.1186/s13049-021-00846-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO - World Map - COVID-19. 2020 [https://covid19.who.int/ - Accessed online: October, 31st 2020] [Available from: https://covid19.who.int/ - Accessed online: October, 19th 2020].</Citation></Reference><Reference><Citation>Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323(16):1545&#x2013;1546. doi: 10.1001/jama.2020.4031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4031</ArticleId><ArticleId IdType="pubmed">32167538</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052&#x2013;2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly A, Alessandri C, Skripkina E, Meffert A, Clariot S, de Roux Q, et al. Rescue fibrinolysis in suspected massive pulmonary embolism during SARS-CoV-2 pandemic. Resuscitation. 2020;152:86&#x2013;88. doi: 10.1016/j.resuscitation.2020.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2020.05.020</ArticleId><ArticleId IdType="pmc">PMC7238971</ArticleId><ArticleId IdType="pubmed">32445784</ArticleId></ArticleIdList></Reference><Reference><Citation>Creel-Bulos C, Hockstein M, Amin N, Melhem S, Truong A, Sharifpour M. Acute Cor Pulmonale in critically ill patients with Covid-19. N Engl J Med. 2020;382(21):e70. doi: 10.1056/NEJMc2010459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010459</ArticleId><ArticleId IdType="pmc">PMC7281714</ArticleId><ArticleId IdType="pubmed">32374956</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah P, Smith H, Olarewaju A, Jani Y, Cobb A, Owens J, et al. Is cardiopulmonary resuscitation futile in coronavirus disease 2019 patients experiencing in-hospital cardiac arrest? Crit Care Med. 2021;49(2):201&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33093278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayek SS, Brenner SK, Azam TU, Shadid HR, Anderson E, Berlin H, et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ. 2020;371:m3513. doi: 10.1136/bmj.m3513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3513</ArticleId><ArticleId IdType="pmc">PMC7525342</ArticleId><ArticleId IdType="pubmed">32998872</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, et al. Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N Engl J Med. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204428</ArticleId><ArticleId IdType="pubmed">32348640</ArticleId></ArticleIdList></Reference><Reference><Citation>Marijon E, Karam N, Jost D, Perrot D, Frattini B, Derkenne C, et al. Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study. Lancet Public Health. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255168</ArticleId><ArticleId IdType="pubmed">32473113</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao F, Xu S, Ma X, Xu Z, Lyu J, Ng M, et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. 2020;151:18&#x2013;23. doi: 10.1016/j.resuscitation.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2020.04.005</ArticleId><ArticleId IdType="pmc">PMC7151543</ArticleId><ArticleId IdType="pubmed">32283117</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung C-W, Lu T-C, Fang C-C, Huang C-H, Chen W-J, Chen S-C, et al. Impact of COVID-19 pandemic on emergency department services acuity and possible collateral damage. Resuscitation.&#xa0;Resuscitation. 2020;153:185&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308005</ArticleId><ArticleId IdType="pubmed">32585231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth V, Chishti I, Rothman A, Redlener M, Liang J, Pan D, et al. Outcomes of in-hospital cardiac arrest in patients with COVID-19 in New York City. Resuscitation. 2020;155:3&#x2013;5. doi: 10.1016/j.resuscitation.2020.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2020.07.011</ArticleId><ArticleId IdType="pmc">PMC7372263</ArticleId><ArticleId IdType="pubmed">32707146</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. Jama. 2019;321(12):1200&#x2013;1210. doi: 10.1001/jama.2019.1696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.1696</ArticleId><ArticleId IdType="pmc">PMC6482460</ArticleId><ArticleId IdType="pubmed">30912843</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke Statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56&#x2013;e528. doi: 10.1161/CIR.0000000000000659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000659</ArticleId><ArticleId IdType="pubmed">30700139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurmi J, Harjola VP, Nolan J, Castr&#xe9;n M. Observations and warning signs prior to cardiac arrest. Should a medical emergency team intervene earlier? Acta Anaesthesiol Scand. 2005;49(5):702&#x2013;706. doi: 10.1111/j.1399-6576.2005.00679.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2005.00679.x</ArticleId><ArticleId IdType="pubmed">15836688</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen LW, Kim WY, Chase M, Berg KM, Mortensen SJ, Moskowitz A, et al. The prevalence and significance of abnormal vital signs prior to in-hospital cardiac arrest. Resuscitation. 2016;98:112&#x2013;117. doi: 10.1016/j.resuscitation.2015.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2015.08.016</ArticleId><ArticleId IdType="pmc">PMC4715919</ArticleId><ArticleId IdType="pubmed">26362486</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DA, DeVita MA, Bellomo R. Rapid-response teams. N Engl J Med. 2011;365(2):139&#x2013;146. doi: 10.1056/NEJMra0910926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0910926</ArticleId><ArticleId IdType="pubmed">21751906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: incidence, prognosis and possible measures to improve survival. Intensive Care Med. 2007;33(2):237&#x2013;245. doi: 10.1007/s00134-006-0326-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-006-0326-z</ArticleId><ArticleId IdType="pubmed">17019558</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan JP, Soar J, Smith GB, Gwinnutt C, Parrott F, Power S, et al. Incidence and outcome of in-hospital cardiac arrest in the United Kingdom National Cardiac Arrest Audit. Resuscitation. 2014;85(8):987&#x2013;992. doi: 10.1016/j.resuscitation.2014.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2014.04.002</ArticleId><ArticleId IdType="pubmed">24746785</ArticleId></ArticleIdList></Reference><Reference><Citation>Efendijev I, Nurmi J, Castr&#xe9;n M, Skrifvars MB. Incidence and outcome from adult cardiac arrest occurring in the intensive care unit: a systematic review of the literature. Resuscitation. 2014;85(4):472&#x2013;479. doi: 10.1016/j.resuscitation.2013.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2013.12.027</ArticleId><ArticleId IdType="pubmed">24412160</ArticleId></ArticleIdList></Reference><Reference><Citation>Schluep M, Gravesteijn BY, Stolker RJ, Endeman H, Hoeks SE. One-year survival after in-hospital cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2018;132:90&#x2013;100. doi: 10.1016/j.resuscitation.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2018.09.001</ArticleId><ArticleId IdType="pubmed">30213495</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VRM, Deakin CD, et al. European resuscitation council and European Society of Intensive Care Medicine Guidelines for post-resuscitation care 2015: section 5 of the European resuscitation council guidelines for resuscitation 2015. Resuscitation. 2015;95:202&#x2013;222. doi: 10.1016/j.resuscitation.2015.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2015.07.018</ArticleId><ArticleId IdType="pubmed">26477702</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan JP, Berg RA, Andersen LW, Bhanji F, Chan PS, Donnino MW, et al. Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: Update of the Utstein Resuscitation Registry Template for In-Hospital Cardiac Arrest: A Consensus Report From a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia) Resuscitation. 2019;144:166&#x2013;177. doi: 10.1016/j.resuscitation.2019.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2019.08.021</ArticleId><ArticleId IdType="pubmed">31536777</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol. 2002;40(12):2110&#x2013;2116. doi: 10.1016/S0735-1097(02)02594-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(02)02594-9</ArticleId><ArticleId IdType="pubmed">12505221</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrmann V, J&#xe4;ger B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122(5&#x2013;6):129&#x2013;139. doi: 10.1007/s00508-010-1357-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-010-1357-6</ArticleId><ArticleId IdType="pubmed">20361374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526&#x2013;2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W, M&#xf8;ller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Intensive Care Med. 2020;46(5):854&#x2013;887. doi: 10.1007/s00134-020-06022-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06022-5</ArticleId><ArticleId IdType="pmc">PMC7101866</ArticleId><ArticleId IdType="pubmed">32222812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C. German recommendations for critically ill patients with COVID-19. Medizinische Klinik, Intensivmedizin und Notfallmedizin. 2020:1&#x2013;4.</Citation></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. JAMA. 1993;270(24):2957&#x2013;2963. doi: 10.1001/jama.1993.03510240069035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1993.03510240069035</ArticleId><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim ZJ, Reddy MP, Afroz A, Billah B, Shekar K, Subramaniam A. Incidence and outcome of out-of-hospital cardiac arrests in the COVID-19 era: a systematic review and meta-analysis. Resuscitation.&#xa0;2020;157:248&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603976</ArticleId><ArticleId IdType="pubmed">33137418</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel MAF, Redfern OC, Hatch R, Young JD, Tarassenko L, Watkinson PJ. Trajectories of vital signs in patients with COVID-19. Resuscitation. 2020;156:99&#x2013;106. doi: 10.1016/j.resuscitation.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7481128</ArticleId><ArticleId IdType="pubmed">32918984</ArticleId></ArticleIdList></Reference><Reference><Citation>Covino M, Sandroni C, Santoro M, Sabia L, Simeoni B, Bocci MG, et al. Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores. Resuscitation. 2020;156:84&#x2013;91. doi: 10.1016/j.resuscitation.2020.08.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2020.08.124</ArticleId><ArticleId IdType="pmc">PMC7480278</ArticleId><ArticleId IdType="pubmed">32918985</ArticleId></ArticleIdList></Reference><Reference><Citation>Roedl K, Jarczak D, Blohm R, Winterland S, M&#xfc;ller J, Fuhrmann V, et al. Epidemiology of intensive care unit cardiac arrest: characteristics, comorbidities, and post-cardiac arrest organ failure - a prospective observational study. Resuscitation. 2020;156:92&#x2013;98. doi: 10.1016/j.resuscitation.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2020.09.003</ArticleId><ArticleId IdType="pubmed">32920114</ArticleId></ArticleIdList></Reference><Reference><Citation>Leloup M, Briatte I, Langlois A, Cariou A, Lesieur O. Unexpected cardiac arrests occurring inside the ICU: outcomes of a French prospective multicenter study. Intensive Care Med. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32152653</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapa SB, Kakar TS, Mayer C, Khanal D. Clinical outcomes of in-hospital cardiac arrest in COVID-19. JAMA Intern Med. 2021;181(2):279&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522772</ArticleId><ArticleId IdType="pubmed">32986117</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39907787</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>Association between vertebral fractures and brain volume: insights from a community cohort study.</ArticleTitle><Pagination><StartPage>627</StartPage><EndPage>636</EndPage><MedlinePgn>627-636</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-025-07403-6</ELocationID><Abstract><AbstractText Label="UNLABELLED">Investigating vertebral fractures and brain structure, we found significant gray matter volume reductions in the right hippocampus, amygdala, and parahippocampal gyrus, especially in males. These findings emphasize the importance of integrating skeletal and neural health in osteoporosis management.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Vertebral fractures (VF) due to osteoporosis impact morbidity and quality of life in the elderly. The relationship between VF and changes in brain structure remains underexplored. This study aimed to investigate the association between VF and gray matter volume (GMV) reductions in specific brain regions and to explore potential sex differences.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from 1,751 participants (571 males, 1,180 females; mean age 64.9, range 18-97) in the fourth survey of the population-based Research on Osteoarthritis/Osteoporosis Against Disability study (2015-2016) were used. Participants were classified into those with and without VF (VF&#x2009;+&#x2009;and VF&#x2009;-&#x2009;groups) based on Genant's semiquantitative method, assessed by spine radiographs. Voxel-based morphometry was applied to MRI images to measure GMV, and a general linear model analysis was performed to compare GMV between groups, adjusting for age, sex, total brain volume, and Mini-Mental State Examination scores as covariates. Additionally, a two-way analysis of variance was conducted on the significant GMV cluster, with sex and VF presence as independent variables, to explore interaction effects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The VF+ group consisted of 113 participants, while the VF- group included 1,638 participants.&#xa0;The analysis identified a significant cluster with reduced GMV in the VF&#x2009;+&#x2009;group compared to the VF&#x2009;-&#x2009;group. This cluster included the right hippocampus, right amygdala, and right parahippocampal gyrus. Further analysis revealed that males in the VF&#x2009;+&#x2009;group exhibited more pronounced GMV reductions in the significant cluster compared to females.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings suggest that VF is associated with significant reductions in brain regions critical for memory, emotional processing, and visuospatial memory, with more severe effects observed in males.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horii</LastName><ForeName>Chiaki</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kodama</LastName><ForeName>Hiroyasu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurophysiology, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirokoshi</LastName><ForeName>Tomohiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurophysiology, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Akitoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osada</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konishi</LastName><ForeName>Seiki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oshima</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iidaka</LastName><ForeName>Toshiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, Faculty of Medicine, the University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muraki</LastName><ForeName>Shigeyuki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, Faculty of Medicine, the University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oka</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Musculoskeletal AI System Development, Faculty of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawaguchi</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Tokyo Neurological Center, Toranomon 4-1-17, Minato-Ku, Tokyo, 105-0001, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akune</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Rehabilitation Center for Persons With Disabilities, Namiki 4-1, Tokorozawa, Saitama, 359-0042, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashizume</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Wakayama Medical University School of Medicine, Kimiidera 811-1, Wakayama, 641-8509, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Wakayama Medical University School of Medicine, Kimiidera 811-1, Wakayama, 641-8509, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Munehito</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Wakayama Medical University School of Medicine, Kimiidera 811-1, Wakayama, 641-8509, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Kozo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Towa Hospital, Towa 4-7-10, Adachi-Ku, Tokyo, 120-0003, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shojima</LastName><ForeName>Masaaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Teikyo University Hospital, Kaga 2-11-1, Itabashi-Ku, Tokyo, 173-8606, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Sakae</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshimura</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9206-4658</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, Faculty of Medicine, the University of Tokyo, Hongo 7-3-1, Bunkyo-Ku, Tokyo, 113-8655, Japan. noripu2yoshi@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>H25-Choujyu-007</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>H25-Nanchitou (Men)-005</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>19FA1901</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>19FA0701</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>24FA1003</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>24FA0601</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>08033011-00262</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>B19H03895</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>B26293139</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>21K19631</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>18K18447</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>21K18291</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>B26293331</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>26670307</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>B26293329</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>25670293</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>19H05654</GrantID><Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency><Country/></Grant><Grant><GrantID>17dk0110028h0001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>17gk0210007h0003</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>19gk0210018h0002</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>22gk0210034h0001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>23gk0210034h0002</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>24gk0210034h003</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>22dk0110047h0001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>23dk0110047h0002</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>24dk0110047h0003</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>22dk0110048h0001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>23dk0110048h0002</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>24dk0110048y0003</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>2015</GrantID><Agency>Japan Osteoporosis Foundation</Agency><Country/></Grant><Grant><GrantID>2014-1</GrantID><Agency>Japanese Orthopaedic Association</Agency><Country/></Grant><Grant><GrantID>2015</GrantID><Agency>Japanese Society for Musculoskeletal Medicine</Agency><Country/></Grant><Grant><GrantID>2017</GrantID><Agency>Japanese Society for Musculoskeletal Medicine</Agency><Country/></Grant><Grant><GrantID>2016</GrantID><Agency>Mitsui Sumitomo Insurance Welfare Foundation</Agency><Country/></Grant><Grant><GrantID>2024</GrantID><Agency>Mitsui Sumitomo Insurance Welfare Foundation</Agency><Country/></Grant><Grant><GrantID>2017</GrantID><Agency>Japan Dairy Association</Agency><Country/></Grant><Grant><GrantID>2023</GrantID><Agency>Suzuken Memorial Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="Y">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain volume</Keyword><Keyword MajorTopicYN="N">Gray matter volume</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword><Keyword MajorTopicYN="N">Voxel-based morphometry</Keyword></KeywordList><CoiStatement>Declarations. Competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>11</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>5</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>5</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39907787</ArticleId><ArticleId IdType="pmc">PMC12064467</ArticleId><ArticleId IdType="doi">10.1007/s00198-025-07403-6</ArticleId><ArticleId IdType="pii">10.1007/s00198-025-07403-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Papaioannou A, Watts NB, Kendler DL, Yuen CK, Adachi JD, Ferko N (2002) Diagnosis and management of vertebral fractures in elderly adults. Am J Med 113:220&#x2013;228</Citation><ArticleIdList><ArticleId IdType="pubmed">12208381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HT, Nguyen BT, Thai THN, Tran AV, Nguyen TT, Vo T, Mai LD, Tran TS, Nguyen TV, Ho-Pham LT (2024) Prevalence, incidence of and risk factors for vertebral fracture in the community: the Vietnam Osteoporosis Study. Sci Rep 14:32</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10761939</ArticleId><ArticleId IdType="pubmed">38168502</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson WA, Carlson BC, Poppendeck H et al (2020) Osteoporosis-related Vertebral Fragility Fractures: A Review and Analysis of the American Orthopaedic Association&#x2019;s Own the Bone Database. Spine (Phila Pa 1976) 45:E430&#x2013;E438</Citation><ArticleIdList><ArticleId IdType="pubmed">31770343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostom S, Allali F, Bennani L, Abouqal R, Hajjaj-Hassouni N (2012) The prevalence of vertebral fractures and health-related quality of life in postmenopausal women. Rheumatol Int 32:971&#x2013;980</Citation><ArticleIdList><ArticleId IdType="pubmed">21243498</ArticleId></ArticleIdList></Reference><Reference><Citation>Old JL, Calvert M (2004) Vertebral compression fractures in the elderly. Am Fam Physician 69:111&#x2013;116</Citation><ArticleIdList><ArticleId IdType="pubmed">14727827</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N, Darvishi N, Bartina Y, Larti M, Kiaei A, Hemmati M, Shohaimi S, Mohammadi M (2021) Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16:669</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590304</ArticleId><ArticleId IdType="pubmed">34774085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayer SR, Mears SC, Pangle AK, Mendiratta P, Wei JY, Azhar G (2021) Does Superior Bone Health Promote a Longer Lifespan? Geriatr Orthop Surg Rehabil 12:21514593211036230</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8358490</ArticleId><ArticleId IdType="pubmed">34395047</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Huang X, Wu J et al (2022) The Global Burden of Osteoporosis, Low Bone Mass, and Its Related Fracture in 204 Countries and Territories, 1990&#x2013;2019. Front Endocrinol (Lausanne) 13:882241</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9165055</ArticleId><ArticleId IdType="pubmed">35669691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zohar A, Getzler I, Behrbalk E (2023) Higher Mortality Rate in Patients with Vertebral Compression Fractures is due to Deteriorated Medical Status Prior to the Fracture Event. Geriatr Orthop Surg Rehabil 14:21514593231153104</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9903013</ArticleId><ArticleId IdType="pubmed">36760863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes JB, Fung LK, Cha CC, Gabriel GM, Takayama L, Figueiredo CP, Pereira RM (2012) The impact of asymptomatic vertebral fractures on quality of life in older community-dwelling women: the Sao Paulo Ageing &amp; Health Study. Clinics (Sao Paulo) 67:1401&#x2013;1406</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3521802</ArticleId><ArticleId IdType="pubmed">23295593</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller PD (2016) Underdiagnosis and Undertreatment of Osteoporosis: The Battle to Be Won. J Clin Endocrinol Metab 101:852&#x2013;859</Citation><ArticleIdList><ArticleId IdType="pubmed">26909798</ArticleId></ArticleIdList></Reference><Reference><Citation>Loskutova N, Honea RA, Vidoni ED, Brooks WM, Burns JM (2009) Bone density and brain atrophy in early Alzheimer&#x2019;s disease. J Alzheimers Dis 18:777&#x2013;785</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2842449</ArticleId><ArticleId IdType="pubmed">19661621</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Lu H, Fan M et al (2024) Bidirectional mediation of bone mineral density and brain atrophy on their associations with gait variability. Sci Rep 14:8483</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11009386</ArticleId><ArticleId IdType="pubmed">38605086</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura N, Muraki S, Nakamura K, Tanaka S (2017) Epidemiology of the locomotive syndrome: The research on osteoarthritis/osteoporosis against disability study 2005&#x2013;2015. Mod Rheumatol 27:1&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">27538793</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura N, Muraki S, Oka H et al (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620&#x2013;628</Citation><ArticleIdList><ArticleId IdType="pubmed">19568689</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T (2010) Cohort profile: research on Osteoarthritis/Osteoporosis Against Disability study. Int J Epidemiol 39:988&#x2013;995</Citation><ArticleIdList><ArticleId IdType="pubmed">19749026</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR (1975) &#x201c;Mini-mental state&#x201d;. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189&#x2013;198</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakusa M, Granda G, Kogoj A, Mlakar J, Vodusek DB (2006) Mini-Mental State Examination: standardization and validation for the elderly Slovenian population. Eur J Neurol 13:141&#x2013;145</Citation><ArticleIdList><ArticleId IdType="pubmed">16490044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciesielska N, Sokolowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kedziora-Kornatowska K (2016) Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol 50:1039&#x2013;1052</Citation><ArticleIdList><ArticleId IdType="pubmed">27992895</ArticleId></ArticleIdList></Reference><Reference><Citation>Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137&#x2013;1148</Citation><ArticleIdList><ArticleId IdType="pubmed">8237484</ArticleId></ArticleIdList></Reference><Reference><Citation>Horii C, Iidaka T, Muraki S et al (2022) The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women: the ROAD study third and fourth surveys. Osteoporos Int 33:889&#x2013;899</Citation><ArticleIdList><ArticleId IdType="pubmed">34797391</ArticleId></ArticleIdList></Reference><Reference><Citation>Horii C, Asai Y, Iidaka T et al (2019) Differences in prevalence and associated factors between mild and severe vertebral fractures in Japanese men and women: the third survey of the ROAD study. J Bone Miner Metab 37:844&#x2013;853</Citation><ArticleIdList><ArticleId IdType="pubmed">30607619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38:95&#x2013;113</Citation><ArticleIdList><ArticleId IdType="pubmed">17761438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae IS, Kim JM, Cheong JH, Han MH, Ryu JI (2019) Association between cerebral atrophy and osteoporotic vertebral compression fractures. PLoS ONE 14:e0224439</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6830774</ArticleId><ArticleId IdType="pubmed">31689324</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajmohan V, Mohandas E (2007) The limbic system. Indian J Psychiatry 49:132&#x2013;139</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917081</ArticleId><ArticleId IdType="pubmed">20711399</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaacson RL (2013) A perspective for the interpretation of limbic system function. Physiol Psychol 8:183&#x2013;188</Citation></Reference><Reference><Citation>Bird CM, Burgess N (2008) The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci 9:182&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pubmed">18270514</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss JL, Bridge DJ, Cohen NJ, Walker JA (2017) A Closer Look at the Hippocampus and Memory. Trends Cogn Sci 21:577&#x2013;588</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5659202</ArticleId><ArticleId IdType="pubmed">28625353</ArticleId></ArticleIdList></Reference><Reference><Citation>Spindler M, Thiel CM (2023) Hypothalamic microstructure and function are related to body mass, but not mental or cognitive abilities across the adult lifespan. Geroscience 45:277&#x2013;291</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886766</ArticleId><ArticleId IdType="pubmed">35896889</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao T, Zhang S, Lee LE, Chao HH, van Dyck C, Li CR (2018) Exploring Age-Related Changes in Resting State Functional Connectivity of the Amygdala: From Young to Middle Adulthood. Front Aging Neurosci 10:209</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6055042</ArticleId><ArticleId IdType="pubmed">30061823</ArticleId></ArticleIdList></Reference><Reference><Citation>St Jacques PL, Dolcos F, Cabeza R (2009) Effects of aging on functional connectivity of the amygdala for subsequent memory of negative pictures: a network analysis of functional magnetic resonance imaging data. Psychol Sci 20:74&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3633516</ArticleId><ArticleId IdType="pubmed">19152542</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger JI, Billig AJ, Sedley W, Kumar S, Griffiths TD, Gander PE (2024) What is the role of the hippocampus and parahippocampal gyrus in the persistence of tinnitus? Hum Brain Mapp 45:e26627</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10878198</ArticleId><ArticleId IdType="pubmed">38376166</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann O, Mattingley JB (2016) Functional Organization of the Parahippocampal Cortex: Dissociable Roles for Context Representations and the Perception of Visual Scenes. J Neurosci 36:2536&#x2013;2542</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6705495</ArticleId><ArticleId IdType="pubmed">26911698</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Wang Z, Du Z et al (2020) Impaired Parahippocampal Gyrus-Orbitofrontal Cortex Circuit Associated with Visuospatial Memory Deficit as a Potential Biomarker and Interventional Approach for Alzheimer Disease. Neurosci Bull 36:831&#x2013;844</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410893</ArticleId><ArticleId IdType="pubmed">32350798</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohbot VD, Allen JJ, Dagher A, Dumoulin SO, Evans AC, Petrides M, Kalina M, Stepankova K, Nadel L (2015) Role of the parahippocampal cortex in memory for the configuration but not the identity of objects: converging evidence from patients with selective thermal lesions and fMRI. Front Hum Neurosci 9:431</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4522562</ArticleId><ArticleId IdType="pubmed">26283949</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminoff EM, Kveraga K, Bar M (2013) The role of the parahippocampal cortex in cognition. Trends Cogn Sci 17:379&#x2013;390</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786097</ArticleId><ArticleId IdType="pubmed">23850264</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura N, Iidaka T, Horii C et al (2022) Epidemiology of locomotive syndrome using updated clinical decision limits: 6-year follow-ups of the ROAD study. J Bone Miner Metab 40:623&#x2013;635</Citation><ArticleIdList><ArticleId IdType="pubmed">35536512</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15708170</PMID><DateCompleted><Year>2005</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0167-5273</ISSN><JournalIssue CitedMedium="Print"><Volume>98</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: a case series and a systematic review of the literature.</ArticleTitle><Pagination><StartPage>395</StartPage><EndPage>401</EndPage><MedlinePgn>395-401</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The role of programmed ventricular stimulation (PVS) in patients with idiopathic dilated cardiomyopathy (DCM) and syncope receiving implantable cardioverter-defibrillators (ICD) remains controversial.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Between 1994 and July 2002, 20 patients with DCM and syncope underwent PVS and ICD implantation at the Onassis Cardiac Surgery Center or the Alexandra General Hospital. At PVS 10 patients had inducible sustained monomorphic ventricular tachycardia (SMVT), 3 patients had inducible sustained polymorphic ventricular tachycardia or ventricular fibrillation, and 7 patients had no inducible arrhythmia. The latter 7 patients received an ICD because of clinical occurrence of ventricular tachycardia (n=5) or fibrillation (n=2). Mean age was 55+/-14 years; 80% were men. During a mean follow-up of 2.8+/-2.3 years, 12 of the 20 patients received an appropriate shock. The incidence of appropriate shocks at 1 and 3 years was 69% and 84% in the inducible SMVT group, and 56% and 67% in the group without inducible SMVT (p=0.93, log rank test). Overall survival was similar in both groups (p=0.53). In a systematic review of the published literature 18 of 75 (24%) patients with DCM, syncope and a negative PVS had an appropriate ICD shock after a mean follow-up of 27 months.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PVS has a limited role in risk stratification of patients with DCM and syncope.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brilakis</LastName><ForeName>Emmanouil S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, 200 First street SW, Rochester, MN 55905, USA. brilakis.emmanouil@mayo.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Maounis</LastName><ForeName>Themos N</ForeName><Initials>TN</Initials></Author><Author ValidYN="Y"><LastName>Rokas</LastName><ForeName>Stylianos G</ForeName><Initials>SG</Initials></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Win-Kuang</ForeName><Initials>WK</Initials></Author><Author ValidYN="Y"><LastName>Stamatelopoulos</LastName><ForeName>Stamatios F</ForeName><Initials>SF</Initials></Author><Author ValidYN="Y"><LastName>Cokkinos</LastName><ForeName>Dennis V</ForeName><Initials>DV</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="N">Cardiomyopathy, Dilated</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015716" MajorTopicYN="N">Electrocardiography, Ambulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010138" MajorTopicYN="Y">Pacemaker, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013575" MajorTopicYN="N">Syncope</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>23</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2003</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>2</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>6</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>2</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15708170</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2003.12.012</ArticleId><ArticleId IdType="pii">S0167527304000804</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31353272</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Patient information sources when facing repair of abdominal aortic aneurysm.</ArticleTitle><Pagination><StartPage>497</StartPage><EndPage>504</EndPage><MedlinePgn>497-504</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2019.04.460</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(19)31127-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Shared medical decision making is most important when there are competing options for repair such as in treatment of abdominal aortic aneurysm (AAA). We sought to understand the sources of patients' pre-existing knowledge about AAA to better inform treating physicians about patients' needs for preoperative counseling.</AbstractText><AbstractText Label="METHODS">We performed a multicenter survey of patients facing AAA repair at 20 Veterans Affairs hospitals across the United States as part of the Preferences for Open Versus Endovascular Repair of AAA study. A validated survey instrument was administered to examine the sources of information available and commonly used by patients to learn about their repair options. The survey was administered by study personnel before the patient had any interaction with the vascular surgeon because survey data were collected before the vascular clinic visit.</AbstractText><AbstractText Label="RESULTS">Preliminary analysis of data from 99 patients showed that our cohort was primarily male (99%) and elderly (mean age 73&#xa0;years). Patients commonly had a history of hypertension (86%), prior myocardial infarction (32%), diabetes (32%), and were overweight (58%). Patients arrived at their surgeon's office appointment with limited information. A majority of patients (52%) reported that they had not talked to their primary care physician at all about their options for AAA repair, and one-half (50%) reported that their view of the different surgical options had not been influenced by anyone. Slightly less than one-half of patients reported that they did not receive any information about open surgical aneurysm repair and endovascular aortic aneurysm repair (41% and 37%, respectively). Few patients indicated using the internet as their main source of information about open surgical aneurysm repair and endovascular aortic aneurysm repair (10% and 11%, respectively).</AbstractText><AbstractText Label="CONCLUSIONS">Patients are commonly referred for AAA repair having little to no information regarding AAA pathology or repair options. Fewer than one in five patients searched the internet or had accessed other sources of information on their own. Most vascular surgeons should assume that patients will present to their first vascular surgery appointment with minimal understanding of the treatment options available to them.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Peter B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt; Geisel School of Medicine at Dartmouth, Hanover, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanken</LastName><ForeName>Zachary J</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perri</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Columbo</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Ravinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spangler</LastName><ForeName>Emily L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Birmingham VA, Birmingham, Ala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newhall</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooke</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Salt Lake City VA, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dosluoglu</LastName><ForeName>Hasan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Buffalo VAMC, Buffalo, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Eugene S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Sacramento VAMC, Mather, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raffetto</LastName><ForeName>Joseph D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>West Roxbury VA, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Peter K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Ann Arbor VAMC, Ann Arbor, Mich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Gale L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Seattle VAMC, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mureebe</LastName><ForeName>Leila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Durham VAMC, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kougias</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Houston VAMC, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johanning</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Omaha VAMC, Omaha, Neb.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arya</LastName><ForeName>Shipra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Atlanta VAMC, Atlanta, Ga.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scali</LastName><ForeName>Salvatore T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Gainesville VAMC, Gainesville, Fla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suckow</LastName><ForeName>Bjoern D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orion</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>West Haven VAMC, West Haven, Conn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halpern</LastName><ForeName>Vivienne</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Phoenix VAMC, Phoenix, Ariz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Los Angeles VAMC, Los Angeles, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inhat</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Minneapolis VAMC, Minneapolis, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Muskogee VAMC, Muskogee, Okla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzeng</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pittsburgh VAMC, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Tucson VAMC, Tucson, Ariz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barry</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital Center for Shared Decision Making, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirovich</LastName><ForeName>Brenda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodney</LastName><ForeName>Philip P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Surgery and VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt. Electronic address: philip.goodney@hitchcock.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PROVE-AAA Study Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 HX001880</GrantID><Acronym>HX</Acronym><Agency>HSRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="Y">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057226" MajorTopicYN="N">Information Seeking Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal aortic aneurysm</Keyword><Keyword MajorTopicYN="N">Decision aid</Keyword><Keyword MajorTopicYN="N">EVAR</Keyword><Keyword MajorTopicYN="N">Information</Keyword><Keyword MajorTopicYN="N">Patient education</Keyword><Keyword MajorTopicYN="N">Shared decision making</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31353272</ArticleId><ArticleId IdType="mid">NIHMS1949096</ArticleId><ArticleId IdType="pmc">PMC10767985</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2019.04.460</ArticleId><ArticleId IdType="pii">S0741-5214(19)31127-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eliason JL, Upchurch GR Jr. Endovascular abdominal aortic aneurysm repair. Circulation. 2008;117(13):1738&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">18378627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Archives of internal medicine. 2000;160(10):1425&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">10826454</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederle FA, Stroupe KT, Open Versus Endovascular Repair Veterans Affairs Cooperative Study G. Cost-effectiveness at two years in the VA Open Versus Endovascular Repair Trial. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2012;44(6):543&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23116986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederle FA, Freischlag JA, Kyriakides TC, Padberg FT Jr., Matsumura JS, Kohler TR, et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA : the journal of the American Medical Association. 2009;302(14):1535&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">19826022</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg FT Jr., Kohler TR, et al. Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. The New England journal of medicine. 2012;367(21):1988&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">23171095</ArticleId></ArticleIdList></Reference><Reference><Citation>Schermerhorn ML, Buck DB, O&#x2019;Malley AJ, Curran T, McCallum JC, Darling J, et al. Long-Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population. The New England journal of medicine. 2015;373(4):328&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532303</ArticleId><ArticleId IdType="pubmed">26200979</ArticleId></ArticleIdList></Reference><Reference><Citation>Reise JA, Sheldon H, Earnshaw J, Naylor AR, Dick F, Powell JT, et al. Patient preference for surgical method of abdominal aortic aneurysm repair: postal survey. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2010;39(1):55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">19775919</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterborn RJ, Amin I, Lyratzopoulos G, Walker N, Varty K, Campbell WB. Preferences for endovascular (EVAR) or open surgical repair among patients with abdominal aortic aneurysms under surveillance. Journal of vascular surgery. 2009;49(3):576&#x2013;81 e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">19268761</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AW, Sedrakyan A, Mao J, Venermo M, Faizer R, Debus S, et al. Variations in Abdominal Aortic Aneurysm Care: A Report From the International Consortium of Vascular Registries. Circulation. 2016;134(24):1948&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5147037</ArticleId><ArticleId IdType="pubmed">27784712</ArticleId></ArticleIdList></Reference><Reference><Citation>The Veterans Administration Makes Shared Decision Making Resources Available to Help with Long Term Care Choices. The Informed Medical Decisions Foundation; [cited 2014]; Available from: http://www.informedmedicaldecisions.org/2013/03/28/the-veterans-administration-makes-shared-decision-making-resources-availableto-help-with-long-term-care-choices/.</Citation></Reference><Reference><Citation>Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, et al. Patient involvement in surgery treatment decisions for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(24):5526&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">16110013</ArticleId></ArticleIdList></Reference><Reference><Citation>Boss EF, Mehta N, Nagarajan N, Links A, Benke JR, Berger Z, et al. Shared Decision Making and Choice for Elective Surgical Care: A Systematic Review. Otolaryngol Head Neck Surg. 2016;154(3):405&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4857133</ArticleId><ArticleId IdType="pubmed">26645531</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein JN, Clay K, Morgan TS. Informed patient choice: patient-centered valuing of surgical risks and benefits. Health affairs. 2007;26(3):726&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2918374</ArticleId><ArticleId IdType="pubmed">17485750</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6478132</ArticleId><ArticleId IdType="pubmed">28402085</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabrera C, Zabalegui A, Bonet M, Caro M, Areal J, Gonzalez JR, et al. A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer: A Randomized Controlled Trial. Cancer Nurs. 2015;38(3):E42&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">25010250</ArticleId></ArticleIdList></Reference><Reference><Citation>Preferences for Open Vs.
Endovascular Repair for Aortic Abdominal Aneurysm. Available from: https://ClinicalTrials.gov/show/NCT03115346.</Citation></Reference><Reference><Citation>Columbo JA, Goodney PP, Kang R, Spangler EL, Newhall K, Brooke BS, et al. Design of The PReferences for Open Versus Endovascular Repair of Abdominal Aortic Aneurysm (PROVE-AAA) Trial. Ann Vasc Surg (In Press). 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10740366</ArticleId><ArticleId IdType="pubmed">31075459</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute TP. Survey of Patient Preference for Method of Abdominal Aortic Aneurysm Repair. In: Institute TP, editor.</Citation></Reference><Reference><Citation>Amante DJ, Hogan TP, Pagoto SL, English TM, Lapane KL. Access to care and use of the Internet to search for health information: results from the US National Health Interview Survey. J Med Internet Res. 2015;17(4):e106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4430679</ArticleId><ArticleId IdType="pubmed">25925943</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DM, Scott GN, Courtney DM, Czerniak A, Aldeen AZ, Gravenor S, et al. What Did You Google? Describing Online Health Information Search Patterns of ED patients and Their Relationship with Final Diagnoses. West J Emerg Med. 2017;18(5):928&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576630</ArticleId><ArticleId IdType="pubmed">28874946</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott G, McCarthy DM, Aldeen AZ, Czerniak A, Courtney DM, Dresden SM. Use of Online Health Information by Geriatric and Adult Emergency Department Patients: Access, Understanding, and Trust. Acad Emerg Med. 2017;24(7):796&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">28423457</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva C, Talwar A, Doyle M. Improving informed consent in cardiac surgery by enhancing preoperative education. Patient education and counseling. 2018;101(12):2047&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">29937111</ArticleId></ArticleIdList></Reference><Reference><Citation>NCVAS. Profile of Veterans: 2014. Data from the American Community Survey. 2016.</Citation></Reference><Reference><Citation>Reddy A, Pollack CE, Asch DA, Canamucio A, Werner RM. The Effect of Primary Care Provider Turnover on Patient Experience of Care and Ambulatory Quality of Care. JAMA Intern Med. 2015;175(7):1157&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5561428</ArticleId><ArticleId IdType="pubmed">25985320</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. Journal of vascular surgery. 2010;52(3):539&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">20630687</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38642122</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1068</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European journal of orthopaedic surgery &amp; traumatology : orthopedie traumatologie</Title><ISOAbbreviation>Eur J Orthop Surg Traumatol</ISOAbbreviation></Journal><ArticleTitle>A prospective randomized control trial comparing outcomes of casting, pinning, and plating for distal end of radius fractures (AO type A2, A3, C1, or C2) in the elderly population.</ArticleTitle><Pagination><StartPage>2473</StartPage><EndPage>2482</EndPage><MedlinePgn>2473-2482</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00590-024-03949-z</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">With this prospective randomized control trial (RCT), we aim to provide the outcome analyses of the three most used treatment modalities for distal end of radius (DER) fracture management in the elderly.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective randomized control trial was performed. Fifty-two patients with DER fractures (AO A2, A3, C1, or C2) were randomized to the casting (n&#x2009;=&#x2009;17), percutaneous pinning (n&#x2009;=&#x2009;18), and the volar plating group (n&#x2009;=&#x2009;17). Radiological measurements measured were radial inclination (RI), radial height (RH), volar tilt (VT), and ulnar variance (UV). The outcome was measured based on range-of-motion, grip strength, Patient-Related-Wrist-Evaluation (PRWE) score, and the Quick-Disabilities-of-the-Arm-Shoulder-Hand (QDASH) score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Immediate post-operative and 1-year-follow-up X-rays showed a significant difference measurement between the groups (p&#x2009;&lt;&#x2009;0.05). Pairwise comparisons of the casting and pinning groups (p&#x2009;&lt;&#x2009;0.05) and the casting and plating groups (p&#x2009;&lt;&#x2009;0.05) revealed significant differences at the 1-year follow-up, but not the pinning and plating groups (p&#x2009;&gt;&#x2009;0.05). The analysis found significant differences in clinical outcomes after 1 month of follow-up, with the plating group outperforming the other two (p&#x2009;&gt;&#x2009;0.05). However, after a year of follow-up, all groups had comparable outcomes; however, the plating group showed improved palmar flexion (p&#x2009;&lt;&#x2009;0.001), radial deviation (p&#x2009;&lt;&#x2009;0.001), and a lower PRWE score (p&#x2009;&lt;&#x2009;0.05), indicating better wrist function. Complications were more in casting group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study found a radiologically significant difference between groups throughout the follow-up, but it did not affect functional results. Clinical outcomes were similar across the groups, with plating showing better palmar flexion and radial deviation. Grip strength was also better in the plating group, but statistically insignificant. The study suggests plating should be chosen over other treatments for high-demand patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Owais</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-6242-0137</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics and Trauma, Ganga Medical Center and Hospital Pvt LTD., 313, Mettupalayam Road, Coimbatore, 641043, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balakrishnan</LastName><ForeName>Pradeep</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Trauma, Ganga Medical Center and Hospital Pvt LTD., 313, Mettupalayam Road, Coimbatore, 641043, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perumal</LastName><ForeName>Ramesh</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7573-6299</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics and Trauma, Ganga Medical Center and Hospital Pvt LTD., 313, Mettupalayam Road, Coimbatore, 641043, India. orthoram@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agraharam</LastName><ForeName>Devendra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Trauma, Ganga Medical Center and Hospital Pvt LTD., 313, Mettupalayam Road, Coimbatore, 641043, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velmurugesan</LastName><ForeName>Purnaganapathi Sundaram</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Trauma, Ganga Medical Center and Hospital Pvt LTD., 313, Mettupalayam Road, Coimbatore, 641043, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayaramaraju</LastName><ForeName>Dheenadhayalan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Trauma, Ganga Medical Center and Hospital Pvt LTD., 313, Mettupalayam Road, Coimbatore, 641043, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajasekaran</LastName><ForeName>Shanmuganathan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Spine Surgery, Ganga Medical Center and Hospital, Coimbatore, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Eur J Orthop Surg Traumatol</MedlineTA><NlmUniqueID>9518037</NlmUniqueID><ISSNLinking>1633-8065</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011885" MajorTopicYN="Y">Radius Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002370" MajorTopicYN="Y">Casts, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001860" MajorTopicYN="Y">Bone Plates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018737" MajorTopicYN="Y">Hand Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="Y">Fracture Fixation, Internal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="Y">Range of Motion, Articular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001858" MajorTopicYN="Y">Bone Nails</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Casting</Keyword><Keyword MajorTopicYN="N">Distal radius fracture</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Functional outcome</Keyword><Keyword MajorTopicYN="N">Pinning</Keyword><Keyword MajorTopicYN="N">Plating</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>20</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>20</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38642122</ArticleId><ArticleId IdType="doi">10.1007/s00590-024-03949-z</ArticleId><ArticleId IdType="pii">10.1007/s00590-024-03949-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sabharwal S, Wilson H, Reilly P, Gupte CM (2015) Heterogeneity of the definition of elderly age in current orthopaedic research. Springerplus 4:516. https://doi.org/10.1186/s40064-015-1307-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40064-015-1307-x</ArticleId><ArticleId IdType="pubmed">26405636</ArticleId><ArticleId IdType="pmc">4573966</ArticleId></ArticleIdList></Reference><Reference><Citation>(2020) Older persons. In: UNHCR. https://emergency.unhcr.org/protection/persons-risk/older-persons . Accessed 26 Dec 2023</Citation></Reference><Reference><Citation>Nellans KW, Kowalski E, Chung KC (2012) The epidemiology of distal radius fractures. Hand Clin 28:113&#x2013;125. https://doi.org/10.1016/j.hcl.2012.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hcl.2012.02.001</ArticleId><ArticleId IdType="pubmed">22554654</ArticleId><ArticleId IdType="pmc">3345129</ArticleId></ArticleIdList></Reference><Reference><Citation>MacIntyre NJ, Dewan N (2016) Epidemiology of distal radius fractures and factors predicting risk and prognosis. J Hand Ther Off J Am Soc Hand Ther 29:136&#x2013;145. https://doi.org/10.1016/j.jht.2016.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jht.2016.03.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannabouathong C, Hussain N, Guerra-Farfan E, Bhandari M (2019) Interventions for distal radius fractures: a network meta-analysis of randomized trials. J Am Acad Orthop Surg 27:e596&#x2013;e605. https://doi.org/10.5435/JAAOS-D-18-00424</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-18-00424</ArticleId><ArticleId IdType="pubmed">31232797</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton RA, Gaston MS, Ralston SH et al (2009) Association between decreased bone mineral density and severity of distal radial fractures. J Bone Jt Surg-Am 91:613&#x2013;619. https://doi.org/10.2106/JBJS.H.00486</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.H.00486</ArticleId></ArticleIdList></Reference><Reference><Citation>Arti HR, Farahnak R (2020) A comparative study on treatment outcomes of bandage and casting in non-displaced extra-articular fracture of distal radius: a clinical trial study. Pol Przegl Chir 92:12&#x2013;15. https://doi.org/10.5604/01.3001.0014.3760</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/01.3001.0014.3760</ArticleId><ArticleId IdType="pubmed">33408261</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh R, Maranna G, Kumar R (2016) A comparative study between closed reduction and cast application versus percutaneous K- wire fixation for extra-articular fracture distal end of radius. J Clin Diagn Res JCDR. https://doi.org/10.7860/JCDR/2016/18266.7220</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2016/18266.7220</ArticleId><ArticleId IdType="pubmed">28208978</ArticleId></ArticleIdList></Reference><Reference><Citation>Das AK, Sundaram N, Prasad TG, Thanhavelu SK (2011) Percutaneous pinning for non-comminuted extra-articular fractures of distal radius. Indian J Orthop 45:422&#x2013;426. https://doi.org/10.4103/0019-5413.83949</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5413.83949</ArticleId><ArticleId IdType="pubmed">21886923</ArticleId><ArticleId IdType="pmc">3162678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochen Y, Peek J, van der Velde D et al (2020) Operative versus nonoperative treatment of distal radius fractures in adults: a systematic review and meta-analysis. JAMA Netw Open 3:e203497. https://doi.org/10.1001/jamanetworkopen.2020.3497</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.3497</ArticleId><ArticleId IdType="pubmed">32324239</ArticleId><ArticleId IdType="pmc">7180423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenney PJ, McQueen MM, Elton R (2006) Prediction of instability in distal radial fractures. J Bone Joint Surg Am 88:1944&#x2013;1951. https://doi.org/10.2106/JBJS.D.02520</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.D.02520</ArticleId><ArticleId IdType="pubmed">16951109</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora R, Lutz M, Deml C et al (2011) A prospective randomized trial comparing nonoperative treatment with volar locking plate fixation for displaced and unstable distal radial fractures in patients sixty-five years of age and older. J Bone Jt Surg 93:2146&#x2013;2153. https://doi.org/10.2106/JBJS.J.01597</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.J.01597</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Mendez D, Lizaur-Utrilla A, de Juan Herrero J (2018) Intra-articular distal radius fractures in elderly patients: a randomized prospective study of casting versus volar plating. J Hand Surg Eur 43:142&#x2013;147. https://doi.org/10.1177/1753193417727139</Citation></Reference><Reference><Citation>MacDermid JC (1996) Development of a scale for patient rating of wrist pain and disability. J Hand Ther 9:178&#x2013;183. https://doi.org/10.1016/S0894-1130(96)80076-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0894-1130(96)80076-7</ArticleId><ArticleId IdType="pubmed">8784681</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaton DE, Wright JG, Katz JN (2005) Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Jt Surg 87:1038&#x2013;1046. https://doi.org/10.2106/JBJS.D.02060</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.D.02060</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauresh V (2014) Distal end radius fractures: evaluation of results of various treatments and assessment of treatment choice. Chin J Traumatol 17:214&#x2013;219. https://doi.org/10.3760/cma.j.issn.1008-1275.2014.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.1008-1275.2014.04.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Achten J, Sones W, Dias J et al (2019) Surgical fixation with K-wires versus plaster casting in the treatment of dorsally displaced distal radius fractures: protocol for distal radius acute fracture fixation trial 2 (DRAFFT 2). BMJ Open 9:e028474. https://doi.org/10.1136/bmjopen-2018-028474</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028474</ArticleId><ArticleId IdType="pubmed">30904879</ArticleId><ArticleId IdType="pmc">6475232</ArticleId></ArticleIdList></Reference><Reference><Citation>Trumble TE, Schmitt SR, Vedder NB (1994) Factors affecting functional outcome of displaced intra-articular distal radius fractures. J Hand Surg 19:325&#x2013;340. https://doi.org/10.1016/0363-5023(94)90028-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0363-5023(94)90028-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozental TD, Blazar PE (2006) Functional outcome and complications after volar plating for dorsally displaced, unstable fractures of the distal radius. J Hand Surg 31:359&#x2013;365. https://doi.org/10.1016/j.jhsa.2005.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhsa.2005.10.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozental TD, Beredjiklian PK, Bozentka DJ (2003) Functional outcome and complications following two types of dorsal plating for unstable fractures of the distal part of the radius. J Bone Jt Surg-Am 85:1956&#x2013;1960. https://doi.org/10.2106/00004623-200310000-00014</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-200310000-00014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamath AF, Zurakowski D, Day CS (2006) Low-profile dorsal plating for dorsally angulated distal radius fractures: an outcomes study. J Hand Surg 31:1061&#x2013;1067. https://doi.org/10.1016/j.jhsa.2006.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhsa.2006.05.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopylov P, Johnell O, Redlund-Johnell I, Bengner U (1993) Fractures of the distal end of the radius in young adults: a 30-year follow-up. J Hand Surg 18:45&#x2013;49. https://doi.org/10.1016/0266-7681(93)90195-L</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0266-7681(93)90195-L</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzopardi T, Ehrendorfer S, Coulton T, Abela M (2005) Unstable extra-articular fractures of the distal radius: a prospective, randomised study of immobilisation in a cast versus supplementary percutaneous pinning. J Bone Joint Surg Br 87-B:837&#x2013;840. https://doi.org/10.1302/0301-620X.87B6.15608</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.87B6.15608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung KC, Kim HM, Malay S et al (2021) Comparison of 24-month outcomes after treatment for distal radius fracture: the WRIST randomized clinical trial. JAMA Netw Open 4:e2112710. https://doi.org/10.1001/jamanetworkopen.2021.12710</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12710</ArticleId><ArticleId IdType="pubmed">34137830</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal RN, Shapiro LM (2022) American Academy of Orthopaedic Surgeons/American society for surgery of the hand clinical practice guideline summary management of distal radius fractures. J Am Acad Orthop Surg 30:e480&#x2013;e486. https://doi.org/10.5435/JAAOS-D-21-00719</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-21-00719</ArticleId><ArticleId IdType="pubmed">35143462</ArticleId><ArticleId IdType="pmc">9196973</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30891608</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Prophylactic implantable cardioverter-defibrillator in the very elderly.</ArticleTitle><Pagination><StartPage>1063</StartPage><EndPage>1069</EndPage><MedlinePgn>1063-1069</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euz041</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Current guidelines do not propose any age cut-off for the primary prevention implantable cardioverter-defibrillator (ICD). However, the risk/benefit balance in the very elderly population has not been well studied.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">In a multicentre French study assessing patients implanted with an ICD for primary prevention, outcomes among patients aged &#x2265;80&#x2009;years were compared with &lt;80&#x2009;years old controls matched for sex and underlying heart disease (ischaemic and dilated cardiomyopathy). A total of 300 ICD recipients were enrolled in this specific analysis, including 150 patients &#x2265;80&#x2009;years (mean age 81.9&#x2009;&#xb1;&#x2009;2.0&#x2009;years; 86.7% males) and 150 controls (mean age 61.8&#x2009;&#xb1;&#x2009;10.8&#x2009;years). Among older patients, 92 (75.6%) had no more than one associated comorbidity. Most subjects in the elderly group got an ICD as part of a cardiac resynchronization therapy procedure (74% vs. 46%, P&#x2009;&lt;&#x2009;0.0001). After a mean follow-up of 3.0&#x2009;&#xb1;&#x2009;2&#x2009;years, 53 patients (35%) in the elderly group died, including 38.2% from non cardiovascular causes of death. Similar proportion of patients received &#x2265;1 appropriate therapy (19.4% vs. 21.6%; P&#x2009;=&#x2009;0.65) in the elderly group and controls, respectively. There was a trend towards more early perioperative events (P&#x2009;=&#x2009;0.10) in the elderly, with no significant increase in late complications (P&#x2009;=&#x2009;0.73).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Primary prevention ICD recipients &#x2265;80&#x2009;years in the real world had relatively low associated comorbidity. Rates of appropriate therapies and device-related complications were similar, compared with younger subjects. Nevertheless, the inherent limitations in interpreting observational data on this particular competing risk situation call for randomized controlled trials to provide definitive answers. Meanwhile, a careful multidisciplinary evaluation is needed to guide patient selection for ICD implantation in the elderly population.</AbstractText><CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. &#xa9; The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zakine</LastName><ForeName>Cyril</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Rodrigue</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University Hospital of Poitiers, Poitiers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narayanan</LastName><ForeName>Kumar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maxcure Hospitals, Hyderabad, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gandjbakhch</LastName><ForeName>Estelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>La Piti&#xe9; Salp&#xea;tri&#xe8;re Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Algalarrondo</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Antoine-B&#xe9;cl&#xe8;re Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lellouche</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Henri Mondor Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perier</LastName><ForeName>Marie-C&#xe9;cile</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Georges Pompidou Hospital, Cardiology Department, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fauchier</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Tours University Hospital, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gras</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hopital priv&#xe9; du Confluent, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bordachar</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital od Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piot</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centre Cardiologique du Nord, Saint Denis, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babuty</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Tours University Hospital, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadoul</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Nancy University Hospital, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defaye</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital of Grenoble, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deharo</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>La Timone University Hospital, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klug</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Lille University Hospital, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leclercq</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Rennes University Hospital, Universit&#xe9; de Rennes, CIC-IT, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Extramiana</LastName><ForeName>Fabrice</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Bichat-Claude-Bernard Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boveda</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinique Pasteur, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marijon</LastName><ForeName>Eloi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Georges Pompidou Hospital, Cardiology Department, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Descartes University, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011322" MajorTopicYN="Y">Primary Prevention</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmias</Keyword><Keyword MajorTopicYN="N">Geriatrics</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter-defibrillator</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Sudden death</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30891608</ArticleId><ArticleId IdType="doi">10.1093/europace/euz041</ArticleId><ArticleId IdType="pii">5396693</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22270056</PMID><DateCompleted><Year>2012</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2763</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>4</Issue><PubDate><Year>2012</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Bone</Title><ISOAbbreviation>Bone</ISOAbbreviation></Journal><ArticleTitle>A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) study.</ArticleTitle><Pagination><StartPage>917</StartPage><EndPage>924</EndPage><MedlinePgn>917-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bone.2012.01.003</ELocationID><Abstract><AbstractText>The Matrilin3 gene (MATN3) encodes an extracellular matrix protein, which modulates chondrocyte differentiation. The aim of this study was to test for association of MATN3 polymorphisms with bone mineral density (BMD), fracture, vertebral fracture, bone turnover or 25-hydroxyvitamin D [25(OH)D] in postmenopausal women. A community-based population of 1488 postmenopausal women was randomly selected in Beijing. The history of fracture and vertebral fracture was obtained via questionnaire and vertebral X-ray respectively. BMD of lumbar spine (2-4), femoral neck and total hip were measured by dual energy X-ray absorptiometry. Serum N-terminal procollagen of type 1 collagen (P1NP), &#x3b2;-isomerized type I collagen C-telopeptide breakdown products (&#x3b2;-CTX) and 25(OH)D were quantified. Binary logistic regression revealed that Haplotype-4 was significantly associated with vertebral fracture risk in both additive model (p=0.023, OR=1.521) and dominant model (p=0.028, OR=1.623). The significance remained after 10,000 permutation tests to correct multiple testing (p=0.042). Re-selected age matched vertebral fracture case-control groups revealed similar associations in additive model (p=0.014, OR=1.927, 95%CI=1.142-3.253) and in dominant model (p=0.011, OR=2.231, 95%CI=1.200-4.148). However, no significant association was found between MATN3 polymorphisms and serum &#x3b2;-CTX, P1NP, 25(OH)D levels, or BMD. In linear regression, Haplotype-2 approached marginal significance in association with femoral neck BMD T-score (p=0.050), but this would account for only 0.2% of BMD variation in our sample. This study suggests that Haplotype-4 of MATN3 is associated with vertebral fracture risk independent of BMD in Chinese postmenopausal women. Efforts should be made to replicate our finding in other, similar and ethnically diverse, populations.</AbstractText><CopyrightInformation>Copyright &#xc2;&#xa9; 2011 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Weibo</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xin</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiuping</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiran</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenbo</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Ning</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mei</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ou</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yue</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Lianmei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Shuli</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Yu</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fan</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Youxia</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Yanmin</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Che</LastName><ForeName>Ying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Ruixin</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xueying</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qian</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ling</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P20 GM104937</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bone</MedlineTA><NlmUniqueID>8504048</NlmUniqueID><ISSNLinking>1873-2763</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024042">Collagen Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016326">Extracellular Matrix Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064235">Matrilin Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011347">Procollagen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C052929">collagen type I trimeric cross-linked peptide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C047202">procollagen Type I N-terminal peptide</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>A288AR3C9H</RegistryNumber><NameOfSubstance UI="C104450">25-hydroxyvitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024042" MajorTopicYN="N">Collagen Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016326" MajorTopicYN="N">Extracellular Matrix Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015810" MajorTopicYN="N">Linkage Disequilibrium</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064235" MajorTopicYN="N">Matrilin Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011347" MajorTopicYN="N">Procollagen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of interest statement. No disclosure.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22270056</ArticleId><ArticleId IdType="mid">NIHMS508501</ArticleId><ArticleId IdType="pmc">PMC6122846</ArticleId><ArticleId IdType="doi">10.1016/j.bone.2012.01.003</ArticleId><ArticleId IdType="pii">S8756-3282(12)00011-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harris M, Nguyen TV, Howard GM, Kelly PJ, Eisman JA. Genetic and environmental correlations between bone formation and bone mineral density: a twin study. Bone 1998;22:141&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9477237</ArticleId></ArticleIdList></Reference><Reference><Citation>Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr. Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 1991;6:561&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">1887818</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan EL, Cardon LR, Sinsheimer JS, Wass JA, Brown MA. Site and gender specificity of inheritance of bone mineral density. J Bone Miner Res 2003;18:1531&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12929944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;guen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G. Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 1995;10:2017&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">8619384</ArticleId></ArticleIdList></Reference><Reference><Citation>Arde&#x148;a GJ, Paz-Pacheco E, Jimeno CA, Lantion-Ang FL, Paterno E, Juban N. Knowledge, attitudes and practices of persons with type 2 diabetes in a rural community: phase I of the community-based Diabetes Self-Management Education (DSME) Program in San Juan, Batangas, Philippines. Diabetes Res Clin Pract 2010;90:160&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20828851</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan CP, Brown CJ, Goode PS, Burgio KL, Allman RM, Johnson TM II. The association of nocturia with incident falls in an elderly community-dwelling cohort. Int J Clin Pract 2010;64:577&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3222329</ArticleId><ArticleId IdType="pubmed">20456212</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagener R, Kobbe B, Paulsson M. Primary structure of matrilin-3, a new member of a family of extracellular matrix proteins related to cartilage matrix protein (matrilin-1) and von Willebrand factor. FEBS Lett 1997;413:129&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9287130</ArticleId></ArticleIdList></Reference><Reference><Citation>Budde B, Blumbach K, Yl&#xf6;stalo J, Zaucke F, Ehlen HW, Wagener R, et al. Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Mol Cell Biol 2005;25:10465&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1291247</ArticleId><ArticleId IdType="pubmed">16287859</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagener R, Ehlen HW, Ko YP, Kobbe B, Mann HH, Sengle G, et al. The matrilins&#x2014;adaptor proteins in the extracellular matrix. FEBS Lett 2005;579:3323&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15943978</ArticleId></ArticleIdList></Reference><Reference><Citation>Claus S, Aubert-Foucher E, Demoor M, Camuzeaux B, Paumier A, Piperno M, et al. Chronic exposure of bone morphogenetic protein-2 favors chondrogenic expression in human articular chondrocytes amplified in monolayer cultures. J Cell Biochem 2010;111:1642&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">21053273</ArticleId></ArticleIdList></Reference><Reference><Citation>Reneland RH, Mah S, Kammerer S, Hoyal CR, Marnellos G, Wilson SG, et al. Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med Genet 2005;6:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC554993</ArticleId><ArticleId IdType="pubmed">15752431</ArticleId></ArticleIdList></Reference><Reference><Citation>Styrkarsdottir U, Cazier JB, Kong A, Rolfsson O, Larsen H, Bjarnadottir E, et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 2003;1:E69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC270020</ArticleId><ArticleId IdType="pubmed">14691541</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu LR, Wilson SG, Dick IM, Islam FM, Devine A, Prince RL. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone 2005;36:555&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">15777683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronenberg hM Developmental regulation of the growth plate. Nature 2003;423: 332&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12748651</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman BI, Bowden DW, Ziegler JT, Langefeld CD, Lehtinen AB, Rudock ME, et al. Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J Bone Miner Res 2009;24:1719&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743282</ArticleId><ArticleId IdType="pubmed">19453255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Koh JM, Hwang JY, Choi KY, Lee SH, Park EK, et al. Association of a RUNX2 promoter polymorphism with bone mineral density in postmenopausal Korean women. Calcif Tissue Int 2009;84:439&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">19424741</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Weyden L, Wei L, Luo J, Yang X, Birk DE, Adams DJ, et al. Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis. Am J Pathol 2006;169: 515&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1698783</ArticleId><ArticleId IdType="pubmed">16877353</ArticleId></ArticleIdList></Reference><Reference><Citation>Borochowitz ZU, Scheffer D, Adir V, Dagoneau N, Munnich A, Cormier-Daire V. Spondylo-epi-metaphyseal dysplasia (SEMD) matrilin 3 type: homozygote matrilin 3 mutation in a novel form of SEMD. J Med Genet 2004;41:366&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1735768</ArticleId><ArticleId IdType="pubmed">15121775</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotterill SL,Jackson GC, Leighton MP, Wagener R, M&#xe4;kitie O, Cole WG, et al. Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3. Hum Mutat 2005;26:557&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726956</ArticleId><ArticleId IdType="pubmed">16287128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fresquet M, Jackson GC, Loughlin J, Briggs MD. Novel mutations in exon 2 of MATN3 affect residues within the alpha-helices of the A-domain and can result in the intracellular retention of mutant matrilin-3. Hum Mutat 2008;29:330.</Citation><ArticleIdList><ArticleId IdType="pubmed">18205203</ArticleId></ArticleIdList></Reference><Reference><Citation>Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001;10:537&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">11181578</ArticleId></ArticleIdList></Reference><Reference><Citation>Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 2002;39:91&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1735035</ArticleId><ArticleId IdType="pubmed">11836356</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkow ME, Gardner JC, Ness JV, Paeper BW, Kovacevich BR, Proll S, et al. Bone dysplasia sclerosteosis results from loss of the sost gene product, a novel cystine knot-containing protein. Am J Hum Genet 2001;68:577&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1274471</ArticleId><ArticleId IdType="pubmed">11179006</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001;107:513&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11719191</ArticleId></ArticleIdList></Reference><Reference><Citation>Koller DL, Ichikawa S, Johnson ML, Lai D, Xuei X, Edenberg HJ, et al. Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 2005;20:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">15619672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornak U, Ostertag A, Branger S, Benichou O, de Vernejoul MC. Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II. J Clin Endocrinol Metab 2006;91:995&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">16368748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralston SH. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 2002;87:2460&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12050200</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang QY, Kung AW. Genetics of osteoporosis. Mol Genet Metab 2006;88: 295&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">16762578</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang QY, Li GH, Cheung WM, Song YQ, Kung AW. Prediction of osteoporosis candidate genes by computational disease-gene identification strategy. J Hum Genet 2008;53:644&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18463784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZH, Shen JX, Liu ZH. Retrospective study on standardization of BMD machines in China. Chin J Osteoporos 2005;11:133&#x2013;45.</Citation></Reference><Reference><Citation>Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">8237484</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004;34:195&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">14751578</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts NB, Cooper C, Lindsay R, Eastell R, Manhart MD, Barton IP, et al. Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom 2004;7:255&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">15319494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes JB, Danilevicius CF, Takayama L, Caparbo VF, Menezes PR, Scazufca M, et al. Prevalence and risk factors of radiographic vertebral fracture in Brazilian community-dwelling elderly. Osteoporos Int 2011;22:711&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20442985</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman KL, Mortier GR, Chapman K, Loughlin J, Grant ME, Briggs MD. Mutations in the region encoding the vonWillebrand factor Adomain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat Genet 2001;28:393&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11479597</ArticleId></ArticleIdList></Reference><Reference><Citation>Otten C, Hansen U, Talke A, Wagener R, Paulsson M, Zaucke F. A matrilin-3 mutation associated with osteoarthritis does not affect collagen affinity but promotes the formation of wider cartilage collagen fibrils. Hum Mutat 2010;31:254&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">20077500</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YZ, Pei YF, Liu JF, Yang F. Powerful bivariate genome-wide association analyses suggest the SOX6 gene influencing both obesity and osteoporosis phenotypes in males. PLoS One 2009;4:e6827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2730014</ArticleId><ArticleId IdType="pubmed">19714249</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta NS, Abou-Samra AB. PTH and PTHrP signaling in osteoblasts. Cell Signal 2009;21:1245&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2723940</ArticleId><ArticleId IdType="pubmed">19249350</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolae C, Ko YP, Miosge N, Niehoff A, Studer D, Enggist L, et al. Abnormal collagen fibrils in cartilage of matrilin-1/matrilin-3-deficient mice. J Biol Chem 2007;282: 22163&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">17502381</ArticleId></ArticleIdList></Reference><Reference><Citation>Stef&#xe1;nsson SE, J&#xf3;nsson H, Ingvarsson T, Manolescu I, J&#xf3;nsson HH, Olafsd&#xf3;ttir G, et al. Genomewide scan for hand osteoarthritis: a novel mutation in matrilin-3. Am J Hum Genet 2003;72:1448&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1180305</ArticleId><ArticleId IdType="pubmed">12736871</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JL, Meulenbelt I, Riyazi N, Kloppenburg M, Houwing-Duistermaat JJ, Seymour AB, et al. Association of matrilin-3 polymorphisms with spinal disc degeneration and osteoarthritis of the first carpometacarpal joint of the hand. Ann Rheum Dis 2006;65:1060&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1798238</ArticleId><ArticleId IdType="pubmed">16396979</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullig O, Tagariello A, Schweizer A, Swoboda B, Schaller P, Winterpacht A. MATN3 (matrilin-3) sequence variation (pT303M) is a risk factor for osteoarthritis of the CMC1 joint of the hand, but not for knee osteoarthritis. Ann Rheum Dis 2007;66: 279&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1798488</ArticleId><ArticleId IdType="pubmed">17242023</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliasson GJ, Verbruggen G, Stefansson SE, Ingvarsson T, Jonsson H. Hand radiology characteristics of patients carrying the T(303)M mutation in the gene for matrilin-3. Scand J Rheumatol 2006;35:138&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">16641049</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendina D, Gianfrancesco F, Filippo GD, Merlotti D, Esposito T, Mingione A, et al. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol 2010;163: 165&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">20335500</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshandel D, Holliday KL, Pye SR, Boonen S, Borghs H, Vanderschueren D, et al. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res 2010;25: 1830&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20205168</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26602970</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-4713</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Ophthalmology</Title><ISOAbbreviation>Ophthalmology</ISOAbbreviation></Journal><ArticleTitle>Trabeculectomy Can Improve Long-Term Visual Function in Glaucoma.</ArticleTitle><Pagination><StartPage>117</StartPage><EndPage>128</EndPage><MedlinePgn>117-28</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ophtha.2015.09.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0161-6420(15)01096-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To measure the magnitude and direction of visual field (VF) rates of change in glaucoma patients after intraocular pressure (IOP) reduction with trabeculectomy.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective, comparative, longitudinal cohort study.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients with open-angle glaucoma.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients who underwent trabeculectomy (Trab) with mitomycin-C (74 eyes of 64 patients) with &#x2265;4 reliable VF measurements before and after trabeculectomy and at least 4 years of follow-up before and after surgery were included. Decay or improvement exponential models were used to calculate pointwise rates of perimetric change before and after surgery. A separate comparison (Comp) group with unoperated glaucoma (71 eyes of 65 patients) with similar baseline damage, number of VF tests, and follow-up was used to address possible regression to the mean. Proportions of VF locations decaying or improving before and after surgery in the Trab group, and during the first and second halves of follow-up in the Comp group, were calculated. A multivariate analysis was used to explore variables associated with VF improvement.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The rate of pointwise VF change before and after surgery in the Trab group and Comp group.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in the Trab group were followed for 5.1&#xb1;2.1 years (mean &#xb1; standard deviation) before and 5.4&#xb1;2.3 years after surgery, with 8.9&#xb1;4.7 VF tests before and 9.0&#xb1;4.4 VF tests after surgery. The mean rate of change for all VF locations slowed from -2.5&#xb1;9.3%/year before surgery to -0.10&#xb1;13.1%/year after surgery (P &lt; 0.001). In the Trab group, 70% of locations decayed and 30% improved preoperatively; postoperatively, 56% decayed and 44% improved. The differences between the Trab and Comp groups were significant (P &lt; 0.0001, chi-square test). The magnitude of IOP reduction correlated with the excess number of VF locations that exhibited long-term improvement postoperatively (P = 0.009). In the Trab group, 57% of eyes had &#x2265;10 improving VF locations postoperatively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results show that trabeculectomy slows the rate of perimetric decay and provide evidence of sustained, long-term improvement of visual function in glaucoma. These findings suggest the possibility of reversal of glaucomatous dysfunction of retinal ganglion cells and their central projections.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caprioli</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California. Electronic address: caprioli@jsei.ucla.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Leon</LastName><ForeName>John Mark</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azarbod</LastName><ForeName>Parham</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouri-Mahdavi</LastName><ForeName>Kouros</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California; Department of Biostatistics and Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afifi</LastName><ForeName>Abdelmonem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ophthalmology</MedlineTA><NlmUniqueID>7802443</NlmUniqueID><ISSNLinking>0161-6420</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Indian J Ophthalmol. 2023 May;71(5):1953-1959. doi: 10.4103/ijo.IJO_2071_22.</RefSource><PMID Version="1">37203064</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="N">Trabeculectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26602970</ArticleId><ArticleId IdType="doi">10.1016/j.ophtha.2015.09.027</ArticleId><ArticleId IdType="pii">S0161-6420(15)01096-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32027383</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Laryngoscope</Title><ISOAbbreviation>Laryngoscope</ISOAbbreviation></Journal><ArticleTitle>The Reflux Symptom Index and Symptom Overlap in Dysphonic Patients.</ArticleTitle><Pagination><StartPage>2631</StartPage><EndPage>2636</EndPage><MedlinePgn>2631-2636</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.28506</ELocationID><Abstract><AbstractText Label="OBJECTIVES/HYPOTHESIS">The Reflux Symptom Index (RSI) is a validated quality-of-life instrument that quantifies symptoms associated with laryngopharyngeal reflux (LPR). Many dysphonic patients are managed empirically for reflux. In this study, we examine responses to the RSI in patients with dysphonia attributable to a variety of pathologies.</AbstractText><AbstractText Label="STUDY DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="METHODS">This is an institutional review board-approved study. All patients presented to a tertiary care voice center January 2011 to June 2016 with the chief complaint of dysphonia. Patients were analyzed by 1) diagnosis and 2) treatment modality: surgery, medicine, or voice therapy (VT). Data collected included pre- and postintervention RSI and Voice Handicap Index, demographic, and clinical information. Statistical analysis was performed using SPSS.</AbstractText><AbstractText Label="RESULTS">Five hundred forty-six dysphonic patients were included. One hundred forty required surgery, 155 were treated with VT alone, and 251 were medically managed (MM). Prior to therapy, 63.4% of surgery patients, 62.5% of VT patients, and 74.6% of MM patients had an abnormal RSI with a score greater than 13. The most common diagnosis for each group was vocal cord paresis/paralysis (surgery), vocal fold atrophy (VT), and LPR (MM). There was a statistically significant improvement in RSI after treatment for each group.</AbstractText><AbstractText Label="CONCLUSIONS">In patients with dysphonia, pretreatment RSI scores were elevated for a variety of laryngeal pathologies. Scores often improved with directed treatment, regardless of etiology. This highlights the symptom overlap between reflux and nonreflux causes of dysphonia, and the importance of a comprehensive workup for patients with voice complaints.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">4 Laryngoscope, 130:2631-2636, 2020.</AbstractText><CopyrightInformation>&#xa9; 2020 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kavookjian</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9506-8902</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Missouri, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irwin</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Missouri, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garnett</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Missouri, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraft</LastName><ForeName>Shannon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Missouri, U.S.A.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Laryngoscope</MedlineTA><NlmUniqueID>8607378</NlmUniqueID><ISSNLinking>0023-852X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055154" MajorTopicYN="N">Dysphonia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007818" MajorTopicYN="N">Laryngeal Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057045" MajorTopicYN="N">Laryngopharyngeal Reflux</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Reflux severity index</Keyword><Keyword MajorTopicYN="N">dysphonia</Keyword><Keyword MajorTopicYN="N">laryngopharyngeal reflux</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32027383</ArticleId><ArticleId IdType="doi">10.1002/lary.28506</ArticleId></ArticleIdList><ReferenceList><Title>BIBLIOGRAPHY</Title><Reference><Citation>Roy N, Merrill RM, Gray SD, Smith EM. Voice disorders in the general population: prevalence, risk factors and occupational impact. Laryngoscope 2005;115:1988-1995.</Citation></Reference><Reference><Citation>Cohen SM. Self-reported impact of dysphonia in a primary care population: an epidemiological study. Laryngoscope 2010;120:2022-2032.</Citation></Reference><Reference><Citation>Cohen SM, Kim J, Roy N, Asche C, Courey M. Direct health care costs of laryngeal diseases and disorders. Laryngoscope 2012;122:1582-1588.</Citation></Reference><Reference><Citation>Ramig LO, Verdolini K. Treatment efficacy: voice disorders. J Speech Lang Hear Res 1998;41:S101-S116.</Citation></Reference><Reference><Citation>Wiener GJ, Koufman JA, Wu WC, Cooper JB, Richter JE, Castell DO. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-hr ambulatory pH monitoring. Am J Gastroenterol 1989;84:1503-1507.</Citation></Reference><Reference><Citation>Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000;123:343-385.</Citation></Reference><Reference><Citation>Cherry J, Magulies SI. Contact ulcer of the larynx. Laryngoscope 1968;78:1937-1940.</Citation></Reference><Reference><Citation>Delahunty JE, Cherry J. Experimentally produced vocal cord granulomas. Laryngoscope 1968;78:1941-1947.</Citation></Reference><Reference><Citation>Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(4 pt 2 suppl 53):1-78.</Citation></Reference><Reference><Citation>Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptoms index (RSI). J Voice 2002;16:274-277.</Citation></Reference><Reference><Citation>Johnson A, Jacobson B, Grywalski C, Silbergleit A, Jacobson G, Benninger MS. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 1997;6:66-70.</Citation></Reference><Reference><Citation>Solomon NP, Helou LB, Henry LR, et al. Utility of the voice handicap index as an indicator of postthyroidectomy voice dysfunction. J Voice 2013;27:348-354.</Citation></Reference><Reference><Citation>Francis DO, Vaezi M. Should the reflux be reflux? Throat symptoms and alternative explanations. Clin Gastroenterol Hepatol 2015;13:1560-1566.</Citation></Reference><Reference><Citation>Holcomb AJ, Hamill CS, Irwin T, Sykes K, Garnett JD, Kraft S. Practice patterns of referring physicians in management of the dysphonic patient. Otolaryngol Head Neck Surg 2018;158:1072-1078.</Citation></Reference><Reference><Citation>Cohen SM, Pitman MJ, Noordzij JP, Courey M. Management of dysphonic patients by otolaryngologists. Otolaryngol Head Neck Surg 2012;147:289-294.</Citation></Reference><Reference><Citation>Ruiz R, Jeswari S, Andrews K, et al. Hoarseness and laryngopharyngeal reflux a survey of primary care physician practice patterns. JAMA Otolaryngol Head Neck Surg 2014;140:192-196.</Citation></Reference><Reference><Citation>Chen M, Hou C, Chen T, Lin Z, Wang X, Zeng Y. Reflux symptoms index and reflux findings score in 91 asymptomatic volunteers. Acta Otolaryngol 2018;138:659-663.</Citation></Reference><Reference><Citation>Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005;294:1540-1543.</Citation></Reference><Reference><Citation>Sulica L. Hoarseness misattributed to reflux: sources and patterns of error. Ann Otol Rhinol Laryngol 2014;123:442-445.</Citation></Reference><Reference><Citation>Cohen SM, Garrett CG. Hoarseness: is it really laryngopharyngeal reflux? Laryngoscope 2008;18:363-366.</Citation></Reference><Reference><Citation>Altman KW, Atkinson C, Lazarus C. Current and emerging concepts in muscle tension dysphonia: a 30-month review. J Voice 2005;19:261-267.</Citation></Reference><Reference><Citation>Park KH, Choi SM, Kwon SU, Yoon SW, Kim SUK. Diagnosis of laryngopharyngeal reflux among globus patients. Otolaryngol Head Neck Surg 2006;134:81-85.</Citation></Reference><Reference><Citation>Patel AK, Mildenhall NR, Kim W, Carroll TL. Symptom overlap between laryngopharyngeal reflux and glottic insufficiency in vocal fold atrophy patients. Ann Otol Laryngol Rhinol 2014;123:265-270.</Citation></Reference><Reference><Citation>Park JO, Shim MR, Hwang YS, et al. Combination of voice therapy and antireflux therapy rapidly recovers voice-related symptoms in laryngopharyngeal reflux patients. Otolaryngol Head Neck Surg 2012;146:92-97.</Citation></Reference><Reference><Citation>Ruddy BH, Pitts TE, Lehman J, Spector B, Lewis V, Sapienza CM. Improved voluntary cough immediately following office based vocal fold medialization injections. Laryngoscope 2014;124:1645-1647.</Citation></Reference><Reference><Citation>Stachler RJ, Francis DO, Schwartz SR, et al. Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngol Head Neck Surg 2018;158:S1-S42.</Citation></Reference><Reference><Citation>Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR. Proton pump inhibitors and the risk for hospital-acquired Clostridium difficile infection. Mayo Clin Proc 2013;88:1085-1090.</Citation></Reference><Reference><Citation>Bahitiri E, Islami H, Hoxha R, et al. Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors. J Bone Miner Metab 2016;34:571-579.</Citation></Reference><Reference><Citation>Maggio M, Lauretani F, Ceda GP, et al. Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals. Bone 2013;57:437-442.</Citation></Reference><Reference><Citation>Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: critical review. Clin Nephrol 2007;68:65-72.</Citation></Reference><Reference><Citation>Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 2016;27:3153-3163.</Citation></Reference><Reference><Citation>Rojo LE, Alzate-Morales J, Saavedra IN, Davies P, Maccioni RB. Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. J Alzheimers Dis 2010;19:573-589.</Citation></Reference><Reference><Citation>Haenisch B, von Holt K, Wiese B, et al. Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci 2015;265:419-428.</Citation></Reference><Reference><Citation>Gomm W, Von Holt K, Thome F, et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepdemiological claims data analysis. JAMA Neurol 2016;73:410-416.</Citation></Reference><Reference><Citation>Noordzji JP, Khidr A, vans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001;111:2147-2151.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29452692</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1913</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>The American journal of cardiology</Title><ISOAbbreviation>Am J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction.</ArticleTitle><Pagination><StartPage>805</StartPage><EndPage>809</EndPage><MedlinePgn>805-809</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2017.12.036</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9149(18)30057-2</ELocationID><Abstract><AbstractText>The aim of the study was to assess the clinical significance of complex ventricular arrhythmias (VAs) (sustained ventricular tachycardia [sVT] and ventricular fibrillation [VF]) in patients with ST-segment elevation myocardial infarction (STEMI) depending on timing of arrhythmia. We analyzed 4,363 consecutive patients with STEMI treated invasively between 2004 and 2014. The median follow-up was 69.6 months (range: 0 to 139.8 months). The study population was divided into 2 main groups; VA group encompassed 476 patients (10.91%) with VAs, whereas 3,887 subjects (89.09%) without VT or VF were included into the control group. In VA population, prereperfusion VA (34.24%; n&#x2009;=&#x2009;163) was the most common arrhythmia, whereas reperfusion-induced, early postreperfusion, and late postreperfusion VAs were diagnosed in 103 (21.64%), 103 (21.64%), and 107 (22.48%) patients, respectively. Every type of sVT or VF complicating STEMI portended significantly worse in-hospital prognosis, however a late onset arrhythmia was associated with the highest (over fivefold) and reperfusion-induced VA with the lowest (less than threefold) increase in mortality risk compared with the control group. On the contrary, long-term mortality was significantly increased only in subjects with late postreperfusion and prereperfusion VAs compared with VA-free population (43.93% and 36.81%, respectively vs 22.58%; p&#x2009;&lt;0.001). Apart from cardiogenic shock on admission, late postreperfusion (hazard ratio 3.39) and prereperfusion VAs (hazard ratio 2.76) were the strongest independent predictors of death in the analyzed population. In conclusion, 1 in 10 patients with STEMI treated invasively was affected by sVT or VF. The clinical impact of VAs was strongly dependent on timing of arrhythmia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Podolecki</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland. Electronic address: tomekpod@interia.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenarczyk</LastName><ForeName>Radoslaw</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalczyk</LastName><ForeName>Jacek</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jedrzejczyk-Patej</LastName><ForeName>Ewa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chodor</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazurek</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francuz</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Streb</LastName><ForeName>Witold</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitrega</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center of Heart Diseases, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalarus</LastName><ForeName>Zbigniew</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Zabrze, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Cardiol</MedlineTA><NlmUniqueID>0207277</NlmUniqueID><ISSNLinking>0002-9149</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="Y">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="N">Percutaneous Coronary Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="Y">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="N">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29452692</ArticleId><ArticleId IdType="doi">10.1016/j.amjcard.2017.12.036</ArticleId><ArticleId IdType="pii">S0002-9149(18)30057-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30395687</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-4681</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</Title><ISOAbbreviation>J Bone Miner Res</ISOAbbreviation></Journal><ArticleTitle>Adding Lateral Spine Imaging for Vertebral Fractures to Densitometric Screening: Improving Ascertainment of Patients at High Risk of Incident Osteoporotic Fractures.</ArticleTitle><Pagination><StartPage>282</StartPage><EndPage>289</EndPage><MedlinePgn>282-289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jbmr.3595</ELocationID><Abstract><AbstractText>The current diagnosis of osteoporosis is limited to a T-score &#x2264;-2.5. However, asymptomatic vertebral fractures (VF) are known to predict a high risk of subsequent fractures and pharmaceutical intervention is known to reduce future fracture risk in these individuals. In a prospective, population-based cohort of ambulant older women, we sought to evaluate the role of VF detection by screening densitometric lateral spine imaging (LSI) for VF at time of bone density testing to the effect on the magnitude of fracture risk. A total of 1084 women (mean age 75 years&#x2009;&#xb1;&#x2009;SD 3 years) had baseline LSI that identified 100 (9%) women with VFs and 89 (8%) with femoral neck (FN) T-score osteoporosis &#x2264;-2.5. Follow-up identified incident clinical spine fracture in 73 (7%), 305 (28%) with any fracture-related hospitalization, and 121 (11%) with a hip fracture-related hospitalization. Compared with those without baseline VF, in those with baseline VF, relative risk (RR) for incident clinical spine, hip, and any fracture were 3.46 (95% confidence interval [CI] 2.14-5.60, p &lt; 0.001); 1.72 (95% CI 1.09-2.71, p&#x2009;=&#x2009;0.02), and 1.4 (95% CI 1.07-1.84, p&#x2009;=&#x2009;0.02), respectively. In 675 (62%) of women with femoral neck osteopenia (T-score &lt;-1 to &gt;-2.5), 61 (9%) also had a VF. Compared with those without baseline VF, RR for any incident fragility fractures and fractures at spine and hip in those with baseline VF were 1.6 (95% CI 1.2-2.1, p &lt; 0.01), 3.9 (95% CI 2.2-6.9, p &lt; 0.01), and 1.6 (95% CI 0.9-2.8, p&#x2009;=&#x2009;0.10), respectively. On basis of the prognosis, older women with LSI VF with osteopenia should be diagnosed with osteoporosis and should be considered for pharmaceutical intervention. &#xa9; 2018 American Society for Bone and Mineral Research.</AbstractText><CopyrightInformation>&#xa9; 2018 American Society for Bone and Mineral Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prince</LastName><ForeName>Richard L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Medical School, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Joshua R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Medical School, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Kidney Research, Children's Hospital at Westmead, School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Wai H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Medical School, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Germaine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Kidney Research, Children's Hospital at Westmead, School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Kevin E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Skeletal Health, Hologic, Inc., Marlborough, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoo</LastName><ForeName>Ben C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Medical School, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Technology and Physics, Sir Charles Gairdner Hospital, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical School, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiel</LastName><ForeName>Douglas P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Institute for Aging Research, Hebrew Senior Life, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schousboe</LastName><ForeName>John T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Park Nicollet Osteoporosis Center and HealthPartners Institute, and Division of Health Policy and Management, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR041398</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Bone Miner Res</MedlineTA><NlmUniqueID>8610640</NlmUniqueID><ISSNLinking>0884-0431</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="Y">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="Y">Osteoporosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="Y">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DXA</Keyword><Keyword MajorTopicYN="N">FRACTURE IDENTIFICATION</Keyword><Keyword MajorTopicYN="N">LATERAL SPINE IMAGING</Keyword><Keyword MajorTopicYN="N">VERTEBRAL FRACTURE ASSESSMENT</Keyword><Keyword MajorTopicYN="N">aBMD</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30395687</ArticleId><ArticleId IdType="doi">10.1002/jbmr.3595</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39674405</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Complementary effects of postoperative delirium and frailty on 30-day outcomes in spine surgery.</ArticleTitle><Pagination><StartPage>966</StartPage><EndPage>973</EndPage><MedlinePgn>966-973</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2024.12.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(24)01202-6</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">With an increasingly older population, the number of frail patients requiring surgical management for degenerative spine diseases is rapidly increasing. Older patients are at increased risk of developing postoperative delirium (POD), which increases the odds of postoperative morbidity and mortality in spine surgery patients. Therefore, frail spine surgery patients may be at greater risk of developing POD and subsequent adverse outcomes.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To understand the relationship between frailty and POD in spine surgery patients, and the effect of POD on nonfatal and fatal adverse outcomes in frail patients.</AbstractText><AbstractText Label="STUDY DESIGN/SETTING" NlmCategory="METHODS">Retrospective cohort study utilizing data from the 2021 American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">Patients aged &#x2265;75 years undergoing spine surgery screened for POD, with a total sample size of 4,195 patients.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Primary outcomes were postoperative delirium (POD), 30-day mortality, and nonfatal adverse outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Frailty was measured using the Risk Analysis Index (RAI) with tiered cutoffs indicating increasing frailty. Statistical methods included multivariable logistic regression and mediation analysis to evaluate the relationships between RAI, postoperative delirium, and 30-day mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 4,195 spine surgery patients aged &#x2265;75 years screened for POD, 353 (8.4%) exhibited POD. POD patients had significantly higher RAI scores relative to those without POD (p&lt;.001). Multivariable analysis demonstrated that increasing frailty predicted POD (p&lt;.001). In patients with POD, there were increased odds of mortality and all nonfatal adverse outcomes within 30 days (p&lt;.001). A complementary mediation effect of POD on frailty's contribution to 30-day mortality was observed (p&lt;.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">POD and increasing preoperative frailty RAI scores were independent predictors of mortality and morbidity in older spine surgery patients. POD has a significant synergistic contribution to the adverse effects of frailty following spine surgery. The RAI may be used to identify frail patients at risk of developing POD to enable optimal surgical candidate selection and provide opportunities for risk mitigation, such as prehabilitation and/or specialized perioperative care teams for frail patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Nithin K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Campbell University School of Osteopathic Medicine, Lillington, NC, USA; Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, USA. Electronic address: n_gupta0210@email.campbell.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prvulovic</LastName><ForeName>Stefan T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, USA; School of Medicine, Georgetown University, Washington DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoghi</LastName><ForeName>Sina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, USA; Student Research Committee, Shiraz, University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chmait</LastName><ForeName>Hikmat R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, USA; Department of Orthopedic Surgery, University of Vermont Larner College of Medicine, Burlington VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covell</LastName><ForeName>Michael M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, USA; School of Medicine, Georgetown University, Washington DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabet</LastName><ForeName>Cameron J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>School of Medicine, Georgetown University, Washington DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeGenova</LastName><ForeName>Daniel T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, OhioHealth, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisi</LastName><ForeName>Marc D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, USA; Hurley Neurological Center, Hurley Medical Center, Flint, MI, USA; Michigan State College of Medicine, Flint, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Meic H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, USA; Maine Medical Center, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowers</LastName><ForeName>Christian A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, USA; Michigan State College of Medicine, Flint, MI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013122" MajorTopicYN="Y">Spinal Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Postoperative delirium</Keyword><Keyword MajorTopicYN="N">Risk Analysis Index</Keyword><Keyword MajorTopicYN="N">Spine</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>14</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39674405</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2024.12.017</ArticleId><ArticleId IdType="pii">S1529-9430(24)01202-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23032867</PMID><DateCompleted><Year>2013</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>36</EndPage><MedlinePgn>29-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2012.09.126</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(12)01185-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The approval of an entirely subcutaneous implantable-cardioverter defibrillator (ICD) system (S-ICD) has raised attention about this promising technology. It was developed to overcome lead failure and infection problems of conventional transvenous ICD systems. Nevertheless, lead migration of the initial design and inappropriate shock rates have raised concerns regarding its reliability and safety.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this study was to report the largest multicenter series to date of patients with the new device in comparison with a matched conventional transvenous ICD collective with focus on perioperative complications, conversion of induced ventricular fibrillation (VF), and short-term follow-up.</AbstractText><AbstractText Label="METHODS/RESULTS" NlmCategory="RESULTS">Sixty-nine patients (50 male and 19 female; mean age 45.7 &#xb1; 15.7 years) received an S-ICD in three German centers and were randomly assigned to 69 sex- and age-matched conventional ICD patients. The indication was primary prevention in 41 patients (59.4%) without difference between groups (34 control patients; P = .268). The predominant underlying heart disease was ischemic cardiomyopathy in 11 (15.9%), dilated cardiomyopathy in 25 (36.2%), and hypertrophic cardiomyopathy in 10 (14.5%) in the S-ICD group. Mean implantation time was 70.8 &#xb1; 27.9 minutes (P = .398). Conversion rates of induced VF were 89.5% for 65 J (15-J safety margin) and 95.5% including reversed shock polarity (15-J safety margin) in the study group. Termination of induced VF was successful in 90.8% (10-J safety margin, device dependent) of the control patients (P = .815). Procedural complications were similar between the 2 groups. Mean follow-up was 217 &#xb1; 138 days. During follow-up, 3 patients with S-ICD were appropriately treated for ventricular arrhythmias. Three inappropriate episodes (5.2%) occurred in 3 S-ICD patients due to T-wave oversensing, whereas atrial fibrillation with rapid conduction was the predominant reason for inappropriate therapy in conventional devices (P = .745).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The novel S-ICD system can be implanted safely with similar perioperative adverse events compared with standard transvenous devices. Our case-control study demonstrates a 10.4% failure of conversion of induced VF with the S-ICD set to standard polarity and 15-J safety margin and comparable inappropriate shock rates during short-term follow-up.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>K&#xf6;be</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Germany. koebeju@mednet.uni-muenster.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinke</LastName><ForeName>Florian</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Dong-In</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Martens</LastName><ForeName>Eimo</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>K&#xe4;&#xe4;b</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>L&#xf6;her</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Amler</LastName><ForeName>Susanne</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lichtenberg</LastName><ForeName>Artur</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Joachim</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Eckardt</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Heart Rhythm. 2013 Jan;10(1):37-8. doi: 10.1016/j.hrthm.2012.10.013.</RefSource><PMID Version="1">23059129</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011322" MajorTopicYN="N">Primary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23032867</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2012.09.126</ArticleId><ArticleId IdType="pii">S1547-5271(12)01185-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28285395</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-3023</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International urogynecology journal</Title><ISOAbbreviation>Int Urogynecol J</ISOAbbreviation></Journal><ArticleTitle>Two techniques for assessing postoperative voiding function, a randomized trial.</ArticleTitle><Pagination><StartPage>1567</StartPage><EndPage>1572</EndPage><MedlinePgn>1567-1572</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00192-017-3310-y</ELocationID><Abstract><AbstractText Label="INTRODUCTION AND HYPOTHESIS" NlmCategory="OBJECTIVE">Post-operative voiding dysfunction is common after sling placement and is assessed with a voiding trial (VT) before discharge. We hypothesized that an operating room (OR) initiated retrograde VT (OR-fill) would decrease time to discharge compared with a post-anesthesia care unit (PACU) initiated retrograde VT (PACU-fill).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a parallel non-blinded randomized trial, of women undergoing outpatient sling surgery at a university hospital. In the OR-fill group, fill was initiated after sling placement during cystoscopy by leaving fluid in the bladder. In the PACU-fill group, fill was initiated in the PACU. Pre-VT volumes were recorded and a PVR&#x2009;&#x2264;&#x2009;100&#xa0;mL defined a passed VT. The primary outcome was total PACU time, defined as arrival in PACU until discharge home.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty women were assigned to the OR-fill group and 29 to the PACU-fill group. Time from PACU arrival to VT was shorter in the OR-fill group (41.5 [31.0, 69.3] min vs 69.0 [44.0, 107.0] min, p&#x2009;=&#x2009;0.03), but total PACU time in the groups was similar (125.0 [90.5, 180.5] min vs 131.5 [93.5, 178.0] min, p&#x2009;=&#x2009;0.76). Bladder volume before VT was greater in the OR-fill group (557.3&#x2009;&#xb1;&#x2009;187.3&#xa0;mL vs 433.0&#x2009;&#xb1;&#x2009;171.2&#xa0;mL, p&#x2009;=&#x2009;0.01). VT pass rates of the two groups were not significantly different (OR-fill 16.7% vs PACU-fill 24.1%, p&#x2009;=&#x2009;0.48).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">OR-fill VT did not decrease total PACU time compared with PACU-fill VT. No overdistension was seen in either group; transient postoperative voiding dysfunction was common.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Myers</LastName><ForeName>Erinn M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Carolinas HealthCare System, 2001 Vail Avenue, Suite 360, Charlotte, NC, 28207, USA. erinn.myers@carolinas.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matthews</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Wake Forrest Baptist Medical Center, Winston Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crane</LastName><ForeName>Andrea K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>WakeMed Health and Hospitals, Raleigh, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>AnnaMarie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>The University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geller</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>The University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int Urogynecol J</MedlineTA><NlmUniqueID>101567041</NlmUniqueID><ISSNLinking>0937-3462</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int Urogynecol J. 2018 May;29(5):771. doi: 10.1007/s00192-018-3608-4.</RefSource><PMID Version="1">29552741</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="Y">Gynecologic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011997" MajorTopicYN="N">Recovery Room</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053825" MajorTopicYN="N">Suburethral Slings</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014546" MajorTopicYN="N">Urinary Catheterization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014549" MajorTopicYN="N">Urinary Incontinence</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014554" MajorTopicYN="Y">Urination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Midurethral sling</Keyword><Keyword MajorTopicYN="N">Retrograde voiding trial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28285395</ArticleId><ArticleId IdType="doi">10.1007/s00192-017-3310-y</ArticleId><ArticleId IdType="pii">10.1007/s00192-017-3310-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anesth Analg. 1999 Jul;89(1):90-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10389784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Anat. 2004 Feb;186(1):55-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14994912</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 2002 Mar;46(3):279-82</Citation><ArticleIdList><ArticleId IdType="pubmed">11939918</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurourol Urodyn. 2010 Sep;29(7):1262-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20878996</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurourol Urodyn. 2002;21(2):167-78</Citation><ArticleIdList><ArticleId IdType="pubmed">11857671</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurourol Urodyn. 2012 Mar;31(3):317-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22419355</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2007 Dec;197(6):627.e1-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18060956</ArticleId></ArticleIdList></Reference><Reference><Citation>Obstet Gynecol. 2011 Sep;118(3):637-42</Citation><ArticleIdList><ArticleId IdType="pubmed">21860294</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Urol. 2004;6 Suppl 3:S3-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16985863</ArticleId></ArticleIdList></Reference><Reference><Citation>Female Pelvic Med Reconstr Surg. 2016 May-Jun;22(3):172-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26945265</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurourol Urodyn. 2014 Nov;33(8):1225-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23983149</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2001 Nov;58(5):697-701</Citation><ArticleIdList><ArticleId IdType="pubmed">11711343</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Jun 3;362(22):2066-76</Citation><ArticleIdList><ArticleId IdType="pubmed">20479459</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1998 Sep;87(3):628-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9728843</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2002 Jul;187(1):49-52</Citation><ArticleIdList><ArticleId IdType="pubmed">12114887</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2008 Nov;180(5):2076-80</Citation><ArticleIdList><ArticleId IdType="pubmed">18804239</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2011 Nov;205(5):498.e1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21925636</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Urogynecol J Pelvic Floor Dysfunct. 2006 Nov;17(6):570-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16583182</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Urogynecol J. 2010 Nov;21(11):1353-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20577714</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Neurourol J. 2012 Mar;16(1):30-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22500251</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Urol Nephrol. 1986;20(3):197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">3787196</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29356207</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.</ArticleTitle><Pagination><StartPage>603</StartPage><EndPage>608</EndPage><MedlinePgn>603-608</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.13431</ELocationID><Abstract><AbstractText Label="INTRODUCTION">In patients with ischemic heart disease and ventricular tachycardia (VT) refractory to high dose amiodarone, the two most common therapeutic options are adjunctive mexiletine therapy or catheter ablation. There are little existing data on the efficacy of these strategies. We examined the relative efficacy of adjunctive mexiletine and catheter ablation among patients enrolled in the VANISH trial.</AbstractText><AbstractText Label="METHODS">All subjects enrolled in the VANISH trial who had VT refractory to high dose&#xa0;(&#x2265;&#xa0;300&#xa0;mg daily) amiodarone at baseline were included. Per protocol, subjects randomized to escalated drug therapy received adjunctive mexiletine.</AbstractText><AbstractText Label="RESULTS">Nineteen of the 259 patients were receiving high-dose amiodarone at baseline and 11 were randomized to escalated therapy with mexiletine and 8 to ablation. The adjunctive mexiletine group had a higher rate of the primary composite outcome (death, VT storm, or appropriate shock) in comparison to catheter ablation (HR 6.87 [2.08-22.8]). Over 90% of the patients in the adjunctive mexiletine/group experienced a primary endpoint during a median 9.2 months' follow-up. There was no difference in the rate of adverse events between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS">Mexiletine has limited efficacy in the treatment of recurrent VT despite high-dose amiodarone therapy, in patients with ischemic heart disease. Catheter ablation is a superior strategy in this population.</AbstractText><CopyrightInformation>&#xa9; 2018 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deyell</LastName><ForeName>Marc W</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0001-8434-7076</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Services, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinberg</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut Universitaire de Cardiologie et Pneumologie de Qu&#xe9;bec, Universite Laval, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doucette</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parkash</LastName><ForeName>Ratika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nault</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institut Universitaire de Cardiologie et Pneumologie de Qu&#xe9;bec, Universite Laval, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Essebag</LastName><ForeName>Vidal</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>McGill University Health Centre and H&#xf4;pital Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardner</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterns</LastName><ForeName>Laurence D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Royal Jubilee Hospital, Victoria, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Healey</LastName><ForeName>Jeff S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hruczkowski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivard</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut de Cardiologie de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leong-Sit</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Heart Rhythm Service, University Hospital, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nery</LastName><ForeName>Pablo B</ForeName><Initials>PB</Initials><Identifier Source="ORCID">0000-0001-7482-8474</Identifier><AffiliationInfo><Affiliation>University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapp</LastName><ForeName>John L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Medicine, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>1U511HHV4Z</RegistryNumber><NameOfSubstance UI="D008801">Mexiletine</NameOfSubstance></Chemical><Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber><NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000638" MajorTopicYN="N">Amiodarone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057915" MajorTopicYN="Y">Drug Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008801" MajorTopicYN="N">Mexiletine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amiodarone</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">ischemic heart disease</Keyword><Keyword MajorTopicYN="N">mexiletine</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29356207</ArticleId><ArticleId IdType="doi">10.1111/jce.13431</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26721301</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0929</ISSN><JournalIssue CitedMedium="Internet"><Volume>150</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Toxicological sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol Sci</ISOAbbreviation></Journal><ArticleTitle>Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.</ArticleTitle><Pagination><StartPage>292</StartPage><EndPage>300</EndPage><MedlinePgn>292-300</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/toxsci/kfv325</ELocationID><Abstract><AbstractText>An essential metal hypothesis for neurodegenerative disease suggests an alteration in metal homeostasis contributing to the onset and progression of disease. Similar associations have been proposed for nonessential metals. To examine the relationship between metal levels in brain tissue and ventricular fluid (VF), postmortem samples of frontal cortex (FC) and VF from Alzheimer's disease (AD) cases and nondemented elderly subjects were analyzed for arsenic (As), cadmium (Cd), chromium (Cr), cobalt (Co), copper (Cu), iron (Fe), lead (Pb), manganese (Mn), mercury (Hg), nickel (Ni), tin (Sn), vanadium (V), and zinc (Zn) using inductively coupled plasma sector field mass spectrometry. All metals, with exception of equivalent Pb levels, were lower in the VF, compared to FC. Within-subject comparisons demonstrated that VF levels were not representative of levels within brain tissue. The essential metals Cu, Fe, and Zn were found highest in both compartments. Cd, Hg, and V levels in the VF were below the limit of quantification. In AD cases, FC levels of Fe were higher and As and Cd were lower than levels in controls, while levels of As in the VF were higher. Parameter estimates for FC metal levels indicated an association of Braak stage and higher Fe levels and an association of Braak stage and lower As, Mn, and Zn levels. The data showed no evidence of an accumulation of nonessential metals within the AD brain and, with the exception of As, showed no significant shift in the ratio of FC to VF levels to indicate differential clearance.</AbstractText><CopyrightInformation>Published by Oxford University Press on behalf of the Society of Toxicology 2015. This work is written by US Government employees and is in the public domain in the US.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szabo</LastName><ForeName>Steven T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>*Veterans Affairs Medical Center, Mental Health Service Line, Durham, North Carolina 27705; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27705; steven.szabo@duke.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harry</LastName><ForeName>G Jean</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Neurotoxicology Group, National Toxicology Program Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>Kathleen M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Joseph and Kathleen ADRC, Duke University Medical Center, Durham, North Carolina 27705;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szabo</LastName><ForeName>David T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>RAI Services Company, Winston Salem, North Carolina 27102; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birnbaum</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Cancer Institute, National Institutes of Health (NIH), Research Triangle Park, North Carolina 27709.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN27320100003C</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA BC 011476</GrantID><Acronym>BC</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1Z01ES101623</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES021164</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30AG028377</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019216">Metals, Heavy</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014131">Trace Elements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019216" MajorTopicYN="Y">Metals, Heavy</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014131" MajorTopicYN="Y">Trace Elements</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyloid beta</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">cerebral spinal fluid</Keyword><Keyword MajorTopicYN="N">heavy metals</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26721301</ArticleId><ArticleId IdType="pmc">PMC4881830</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfv325</ArticleId><ArticleId IdType="pii">kfv325</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adlard P. A., Bush A. I. (2006). Metals and Alzheimer&#x2019;s disease. J. Alzheimers Dis. 10, 145&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">17119284</ArticleId></ArticleIdList></Reference><Reference><Citation>Akatsu H., Hori A., Yamamoto T., Yoshida M., Mimuro M., Hashizume Y., Tooyama I., Yezdimer E. M. (2012). Essential metal abnormalities in progressive dementias. Biometals 25, 337&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">22080191</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrasi E., Farkas E., Gawlik D., Rosick U., Bratter P. (2000). Brain iron and zinc contents of German patients with Alzheimer disease. J. Alzheimers Dis. 2, 17&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">12214107</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwood C. S., Scarpa R. C., Huang X., Moir R. D., Jones W. D., Fairlie D. P., Tanzi R. E., Bush A. I. (2000). Characterization of copper interactions with Alzheimer amyloid beta peptides: Identification of an attomolar-affinity copper binding site on amyloid beta1&#x2013;42. J. Neurochem. 75, 1219&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">10936205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayton S., Lei P., Bush A. I. (2013). Metallostasis in Alzheimer&#x2019;s disease. Free. Radic. Biol. Med. 62, 76&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">23142767</ArticleId></ArticleIdList></Reference><Reference><Citation>Basun H., Forssell L. G., Wetterberg L., Winblad B. (1991). Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer&#x2019;s disease. J. Neural Transm. Park. Dis. Dement. Sect. 3, 231&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">1772577</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum L., Chan I. H., Cheung S. K., Goggins W B., Mok V., Lam L., Leung V., Hui E., Ng C., Woo J., et al. (2010). Serum zinc is decreased in Alzheimer&#x2019;s disease and serum arsenic correlates positively with cognitive ability. Biometals 23, 173&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">19911117</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorklund N. L., Sadagoparamanujam V. M., Taglialatela G. (2012). Selective, quantitative measurement of releasable synaptic zinc in human autopsy hippocampal brain tissue from Alzheimer&#x2019;s disease patients. J. Neurosci. Methods 203, 146&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3221793</ArticleId><ArticleId IdType="pubmed">21945000</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Braak E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta. Neuropathol. 82, 239&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bressler J. P., Olivi L., Cheong J. H., Kim Y., Maerten A., Bannon D. (2007). Metal transporters in intestine and brain: Their involvement in metal-associated neurotoxicities. Hum. Exp. Toxicol. 26, 221&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">17439925</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucossi S., Ventriglia M., Panetta V., Salustri C., Pasqualetti P., Mariani S., Siotto M., Rossini P. M., Squitti R. (2011). Copper in Alzheimer&#x2019;s disease: A meta-analysis of serum,plasma, and cerebrospinal fluid studies. J. Alzheimers Dis. 24, 175&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">21187586</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush A. I., Tanzi R. E. (2008). Therapeutics for Alzheimer&#x2019;s disease based on the metal hypothesis. Neurotherapeutics 5, 421&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2518205</ArticleId><ArticleId IdType="pubmed">18625454</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan F. M., Reynolds G. P., Ward N. I. (1993). Hippocampal tin, aluminum and zinc in Alzheimer&#x2019;s disease. Biometals 6, 149&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">8400761</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespo A. C., Silva B., Marques L., Marcelino E., Maruta C., Costa S., Timoteo A., Vilares A., Couto F. S., Faustino P., et al. (2014). Genetic and biochemical markers in patients with Alzheimer&#x2019;s disease support a concerted systemic iron homeostasis dysregulation. Neurobiol. Aging 35, 777&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pubmed">24199959</ArticleId></ArticleIdList></Reference><Reference><Citation>Danscher G., Jensen K. B., Frederickson C. J., Kemp K., Andreasen A., Juhl S., Stoltenberg M., Ravid R. (1997). Increased amount of zinc in the hippocampus and amygdala of Alzheimer&#x2019;s diseased brains: A proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J. Neurosci. Methods. 76, 53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">9334939</ArticleId></ArticleIdList></Reference><Reference><Citation>Deibel M. A., Ehmann W. D., Markesbery W. R. (1996). Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer&#x2019;s disease: Possible relation to oxidative stress. J. Neurol. Sci. 143, 137&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">8981312</ArticleId></ArticleIdList></Reference><Reference><Citation>Duce J. A., Tsatsanis A., Cater M. A., James S. A., Robb E., Wikhe K., Leong S. L., Perez K., Johanssen T., Greenough M. A., et al. (2010). Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer&#x2019;s disease. Cell 142, 857&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2943017</ArticleId><ArticleId IdType="pubmed">20817278</ArticleId></ArticleIdList></Reference><Reference><Citation>Exley C., House E., Polwart A., Esiri M. M. (2012). Brain burdens of aluminum, iron, and copper and their relationships with amyloid-beta pathology in 60 human brains. J. Alzheimers Dis. 31, 725&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">22699848</ArticleId></ArticleIdList></Reference><Reference><Citation>Faller P. (2009). Copper and zinc binding to amyloid-beta: Coordination, dynamics, aggregation, reactivity and metal-ion transfer. Chembiochem 10, 2837&#x2013;2845.</Citation><ArticleIdList><ArticleId IdType="pubmed">19877000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhardsson L., Blennow K., Lundh T., Londos E., Minthon L. (2009). Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer&#x2019;s disease. Dement. Geriatr. Cogn. Disord. 28, 88&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19672066</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhardsson L., Lundh T., Londos E., Minthon L. (2011). Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer&#x2019;s disease. J. Neural. Transm. 118, 957&#x2013;962.</Citation><ArticleIdList><ArticleId IdType="pubmed">21373763</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhardsson L., Lundh T., Minthon L., Londos E. (2008). Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer&#x2019;s disease. Dement. Geriatr. Cogn. Disord. 25, 508&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">18463412</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham S. F., Nasaruddin M. B., Carey M., Holscher C., McGuinness B., Kehoe P. G., Love S., Passmore P., Elliott C. T., Meharg A. A., et al. (2014). Age-associated changes of brain copper, iron, and zinc in Alzheimer&#x2019;s disease and dementia with lewy bodies. J. Alzheimers Dis. 42, 1407&#x2013;1413.</Citation><ArticleIdList><ArticleId IdType="pubmed">25024342</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenough M. A., Camakaris J., Bush A. I. (2013). Metal dyshomeostasis and oxidative stress in Alzheimer&#x2019;s disease. Neurochem. Int. 62, 540&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">22982299</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenough M. A., Volitakis I., Li Q. X., Laughton K., Evin G., Ho M., Dalziel A H., Camakaris J., Bush A. I. (2011). Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper/zinc superoxide dismutase activity.J . Biol. Chem. 286, 9776&#x2013;9786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3058959</ArticleId><ArticleId IdType="pubmed">21239495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha C., Ryu J., Park C. B. (2007). Metal ions differentially influence the aggregation and deposition of Alzheimer&#x2019;s beta-amyloid on a solid template. Biochemistry 46, 6118&#x2013;6125.</Citation><ArticleIdList><ArticleId IdType="pubmed">17455909</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagemeier J., Geurts J. J., Zivadinov R. (2012). Brain iron accumulation in aging and neurodegenerative disorders. Expert Rev. Neurother. 12, 1467&#x2013;1480.</Citation><ArticleIdList><ArticleId IdType="pubmed">23237353</ArticleId></ArticleIdList></Reference><Reference><Citation>House E., Esiri M., Forster G., Ince P. G., Exley C. (2012). Aluminium, iron and copper in human brain tissues donated to the Medical Research Council&#x2019;s Cognitive Function and Ageing Study. Metallomics 4, 56&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">22045115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozumi I., Hasegawa T., Honda A., Ozawa K., Hayashi Y., Hashimoto K., et al. (2011). Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J. Neurol. Sci. 303, 95&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">21292280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulette C. M., Welsh-Bohmer K. A., Crain B., Szymanski M. H., Sinclaire N. O., Roses A. D. (1997). Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer&#x2019;s Disease Research Center experience. Arch. Pathol. Lab. Med. 121, 615&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">9199629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman B. T., Trojanowski J. Q. (1997). Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol. Exp. Neurol. 56, 1095&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">9329452</ArticleId></ArticleIdList></Reference><Reference><Citation>James S. A., Volitakis I., Adlard P. A., Duce J. A., Masters C. L., Cherny R. A., Bush A. I. (2012). Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic. Biol. Med. 52, 298&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">22080049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes K. O., Sparks D. L., Streit W. J. (2008). Microglial dystrophy in the aged and Alzheimer&#x2019;s disease brain is associated with ferritin immunoreactivity. Glia 56, 1048&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pubmed">18442088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R. (1998). Copper, iron and zinc in Alzheimer&#x2019;s disease senile plaques. J. Neurol. Sci. 158, 47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9667777</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy R. C., Kosman D. J. (2015). Iron transport across the blood-brain barrier: Development, neurovascular regulation and cerebral amyloid angiopathy. Cell. Mol. Life. Sci. 2, 709&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4312246</ArticleId><ArticleId IdType="pubmed">25355056</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller D. S., Lowes S., Pritchard J. B. (2005). The molecular basis of xenobiotic transport and metabolism in choroid plexus. In The Blood-Cerebrospinal Fluid Barrier (Zheng W., Chodobski A., Eds.), pp. 147&#x2013;173. CRC Press, Boca Raton, FL.</Citation></Reference><Reference><Citation>Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. (1991). The Consortium to Establish a Registry for Alzheimer&#x2019;s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer&#x2019;s disease. Neurology 41, 479&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">2011243</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabuurs R. J., Natte R., de Ronde F. M., Hegeman-Kleinn I., Dijkstra J., van Duinen S. G., Webb A. G., Rozemuller A. J., van Buchem M. A., van der Weerd L. (2013). MR microscopy of human amyloid-beta deposits: Characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid. J. Alzheimers Dis. 34, 1037&#x2013;1049.</Citation><ArticleIdList><ArticleId IdType="pubmed">23340037</ArticleId></ArticleIdList></Reference><Reference><Citation>Nischwitz V, Berthele A, Michalke B. (2008). Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier. Anal Chim Acta. 627, 258&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">18809082</ArticleId></ArticleIdList></Reference><Reference><Citation>Panayi A. E., Spyrou N. M., Iversen B. S., White M. A., Part P. (2002). Determination of cadmium and zinc in Alzheimer&#x2019;s brain tissue using inductively coupled plasma mass spectrometry. J. Neurol. Sci. 195, 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11867068</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J. H., Lee D. W., Park K. S., Joung H. (2014). Serum trace metal levels in Alzheimer&#x2019;s disease and normal control groups. Am. J. Alzheimers Dis. 29, 76&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11008137</ArticleId><ArticleId IdType="pubmed">24164932</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana C., Bellefqih S., Laval J. Y., Guerquin-Kern J. L., Wu T. D., Avila J., Ferrer I., Arranz R., Patino C. (2006). Study of the localization of iron, ferritin, and hemosiderin in Alzheimer&#x2019;s disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol. 153, 42&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">16364657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos P., Santos A., Pinto N. R., Mendes R., Magalhaes T., Almeida A. (2014). Iron levels in the human brain: A post-mortem study of anatomical region differences and age-related changes. J. Trace. Elem. Med. Biol. 28, 13&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">24075790</ArticleId></ArticleIdList></Reference><Reference><Citation>Raven E. P., Lu P. H., Tishler T. A., Heydari P., Bartzokis G. (2013). Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer&#x2019;s disease detected in&#xa0;vivo with magnetic resonance imaging. J. Alzheimers Dis. 37, 127&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">23792695</ArticleId></ArticleIdList></Reference><Reference><Citation>Religa D., Strozyk D., Cherny R. A., Volitakis I., Haroutunian V., Winblad B., Naslund J., Bush A. I. (2006). Elevated cortical zinc in Alzheimer disease. Neurology 67, 69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">16832080</ArticleId></ArticleIdList></Reference><Reference><Citation>Savelieff M. G., Lee S., Liu Y., Lim M. H. (2013). Untangling amyloid-beta, tau, and metals in Alzheimer&#x2019;s disease. ACS Chem. Biol. 8, 856&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pubmed">23506614</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheiber I. F., Mercer J. F., Dringen R. (2014). Metabolism and functions of copper in brain. Prog. Neurobiol. 116, 33&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">24440710</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrag M., Mueller C., Oyoyo U., Smith M. A., Kirsch W. M. (2011). Iron, zinc and copper in the Alzheimer&#x2019;s disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog. Neurobiol. 94, 296&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3134620</ArticleId><ArticleId IdType="pubmed">21600264</ArticleId></ArticleIdList></Reference><Reference><Citation>Squitti R. (2012). Metals in Alzheimer&#x2019;s disease: A systemic perspective. Front. Biosci. 17, 451&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">22201755</ArticleId></ArticleIdList></Reference><Reference><Citation>Squitti R., Siotto M., Polimanti R. (2014). Low-copper diet as a preventive strategy for Alzheimer&#x2019;s disease. Neurobiol. Aging. 35, S40&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">24913894</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava R. A., Jain J. C. (2002). Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer&#x2019;s disease brain. J. Neurol. Sci. 196, 45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">11959156</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh S. W., Jensen K. B., Jensen M. S., Silva D. S., Kesslak P. J., Danscher G., Frederickson C. J. (2000). Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer&#x2019;s diseased brains. Brain Res. 852, 274&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">10678753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventriglia M., Brewer G. J., Simonelli I., Mariani S., Siotto M., Bucossi S., Squitti R. (2015). Zinc in Alzheimer&#x2019;s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies. J. Alzheimers Dis. 46, 75&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">25697706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventriglia M., Bucossi S., Panetta V., Squitti R. (2012). Copper in Alzheimer&#x2019;s disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies. J. Alzheimers Dis. 30, 981&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pubmed">22475798</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigel K. J., Lynch S. G., LeVine S. M. (2014). Iron chelation and multiple sclerosis. ASN Neuro 6, e00136, doi: 10.1042/AN20130037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906635</ArticleId><ArticleId IdType="pubmed">24397846</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Finkelstein D. I., Adlard P. A. (2014). Interactions of metals and apolipoprotein E in Alzheimer&#x2019;s disease. Front. Aging Neurosci. 6, 121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4054654</ArticleId><ArticleId IdType="pubmed">24971061</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokel R. A. (2006). Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J. Alzheimers Dis. 10, 223&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">17119290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecca L., Youdim M. B., Riederer P., Connor J. R., Crichton R. R. (2004). Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pubmed">15496864</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Surguladze N., Slagle-Webb B., Cozzi A., Connor J. R. (2006). Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54, 795&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">16958088</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Monnot A. D. (2012). Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative disease. Pharmacol. Ther. 133, 177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268876</ArticleId><ArticleId IdType="pubmed">22115751</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28452822</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>124</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>A Prospective, Randomized, Clinical Trial on the Effects of a Valveless Trocar on Respiratory Mechanics During Robotic Radical Cystectomy: A Pilot Study.</ArticleTitle><Pagination><StartPage>1794</StartPage><EndPage>1801</EndPage><MedlinePgn>1794-1801</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000002027</ELocationID><Abstract><AbstractText Label="BACKGROUND">Prolonged pneumoperitoneum and Trendelenburg positioning for robot-assisted radical cystectomy (RARC) are essential for optimizing visualization of the operative field, although they worsen hemodynamic and respiratory function. Our hypothesis is that the use of a valveless trocar (VT) may improve respiratory mechanics.</AbstractText><AbstractText Label="METHODS">In this prospective, 2-arm parallel trial, patients ASA II to III undergoing RARC were randomly assigned into 2 groups: in the VT group, the capnoperitoneum was maintained with a VT; in the control group, the capnoperitoneum was maintained with a standard trocar (ST group). Inspiratory plateau pressure (Pplat), static compliance (Cstat), minute volume (MV), tidal volume (Vt), and carbon dioxide (CO2) elimination rate were recorded at these times: 15 minutes after anesthesia induction (T0), 10 minutes (T1) and 60 minutes (T2) after first robot docking, 10 minutes before first undocking (T3), 10 minutes (T4) and 60 minutes (T5) after second docking, 10 minutes before second undocking (T6), and 10 minutes before extubation (T7). The primary end point of the study was the assessment of Pplat mean value from T1 to T6.</AbstractText><AbstractText Label="RESULTS">A total of 56 patients were evaluated: 28 patients in the VT group and 28 in the ST group. VT group had lower Pplat (means and standard error, VT group 30 [0.66] versus ST group 34 [0.66] cm H2O, with estimated mean difference and 95% confidence interval, -4.1 [-5.9 to -2.2], P &lt; .01), lower MV (means and standard error, VT group 8.2 [0.22] versus ST group 9.8 [0.21] L min, P &lt; .01), lower CO2 elimination rate (means and standard error, VT group 4.2 [0.25] versus ST group 5.4 [0.24] mL kg min, P &lt; .01), lower end-tidal CO2 (ETCO2) (means and standard error, VT group 28.8 [0.48] versus ST group 31.3 [0.46] mm Hg, P &lt; .01), and higher Cstat (means and standard error, VT group 26 [0.9] versus ST group 22.1 [0.9] mL cm H2O, P &lt; .01). Both groups had similar Vt (P = .24).</AbstractText><AbstractText Label="CONCLUSIONS">During RARC, use of a VT was associated with a significantly lower Pplat and improvement in other respiratory parameters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Covotta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the *Department of Anesthesiology, Regina Elena National Cancer Institute, Rome, Italy; and &#x2020;Research Institute on Sustainable Economic Growth of the National Research Council of Italy, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claroni</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Torregiani</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Naccarato</LastName><ForeName>Alessia</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tribuzi</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Zinilli</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Forastiere</LastName><ForeName>Ester</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2018 Apr;126(4):1426. doi: 10.1213/ANE.0000000000002822.</RefSource><PMID Version="1">29337725</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2018 Apr;126(4):1425-1426. doi: 10.1213/ANE.0000000000002823.</RefSource><PMID Version="1">29337726</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015653" MajorTopicYN="N">Cystectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018475" MajorTopicYN="N">Head-Down Tilt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011028" MajorTopicYN="N">Pneumoperitoneum, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="Y">Respiratory Mechanics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012384" MajorTopicYN="N">Rome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013525" MajorTopicYN="Y">Surgical Instruments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28452822</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000002027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19282713</PMID><DateCompleted><Year>2009</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-8651</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Regional anesthesia and pain medicine</Title><ISOAbbreviation>Reg Anesth Pain Med</ISOAbbreviation></Journal><ArticleTitle>Ketamine as an adjuvant in lidocaine intravenous regional anesthesia: a randomized, double-blind, systemic control trial.</ArticleTitle><Pagination><StartPage>130</StartPage><EndPage>133</EndPage><MedlinePgn>130-3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/AAP.0b013e31819bb006</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Ketamine delays and minimizes intraoperative tourniquet pain when added to lidocaine-based intravenous regional anesthesia (IVRA). It is unclear if adding ketamine to the IVRA injectate is more efficacious compared with systemic administration. This study compares intraoperative tourniquet pain, postoperative analgesia, and side effects of systemic versus IVRA ketamine during outpatient hand surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a randomized, double-blind, systemic control study of 40 patients undergoing hand surgery using lidocaine IVRA. In group IVRA, 0.1 mg/kg ketamine in 1 mL of normal saline was added to the IVRA lidocaine, and 1 mL of normal saline was administered via a peripheral IV line. In group systemic, 1 mL of normal saline was added to the IVRA syringe, and 0.1 mg/kg ketamine in 1 mL of normal saline was administered via a peripheral intravenous line. Ten minutes after proximal tourniquet inflation, the distal tourniquet was inflated, and the proximal tourniquet deflated. Tourniquet pain was measured every 10 mins. Need for intraoperative opioids was recorded. Recovery room pain scores, analgesic needs, and sedation scores were compared. Patients were contacted 24 hrs after surgery and reported their analgesic consumption, satisfaction scores, and the occurrence of any unpleasant psychologic effects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Groups IVRA and systemic were comparable in demographic and surgical parameters. There were no differences between groups in intraoperative tourniquet pain scores, intraoperative fentanyl requirements, recovery room pain or sedation scores, postsurgical analgesic needs, or patient satisfaction scores.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In comparison to systemic administration, there is no selective benefit to adding ketamine to the IVRA injectate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viscomi</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Vermont College of Medicine, Burlington, VT 05401, USA. christopher.viscomi@vtmednet.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friend</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Colleen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Todd</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Yarnell</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Reg Anesth Pain Med</MedlineTA><NlmUniqueID>9804508</NlmUniqueID><ISSNLinking>1098-7339</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000759">Adjuvants, Anesthesia</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000759" MajorTopicYN="N">Adjuvants, Anesthesia</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="N">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006225" MajorTopicYN="N">Hand</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="N">Lidocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>3</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>3</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>4</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19282713</ArticleId><ArticleId IdType="doi">10.1097/AAP.0b013e31819bb006</ArticleId><ArticleId IdType="pii">00115550-200903000-00010</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32341306</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1159</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>19</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Spine</Title><ISOAbbreviation>Spine (Phila Pa 1976)</ISOAbbreviation></Journal><ArticleTitle>The Impact of Geometrical Spinal Shape on Fresh Vertebral Fractures in Elderly Volunteers: A Longitudinal Cohort Analysis.</ArticleTitle><Pagination><StartPage>E1232</StartPage><EndPage>E1238</EndPage><MedlinePgn>E1232-E1238</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BRS.0000000000003534</ELocationID><Abstract><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Four-year, longitudinal cohort study.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to investigate the effect of original spinal shape on incidental vertebral fractures (VFs) and to identify the influence of changes in pre- and post-fracture geometrical spinal shape.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA" NlmCategory="BACKGROUND">Clinical evidence demonstrates that VFs cause spinal kyphosis, morbidities, and deteriorating quality of life in elderly people. However, knowledge of geometrical spinal shapes that affect incidental VFs is limited.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Three hundred seventeen volunteers underwent whole spine radiography as part of a health screening in both 2012 and 2016. We extracted volunteers with incidental VF in 2016. Sex- and age-matched volunteers without VF were enrolled as controls. Baseline demographic variables, geometrical spinal shape, and spinopelvic parameters were compared between the two groups. In volunteers with incidental VF, we investigated the association between baseline spinal shape and post-fracture shape.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-seven volunteers (12 men; mean age 75.4&#x200a;&#xb1;&#x200a;5.4 and 15 women; mean age 71.6&#x200a;&#xb1;&#x200a;7.9) with VF were enrolled, and 175 volunteers (48 men, 127 women) without VF were selected as controls. In men with VF, the thoracic kyphosis apex was located significantly more posteriorly and caudally than in those without VF. In women with VF, the lordosis apex was located significantly more posteriorly and caudally than in those without VF. After fractures occurring above the inflexion vertebra, the low anterior apex spine (L5) changed its geometrical shape in that the posterior apex and the inflexion vertebra shifted significantly more posteriorly compared to the high anterior apex spine (L4/5).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Original geometrical spinal shape affected the occurrence of VF, and post-fracture spinal shape depended on the positional relationship between the inflexion vertebra and fractured vertebra. Our study helps to understand the influence of geometrical spinal shape on the risks of VF.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamato</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Geriatric Musculoskeletal Health, Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, General Aoyama Hospital, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Togawa</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Kindai University Nara Hospital, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Tomohiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Go</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasuda</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arima</LastName><ForeName>Hideyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banno</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oe</LastName><ForeName>Shin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Geriatric Musculoskeletal Health, Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ushirozako</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ide</LastName><ForeName>Koichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Yuh</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuyama</LastName><ForeName>Yukihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine (Phila Pa 1976)</MedlineTA><NlmUniqueID>7610646</NlmUniqueID><ISSNLinking>0362-2436</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007738" MajorTopicYN="N">Kyphosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008141" MajorTopicYN="N">Lordosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013904" MajorTopicYN="N">Thoracic Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32341306</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000003534</ArticleId><ArticleId IdType="pii">00007632-202010010-00007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Itoi E, Sakurai M, Mizunashi K, et al. Long-term observations of vertebral fractures in spinal osteoporotics. Calcif Tissue Int 1990; 47:202&#x2013;208.</Citation></Reference><Reference><Citation>Xu W, Perera S, Medich D, et al. Height loss, vertebral fractures, and the misclassifigication of osyteoporosis. Bone 2011; 48:307&#x2013;311.</Citation></Reference><Reference><Citation>Kendler DL, Bauer DC, Davison KS, et al. Vertebral fractures: clinical importance and management. Am J Med 2016; 129: 221.e1-221.e10.</Citation></Reference><Reference><Citation>Raffaet&#xe0; G, Falossi F, Menconi A, et al. Efficacy of a specific rehabilitation protocol in postural control of a young woman with multiple fragility vertebral fractures: a case report. Clin Cases Miner Bone Metab 2016; 13:67&#x2013;70.</Citation></Reference><Reference><Citation>Kanazawa I, Takeno A, Tanaka Kichiro, et al. Osteoporosis and vertebral fracture are associated with deterioration of activities of daily living and quality of life in patients with type 2 diabetes mellitus. J Bone Miner Metab 2019; 37:503&#x2013;511.</Citation></Reference><Reference><Citation>Watanabe R, Shiraki M, Saito M, et al. Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women. Osteoporos Int 2018; 29:625&#x2013;633.</Citation></Reference><Reference><Citation>Ohba T, Ebata S, Koyama K, et al. Prevalence and key radiographic spinal malalignment parameters that influence the risk for gastroesophageal reflux disease in patients treated surgically for adult spinal deformity. BMC Gastroenterol 2018; 18:1&#x2013;7.</Citation></Reference><Reference><Citation>van Geel TACM, Bliuc D, Geusens PPM, et al. Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: a prospective cohort study. PLoS One 2018; 13:1&#x2013;13.</Citation></Reference><Reference><Citation>Edidin AA, Ong KL, Lau E, et al. Morbidity and mortality after vertebral fractures: comparison of vertebral augmentation and nonoperative management in the medicare population. Spine (Phila Pa 1976) 2015; 40:1228&#x2013;1241.</Citation></Reference><Reference><Citation>Carlson BC, Robinson WA, Wanderman NR, et al. A review and clinical perspective of the impact of osteoporosis on the spine. Geriatr Orthop Surg Rehabil 2019; 10:215145931986159.</Citation></Reference><Reference><Citation>Kanis JA, Johnell O, Oden A, et al. The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int 2006; 17:527&#x2013;534.</Citation></Reference><Reference><Citation>Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312:1254&#x2013;1259.</Citation></Reference><Reference><Citation>Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15:721&#x2013;739.</Citation></Reference><Reference><Citation>Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005; 16:737&#x2013;742.</Citation></Reference><Reference><Citation>Kanis JA, Johansson H, Oden A, et al. A family history of fracture and fracture risk: a meta-analysis. Bone 2004; 35:1029&#x2013;1037.</Citation></Reference><Reference><Citation>Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004; 19:893&#x2013;899.</Citation></Reference><Reference><Citation>Van Der Klift M, De Laet CEDH, McCloskey EV, et al. The incidence of vertebral fractures in men and women: The Rotterdam study. J Bone Miner Res 2002; 17:1051&#x2013;1056.</Citation></Reference><Reference><Citation>Briggs AM, Diee JH, Van, et al. Thoracic kyphosis affects spinal loads and trunk muscle force. Phys Ther 2007; 87:595&#x2013;607.</Citation></Reference><Reference><Citation>Christiansen BA, Bouxsein ML. Biomechanics of vertebral fractures and the vertebral fracture cascade. Curr Osteoporos Rep 2010; 8:198&#x2013;204.</Citation></Reference><Reference><Citation>Yamato Y, Sato Y, Togawa D, et al. Differences in the geometrical spinal shape in the sagittal plane according to age and magnitude of pelvic incidence in healthy elderly individuals. J Orthop Sci 2019; 1&#x2013;8.</Citation></Reference><Reference><Citation>Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8:1137&#x2013;1148.</Citation></Reference><Reference><Citation>Kanis JA, Oden A, Johansson H, et al. FRAX&#xae; and its applications to clinical practice. Bone 2009; 44:734&#x2013;743.</Citation></Reference><Reference><Citation>Oe S, Togawa D, Yoshida G, et al. Effects of mirror placement on sagittal alignment of the spine during acquisition of full-spine standing X-Rays. Eur Spine J 2018; 27:442&#x2013;447.</Citation></Reference><Reference><Citation>Roussouly P, Gollogly S, Berthonnaud E, et al. Classification of the normal variation in the sagittal alignment of the human lumbar spine and pelvis in the standing position. Spine (Phila Pa 1976) 2005; 30:346&#x2013;353.</Citation></Reference><Reference><Citation>Oe S, Togawa D, Nakai K, et al. The influence of age and sex on cervical spinal alignment among volunteers aged over 50. Spine (Phila Pa 1976) 2015; 40:1487&#x2013;1494.</Citation></Reference><Reference><Citation>Kobayashi T, Atsuta Y, Matsuno T, et al. A longitudinal study of congruent sagittal spinal alignment in an adult cohort. Spine (Phila Pa 1976) 2004; 29:671&#x2013;676.</Citation></Reference><Reference><Citation>Zvekic-Svorcan J, Aleksic J, Jankovic T, et al. Capture the vertebral fracture: risk factors as a prediction. J Back Musculoskelet Rehabil 2019; 32:269&#x2013;276.</Citation></Reference><Reference><Citation>Urrutia J, Besa P, Piza C. Incidental identification of vertebral compression fractures in patients over 60 years old using computed tomography scans showing the entire thoraco-lumbar spine. Arch Orthop Trauma Surg 2019; 139:1497&#x2013;1503.</Citation></Reference><Reference><Citation>Wei Y, Tian W, Zhang GL, et al. Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women. Osteoporos Int 2017; 28:1925&#x2013;1929.</Citation></Reference><Reference><Citation>Okamoto Y, Murakami H, Demura S, et al. The effect of kyphotic deformity because of vertebral fracture: a finite element analysis of a 10&#xb0; and 20&#xb0; wedge-shaped vertebral fracture model. Spine J 2015; 15:713&#x2013;720.</Citation></Reference><Reference><Citation>Cortet B, Roches E, Logier R, et al. Evaluation of spine curvatures after a recent osteoporotic vertebral fracture. Joint Bone Spine 2002; 69:201&#x2013;208.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28284927</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Apneic Oxygenation Versus Low-Tidal-Volume Ventilation in Anesthetized Cardiac Surgical Patients: A Prospective, Single-Center, Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>2000</StartPage><EndPage>2009</EndPage><MedlinePgn>2000-2009</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2016.12.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(16)30735-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To compare the physiology of apneic oxygenation with low-tidal-volume (VT) ventilation during harvesting of the left internal mammary artery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, single-center, randomized trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Single-center teaching hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">The study comprised 24 patients who underwent elective coronary artery bypass grafting surgery.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Apneic oxygenation (apneic group: 12 participants) and low-VT ventilation (low-VT group: 12 participants) (2.5 mL/kg ideal body weight) for 15 minutes during harvesting of the left internal mammary artery.</AbstractText><AbstractText Label="MEASUREMENT AND MAIN RESULTS" NlmCategory="RESULTS">The primary endpoint was an absolute change in partial pressure of arterial carbon dioxide (PaCO<sub>2</sub>). Secondary endpoints were changes in arterial pH, pulmonary artery pressures (PAP), cardiac index, and pulmonary artery acceleration time and ease of surgical access. The mean (standard deviation) absolute increase in PaCO<sub>2</sub> was 31.8 mmHg (7.6) in the apneic group and 17.6 mmHg (8.2) in the low-VT group (baseline-adjusted difference 14.2 mmHg [95% confidence interval 21.0-7.3], p&lt;0.001). The mean (standard deviation) absolute decrease in pH was 0.15 (0.03) in the apneic group and 0.09 (0.03) in the low-VT group baseline-adjusted difference 0.06 [95% confidence interval 0.03-0.09], p&lt;0.001. Differences in the rate of change over time between groups (time-by-treatment interaction) were observed for PaCO<sub>2</sub> (p&lt;0.001), pH (p&lt;0.001), systolic PAP (p = 0.002), diastolic PAP (p = 0.023), and mean PAP (p = 0.034). Both techniques provided adequate ease of surgical access; however, apneic oxygenation was preferred predominantly.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Apneic oxygenation caused a greater degree of hypercarbia and respiratory acidemia compared with low-VT ventilation. Neither technique had deleterious effects on PAP or cardiac function. Both techniques provided adequate ease of surgical access.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Machan</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Churilov</LastName><ForeName>Leonid</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>Param</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellard</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harley</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Melbourne, Victoria, Australia; Department of Surgery and Centre for Anesthesia, Perioperative and Pain Medicine, University of Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayward</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matalanis</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roubos</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seevanayagam</LastName><ForeName>Sivendran</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, University of Melbourne, Victoria, Australia; Department of Surgery and Centre for Anesthesia, Perioperative and Pain Medicine, University of Melbourne, Victoria, Australia. Electronic address: laurence.weinberg@austin.org.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008323" MajorTopicYN="N">Mammary Arteries</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">apneic oxygenation</Keyword><Keyword MajorTopicYN="N">cardiac function</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">hypercarbia</Keyword><Keyword MajorTopicYN="N">low-tidal-volume ventilation</Keyword><Keyword MajorTopicYN="N">pulmonary artery pressures</Keyword><Keyword MajorTopicYN="N">respiratory acidemia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28284927</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2016.12.019</ArticleId><ArticleId IdType="pii">S1053-0770(16)30735-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31511960</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0827</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Calcified tissue international</Title><ISOAbbreviation>Calcif Tissue Int</ISOAbbreviation></Journal><ArticleTitle>Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.</ArticleTitle><Pagination><StartPage>466</StartPage><EndPage>475</EndPage><MedlinePgn>466-475</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00223-019-00598-x</ELocationID><Abstract><AbstractText>Using data from the Peking Vertebral Fracture Study, we conducted a longitudinal cohort study to investigate the association between type 2 diabetes mellitus (T2DM) and the risk of incident fractures, especially of vertebral fractures (VFs), and we also examined the modifying effect of body mass index (BMI) on this association and the effect of bone mineral density (BMD) T-score as a risk factor for incident fractures in T2DM. Chinese postmenopausal women were enrolled (n&#x2009;=&#x2009;982), among whom 186 had T2DM. Incident VFs were confirmed by lateral radiographs of the thoracolumbar spine (T4-L5), while incident clinical non-VFs were self-reported. BMDs at the lumbar spine (LS) and femoral neck (FN) were measured by dual-energy X-ray absorptiometry. T2DM and non-DM women were at similar risk for VFs (OR 0.74, 95% CI 0.32-1.74), even adjusting for age, BMI, BMD, and previous fractures. Meanwhile, T2DM women had nearly twice the risk for non-VFs (HR 1.95, 95% CI 1.11-3.35) compared with non-DM women. After stratifying by BMI, the risk of VFs remained similar between diabetics and non-diabetics despite their BMI status (p for interaction&#x2009;=&#x2009;0.470), and the risk of non-VFs was positively associated with T2DM only in women with BMI&#x2009;&#x2265;&#x2009;25&#xa0;kg/m<sup>2</sup> (HR 3.59, 95% CI 1.68-7.65) (p for interaction&#x2009;=&#x2009;0.065). Although LS BMD T-score was similarly and negatively associated with incident VFs both in T2DM (OR 0.34, 95% CI 0.12-0.88) and non-DM women (OR 0.60, 95% CI 0.44-0.82) (p for interaction&#x2009;=&#x2009;0.430), the FN BMD T-score was not found to be significantly associated with either non-VFs or VFs among T2DM women. Comparing T2DM and non-DM women with similar fracture risks, the mean difference in LS T-score was -&#x2009;0.36 (95% CI -&#x2009;1.77 to 1.04) for VF, and difference in FN T-score was 1.61 (95% CI -&#x2009;0.11 to 3.34) for non-VF. In conclusion, Chinese postmenopausal women with T2DM had a similar risk of incident VFs, but a significantly higher risk of incident non-VF, compared to women without DM. Higher BMI did not modify the effect of T2DM on risk of VFs, but it increased the association between T2DM and risk of non-VFs. LS BMD T-score was similarly and negatively associated with VF risk in T2DM and non-DM women and appear to be useful for clinical evaluation of VF risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiajue</LastName><ForeName>Ruizhi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiuping</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Beijing Liangxiang Hospital, Beijing, 102401, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenbo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department Endocrinology, Peking University Shougang Hospital, Beijing, 100144, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Geriatric Endocrinology, Chinese PLA General Hospital, Beijing, 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiran</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cadre Unit, General Hospital of the Second Artillery Force, Beijing, 100088, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Beijing Haidian Hospital, Beijing, 100080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, China Rehabilitation Research Center, Beijing, 100068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ning</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Beijing Chaoyang Hospital, Beijing, 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ou</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan No. 1, Wangfujing, Dongcheng District, Beijing, 10, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gynaecology and Obstetrics, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Weibo</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-7768-5536</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China. xiaweibo8301@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Calcif Tissue Int</MedlineTA><NlmUniqueID>7905481</NlmUniqueID><ISSNLinking>0171-967X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015663" MajorTopicYN="N">Osteoporosis, Postmenopausal</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Body mass index</Keyword><Keyword MajorTopicYN="N">Bone mineral density</Keyword><Keyword MajorTopicYN="N">Peking vertebral fracture stud</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Vertebral fractures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31511960</ArticleId><ArticleId IdType="doi">10.1007/s00223-019-00598-x</ArticleId><ArticleId IdType="pii">10.1007/s00223-019-00598-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28114587</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1552-5783</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Investigative ophthalmology &amp; visual science</Title><ISOAbbreviation>Invest Ophthalmol Vis Sci</ISOAbbreviation></Journal><ArticleTitle>Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year.</ArticleTitle><Pagination><StartPage>257</StartPage><EndPage>269</EndPage><MedlinePgn>257-269</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1167/iovs.16-19906</ELocationID><Abstract><AbstractText Label="PURPOSE">After promising results of an exploratory study, this study was designed to assess the safety and efficacy of transcorneal electrical stimulation (TES) over 1 year in patients with retinitis pigmentosa (RP).</AbstractText><AbstractText Label="METHODS">We included 52 RP patients in this prospective, randomized, partially-masked study which was done in accordance with rules of good clinical practice. Transcorneal electrical stimulation by Okustim was applied monocularly for 30 minutes per week for 52 consecutive weeks. Patients were assigned randomly to the groups: sham, 150%, or 200% of individual electrical phosphene threshold (EPT). Visual acuity (retroilluminated Snellen charts), visual field (VF; Octopus 900), electroretinography (ERG), rod and cone full-field stimulus threshold, EPTs and IOP were assessed. Primary outcome measures were VF area; secondary outcome measures were development of ERG parameters.</AbstractText><AbstractText Label="RESULTS">The application of TES was tolerated well. Dry eye symptoms (31 of 52 patients) were registered as the main adverse event. Throughout the study period, the VF area showed only a trend for prevention of VF loss in the 200% group (P = 0.24). A significant improvement of light-adapted single flash b-wave was noted for the 200% (P &lt; 0.0001) and 150% (P = 0.006) groups compared to the sham group. Tendencies of improved function were observed for scotopic b-wave amplitude for the 200% group (P = 0.097). Other examination methods did not reach statistical significance.</AbstractText><AbstractText Label="CONCLUSIONS">The safety and acceptable tolerability of weekly TES self-administered by patients at home was confirmed over the course of 1 year. Objectively measured improvements in retinal function with ERG provide support for the potential benefits of TES for RP patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schatz</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Ophthalmology, University of T&#xfc;bingen, T&#xfc;bingen, Germany 2Department of Ophthalmology, Klinikum Stuttgart, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pach</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Klinikum Stuttgart, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gosheva</LastName><ForeName>Mariya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Ophthalmology, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naycheva</LastName><ForeName>Lubka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willmann</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Ophthalmology, University of T&#xfc;bingen, T&#xfc;bingen, Germany 2Department of Ophthalmology, Klinikum Stuttgart, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilhelm</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>STZ eyetrial at the Centre for Ophthalmology, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>STZ eyetrial at the Centre for Ophthalmology, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartz-Schmidt</LastName><ForeName>Karl Ulrich</ForeName><Initials>KU</Initials><AffiliationInfo><Affiliation>Centre for Ophthalmology, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zrenner</LastName><ForeName>Eberhart</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Ophthalmology, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messias</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Otorhinolaryngology and Head &amp; Neck Surgery, University of S&#xe3;o Paulo, Ribeir&#xe3;o Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gekeler</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre for Ophthalmology, University of T&#xfc;bingen, T&#xfc;bingen, Germany 2Department of Ophthalmology, Klinikum Stuttgart, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Invest Ophthalmol Vis Sci</MedlineTA><NlmUniqueID>7703701</NlmUniqueID><ISSNLinking>0146-0404</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003315" MajorTopicYN="N">Cornea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004558" MajorTopicYN="N">Electric Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004596" MajorTopicYN="N">Electroretinography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012160" MajorTopicYN="N">Retina</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017949" MajorTopicYN="N">Retinal Cone Photoreceptor Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017948" MajorTopicYN="N">Retinal Rod Photoreceptor Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012174" MajorTopicYN="N">Retinitis Pigmentosa</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="Y">Visual Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="Y">Visual Fields</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28114587</ArticleId><ArticleId IdType="doi">10.1167/iovs.16-19906</ArticleId><ArticleId IdType="pii">2599022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23756234</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2763</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Bone</Title><ISOAbbreviation>Bone</ISOAbbreviation></Journal><ArticleTitle>Vertebral fractures and abdominal aortic calcification in postmenopausal women. A cohort study.</ArticleTitle><Pagination><StartPage>213</StartPage><EndPage>219</EndPage><MedlinePgn>213-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bone.2013.05.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S8756-3282(13)00218-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Vertebral fracture assessment (VFA) imaging with a bone densitometer can simultaneously detect prevalent vertebral fractures (VFs) and abdominal aortic calcification (AAC).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the relation between the prevalence of VFs using VFA in asymptomatic women and the prevalence and severity of AAC.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This is a cross-sectional study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Subjects were recruited in a third care center from asymptomatic women selected from the general population.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">We enrolled 908 post-menopausal women with a mean age of 60.9 years &#xb1; 7.7 (50 to 91) with no prior known diagnosis of osteoporosis or taking medication interfering with bone metabolism.</AbstractText><AbstractText Label="PRIMARY AND SECONDARY OUTCOME MEASURES" NlmCategory="METHODS">Lateral VFA images and scans of the lumbar spine and proximal femur were obtained using a GE Healthcare Lunar Prodigy densitometer. VFs were defined using a combination of Genant semiquantitative (SQ) approach and morphometry. VFA images were scored for AAC using a validated 24 point scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">VFA images showed that 179 of the participants (19.7%) had at least one grade 2/3 VF, 81% did not have any detectable AAC whereas the prevalence of significant atherosclerotic burden, defined as AAC score of 5 or higher, was 12%. The group of women with 2/3 VFs had a statistically significant higher AAC score and higher proportion of subjects with extended AAC, and lower weight, height, and lumbar spine and hip BMD and T-scores than those without VFA-identified VFs. Multiple regression analysis showed that the presence of grade 2/3 VFs was significantly associated with age, BMI, history of peripheral fracture, AAC score &#x2265; 5 and densitometric osteoporosis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In post-menopausal women, extended AAC is independently associated with prevalent VFs regardless of age, BMI, history of fractures, and BMD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Maghraoui</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Military Hospital Mohammed V, Rabat, Morocco. aelmaghraoui@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezqi</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mounach</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Achemlal</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Bezza</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Dehhaoui</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ghozlani</LastName><ForeName>I</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bone</MedlineTA><NlmUniqueID>8504048</NlmUniqueID><ISSNLinking>1873-2763</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001012" MajorTopicYN="N">Aorta, Abdominal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061205" MajorTopicYN="N">Vascular Calcification</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal aortic calcification</Keyword><Keyword MajorTopicYN="N">Dual-energy X-ray absorptiometry (DXA)</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Vertebral fracture assessment (VFA)</Keyword><Keyword MajorTopicYN="N">Vertebral fractures</Keyword><Keyword MajorTopicYN="N">Women</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23756234</ArticleId><ArticleId IdType="doi">10.1016/j.bone.2013.05.022</ArticleId><ArticleId IdType="pii">S8756-3282(13)00218-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29036525</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>FI1</Issue><PubDate><Year>2018</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Circulating microRNAs in arrhythmogenic right ventricular cardiomyopathy with ventricular arrhythmia.</ArticleTitle><Pagination><StartPage>f37</StartPage><EndPage>f45</EndPage><MedlinePgn>f37-f45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/eux289</ELocationID><Abstract><AbstractText Label="AIMS">MicroRNAs (miRNAs) have been implicated in cardiac diseases. This study aimed to characterize the circulating miRNAs in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and correlate the miRNAs with the clinical outcomes of ARVC.</AbstractText><AbstractText Label="METHODS AND RESULTS">This study included 62 patients with ventricular arrhythmia (VA): 28 patients (45%) had definite ARVC, 11 (18%) had borderline or possible ARVC, and 23 (37%) had idiopathic ventricular tachycardia (VT). In addition, 33 age- and sex-matched healthy subjects were enrolled as normal control subjects. The expression of selected miRNAs was analysed in all study subjects. The clinical outcomes of patients with definite ARVC after catheter ablation were further investigated. On the basis of the miRNA polymerase chain reaction array, we selected 11 miRNAs for analysis of their expression in the plasma of all subjects. Definite ARVC patients had significantly higher expression of circulating miR-144-3p, 145-5p, 185-5p, and 494 than the three other groups. Out of 25 definite ARVC patients who underwent radiofrequency catheter ablation, recurrent VA occurred in 8 patients (32%) during the follow-up period (45&#x2009;&#xb1;&#x2009;20&#x2009;months). Definite ARVC patients with recurrent VA had a higher level of circulating miR-494 than did those without recurrence. Receiver operating characteristic analysis showed miR-494 to be a predictive factor of recurrent VA (area under the curve: 0.832).</AbstractText><AbstractText Label="CONCLUSION">Plasma levels of miR-144-3p, 145-5p, 185-5p, and 494 were significantly elevated in definite ARVC patients with VA. An increased plasma level of miR-494 was associated with the recurrence of VA after ablation in definite ARVC patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Ya-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Shih-Lin</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yenn-Jiang</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Li-Wei</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Fa-Po</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiang</LastName><ForeName>Shuo-Ju</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wuxing Street, Xinyi District, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yu-Feng</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuan</LastName><ForeName>Ta-Chuan</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Tze-Fan</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Jo-Nan</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chin-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yao-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Te</LastName><ForeName>Abigail Louise D</ForeName><Initials>ALD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Yung-Nan</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shih-Ann</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, National Yang-Ming University School of Medicine, No.155, Sec.2, Linong Street, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074166">Circulating MicroRNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554293">MIRN144 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C541010">MIRN145 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C552431">MIRN185 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C547168">MIRN494 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019571" MajorTopicYN="N">Arrhythmogenic Right Ventricular Dysplasia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074166" MajorTopicYN="N">Circulating MicroRNA</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078703" MajorTopicYN="N">Radiofrequency Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29036525</ArticleId><ArticleId IdType="doi">10.1093/europace/eux289</ArticleId><ArticleId IdType="pii">4211029</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30891654</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>278</EndPage><MedlinePgn>271-278</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-019-00535-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The role of catheter ablation as an adjunct and alternative to ICD implantation is not known in patients at risk for recurrent ventricular tachycardia (VT) and sudden cardiac death (SCD) across Asia. Patients with nonischemic etiologies of cardiomyopathy, which are highly prevalent in Asia, have not been previously enrolled in randomized trials of VT ablation.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate whether preemptive catheter ablation in patients with monomorphic VT and an indication for ICD implantation results in improved clinical outcomes compared to ICD implantation with standard medical therapy alone. To examine the natural history of ablation outcomes in the absence of background ICD therapy in patients that refuse randomization.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The PAUSE-SCD study (NCT02848781) is a prospective, multi-center, randomized controlled trial enrolling patients with structural heart disease (EF &lt;&#x2009;50%) with an indication for ICD implantation. Patients are randomized in a 1:1 fashion to two treatment arms: ICD with ablation and ICD with standard medical therapy alone. A prospective registry cohort was designed to follow the outcomes of patients who refuse ICD and randomization but elect to receive catheter ablation as primary therapy. The primary endpoint is defined as a composite of recurrent VT, cardiovascular rehospitalization, and death. Pre-specified secondary endpoints include each of the individual components of the primary endpoint in addition to comparison between randomized and registry patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The PAUSE-SCD study is a prospective, multi-center, randomized, and controlled trial examining the impact of preemptive catheter ablation on cardiovascular outcomes in patients with an indication for ICD at risk for recurrent VT and SCD. It represents the first multi-center VT ablation study in Asia, with a design intended to provide insights into the role of both ICD and ablation therapy in a predominantly nonischemic population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Minglong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shulin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Fuwai Cardiovascular Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>West China Hospital, Si Chuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Chenyang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Yumei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Xianzhang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Hongde</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>West China Hospital, Si Chuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Guosheng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hailei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Ligang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fuwai Cardiovascular Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ruhong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Fa-Po</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>School of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yenn-Jiang</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>School of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hori</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Saitama Medical Center, Dokkyo Medical University, Mibu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komatsu</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueda</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Kyorin University Hospital, Mitaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soejima</LastName><ForeName>Kyoko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Kyorin University Hospital, Mitaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Young Hoon</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Korea University Anam Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogami</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakahara</LastName><ForeName>Shiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Saitama Medical Center, Dokkyo Medical University, Mibu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shih-Ann</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>School of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Roderick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Arrhythmia Care, Pritzker School of Medicine, The University of Chicago Medicine, 5841 S. Maryland Ave. MC 6080, Chicago, IL, 60637, USA. rodericktung@uchicago.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PAUSE-SCD investigators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Partial funding of Investigator Initiated Proposal</GrantID><Agency>Abbott Laboratories</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Interv Card Electrophysiol. 2020 Mar;57(2):219-220. doi: 10.1007/s10840-019-00630-y.</RefSource><PMID Version="1">31650456</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">ICD implantation</Keyword><Keyword MajorTopicYN="N">Sudden cardiac death</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30891654</ArticleId><ArticleId IdType="doi">10.1007/s10840-019-00535-w</ArticleId><ArticleId IdType="pii">10.1007/s10840-019-00535-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Coll Cardiol. 2016 Nov 1;68(18):1990-1998</Citation><ArticleIdList><ArticleId IdType="pubmed">27788854</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2010 Jan;21(1):47-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19656251</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2013 Apr;10(4):490-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23246598</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 2;375(9708):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2015 Apr;8(2):390-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25740836</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2012 May 8;125(18):2184-96</Citation><ArticleIdList><ArticleId IdType="pubmed">22492578</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Dec 16;118(25):2773-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Sep 29;375(13):1221-30</Citation><ArticleIdList><ArticleId IdType="pubmed">27571011</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2012 Jul 10;60(2):132-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22766340</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2012 Apr;5(2):264-72</Citation><ArticleIdList><ArticleId IdType="pubmed">22333344</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2008 Aug;1(3):153-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19808409</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ J. 2013;77(10):2419-31</Citation><ArticleIdList><ArticleId IdType="pubmed">24067274</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2011 Jan;22(1):49-56</Citation><ArticleIdList><ArticleId IdType="pubmed">20653813</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2013 Apr 2;127(13):1359-68</Citation><ArticleIdList><ArticleId IdType="pubmed">23439513</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1995 Aug;26(2):481-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7608454</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Jan 29;117(4):462-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18172038</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11):</Citation><ArticleIdList><ArticleId IdType="pubmed">29150533</ArticleId></ArticleIdList></Reference><Reference><Citation>Singapore Med J. 2016 Apr;57(4):182-7</Citation><ArticleIdList><ArticleId IdType="pubmed">27075476</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2009 Sep 15;54(12):1110-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19744622</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2015 Sep;12(9):1997-2007</Citation><ArticleIdList><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2016 Feb 9;67(5):590-2</Citation><ArticleIdList><ArticleId IdType="pubmed">26846954</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2015 Dec 29;66(25):2872-2882</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2003 Apr 1;91(7):812-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12667566</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Sep 4;359(10):1009-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2001 Oct 30;104(18):2158-63</Citation><ArticleIdList><ArticleId IdType="pubmed">11684624</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2012 Jun;23(6):621-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22486970</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2016 Jul;9(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">27406604</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2000 Mar 21;101(11):1288-96</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32327255</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-4713</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Ophthalmology</Title><ISOAbbreviation>Ophthalmology</ISOAbbreviation></Journal><ArticleTitle>Visual Field Outcomes in the Tube Versus Trabeculectomy Study.</ArticleTitle><Pagination><StartPage>1162</StartPage><EndPage>1169</EndPage><MedlinePgn>1162-1169</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ophtha.2020.02.034</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0161-6420(20)30222-0</ELocationID><Abstract><AbstractText Label="PURPOSE">To describe visual field (VF) outcomes in the Tube Versus Trabeculectomy (TVT) Study.</AbstractText><AbstractText Label="DESIGN">Cohort analysis of patients in a multicenter randomized clinical trial.</AbstractText><AbstractText Label="PARTICIPANTS">A total of 122 eyes of 122 patients, with 61 eyes in both the tube shunt and trabeculectomy groups.</AbstractText><AbstractText Label="METHODS">The TVT Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube shunt surgery (350-mm<sup>2</sup> Baerveldt implant) and trabeculectomy with mitomycin C (MMC) (0.4 mg/ml for 4 minutes) in patients with previous cataract or glaucoma surgery. Enrolled patients underwent perimetry at baseline and annual follow-up visits. The VFs were included if the false-positive rate was &#x2264;20% and false-negative rate was &#x2264;35%. The VFs were excluded if visual acuity &lt;20/400 or loss of &#x2265;2 Snellen lines from baseline was attributed to an etiology other than glaucoma. Longitudinal linear mixed-effects models with best linear unbiased predictions (BLUPs) were applied to estimate rates of change in mean deviation (MD) for each treatment group.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE">Rate of MD change during follow-up period.</AbstractText><AbstractText Label="RESULTS">A total of 436 reliable VFs were analyzed, with an average of 3.6 VFs per eye. Baseline MD was&#xa0;-13.07&#x2009;&#xb1;&#x2009;8.4 decibels (dB) in the tube shunt group and&#xa0;-13.18&#x2009;&#xb1;&#x2009;8.2 dB in the trabeculectomy group (P&#xa0;= 0.99). The rate of change in MD was&#xa0;-0.60 dB/year in the tube group and&#xa0;-0.38 dB/year in the trabeculectomy group (P&#xa0;= 0.34). The 95% confidence intervals for the rates of MD change were&#xa0;-0.77 to&#xa0;-0.44 dB/year in the tube group and&#xa0;-0.56 to&#xa0;-0.20 dB/year in the trabeculectomy group. No significant difference in MD slope was seen when patients were categorized by percentage of visits with intraocular pressure (IOP) &lt;18 mmHg or by average IOP. Univariable and multivariable risk factor analyses identified history of diabetes, elevated IOP, and worse MD as baseline factors associated with more rapid VF loss.</AbstractText><AbstractText Label="CONCLUSIONS">Slow rates of VF loss were observed after randomized surgical treatment in the TVT Study, but no significant difference in the rate of VF loss was seen after tube shunt implantation and trabeculectomy with MMC. Patients with diabetes, higher IOP, and more severe VF loss at baseline were at higher risk for VF progression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swaminathan</LastName><ForeName>Swarup S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jammal</LastName><ForeName>Alessandro A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Duke Eye Center, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kornmann</LastName><ForeName>Helen L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Glaucoma Associates of Texas, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Philip P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feuer</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medeiros</LastName><ForeName>Felipe A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Duke Eye Center, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gedde</LastName><ForeName>Steven J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: sgedde@med.miami.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Tube Versus Trabeculectomy Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 EY014801</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ophthalmology</MedlineTA><NlmUniqueID>7802443</NlmUniqueID><ISSNLinking>0161-6420</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005901" MajorTopicYN="N">Glaucoma</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020327" MajorTopicYN="Y">Glaucoma Drainage Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014065" MajorTopicYN="N">Tonometry, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="Y">Trabeculectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058609" MajorTopicYN="N">Visual Field Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>No conflicting relationship exists for any author.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32327255</ArticleId><ArticleId IdType="mid">NIHMS1571515</ArticleId><ArticleId IdType="pmc">PMC9289722</ArticleId><ArticleId IdType="doi">10.1016/j.ophtha.2020.02.034</ArticleId><ArticleId IdType="pii">S0161-6420(20)30222-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gedde SJ, Schiffman JC, Feuer WJ, et al. The tube versus trabeculectomy study: design and baseline characteristics of study patients. Am J Ophthalmol 2005;140(2):275&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">16086949</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 2012;153(5):789&#x2013;803 e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4460598</ArticleId><ArticleId IdType="pubmed">22245458</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedde SJ, Herndon LW, Brandt JD, et al. Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol 2007;143(1):23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17054896</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb H, Gedde SJ, Schiffman JC, et al. Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study. Am J Ophthalmol 2014;157(6):1179&#x2013;89 e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5584066</ArticleId><ArticleId IdType="pubmed">24531027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauscher FM, Gedde SJ, Schiffman JC, et al. Motility disturbances in the tube versus trabeculectomy study during the first year of follow-up. Am J Ophthalmol 2009;147(3):458&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145604</ArticleId><ArticleId IdType="pubmed">19038375</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha A, Feuer WJ, Barton K, et al. Quality of Life in the Tube Versus Trabeculectomy Study. Am J Ophthalmol 2017;176:228&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">28161049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedde SJ, Schiffman JC, Feuer WJ, et al. Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol 2009;148(5):670&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">19674729</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol 2007;143(1):9&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17083910</ArticleId></ArticleIdList></Reference><Reference><Citation>Yohannan J, Wang J, Brown J, et al. Evidence-based Criteria for Assessment of Visual Field Reliability. Ophthalmology 2017;124(11):1612&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5675138</ArticleId><ArticleId IdType="pubmed">28676280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson B, Heijl A. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Invest Ophthalmol Vis Sci 2000;41(8):2201&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10892863</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird NM, Donnelly C, Ware JH. Longitudinal studies with continuous responses. Stat Methods Med Res 1992;1(3):225&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">1341659</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38(4):963&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">7168798</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros FA, Zangwill LM, Weinreb RN. Improved prediction of rates of visual field loss in glaucoma using empirical Bayes estimates of slopes of change. J Glaucoma 2012;21(3):147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3804256</ArticleId><ArticleId IdType="pubmed">21423039</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros FA, Zangwill LM, Mansouri K, et al. Incorporating risk factors to improve the assessment of rates of glaucomatous progression. Invest Ophthalmol Vis Sci 2012;53(4):2199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3808189</ArticleId><ArticleId IdType="pubmed">22410555</ArticleId></ArticleIdList></Reference><Reference><Citation>The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000;130(4):429&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">11024415</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004;111(9):1627&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">15350314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma: Mosby, 1993.</Citation></Reference><Reference><Citation>Mills RP, Budenz DL, Lee PP, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 2006;141(1):24&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16386972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederer F, Gaasterland DE, Sullivan EK, Investigators A. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials 1994;15(4):299&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">7956270</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 1999;106(4):653&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">10201583</ArticleId></ArticleIdList></Reference><Reference><Citation>See JL, Nicolela MT, Chauhan BC. Rates of neuroretinal rim and peripapillary atrophy area change: a comparative study of glaucoma patients and normal controls. Ophthalmology 2009;116(5):840&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19410941</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild JM, Hutchings N, Hussey MK, et al. Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma. Ophthalmology 1997;104(5):808&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">9160027</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouri-Mahdavi K, Hoffman D, Ralli M, Caprioli J. Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol 2007;125(9):1176&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">17846355</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Kim CS, Hong SP. Rate of visual field progression in primary open-angle glaucoma and primary angle-closure glaucoma. Korean J Ophthalmol 2004;18(2):106&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">15635823</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol 2008;145(2):343&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">18078852</ArticleId></ArticleIdList></Reference><Reference><Citation>Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999;106(11):2144&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">10571351</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch DC, Gillespie BW, Lichter PR, et al. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology 2009;116(2):200&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3316491</ArticleId><ArticleId IdType="pubmed">19019444</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998;126(4):487&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">9780093</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moraes CG, Demirel S, Gardiner SK, et al. Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group. Invest Ophthalmol Vis Sci 2012;53(4):1704&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342789</ArticleId><ArticleId IdType="pubmed">22395889</ArticleId></ArticleIdList></Reference><Reference><Citation>Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 1994;101(8):1445&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">7741836</ArticleId></ArticleIdList></Reference><Reference><Citation>Three-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1993;115(1):82&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">8420383</ArticleId></ArticleIdList></Reference><Reference><Citation>Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol 1996;121(4):349&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">8604728</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch DC, Gillespie BW, Niziol LM, et al. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2011;118(9):1766&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3161134</ArticleId><ArticleId IdType="pubmed">21600658</ArticleId></ArticleIdList></Reference><Reference><Citation>Tojo N, Oka M, Miyakoshi A, et al. Comparison of fluctuations of intraocular pressure before and after selective laser trabeculoplasty in normal-tension glaucoma patients. J Glaucoma 2014;23(8):e138&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">24248000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothy P, Toth M, Hollo G. Influence of selective laser trabeculoplasty on 24-hour diurnal intraocular pressure fluctuation in primary open-angle glaucoma: a pilot study. Ophthalmic Surg Lasers Imaging 2010;41(3):342&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20507019</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. Br J Ophthalmol 2009;93(4):497&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">19106150</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmberg P What is it about pressure that really matters in glaucoma? Ophthalmology 2007;114(2):203&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">17270670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PP, Budenz DL. The effects of cataract extraction on the visual field of eyes with chronic open-angle glaucoma. Am J Ophthalmol 1998;125(3):325&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">9512149</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators A The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol 2001;119(12):1771&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11735786</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelman RA, Brauner SC, Afshari NA, Grosskreutz CL. Cataract formation after initial trabeculectomy in young patients. Ophthalmology 2003;110(3):625&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12623833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew RG, Murdoch IE. The silent enemy: a review of cataract in relation to glaucoma and trabeculectomy surgery. Br J Ophthalmol 2011;95(10):1350&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">21217138</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders LJ, Medeiros FA, Weinreb RN, Zangwill LM. What rates of glaucoma progression are clinically significant? Expert Rev Ophthalmol 2016;11(3):227&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5898440</ArticleId><ArticleId IdType="pubmed">29657575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung JJ, Chen MH, Frambach CR, et al. Spectral Domain Versus Swept Source Optical Coherence Tomography Angiography of the Retinal Capillary Plexuses in Sickle Cell Maculopathy. Retin Cases Brief Rep 2018;12(2):87&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">27749746</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang L, Herbort CP Jr. SLO Fundus Imaging Is the Most Sensitive Modality of Multimodal Imaging for Macular Microembolisms with Subtle Signs. Klin Monbl Augenheilkd 2016;233(4):434&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27116502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley PD, Sim DA, Keane PA, et al. The Evaluation of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci 2016;57(2):626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">26903223</ArticleId></ArticleIdList></Reference><Reference><Citation>Usman M An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI). Cureus 2018;10(7):e3064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166915</ArticleId><ArticleId IdType="pubmed">30280060</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmunds B, Bunce CV, Thompson JR, et al. Factors associated with success in first-time trabeculectomy for patients at low risk of failure with chronic open-angle glaucoma. Ophthalmology 2004;111(1):97&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">14711719</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugkulstone CE, Smith LF, Vernon SA. Trabeculectomy in diabetic patients with glaucoma. Eye (Lond) 1993;7 (Pt 4):502&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8253227</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin DH, Hughes BA, Song MS, et al. Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure. Ophthalmology 1996;103(11):1925&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">8942891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kass MA. The ocular hypertension treatment study. J Glaucoma 1994;3(2):97&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">19920560</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120(6):714&#x2013;20; discussion 829&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">12049575</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HC, Stein JD, Nan B, et al. Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus. JAMA Ophthalmol 2015;133(8):915&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4537372</ArticleId><ArticleId IdType="pubmed">26022641</ArticleId></ArticleIdList></Reference><Reference><Citation>Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121(1):48&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">12523884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108(11):1943&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">11713061</ArticleId></ArticleIdList></Reference><Reference><Citation>Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114(11):1965&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">17628686</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol 1989;108(2):130&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">2757094</ArticleId></ArticleIdList></Reference><Reference><Citation>Artes PH, Iwase A, Ohno Y, et al. Properties of perimetric threshold estimates from Full Threshold, SITA Standard, and SITA Fast strategies. Invest Ophthalmol Vis Sci 2002;43(8):2654&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12147599</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogagnolo P, Sangermani C, Oddone F, et al. Long-term perimetric fluctuation in patients with different stages of glaucoma. Br J Ophthalmol 2011;95(2):189&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">20675728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33185243</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Impact of access route to the left ventricle on asymptomatic periprocedural brain injury: the results of a randomized trial in patients undergoing catheter ablation of ventricular tachycardia.</ArticleTitle><Pagination><StartPage>610</StartPage><EndPage>615</EndPage><MedlinePgn>610-615</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euaa320</ELocationID><Abstract><AbstractText Label="AIMS">Catheter ablation of ventricular tachycardia (VT) is an effective treatment in patients with structural heart disease (SHD) and recurrent arrhythmias. However, the procedure is associated with the risk of complications, including both manifest and asymptomatic cerebral thromboembolic events. We hypothesized that periprocedural asymptomatic brain injury (ABI) can be reduced by using transseptal instead of the retrograde access route to the left ventricle (LV).</AbstractText><AbstractText Label="METHODS AND RESULTS">Consecutive patients undergoing VT ablation for SHD were randomized 1:1 to either retrograde or transseptal LV access. All patients underwent radiofrequency ablation in conscious sedation with the use of an irrigated tip catheter. The degree of brain damage was evaluated by serum level of biomarker S100B. Significant ABI was defined as a post-ablation relative increase of S100B level &gt;30%. A total of 144 patients (66&#x2009;&#xb1;&#x2009;9&#x2009;years; 14 females; 90% coronary artery disease; LV ejection fraction: 30&#x2009;&#xb1;&#x2009;8%) were enrolled and 72 were allocated to each study groups. Symptomatic neurological complication of the procedure was not observed in any subject. A significant ABI was detected in 19.4% of patients. It was more commonly observed in subjects randomized to retrograde vs. transseptal LV access (26.4% vs. 12.5%, P&#x2009;=&#x2009;0.04). In a multivariate analysis, only retrograde LV access and advanced age were independent determinants of significant ABI.</AbstractText><AbstractText Label="CONCLUSION">Significant ABI after ablation of VT in patients with SHD can be detected in one-fifth of subjects. Retrograde access to LV is associated with a two-fold higher probability of significant ABI.</AbstractText><CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. &#xa9; The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bori&#x161;incov&#xe1;</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute for Clinical and Experimental Medicine, V&#xed;de&#x148;sk&#xe1; 1958/9, 140 21 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peichl</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute for Clinical and Experimental Medicine, V&#xed;de&#x148;sk&#xe1; 1958/9, 140 21 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wichterle</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute for Clinical and Experimental Medicine, V&#xed;de&#x148;sk&#xe1; 1958/9, 140 21 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x160;ramko</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute for Clinical and Experimental Medicine, V&#xed;de&#x148;sk&#xe1; 1958/9, 140 21 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldhoon</LastName><ForeName>Bashar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute for Clinical and Experimental Medicine, V&#xed;de&#x148;sk&#xe1; 1958/9, 140 21 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franekov&#xe1;</LastName><ForeName>Janka</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute for Clinical and Experimental Medicine, V&#xed;de&#x148;sk&#xe1; 1958/9, 140 21 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x10c;ih&#xe1;k</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute for Clinical and Experimental Medicine, V&#xed;de&#x148;sk&#xe1; 1958/9, 140 21 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kautzner</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute for Clinical and Experimental Medicine, V&#xed;de&#x148;sk&#xe1; 1958/9, 140 21 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="Y">Brain Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>13</Day><Hour>8</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33185243</ArticleId><ArticleId IdType="doi">10.1093/europace/euaa320</ArticleId><ArticleId IdType="pii">5980469</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40654169</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Effectiveness and Safety of Intramyocardial Needle Ablation for Refractory Ventricular Tachycardia and Premature Ventricular Complexes: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>2279</StartPage><EndPage>2286</EndPage><MedlinePgn>2279-2286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.70000</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Intramyocardial needle ablation is a novel technique for treating refractory ventricular tachycardia (VT) and premature ventricular complexes (PVC). However, studies defining the effectiveness and safety of this procedure are limited. This meta-analysis aims to evaluate the safety and effectiveness of needle ablation for VT and PVC refractory to standard ablation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Embase, Ovid (includes Medline), and ClinicalTrials.gov were searched from inception to December 31, 2024. Human studies on needle ablation for recurrent VT and PVC were included. Primary outcome was immediate effectiveness (no immediate post-procedural inducible VT or PVC). Secondary outcomes were long-term effectiveness (no clinical VT or PVC at 6 months) and safety (composite measure of peri- and post-procedural complications).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of five studies including 180 patients (140 VT; 40 PVC) were analyzed. Mean ages ranged from 54 to 66 years. Among 129 patients with VT, immediate effectiveness was 75% (95% CI, 54-92; I<sup>2</sup> 80%), and cumulative freedom from clinical VT dropped to 43% at 6 months (95% CI, 35-52; I<sup>2</sup> 0%). Among 40 patients with PVC, immediate effectiveness was 82% (95% CI, 67-94; I<sup>2</sup> 0%), and long-term effectiveness was 76% (95% CI, 61-90; I<sup>2</sup> 0%). Safety outcomes were reported in 19% of patients (95% CI, 13-27; I<sup>2</sup> 0%) and 10% of patients (95% CI 1, 23; I<sup>2</sup> 0%) in the VT and PVC arm, respectively. Death related to ablation was report in 7 patients (5.0%) only in the VT studies.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intramyocardial needle ablation is an emerging alternative approach for refractory VT and PVC ablation, showing cautious but promising results and safety profiles. Prospective studies and an international registry could provide valuable insights needed for optimal patient selection and protocol refinement.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Kartik</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9476-9264</Identifier><AffiliationInfo><Affiliation>Edith and Benson Ford Heart and Vascular Institute, Division of Cardiovascular Diseases, Henry Ford Hospital, Detroit, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Muhammad Ahmad</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Henry Ford Jackson, Jackson, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawlley</LastName><ForeName>Bharat</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4987-9661</Identifier><AffiliationInfo><Affiliation>Department of Medicine, State University of New York Upstate Medical University, Syracuse, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Vardhmaan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Atul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siontis</LastName><ForeName>Konstantinos C</ForeName><Initials>KC</Initials><Identifier Source="ORCID">0000-0002-6658-0971</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deskhmukh</LastName><ForeName>Abhishekh</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9560-1102</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Arfaat</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Edith and Benson Ford Heart and Vascular Institute, Division of Cardiovascular Diseases, Henry Ford Hospital, Detroit, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raad</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Edith and Benson Ford Heart and Vascular Institute, Division of Cardiovascular Diseases, Henry Ford Hospital, Detroit, Michigan, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Michigan State University, Detroit, Michigan, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018879" MajorTopicYN="Y">Ventricular Premature Complexes</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055011" MajorTopicYN="Y">Ablation Techniques</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009339" MajorTopicYN="Y">Needles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">intramyocardial needle ablation</Keyword><Keyword MajorTopicYN="N">premature ventricular complex</Keyword><Keyword MajorTopicYN="N">radiofrequency ablation</Keyword><Keyword MajorTopicYN="N">recurrent arrhythmia</Keyword><Keyword MajorTopicYN="N">refractory arrhythmia</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40654169</ArticleId><ArticleId IdType="pmc">PMC12420884</ArticleId><ArticleId IdType="doi">10.1111/jce.70000</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arenal &#xc1;., &#xc1;vila P., Jim&#xe9;nez&#x2010;Candil J., et al., &#x201c;Substrate Ablation Vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia,&#x201d; Journal of the American College of Cardiology 79 (2022): 1441&#x2013;1453.</Citation><ArticleIdList><ArticleId IdType="pubmed">35422240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R., Xue Y., Chen M., et al., &#x201c;First&#x2010;Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE&#x2010;SCD Randomized Trial,&#x201d; Circulation 145 (2022): 1839&#x2013;1849.</Citation><ArticleIdList><ArticleId IdType="pubmed">35507499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp John L., Tang Anthony S. L., Parkash R., et al., &#x201c;Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia,&#x201d; New England Journal of Medicine 392, no. 8 (2024): 737&#x2013;747, 10.1056/NEJMoa2409501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2409501</ArticleId><ArticleId IdType="pubmed">39555820</ArticleId></ArticleIdList></Reference><Reference><Citation>Virk S. A. and Kumar S., &#x201c;Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease,&#x201d; JACC: Clinical Electrophysiology 9 (2023): 255&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">36858693</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati S. R., Choudry S., Koruth J. S., Miller M. A., Whang W., and Reddy V. Y., &#x201c;Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts,&#x201d; Journal of the American College of Cardiology 70 (2017): 2909&#x2013;2923.</Citation><ArticleIdList><ArticleId IdType="pubmed">29216987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati S. R., Koruth J. S., Choudry S., Miller M. A., Whang W., and Reddy V. Y., &#x201c;Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease,&#x201d; Journal of the American College of Cardiology 70 (2017): 2924&#x2013;2941.</Citation><ArticleIdList><ArticleId IdType="pubmed">29216988</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsia H. H. and Xiong N., &#x201c;Infusion Needle Ablation Catheter,&#x201d; Journal of the American College of Cardiology 73 (2019): 1426&#x2013;1429.</Citation><ArticleIdList><ArticleId IdType="pubmed">30922473</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp J. L., &#x201c;Needle Ablation for Ventricular Tachycardia: From Bench to Bedside,&#x201d; Canadian Journal of Cardiology 38 (2022): 1150&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pubmed">35781012</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R., Raiman M., Liao H., et al., &#x201c;Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia,&#x201d; Journal of the American College of Cardiology 75 (2020): 884&#x2013;897.</Citation><ArticleIdList><ArticleId IdType="pubmed">32130924</ArticleId></ArticleIdList></Reference><Reference><Citation>Guandalini G. S., Liang J. J., and Marchlinski F. E., &#x201c;Ventricular Tachycardia Ablation,&#x201d; JACC: Clinical Electrophysiology 5 (2019): 1363&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">31857035</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson W. G. and Sapp J. L., &#x201c;Newer Methods for Ventricular Tachycardia Ablation and When to Use Them,&#x201d; Canadian Journal of Cardiology 38 (2022): 502&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">34942300</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer B., Tanigawa S., Nakamura T., et al., &#x201c;Characteristics of Myocardial Tissue Staining and Lesion Creation With an Infusion&#x2010;Needle Ablation Catheter for the Treatment of Ventricular Tachycardia in Humans,&#x201d; Heart Rhythm: The Official Journal of the Heart Rhythm Society 17 (2020): 398&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">31604127</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp J. L., Beeckler C., Pike R., et al., &#x201c;Initial Human Feasibility of Infusion Needle Catheter Ablation for Refractory Ventricular Tachycardia,&#x201d; Circulation 128 (2013): 2289&#x2013;2295.</Citation><ArticleIdList><ArticleId IdType="pubmed">24036605</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M. J., McKenzie J. E., Bossuyt P. M., et al., &#x201c;The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,&#x201d; BMJ 372 (2021): n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>G. A. Wells BS, Connell D. O'., and The Newcastle&#x2010;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta&#x2010;Analyses , The Ottawa Hospital Research Institute.</Citation></Reference><Reference><Citation>Stevenson W. G., Tedrow U. B., Reddy V., et al., &#x201c;Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular Arrhythmias,&#x201d; Journal of the American College of Cardiology 73 (2019): 1413&#x2013;1425.</Citation><ArticleIdList><ArticleId IdType="pubmed">30922472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedrow U. B., Kurata M., Kawamura I., et al., &#x201c;Worldwide Experience With an Irrigated Needle Catheter for Ablation of Refractory Ventricular Arrhythmias,&#x201d; JACC: Clinical Electrophysiology 9 (2023): 1475&#x2013;1486.</Citation><ArticleIdList><ArticleId IdType="pubmed">37278684</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer D. L., Wilber D. J., Kapa S., et al., &#x201c;Ablation of Refractory Ventricular Tachycardia Using Intramyocardial Needle Delivered Heated Saline&#x2010;Enhanced Radiofrequency Energy: A First&#x2010;in&#x2010;Man Feasibility Trial,&#x201d; Circulation. Arrhythmia and Electrophysiology 15 (2022): e010347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388560</ArticleId><ArticleId IdType="pubmed">35776711</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez&#x2010;Somonte P., Dyrda K., Nault I., Rivard L., and Verma A., &#x201c;Evaluation of Saline&#x2010;Enhanced Radiofrequency Needle&#x2010;Tip Ablation for Ventricular Tachycardia (SERF VT CANADA Trial),&#x201d; Canadian Journal of Cardiology 38 (2022): 1277&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pubmed">35714882</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati S. R., Nakamura T., Nakajima I., et al., &#x201c;Intramural Needle Ablation for Refractory Premature Ventricular Contractions,&#x201d; Circulation. Arrhythmia and Electrophysiology 15 (2022): e010020.</Citation><ArticleIdList><ArticleId IdType="pubmed">35476455</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson W. G., Wilber D. J., Natale A., et al., &#x201c;Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction the Multicenter Thermocool Ventricular Tachycardia Ablation Trial,&#x201d; Circulation 118 (2008): 2773&#x2013;2782.</Citation><ArticleIdList><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>Koruth J. S., Iwasawa J., Enomoto Y., et al., &#x201c;Chamber&#x2010;Specific Radiofrequency Lesion Dimension Estimation Using Novel Catheter&#x2010;Based Tissue Interface Temperature Sensing,&#x201d; JACC: Clinical Electrophysiology 3 (2017): 1092&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pubmed">29759491</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp J. L., Cooper J. M., Soejima K., et al., &#x201c;Deep Myocardial Ablation Lesions Can be Created With a Retractable Needle&#x2010;Tipped Catheter,&#x201d; Pacing and Clinical Electrophysiology 27 (2004): 594&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">15125714</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki A., Lehmann H. I., Wang S., et al., &#x201c;Impact of Myocardial Fiber Orientation on Lesions Created by a Novel Heated Saline&#x2010;Enhanced Radiofrequency Needle&#x2010;Tip Catheter: An MRI Lesion Validation Study,&#x201d; Heart Rhythm: the Official Journal of the Heart Rhythm Society 18 (2021): 443&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">33212248</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussinovitch U., Wang P., Babakhanian M., et al., &#x201c;Needle&#x2010;Tipped Catheter Ablation of Papillary Muscle Results in Deeper and Larger Ablation Lesions,&#x201d; Journal of Cardiovascular Translational Research 16 (2023): 636&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10115905</ArticleId><ArticleId IdType="pubmed">36264437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding W. Y., Pearman C. M., Bonnett L., et al., &#x201c;Complication Rates Following Ventricular Tachycardia Ablation in Ischaemic and Non&#x2010;Ischaemic Cardiomyopathies: A Systematic Review,&#x201d; Journal of Interventional Cardiac Electrophysiology 63 (2022): 59&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755671</ArticleId><ArticleId IdType="pubmed">33512605</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangeli P., Frankel D. S., Tung R., et al., &#x201c;Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease,&#x201d; Journal of the American College of Cardiology 69 (2017): 2105&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pubmed">28449770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan A., Futyma P., Metzner A., et al., &#x201c;Management of Ventricular Tachycardias: Insights on Centre Settings, Procedural Workflow, Endpoints, and Implementation of Guidelines&#x2010;Results From an EHRA Survey,&#x201d; EP Europace 26, no. 2 (2024): euae030, 10.1093/europace/euae030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euae030</ArticleId><ArticleId IdType="pmc">PMC10872712</ArticleId><ArticleId IdType="pubmed">38363995</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT05337241Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT. ClinicalTrials.gov.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39847180</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1613-2246</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Japanese journal of ophthalmology</Title><ISOAbbreviation>Jpn J Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Two-year randomized controlled trial of circumferential versus segmental ab externo angle surgery in patients with primary open angle glaucoma.</ArticleTitle><Pagination><StartPage>279</StartPage><EndPage>286</EndPage><MedlinePgn>279-286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10384-024-01150-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the surgical outcomes of visco-circumferential-suture-trabeculotomy (VCST) and rigid probe segmental viscotrabeculotomy (VT) in primary open-angle glaucoma (POAG).</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">A prospective randomized controlled study.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Patients presenting with POAG and operated upon in Mansoura Ophthalmic Center in Mansoura, Egypt between February 2017 and September 2021 were enrolled. Study eyes were randomized to either VCST or VT and follow up extended for 24 months. Success was defined as an intra ocular pressure (IOP)&#x2264;18 mmHg with a 40% reduction from baseline. Complications were noted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study enrolled 166 (82 in the circumferential group) eyes of 107 patients. There were no statistically significant differences between both groups in any demographic or preoperative clinical characteristics. The IOP trend demonstrated marked initial reduction (from 32.3&#xb1;2.4 and 31.8&#xb1;2.6 mmHg preoperatively in VCST and VT groups respectively) followed by a slow gradual rise over subsequent follow-up settling at lower IOP values in the circumferential (12.4&#xb1;1.2 mmHg) than in the segmental group (15.5&#xb1;0.9 mmHg) (p&lt;0.001), both settling at significantly lower levels than preoperative values. The survival curve demonstrates complete success rates at 12, 15, 18, and 24 months were 98.8%, 96.4%, 95.1%, and 85.4% in the circumferential group and 98.8%, 92.9%, 91.7%, 79.8% in the segmental group respectively. Minimal self-limiting hyphema was universal in all study eyes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Angle procedures -segmental and circumferential- are effective in lowering the IOP for at least 2 years in eyes with POAG, with circumferential angle surgery providing a greater reduction of IOP and requiring fewer subsequent glaucoma procedures.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elwehidy</LastName><ForeName>Ahmed Samy</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayoumi</LastName><ForeName>Nader Hussein Lotfy</ForeName><Initials>NHL</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elwehidy</LastName><ForeName>Mostafa A S</ForeName><Initials>MAS</Initials><AffiliationInfo><Affiliation>Resident of Ophthalmology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaky</LastName><ForeName>Nashaat Shawky</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagras</LastName><ForeName>Sherein M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayoumi</LastName><ForeName>Nader H L</ForeName><Initials>NHL</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Alexandria University, Alexandria, Egypt. nader.bayoumi@alexmed.edu.eg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Jpn J Ophthalmol</MedlineTA><NlmUniqueID>0044652</NlmUniqueID><ISSNLinking>0021-5155</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="Y">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="Y">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013536" MajorTopicYN="N">Suture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014065" MajorTopicYN="N">Tonometry, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="Y">Trabeculectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Intraocular pressure</Keyword><Keyword MajorTopicYN="N">Primary open angle glaucoma</Keyword><Keyword MajorTopicYN="N">Trabeculotomy</Keyword><Keyword MajorTopicYN="N">Viscotrabeculotomy</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: A. S. Elwehidy, None; N. HL. Bayoumi, None; M. AS. Elwehidy, None; N. S. Zaky, None; S. M. Hagras, None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>14</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>23</Day><Hour>12</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>23</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39847180</ArticleId><ArticleId IdType="pmc">PMC12003612</ArticleId><ArticleId IdType="doi">10.1007/s10384-024-01150-7</ArticleId><ArticleId IdType="pii">10.1007/s10384-024-01150-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1856963</ArticleId><ArticleId IdType="pubmed">16488940</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapetanakis VV, Chan MPY, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016;100:86&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4717368</ArticleId><ArticleId IdType="pubmed">26286821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusthaus J, Goldberg I. Current management of glaucoma. Med J Aust [Internet]. 2019 Mar 1 [cited 2023 Sep 14];210(4):180&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">30767238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153:804&#x2013;14. e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3653167</ArticleId><ArticleId IdType="pubmed">22244522</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva I, Brusini P, Oddone F, Michelessi M, Weinreb RN, Quaranta L. Canaloplasty in the treatment of open-angle glaucoma: a review of patient selection and outcomes. Adv Ther;36:31&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6318242</ArticleId><ArticleId IdType="pubmed">30488337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Xin C, Han Y, Shi Y, Ziaei S, Wang N. Intermediate outcomes of ab externo circumferential trabeculotomy and canaloplasty in POAG patients with prior incisional glaucoma surgery. BMC Ophthalmol. 2020;20:389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7531087</ArticleId><ArticleId IdType="pubmed">33008405</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktas Z, Ucgul AY, Bektas C, Sahin Karamert S. Surgical outcomes of prolene gonioscopy-assisted transluminal trabeculotomy in patients with moderate to advanced open-angle glaucoma. J Glaucoma. 2019;28:884&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31385914</ArticleId></ArticleIdList></Reference><Reference><Citation>de Faria BM, Daga FB, Rebou&#xe7;as-Santos V, de Ara&#xfa;jo RB, Neto CM, Jacobina JS, et al. Gonioscopy-assisted transluminal trabeculotomy (GATT) outcomes in eyes with open-angle glaucoma resistant to maximum treatment. Arq Bras Oftalmol. 2021;84:587&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11884373</ArticleId><ArticleId IdType="pubmed">34320113</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalinbas D, Dilekmen N, Hepsen IF. Comparison of ab externo and ab interno 360-degree suture trabeculotomy in adult open-angle glaucoma. J Glaucoma. 2020;29:1088&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">32769730</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktas Z, Hepsen IF, Dilekmen N, Onol M. Are the outcomes of circumferential trabeculotomy for adult open angle glaucoma comparable to those of trabeculectomy? Clin Exp Ophthalmol. 2016;44:858&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27221977</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmatnejad K, Pruzan NL, Amanullah S, Shaukat BA, Resende AF, Waisbourd M, et al. Surgical outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) in patients with open-angle glaucoma. J Glaucoma. 2017;26:1137&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">29035912</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover DS, Smith O, Fellman RL, Godfrey DG, Gupta A, De Oca IM, et al. Gonioscopy-assisted transluminal trabeculotomy: an ab interno circumferential trabeculotomy: 24 months follow-up. J Glaucoma. 2018;27:393&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">29613978</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwehidy AS, Hagras SM, Bayoumi N, AbdelGhafar AE, Badawi AE. Five-year results of viscotrabeculotomy versus conventional trabeculotomy in primary congenital glaucoma: a randomized controlled study. Eur J Ophthalmol. 2021;31:786&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">32450720</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwehidy AS, Bayoumi NH, Elzeini RM, Abdelkader A. Visco-circumferential-suture-trabeculotomy versus rigid-probe viscotrabeculotomy in neonatal-onset primary congenital glaucoma. J Glaucoma. 2023;32:30.</Citation><ArticleIdList><ArticleId IdType="pubmed">37054437</ArticleId></ArticleIdList></Reference><Reference><Citation>El Sayed YM, Gawdat GI. Microcatheter-assisted trabeculotomy versus 2-site trabeculotomy with the rigid probe trabeculotome in primary congenital glaucoma. J Glaucoma. 2018;27:371&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29394197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Wang Y, Xin C, Sun Y, Cao K, Wang H, et al. Ab interno vs. ab externo microcatheter-assisted circumferential trabeculotomy in treating patients with primary open-angle glaucoma. Front Med. 2021;8:795172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8720850</ArticleId><ArticleId IdType="pubmed">34988099</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwehidy AS, Bayoumi NHL, Abd Elfattah D, Hagras SM. Surgical outcomes of visco-circumferential-suture-trabeculotomy versus rigid probe trabeculotomy in primary congenital glaucoma: a 3-year randomized controlled study. J Glaucoma. 2022;31:48&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">34628421</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwehidy AS, Mokbel TH, Bayoumi NHL, Badawi AE, Hagras SM. Viscotrabeculotomy versus trabeculectomy in the surgical treatment of open angle glaucoma: a single center, randomised controlled trial. Jpn J Ophthalmol. 2021;65:395&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">33415606</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao JB, Sarkisian SR, Freedman SF. Illuminated microcatheter-facilitated 360-degree trabeculotomy for refractory aphakic and juvenile open-angle glaucoma. J Glaucoma. 2014;23:449&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">23661045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim ME, Dao JB, Freedman SF. 360-degree trabeculotomy for medically refractory glaucoma following cataract surgery and juvenile open-angle glaucoma. Am J Ophthalmol. 2017;175:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27916715</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnicka AR, Mt.-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a bayesian meta-analysis. Investig Ophthalmol Vis Sci. 2006;47:4254&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">17003413</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021;11:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8253788</ArticleId><ArticleId IdType="pubmed">34215769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahabadi N, Zeppieri M, Tripathy K. Open Angle Glaucoma. [Updated March 7 2024]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; January 2024. https://www.ncbi.nlm.nih.gov/books/NBK441887/ Accessed 14 November 2024.</Citation></Reference><Reference><Citation>Takata M, Ishikawa H, Ikeda T, Gomi F. Conventional trabeculotomy versus gonioscopy-assisted transluminal trabeculotomy: a retrospective cohort study. J Clin Med. 2022;11:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8745353</ArticleId><ArticleId IdType="pubmed">35011786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yu P, Zhang Y, Sugihara K, Zhu X, Zhang Y, et al. Influence of goniotomy size on treatment safety and efficacy for primary open-angle glaucoma: a multicenter study. Am J Ophthalmol. 2023;256:118&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">37573988</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaram H. Intraocular pressure reduction in glaucoma: does every mmHg count? Taiwan J Ophthalmol. 2020;10:255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787090</ArticleId><ArticleId IdType="pubmed">33437597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin S, Nitta T, Shinmei Y, Aoyagi M, Nitta A, Ohno S, et al. Reduction of intraocular pressure using a modified 360-degree suture trabeculotomy technique in primary and secondary open-angle glaucoma: a pilot study. J Glaucoma. 2012;21:401&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21543994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16192502</PMID><DateCompleted><Year>2005</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-2999</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>4</Issue><PubDate><Year>2005</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>The pulmonary immune effects of mechanical ventilation in patients undergoing thoracic surgery.</ArticleTitle><Pagination><StartPage>957</StartPage><EndPage>965</EndPage><MedlinePgn>957-965</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/01.ane.0000172112.02902.77</ELocationID><Abstract><AbstractText Label="UNLABELLED">Mechanical ventilation (MV) may induce an inflammatory alveolar response. One-lung ventilation (OLV) with tidal volumes (Vt) as used during two-lung ventilation is a suggested algorithm but may impose mechanical stress of the dependent lung and potentially aggravate alveolar mediator release. We studied whether ventilation with different Vt modifies pulmonary immune function, hemodynamics, and gas exchange. Thirty-two patients undergoing open thoracic surgery were randomized to receive either MV with Vt = 10 mL/kg (n = 16) or Vt = 5 mL/kg (n = 16) adjusted to normal Pa(CO2) during and after OLV. Fiberoptic bronchoalveolar lavage of the ventilated lung was performed, and cells, protein, tumor necrosis factor (TNF)-alpha, interleukin (IL)-8, soluble intercellular adhesion molecule (sICAM)-1, IL-10, and elastase were determined in the bronchoalveolar lavage. Data were analyzed by parametric or nonparametric tests, as indicated. In all patients, an increase of proinflammatory variables was found. The time courses of intra-alveolar cells, protein, albumin, IL-8, elastase, and IL-10 did not differ between the groups after OLV and postoperatively. TNF-alpha (8.4 versus 5.0 microg/mL) and sICAM-1 (52.7 versus 27.5 microg/mL) concentrations were significantly smaller after OLV with Vt = 5 mL/kg. These results indicate that MV may induce epithelial damage and a proinflammatory response in the ventilated lung. Reduction of tidal volume during OLV may reduce alveolar concentrations of TNF-alpha and of sICAM-1.</AbstractText><AbstractText Label="IMPLICATIONS" NlmCategory="CONCLUSIONS">Reductions of tidal volume, with subsequently decreased peak airway pressures, may reduce some alveolar inflammatory responses seen with mechanical ventilation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>*Department of Anesthesiology and Intensive Care Medicine, &#x2020;Department of Cardiovascular and Thoracic Surgery, &#x2021;Institute of Immunology, and &#xa7;Department of Cardiology, Angiology, and Pneumology, Otto-von-Guericke-University, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozian</LastName><ForeName>Alf</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Huth</LastName><ForeName>Christof</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>B&#xfc;hling</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Kretzschmar</LastName><ForeName>Moritz</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Welte</LastName><ForeName>Tobias</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hachenberg</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>126547-89-5</RegistryNumber><NameOfSubstance UI="D018799">Intercellular Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.37</RegistryNumber><NameOfSubstance UI="D019272">Leukocyte Elastase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018799" MajorTopicYN="N">Intercellular Adhesion Molecule-1</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019272" MajorTopicYN="N">Leukocyte Elastase</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="Y">Thoracic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>10</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16192502</ArticleId><ArticleId IdType="doi">10.1213/01.ane.0000172112.02902.77</ArticleId><ArticleId IdType="pii">00000539-200510000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Broccard AF, Hotchkiss JR, Suzuki S, et al. Effects of mean airway pressure and tidal excursion on lung injury induced by mechanical ventilation in an isolated perfused rabbit lung model. Crit Care Med 1999;27:1533&#x2013;41.</Citation></Reference><Reference><Citation>Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999;116:9&#x2013;15.</Citation></Reference><Reference><Citation>Dreyfuss D, Ricard JD, Saumon G. On the physiologic and clinical relevance of lung-borne cytokines during ventilator-induced lung injury. Am J Respir Crit Care Med 2003;167:1467&#x2013;71.</Citation></Reference><Reference><Citation>Tremblay L, Valenza F, Ribeiro SP, et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997;99:944&#x2013;52.</Citation></Reference><Reference><Citation>Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998;157:294&#x2013;323.</Citation></Reference><Reference><Citation>Tremblay LN, Miatto D, Hamid Q, et al. Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA. Crit Care Med 2002;30:1693&#x2013;700.</Citation></Reference><Reference><Citation>Pugin J. Molecular mechanisms of lung cell activation induced by cyclic stretch. Crit Care Med 2003;31:S200&#x2013;6.</Citation></Reference><Reference><Citation>Brodsky JB, Fitzmaurice B. Modern anesthetic techniques for thoracic operations. World J Surg 2001;25:162&#x2013;6.</Citation></Reference><Reference><Citation>Tugrul M, Camci E, Karadeniz H, et al. Comparison of volume controlled with pressure controlled ventilation during one-lung anaesthesia. Br J Anaesth 1997;79:306&#x2013;10.</Citation></Reference><Reference><Citation>de Abreu MG, Heintz M, Heller A, et al. One-lung ventilation with high tidal volumes and zero positive end-expiratory pressure is injurious in the isolated rabbit lung model. Anesth Analg 2003;96:220&#x2013;8.</Citation></Reference><Reference><Citation>Kotani N, Lin CY, Wang JS, et al. Loss of alveolar macrophages during anesthesia and operation in humans. Anesth Analg 1995;81:1255&#x2013;62.</Citation></Reference><Reference><Citation>Kotani N, Hashimoto H, Sessler DI, et al. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia. Anesthesiology 1998;89:1125&#x2013;32.</Citation></Reference><Reference><Citation>Wrigge H, Uhlig U, Zinserling J, et al. The effects of different ventilatory settings on pulmonary and systemic inflammatory responses during major surgery. Anesth Analg 2004;98:775&#x2013;81.</Citation></Reference><Reference><Citation>Kotani N, Hashimoto H, Sessler DI, et al. Neutrophil number and interleukin-8 and elastase concentrations in bronchoalveolar lavage fluid correlate with decreased arterial oxygenation after cardiopulmonary bypass. Anesth Analg 2000;90:1046&#x2013;51.</Citation></Reference><Reference><Citation>Frass OM, Buhling F, Tager M, et al. Antioxidant and antiprotease status in peripheral blood and BAL fluid after cardiopulmonary bypass. Chest 2001;120:1599&#x2013;608.</Citation></Reference><Reference><Citation>Strieter RM, Belperio JA, Keane MP. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 2003;16:193&#x2013;8.</Citation></Reference><Reference><Citation>Maus U, Rosseau S, Knies U, et al. Expression of proinflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia. Eur Respir J 1998;11:534&#x2013;41.</Citation></Reference><Reference><Citation>Rich EA, Panuska JR, Wallis RS, et al. Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am Rev Respir Dis 1989;139:1010&#x2013;6.</Citation></Reference><Reference><Citation>Wrigge H, Zinserling J, Stuber F, et al. Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function. Anesthesiology 2000;93:1413&#x2013;7.</Citation></Reference><Reference><Citation>Schutte H, Lohmeyer J, Rosseau S, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996;9:1858&#x2013;67.</Citation></Reference><Reference><Citation>Boutten A, Dehoux MS, Seta N, et al. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1996;153:336&#x2013;42.</Citation></Reference><Reference><Citation>Kinoshita M, Ono S, Mochizuki H. Neutrophils mediate acute lung injury in rabbits: role of neutrophil elastase. Eur Surg Res 2000;32:337&#x2013;46.</Citation></Reference><Reference><Citation>Lee JH, Del Sorbo, L, Uhlig S, et al. Intercellular adhesion molecule-1 mediates cellular cross-talk between parenchymal and immune cells after lipopolysaccharide neutralization. J Immunol 2004;172:608&#x2013;16.</Citation></Reference><Reference><Citation>Farivar AS, Krishnadasan B, Naidu BV, et al. Endogenous interleukin-4 and interleukin-10 regulate experimental lung ischemia reperfusion injury. Ann Thorac Surg 2003;76:253&#x2013;9.</Citation></Reference><Reference><Citation>Fu Z, Costello ML, Tsukimoto K, et al. High lung volume increases stress failure in pulmonary capillaries. J Appl Physiol 1992;73:123&#x2013;33.</Citation></Reference><Reference><Citation>Tsukimoto K, Mathieu-Costello O, Prediletto R, et al. Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J Appl Physiol 1991;71:573&#x2013;82.</Citation></Reference><Reference><Citation>Bhattacharya J, Staub NC. Direct measurement of microvascular pressures in the isolated perfused dog lung. Science 1980;210:327&#x2013;8.</Citation></Reference><Reference><Citation>West JB, Tsukimoto K, Mathieu-Costello O, Prediletto R. Stress failure in pulmonary capillaries. J Appl Physiol 1991;70:1731&#x2013;42.</Citation></Reference><Reference><Citation>Licker M, Spiliopoulos A, Frey JG, et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest 2002;121:1890&#x2013;7.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33630902</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Kinetic and static perimetry after 16 years and additional OCT-A analysis in eyes with long-lasting optic disc drusen.</ArticleTitle><Pagination><StartPage>e0247399</StartPage><MedlinePgn>e0247399</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0247399</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0247399</ELocationID><Abstract><AbstractText>The aim of the study is to evaluate the progression of visual field (VF) defects over 16 years of observation and to assess abnormalities in vessels and retinal nerve fibre layer (RNFL) thickness in patients with optic disc drusen (ODD). Both static automated perimetry (SAP) and semi-automated kinetic perimetry (SKP) were performed in 16 eyes of 8 patients (mean age 54 years) with ODD among 26 eyes of 13 patients examined 16 years before. The area of I2e, I4e, III4e, and V4e isopters was measured in deg2. The MD and PSD parameters were estimated using SAP. Optical coherence tomography angiography (OCT-A) was additionally performed in 16 ODD eyes and 16 eyes of 8 healthy subjects to estimate the RNFL thickness and vessel density of the optic nerve disc and the macula. The differences in all isopter areas of SKP and SAP parameters after 16 years were not significant. The analysis of OCT-A showed a significant reduction of the vessel density and RNFL of the peripapillary area in each segment in patients with ODD, compared with the control group. The highest reduction of RNFL was observed in the superior segment of the optic disc area (92.56&#x3bc;m vs 126.63&#x3bc;m) also the macular thickness was decreased in ODD patients, compared with the control group. In the macula, there was a significant vascular defect in the whole superficial layer and in the parafoveal deep layer. A strong significant correlation of the parafoveal deep plexus with MD and PSD parameters was detected. In conclusion, VF loss due to ODD after 16 years of the follow-up was not significant both in SKP and SAP. ODD caused a reduced vessel density and RNFL, as well as macular thickness in OCT-A. SAP parameters were influenced by parafoveal deep plexus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koman-Wierdak</LastName><ForeName>Edyta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8870-7152</Identifier><AffiliationInfo><Affiliation>Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowomiejska</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5805-8761</Identifier><AffiliationInfo><Affiliation>Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brzozowska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departament of Mathematics and Medical Biostatistics, Medical University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowakowska</LastName><ForeName>Dominika</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1200-563X</Identifier><AffiliationInfo><Affiliation>Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toro</LastName><ForeName>Mario Damiano</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0001-7152-2613</Identifier><AffiliationInfo><Affiliation>Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Collegium Medicum Cardinal Stefan Wyszynski University, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonfiglio</LastName><ForeName>Vincenza</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Experimental Biomedicine and Clinical Neuroscience, Ophthalmology Section, University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reibaldi</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Eye Clinic Section, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avitabile</LastName><ForeName>Teresio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rejdak</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000792" MajorTopicYN="N">Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008266" MajorTopicYN="N">Macula Lutea</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009412" MajorTopicYN="N">Nerve Fibers</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009898" MajorTopicYN="N">Optic Disk</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015594" MajorTopicYN="N">Optic Disk Drusen</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012165" MajorTopicYN="N">Retinal Ganglion Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012171" MajorTopicYN="N">Retinal Vessels</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058609" MajorTopicYN="N">Visual Field Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>25</Day><Hour>17</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33630902</ArticleId><ArticleId IdType="pmc">PMC7906410</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0247399</ArticleId><ArticleId IdType="pii">PONE-D-20-23095</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hamman S, Malmqvist L, Costello F.Optic disc drusen: understanding an old problem from a new perspective. Acta Ophthalmol. 2018;96: 673&#x2013;684. 10.1111/aos.13748</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.13748</ArticleId><ArticleId IdType="pubmed">29659172</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorentzen SE. Drusen of the optic disk. A clinical and genetic study. Acta Ophthalmol (Copenh) 1966; 90(Suppl): 1&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">6012937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AG, Zimmerman MB. The rate of visual field loss in optic nerve head drusen. Am J Ophthalmol. 2005;139: 1062&#x2013;1066. 10.1016/j.ajo.2005.01.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2005.01.020</ArticleId><ArticleId IdType="pubmed">15953437</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustonen E. Pseudopapilloedema with and without verified optic disc drusen. A clinical analysis II: visual fields. Acta Ophthalmol (Copenh). 1983;61(6):1057&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">6659908</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmqvist L, Wegener M, Sander BA, Hamann S. Peripapillary retinal nerve fiber layer thickness corresponds to drusen location and extent of visual field defects in superficial and buried optic disc drusen. J Neuroophthalmol. 2016;36: 41&#x2013;45. 10.1097/WNO.0000000000000325</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0000000000000325</ArticleId><ArticleId IdType="pubmed">26720518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins JM, Pomeranz HD. Visual manifestations of visible and buried optic disc drusen. J Neuroophthalmol. 2004;24(2):125&#x2013;129. 10.1097/00041327-200406000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00041327-200406000-00006</ArticleId><ArticleId IdType="pubmed">15179065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowomiejska K, Rejdak R, Zag&#xf3;rski Z &amp; &#x17b;arnowski T. Comparison of static automated perimetry and semi&#x2010;automated kinetic perimetry in patients with bilateral visible optic nerve head drusen. Acta Ophthalmol. 2009;87(7): 801&#x2013;805. 10.1111/j.1755-3768.2008.01364.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-3768.2008.01364.x</ArticleId><ArticleId IdType="pubmed">18721249</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmqvist L, Lund&#x2010;Andersen H, Hamann S. Long&#x2010;term evolution of superficial optic disc drusen. Acta Ophthalmol. 2017;95: 352&#x2013;356. 10.1111/aos.13315</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.13315</ArticleId><ArticleId IdType="pubmed">27996202</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval S, Visa J, Contreras I. visual field defects due to optic disk drusen in children. Graefes Arch Clin Exp Ophthalmol. 2013;251(10):2445&#x2013;2450. 10.1007/s00417-013-2384-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-013-2384-6</ArticleId><ArticleId IdType="pubmed">23733034</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Rodriguez P, Gili P,Martin-Rios MD. Ophthalmic features of optic disc drusen. Ophthalmologica. 2012;228(1):59&#x2013;66. 10.1159/000337842</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000337842</ArticleId><ArticleId IdType="pubmed">22584542</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulauf M, LeBlanc RP, Flammer J. Normal visual fields measured with Octopus&#x2010;Program G1. II. Global visual field indices. Graefes Arch Clin Exp Ophthalmol. 1994;232: 516&#x2013;522. 10.1007/BF00181993</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00181993</ArticleId><ArticleId IdType="pubmed">7959089</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisen L. Evolution of drusen of the optic nerve head over 23 years. Acta Ophthalmol. 2008;86: 111&#x2013;112. 10.1111/j.1600-0420.2007.00986.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0420.2007.00986.x</ArticleId><ArticleId IdType="pubmed">18233998</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz BJ, Pomeranz HD. Visual field defects and retinal nerve fiber layer defects in eyes with buried optic nerve drusen. Am J Ophthalmol. 2006;141: 248&#x2013;253. 10.1016/j.ajo.2005.09.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2005.09.029</ArticleId><ArticleId IdType="pubmed">16458676</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaier ED, Rizzo JF 3rd, Miller JB, Cestari DM. Focal Capillary Dropout Associated With Optic Disc Drusen Using Optical Coherence Tomographic Angiography. J Neuroophthalmol. 2017;37(4):405&#x2013;410. 10.1097/WNO.0000000000000502</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0000000000000502</ArticleId><ArticleId IdType="pubmed">28520583</ArticleId></ArticleIdList></Reference><Reference><Citation>Cennamo G, Tebaldi S, Amoroso F, Arvanitis D, Breve M, Cennamo G. Optical Coherence Tomography Angiography in Optic Nerve Drusen. Ophthalmic Res. 2018; 59:76&#x2013;80. 10.1159/000481889</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481889</ArticleId><ArticleId IdType="pubmed">29186723</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Reyes E, Hoskens K, Mansouri K. Optic Nerve Head Drusen: Imaging Using Optical Coherence Tomography Angiography. J Glaucoma. 2017;26:845&#x2013;849. 10.1097/IJG.0000000000000730</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IJG.0000000000000730</ArticleId><ArticleId IdType="pubmed">28767460</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi&#xe7;er O, Atilla H. Microvascular Changes Associated with Optic Disc Drusen: Case Report. Turk J Ophthalmol. 2019;49(5): 300&#x2013;304. 10.4274/tjo.galenos.2019.14194</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/tjo.galenos.2019.14194</ArticleId><ArticleId IdType="pmc">PMC6823588</ArticleId><ArticleId IdType="pubmed">31650815</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh S, Noecker RJ, Schuman JS, Hedges TR 3rd, Weiter JJ, Mattox C. Effect of optic nerve head drusen on nerve fiber layer thickness. Ophthalmology. 1998;105: 878&#x2013;885. 10.1016/S0161-6420(98)95031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-6420(98)95031-X</ArticleId><ArticleId IdType="pmc">PMC1937403</ArticleId><ArticleId IdType="pubmed">9593392</ArticleId></ArticleIdList></Reference><Reference><Citation>Gili P, Flores&#x2010;Rodriguez P, Martin&#x2010;Rios MD, Carrasco Font C. Anatomical and functional impairment of the nerve fiber layer in patients with optic nerve head drusen. Graefes Arch Clin Exp Ophthalmol. 2013;251: 2421&#x2013;2428. 10.1007/s00417-013-2438-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-013-2438-9</ArticleId><ArticleId IdType="pubmed">23955723</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelke H, Shajari M, Riedel J, Mohr N, Priglinger SG, Mackert MJ. OCT angiography in optic disc drusen: comparison with structural and functional parameters. Br J Ophthalmol. 2019; 0:1&#x2013;5. 10.1136/bjophthalmol-2019-314096</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2019-314096</ArticleId><ArticleId IdType="pubmed">31744797</ArticleId></ArticleIdList></Reference><Reference><Citation>Casado A, Rebolleda G, Guerrero L. Measurement of retinal nerve fiber layer and macular ganglion cell-inner plexiform layer with spectral-domain optical coherence tomography in patients with optic nerve head drusen. Graefes Arch Clin Exp Ophthalmol. 2014;252:1653&#x2013;60. 10.1007/s00417-014-2773-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-014-2773-5</ArticleId><ArticleId IdType="pubmed">25128962</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistlberger A, Sitte S, Hommer A, Emesz M, Dengg S, Hitzl W et al.. Scanning laser polarimetry (SLP) for optic nerve head drusen. Int Ophthalmol. 2001;23: 233&#x2013;237. 10.1023/a:1014401202762</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1014401202762</ArticleId><ArticleId IdType="pubmed">11944846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Mrejen S, Spaide RF. Multimodal imaging of optic disc drusen. Am J Ophthalmol. 2013;156: 275&#x2013;282. 10.1016/j.ajo.2013.03.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2013.03.039</ArticleId><ArticleId IdType="pubmed">23677136</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Zhou X, Chu Z, Stell L, Shariati MA, Wang RK et al.. Vision loss in optic disc drusen correlates with increased macular vessel diameter and flux and reduced peripapillary vascular density. Am J Ophthalmol. 2020;28:S0002-9394(20)30187-2. 10.1016/j.ajo.2020.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2020.04.019</ArticleId><ArticleId IdType="pmc">PMC8186883</ArticleId><ArticleId IdType="pubmed">32360344</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27756403</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7525</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Health and quality of life outcomes</Title><ISOAbbreviation>Health Qual Life Outcomes</ISOAbbreviation></Journal><ArticleTitle>Fatigue in intensive care survivors one year after discharge.</ArticleTitle><Pagination><StartPage>148</StartPage><MedlinePgn>148</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">148</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fatigue has not been investigated in long-term Intensive Care Unit (ICU) survivors. This study aimed to assess fatigue through a specific instrument, namely the Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) scale, in ICU survivors one year after hospital discharge. A secondary aim was to compare the findings of FACIT-F with those of the Vitality domain (VT) of the 36-item Short-Form Health Survey (SF-36).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective cohort study was performed on 56 adult patients with a Length Of Stay (LOS) in ICU longer than 72&#xa0;h. At one year after hospital discharge, FACIT-F and SF-36 questionnaires were administered to consenting patients by direct interview. FACIT-F was measured as raw (range 0-52), and FACIT-F-trans value (range 0-100). Past medical history, and demographic and clinical ICU-related variables were collected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The patients' median age was 67.5, Simplified Acute Physiology Score II 31, and LOS in ICU 5&#xa0;days. The median raw FACIT-F of the patients was 41, and Cronbach's &#x3b1; was 0.937. The correlation coefficient between FACIT-F-trans and VT of SF-36 was 0.660 (p&#x2009;&lt;&#x2009;0.001). Both FACIT-F and VT were related to dyspnoea scale (p&#x2009;=&#x2009;0.01). A Bland-Altman plot of VT vs FACIT-F-trans showed a bias of -0.8 with 95&#xa0;% limits of agreement from 35.7 to -34.1. The linear regression between differences and means was 0.639, suggesting a significant proportional bias.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The 13-item FACIT-F questionnaire is valid to assess fatigue of long-term ICU survivors. VT of SF-36 relates to FACIT-F, but consists of only four items assessing two positive and two negative aspects. FACIT-F grasps the negative aspects of fatigue better than VT. Specific tools assess specific conditions better that general tools.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov: NCT02684877 .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spadaro</LastName><ForeName>Savino</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Morphology, Experimental Medicine and Surgery, Section of Anaesthesia and Intensive Care, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8. 44121, Cona, Ferrara, Italy. savinospadaro@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capuzzo</LastName><ForeName>Maurizia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Morphology, Experimental Medicine and Surgery, Section of Anaesthesia and Intensive Care, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8. 44121, Cona, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valpiani</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Research and Innovation Office, Azienda Ospedaliero-Universitaria S. Anna, Cona, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertacchini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Morphology, Experimental Medicine and Surgery, Section of Anaesthesia and Intensive Care, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8. 44121, Cona, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragazzi</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Morphology, Experimental Medicine and Surgery, Section of Anaesthesia and Intensive Care, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8. 44121, Cona, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalla Corte</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Morphology, Experimental Medicine and Surgery, Section of Anaesthesia and Intensive Care, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8. 44121, Cona, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terranova</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Morphology, Experimental Medicine and Surgery, Section of Anaesthesia and Intensive Care, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8. 44121, Cona, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marangoni</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Morphology, Experimental Medicine and Surgery, Section of Anaesthesia and Intensive Care, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8. 44121, Cona, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volta</LastName><ForeName>Carlo Alberto</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Morphology, Experimental Medicine and Surgery, Section of Anaesthesia and Intensive Care, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8. 44121, Cona, Ferrara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02684877</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Qual Life Outcomes</MedlineTA><NlmUniqueID>101153626</NlmUniqueID><ISSNLinking>1477-7525</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="Y">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FACIT-F scale</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Outcome</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27756403</ArticleId><ArticleId IdType="pmc">PMC5069802</ArticleId><ArticleId IdType="doi">10.1186/s12955-016-0554-z</ArticleId><ArticleId IdType="pii">10.1186/s12955-016-0554-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Care. 2014;31:562&#x2013;75. doi: 10.1177/1049909113494748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049909113494748</ArticleId><ArticleId IdType="pubmed">23892338</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson A. Fatigue in cancer patients: a review of the literature. Eur J Cancer Care. 1995;4:20&#x2013;32. doi: 10.1111/j.1365-2354.1995.tb00049.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2354.1995.tb00049.x</ArticleId><ArticleId IdType="pubmed">7620651</ArticleId></ArticleIdList></Reference><Reference><Citation>Barsevick AM, Irwin MR, Hinds P, Miller A, Berger A, Jacobsen P, Ancoli-Israel S, Reeve BB, Mustian K, O'Mara A, Lai JS, Fisch M, Cella D. National Cancer Institute Clinical Trials Planning Meeting. Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst. 2013;105:1432&#x2013;40. doi: 10.1093/jnci/djt242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djt242</ArticleId><ArticleId IdType="pmc">PMC3888121</ArticleId><ArticleId IdType="pubmed">24047960</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall A, Campbell HS, Sanson-Fisher R, Lynagh M, D'Este C, Burkhalter R, Carey M. Unmet needs of Australian and Canadian haematological cancer survivors: a cross-sectional international comparative study. Psychooncology. 2013;22:2032&#x2013;8. doi: 10.1002/pon.3247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.3247</ArticleId><ArticleId IdType="pubmed">23436539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106:751&#x2013;758. doi: 10.1002/cncr.21671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.21671</ArticleId><ArticleId IdType="pubmed">16400678</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuzzo M, Bianconi M. Our paper 20&#xa0;years later: 1-year survival and 6-month quality of life after intensive care. Intensive Care Med. 2015;41:605&#x2013;14. doi: 10.1007/s00134-015-3654-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3654-z</ArticleId><ArticleId IdType="pubmed">25605472</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaboyer W, Grace J. Following the path of ICU survivors: a quality-improvement activity. Nurs Crit Care. 2003;8:149&#x2013;55. doi: 10.1046/j.1478-5153.2003.00020.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1478-5153.2003.00020.x</ArticleId><ArticleId IdType="pubmed">12940690</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenbergen S, Rijkenberg S, Adonis T, Kroeze G, van Stijn I, Endeman H. Long-term treated intensive care patients outcomes: the one-year mortality rate, quality of life, health care use and long-term complications as reported by general practitioners. BMC Anesthesiol. 2015;15:142. doi: 10.1186/s12871-015-0121-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-015-0121-x</ArticleId><ArticleId IdType="pmc">PMC4604105</ArticleId><ArticleId IdType="pubmed">26459381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS) Arthritis Care Res (Hoboken) 2011;63 Suppl 11:S263&#x2013;86. doi: 10.1002/acr.20579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20579</ArticleId><ArticleId IdType="pubmed">22588750</ArticleId></ArticleIdList></Reference><Reference><Citation>Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System. J Pain Symptom Manage. 1997;13:63&#x2013;74. doi: 10.1016/S0885-3924(96)00274-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0885-3924(96)00274-6</ArticleId><ArticleId IdType="pubmed">9095563</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94:528&#x2013;38. doi: 10.1002/cncr.10245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.10245</ArticleId><ArticleId IdType="pubmed">11900238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran V, Bhella S, Schentag C, Gladman DD. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis. 2007;66:936&#x2013;9. doi: 10.1136/ard.2006.065763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2006.065763</ArticleId><ArticleId IdType="pmc">PMC1955111</ArticleId><ArticleId IdType="pubmed">17324972</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinsley A, Macklin EA, Korzenik JR, Sands BE. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34:1328&#x2013;36. doi: 10.1111/j.1365-2036.2011.04871.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2011.04871.x</ArticleId><ArticleId IdType="pubmed">21999576</ArticleId></ArticleIdList></Reference><Reference><Citation>Stridsman C, M&#xfc;llerova H, Sk&#xe4;r L, Lindberg A. Fatigue in COPD and the impact of respiratory symptoms and heart disease--a population-based study. COPD. 2013;10:125&#x2013;32. doi: 10.3109/15412555.2012.728642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15412555.2012.728642</ArticleId><ArticleId IdType="pubmed">23547627</ArticleId></ArticleIdList></Reference><Reference><Citation>Stridsman C, Sk&#xe4;r L, Hedman L, R&#xf6;nmark E, Lindberg A. Fatigue Affects Health Status and Predicts Mortality Among Subjects with COPD: Report from the Population-Based OLIN COPD Study. COPD. 2015;12:199&#x2013;206. doi: 10.3109/15412555.2014.922176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15412555.2014.922176</ArticleId><ArticleId IdType="pubmed">24983402</ArticleId></ArticleIdList></Reference><Reference><Citation>Acaster S, Dickerhoof R, DeBusk K, Bernard K, Strauss W, Allen LF. Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia. Health Qual Life Outcomes. 2015;13:60. doi: 10.1186/s12955-015-0257-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-015-0257-x</ArticleId><ArticleId IdType="pmc">PMC4434873</ArticleId><ArticleId IdType="pubmed">25980742</ArticleId></ArticleIdList></Reference><Reference><Citation>Egerton T, Riphagen II, Nyg&#xe5;rd AJ, Thingstad P, Helbostad JL. Systematic content evaluation and review of measurement properties of questionnaires for measuring self-reported fatigue among older people. Qual Life Res. 2015;24:2239&#x2013;55. doi: 10.1007/s11136-015-0963-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-015-0963-1</ArticleId><ArticleId IdType="pubmed">25778536</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957&#x2013;2963. doi: 10.1001/jama.1993.03510240069035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1993.03510240069035</ArticleId><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, de Mendon&#xe7;a A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26:1793&#x2013;800. doi: 10.1097/00003246-199811000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199811000-00016</ArticleId><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Sherbourne CD. The MOS 36-item Short-Form health status survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998;51:1025&#x2013;36. doi: 10.1016/S0895-4356(98)00094-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(98)00094-8</ArticleId><ArticleId IdType="pubmed">9817120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Snow KK, Kosinski M. Gandek B SF-36 health survey: Manual and interpretation guide. Boston: The Health Institute; 1993.</Citation></Reference><Reference><Citation>Bestall JC, Paula EA, Garroda R, Garnhama R, Jonesb PW, Wedzichaa JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581&#x2013;586. doi: 10.1136/thx.54.7.581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolone G, Mosconi P, Ware J. Il questionario sullo stato di salute SF-36. Manuale d&#x2019;uso e Guida all&#x2019;Interpretazione dei Risultati. Milan: Guerini Ed Associati; 1997.</Citation></Reference><Reference><Citation>Kwakkenbos L, Willems LM, Baron M, Hudson M, van den Ende CH, Thombs BD, Canadian Scleroderma Research Group The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis. PloS one. 2014;17(9(3)):e91979. doi: 10.1371/journal.pone.0091979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0091979</ArticleId><ArticleId IdType="pmc">PMC3956818</ArticleId><ArticleId IdType="pubmed">24638101</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettil&#xe4; V, Kaarlola A, M&#xe4;kel&#xe4;inen A. Health-related quality of life of multiple organ dysfunction patients one year after intensive care. Intensive Care Med. 2000;26:1473&#x2013;9. doi: 10.1007/s001340000629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340000629</ArticleId><ArticleId IdType="pubmed">11126259</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhren H, Ekeberg &#xd8;, Stokland O. Health-related quality of life and return to work after critical illness in general intensive care unit patients: a 1-year follow-up study. Crit Care Med. 2010;38:1554&#x2013;61. doi: 10.1097/CCM.0b013e3181e2c8b1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181e2c8b1</ArticleId><ArticleId IdType="pubmed">20473149</ArticleId></ArticleIdList></Reference><Reference><Citation>Orwelius L, Nordlund A, Nordlund P, Simonsson E, B&#xe4;ckman C, Samuelsson A, Sj&#xf6;berg F. Pre-existing disease: the most important factor for health related quality of life long-term after critical illness: a prospective, longitudinal, multicentre trial. Crit Care. 2010;14:R67. doi: 10.1186/cc8967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8967</ArticleId><ArticleId IdType="pmc">PMC2887189</ArticleId><ArticleId IdType="pubmed">20398310</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths J, Hatch RA, Bishop J, Morgan K, Jenkinson C, Cuthbertson BH, Brett SJ. An exploration of social and economic outcome and associated health-related quality of life after critical illness in general intensive care unit survivors: a 12-month follow-up study. Crit Care. 2013;17:R100. doi: 10.1186/cc12745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12745</ArticleId><ArticleId IdType="pmc">PMC3706775</ArticleId><ArticleId IdType="pubmed">23714692</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuthbertson BH, Scott J, Strachan M, Kilonzo M, Vale L. Quality of life before and after intensive care. Anaesthesia. 2005;60:332&#x2013;9. doi: 10.1111/j.1365-2044.2004.04109.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2004.04109.x</ArticleId><ArticleId IdType="pubmed">15766335</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofhuis JG, van Stel HF, Schrijvers AJ, Rommes JH, Spronk PE. ICU survivors show no decline in health-related quality of life after 5&#xa0;years. Intensive Care Med. 2015;41:495&#x2013;504. doi: 10.1007/s00134-015-3669-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3669-5</ArticleId><ArticleId IdType="pubmed">25672277</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiumello D, Taccone P, Berto V, Marino A, Migliara G, Lazzerini M, Gattinoni L. Long-term outcomes in survivors of acute respiratory distress syndrome ventilated in supine or prone position. Intensive Care Med. 2012;38:221&#x2013;9. doi: 10.1007/s00134-011-2445-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2445-4</ArticleId><ArticleId IdType="pubmed">22187085</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Health Observatory Data Repository . World Health Statistics 2015. Geneva: World Health Organization; 2015. Life expectancy &#x2013; Data by country" (CSV)</Citation></Reference><Reference><Citation>Capuzzo M, Bertacchini S, Jones C, Griffiths R, Ambrosio MR, Bondanelli M, Alvisi R. Patients with PTSD after intensive care avoid hospital contact at 2-year follow-up. Acta Anaesthesiol Scand. 2008;52:313&#x2013;4. doi: 10.1111/j.1399-6576.2007.01558.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2007.01558.x</ArticleId><ArticleId IdType="pubmed">18201316</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14980936</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-2999</ISSN><JournalIssue CitedMedium="Print"><Volume>98</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>The effects of different ventilatory settings on pulmonary and systemic inflammatory responses during major surgery.</ArticleTitle><Pagination><StartPage>775</StartPage><MedlinePgn>775-81, table of contents</MedlinePgn></Pagination><Abstract><AbstractText Label="UNLABELLED">Mechanical ventilation with high tidal volumes (V(T)) and zero or low positive end-expiratory pressure increased mediator release to inflammatory stimuli or acute lung injury. We studied whether mechanical ventilation modifies the inflammatory responses during major thoracic or abdominal surgery. Sixty-four patients undergoing elective thoracotomy (n = 34) or laparotomy (n = 30) were randomized to receive either mechanical ventilation with V(T) = 12 or 15 mL/kg ideal body weight, respectively, and zero end-expiratory pressure, or V(T) = 6 mL/kg ideal body weight with positive end-expiratory pressure of 10 cm H(2)O. In 62 patients who completed the study, arterial oxygenation was not different between groups. Tumor necrosis factor, interleukin (IL)-1, IL-6, IL-8, IL-10, and IL-12 were determined by cytometric bead array in plasma after 0, 1, 2, and 3 h and in tracheal aspirates after 3 h of mechanical ventilation. Data were log-transformed and analyzed using parametric or nonparametric tests, as indicated. All plasma mediators increased more during abdominal than during thoracic surgery, although the differences were small. However, neither time course nor concentrations of pulmonary or systemic mediators differed between the two ventilatory settings. Our data suggest that the ventilatory settings we studied do not affect inflammatory reactions during major surgery within 3 h.</AbstractText><AbstractText Label="IMPLICATIONS" NlmCategory="CONCLUSIONS">In 62 patients undergoing elective major thoracic or abdominal surgery, mechanical ventilation with low tidal volumes and positive end-expiratory pressure or high tidal volumes and zero end-expiratory pressure did not result in different pulmonary or systemic levels of measured inflammatory markers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wrigge</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, University of Bonn, Bonn, Germany. hermann.wriggs@ukb.uni-bonn.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhlig</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Zinserling</LastName><ForeName>J&#xf6;rg</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Behrends-Callsen</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Ottersbach</LastName><ForeName>Gunther</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Uhlig</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Putensen</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018925">Chemokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14980936</ArticleId><ArticleId IdType="doi">10.1213/01.ane.0000100663.11852.bf</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38888506</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-0514</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Shock (Augusta, Ga.)</Title><ISOAbbreviation>Shock</ISOAbbreviation></Journal><ArticleTitle>EXAMINING THE IMPACT OF PERMISSIBILITY HYPERCAPNIA ON POSTOPERATIVE DELIRIUM AMONG ELDERLY PATIENTS UNDERGOING THORACOSCOPIC-LAPAROSCOPIC ESOPHAGECTOMY: A SINGLE-CENTER INVESTIGATIVE STUDY.</ArticleTitle><Pagination><StartPage>319</StartPage><EndPage>326</EndPage><MedlinePgn>319-326</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SHK.0000000000002400</ELocationID><Abstract><AbstractText>Objective: This study explores how permissive hypercapnia, a key aspect of lung-protective ventilation, impacts postoperative delirium in elderly patients following thoracic surgery. Methods: A single-center trial at The Second Hospital of Anhui Medical University involved 136 elderly patients undergoing thoracoscopic esophageal cancer resection. Randomly assigned to maintain PaCO 2 35-45 mm Hg (group N) or 46-55 mm Hg (group H). Primary outcome: postoperative delirium (POD) incidence 1-3 days post-surgery. Secondary endpoints included monitoring rSO 2 , cardiovascular parameters (MAP, HR), pH, OI, and respiratory parameters (VT, RR, Cdyn, PIP) at specific time points. Perioperative tests assessed CRP/ALB ratio (CAR) and systemic inflammatory index (SII). VAS scores were documented for 3 postoperative days. Results: Postoperatively, group H showed significantly lower POD incidence than group N (7.4% vs. 19.1%, P = 0.043). Group H exhibited higher PaCO 2 and rSO 2 during surgery ( P &lt; 0.05). Patients in group H maintained better cardiovascular stability with higher blood pressure and lower heart rate on T2-4 ( P &lt; 0.05). Respiratory parameters were more stable in group H with lower TV, RR, and PIP, and higher Cdyn during OLV ( P &lt; 0.05). Group H had lower pH and higher OI at T2-4 ( P &lt; 0.05). CRP and CAR levels rose less in group H on the first day and 1 week later ( P &lt; 0.05). Conclusions: Maintaining PaCO 2 at 46-55 mm Hg reduces POD incidence, possibly by enhancing rSO 2 levels and stabilizing intraoperative respiration/circulation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 by the Shock Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Yan-Mei</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Long-Gang Central Hospital, Shenzhen, Guangdong 518000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guang-Hui</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Bing-Qian</ForeName><Initials>BQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Wen-Hui</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiao-Fen</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xiao-Ci</ForeName><Initials>XC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xian-Wen</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601 China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ChiCTR</DataBankName><AccessionNumberList><AccessionNumber>ChiCTR2200059008</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Shock</MedlineTA><NlmUniqueID>9421564</NlmUniqueID><ISSNLinking>1073-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006935" MajorTopicYN="Y">Hypercapnia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="Y">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013906" MajorTopicYN="Y">Thoracoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>17</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>10</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38888506</ArticleId><ArticleId IdType="doi">10.1097/SHK.0000000000002400</ArticleId><ArticleId IdType="pii">00024382-202409000-00003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong C, Churilov L, Cowie D, et al. Randomised controlled trial to investigate the relationship between mild hypercapnia and cerebral oxygen saturation in patients undergoing major surgery. BMJ Open . 2020;10(2):e029159.</Citation></Reference><Reference><Citation>Cheng Q, Li L, Lin D, et al. Effects of acute hypercapnia on cognitive function in patients undergoing bronchoscope intervention. J Thorac Dis . 2019;11(3):1065&#x2013;1071.</Citation></Reference><Reference><Citation>Zhu L, Shi H, Zhu C, et al. Impact of permissive hypercapnia on regional cerebral oxygen saturation and postoperative cognitive function in patients undergoing cardiac valve replacement. Ann Palliat Med . 2020;9(6):4066&#x2013;4073.</Citation></Reference><Reference><Citation>Ito H, Kanno I, Ibaraki M, et al. Changes in human cerebral blood flow and cerebral blood volume during hypercapnia and hypocapnia measured by positron emission tomography. J Cereb Blood Flow Metab . 2003;23(6):665&#x2013;670.</Citation></Reference><Reference><Citation>Matta BF, Lam AM, Mayberg TS, et al. Cerebrovascular response to carbon dioxide during sodium nitroprusside&#x2013; and isoflurane-induced hypotension. Br J Anaesth . 1995;74(3):296&#x2013;300.</Citation></Reference><Reference><Citation>Ishiyama T, Kotoda M, Asano N, et al. Effects of hyperventilation on cerebral oxygen saturation estimated using near-infrared spectroscopy: a randomised comparison between propofol and sevoflurane anaesthesia. Eur J Anaesthesiol . 2016;33(12):929&#x2013;935.</Citation></Reference><Reference><Citation>Liu Q, Li L, Wei J, et al. Correlation and influencing factors of preoperative anxiety, postoperative pain, and delirium in elderly patients undergoing gastrointestinal cancer surgery. BMC Anesthesiol . 2023;23(1):78.</Citation></Reference><Reference><Citation>Pangman VC, Sloan J, Guse L. An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice. Appl Nurs Res . 2000;13(4):209&#x2013;213.</Citation></Reference><Reference><Citation>American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Association, 2013.</Citation></Reference><Reference><Citation>Cao SJ, Zhang Y, Zhang YX, et al; First Study of Perioperative Organ Protection (SPOP1) Investigators. Delirium in older patients given propofol or sevoflurane anaesthesia for major cancer surgery: a multicentre randomised trial. Br J Anaesth . 2023;131(2):253&#x2013;265.</Citation></Reference><Reference><Citation>Low DE, Kunz S, Schembre D, et al. Esophagectomy&#x2014;it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer. J Gastrointest Surg . 2007;11(11):1395&#x2013;1402, discussion 1402.</Citation></Reference><Reference><Citation>Shimakawa T, Asaka S, Miyazawa M, et al. Esophageal cancer surgery in elderly patients aged 80 years or older. Gan To Kagaku Ryoho . 2018;45(13):2123&#x2013;2125.</Citation></Reference><Reference><Citation>Takeuchi M, Takeuchi H, Fujisawa D, et al. Incidence and risk factors of postoperative delirium in patients with esophageal cancer. Ann Surg Oncol . 2012;19(12):3963&#x2013;3970.</Citation></Reference><Reference><Citation>Lei L, Katznelson R, Fedorko L, et al. Cerebral oximetry and postoperative delirium after cardiac surgery: a randomised, controlled trial. Anaesthesia . 2017;72(12):1456&#x2013;1466.</Citation></Reference><Reference><Citation>Mailhot T, Cossette S, Lambert J, et al. Cerebral oximetry as a biomarker of postoperative delirium in cardiac surgery patients. J Crit Care . 2016;34:17&#x2013;23.</Citation></Reference><Reference><Citation>Wang X, Feng K, Liu H, et al. Regional cerebral oxygen saturation and postoperative delirium in endovascular surgery: a prospective cohort study. Trials . 2019;20(1):504.</Citation></Reference><Reference><Citation>Joe YE, Lee CY, Kim N, et al. Effect of permissive hypercarbia on lung oxygenation during one-lung ventilation and postoperative pulmonary complications in patients undergoing thoracic surgery: a prospective randomised controlled trial. Eur J Anaesthesiol . 2023;40(9):691&#x2013;698.</Citation></Reference><Reference><Citation>Mitschelen M, Garteiser P, Carnes BA, et al. Basal and hypercapnia-altered cerebrovascular perfusion predict mild cognitive impairment in aging rodents. Neuroscience . 2009;164(3):918&#x2013;928.</Citation></Reference><Reference><Citation>Vranken NPA, Weerwind PW, Sutedja NA, et al. Cerebral oximetry and autoregulation during cardiopulmonary bypass: a review. J Extra Corpor Technol . 2017;49(3):182&#x2013;191.</Citation></Reference><Reference><Citation>&#x160;everdija EE, Vranken NPA, Simons AP, et al. Hemodilution combined with hypercapnia impairs cerebral autoregulation during normothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth . 2015;29(5):1194&#x2013;1199.</Citation></Reference><Reference><Citation>Uchida K. Respiratory rate as a factor in lung injury&#x2014;not just what you set, but how you set. Anesthesiology . 2023;138(4):351&#x2013;353.</Citation></Reference><Reference><Citation>Rawley M, Harris E, Pospishil L, et al. Assessing provider adherence to a lung protective ventilation protocol in patients undergoing thoracic surgery using one-lung ventilation. AANA J . 2022;90(6):439&#x2013;445.</Citation></Reference><Reference><Citation>Uhlig C, Neto AS, van der Woude M, et al; LAS VEGAS# investigators, Protective Ventilation Network (PROVEnet), Clinical Trial Network of the European Society of Anaesthesiology. Intraoperative mechanical ventilation practice in thoracic surgery patients and its association with postoperative pulmonary complications: results of a multicenter prospective observational study. BMC Anesthesiol . 2020;20(1):179.</Citation></Reference><Reference><Citation>Wang J, Zhu L, Li Y, et al. The potential role of lung-protective ventilation in preventing postoperative delirium in elderly patients undergoing prone spinal surgery: a preliminary study. Med Sci Monit . 2020;26:e926526.</Citation></Reference><Reference><Citation>Yang WC, Song CY, Wang N, et al. Hypercapnic acidosis confers antioxidant and anti-apoptosis effects against ventilator-induced lung injury. Lab Invest . 2013;93(12):1339&#x2013;1349.</Citation></Reference><Reference><Citation>Ga&#x142;ga&#x144;ska H, Jarmuszkiewicz W, Ga&#x142;ga&#x144;ski &#x141;. Carbon dioxide and MAPK signalling: towards therapy for inflammation. Cell Commun Signal . 2023;21(1):280.</Citation></Reference><Reference><Citation>Phelan DE, Mota C, Lai C, et al. Carbon dioxide&#x2013;dependent signal transduction in mammalian systems. Interface Focus . 2021;11(2):20200033.</Citation></Reference><Reference><Citation>Pathak A, Agrawal A. Evolution of C-reactive protein. Front Immunol . 2019;10:943.</Citation></Reference><Reference><Citation>Dean B. Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies. Int J Neuropsychopharmacol . 2011;14(7):997&#x2013;1012.</Citation></Reference><Reference><Citation>Ullah I, Awan HA, Aamir A, et al. Role and perspectives of inflammation and C-reactive protein (CRP) in psychosis: an economic and widespread tool for assessing the disease. Int J Mol Sci . 2021;22(23):13032.</Citation></Reference><Reference><Citation>Calsolaro V, Edison P. Neuroinflammation in Alzheimer's disease: current evidence and future directions. Alzheimers Dement . 2016;12(6):719&#x2013;732.</Citation></Reference><Reference><Citation>Ge X, Cao Y, Wang H, et al. Diagnostic accuracy of the postoperative ratio of C-reactive protein to albumin for complications after colorectal surgery. World J Surg Oncol . 2017;15(1):15.</Citation></Reference><Reference><Citation>Guo S, He X, Chen Q, et al. The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients. BMC Cancer . 2017;17(1):171.</Citation></Reference><Reference><Citation>Peng J, Wu G, Chen J, et al. Preoperative C-reactive protein/albumin ratio, a risk factor for postoperative delirium in elderly patients after total joint arthroplasty. J Arthroplasty . 2019;34(11):2601&#x2013;2605.</Citation></Reference><Reference><Citation>Zhang F, Niu M, Wang L, et al. Systemic-immune-inflammation index as a promising biomarker for predicting perioperative ischemic stroke in older patients who underwent non-cardiac surgery. Front Aging Neurosci . 2022;14:865244.</Citation></Reference><Reference><Citation>Chi L, Wang N, Yang W, et al. Protection of myocardial ischemia-reperfusion by therapeutic hypercapnia: a mechanism involving improvements in mitochondrial biogenesis and function. J Cardiovasc Transl Res . 2019;12(5):467&#x2013;477.</Citation></Reference><Reference><Citation>Xu QL, Li H, Zhu YJ, et al. The treatments and postoperative complications of esophageal cancer: a review. J Cardiothorac Surg . 2020;15(1):163.</Citation></Reference><Reference><Citation>Kaufmann K, Heinrich S. Minimizing postoperative pulmonary complications in thoracic surgery patients. Curr Opin Anaesthesiol . 2021;34(1):13&#x2013;19.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32863075</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8406</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of arthroplasty</Title><ISOAbbreviation>J Arthroplasty</ISOAbbreviation></Journal><ArticleTitle>A Poster Summarizing the American Academy of Orthopaedic Surgeons Knee Osteoarthritis Clinical Practice Guideline Is a Powerful Tool for Patient Education: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>102</StartPage><EndPage>106.e5</EndPage><MedlinePgn>102-106.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2020.07.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-5403(20)30763-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">In 2013, the American Academy of Orthopaedic Surgeons (AAOS) published an evidence-based clinical practice guideline (CPG) on conservative treatment options for patients with knee osteoarthritis (OA). The purpose of this study is to evaluate the effectiveness of a poster outlining the AAOS knee OA CPG on patient comprehension and satisfaction in the clinic.</AbstractText><AbstractText Label="METHODS">This is a prospective 2-armed randomized controlled trial. Patients were eligible if they were of age 40-85 years, had degenerative knee OA, and did not consent for surgery. Patients were randomized to nonposter (standard care) and poster rooms. Knee OA treatment options were described to the patient verbally and posters were used as a teaching tool when present. The main outcomes were comprehension and satisfaction scores on a survey.</AbstractText><AbstractText Label="RESULTS">Of the 105 patients enrolled, 51 (48.6%) were randomized to usual care (control) and 54 (51.4%) to the intervention (poster). Poster patients outperformed control patients with an average of 55.3% &#xb1; 16.7% (mean &#xb1; SD) compared to 39.5% &#xb1; 13.3% correct answers (P &lt; .001). And 66.7% of poster patients and 29.4% of control patients achieved an adequately informed status of &gt;50% correct answers (P &lt; .001; 50.5% overall). With a maximum possible score of 10, visit satisfaction scores were 9.4 &#xb1; 1.0 in poster patients and 9.2 &#xb1; 1.7 in control patients (P&#xa0;= .50).</AbstractText><AbstractText Label="CONCLUSION">Patients educated using an AAOS knee CPG poster showed significant improvements in knowledge and were more likely to achieve an adequately informed status. No difference existed in visit satisfaction. A poster offers a low-cost, effective educational tool.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Level&#xa0;1.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Squiers</LastName><ForeName>Monte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Spectrum Health - Department of Orthopaedic Surgery Residency Program, Michigan State College of Human Medicine, Grand Rapids, MI; University of Vermont Medical Center, Department of Orthopaedic Surgery, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelms</LastName><ForeName>Nathaniel J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>University of Vermont Medical Center, Department of Orthopaedic Surgery, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Alan T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Spectrum Health - Department of Research &amp; Scholarly Activity Support, Michigan State College of Human Medicine, Grand Rapids, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halsey</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>University of Vermont Medical Center, Department of Orthopaedic Surgery, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slauterbeck</LastName><ForeName>James R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>University of Vermont Medical Center, Department of Orthopaedic Surgery, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankstein</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Vermont Medical Center, Department of Orthopaedic Surgery, Burlington, VT.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Arthroplasty</MedlineTA><NlmUniqueID>8703515</NlmUniqueID><ISSNLinking>0883-5403</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072161" MajorTopicYN="Y">Orthopedic Surgeons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020370" MajorTopicYN="Y">Osteoarthritis, Knee</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AAOS clinical practice guideline</Keyword><Keyword MajorTopicYN="N">knee osteoarthritis</Keyword><Keyword MajorTopicYN="N">patient education</Keyword><Keyword MajorTopicYN="N">poster</Keyword><Keyword MajorTopicYN="N">shared decision-making</Keyword><Keyword MajorTopicYN="N">visual aid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32863075</ArticleId><ArticleId IdType="doi">10.1016/j.arth.2020.07.007</ArticleId><ArticleId IdType="pii">S0883-5403(20)30763-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39696811</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-726X</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions</Title><ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>The Utility of Coronary Revascularization to Reduce Ventricular Arrhythmias in Coronary Artery Disease Patients: A Systematic Review.</ArticleTitle><Pagination><StartPage>605</StartPage><EndPage>612</EndPage><MedlinePgn>605-612</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.31361</ELocationID><Abstract><AbstractText>Ventricular arrhythmias (VA) are a major cause of morbidity and mortality in patients with coronary artery disease (CAD). Current guidelines recommend revascularization of significant CAD to improve survival in patients with ventricular fibrillation (VF), polymorphic ventricular tachycardia (VT), or those who are post-cardiac arrest. However, revascularization is not recommended for CAD patients with suspected scar-mediated monomorphic VT. There is a paucity of data detailing the utility of revascularization in reducing VA in CAD patients who do not present with acute coronary syndrome (ACS) and are not immediately post-cardiac arrest, which is the focus of this review. Medline, Scopus, and the Cochrane Central Register of Controlled Trials were systematically searched to identify relevant studies addressing this question. Studies that included patients presenting with ACS or those who were immediately post-cardiac arrest at the time of revascularization were excluded. In total, five studies comprising 2663 patients were reviewed.</AbstractText><CopyrightInformation>&#xa9; 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Junarta</LastName><ForeName>Joey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, New York University Langone Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddiqui</LastName><ForeName>Muhammad U</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Jefferson Heart Institute, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abaza</LastName><ForeName>Ehab</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, New York University Langone Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0007-7466-8213</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, New York University Langone Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Anjani</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0510-8777</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, New York University Langone Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aizer</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, New York University Langone Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razzouk</LastName><ForeName>Louai</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0306-6182</Identifier><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, New York University Langone Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Sunil V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, New York University Langone Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Catheter Cardiovasc Interv</MedlineTA><NlmUniqueID>100884139</NlmUniqueID><ISSNLinking>1522-1946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009204" MajorTopicYN="Y">Myocardial Revascularization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronary artery bypass graft surgery</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">coronary revascularization</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia</Keyword><Keyword MajorTopicYN="N">ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>17</Day><Hour>17</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>1</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39696811</ArticleId><ArticleId IdType="doi">10.1002/ccd.31361</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>J. M. Canty, Jr., G. Suzuki, M. D. Banas, F. Verheyen, M. Borgers, and J. A. Fallavollita, &#x201c;Hibernating Myocardium: Chronically Adapted to Ischemia But Vulnerable to Sudden Death,&#x201d; Circulation Research 94, no. 8 (2004): 1142&#x2013;1149.</Citation></Reference><Reference><Citation>J. S. Lawton, J. E. Tamis&#x2010;Holland, S. Bangalore, et al., &#x201c;ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,&#x201d; Circulation. 2022 145, no. 3 (2021): e18&#x2013;e114.</Citation></Reference><Reference><Citation>D. Perera, H. P. Morgan, M. Ryan, et al., &#x201c;Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED&#x2010;BCIS2 Trial,&#x201d; Circulation 148, no. 11 (2023): 862&#x2013;871.</Citation></Reference><Reference><Citation>I. Elsokkari, R. Parkash, C. J. Gray, et al., &#x201c;Effect of Coronary Revascularization on Long&#x2010;Term Clinical Outcomes in Patients With Ischemic Cardiomyopathy and Recurrent Ventricular Arrhythmia,&#x201d; Pacing and Clinical Electrophysiology 41, no. 7 (2018): 775&#x2013;779.</Citation></Reference><Reference><Citation>B. Mond&#xe9;sert, P. Khairy, G. Schram, et al., &#x201c;Impact of Revascularization in Patients with Sustained Ventricular Arrhythmias, Prior Myocardial Infarction, and Preserved Left Ventricular Ejection Fraction,&#x201d; Heart Rhythm 13, no. 6 (2016): 1221&#x2013;1227.</Citation></Reference><Reference><Citation>A. Di Marco, I. Anguera, L. Nombela&#x2010;Franco, et al., &#x201c;Revascularization of Coronary Chronic Total Occlusions in an Infarct&#x2010;Related Artery and Recurrence of Ventricular Arrhythmias Among Patients With Secondary Prevention Implantable Cardioverter Defibrillator,&#x201d; Catheterization and Cardiovascular Interventions 97, no. 1 (2021): E1&#x2013;E11.</Citation></Reference><Reference><Citation>C. Godino, A. Giannattasio, A. Scotti, et al., &#x201c;Risk of Cardiac and Sudden Death With and Without Revascularisation of a Coronary Chronic Total Occlusion,&#x201d; Heart 105, no. 14 (2019): 1096&#x2013;1102.</Citation></Reference><Reference><Citation>W. G. Stevenson, P. L. Friedman, P. T. Sager, et al., &#x201c;Exploring Postinfarction Reentrant Ventricular Tachycardia With Entrainment Mapping,&#x201d; Journal of the American College of Cardiology 29, no. 6 (1997): 1180&#x2013;1189.</Citation></Reference><Reference><Citation>E. A. Rog&#x2010;Zielinska, R. A. Norris, P. Kohl, and R. Markwald, &#x201c;The Living Scar&#x2014;Cardiac Fibroblasts and the Injured Heart,&#x201d; Trends in Molecular Medicine 22, no. 2 (2016): 99&#x2013;114.</Citation></Reference><Reference><Citation>S. Rohr, &#x201c;Myofibroblasts in Diseased Hearts: New Players in Cardiac Arrhythmias?,&#x201d; Heart Rhythm: The Official Journal of the Heart Rhythm Society 6, no. 6 (2009): 848&#x2013;856.</Citation></Reference><Reference><Citation>E. M. Cherry, F. H. Fenton, and R. F. Gilmour, Jr., &#x201c;Mechanisms of Ventricular Arrhythmias: A Dynamical Systems&#x2010;Based Perspective,&#x201d; American Journal of Physiology&#x2010;Heart and Circulatory Physiology 302, no. 12 (2012): H2451&#x2013;H2463.</Citation></Reference><Reference><Citation>Y. Tsuji, J. Heijman, S. Nattel, and D. Dobrev, &#x201c;Electrical Storm: Recent Pathophysiological Insights and Therapeutic Consequences,&#x201d; Basic Research in Cardiology 108, no. 2 (2013): 336.</Citation></Reference><Reference><Citation>G. S. Werner, U. Emig, O. Mutschke, G. Schwarz, P. Bahrmann, and H. R. Figulla, &#x201c;Regression of Collateral Function After Recanalization of Chronic Total Coronary Occlusions: A Serial Assessment By Intracoronary Pressure and Doppler Recordings,&#x201d; Circulation 108, no. 23 (2003): 2877&#x2013;2882.</Citation></Reference><Reference><Citation>H. Tamai, P. B. Berger, E. Tsuchikane, et al., &#x201c;Frequency and Time Course of Reocclusion and Restenosis in Coronary Artery Occlusions After Balloon Angioplasty Versus Wiktor Stent Implantation: Results From the Mayo&#x2010;Japan Investigation for Chronic Total Occlusion (MAJIC) Trial,&#x201d; American Heart Journal 147, no. 3 (2004): 475.</Citation></Reference><Reference><Citation>H. V. Anderson, R. E. Shaw, R. G. Brindis, et al., &#x201c;A Contemporary Overview of Percutaneous Coronary Interventions,&#x201d; Journal of the American College of Cardiology 39, no. 7 (2002): 1096&#x2013;1103.</Citation></Reference><Reference><Citation>D. O. Williams, R. Holubkov, W. Yeh, et al., &#x201c;Percutaneous Coronary Intervention in the Current Era Compared With 1985&#x2010;1986: The National Heart, Lung, and Blood Institute Registries,&#x201d; Circulation 102, no. 24 (2000): 2945&#x2013;2951.</Citation></Reference><Reference><Citation>W. K. Chi, M. Gong, G. Bazoukis, et al., &#x201c;Impact of Coronary Artery Chronic Total Occlusion on Arrhythmic and Mortality Outcomes,&#x201d; JACC: Clinical Electrophysiology 4, no. 9 (2018): 1214&#x2013;1223.</Citation></Reference><Reference><Citation>G. Tse and J. M. Yeo, &#x201c;Conduction Abnormalities and Ventricular Arrhythmogenesis: The Roles of Sodium Channels and Gap Junctions,&#x201d; IJC Heart &amp; Vasculature 9 (2015): 75&#x2013;82.</Citation></Reference><Reference><Citation>A. Myat, M. Patel, J. Silberbauer, and D. Hildick&#x2010;Smith, &#x201c;Impact of Chronic Total Coronary Occlusion Revascularisation on Infarct&#x2010;Related Myocardial Scars Responsible for Recurrent Ventricular Tachycardia,&#x201d; EuroIntervention 16, no. 14 (2021): 1204&#x2013;1206.</Citation></Reference><Reference><Citation>K. Yamashita, W. Igawa, M. Ono, et al., &#x201c;Impact of Recanalization of Chronic Total Occlusion on Left Ventricular Electrical Remodeling,&#x201d; Pacing and Clinical Electrophysiology 42, no. 6 (2019): 712&#x2013;721.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38902707</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1465-993X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>20</Day></PubDate></JournalIssue><Title>Respiratory research</Title><ISOAbbreviation>Respir Res</ISOAbbreviation></Journal><ArticleTitle>Chronic obstructive pulmonary disease affects outcome in surgical patients with perioperative organ injury: a retrospective cohort study in Germany.</ArticleTitle><Pagination><StartPage>251</StartPage><MedlinePgn>251</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">251</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12931-024-02882-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The impact of chronic obstructive pulmonary disease (COPD) on outcome in perioperative organ injury (POI) has not yet been investigated sufficiently.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study analysed data of surgical patients with POI, namely delirium, stroke, acute myocardial infarction, acute respiratory distress syndrome, acute liver injury (ALI), or acute kidney injury (AKI), in Germany between 2015 and 2019. We compared in-hospital mortality, hospital length of stay (HLOS) and perioperative ventilation time (VT) in patients with and without COPD.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We analysed the data of 1,642,377 surgical cases with POI of which 10.8% suffered from COPD. In-hospital mortality was higher (20.6% vs. 15.8%, p&#x2009;&lt;&#x2009;0.001) and HLOS (21&#xa0;days (IQR,&#xa0;12-34) vs. 16&#xa0;days (IQR,&#xa0;10-28), p&#x2009;&lt;&#x2009;0.001) and VT (199&#xa0;h (IQR, 43-547) vs. 125&#xa0;h (IQR, 32-379), p&#x2009;&lt;&#x2009;0.001) were longer in COPD patients. Within the POI examined, AKI was the most common POI (57.8%), whereas ALI was associated with the highest mortality (54.2%). Regression analysis revealed that COPD was associated with a slightly higher risk of in-hospital mortality (OR, 1.19;&#xa0;95% CI:1.18-1.21) in patients with any POI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">COPD in patients with POI is associated with higher mortality, longer HLOS and longer VT. Especially patients suffering from ALI are susceptible to the detrimental effects of COPD on adverse outcome.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hochhausen</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. nhochhausen@ukaachen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mechelinck</LastName><ForeName>Mare</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroh</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, Pediatric, and Transplantation Surgery, Medical Faculty, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossaint</LastName><ForeName>Rolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kork</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Res</MedlineTA><NlmUniqueID>101090633</NlmUniqueID><ISSNLinking>1465-9921</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic obstructive pulmonary disease</Keyword><Keyword MajorTopicYN="N">In-hospital mortality</Keyword><Keyword MajorTopicYN="N">Perioperative organ injury</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>20</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38902707</ArticleId><ArticleId IdType="pmc">PMC11191349</ArticleId><ArticleId IdType="doi">10.1186/s12931-024-02882-3</ArticleId><ArticleId IdType="pii">10.1186/s12931-024-02882-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lobo SM, Rezende E, Knibel MF, Silva NB, P&#xe1;ramo JA, N&#xe1;cul FE, et al. Early determinants of death due to multiple organ failure after noncardiac surgery in high-risk patients. Anesth Analg. 2011;112:877&#x2013;83. doi: 10.1213/ANE.0b013e3181e2bf8e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181e2bf8e</ArticleId><ArticleId IdType="pubmed">20530615</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad C, Eltzschig HK. Disease mechanisms of Perioperative Organ Injury. Anesth Analg. 2020;131:1730&#x2013;50. doi: 10.1213/ANE.0000000000005191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005191</ArticleId><ArticleId IdType="pmc">PMC7673233</ArticleId><ArticleId IdType="pubmed">33186161</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad BI, Alhajahjeh AA, Altarazi A, El-Amayreh L, Hamdan M, AlQuabeh B, et al. Preoperative and intraoperative risk factors for acute kidney injury after hip fracture surgery: a cohort retrospective study. Ren Fail. 2023;45:2223313. doi: 10.1080/0886022X.2023.2223313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022X.2023.2223313</ArticleId><ArticleId IdType="pmc">PMC10286670</ArticleId><ArticleId IdType="pubmed">37340972</ArticleId></ArticleIdList></Reference><Reference><Citation>Adiyeke E, Ren Y, Ruppert MM, Shickel B, Kane-Gill SL, Murugan R, et al. A deep learning-based dynamic model for predicting acute kidney injury risk severity in postoperative patients. Surgery. 2023;174:709&#x2013;14. doi: 10.1016/j.surg.2023.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2023.05.003</ArticleId><ArticleId IdType="pmc">PMC10683578</ArticleId><ArticleId IdType="pubmed">37316372</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-Wirtz LM, Ruetzler K, R&#xf6;ssler J. Intraoperative hypotension and delirium. J Clin Anesth. 2023;89:111153. doi: 10.1016/j.jclinane.2023.111153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2023.111153</ArticleId><ArticleId IdType="pubmed">37245475</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathare P, Elbayomi M, Weyand M, Griesbach C, Harig F. MELD-score for risk stratification in cardiac surgery. Heart Vessels. 2023;38:1156&#x2013;63. doi: 10.1007/s00380-023-02262-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-023-02262-9</ArticleId><ArticleId IdType="pmc">PMC10372113</ArticleId><ArticleId IdType="pubmed">37004541</ArticleId></ArticleIdList></Reference><Reference><Citation>Atar D, Rosseland LA, Jammer I, Aakre KM, Wiseth R, Molund M, et al. Implementing screening for myocardial injury in non-cardiac surgery: perspectives of an ad-hoc interdisciplinary expert group. Scandinavian Cardiovasc J. 2023;57:31&#x2013;9. doi: 10.1080/14017431.2022.2112071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14017431.2022.2112071</ArticleId><ArticleId IdType="pubmed">37141087</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng W, Qiao H, Wang Z, Niu Z, Lv X. Analysis of prognosis and risk factors for postoperative hepatic dysfunction in patients with Acute Type A aortic dissection. Anatol J Cardiol. 2023;27:197&#x2013;204. doi: 10.14744/AnatolJCardiol.2022.2644.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/AnatolJCardiol.2022.2644</ArticleId><ArticleId IdType="pmc">PMC10098375</ArticleId><ArticleId IdType="pubmed">36995052</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi C, Lemmink G, Humanez J. Postoperative respiratory failure and Advanced Ventilator settings. Anesthesiol Clin. 2023;41:141&#x2013;59. doi: 10.1016/j.anclin.2022.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2022.11.005</ArticleId><ArticleId IdType="pubmed">36871996</ArticleId></ArticleIdList></Reference><Reference><Citation>Nepogodiev D, Martin J, Biccard B, Makupe A, Bhangu A, Nepogodiev D, et al. Global burden of postoperative death. Lancet. 2019;393:401. doi: 10.1016/S0140-6736(18)33139-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)33139-8</ArticleId><ArticleId IdType="pubmed">30722955</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in Europe: a 7&#xa0;day cohort study. Lancet. 2012;380:1059&#x2013;65. doi: 10.1016/S0140-6736(12)61148-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61148-9</ArticleId><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock EL, Feiner JR, Chen L-L, Perioperative mortality. 2010 to 2014: a retrospective cohort study using the national anesthesia clinical outcomes registry. Anesthesiology. 2015;123: 1312&#x2013;1321. 10.1097/ALN.0000000000000882.</Citation><ArticleIdList><ArticleId IdType="pubmed">26492481</ArticleId></ArticleIdList></Reference><Reference><Citation>Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021;397:928&#x2013;40. doi: 10.1016/S0140-6736(21)00458-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00458-X</ArticleId><ArticleId IdType="pubmed">33631128</ArticleId></ArticleIdList></Reference><Reference><Citation>Agust&#xed; A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023;61:2300239. doi: 10.1183/13993003.00239-2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00239-2023</ArticleId><ArticleId IdType="pmc">PMC10066569</ArticleId><ArticleId IdType="pubmed">36858443</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi: 10.1371/journal.pmed.0030442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0030442</ArticleId><ArticleId IdType="pmc">PMC1664601</ArticleId><ArticleId IdType="pubmed">17132052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M, Audisio K, Rahouma M, Robinson NB, Soletti GJ, Cancelli G, et al. Association between sternal wound complications and 10-year mortality following coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2023;166:532&#x2013;e5394. doi: 10.1016/j.jtcvs.2021.10.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2021.10.067</ArticleId><ArticleId IdType="pubmed">35063171</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zheng H, Yan W, Cao N, Yan T, Zhu H, et al. The impact of chronic obstructive pulmonary disease on the prognosis outcomes of patients with percutaneous coronary intervention or coronary artery bypass grafting: a meta-analysis. Heart Lung. 2023;60:8&#x2013;14. doi: 10.1016/j.hrtlng.2023.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2023.02.017</ArticleId><ArticleId IdType="pubmed">36868093</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R, Hammelef E, Sabitsky M, Ream C, Khalilieh S, Zohar N, et al. Chronic obstructive Pulmonary Disease is Associated with worse oncologic outcomes in early-stage resected pancreatic and Periampullary cancers. Biomedicines. 2023;11:1684. doi: 10.3390/biomedicines11061684.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11061684</ArticleId><ArticleId IdType="pmc">PMC10296111</ArticleId><ArticleId IdType="pubmed">37371779</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng T, Yang C, Ding C, Zhang X. Chronic obstructive Pulmonary Disease is Associated with serious infection and venous thromboembolism in patients undergoing hip or knee arthroplasties: a Meta-analysis of Observational studies. J Arthroplasty. 2023;38:578&#x2013;85. doi: 10.1016/j.arth.2022.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2022.09.005</ArticleId><ArticleId IdType="pubmed">36113753</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin K-H, Kim J-U, Jang I-T, Han S-B, Kim S-B. Impact of Chronic Obstructive Pulmonary Disease on outcomes after total joint arthroplasty: a Meta-analysis and systematic review. Indian J Orthop. 2023;57:211&#x2013;26. doi: 10.1007/s43465-022-00794-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43465-022-00794-2</ArticleId><ArticleId IdType="pmc">PMC9880123</ArticleId><ArticleId IdType="pubmed">36777112</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130&#x2013;9. doi: 10.1097/01.mlr.0000182534.19832.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373&#x2013;83. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Luque-Fernandez M, Maringe C, Nelson P. CVAUROC: Stata module to compute cross-validated area under the curve for ROC analysis after predictive modelling for binary outcomes. 2017.</Citation></Reference><Reference><Citation>Daniels B. CROSSFOLD: Stata module to perform k-fold cross-validation. Statistical Software Components. 2012 [cited 30 Mar 2023]. Available: https://www.semanticscholar.org/paper/CROSSFOLD%3A-Stata-module-to-perform-k-fold-Daniels/ce0709cbf8459b3796fe8de098a754caa9e55ae6.</Citation></Reference><Reference><Citation>Sankar A, Thorpe K, McIsaac DI, Luo J, Wijeysundera DN, Gershon AS. Survival and health care costs after inpatient elective surgery: comparison of patients with and without chronic obstructive pulmonary disease. CMAJ. 2023;195:E62&#x2013;71. doi: 10.1503/cmaj.220733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.220733</ArticleId><ArticleId IdType="pmc">PMC9851642</ArticleId><ArticleId IdType="pubmed">36649951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields AC, Divino CM. Surgical outcomes in patients with chronic obstructive pulmonary disease undergoing abdominal operations: an analysis of 331,425 patients. Surgery. 2016;159:1210&#x2013;6. doi: 10.1016/j.surg.2015.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2015.11.007</ArticleId><ArticleId IdType="pubmed">26704782</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D. Correlation Analysis of Early Renal Injury in Elderly patients with Acute exacerbations of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022;17:2109&#x2013;15. doi: 10.2147/COPD.S377847.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S377847</ArticleId><ArticleId IdType="pmc">PMC9464007</ArticleId><ArticleId IdType="pubmed">36097592</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiropoulou E, Samanidis G, Kanakis M, Nenekidis I. Risk factors for Acute postoperative delirium in cardiac surgery patients&#x2009;&gt;&#x2009;65 Years Old. J Pers Med. 2022;12:1529. doi: 10.3390/jpm12091529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12091529</ArticleId><ArticleId IdType="pmc">PMC9503473</ArticleId><ArticleId IdType="pubmed">36143313</ArticleId></ArticleIdList></Reference><Reference><Citation>van Beers M, Janssen DJA, Gosker HR, Schols AMWJ. Cognitive impairment in chronic obstructive pulmonary disease: disease burden, determinants and possible future interventions. Expert Rev Respir Med. 2018;12:1061&#x2013;74. doi: 10.1080/17476348.2018.1533405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2018.1533405</ArticleId><ArticleId IdType="pubmed">30296384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SS, Chen S, McAvay GJ, Tinetti ME. Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults. J Am Geriatr Soc. 2012;60:1839&#x2013;46. doi: 10.1111/j.1532-5415.2012.04171.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2012.04171.x</ArticleId><ArticleId IdType="pmc">PMC3470752</ArticleId><ArticleId IdType="pubmed">23035917</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest. 2013;144:119&#x2013;27. doi: 10.1378/chest.12-2099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.12-2099</ArticleId><ArticleId IdType="pubmed">23349026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirov H, Caldonazo T, Audisio K, Rahouma M, Robinson NB, Cancelli G, et al. Association of liver dysfunction with outcomes after cardiac surgery-a meta-analysis. Interact Cardiovasc Thorac Surg. 2022;35:ivac280. doi: 10.1093/icvts/ivac280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivac280</ArticleId><ArticleId IdType="pmc">PMC9741516</ArticleId><ArticleId IdType="pubmed">36477871</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Liu X, Meng J, Liu D, Huang Y, Sang L, Xu Y, Xu Z, He W, Chen S, Zhang R, Liu X, Li Y. Electrical impedance tomography for titration of positive end-expiratory pressure in acute respiratory distress syndrome patients with chronic obstructive pulmonary disease. Crit Care. 2022;26(1):339. doi: 10.1186/s13054-022-04201-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04201-y</ArticleId><ArticleId IdType="pmc">PMC9635124</ArticleId><ArticleId IdType="pubmed">36333809</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay E, Lemiale V, Mourvillier B, Garrouste-Orgeas M, Schwebel C, Ruckly S, Argaud L, Cohen Y, Souweine B, Papazian L, Reignier J, Marcotte G, Siami S, Kallel H, Darmon M, Timsit JF, OUTCOMEREA Study Group Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions. Intensive Care Med. 2018;44(7):1050&#x2013;60. doi: 10.1007/s00134-018-5209-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5209-6</ArticleId><ArticleId IdType="pmc">PMC7095161</ArticleId><ArticleId IdType="pubmed">29881987</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadre SK, Duggal A, Mireles-Cabodevila E, Krishnan S, Wang XF, Zell K, Guzman J. Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD) Med (Baltim) 2018;97(17):e0487. doi: 10.1097/MD.0000000000010487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000010487</ArticleId><ArticleId IdType="pmc">PMC5944543</ArticleId><ArticleId IdType="pubmed">29703009</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothnie KJ, Yan R, Smeeth L, Quint JK. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2015;5:e007824. doi: 10.1136/bmjopen-2015-007824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-007824</ArticleId><ArticleId IdType="pmc">PMC4567661</ArticleId><ArticleId IdType="pubmed">26362660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21035866</PMID><DateCompleted><Year>2011</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2011</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-4713</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>3</Issue><PubDate><Year>2011</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Ophthalmology</Title><ISOAbbreviation>Ophthalmology</ISOAbbreviation></Journal><ArticleTitle>YAG laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized, controlled trial.</ArticleTitle><Pagination><StartPage>468</StartPage><EndPage>473</EndPage><MedlinePgn>468-73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ophtha.2010.07.026</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To test the hypothesis that neodymium:yttrium-aluminum-garnet (Nd:YAG) laser peripheral iridotomy (LPI) significantly reduces the incidence of conversion from pigment dispersion syndrome (PDS) with ocular hypertension (OHT) to pigmentary glaucoma (PG).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, randomized, controlled 3-year trial.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">One hundred sixteen eyes of 116 patients with PDS and OHT.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Patients were assigned randomly either to Nd:YAG LPI or to a control group (no laser).</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome measure was conversion to PG within 3 years, based on full-threshold visual field (VF) analysis using the Ocular Hypertension Treatment Study criteria. Secondary outcome measures were whether eyes required topical antiglaucoma medications during the study period and the time to conversion or medication.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-seven patients were randomized to undergo laser treatment and 59 were randomized to no laser (controls). Age, gender, spherical equivalent refraction, and intraocular pressure at baseline were similar between groups. Outcome data were available for 105 (90%) of recruited subjects, 52 in the laser treatment group and 53 in the no laser treatment group. Patients were followed up for a median of 35.9 months (range, 10-36 months) in the laser arm and 35.9 months (range, 1-36 months) in the control arm. Eight eyes (15%) in the laser group and 3 eyes (6%) in the control group converted to glaucoma in the study period. The proportion of eyes started on medical treatment was similar in the 2 groups: 8 eyes (15%) in the laser group and 9 eyes (17%) in the control group. Survival analyses showed no evidence of any difference in time to VF progression or commencement of topical therapy between the 2 groups. Cataract extraction was performed on 1 patient in the laser group and in 1 patient in the control group during the study period (laser eye at 18 months; control eye at 34 months).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study suggests that there was no benefit of Nd:YAG LPI in preventing progression from PDS with OHT to PG within 3 years of follow-up.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Glaucoma Service, Moorfields Eye Hospital, London, United Kingdom. andy.scott@ucl.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotecha</LastName><ForeName>Aachal</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bunce</LastName><ForeName>Catey</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Balidis</LastName><ForeName>Miltos</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Garway-Heath</LastName><ForeName>David F</ForeName><Initials>DF</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Wormald</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ophthalmology</MedlineTA><NlmUniqueID>7802443</NlmUniqueID><ISSNLinking>0161-6420</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017889" MajorTopicYN="N">Exfoliation Syndrome</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005901" MajorTopicYN="N">Glaucoma</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032801" MajorTopicYN="N">Iridectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007498" MajorTopicYN="N">Iris</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053685" MajorTopicYN="Y">Laser Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053844" MajorTopicYN="Y">Lasers, Solid-State</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009798" MajorTopicYN="N">Ocular Hypertension</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014065" MajorTopicYN="N">Tonometry, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21035866</ArticleId><ArticleId IdType="doi">10.1016/j.ophtha.2010.07.026</ArticleId><ArticleId IdType="pii">S0161-6420(10)00807-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19049338</PMID><DateCompleted><Year>2009</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1523-4681</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2009</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</Title><ISOAbbreviation>J Bone Miner Res</ISOAbbreviation></Journal><ArticleTitle>Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications.</ArticleTitle><Pagination><StartPage>702</StartPage><EndPage>709</EndPage><MedlinePgn>702-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1359/jbmr.081207</ELocationID><Abstract><AbstractText>Although patients with type 2 diabetes (T2DM) have an increased risk of hip fracture, risk of vertebral fracture (VF) and its association with BMD are still unclear. We examined Japanese T2DM patients (161 men &gt;50 yr and 137 postmenopausal women) and non-DM controls (76 and 622, respectively) by lateral spine radiography and DXA at the lumbar spine (L), femoral neck (FN), and radius (R). Logistic regression analysis adjusted for age, body mass index, and L-BMD showed that the presence of T2DM was an independent risk factor for prevalent VFs in women (OR = 1.86, p = 0.019) and men (OR = 4.73, p &lt; 0.001). BMD at any site, however, was not significantly associated with the presence of prevalent VFs in T2DM patients, in contrast to the significant association in controls (at least p = 0.010). Comparison of T2DM patients with and without VFs showed no significant differences in BMD values, bone markers, or diabetes status. Receiver operating characteristic analysis showed that the absolute L-, FN-, and R-BMD values for detecting prevalent VFs were higher in T2DM patients than controls, whereas their sensitivity and specificity were lower. T2DM patients may have an increased risk of VFs independent of BMD or diabetic complication status, suggesting that bone quality may define bone fragility in T2DM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Shimane, Japan. masa-ya@med.shimane-u.ac.jp</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Toru</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Yamauchi</LastName><ForeName>Mika</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kaji</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Sugimoto</LastName><ForeName>Toshitsugu</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Bone Miner Res</MedlineTA><NlmUniqueID>8610640</NlmUniqueID><ISSNLinking>0884-0431</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>12</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>7</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>12</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19049338</ArticleId><ArticleId IdType="doi">10.1359/jbmr.081207</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>